index,trialid,source_register,date_registration,date_enrollement,retrospective_registration,normed_spon_names,recruitment_status,phase,study_type,countries,public_title,study_category,intervention,intervention_list,target_enrollment,web_address,cross_registrations
0,NCT04246242,ClinicalTrials.gov,2020-01-27,2020-01-25,True,Xiangya Hospital of Central South University,Not Recruiting,Phase 4,Interventional,No Country Given,A Randomized Multicenter Controlled Clinical Trial of Arbidol in Patients With 2019 Novel Coronavirus (2019-nCoV),Drug,Umifenovir,Umifenovir,500,https://clinicaltrials.gov/show/NCT04246242,None
1,NCT04252885,ClinicalTrials.gov,2020-01-30,2020-01-28,True,Guangzhou 8th People's Hospital,Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Drug,Lopinavir/ritonavir vs. umifenovir,Lopinavir/ritonavir; Umifenovir,125,https://clinicaltrials.gov/show/NCT04252885,None
2,NCT04255940,ClinicalTrials.gov,2020-02-03,2020-01-20,True,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Observational,China,2019-nCoV Outbreak and Cardiovascular Diseases,Clinical Presentation,No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04255940,None
3,NCT04260308,ClinicalTrials.gov,2020-02-03,2020-02-03,False,Huazhong University of Science and Technology,Recruiting,Not Applicable,Observational,China,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,Other (psych),No Intervention,No Intervention,30000,https://clinicaltrials.gov/show/NCT04260308,None
4,NCT04260594,ClinicalTrials.gov,2020-02-06,2020-02-07,False,Jieming QU,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Drug,Umifenovir,Umifenovir,380,https://clinicaltrials.gov/show/NCT04260594,None
5,NCT04261426,ClinicalTrials.gov,2020-02-06,2020-02-10,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,ATMP,Immunoglobulin,Immunoglobulin,80,https://clinicaltrials.gov/show/NCT04261426,None
6,NCT04261907,ClinicalTrials.gov,2020-02-06,2020-02-07,False,The First Affiliated Hospital of Zhejiang University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Drug,SC09 + ritonavir vs. lopinavir/ritonavir,ASC09; lopinavir/ritonavir,160,https://clinicaltrials.gov/show/NCT04261907,None
7,ChiCTR2000029953,ChiCTR,2020-02-17,2020-02-01,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Construction and Analysis of Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=49217,None
8,ChiCTR2000029949,ChiCTR,2020-02-16,2020-02-16,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,Oxygen,40,http://www.chictr.org.cn/showproj.aspx?proj=49181,None
9,ChiCTR2000029947,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49599,None
10,ChiCTR2000029941,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49596,None
11,ChiCTR2000029939,ChiCTR,2020-02-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",Drug,Chloroquine,Chloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49612,None
12,ChiCTR2000029935,ChiCTR,2020-02-16,2020-02-06,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),Drug,Chloroquine,Chloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49607,None
13,ChiCTR2000029907,ChiCTR,2020-02-16,2020-02-16,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Study for construction and assessment of early warning score of the clinical risk of novel coronavirus (COVID-19) infected patients,Clinical Presentation,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=49587,None
14,ChiCTR2000029905,ChiCTR,2020-02-16,2020-02-10,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,A medical records based study of novel coronavirus pneumonia (COVID-19) and influenza virus co-infection,Clinical Presentation,No Intervention,No Intervention,271,http://www.chictr.org.cn/showproj.aspx?proj=49595,None
15,ChiCTR2000029896,ChiCTR,2020-02-16,2020-01-31,True,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49432,None
16,ChiCTR2000029883,ChiCTR,2020-02-16,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study on the sensitivity of nasopharyngeal and oropharyngeal swabbing for the detection of SARS-CoV-2 by real-time PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=49549,None
17,ChiCTR2000029870,ChiCTR,2020-02-15,2020-02-15,False,Jiangsu Institute of Parasitic Diseases,Recruiting,Not Applicable,Diagnostic test,China,Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel Coronavirus Pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://www.chictr.org.cn/showproj.aspx?proj=49563,None
18,ChiCTR2000029869,ChiCTR,2020-02-15,2020-02-10,True,Huangshi Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49486,None
19,ChiCTR2000029867,ChiCTR,2020-02-15,2020-02-15,False,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Drug,Carrimycin vs. lopinavir/ritonavir,Carrimycin; lopinavir; ritonavir,520,http://www.chictr.org.cn/showproj.aspx?proj=49514,None
20,ChiCTR2000029855,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,180,http://www.chictr.org.cn/showproj.aspx?proj=49543,None
21,ChiCTR2000029853,ChiCTR,2020-02-15,2020-02-16,False,People's Hospital of Guangshan County,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,20,http://www.chictr.org.cn/showproj.aspx?proj=49532,None
22,ChiCTR2000029850,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,20,http://www.chictr.org.cn/showproj.aspx?proj=49533,None
23,ChiCTR2000029849,ChiCTR,2020-02-15,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Intestinal microbiome,Intestinal microbiome,60,http://www.chictr.org.cn/showproj.aspx?proj=49530,None
24,ChiCTR2000029839,ChiCTR,2020-02-15,2020-02-10,True,Ningbo First Hospital,Recruiting,Not Applicable,Observational,China,"An observational study on the clinical characteristics, treatment and outcome of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49439,None
25,ChiCTR2000029822,ChiCTR,2020-02-14,2020-02-07,True,Nanjing Second Hospital,Recruiting,Not Applicable,Interventional,No Country Given,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://www.chictr.org.cn/showproj.aspx?proj=49502,None
26,ChiCTR2000029821,ChiCTR,2020-02-14,2020-02-14,False,Deyang Integrated Traditional Chinese and Western Medicine Hospital,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49306,None
27,ChiCTR2000029819,ChiCTR,2020-02-14,2020-02-11,True,"Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University",Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.chictr.org.cn/showproj.aspx?proj=49490,None
28,ChiCTR2000029815,ChiCTR,2020-02-14,2020-02-01,True,Guangdong Provincial Hospital of Chinese Medicine,Recruiting,Not Applicable,Observational,China,Psychological survey of frontline medical staff in various regions of China during the epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,800,http://www.chictr.org.cn/showproj.aspx?proj=49346,None
29,ChiCTR2000029814,ChiCTR,2020-02-14,2020-02-14,False,Children's Hospital of Fudan University,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,30,http://www.chictr.org.cn/showproj.aspx?proj=49387,None
30,ChiCTR2000029813,ChiCTR,2020-02-14,2020-02-14,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=49425,None
31,ChiCTR2000029811,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49355,None
32,ChiCTR2000029810,ChiCTR,2020-02-14,2020-02-16,False,Shenzhen Second People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,http://www.chictr.org.cn/showproj.aspx?proj=49407,None
33,ChiCTR2000029806,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),Drug,PD1 vs. thymosin,PD1; Thymosin,120,http://www.chictr.org.cn/showproj.aspx?proj=49161,None
34,ChiCTR2000029805,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of severe novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49188,None
35,ChiCTR2000029804,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Prognosis,China,Clinical Application of ECMO in the Treatment of Patients with Very Serious Respiratory Failure due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,Oxygen,100,http://www.chictr.org.cn/showproj.aspx?proj=49178,None
36,ChiCTR2000029790,ChiCTR,2020-02-13,2020-02-17,False,Shanghai Pulmonary Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49453,None
37,ChiCTR2000029789,ChiCTR,2020-02-13,2020-02-15,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49348,None
38,ChiCTR2000029788,ChiCTR,2020-02-13,2020-03-01,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49452,None
39,ChiCTR2000029782,ChiCTR,2020-02-13,2020-01-30,True,Zhejiang Provincial People's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study for the changes in mental state of medical staff in the department of radiotherapy in a comprehensive tertiary hospital in Zhejiang Province during the epidemic of novel coronavirus infection (COVID-19),Other (psych),No Intervention,No Intervention,27,http://www.chictr.org.cn/showproj.aspx?proj=49445,None
40,ChiCTR2000029779,ChiCTR,2020-02-13,2020-02-14,False,Wuxi People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging,Clinical Presentation,No Intervention,No Intervention,0,http://www.chictr.org.cn/showproj.aspx?proj=49378,None
41,ChiCTR2000029778,ChiCTR,2020-02-13,2020-02-14,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,600,http://www.chictr.org.cn/showproj.aspx?proj=49422,None
42,ChiCTR2000029777,ChiCTR,2020-02-13,2020-02-05,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49380,None
43,ChiCTR2000029776,ChiCTR,2020-02-13,2020-02-11,True,The First Affiliated Hospital of Wenzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Polyinosinic-polycytidylic acid,Polyinosinic-polycytidylic acid,40,http://www.chictr.org.cn/showproj.aspx?proj=49342,None
44,ChiCTR2000029769,ChiCTR,2020-02-13,2020-02-15,False,Enze Hospital of Taizhou Enze Medical Center (Group),Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=49415,None
45,ChiCTR2000029768,ChiCTR,2020-02-13,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",Drug,Diammonium glycyrrhizinate + Vitamin C,Diammonium glycyrrhizinate; Vitamin C,60,http://www.chictr.org.cn/showproj.aspx?proj=49131,None
46,ChiCTR2000029765,ChiCTR,2020-02-13,2020-02-10,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,Tocilizumab,188,http://www.chictr.org.cn/showproj.aspx?proj=49409,None
47,ChiCTR2000029764,ChiCTR,2020-02-13,2020-02-16,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Imaging Features and Mechanisms of Novel Coronavirus Pneumonia (COVID-19): a Multicenter Study,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49388,None
48,ChiCTR2000029763,ChiCTR,2020-02-12,2020-02-13,False,China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,408,http://www.chictr.org.cn/showproj.aspx?proj=49408,None
49,ChiCTR2000029758,ChiCTR,2020-02-12,2020-02-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill Patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49295,None
50,ChiCTR2000029756,ChiCTR,2020-02-12,2020-02-15,False,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,238,http://www.chictr.org.cn/showproj.aspx?proj=49222,None
51,ChiCTR2000029754,ChiCTR,2020-02-12,2020-02-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Study for the Effect of Novel Coronavirus Pneumonia (COVID-19) on the Health of Different People,Clinical Presentation,No Intervention,No Intervention,1500,http://www.chictr.org.cn/showproj.aspx?proj=49370,None
52,ChiCTR2000029751,ChiCTR,2020-02-12,2020-02-01,True,The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,350,http://www.chictr.org.cn/showproj.aspx?proj=49354,None
53,ChiCTR2000029747,ChiCTR,2020-02-11,2020-02-11,False,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49287,None
54,ChiCTR2000029742,ChiCTR,2020-02-11,2020-02-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://www.chictr.org.cn/showproj.aspx?proj=49297,None
55,ChiCTR2000029741,ChiCTR,2020-02-11,2020-02-12,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",Drug,Lopinavir/ritonavir vs. chloroquine,Lopinavir/ritonavir; Chloroquine,112,http://www.chictr.org.cn/showproj.aspx?proj=49263,None
56,ChiCTR2000029739,ChiCTR,2020-02-11,2020-02-12,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydrogen + Oxygen vs Oxygen,Hydrogen; Oxygen,440,http://www.chictr.org.cn/showproj.aspx?proj=49283,None
57,ChiCTR2000029735,ChiCTR,2020-02-10,2020-01-26,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=49279,None
58,ChiCTR2000029734,ChiCTR,2020-02-10,2020-02-08,True,The First People's Hospital of Huaihua,Recruiting,Not Applicable,Observational,China,Epidemiological investigation and clinical characteristics analysis of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=48868,None
59,ChiCTR2000029732,ChiCTR,2020-02-10,2020-02-10,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Impact of vitamin D deficiency on prognosis of patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,156,http://www.chictr.org.cn/showproj.aspx?proj=49302,None
60,ChiCTR2000029695,ChiCTR,2020-02-10,2020-03-01,False,Shenzhen Third People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled Breath,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,http://www.chictr.org.cn/showproj.aspx?proj=49219,None
61,ChiCTR2000029656,ChiCTR,2020-02-09,2020-02-14,False,Wuhan Pulmonary Hosptial,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Corticosteroids,Methylprednisolone,100,http://www.chictr.org.cn/showproj.aspx?proj=49086,None
62,ChiCTR2000029639,ChiCTR,2020-02-08,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",Other (psych),No Intervention,No Intervention,192,http://www.chictr.org.cn/showproj.aspx?proj=49187,None
63,ChiCTR2000029637,ChiCTR,2020-02-08,2020-02-07,True,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,An observational study for Xin-Guan-1 formula  in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49127,None
64,ChiCTR2000029636,ChiCTR,2020-02-08,2020-02-09,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,ATMP,Vaccine,Vaccine,40,http://www.chictr.org.cn/showproj.aspx?proj=49215,None
65,ChiCTR2000029628,ChiCTR,2020-02-07,2020-02-07,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A clinical observational study for Xin-Guan-2 formula in the treatment of suspected novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49155,None
66,ChiCTR2000029626,ChiCTR,2020-02-07,2020-02-17,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Basic Science,China,Immune Repertoire (TCR & BCR) Evaluation and Immunotherapy Research in Peripheral Blood of Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=49170,None
67,ChiCTR2000029625,ChiCTR,2020-02-07,2020-02-17,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Diagnostic test,China,Construction of Early Warning and Prediction System for Patients with Severe / Critical Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=49177,None
68,ChiCTR2000029624,ChiCTR,2020-02-07,2020-02-08,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A real world study for traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,500,http://www.chictr.org.cn/showproj.aspx?proj=49132,None
69,ChiCTR2000029621,ChiCTR,2020-02-07,2020-02-07,False,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Umifenovir,Umifenovir,380,http://www.chictr.org.cn/showproj.aspx?proj=49165,None
70,ChiCTR2000029609,ChiCTR,2020-02-06,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine vs. lopinavir/ritonavir,Chloroquine; lopinavir; ritonavir,205,http://www.chictr.org.cn/showproj.aspx?proj=49145,None
71,ChiCTR2000029606,ChiCTR,2020-02-07,2020-01-25,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (stem cells),Cells (stem cells),63,http://www.chictr.org.cn/showproj.aspx?proj=49146,None
72,ChiCTR2000029603,ChiCTR,2020-02-06,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",Drug,ASCO9 + Ritonavir vs. Lopinavir/ritonavir,ASC09; Ritonavir; Lopinavir/ritonavir,160,http://www.chictr.org.cn/showproj.aspx?proj=49075,None
73,ChiCTR2000029602,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=48985,None
74,ChiCTR2000029601,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=48988,None
75,ChiCTR2000029600,ChiCTR,2020-02-06,2020-01-30,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Favipiravir + interferon alpha vs. interferon alpha + Lopinavir/ritonavir + interferon alpha vs. interferon alpha,Favipiravir; interferon alpha; Lopinavir/ritonavir,90,http://www.chictr.org.cn/showproj.aspx?proj=49042,None
76,ChiCTR2000029578,ChiCTR,2020-02-05,2020-02-06,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=49080,None
77,ChiCTR2000029572,ChiCTR,2020-02-05,2020-02-05,False,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,ATMP,Cells (mononuclear),Cells (mononuclear),30,http://www.chictr.org.cn/showproj.aspx?proj=41760,None
78,ChiCTR2000029569,ChiCTR,2020-02-04,2020-02-05,False,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,ATMP,Cells (mononuclear),Cells (mononuclear),30,http://www.chictr.org.cn/showproj.aspx?proj=49062,None
79,ChiCTR2000029559,ChiCTR,2020-02-04,2020-01-31,True,Renmin Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,300,http://www.chictr.org.cn/showproj.aspx?proj=48880,None
80,ChiCTR2000029558,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48792,None
81,ChiCTR2000029548,ChiCTR,2020-02-04,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Baloxavir + Marboxil vs. Favipiravir vs. Lopinavir/ritonavir,Baloxavir; Marboxil; Favipiravir; Lopinavir/ritonavir,30,http://www.chictr.org.cn/showproj.aspx?proj=49015,None
82,ChiCTR2000029544,ChiCTR,2020-02-03,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",Drug,Baloxavir + Marboxil vs. Favipiravir,Baloxavir; Marboxil; Favipiravir,30,http://www.chictr.org.cn/showproj.aspx?proj=49013,None
83,ChiCTR2000029542,ChiCTR,2020-02-03,2020-02-03,False,Sun Yat sen Memorial Hospital of Sun Yat sen University,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,20,http://www.chictr.org.cn/showproj.aspx?proj=48968,None
84,ChiCTR2000029541,ChiCTR,2020-02-03,2020-02-10,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Darunavir + Cobicistat vs. Lopinavir/ritonavir,Darunavir; Cobicistat; Lopinavir/ritonavir,100,http://www.chictr.org.cn/showproj.aspx?proj=48992,None
85,ChiCTR2000029539,ChiCTR,2020-02-03,2020-02-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,Lopinavir; Ritonavir,328,http://www.chictr.org.cn/showproj.aspx?proj=48991,None
86,ChiCTR2000029518,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,140,http://www.chictr.org.cn/showproj.aspx?proj=48860,None
87,ChiCTR2000029517,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48861,None
88,ChiCTR2000029495,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,90,http://www.chictr.org.cn/showproj.aspx?proj=48971,None
89,ChiCTR2000029493,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48931,None
90,ChiCTR2000029487,ChiCTR,2020-02-02,2020-02-10,False,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48965,None
91,ChiCTR2000029468,ChiCTR,2020-02-02,2020-02-01,True,"Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences",Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir + emtricitabine + tenofovir vs. lopinavir/ritonavir,Lopinavir/ritonavir; Emtricitabine; Tenofovir,120,http://www.chictr.org.cn/showproj.aspx?proj=48919,None
92,ChiCTR2000029462,ChiCTR,2020-02-02,2020-02-01,True,The First Affiliated Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48922,None
93,ChiCTR2000029461,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48927,None
94,ChiCTR2000029460,ChiCTR,2020-02-02,2020-02-02,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (exercise),Exercise,Exercise,100,http://www.chictr.org.cn/showproj.aspx?proj=48930,None
95,ChiCTR2000029459,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.chictr.org.cn/showproj.aspx?proj=48929,None
96,ChiCTR2000029439,ChiCTR,2020-02-01,2020-02-02,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=48904,None
97,ChiCTR2000029438,ChiCTR,2020-02-01,2020-02-04,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48911,None
98,ChiCTR2000029437,ChiCTR,2020-02-01,2020-02-03,False,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=48913,None
99,ChiCTR2000029436,ChiCTR,2020-02-01,2020-02-01,False,The First Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48884,None
100,ChiCTR2000029435,ChiCTR,2020-02-01,2020-02-01,False,Wuhan First Hospital,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=48827,None
101,ChiCTR2000029432,ChiCTR,2020-02-01,2020-02-01,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=48881,None
102,ChiCTR2000029431,ChiCTR,2020-02-01,2020-01-29,True,Affiliated Zhongshan Hospital of Dalian University,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,45,http://www.chictr.org.cn/showproj.aspx?proj=48907,None
103,ChiCTR2000029430,ChiCTR,2020-02-01,2020-02-03,False,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the TCM syndrome characteristics of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,600,http://www.chictr.org.cn/showproj.aspx?proj=48902,None
104,ChiCTR2000029418,ChiCTR,2020-01-30,2020-02-03,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://www.chictr.org.cn/showproj.aspx?proj=48886,None
105,ChiCTR2000029400,ChiCTR,2020-01-29,2020-01-29,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=48824,None
106,ChiCTR2000029381,ChiCTR,2020-01-27,2020-01-24,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=48768,None
107,NCT04268537,ClinicalTrials.gov,2020-02-08,2020-02-10,False,"Southeast University, China",Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,Drug,PD1 vs. thymosin,PD1; Thymosin,120,https://clinicaltrials.gov/show/NCT04268537,None
108,ChiCTR2000030188,ChiCTR,2020-02-24,2020-02-15,True,Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50025,None
109,ChiCTR2000030185,ChiCTR,2020-02-24,2020-02-24,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Diagnostic test,China,"The Value of Critical Care Ultrasound in Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive Prevention of Novel Coronavirus Pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,http://www.chictr.org.cn/showproj.aspx?proj=50058,None
110,ChiCTR2000030179,ChiCTR,2020-02-24,2020-02-24,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,100,http://www.chictr.org.cn/showproj.aspx?proj=50059,None
111,ChiCTR2000030173,ChiCTR,2020-02-24,2020-02-17,True,"Hunan yuanpin Cell Biotechnology Co., Ltd",Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,http://www.chictr.org.cn/showproj.aspx?proj=49229,None
112,ChiCTR2000030170,ChiCTR,2020-02-24,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),Drug,Jakotinib,Jakotinib,16,http://www.chictr.org.cn/showproj.aspx?proj=50017,None
113,ChiCTR2000030167,ChiCTR,2020-02-24,2020-03-02,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Interleukin-2,Interleukin-2,80,http://www.chictr.org.cn/showproj.aspx?proj=49567,None
114,ChiCTR2000030166,ChiCTR,2020-02-24,2020-02-25,False,The Fifth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=49696,None
115,ChiCTR2000030165,ChiCTR,2020-02-24,2020-02-24,False,Tianjin University,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,Ozone,60,http://www.chictr.org.cn/showproj.aspx?proj=49947,None
116,ChiCTR2000030164,ChiCTR,2020-02-24,2020-02-24,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Observational,China,A cross-sectional study of novel coronavirus pneumonia (COVID-19) patients in ICU,Clinical Presentation,No Intervention,No Intervention,10,http://www.chictr.org.cn/showproj.aspx?proj=49983,None
117,ChiCTR2000030138,ChiCTR,2020-02-24,2020-02-24,False,Chinese PLA General Hospital,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),60,http://www.chictr.org.cn/showproj.aspx?proj=50004,None
118,ChiCTR2000030137,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Observational,China,Humanistic Care in Healthcare Workers in Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,Humanistic Care,130,http://www.chictr.org.cn/showproj.aspx?proj=50007,None
119,ChiCTR2000030136,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,Humanistic Care,130,http://www.chictr.org.cn/showproj.aspx?proj=50005,None
120,ChiCTR2000030118,ChiCTR,2020-02-23,2020-02-24,False,Shenzhen National Medicine Inheritance Medical Research Institute co. LTD,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49594,None
121,ChiCTR2000030117,ChiCTR,2020-02-23,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,348,http://www.chictr.org.cn/showproj.aspx?proj=49762,None
122,ChiCTR2000030116,ChiCTR,2020-02-23,2020-02-01,True,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),16,http://www.chictr.org.cn/showproj.aspx?proj=49901,None
123,ChiCTR2000030115,ChiCTR,2020-02-23,2020-02-27,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A clinical research for the changes of Blood cortisol ACTH level and adrenal morphology in blood cortisol to guide the application of individualized hormone in severe novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,50,http://www.chictr.org.cn/showproj.aspx?proj=49964,None
124,ChiCTR2000030113,ChiCTR,2020-02-23,2020-02-22,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,Drug,Favipiravir vs. ritonavir,Favipiravir,30,http://www.chictr.org.cn/showproj.aspx?proj=49988,None
125,ChiCTR2000030102,ChiCTR,2020-02-23,2020-02-24,False,Tianjin Huanhu Hospital,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Ozone,Ozone,180,http://www.chictr.org.cn/showproj.aspx?proj=49747,None
126,ChiCTR2000030096,ChiCTR,2020-02-23,2020-02-17,True,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,Study for establishment of correlation between virological dynamics and clinical features in noveal coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=49794,None
127,ChiCTR2000030094,ChiCTR,2020-02-23,2020-03-01,False,Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Effects of novel coronavirus pneumonia (COVID-19) on menstruation, TCM body construction and psychological state for female at different ages",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49970,None
128,ChiCTR2000030093,ChiCTR,2020-02-23,2020-03-01,False,The Second Hospital of Shanxi Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=49932,None
129,ChiCTR2000030092,ChiCTR,2020-02-23,2020-02-12,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Assessment of cardiac function in patients with Novel Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques,Clinical Presentation,No Intervention,No Intervention,800,http://www.chictr.org.cn/showproj.aspx?proj=49880,None
130,ChiCTR2000030090,ChiCTR,2020-02-22,2020-02-22,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,Other (exercise),Exercise,Exercise,400,http://www.chictr.org.cn/showproj.aspx?proj=49910,None
131,ChiCTR2000030089,ChiCTR,2020-02-22,2020-02-28,False,Shanghai Changzheng Hospital,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Drug,Adalimumab,Adalimumab,60,http://www.chictr.org.cn/showproj.aspx?proj=49889,None
132,ChiCTR2000030088,ChiCTR,2020-02-22,2020-03-01,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),40,http://www.chictr.org.cn/showproj.aspx?proj=49902,None
133,ChiCTR2000030087,ChiCTR,2020-02-22,2020-02-12,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for the diagnostic value of pulmonary ultrasound for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,800,http://www.chictr.org.cn/showproj.aspx?proj=49919,None
134,ChiCTR2000030086,ChiCTR,2020-02-22,2020-02-24,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the effects on medical providers' infection rate and mental health after performing different anesthesia schemes in cesarean section for novel coronavirus pneumonia (COVID-19) puerperae,Clinical Presentation,No Intervention,No Intervention,210,http://www.chictr.org.cn/showproj.aspx?proj=49934,None
135,ChiCTR2000030084,ChiCTR,2020-02-22,2020-02-24,False,The First Hospital of Shanxi Medical University,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,Other (psych),Psychological,Psychological,180,http://www.chictr.org.cn/showproj.aspx?proj=49952,None
136,ChiCTR2000030058,ChiCTR,2020-02-22,2020-03-10,False,Renmin Hospital of Wuhan University,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Leflunomide,Leflunomide,200,http://www.chictr.org.cn/showproj.aspx?proj=49831,None
137,ChiCTR2000030056,ChiCTR,2020-02-22,2020-02-23,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the effect of early endotracheal intubation on the outcome of novel coronavirus pneumonia (COVID-19) patients,Other (physical),Endotracheal Intubation,Endotracheal Intubation,100,http://www.chictr.org.cn/showproj.aspx?proj=49904,None
138,ChiCTR2000030054,ChiCTR,2020-02-22,2020-02-22,False,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",Drug,Chloroquine + Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49869,None
139,ChiCTR2000030046,ChiCTR,2020-02-21,2020-02-07,True,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),ATMP,Plasma,Plasma,10,http://www.chictr.org.cn/showproj.aspx?proj=49861,None
140,ChiCTR2000030043,ChiCTR,2020-02-21,2020-02-21,False,Peking University Third Hospital,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49866,None
141,ChiCTR2000030041,ChiCTR,2020-02-21,2020-02-25,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,40,http://www.chictr.org.cn/showproj.aspx?proj=49891,None
142,ChiCTR2000030039,ChiCTR,2020-02-21,2020-05-31,False,Affiliated Hospital of Xuzhou Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,90,http://www.chictr.org.cn/showproj.aspx?proj=49544,None
143,ChiCTR2000030034,ChiCTR,2020-02-21,2020-02-07,True,Tongde Hospital of Zhejiang Province,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,132,http://www.chictr.org.cn/showproj.aspx?proj=49647,None
144,ChiCTR2000030033,ChiCTR,2020-02-21,2020-02-24,False,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,828,http://www.chictr.org.cn/showproj.aspx?proj=49703,None
145,ChiCTR2000030032,ChiCTR,2020-02-21,2020-02-10,True,Xi'an Chest Hospital,Recruiting,Not Applicable,Observational,China,Study on ultrasonographic manifestations of new type of novel coronavirus pneumonia (covid-19) in non-critical stage of pulmonary lesions,Clinical Presentation,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=49816,None
146,ChiCTR2000030030,ChiCTR,2020-02-20,2020-02-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for acute kidney injury in novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=49841,None
147,ChiCTR2000030029,ChiCTR,2020-02-21,2020-02-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),Drug,Suramin,Suramin,20,http://www.chictr.org.cn/showproj.aspx?proj=49824,None
148,ChiCTR2000030027,ChiCTR,2020-02-20,2020-02-20,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49852,None
149,ChiCTR2000030021,ChiCTR,2020-02-20,2020-02-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based analysis for the clinical characteristics of novel coronavirus pneumonia (COVID-19) in immunocompromised patients,Clinical Presentation,No Intervention,No Intervention,10,http://www.chictr.org.cn/showproj.aspx?proj=49690,None
150,ChiCTR2000030020,ChiCTR,2020-02-20,2020-02-06,True,"Second Hospital of University of South China, Hengyang",Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=49812,None
151,ChiCTR2000030019,ChiCTR,2020-02-20,2020-02-28,False,"Zhongshan Hospital, Fudan University",Not Recruiting,Not Applicable,Observational,China,"The COVID-19 Mobile Health Study (CMHS), a large-scale clinical observational registration study using nCapp",Clinical Presentation,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=49768,None
152,ChiCTR2000030017,ChiCTR,2020-02-20,2020-02-17,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Feature of Multiple Organs in Ultrasound Investigation for Clinical Management and Prognostic Evaluation of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49798,None
153,ChiCTR2000030016,ChiCTR,2020-02-19,2020-02-04,True,Guangxi Medical University,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),ATMP,Vaccine,Vaccine,60,http://www.chictr.org.cn/showproj.aspx?proj=49799,None
154,ChiCTR2000030015,ChiCTR,2020-02-20,2020-02-19,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Basic Science,China,Study for the correlation between the incidence and outcome of novel coronary pneumonia (COVID-2019) and ovarian function in women,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=49800,None
155,ChiCTR2000030012,ChiCTR,2020-02-19,2020-02-19,False,"The First People's Hospital of Chenzhou, Institute of Translational Medicine,University of South China",Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),ATMP,Antibody,Antibody,20,http://www.chictr.org.cn/showproj.aspx?proj=49718,None
156,ChiCTR2000030010,ChiCTR,2020-02-19,2020-02-19,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",ATMP,Plasma,Plasma,100,http://www.chictr.org.cn/showproj.aspx?proj=49777,None
157,ChiCTR2000030008,ChiCTR,2020-02-19,2020-02-12,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Correalation between anxiety as well as depression and gut microbiome among staff of hospital during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49426,None
158,ChiCTR2000030007,ChiCTR,2020-02-19,2020-02-03,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),Drug,G-CSF,G-CSF,200,http://www.chictr.org.cn/showproj.aspx?proj=49619,None
159,ChiCTR2000030006,ChiCTR,2020-02-19,2020-02-19,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,Ozone,60,http://www.chictr.org.cn/showproj.aspx?proj=49737,None
160,ChiCTR2000030004,ChiCTR,2020-02-19,2020-02-20,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Effect of Novel Coronavirus Pneumonia (COVID-19) on the Mental Health of College Students,Other (psych),No Intervention,No Intervention,150000,http://www.chictr.org.cn/showproj.aspx?proj=49783,None
161,ChiCTR2000030003,ChiCTR,2020-02-19,2020-02-19,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,480,http://www.chictr.org.cn/showproj.aspx?proj=49770,None
162,ChiCTR2000030002,ChiCTR,2020-02-19,2020-02-15,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Tranilast,Tranilast,60,http://www.chictr.org.cn/showproj.aspx?proj=49738,None
163,ChiCTR2000030001,ChiCTR,2020-02-19,2020-02-15,True,Health commission of Heilongjiang province,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",Drug,Triazavirin,Triazavirin,240,http://www.chictr.org.cn/showproj.aspx?proj=49723,None
164,ChiCTR2000030000,ChiCTR,2020-02-19,2020-02-16,True,The Ninth Hospital of Nanchang,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=49748,None
165,ChiCTR2000029999,ChiCTR,2020-02-19,2020-02-20,False,Shanghai 10th People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,Probiotics,60,http://www.chictr.org.cn/showproj.aspx?proj=49717,None
166,ChiCTR2000029996,ChiCTR,2020-02-20,2020-02-20,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",Drug,Favipiravir,Favipiravir,60,http://www.chictr.org.cn/showproj.aspx?proj=49510,None
167,ChiCTR2000029995,ChiCTR,2020-02-19,2020-02-20,False,Shanghai General Hospital of Shanghai Jiaotong University,Recruiting,Not Applicable,Observational,China,Study on anxiety of different populations under novel coronavirus (COVID-19) infection,Other (psych),No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49418,None
168,ChiCTR2000029994,ChiCTR,2020-02-18,2020-02-19,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49309,None
169,ChiCTR2000029992,ChiCTR,2020-02-18,2020-02-17,True,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine + Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49574,None
170,ChiCTR2000029990,ChiCTR,2020-02-18,2020-01-30,True,"Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),120,http://www.chictr.org.cn/showproj.aspx?proj=49674,None
171,ChiCTR2000029989,ChiCTR,2020-02-18,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),Drug,Interferon alfa,Interferon alfa,300,http://www.chictr.org.cn/showproj.aspx?proj=49720,None
172,ChiCTR2000029988,ChiCTR,2020-02-18,2020-02-13,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,80,http://www.chictr.org.cn/showproj.aspx?proj=49218,None
173,ChiCTR2000029985,ChiCTR,2020-02-18,2020-02-10,True,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Study for mental health status and influencing factors of nurses during epidemic prevention of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,1853,http://www.chictr.org.cn/showproj.aspx?proj=49711,None
174,ChiCTR2000029981,ChiCTR,2020-02-18,2020-02-18,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,Study for nucleic acid detection of novel coronavirus pneumonia (COVID-2019) in female vaginal secretions,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,http://www.chictr.org.cn/showproj.aspx?proj=49692,None
175,ChiCTR2000029978,ChiCTR,2020-02-18,2020-02-21,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=49702,None
176,ChiCTR2000029974,ChiCTR,2020-02-18,2020-02-09,True,"Qingdao East Sea Pharmaceutical Co., Ltd.",Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",Supplement,Probiotics,Probiotics,300,http://www.chictr.org.cn/showproj.aspx?proj=49321,None
177,ChiCTR2000029972,ChiCTR,2020-02-17,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Other (physical),Ultra short wave electrotherapy,Ultra short wave electrotherapy,40,http://www.chictr.org.cn/showproj.aspx?proj=49664,None
178,ChiCTR2000029960,ChiCTR,2020-02-17,2020-02-28,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49639,None
179,ChiCTR2000029959,ChiCTR,2020-02-17,2020-01-25,True,"West China Second Hospital, Sichuan University",Recruiting,Not Applicable,Observational,China,Clinical observation and research of  Severe acute respiratory syndrome coronavirus 2(COVID-19) infection in perinatal newborns,Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=49636,None
180,ChiCTR2000029956,ChiCTR,2020-02-17,2020-02-18,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49618,None
181,ChiCTR2000029954,ChiCTR,2020-02-17,2020-04-30,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49402,None
182,ChiCTR2000029866,ChiCTR,2020-02-15,2020-02-17,False,Enze Hospital of Taizhou Enze Medical Center (Group),Recruiting,Not Applicable,Diagnostic test,China,Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics,Genomics,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=49519,None
183,ChiCTR2000029865,ChiCTR,2020-02-15,2020-02-20,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Descriptive study on the clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in cardiovascular patients,Prognosis,No Intervention,No Intervention,1200,http://www.chictr.org.cn/showproj.aspx?proj=49545,None
184,ChiCTR2000029851,ChiCTR,2020-02-15,2020-02-19,False,"Zhongshan Hospital, Fudan University",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",Supplement,Alpha lipoic acid,Alpha lipoic acid,68,http://www.chictr.org.cn/showproj.aspx?proj=49534,None
185,ChiCTR2000029803,ChiCTR,2020-02-14,2020-02-20,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydroxychloroquine vs. Umeprevir,Hydroxychloroquine; Umeprevir,320,http://www.chictr.org.cn/showproj.aspx?proj=49428,None
186,ChiCTR2000029781,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49138,None
187,ChiCTR2000029780,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49220,None
188,ChiCTR2000029740,ChiCTR,2020-02-11,2020-02-11,False,The First Hospital of Peking University,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),Drug,Hydroxychloroquine,Hydroxychloroquine,78,http://www.chictr.org.cn/showproj.aspx?proj=49317,None
189,NCT04270383,ClinicalTrials.gov,2020-02-11,2020-02-15,False,Beijing Children's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04270383,None
190,NCT04273529,ClinicalTrials.gov,2020-02-14,2020-02-20,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Drug,Thalidomide,Thalidomide,100,https://clinicaltrials.gov/show/NCT04273529,None
191,NCT04273581,ClinicalTrials.gov,2020-02-14,2020-02-18,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Drug,Thalidomide + Corticosteroids,Thalidomide; Methylprednisolone,40,https://clinicaltrials.gov/show/NCT04273581,None
192,NCT04275245,ClinicalTrials.gov,2020-02-06,2020-02-03,True,Tang-Du Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Drug,Mepolizumab,Mepolizumab,20,https://clinicaltrials.gov/show/NCT04275245,None
193,NCT04275947,ClinicalTrials.gov,2020-02-17,2020-02-14,True,Chinese Alliance Against Lung Cancer,Recruiting,Not Applicable,Observational,China,The COVID-19 Mobile Health Study (CMHS),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,450,https://clinicaltrials.gov/show/NCT04275947,None
194,NCT04279197,ClinicalTrials.gov,2020-02-15,2020-02-15,False,ShuGuang Hospital,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,136,https://clinicaltrials.gov/show/NCT04279197,None
195,NCT04279782,ClinicalTrials.gov,2020-02-15,2020-01-20,True,The Third Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04279782,None
196,NCT04279795,ClinicalTrials.gov,2020-02-19,2020-01-20,True,The Third Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04279795,None
197,NCT04279899,ClinicalTrials.gov,2020-02-18,2020-02-01,True,Children's Hospital of Fudan University,Recruiting,Not Applicable,Observational,China,The Investigation of the Neonates With or With Risk of COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04279899,None
198,NCT04280588,ClinicalTrials.gov,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,Drug,Fingolimod,Fingolimod,30,https://clinicaltrials.gov/show/NCT04280588,None
199,ChiCTR2000030442,ChiCTR,2020-03-02,2020-03-05,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",Drug (+ ATMP + Other (renal)),Tocilizumab + immunoglobulin + renal replacement therapy,Tocilizumab; Immunoglobulin; Renal replacement therapy,100,http://www.chictr.org.cn/showproj.aspx?proj=50380,None
200,ChiCTR2000030433,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50273,None
201,ChiCTR2000030432,ChiCTR,2020-03-01,2020-03-02,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50268,None
202,ChiCTR2000030424,ChiCTR,2020-03-01,2020-03-02,False,Henan Provincial People's Hospital,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,30,http://www.chictr.org.cn/showproj.aspx?proj=50174,None
203,ChiCTR2000030420,ChiCTR,2020-03-01,2020-03-01,False,"Institute of Integrative Medicine of Dalian Medical University, Dalian, China",Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=50286,None
204,ChiCTR2000030418,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50341,None
205,ChiCTR2000030398,ChiCTR,2020-03-01,2020-02-27,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",Drug,Bismuth potassium citrate,Bismuth potassium citrate,340,http://www.chictr.org.cn/showproj.aspx?proj=50173,None
206,ChiCTR2000030391,ChiCTR,2020-03-01,2020-03-01,False,Lishui Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=30796,None
207,ChiCTR2000030390,ChiCTR,2020-03-01,2020-01-01,True,Key Laboratory of Ministry of Industry and Information Technology of Biomedical Engineering and Translational Medicine,Recruiting,Not Applicable,Diagnostic test,China,Research and Development of Diagnostic Assistance Decision Support System for novel coronavirus pneumonia (COVID-19) Based on Big Data Technology,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3000,http://www.chictr.org.cn/showproj.aspx?proj=50224,None
208,ChiCTR2000030389,ChiCTR,2020-03-01,2020-02-29,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50278,None
209,ChiCTR2000030387,ChiCTR,2020-03-01,2020-03-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical observation and research of multiple organs injury in severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,130,http://www.chictr.org.cn/showproj.aspx?proj=50329,None
210,ChiCTR2000030386,ChiCTR,2020-02-18,2020-03-01,False,Hunan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=50323,None
211,ChiCTR2000030382,ChiCTR,2020-02-17,2020-03-01,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50325,None
212,ChiCTR2000030363,ChiCTR,2020-02-29,2020-02-23,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Novel Coronavirus Infected Disease (COVID-19) in children: epidemiology, clinical features and treatment outcome",Clinical Presentation (Epidemiology),No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=49984,None
213,ChiCTR2000030334,ChiCTR,2020-02-28,2020-02-19,True,Nanjing Second Hospital,Recruiting,Not Applicable,Diagnostic test,China,microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,25,http://www.chictr.org.cn/showproj.aspx?proj=49491,None
214,ChiCTR2000030333,ChiCTR,2020-02-28,2020-03-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label controlled trial for the efficacy and safety of Pirfenidone in patients with severe and critical novel coronavirus pneumonia (COVID-19)",Drug,Pirfenidone,Pirfenidone,292,http://www.chictr.org.cn/showproj.aspx?proj=48801,None
215,ChiCTR2000030327,ChiCTR,2020-02-28,2020-01-21,True,The Second Affiliated hospital of Anhui Medical University,Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50214,None
216,ChiCTR2000030325,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Observational,China,A survey of mental health of first-line medical service providers and construction of crisis intervention model for novel coronavirus pneumonia (COVID-19) in Xiangyang,Other (psych),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=50227,None
217,ChiCTR2000030324,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=50231,None
218,ChiCTR2000030322,ChiCTR,2020-02-28,2020-02-01,True,Xinyang Central Hospital,Recruiting,Not Applicable,Observational,China,Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,No Intervention,210,http://www.chictr.org.cn/showproj.aspx?proj=50240,None
219,ChiCTR2000030317,ChiCTR,2020-02-28,2020-03-01,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,Other (physical),Gastroscope mask,Gastroscope mask,300,http://www.chictr.org.cn/showproj.aspx?proj=50247,None
220,ChiCTR2000030315,ChiCTR,2020-02-28,2020-01-01,True,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50255,None
221,ChiCTR2000030314,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=50248,None
222,ChiCTR2000030305,ChiCTR,2020-02-28,2020-03-09,False,Li Caixia,Not Recruiting,Not Applicable,Observational,China,Multiomics study and emergency plan optimization of spleen strengthening clearing damp and stomach therapy combined with antiviral therapy for novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=50223,None
223,ChiCTR2000030293,ChiCTR,2020-02-27,2020-03-01,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Clinical observation and research plan of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=50195,None
224,ChiCTR2000030290,ChiCTR,2020-02-27,2020-02-11,True,Xiamen University,Not Recruiting,Not Applicable,Observational,China,Health related quality of life and its influencing factors among front line nurses caring patients with new coronavirus pneumonia (COVID-19) from two hospitals in China,Other (psych),No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=50175,None
225,ChiCTR2000030283,ChiCTR,2020-02-27,2020-02-27,False,Xianning Central Hospital,Recruiting,Not Applicable,Observational,China,Correlation between imaging characteristics and laboratory tests of new coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50119,None
226,ChiCTR2000030265,ChiCTR,2020-02-26,2020-02-24,True,The First Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),Other (renal),Renal replacement therapy,Renal replacement therapy,30,http://www.chictr.org.cn/showproj.aspx?proj=49691,None
227,ChiCTR2000030264,ChiCTR,2020-02-26,2020-02-28,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,ICU healthcare personnel burnout investigation during the fight against novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=50161,None
228,ChiCTR2000030263,ChiCTR,2020-02-26,2020-02-20,True,Beijing Geriatric Hospital,Not Recruiting,Not Applicable,Epidemiological research,China,Investigation and analysis of psychological status of hospital staff during the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50140,None
229,ChiCTR2000030261,ChiCTR,2020-02-26,2020-03-01,False,Wuxi Fifth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),26,http://www.chictr.org.cn/showproj.aspx?proj=49963,None
230,ChiCTR2000030260,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,Other (nutrition),Nutrition,Nutrition,20,http://www.chictr.org.cn/showproj.aspx?proj=50130,None
231,ChiCTR2000030259,ChiCTR,2020-02-26,2020-02-22,True,Shanghai Changzheng Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",Drug,Danoprevir + Ritonavir,Danoprevir; Ritonavir,60,http://www.chictr.org.cn/showproj.aspx?proj=49918,None
232,ChiCTR2000030258,ChiCTR,2020-02-26,2020-02-21,True,The Fourth Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Hydrogen,Hydrogen,60,http://www.chictr.org.cn/showproj.aspx?proj=49887,None
233,ChiCTR2000030257,ChiCTR,2020-02-26,2020-03-09,False,Puren Hospital of Wuhan City,Not Recruiting,Not Applicable,Observational,China,The coagulation function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50006,None
234,ChiCTR2000030255,ChiCTR,2020-02-26,2020-03-01,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=50089,None
235,ChiCTR2000030253,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Phase 1,Diagnostic test,China,Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.chictr.org.cn/showproj.aspx?proj=50143,None
236,ChiCTR2000030226,ChiCTR,2020-02-26,2020-02-01,True,The Fourth Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,China,"The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study",Prognosis,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=49855,None
237,ChiCTR2000030225,ChiCTR,2020-02-26,2020-02-22,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=49945,None
238,ChiCTR2000030223,ChiCTR,2020-02-26,2020-02-20,True,No Sponsor Name Given,Recruiting,Not Applicable,Health services research,China,Quality of life among Chinese residents during and after novel coronavirus pneumonia (COVID19) outbreak: an online survey,Other (psych),No Intervention,No Intervention,5000,http://www.chictr.org.cn/showproj.aspx?proj=50026,None
239,ChiCTR2000030222,ChiCTR,2020-02-25,2020-02-21,True,The Thirteenth People's Hospital of Chongqing,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of participants                                        Study for the Impact of Novel Coronavirus Pneumonia (COVID-19) to the Health of the elderly People,Cancelled,Cancelled,Cancelled,658,http://www.chictr.org.cn/showproj.aspx?proj=50048,None
240,ChiCTR2000030219,ChiCTR,2020-02-25,2020-01-21,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50110,None
241,ChiCTR2000030218,ChiCTR,2020-02-25,2020-01-22,True,The Fifth People's Hospital of Ganzhou,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),Drug,Lopinavir/ritonavir (+ Tradtional Medicine),Lopinavir; Ritonavir; Traditional Medicine,80,http://www.chictr.org.cn/showproj.aspx?proj=50115,None
242,ChiCTR2000030215,ChiCTR,2020-02-25,2020-02-26,False,"The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50107,None
243,ChiCTR2000030196,ChiCTR,2020-02-25,2020-02-20,True,Central South Hospital of Wuhan University,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,Tocilizumab,60,http://www.chictr.org.cn/showproj.aspx?proj=49883,None
244,ChiCTR2000030162,ChiCTR,2020-02-24,2020-03-01,False,Cancelled,Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                     Study for the water extract of soybean in the treatment of patients with novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49570,None
245,ChiCTR2000030091,ChiCTR,2020-02-23,2020-02-22,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),Other (exercise),Exercise,Exercise,200,http://www.chictr.org.cn/showproj.aspx?proj=49914,None
246,ChiCTR2000030042,ChiCTR,2020-02-21,2020-02-21,False,Chongqing Liangjiang New Area First People's Hospital,Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                                                                A Medical Records Based Study for Construction and Analysis of Diagnosis Predictive&,Cancelled,Cancelled,Cancelled,240,http://www.chictr.org.cn/showproj.aspx?proj=49899,None
247,ChiCTR2000030022,ChiCTR,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Anhui Medical University,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49797,None
248,ChiCTR2000030013,ChiCTR,2020-02-19,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,Drug,Interferon alfa,Interferon alfa,450,http://www.chictr.org.cn/showproj.aspx?proj=49796,None
249,ChiCTR2000029991,ChiCTR,2020-02-18,2020-02-18,False,The First Affiliated Hospital of Nanchang University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=49666,None
250,ChiCTR2000029975,ChiCTR,2020-02-18,2020-02-24,False,The First Hospital of Jilin University,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,10,http://www.chictr.org.cn/showproj.aspx?proj=49592,None
251,ChiCTR2000029952,ChiCTR,2020-02-17,2020-02-17,False,Chongqing Three Gorges Central Hospital,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                         Medical records based study for epidemiological and clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Chongqing,Cancelled,Cancelled,Cancelled,0,http://www.chictr.org.cn/showproj.aspx?proj=49630,None
252,ChiCTR2000029900,ChiCTR,2020-02-16,2020-02-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Research for Risks Associated with Novel Coronavirus Pneumonia (COVID-19) in the Hospital Workers and Nosocomial  Prevention and Control Strategy,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49377,None
253,ChiCTR2000029899,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49536,None
254,ChiCTR2000029898,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49482,None
255,ChiCTR2000029829,ChiCTR,2020-02-15,2020-02-15,False,Chongqing Three Gorges Central Hospital,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                                 Medical records based study for Heart-type fatty acid-binding protein on prognosis of novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,40,http://www.chictr.org.cn/showproj.aspx?proj=49520,None
256,ChiCTR2000029762,ChiCTR,2020-02-12,2020-02-12,False,The First Affiliated Hospital of Chongqing Medical University,Not Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                                                                              Clinical study for the effect and,Cancelled,Cancelled,Cancelled,60,http://www.chictr.org.cn/showproj.aspx?proj=49404,None
257,ChiCTR2000029761,ChiCTR,2020-02-12,2020-02-13,False,The First Affiliated Hospital of Chongqing Medical University,Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                Clinical study on the safety and effectiveness of Hydroxychloroquine Sulfate tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,240,http://www.chictr.org.cn/showproj.aspx?proj=49400,None
258,ChiCTR2000029760,ChiCTR,2020-02-12,2020-02-12,False,The Second Affiliated Hospital of Chongqing Medical University,Not Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                              A study for the efficacy of hydroxychloroquine for mild and moderate COVID-19 infectious diseases,Cancelled,Cancelled,Cancelled,240,http://www.chictr.org.cn/showproj.aspx?proj=49369,None
259,ChiCTR2000029759,ChiCTR,2020-02-12,2020-02-15,False,The Second Affiliated Hospital of Chongqing Medical University,Not Recruiting,Not Applicable,Interventional,China,"Retracted due to lack of patient                               A multicenter, randomized, open label, controlled trial for the efficacy and safety of ASC09/ Ritonavir compound tablets and Lopinavir/ Ritonavir (Kaletra) and Arbidol tablets in the treatm",Cancelled,Cancelled,Cancelled,60,http://www.chictr.org.cn/showproj.aspx?proj=49352,None
260,ChiCTR2000029755,ChiCTR,2020-02-12,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49301,None
261,ChiCTR2000029728,ChiCTR,2020-02-10,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,500,http://www.chictr.org.cn/showproj.aspx?proj=49250,None
262,ChiCTR2000029387,ChiCTR,2020-01-29,2020-01-25,True,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",Drug,"Ribavirin + Interferon alfa
vs. lopinavir/ritonavir + interferon alfa
vs. ribavirin + interferon alfa vs. lopinavir/ritonavir",Ribavirin; Interferon alpha; Lopinavir; Ritonavir,108,http://www.chictr.org.cn/showproj.aspx?proj=48782,None
263,ChiCTR2000029386,ChiCTR,2020-01-29,2020-01-29,False,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,Drug,Corticosteroids,Methylprednisolone,48,http://www.chictr.org.cn/showproj.aspx?proj=48777,None
264,NCT04276987,ClinicalTrials.gov,2020-02-16,2020-02-15,True,Ruijin Hospital,Not Recruiting,Phase 1,Interventional,No Country Given,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04276987,None
265,NCT04281693,ClinicalTrials.gov,2020-02-20,2020-02-01,True,Affiliated Hospital to Academy of Military Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04281693,None
266,NCT04282902,ClinicalTrials.gov,2020-02-10,2020-02-04,True,Huilan Zhang,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Drug,Pirfenidone,Pirfenidone,294,https://clinicaltrials.gov/show/NCT04282902,None
267,NCT04284046,ClinicalTrials.gov,2020-02-22,2020-01-31,True,Shanghai General Hospital of Shanghai Jiaotong University,Not Recruiting,Not Applicable,Observational,China,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Prognosis,No Intervention,No Intervention,39,https://clinicaltrials.gov/show/NCT04284046,None
268,NCT04286503,ClinicalTrials.gov,2020-02-25,2020-02-23,True,"Beijing You'an Hospital, Capital Medical University",Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Drug,Carrimycin vs. lopinavir/ritonavir or Umifenovir or chloroquine,Carrimycin; lopinavir; ritonavir; Umifenovir; chloroquine,520,https://clinicaltrials.gov/show/NCT04286503,None
269,ChiCTR2000030627,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,ATMP,Plasma,Plasma,30,http://www.chictr.org.cn/showproj.aspx?proj=50727,None
270,ChiCTR2000030593,ChiCTR,2020-03-08,2020-03-10,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Observational,China,"Novel coronavirus pneumonia (COVID-19) antiviral related liver dysfunction: a multicenter, retrospective, observational study",Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=50228,None
271,ChiCTR2000030581,ChiCTR,2020-03-08,2020-02-02,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,The immediate psychological impact of novel coronavirus pneumonia (COVID-19) outbreak on medical students in anesthesiology and how the cope,Other (psych),No Intervention,No Intervention,192,http://www.chictr.org.cn/showproj.aspx?proj=50394,None
272,ChiCTR2000030579,ChiCTR,2020-03-08,2020-02-15,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Risk Factors for Outcomes of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50692,None
273,ChiCTR2000030578,ChiCTR,2020-03-08,2020-03-07,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=50690,None
274,ChiCTR2000030574,ChiCTR,2020-03-07,2020-03-08,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Research on peripheral immunity function monitoring and its clinical application in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=49953,None
275,ChiCTR2000030564,ChiCTR,2020-03-07,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Psychological Intervention of Children with Novel Coronavirus Disease (COVID-19),Other (psych),Psychological,Psychological,120,http://www.chictr.org.cn/showproj.aspx?proj=50653,None
276,ChiCTR2000030559,ChiCTR,2020-03-07,2020-03-07,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based study for the safety of artificial liver cluster nursing in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,12,http://www.chictr.org.cn/showproj.aspx?proj=50583,None
277,ChiCTR2000030557,ChiCTR,2020-03-07,2020-03-10,False,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Observational,China,"A retrospective study on virus typing, Hematological Immunology and case Review of novel coronavirus infected and convalescent patients (COVID-19)",Clinical Presentation,No Intervention,No Intervention,1030,http://www.chictr.org.cn/showproj.aspx?proj=50667,None
278,ChiCTR2000030556,ChiCTR,2020-03-07,2020-03-15,False,Anhui Cancer Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study of nano-nose and its extended technology in diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=50672,None
279,ChiCTR2000030552,ChiCTR,2020-03-07,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Critical ultrasound in evaluating cardiopulmonary function in critical patients infected with 2019 novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,70,http://www.chictr.org.cn/showproj.aspx?proj=49708,None
280,ChiCTR2000030544,ChiCTR,2020-03-06,2020-02-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the risk factors of critically ill patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,1500,http://www.chictr.org.cn/showproj.aspx?proj=50134,None
281,ChiCTR2000030543,ChiCTR,2020-03-06,2020-02-14,True,Central Theater General Hospital of PLA,Recruiting,Not Applicable,Observational,China,Detection of coronavirus in simultaneously collecting tears and throat swab samples collected from the patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,35,http://www.chictr.org.cn/showproj.aspx?proj=50541,None
282,ChiCTR2000030542,ChiCTR,2020-03-06,2020-03-09,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,"A clinical study about the diagnosis and prognosis evaluation of novel coronacirus pneumonia (COVID-19) based on viral genome, host genomic sequencing, relative cytokines and other laboratory indexes.",Genomics,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=50608,None
283,ChiCTR2000030541,ChiCTR,2020-03-06,2020-03-06,False,"Xiamen Medical College,Shijiazhuang Medical College",Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) epidemic survey of medical students in various provinces and municipalities throughout the country,Clinical Presentation,No Intervention,No Intervention,1300,http://www.chictr.org.cn/showproj.aspx?proj=50623,None
284,ChiCTR2000030540,ChiCTR,2020-03-06,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,Other (renal),Renal replacement therapy,Renal replacement therapy,152,http://www.chictr.org.cn/showproj.aspx?proj=50658,None
285,ChiCTR2000030535,ChiCTR,2020-03-06,2020-02-20,True,Wuhan Red Cross Hospital,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,Drug,Ebastine + Interferon alpha + Lopinavir vs. Interferon alpha + Lopinavir,Ebastine; interferon alpha; lopinavir,100,http://www.chictr.org.cn/showproj.aspx?proj=49790,None
286,ChiCTR2000030522,ChiCTR,2020-03-06,2020-03-09,False,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=44213,None
287,ChiCTR2000030518,ChiCTR,2020-03-05,2020-02-29,True,The Second Affiliated Hospital of Wenzhou Medical University,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50586,None
288,ChiCTR2000030503,ChiCTR,2020-03-05,2020-01-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49632,None
289,ChiCTR2000030493,ChiCTR,2020-03-04,2020-03-04,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Survey for sleep, anxiety and depression status of Chinese residents during the outbreak of novel coronavirus infected disases (COVID-19)",Other (psych),No Intervention,No Intervention,1300,http://www.chictr.org.cn/showproj.aspx?proj=50547,None
290,ChiCTR2000030492,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Retrospective study for integrate Chinese and conventional medicine  treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=50549,None
291,ChiCTR2000030491,ChiCTR,2020-03-04,2020-03-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,A medical records based study for Comparing Differences of Clinical Features and Outcomes of Novel Coronavirus Pneumonia (COVID-19) Patients between Sichuan Province and Wuhan City,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50552,None
292,ChiCTR2000030490,ChiCTR,2020-03-04,2020-02-01,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Diammonium glycyrrhizinate + Hydrogen,Diammonium glycyrrhizinate; Hydrogen,100,http://www.chictr.org.cn/showproj.aspx?proj=50487,None
293,ChiCTR2000030489,ChiCTR,2020-03-04,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Epidemiological research,China,Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases,Clinical Presentation,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=50490,None
294,ChiCTR2000030487,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,10,http://www.chictr.org.cn/showproj.aspx?proj=50507,None
295,ChiCTR2000030485,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for timing of mechanical ventilation for critically ill patients with novel coronavirus pneumonia (COVID-19): A medical records based retrospective Cohort study,Other (physical),Mechanical ventilation,Mechanical ventilation,90,http://www.chictr.org.cn/showproj.aspx?proj=50459,None
296,ChiCTR2000030484,ChiCTR,2020-03-03,2020-02-02,True,Hubei Shiyan Taihe hospital,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),90,http://www.chictr.org.cn/showproj.aspx?proj=50263,None
297,ChiCTR2000030482,ChiCTR,2020-03-03,2020-03-06,False,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,"A Multicenter, Long- term Follow-up and Registration Study for Myocardial Injury and Prognosis of Novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,No Intervention,8000,http://www.chictr.org.cn/showproj.aspx?proj=50353,None
298,ChiCTR2000030481,ChiCTR,2020-03-03,2020-03-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,Drug,Corticosteroids,Corticosteroids,200,http://www.chictr.org.cn/showproj.aspx?proj=50453,None
299,ChiCTR2000030480,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon alfa,Interferon alfa,328,http://www.chictr.org.cn/showproj.aspx?proj=50470,None
300,ChiCTR2000030479,ChiCTR,2020-03-03,2020-02-26,True,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50450,None
301,ChiCTR2000030477,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,19,http://www.chictr.org.cn/showproj.aspx?proj=50458,None
302,ChiCTR2000030475,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,Blood purification,19,http://www.chictr.org.cn/showproj.aspx?proj=50452,None
303,ChiCTR2000030472,ChiCTR,2020-03-03,2020-02-25,True,Shenyang Sixth People's Hospital,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=49753,None
304,ChiCTR2000030471,ChiCTR,2020-03-02,2020-03-02,False,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,394,http://www.chictr.org.cn/showproj.aspx?proj=50421,None
305,ChiCTR2000030469,ChiCTR,2020-03-02,2020-02-27,True,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,96,http://www.chictr.org.cn/showproj.aspx?proj=50082,None
306,ChiCTR2000030468,ChiCTR,2020-03-02,2020-02-28,True,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Study for the key technique of integrative therapy of Novel Coronavirus Pneumonia (COVID-19): the TCM symptoms and treatment regulation,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,950,http://www.chictr.org.cn/showproj.aspx?proj=50390,None
307,ChiCTR2000030467,ChiCTR,2020-03-02,2020-03-01,True,"Dalian Medical University, Dalian, China.",Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50378,None
308,ChiCTR2000030465,ChiCTR,2020-03-02,2020-03-02,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                        Influence of nasal high-fow preoxygenation on video laryngoscope for emergency intubation in patients with critical novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,70,http://www.chictr.org.cn/showproj.aspx?proj=50388,None
309,ChiCTR2000030464,ChiCTR,2020-03-02,2020-03-03,False,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Epidemiological research,No Country Given,Study for the clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50382,None
310,ChiCTR2000030453,ChiCTR,2020-03-02,2020-03-02,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,Clinical study for the effects of ACEIs/ARBs on the infection of novel coronavirus pneumonia (CoVID-19),Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,100,http://www.chictr.org.cn/showproj.aspx?proj=50381,None
311,ChiCTR2000030436,ChiCTR,2020-03-01,2020-03-06,False,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Application of flash glucose monitoring to evaluate the effect of blood glucose changes on prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50297,None
312,ChiCTR2000030312,ChiCTR,2020-02-28,2020-02-29,False,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Not Recruiting,Not Applicable,Interventional,China,"Cancelled, due to modify the protocol                                          A single-center, open-label and single arm trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment&",Cancelled,Cancelled,Cancelled,24,http://www.chictr.org.cn/showproj.aspx?proj=50258,None
313,ChiCTR2000030304,ChiCTR,2020-02-28,2020-03-10,False,The Third Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,Protective factors of mental resilience in first-line nurses with novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=49653,None
314,ChiCTR2000030163,ChiCTR,2020-02-24,2020-02-25,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Observational,China,A Medical Based Retrospective Real World Study for Assessment of Effectiveness of Comprehensive Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,256,http://www.chictr.org.cn/showproj.aspx?proj=50031,None
315,ChiCTR2000030014,ChiCTR,2020-02-20,2020-02-19,True,Wuhan Fourth Hospital,Not Recruiting,Not Applicable,Interventional,China,Cancelled due to lack of patient                               Effect of early pulmonary training on lung function and quality of life for novel coronavirus pneumonia (COVID-19) patients,Cancelled,Cancelled,Cancelled,300,http://www.chictr.org.cn/showproj.aspx?proj=49802,None
316,ChiCTR2000029993,ChiCTR,2020-02-18,2020-02-20,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=49435,None
317,ChiCTR2000029958,ChiCTR,2020-02-17,2020-02-17,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the clinical characteristics of anesthesia novel coronavirus pneumonia (COVID-19) patients during perioperative period and assessment of infection and mental health of Anesthesiology Department,Clinical Presentation,No Intervention,No Intervention,260,http://www.chictr.org.cn/showproj.aspx?proj=49635,None
318,ChiCTR2000029757,ChiCTR,2020-02-12,2020-02-14,False,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,ATMP,Plasma,Plasma,200,http://www.chictr.org.cn/showproj.aspx?proj=49081,None
319,ChiCTR2000029580,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",Drug (+ ATMP),Ruxolimab + Cells (mesenchymal),Ruxolimab; Cells (mesenchymal),70,http://www.chictr.org.cn/showproj.aspx?proj=49088,None
320,ChiCTR2000029579,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49045,None
321,ChiCTR2000029550,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=48775,None
322,ChiCTR2000029549,ChiCTR,2020-02-04,2020-02-03,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49014,None
323,ChiCTR2000029308,ChiCTR,2020-01-23,2020-01-10,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,lopinavir/ritonavir,160,http://www.chictr.org.cn/showproj.aspx?proj=48684,None
324,NCT04292327,ClinicalTrials.gov,2020-02-23,2020-01-01,True,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04292327,None
325,NCT04292340,ClinicalTrials.gov,2020-02-25,2020-02-01,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,ATMP,Plasma,Plasma,15,https://clinicaltrials.gov/show/NCT04292340,None
326,NCT04293887,ClinicalTrials.gov,2020-02-15,2020-03-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2ß in the Treatment of Novel Coronavirus Patients,Drug,Interferon alfa,Interferon alfa,328,https://clinicaltrials.gov/show/NCT04293887,None
327,NCT04295551,ClinicalTrials.gov,2020-03-03,2020-03-14,False,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,https://clinicaltrials.gov/show/NCT04295551,None
328,NCT04296643,ClinicalTrials.gov,2020-03-03,2020-04-01,False,McMaster University,Not Recruiting,Not Applicable,Interventional,No Country Given,Medical Masks vs N95 Respirators for COVID-19,Other (device),Masks,Masks,576,https://clinicaltrials.gov/show/NCT04296643,None
329,NCT04298814,ClinicalTrials.gov,2020-02-26,2020-03-07,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,Other (physical),Endotracheal Intubation,Endotracheal Intubation,120,https://clinicaltrials.gov/show/NCT04298814,None
330,NCT04299711,ClinicalTrials.gov,2020-03-04,2020-10-15,False,University of Macau,Not Recruiting,Not Applicable,Observational,No Country Given,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,Other (psych),No Intervention,No Intervention,3428,https://clinicaltrials.gov/show/NCT04299711,None
331,ChiCTR2000030902,ChiCTR,2020-03-16,2020-02-10,True,Jingzhou Mental Health Center,Recruiting,Not Applicable,Observational,China,Analysis for the mental health status of residents in Jingzhou during the outbreak of the novel coronavirus pneumonia (COVID-19) and corresponding influencing factors,Other (psych),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=51130,None
332,ChiCTR2000030901,ChiCTR,2020-03-16,2020-03-09,True,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of epidemiology and transmission dynamics of patients confirmed with Coronavirus Disease (COVID-19) in Hong Kong,Clinical Presentation ,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51064,None
333,ChiCTR2000030898,ChiCTR,2020-03-16,2020-01-27,True,The Affiliated Hospital to Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluation on the effect of Chushifangyi prescription in preventing novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=50780,None
334,ChiCTR2000030897,ChiCTR,2020-03-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,Probiotics,20,http://www.chictr.org.cn/showproj.aspx?proj=50462,None
335,ChiCTR2000030896,ChiCTR,2020-03-16,2020-02-06,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,24,http://www.chictr.org.cn/showproj.aspx?proj=51028,None
336,ChiCTR2000030895,ChiCTR,2020-03-16,2020-03-14,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Retrospective and Prospective Study for Nosocomial infection in Stomatology Department under the Background of novel coronavirus pneumonia (COVID-19) epidemic period,Clinical Presentation,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=51034,None
337,ChiCTR2000030893,ChiCTR,2020-03-16,2020-03-19,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for effects of crisis intervention based on positive psychology for medical staffs working in the novel coronavirus pneumonia (COVID-19) field,Other (psych),Psychological,Psychological,50,http://www.chictr.org.cn/showproj.aspx?proj=51073,None
338,ChiCTR2000030892,ChiCTR,2020-03-16,2020-03-06,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,Drug,Pirfenidone,Pirfenidone,40,http://www.chictr.org.cn/showproj.aspx?proj=51118,None
339,ChiCTR2000030883,ChiCTR,2020-03-16,2020-02-18,True,"Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University",Recruiting,Not Applicable,Observational,China,Clinical research and preparation development of qingfei detoxification decoction (mixture) for prevention and treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50960,None
340,ChiCTR2000030866,ChiCTR,2020-03-16,2020-02-01,True,The First Hospital of Changsha,Recruiting,Not Applicable,Observational,China,"Open-label, observational study of human umbilical cord derived mesenchymal stem cells in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",ATMP,Cells (mesenchymal),Cells (mesenchymal),30,http://www.chictr.org.cn/showproj.aspx?proj=50299,None
341,ChiCTR2000030865,ChiCTR,2020-03-16,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Establishment of an early warning model for maternal and child vertical transmission of COVID-19 infection,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49933,None
342,ChiCTR2000030864,ChiCTR,2020-03-16,2020-02-01,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50662,None
343,ChiCTR2000030863,ChiCTR,2020-03-16,2020-01-22,True,"Jinling Hospital, Medical School of Nanjing University",Recruiting,Not Applicable,Observational,China,Clinical and CT imaging Characteristics of novel coronavirus pneumonia (COVID-19): An Multicenter Cohort Study,Clinical Presentation,No Intervention,No Intervention,5000,http://www.chictr.org.cn/showproj.aspx?proj=50767,None
344,ChiCTR2000030862,ChiCTR,2020-03-16,2020-01-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Correlation analysis of blood eosinophil cell levels and clinical type category of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study,Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=51107,None
345,ChiCTR2000030861,ChiCTR,2020-03-16,2019-02-27,True,The First Affiliated Hospital of the Guangzhou Medical University,Recruiting,Not Applicable,Health services research,No Country Given,Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling,Other (physical),Other,Other,90,http://www.chictr.org.cn/showproj.aspx?proj=51103,None
346,ChiCTR2000030860,ChiCTR,2020-03-16,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for investigation of dynamic profile of RT-PCR test for SARS-CoV-2 nucleic acid of novel coronavirus pneumonia (COVID-19) patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://www.chictr.org.cn/showproj.aspx?proj=51102,None
347,ChiCTR2000030859,ChiCTR,2020-03-16,2020-03-01,True,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,A medical based analysis for influencing factors of death of novel coronavirus pneumonia (COVID-19) patients in Wuhan third hospital,Prognosis,No Intervention,No Intervention,1305,http://www.chictr.org.cn/showproj.aspx?proj=51025,None
348,ChiCTR2000030858,ChiCTR,2020-03-16,2020-02-06,True,Hubei Cancer Hospital,Recruiting,Not Applicable,Observational,China,"Clinical characteristics and outcomes of 483 mild patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China during the outbreak: A single-center, retrospective study from the mobile cabin hospital",Clinical Presentation,No Intervention,No Intervention,483,http://www.chictr.org.cn/showproj.aspx?proj=51097,None
349,ChiCTR2000030857,ChiCTR,2020-03-16,2020-03-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for bronchoscopic alveolar lavage in the treatment of critically trachea intubation patients with new coronavirus pneumonia (COVID-19),Other (physical),Bronchoscopic lavage,Bronchoscopic lavage,30,http://www.chictr.org.cn/showproj.aspx?proj=51040,None
350,ChiCTR2000030856,ChiCTR,2020-03-16,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,An artificial intelligence assistant system for suspected novel coronavirus pneumonia (COVID-19) based on chest CT,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,http://www.chictr.org.cn/showproj.aspx?proj=51091,None
351,ChiCTR2000030855,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,200,http://www.chictr.org.cn/showproj.aspx?proj=51090,None
352,ChiCTR2000030854,ChiCTR,2020-03-16,2020-01-22,True,Li Lanjuan,Not Recruiting,Not Applicable,Observational,China,"A clinical multicenter study for the occurrence, development and prognosis of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,No Intervention,237,http://www.chictr.org.cn/showproj.aspx?proj=51083,None
353,ChiCTR2000030853,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),Drug,Dexmedetomidine,Dexmedetomidine,200,http://www.chictr.org.cn/showproj.aspx?proj=51081,None
354,ChiCTR2000030852,ChiCTR,2020-03-16,2020-01-27,True,"Beijing An Zhen Hospital, Capital Medical University",Not Recruiting,Not Applicable,Observational,China,Factors associated with death in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=51077,None
355,ChiCTR2000030850,ChiCTR,2020-03-15,2020-03-15,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the physical and mental health status of medical workers under the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,No Intervention,226,http://www.chictr.org.cn/showproj.aspx?proj=51056,None
356,ChiCTR2000030849,ChiCTR,2020-03-15,2020-03-16,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,Other (psych),No Intervention,No Intervention,81,http://www.chictr.org.cn/showproj.aspx?proj=51086,None
357,ChiCTR2000030841,ChiCTR,2020-03-15,2020-02-17,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,10,http://www.chictr.org.cn/showproj.aspx?proj=51072,None
358,ChiCTR2000030839,ChiCTR,2020-03-15,2020-03-01,True,"Tongren Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Screening,China,Preliminary screening of novel coronavirus pneumonia (COVID-19) by special laboratory examination and CT imaging before surgery,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://www.chictr.org.cn/showproj.aspx?proj=50904,None
359,ChiCTR2000030838,ChiCTR,2020-03-15,2020-01-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,Development of warning system with clinical differential diagnosis and prediction for severe type of novel coronavirus pneumonia (COVID-19) patients based on artificial intelligence and CT images,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.chictr.org.cn/showproj.aspx?proj=51071,None
360,ChiCTR2000030836,ChiCTR,2020-03-15,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=51054,None
361,ChiCTR2000030835,ChiCTR,2020-03-15,2020-02-14,True,The First Affiliated Hospital of Xinxiang Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=51050,None
362,ChiCTR2000030834,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Epidemiological Characteristics and Antibody Levels of novel coronavirus pneumonia (COVID-19) of Pediatric Medical Staff working in Quarantine Area,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=51047,None
363,ChiCTR2000030833,ChiCTR,2020-03-15,2020-03-22,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Clinical validation and application of high-throughput novel coronavirus (2019-nCoV) screening detection kit,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,http://www.chictr.org.cn/showproj.aspx?proj=51035,None
364,ChiCTR2000030832,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,800,http://www.chictr.org.cn/showproj.aspx?proj=51044,None
365,ChiCTR2000030831,ChiCTR,2020-03-15,2020-01-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The analysis of related factors on improving oxygenation status by endotracheal intubation ventilation in severe patients suffered from novel coronavirus pneumonia (COVID-19): a single center and descriptive study in Wuhan,Prognosis,No Intervention,No Intervention,75,http://www.chictr.org.cn/showproj.aspx?proj=51036,None
366,ChiCTR2000030830,ChiCTR,2020-03-15,2020-01-01,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Observational,China,Development and application of novel coronavirus pneumonia (COVID-19) intelligent image classification system based on deep learning,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,http://www.chictr.org.cn/showproj.aspx?proj=51009,None
367,ChiCTR2000030819,ChiCTR,2020-03-15,2020-03-01,True,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,"Retrospective analysis of digestive system symptoms in 600 cases of novel coronavirus pneumonia (COVID-19) in Guanggu district, Wuhan",Clinical Presentation,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=51039,None
368,ChiCTR2000030818,ChiCTR,2020-03-15,2020-01-31,True,"The First Affiliated Hospital, Henan Traditional Chinese Medicine University",Not Recruiting,Not Applicable,Observational,China,A medical records based study for the value of Lymphocyte subsets in the diagnose and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,10,http://www.chictr.org.cn/showproj.aspx?proj=51037,None
369,ChiCTR2000030816,ChiCTR,2020-03-15,2020-02-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Nutritional risk assessment and outcome prediction of critically ill novel coronavirus pneumonia (COVID-19) patients,Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51048,None
370,ChiCTR2000030814,ChiCTR,2020-03-15,2020-02-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based analysis of clinical evidence of human-to-human transmission of 2019 novel coronavirus pneumonia (COVID-19) by conjunctival route,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51042,None
371,ChiCTR2000030812,ChiCTR,2020-03-15,2020-01-31,True,Shanghai Ninth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for the virus molecular evolution which driven the immune-pathological responses and the protection mechanisms of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,50,http://www.chictr.org.cn/showproj.aspx?proj=50947,None
372,ChiCTR2000030810,ChiCTR,2020-03-15,2020-02-23,True,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50986,None
373,ChiCTR2000030809,ChiCTR,2020-03-15,2020-02-22,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical outcomes and follow-up of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=51015,None
374,ChiCTR2000030807,ChiCTR,2020-03-15,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical characteristics and prognosis of cancer patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51019,None
375,ChiCTR2000030806,ChiCTR,2020-03-15,2020-02-01,True,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,Retrospective study for the efficacy of ulinastatin combined with ''clear lung detoxification soup'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=51029,None
376,ChiCTR2000030805,ChiCTR,2020-03-15,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,Quantitative CT characteristic estimate the severity of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=51026,None
377,ChiCTR2000030804,ChiCTR,2020-03-15,2020-02-01,True,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,128,http://www.chictr.org.cn/showproj.aspx?proj=51018,None
378,ChiCTR2000030803,ChiCTR,2020-03-15,2020-01-31,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,No Country Given,Collection and analysis of clinical data in severe and critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=51007,None
379,ChiCTR2000030802,ChiCTR,2020-03-15,2020-01-27,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical drug therapy in patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified Drug,Unspecified Drug,2000,http://www.chictr.org.cn/showproj.aspx?proj=51004,None
380,ChiCTR2000030801,ChiCTR,2020-03-15,2020-01-23,True,The Third Hospital of Wuhan,Recruiting,Not Applicable,Observational,China,Analysis of risk factors affecting prognosis of elderly patients infected with novel coronavirus pneumonia (COVID-19): a single-center retrospective observational study,Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50998,None
381,ChiCTR2000030800,ChiCTR,2020-03-15,2020-02-01,True,The Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Diagnostic test,China,Cancelled by the investigator                Study on levels of inflammatory factors in peripheral blood of patients with novel coronavirus pneumonia (COVID-19) and their diagnostic and prognostic value,Cancelled,Cancelled,Cancelled,22,http://www.chictr.org.cn/showproj.aspx?proj=50997,None
382,ChiCTR2000030799,ChiCTR,2020-03-15,2020-01-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=50995,None
383,ChiCTR2000030798,ChiCTR,2020-03-15,2020-02-10,True,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50994,None
384,ChiCTR2000030797,ChiCTR,2020-03-15,2020-03-07,True,"Shanghai Fifth People's Hospital, Fudan University",Recruiting,Not Applicable,Observational,China,clinical study for hemodynamics and cardiac arrhythmia of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50988,None
385,ChiCTR2000030796,ChiCTR,2020-03-15,2020-01-29,True,The Second Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,No Country Given,Clinical characteristics and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=50991,None
386,ChiCTR2000030795,ChiCTR,2020-03-15,2020-03-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multicenter retrospective study of rheumatic  patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,90,http://www.chictr.org.cn/showproj.aspx?proj=50982,None
387,ChiCTR2000030784,ChiCTR,2020-03-14,2020-01-17,True,The People's Hospital of Guangxi Zhuang Autonomous Region,Recruiting,Not Applicable,Observational,China,A study for clinical characteristics of novel coronavirus pneumonia (COVID-19) patients follow-up in Guangxi,Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=50307,None
388,ChiCTR2000030782,ChiCTR,2020-03-14,2020-02-01,True,Cangzhou People's Hospital,Recruiting,Not Applicable,Observational,No Country Given,"The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)",Prognosis,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=50976,None
389,ChiCTR2000030779,ChiCTR,2020-03-14,2020-03-16,False,Shanghai Changzheng Hospital,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50973,None
390,ChiCTR2000030778,ChiCTR,2020-03-14,2020-01-20,True,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for epidemic and clinical features of novel coronavirus pneumonia (COVID-19) in Ningbo First Hospital,Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=50987,None
391,ChiCTR2000030773,ChiCTR,2020-03-14,2020-02-12,True,Huashan Hospital; Fudan Universtiy,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,Blood purification,20,http://www.chictr.org.cn/showproj.aspx?proj=50934,None
392,ChiCTR2000030768,ChiCTR,2020-03-14,2020-02-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Epidemiological research,China,Study for the Psychological Status of Medical Staff of Otolaryngology Head and Neck Surgery in Hubei Province under the Epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,450,http://www.chictr.org.cn/showproj.aspx?proj=50968,None
393,ChiCTR2000030764,ChiCTR,2020-03-13,2020-03-07,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Observational,China,"Research for the influence of epidemic of novel coronavirus pneumonia (COVID-19) on sleep, psychological and chronic diseases among different populations",Clinical Presentation,No Intervention,No Intervention,2800,http://www.chictr.org.cn/showproj.aspx?proj=50852,None
394,ChiCTR2000030763,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A Medical Records Based analysis for Risk Factors for Outcomes After Respiratory Support in Patients with ARDS Due to Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50921,None
395,ChiCTR2000030762,ChiCTR,2020-03-13,2019-12-01,True,The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine,Not Recruiting,Not Applicable,Epidemiological research,China,Diagnosis and treatment of novel coronavirus pneumonia (COVID-19) in common and severe cases based on the theory of ''Shi-Du-Yi (damp and plague)'',Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50950,None
396,ChiCTR2000030761,ChiCTR,2020-03-13,2020-05-31,False,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,Other (renal),Renal replacement therapy,Renal replacement therapy,20,http://www.chictr.org.cn/showproj.aspx?proj=50956,None
397,ChiCTR2000030760,ChiCTR,2020-03-13,2020-03-13,False,Zhejiang Hospital,Not Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Zhejiang province, China",Clinical Presentation,No Intervention,No Intervention,74,http://www.chictr.org.cn/showproj.aspx?proj=50955,None
398,ChiCTR2000030759,ChiCTR,2020-03-13,2020-02-15,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,70,http://www.chictr.org.cn/showproj.aspx?proj=49284,None
399,ChiCTR2000030758,ChiCTR,2020-03-13,2020-03-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified sedation and analgesia,Unspecified (Sedation and analgesia),200,http://www.chictr.org.cn/showproj.aspx?proj=50590,None
400,ChiCTR2000030757,ChiCTR,2020-03-13,2020-03-13,False,Shenzhen-Peking University; The Hong Kong University of Science & Technology Medical Center,Not Recruiting,Not Applicable,Observational,China,Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers,Other (psych),No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50648,None
401,ChiCTR2000030756,ChiCTR,2020-03-13,2020-02-20,True,Shenzhen Hospital of Southern Medical University,Recruiting,Not Applicable,Observational,China,Detection of SARS-CoV-2 in EPS / semen of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation ,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=50705,None
402,ChiCTR2000030755,ChiCTR,2020-03-13,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"A medical records based study for characteristics, prognosis of ederly patients with Novel Coronavirus Pneumonia (COVID-19) in Wuhan area",Prognosis,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=50945,None
403,ChiCTR2000030754,ChiCTR,2020-03-13,2020-03-11,True,The Third Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Diagnostic test,China,Medical records based study for the accuracy of SARS-CoV-2 IgM antibody screening for diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.chictr.org.cn/showproj.aspx?proj=50824,None
404,ChiCTR2000030753,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,No Status Given,Not Applicable,Observational,China,A medical records based analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50901,None
405,ChiCTR2000030752,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A medical records based analysis for risk factors for death in patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=50925,None
406,ChiCTR2000030751,ChiCTR,2020-03-13,2020-01-25,True,Affiliated Hospital of Inner Mongolia University for the Nationalities,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50941,None
407,ChiCTR2000030747,ChiCTR,2020-03-13,2020-02-22,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A prospective cohort  study for comprehensive treatment of Chinese medicine in the treatment of convalescent patients of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,1500,http://www.chictr.org.cn/showproj.aspx?proj=50000,None
408,ChiCTR2000030744,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,Oxygen,30,http://www.chictr.org.cn/showproj.aspx?proj=50910,None
409,ChiCTR2000030742,ChiCTR,2020-03-13,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19)",Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50857,None
410,ChiCTR2000030741,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with  Novel Coronavirus Pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,100,http://www.chictr.org.cn/showproj.aspx?proj=50907,None
411,ChiCTR2000030740,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19).,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50900,None
412,ChiCTR2000030739,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Exploration of the Clinical Characteristics of Patients with Novel Coronavirus Pneumonia (COVID-19) and Its Differences from Patients with Severe Influenza A and MERS,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50896,None
413,ChiCTR2000030722,ChiCTR,2020-03-12,2020-03-09,True,Shanghai First People's Hospital,Not Recruiting,Not Applicable,Observational,China,Auscultatory characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=50338,None
414,ChiCTR2000030721,ChiCTR,2020-03-12,2020-03-16,False,Affiliated Hospital of Guangdong Medical University,Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study for the sensitivity of induced sputum and throat swabs for the detection of SARS-CoV-2 by real-time PCR in patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,http://www.chictr.org.cn/showproj.aspx?proj=50759,None
415,ChiCTR2000030720,ChiCTR,2020-03-11,2020-03-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,Prognosis,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=50793,None
416,ChiCTR2000030719,ChiCTR,2020-03-11,2020-03-01,True,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Recruiting,Not Applicable,Observational,China,A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,1071,http://www.chictr.org.cn/showproj.aspx?proj=50867,None
417,ChiCTR2000030718,ChiCTR,2020-03-11,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,80,http://www.chictr.org.cn/showproj.aspx?proj=50843,None
418,ChiCTR2000030717,ChiCTR,2020-03-11,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for risk assessment and treatment timing of invasive fungal infection in novel coronavirus pneumonia (COVID-19) critical patients,Clinical Presentation,No Intervention,No Intervention,260,http://www.chictr.org.cn/showproj.aspx?proj=50860,None
419,ChiCTR2000030716,ChiCTR,2020-03-11,2020-03-05,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Shedding of SARS-CoV-2 in human semen and evaluation of reproductive health of novel coronavirus pneumonia (COVID-19) male patients,Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=50850,None
420,ChiCTR2000030708,ChiCTR,2020-03-11,2020-03-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cross sectional study of dialysis treatment and mental status under the outbreak of novel coronavirus pneumonia (COVID-2019) in China,Other (renal),Dialysis,Dialysis,1000,http://www.chictr.org.cn/showproj.aspx?proj=50083,None
421,ChiCTR2000030707,ChiCTR,2020-03-11,2020-03-20,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,Retrospective study on novel coronavirus pneumonia (COVID-19) in Tibetan Plateau,Clinical Presentation,No Intervention,No Intervention,78,http://www.chictr.org.cn/showproj.aspx?proj=50160,None
422,ChiCTR2000030706,ChiCTR,2020-03-11,2020-02-09,True,Affiliated Hospital of Zunyi Medical University,Recruiting,Not Applicable,Diagnostic test,China,Cancelled by the investigator                       Application of cas13a-mediated RNA detection in the assay of novel coronavirus nucleic acid (COVID-19),Cancelled,Cancelled,Cancelled,300,http://www.chictr.org.cn/showproj.aspx?proj=50001,None
423,ChiCTR2000030703,ChiCTR,2020-03-10,2020-03-10,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",Drug,"Ixekizumab + up to three of interferon-alfa, lopinavir/ritonavir, chloroquine, ribavirin, umifenovir",Ixekizumab; Interferon alpha; Lopinavir; Ritonavir; Chloroquine; Ribavirin; Umifenovir,40,http://www.chictr.org.cn/showproj.aspx?proj=50251,None
424,ChiCTR2000030702,ChiCTR,2020-03-10,2020-02-15,True,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,ATMP,Plasma,Plasma,50,http://www.chictr.org.cn/showproj.aspx?proj=50537,None
425,ChiCTR2000030701,ChiCTR,2020-03-10,2020-03-10,False,The Third People's Hospital of Shenzhen,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",Drug,Heparin,Heparin,60,http://www.chictr.org.cn/showproj.aspx?proj=50795,None
426,ChiCTR2000030700,ChiCTR,2020-03-10,2020-03-09,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,Drug,Heparin,Heparin,60,http://www.chictr.org.cn/showproj.aspx?proj=50786,None
427,ChiCTR2000030697,ChiCTR,2020-03-10,2020-03-10,False,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,"A multi-center, open-label observation study for psychological status and intervention efficacy of doctors, nurses, patients and their families in novel coronavirus pneumonia (COVID-19) designated hospitals",Other (psych),Psychological,Psychological,1500,http://www.chictr.org.cn/showproj.aspx?proj=50781,None
428,ChiCTR2000030690,ChiCTR,2020-03-10,2020-02-10,True,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Basic Science,China,Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=50261,None
429,ChiCTR2000030687,ChiCTR,2020-03-09,2020-02-01,True,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Not Recruiting,Not Applicable,Basic Science,China,Novel coronavirus pneumonia (COVID-19) associated kidney injury in children,Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=50572,None
430,ChiCTR2000030686,ChiCTR,2020-03-09,2020-03-03,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,The effects of prevention and control measures on treatment and psychological status of cancer patients during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=50714,None
431,ChiCTR2000030683,ChiCTR,2020-03-09,2020-03-09,False,The Sixth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Diagnostic test,China,The prediction value of prognosis of novel coronavirus pneumonia (COVID-19) in elderly patients by modified early warning score (MEWS): a medical records based retrospective observational study,Prognosis,No Intervention,No Intervention,234,http://www.chictr.org.cn/showproj.aspx?proj=50633,None
432,ChiCTR2000030681,ChiCTR,2020-03-09,2020-03-16,False,Liaocheng People's Hospital,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,Other (physical),Extubation,Extubation,240,http://www.chictr.org.cn/showproj.aspx?proj=50763,None
433,ChiCTR2000030679,ChiCTR,2020-03-09,2020-01-28,True,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Recruiting,Not Applicable,Observational,China,Cohort study of Novel Coronavirus Infected Diseases (COVID-19) in children,Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=50730,None
434,ChiCTR2000030619,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Bengbu Medical College,Not Recruiting,Not Applicable,Observational,China,A medical records based real world study for the characteristics and correlation mechanism of traditional Chinese medicine combined with western medicine in the treatment of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,160,http://www.chictr.org.cn/showproj.aspx?proj=50656,None
435,ChiCTR2000030606,ChiCTR,2020-03-08,2020-03-09,False,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50713,None
436,ChiCTR2000030597,ChiCTR,2020-03-08,2020-03-09,False,China Academy of Chinese Medical Science,Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=50702,None
437,ChiCTR2000030580,ChiCTR,2020-03-08,2020-02-01,True,Shanghai General Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,Adamumab,Adamumab,60,http://www.chictr.org.cn/showproj.aspx?proj=50693,None
438,ChiCTR2000030558,ChiCTR,2020-03-07,2020-03-07,False,Guangzhou Panyu Central Hospital,No Status Given,Not Applicable,Epidemiological research,China,Cancelled by the investigator             Epidemiological research of novel coronavirus pneumonia (COVID-19) suspected cases based on virus nucleic acid test combined with low-dose chest CT screening in primary hospital,Cancelled,Cancelled,Cancelled,264,http://www.chictr.org.cn/showproj.aspx?proj=50678,None
439,ChiCTR2000030545,ChiCTR,2020-03-06,2020-02-04,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=50126,None
440,ChiCTR2000030528,ChiCTR,2020-03-06,2020-03-06,False,The Second Clinical College of Guangzhou University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Application of TCM Nursing Scheme in Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50641,None
441,ChiCTR2000030509,ChiCTR,2020-03-05,2020-03-13,False,The First Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator           Clinical Study of NK Cells in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,40,http://www.chictr.org.cn/showproj.aspx?proj=49956,None
442,ChiCTR2000030483,ChiCTR,2020-03-03,2020-03-01,True,The first affiliated hospital of guangzhou university of Chinese medicine,Not Recruiting,Phase 1,Interventional,China,"Cancelled by the investigator         A multicentre, randomized, controlled trial for the Ba-Duan-Jin in the adjunctive treatment of patients with common type novel coronavirus pneumonia (COVID-19)",Cancelled,Cancelled,Cancelled,16,http://www.chictr.org.cn/showproj.aspx?proj=50495,None
443,ChiCTR2000030478,ChiCTR,2020-03-03,2020-02-26,True,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                                    Study for the Effectiveness and Safety of Compound Yuxingcao Mixture in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,120,http://www.chictr.org.cn/showproj.aspx?proj=50460,None
444,ChiCTR2000030476,ChiCTR,2020-03-03,2020-03-03,False,"Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=50455,None
445,ChiCTR2000030466,ChiCTR,2020-03-02,2020-02-26,True,"Yongchuan Hospital, Chongqing Medical University",No Status Given,Not Applicable,Observational,China,Cancelled due to lack of patients                                       Investigation on Mental Health Status and Psychological Intervention of Hospitalized Patients with Novel Coronavirus Pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,50,http://www.chictr.org.cn/showproj.aspx?proj=50387,None
446,ChiCTR2000030417,ChiCTR,2020-03-01,2020-03-01,False,Harbin Infectious Diseases Hospital,No Status Given,Not Applicable,Interventional,China,Cancelled by the investigator                               Efficacy and safety of chloroquine phosphate inhalation combined with standard therapy in the treatment of novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,30,http://www.chictr.org.cn/showproj.aspx?proj=50279,None
447,ChiCTR2000030388,ChiCTR,2020-03-01,2020-02-18,True,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50306,None
448,ChiCTR2000030381,ChiCTR,2020-02-29,2020-02-29,False,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Not Recruiting,Not Applicable,Interventional,China,"Cancelled by investigator           A randomized, open-label, controlled and single-center trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment of novel coronavirus pneumonia (COVID-19) patient",Cancelled,Cancelled,Cancelled,40,http://www.chictr.org.cn/showproj.aspx?proj=50290,None
449,ChiCTR2000030329,ChiCTR,2020-02-28,2020-03-05,False,The Second Affiliated Hospital of Xi'an Medical University,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                          Clinical trial for umbilical cord blood CIK and NK cells in the treatment of mild and general patients infected with novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,90,http://www.chictr.org.cn/showproj.aspx?proj=49779,None
450,ChiCTR2000030306,ChiCTR,2020-02-28,2020-03-19,False,Luohu hospital group medical center of Shenzhen University,No Status Given,Not Applicable,Observational,China,Cancelled by the investigator                               Mechanism of novel coronavirus pneumonia (COVID-19) virus with silent latent immune system induced by envelope protein and vaccine development,Cancelled,Cancelled,Cancelled,15,http://www.chictr.org.cn/showproj.aspx?proj=50222,None
451,ChiCTR2000030221,ChiCTR,2020-02-25,2020-01-31,True,Guangzhou Panyu Central Hospital,Recruiting,Not Applicable,Health services research,No Country Given,Cancelled by the investigator               Study for sleep status of medical staffs of hospitals administrating suspected cases of Novel Coronavirus Pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,960,http://www.chictr.org.cn/showproj.aspx?proj=50071,None
452,ChiCTR2000030187,ChiCTR,2020-02-24,2020-02-25,False,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir,lopinavir/ritonavir,60,http://www.chictr.org.cn/showproj.aspx?proj=50057,None
453,ChiCTR2000030135,ChiCTR,2020-02-24,2020-02-25,False,The Second Affiliated Hospital Of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                  A randomized controlled trial for high-dose Vitamin C in the treatment of severe and critical novel coronavirus pneumonia (COVID-19) patients,Cancelled,Cancelled,Cancelled,39,http://www.chictr.org.cn/showproj.aspx?proj=50002,None
454,ChiCTR2000030114,ChiCTR,2020-02-23,2020-02-24,False,Peking University People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,"Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,http://www.chictr.org.cn/showproj.aspx?proj=49987,None
455,ChiCTR2000030085,ChiCTR,2020-02-22,2020-02-22,False,Affiliated Hospital of Zunyi Medical University,No Status Given,Not Applicable,Diagnostic test,China,Cancelled by the investigator               Study for the false positive rate of IgM / IgG antibody test kit for novel coronavirus pneumonia (COVID-19) in different inpatients,Cancelled,Cancelled,Cancelled,400,http://www.chictr.org.cn/showproj.aspx?proj=49948,None
456,ChiCTR2000030082,ChiCTR,2020-02-22,2020-02-23,False,The First Affiliated Hospital of Nanchang University,No Status Given,Phase 4,Interventional,China,Cancelled by the investigator             Randomized controlled trial for the efficacy of dihydroartemisinine piperaquine in the treatment of mild/common novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,40,http://www.chictr.org.cn/showproj.aspx?proj=49915,None
457,ChiCTR2000030055,ChiCTR,2020-02-22,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Prognosis,China,Multicenter study for the treatment of Dipyridamole with novel coronavirus pneumonia (COVID-19),Drug,Dipyridamole,Dipyridamole,460,http://www.chictr.org.cn/showproj.aspx?proj=49864,None
458,ChiCTR2000030031,ChiCTR,2020-02-21,2020-02-20,True,The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital),No Status Given,Phase 4,Interventional,China,"Cancelled by the investigator                              A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COV",Cancelled,Cancelled,Cancelled,120,http://www.chictr.org.cn/showproj.aspx?proj=49806,None
459,ChiCTR2000030005,ChiCTR,2020-02-19,2020-02-21,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Nucleic acid analysis of novel coronavirus pneumonia (COVID-19) in morning sputum samples and pharyngeal swabs-a prospectively diagnostic test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=49669,None
460,ChiCTR2000029984,ChiCTR,2020-02-18,2020-03-01,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator              Study on the effect of human placenta biological preparation on the defense of immune function against novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,60,http://www.chictr.org.cn/showproj.aspx?proj=49712,None
461,ChiCTR2000029957,ChiCTR,2020-02-17,2020-02-24,False,The Second Affiliated Hospital Of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Observational,China,Cancelled by the investigator                         An observational study of high-dose Vitamin C in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,66,http://www.chictr.org.cn/showproj.aspx?proj=49633,None
462,ChiCTR2000029895,ChiCTR,2020-02-16,2020-02-16,False,Guangzhou Eighth People's Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Cancelled by investigator                Single arm study for the efficacy and safety of GD31 in patients with novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,160,http://www.chictr.org.cn/showproj.aspx?proj=49569,None
463,ChiCTR2000029837,ChiCTR,2020-02-15,2020-02-17,False,Jingzhou Central Hospital,Not Recruiting,Phase 4,Interventional,China,"Cancelled by the investigator          A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COVID-19)",Cancelled,Cancelled,Cancelled,120,http://www.chictr.org.cn/showproj.aspx?proj=49495,None
464,ChiCTR2000029826,ChiCTR,2020-02-14,2020-02-17,False,Jingzhou Central Hospital,Not Recruiting,Phase 4,Interventional,China,"Cancelled by the investigator            A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in serious/critically ill patients with novel coronavirus pneumonia (COVID-19)",Cancelled,Cancelled,Cancelled,45,http://www.chictr.org.cn/showproj.aspx?proj=49481,None
465,ChiCTR2000029820,ChiCTR,2020-02-14,2020-02-01,True,Wuhan Asia General Hospital,No Status Given,Not Applicable,Observational,China,Cancelled by investigator                                      A cox regression analysis of prognosis of novel coronavirus pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,410,http://www.chictr.org.cn/showproj.aspx?proj=49492,None
466,ChiCTR2000029818,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator            Clinical Study for Umbilical Cord Blood Plasma in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,60,http://www.chictr.org.cn/showproj.aspx?proj=49382,None
467,ChiCTR2000029817,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                    Clinical Study of Cord Blood NK Cells Combined with Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,60,http://www.chictr.org.cn/showproj.aspx?proj=49384,None
468,ChiCTR2000029816,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                      Clinical Study for Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,60,http://www.chictr.org.cn/showproj.aspx?proj=49389,None
469,ChiCTR2000029812,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator               Clinical Study for Umbilical Cord Blood Mononuclear Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Cancelled,Cancelled,Cancelled,60,http://www.chictr.org.cn/showproj.aspx?proj=49374,None
470,ChiCTR2000029770,ChiCTR,2020-02-13,2020-02-13,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Study for epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=49412,None
471,ChiCTR2000029592,ChiCTR,2020-02-05,2020-02-07,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical Study of Arbidol Hydrochloride Using for Post-exposure Prophylaxis of 2019-nCoV in High-risk Population Including Medical Staff,Drug (Chemoprophylaxis),Umifenovir,Umifenovir,1000,http://www.chictr.org.cn/showproj.aspx?proj=49069,None
472,NCT04264533,ClinicalTrials.gov,2020-02-04,2020-02-14,False,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,Drug,Vitamin C,Vitamin C,140,https://clinicaltrials.gov/show/NCT04264533,None
473,NCT04285801,ClinicalTrials.gov,2020-02-24,2020-02-14,True,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,Clinical Presentation,No Intervention,No Intervention,8,https://clinicaltrials.gov/show/NCT04285801,None
474,NCT04299724,ClinicalTrials.gov,2020-03-05,2020-02-15,True,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04299724,None
475,NCT04302519,ClinicalTrials.gov,2020-02-27,2020-03-05,False,"CAR-T (Shanghai) Biotechnology Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04302519,None
476,NCT04302688,ClinicalTrials.gov,2020-03-07,2019-12-10,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Accurate Classification System for Patients With COVID-19 Pneumonitis,Prognosis,No Intervention,No Intervention,669,https://clinicaltrials.gov/show/NCT04302688,None
477,NCT04308187,ClinicalTrials.gov,2020-03-12,2020-03-11,True,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Observational,France,Influence of the COvid-19 Epidemic on STRESS,Other (psych),No Intervention,No Intervention,50000,https://clinicaltrials.gov/show/NCT04308187,None
478,ChiCTR2000031163,ChiCTR,2020-03-23,2020-02-16,True,The People's Hospital of Guangxi Zhuang Autonomous Region,Not Recruiting,Not Applicable,Observational,China,The relationship between Vitamin D andnovel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=51390,None
479,ChiCTR2000031150,ChiCTR,2020-03-23,2020-04-01,False,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Health services research,China,Application of radiology in the prevention and control system of emergency respiratory infectious diseases,Other (radiology),Radiology,Radiology,150,http://www.chictr.org.cn/showproj.aspx?proj=51021,None
480,ChiCTR2000031140,ChiCTR,2020-03-22,2020-02-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the impact on fetus and neonates of vertical transmission of 2019-nCoV,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=50605,None
481,ChiCTR2000031139,ChiCTR,2020-03-22,2020-03-20,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),ATMP,Cells (stem cells),Cells (stem cells),20,http://www.chictr.org.cn/showproj.aspx?proj=51404,None
482,ChiCTR2000031138,ChiCTR,2020-03-22,2020-02-26,True,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),Drug,Pirfenidone,Pirfenidone,40,http://www.chictr.org.cn/showproj.aspx?proj=51416,None
483,ChiCTR2000031115,ChiCTR,2020-03-22,2020-05-01,False,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study of peripheral blood T lymphocyte subsets in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=51032,None
484,ChiCTR2000031104,ChiCTR,2020-03-22,2020-02-05,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51185,None
485,ChiCTR2000031090,ChiCTR,2020-03-22,2020-03-23,False,Ningbo Kangning Hospital,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=51148,None
486,ChiCTR2000031089,ChiCTR,2020-03-22,2020-03-13,True,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=51136,None
487,ChiCTR2000031088,ChiCTR,2020-03-22,2020-02-09,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Observational,China,A prognosis study of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,314,http://www.chictr.org.cn/showproj.aspx?proj=51132,None
488,ChiCTR2000031023,ChiCTR,2020-03-21,2020-03-16,True,Hu'nan Cancer Hospital,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,Prognosis,No Intervention,No Intervention,320,http://www.chictr.org.cn/showproj.aspx?proj=50984,None
489,ChiCTR2000031014,ChiCTR,2020-03-21,2020-03-19,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Not Recruiting,Not Applicable,Observational,China,A Study for SARS-COV-2 RNA Level in Blood and Excrement of Novel Coronavirus Pneumonia (COVID-19) Convalescent Patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51348,None
490,ChiCTR2000030996,ChiCTR,2020-03-20,2020-03-18,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=51349,None
491,ChiCTR2000030993,ChiCTR,2020-03-20,2020-03-12,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,A medical records based study for the value of Upper Respiratory Tract Virus Detection in the assessment of rehabilitation of novel coronavirus pneumonia (COVID-19) patient,Prognosis,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=51342,None
492,ChiCTR2000030992,ChiCTR,2020-03-20,2020-03-10,True,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Diagnostic test,No Country Given,A medical records based study for the diagnosis and prognosis prediction AI model of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.chictr.org.cn/showproj.aspx?proj=51338,None
493,ChiCTR2000030989,ChiCTR,2020-03-20,2020-03-20,False,Beijing Normal University,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,Other (psych),Psychological,Psychological,76,http://www.chictr.org.cn/showproj.aspx?proj=51331,None
494,ChiCTR2000030986,ChiCTR,2020-03-20,2020-03-20,False,Shenzhen Third People's Hospital,Recruiting,Not Applicable,Observational,China,Correlation of T lymphocytes level and clinical severity in novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51316,None
495,ChiCTR2000030985,ChiCTR,2020-03-20,2020-03-04,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Psychological Responses of Medical Staff during the Metaphase of novel coronavirus pneumonia (COVID-19) Outbreak in Hubei, China",Other (psych),No Intervention,No Intervention,1300,http://www.chictr.org.cn/showproj.aspx?proj=51311,None
496,ChiCTR2000030961,ChiCTR,2020-03-20,2020-01-01,True,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Observational,No Country Given,"A Medical Records Based Retrospective Study for Clinical Characteristics, Treatments and Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19) in WuHan",Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51291,None
497,ChiCTR2000030952,ChiCTR,2020-03-19,2020-01-18,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Myocardial injury and arrythmias in the novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,93,http://www.chictr.org.cn/showproj.aspx?proj=51278,None
498,ChiCTR2000030951,ChiCTR,2020-03-19,2020-03-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Developing and evaluating of artificial intelligence triage system for suspected novel coronavirus pneumonia (COVID-19): a retrospective study,Other (software),No Intervention,No Intervention,2500,http://www.chictr.org.cn/showproj.aspx?proj=51283,None
499,ChiCTR2000030950,ChiCTR,2020-03-19,2020-02-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Basic Science,China,Study for novel coronavirus pneumonia (COVID-19) patients etiology and immune response and guidance for vaccine design,Clinical Presentation,No Intervention,No Intervention,50,http://www.chictr.org.cn/showproj.aspx?proj=51272,None
500,ChiCTR2000030947,ChiCTR,2020-03-19,2020-02-11,True,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,Oxygen,34,http://www.chictr.org.cn/showproj.aspx?proj=51267,None
501,ChiCTR2000030946,ChiCTR,2020-03-19,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),Drug,Heparin,Heparin,120,http://www.chictr.org.cn/showproj.aspx?proj=51265,None
502,ChiCTR2000030944,ChiCTR,2020-03-18,2020-09-01,False,The Second Affiliated Hospital of Nanchang University,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),ATMP,"Cells, (mesenchymal/NK)",Cells (mesenchymal); Cells (NK),20,http://www.chictr.org.cn/showproj.aspx?proj=50199,None
503,ChiCTR2000030943,ChiCTR,2020-03-18,2020-03-31,False,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Venous Thrombosis Risk of novel coronavirus pneumonia (COVID-19) Patients: A Prospective Study,Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50898,None
504,ChiCTR2000030942,ChiCTR,2020-03-18,2020-01-20,True,Shanghai Kongjiang Hospital,Not Recruiting,Not Applicable,Observational,China,Combined diagnostic value of novel coronavirus (2019-CoV) infection detected by NLR and CRP,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,191,http://www.chictr.org.cn/showproj.aspx?proj=50981,None
505,ChiCTR2000030941,ChiCTR,2020-03-18,2020-01-28,True,"Hu'nan Provincial People's Hospital, Hu'nan Normal University",Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical features and prognosis of severe patients with novel coronavirus pneumonia (COVID-19) in Huanggan, Hubei in Huanggang.",Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51000,None
506,ChiCTR2000030939,ChiCTR,2020-03-18,2020-03-16,True,PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Gene-derived protein,Gene-derived protein,10,http://www.chictr.org.cn/showproj.aspx?proj=51059,None
507,ChiCTR2000030934,ChiCTR,2020-03-18,2020-03-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Novel Coronavirus (2019-COV),Other (software),No Intervention,No Intervention,90,http://www.chictr.org.cn/showproj.aspx?proj=51160,None
508,ChiCTR2000030933,ChiCTR,2020-03-18,2020-03-31,False,The First Affiliated Hospital of Nanchang University,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,108,http://www.chictr.org.cn/showproj.aspx?proj=51184,None
509,ChiCTR2000030932,ChiCTR,2020-03-18,2020-02-01,True,Anqing Municipal Hospital,Recruiting,Not Applicable,Observational,China,Correlation between virological negative conversion and clinical factors and prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51230,None
510,ChiCTR2000030931,ChiCTR,2020-03-18,2020-03-23,False,HuiZhou Municipal Central Hospital,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Characteristic and Outcomes of Hospitalized Patients With Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=51212,None
511,ChiCTR2000030929,ChiCTR,2020-03-17,2020-03-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",ATMP,Plasma,Plasma,60,http://www.chictr.org.cn/showproj.aspx?proj=50696,None
512,ChiCTR2000030922,ChiCTR,2020-03-17,2020-02-26,True,Foshan First People's Hospital,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon + Ribavirin vs. Umifenovir + Ribavirin,Interferon; Ribavirin; Umifenovir,30,http://www.chictr.org.cn/showproj.aspx?proj=51141,None
513,ChiCTR2000030920,ChiCTR,2020-03-17,2020-02-20,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50476,None
514,ChiCTR2000030919,ChiCTR,2020-03-17,2020-03-20,False,Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,An observational study for cardiac and pulmonary ultrasound and evaluation of treatment of severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=51149,None
515,ChiCTR2000030906,ChiCTR,2020-03-17,2020-03-10,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),ATMP,Adenovirus vector,Adenovirus vector,108,http://www.chictr.org.cn/showproj.aspx?proj=51154,None
516,ChiCTR2000030771,ChiCTR,2020-03-14,2020-03-01,True,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Diagnostic test,China,Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies,Genomics,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=50961,None
517,ChiCTR2000030765,ChiCTR,2020-03-13,2019-12-01,True,The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine,Not Recruiting,Not Applicable,Epidemiological research,China,Cancelled by the investigator                 Clinical guidance of diagnose and treatment for novel coronavirus pneumonia (COVID-19) based on ''Shi-Du-Yi'',Cancelled,Cancelled,Cancelled,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50964,None
518,ChiCTR2000030539,ChiCTR,2020-03-06,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,Drug,Hydrogen peroxide,Hydrogen peroxide,40,http://www.chictr.org.cn/showproj.aspx?proj=50660,None
519,ChiCTR2000030519,ChiCTR,2020-03-05,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=50604,None
520,ChiCTR2000030254,ChiCTR,2020-02-26,2020-02-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirus–infected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",Drug,Favipiravir vs. Umifenovir,Favipiravir; Umifenovir,240,http://www.chictr.org.cn/showproj.aspx?proj=50137,None
521,ChiCTR2000030224,ChiCTR,2020-02-26,2020-02-26,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                Clinical study of mesenchymal stem cells in treating severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),32,http://www.chictr.org.cn/showproj.aspx?proj=49968,None
522,ChiCTR2000030168,ChiCTR,2020-02-24,2020-02-29,False,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Observational,China,Cancelled by the investigator                   A real world study for Compound Houttuyniae Mixture for prevention of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,2000,http://www.chictr.org.cn/showproj.aspx?proj=49433,None
523,ChiCTR2000030095,ChiCTR,2020-02-23,2020-02-23,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Observational,China,A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia,Clinical Presentation,No Intervention,No Intervention,94,http://www.chictr.org.cn/showproj.aspx?proj=49845,None
524,ChiCTR2000029955,ChiCTR,2020-02-17,2020-03-01,False,"West China Second Hospital, Sichuan University",Not Recruiting,Not Applicable,Diagnostic test,China,Evaluation of myocardial injury of novel coronavirus pneumonia (COVID-19) assessed by multimodal MRI imaging,Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=49531,None
525,ChiCTR2000029868,ChiCTR,2020-02-15,2020-02-11,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",Drug,Hydroxychloroquine,Hydroxychloroquine,360,http://www.chictr.org.cn/showproj.aspx?proj=49524,None
526,ChiCTR2000029830,ChiCTR,2020-02-15,2020-02-14,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,"A study for the psychological status, social support, and care needs of tumor patients admitted to a general hospital during the novel coronavirus pneumonia (COVID-19) outbreak",Other (psych),No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=49511,None
527,ChiCTR2000029658,ChiCTR,2020-02-09,2020-02-10,False,Central Theater General Hospital of PLA,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,60,http://www.chictr.org.cn/showproj.aspx?proj=49074,None
528,ChiCTR2000029573,ChiCTR,2020-02-05,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",ATMP,Gene-derived protein,Gene-derived protein,480,http://www.chictr.org.cn/showproj.aspx?proj=49065,None
529,ChiCTR2000029496,ChiCTR,2020-02-03,2020-01-29,True,The First Hospital of Changsha; The Second Xiangya Hospital of Central South University,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",ATMP,Gene-derived protein,Gene-derived protein,90,http://www.chictr.org.cn/showproj.aspx?proj=48809,None
530,EUCTR2020-000890-25-FR,EU Clinical Trials Register,2020-03-10,2020-03-05,True,Fondation Méditerranée Infection (FMI) - IHU Méditerranée Infection,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,25,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25,None
531,JPRN-UMIN000039686,JPRN,2020-03-06,2020-02-01,True,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Japan, Australia, Asia, Europe",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease,Drug,Oxygen,Oxygen,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045268,None
532,NCT04251767,ClinicalTrials.gov,2020-01-30,2020-02-05,False,The Second Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,ATMP,Intestinal microbiome,Intestinal microbiome,0,https://clinicaltrials.gov/show/NCT04251767,None
533,NCT04254874,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Drug,Interferon + Umifenovir vs. Umifenovir,Interferon; Umifenovir,100,https://clinicaltrials.gov/show/NCT04254874,None
534,NCT04255017,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Drug,Umeprevir vs. Oseltamivir vs. lopinavir/ritonavir,Umeprevir; Oseltamivir; Lopinavir/ritonavir,400,https://clinicaltrials.gov/show/NCT04255017,None
535,NCT04261270,ClinicalTrials.gov,2020-02-04,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Drug,ASCO9F + Ritonavir vs. Ritonavir + Oseltamivir vs. Oseltamivir,ASCO9F; Ritonavir; Oseltamivir,60,https://clinicaltrials.gov/show/NCT04261270,None
536,NCT04263402,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Drug,Corticosteroids,Methylprednisolone,100,https://clinicaltrials.gov/show/NCT04263402,None
537,NCT04264858,ClinicalTrials.gov,2020-02-08,2020-03-17,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,ATMP,Immunoglobulin,Immunoglobulin,10,https://clinicaltrials.gov/show/NCT04264858,None
538,NCT04272710,ClinicalTrials.gov,2020-02-12,2020-01-25,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,Drug,ACE inhibitors,ACE inhibitors,0,https://clinicaltrials.gov/show/NCT04272710,None
539,NCT04276896,ClinicalTrials.gov,2020-02-17,2020-03-24,False,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04276896,None
540,NCT04283396,ClinicalTrials.gov,2020-02-13,2020-02-21,False,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Study for Novel Coronavirus Pneumonia (NCP),Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04283396,None
541,NCT04287686,ClinicalTrials.gov,2020-02-21,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,ACE enzyme,0,https://clinicaltrials.gov/show/NCT04287686,None
542,NCT04291053,ClinicalTrials.gov,2020-02-27,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,550,https://clinicaltrials.gov/show/NCT04291053,None
543,NCT04292964,ClinicalTrials.gov,2020-03-01,2020-03-01,False,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,No Intervention,201,https://clinicaltrials.gov/show/NCT04292964,None
544,NCT04293692,ClinicalTrials.gov,2020-02-24,2020-02-24,False,Puren Hospital Affiliated to Wuhan University of Science and Technology,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,ATMP,Cells (mesenchymal),Cells (mesenchymal),0,https://clinicaltrials.gov/show/NCT04293692,None
545,NCT04304313,ClinicalTrials.gov,2020-02-14,2020-02-09,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,Drug,Sildenafil,Sildenafil,10,https://clinicaltrials.gov/show/NCT04304313,None
546,NCT04305574,ClinicalTrials.gov,2020-03-08,2020-03-08,False,Jean Liu,Recruiting,Not Applicable,Observational,Singapore,Social Media Use During COVID-19,Other,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04305574,None
547,NCT04306705,ClinicalTrials.gov,2020-03-08,2020-02-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,Drug,Tocilizumab,Tocilizumab,120,https://clinicaltrials.gov/show/NCT04306705,None
548,NCT04308317,ClinicalTrials.gov,2020-03-04,2020-03-05,False,Henan Provincial People's Hospital,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,Drug,Tetrandrine,Tetrandrine,60,https://clinicaltrials.gov/show/NCT04308317,None
549,NCT04312100,ClinicalTrials.gov,2020-03-13,2020-02-01,True,Henan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04312100,None
550,NCT04312464,ClinicalTrials.gov,2020-03-04,2020-01-01,True,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Myocardial Damage in COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04312464,None
551,NCT04313322,ClinicalTrials.gov,2020-03-15,2020-03-16,False,Stem Cells Arabia,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,https://clinicaltrials.gov/show/NCT04313322,None
552,NCT04314271,ClinicalTrials.gov,2020-03-16,2020-03-20,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04314271,None
553,NCT04314817,ClinicalTrials.gov,2020-03-17,2020-03-17,False,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04314817,None
554,NCT04315870,ClinicalTrials.gov,2020-03-18,2020-01-01,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04315870,None
555,NCT04316728,ClinicalTrials.gov,2020-03-14,2020-03-01,True,"Centro Studi Internazionali, Italy",Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04316728,None
556,NCT04316884,ClinicalTrials.gov,2020-03-13,2020-03-12,True,Uppsala University,Recruiting,Not Applicable,Observational,Sweden,Mechanisms for Organ Dysfunction in Covid-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04316884,None
557,NCT04318418,ClinicalTrials.gov,2020-03-19,2020-03-23,False,Neuromed IRCCS,Not Recruiting,Not Applicable,Observational,Italy,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,5000,https://clinicaltrials.gov/show/NCT04318418,None
558,ChiCTR2000031366,ChiCTR,2020-03-29,2020-04-01,False,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Observational,China,Causes of fever in outpatient outside Wuhan during novel coronavirus pneumonia pandemic: a medical records based retrospective analysis,Clinical Presentation,No Intervention,No Intervention,5000,http://www.chictr.org.cn/showproj.aspx?proj=51692,None
559,ChiCTR2000031365,ChiCTR,2020-03-29,2020-01-17,True,Westlake University,Recruiting,Not Applicable,Diagnostic test,China,To explore the pathogenesis and course prediction of novel coronavirus pneumonia (COVID-19) severe patients,Prognosis,No Intervention,No Intervention,0,http://www.chictr.org.cn/showproj.aspx?proj=51694,None
560,ChiCTR2000031361,ChiCTR,2020-03-28,2020-03-31,False,Hubei Maternal and Child Health Care Hospital,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of anesthesia management of emergency cesarean section in non-pneumonia hospital of Wuhan during pandemic of novel coronavirus pneumonia (COVID-19),Drug,Other,Other,2000,http://www.chictr.org.cn/showproj.aspx?proj=51385,None
561,ChiCTR2000031356,ChiCTR,2020-03-28,2020-04-12,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the changes of the brain structure and function in healed patients of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=51499,None
562,ChiCTR2000031337,ChiCTR,2020-03-28,2020-03-18,True,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,"The relationship between habits of using eyes, degree of visual fatigue and myopia progression in students during the novel coronavirus pneumonia (COVID-19) pandemic",Clinical Presentation,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=51170,None
563,ChiCTR2000031336,ChiCTR,2020-03-28,2020-04-12,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,AI based prognostic evaluation of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=51517,None
564,ChiCTR2000031330,ChiCTR,2020-03-27,2020-03-18,True,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,Analysis for prevention and control effects of orthokeratology lens on myopia adolescents during the novel coronavirus pneumonia (COVID-19) pandemic situation,Other (device),Orthokeratology lens,Orthokeratology lens,160,http://www.chictr.org.cn/showproj.aspx?proj=51504,None
565,ChiCTR2000031329,ChiCTR,2020-03-27,2020-03-11,True,Guangdong Second Provincial General Hospital,Recruiting,Not Applicable,Observational,No Country Given,"Influence of novel coronavirus pneumonia (COVID-19) on disease activity, medical and mental condition of patients with rheumatic diseases",Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=51667,None
566,ChiCTR2000031328,ChiCTR,2020-03-27,2020-03-13,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,Other,Sleep aids,Sleep aids,60,http://www.chictr.org.cn/showproj.aspx?proj=51425,None
567,ChiCTR2000031324,ChiCTR,2020-03-27,2020-04-10,False,Nanjing University Medical College Affiliated Drum Tower Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,The investigation on medical adhesive-related skin injury caused by protective dressings of medical staffs during the period of novel coronavirus pneumonia (COVID-19),Other (device),No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=51668,None
568,ChiCTR2000031319,ChiCTR,2020-03-27,2020-04-01,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=51647,None
569,ChiCTR2000031301,ChiCTR,2020-03-27,2020-02-01,True,China-Japan Union Hospital of Jilin Unversity,Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical characteristics and prognosis of novel coronavirus pneumonia (COVID-19) patients with myocardial injury,Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51603,None
570,ChiCTR2000031296,ChiCTR,2020-03-27,2020-01-14,True,Yichang Central People's Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for clinical features of novel coronavirus pneumonia (COVID-19) patients and risk factors of death,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51584,None
571,ChiCTR2000031293,ChiCTR,2020-03-27,2020-03-16,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Epidemiological study of novel coronavirus infection (COVID-19) in children at medium/low risk,Clinical Presentation (Epidemiology),No Intervention,No Intervention,240,http://www.chictr.org.cn/showproj.aspx?proj=51629,None
572,ChiCTR2000031272,ChiCTR,2020-03-26,2020-02-18,True,China European International Business School (CEIBS),Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,Psychological,110,http://www.chictr.org.cn/showproj.aspx?proj=51455,None
573,ChiCTR2000031271,ChiCTR,2020-03-26,2020-04-01,False,The Third Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=51194,None
574,ChiCTR2000031252,ChiCTR,2020-03-25,2020-02-10,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Outcomes and infectivity of patients with asymptomatic novel coronavirus (COVID-19) infection,Clinical Presentation,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=51559,None
575,ChiCTR2000031247,ChiCTR,2020-03-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,No Country Given,Study on the mental state of medical staff  during the epidemic period of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=51540,None
576,ChiCTR2000031246,ChiCTR,2020-03-25,2020-02-01,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Epidemiological survey of close contacts of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,68,http://www.chictr.org.cn/showproj.aspx?proj=51535,None
577,ChiCTR2000031245,ChiCTR,2020-03-25,2020-01-25,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Epidemiologic and Clinical Characteristics of novel coronavirus pneumonia (COVID-19) in surgical patients: a medical records based retrospective study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51518,None
578,ChiCTR2000031244,ChiCTR,2020-03-25,2020-03-25,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Shedding virus and functional prognosis in patients with novel coronavirus pneumonia (COVID-19): a medical records based study,Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51486,None
579,ChiCTR2000031227,ChiCTR,2020-03-25,2020-03-26,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,No Country Given,"Clinical features and prognosis of invasive echanicalventilation patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China: a single-centered, retrospective, observational study",Other (physical),Mechanical ventilation,Mechanical ventilation,40,http://www.chictr.org.cn/showproj.aspx?proj=51473,None
580,ChiCTR2000031214,ChiCTR,2020-03-24,2020-03-31,False,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study on the correlation between novel coronavirus pneumonia (COVID-19) clinical rehabilitation assessment and prognosis,Prognosis,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=51509,None
581,ChiCTR2000031204,ChiCTR,2020-03-24,2020-01-30,True,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine,Chloroquine,300,http://www.chictr.org.cn/showproj.aspx?proj=49420,None
582,ChiCTR2000031203,ChiCTR,2020-03-24,2020-03-16,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,28,http://www.chictr.org.cn/showproj.aspx?proj=51030,None
583,ChiCTR2000031198,ChiCTR,2020-03-23,2020-04-01,False,Nothern Jiangsu People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=51488,None
584,ChiCTR2000031196,ChiCTR,2020-03-23,2020-01-10,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,Drug,Lopinavir/ritonavir + Interferon,Lopinavir/ritonavir; Interferon,90,http://www.chictr.org.cn/showproj.aspx?proj=51112,None
585,ChiCTR2000031187,ChiCTR,2020-03-23,2020-03-23,False,Wuhan Third Hospital; Tongren Hospital of Wuhan University,Not Recruiting,Not Applicable,Epidemiological research,China,A medical records based retrospective study for novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,1292,http://www.chictr.org.cn/showproj.aspx?proj=51442,None
586,ChiCTR2000031176,ChiCTR,2020-03-23,2020-02-20,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,Study on home pharmaceutical care for chronic patients over the novel coronavirus pneumonia (COVID-19) epidemic,Other,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51443,None
587,ChiCTR2000030988,ChiCTR,2020-03-20,2020-03-23,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,204,http://www.chictr.org.cn/showproj.aspx?proj=51317,None
588,ChiCTR2000030962,ChiCTR,2020-03-20,2020-03-01,True,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Clinical efficacy of TCM syndrome differentiation in the treatment of severe/critical type of novel coronavirus pneumonia (COVID-19): a prospective, observational, one-arm clinical study",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=51254,None
589,ChiCTR2000030940,ChiCTR,2020-03-18,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,76,http://www.chictr.org.cn/showproj.aspx?proj=51061,None
590,ChiCTR2000030938,ChiCTR,2020-03-18,2020-02-28,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical investigation and reseach on TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=51239,None
591,ChiCTR2000030937,ChiCTR,2020-03-18,2020-03-19,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,144,http://www.chictr.org.cn/showproj.aspx?proj=51240,None
592,ChiCTR2000030936,ChiCTR,2020-03-18,2020-03-10,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,2840,http://www.chictr.org.cn/showproj.aspx?proj=51100,None
593,ChiCTR2000030923,ChiCTR,2020-03-17,2020-02-15,True,Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=51139,None
594,ChiCTR2000030817,ChiCTR,2020-03-15,2020-02-28,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Multicenter clinical study of evaluation of multi-organ function in patients with novel coronavirus pneumonia (COVID-19) by ultrasound,Clinical Presentation,No Intervention,No Intervention,800,http://www.chictr.org.cn/showproj.aspx?proj=50631,None
595,ChiCTR2000030704,ChiCTR,2020-03-10,2020-02-10,True,The First People's Hospital of Jiangxia District,No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50778,None
596,ChiCTR2000030330,ChiCTR,2020-02-28,2020-02-28,False,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),No Status Given,Not Applicable,Observational,China,Cancelled by the investigator                               Clinical research of 6-minute walk training on motor function of novel coronavirus pneumonia (COVID-19),Other (exercise),Exercise,Exercise,10,http://www.chictr.org.cn/showproj.aspx?proj=50274,None
597,ChiCTR2000030288,ChiCTR,2020-02-27,2020-02-27,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,204,http://www.chictr.org.cn/showproj.aspx?proj=50202,None
598,ChiCTR2000030256,ChiCTR,2020-02-26,2020-02-01,True,"Daping Hospital, Army Medical University",Not Recruiting,Not Applicable,Epidemiological research,China,"Epidemiological and clinical characteristics of COVID-19: a large-scale investigation in epicenter Wuhan, China",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=50078,None
599,ChiCTR2000030198,ChiCTR,2020-02-25,2020-02-24,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,http://www.chictr.org.cn/showproj.aspx?proj=50066,None
600,ChiCTR2000030028,ChiCTR,2020-02-20,2020-02-24,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,PD1,PD1,40,http://www.chictr.org.cn/showproj.aspx?proj=49840,None
601,ChiCTR2000029982,ChiCTR,2020-02-18,2020-03-26,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Prediction of prognosis and antiviral effect of patients with neocoronavirus infected pneumonia based on Peripheral blood exosomal metabolomics analysis and radiomics in CT of lung and its mechanism,Genomics,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=49724,None
602,EUCTR2020-000919-69-NL,EU Clinical Trials Register,2020-03-17,2020-03-17,False,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-Guérin,ATMP,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69,None
603,NCT04288713,ClinicalTrials.gov,2020-02-27,2020-02-25,True,Hudson Medical,Not Recruiting,Phase 2,Expanded Access,No Country Given,Eculizumab (Soliris) in Covid-19 Infected Patients,Drug,Eculizumab,Eculizumab,Not Available,https://clinicaltrials.gov/show/NCT04288713,None
604,NCT04290871,ClinicalTrials.gov,2020-02-27,2020-03-23,False,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Drug,Nitric oxide,Nitric oxide,0,https://clinicaltrials.gov/show/NCT04290871,None
605,NCT04305106,ClinicalTrials.gov,2020-03-09,2020-03-17,False,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Drug,Bevacizumab,Bevacizumab,140,https://clinicaltrials.gov/show/NCT04305106,None
606,NCT04316299,ClinicalTrials.gov,2020-03-17,2020-02-26,True,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Acute Kidney Injury in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,No Intervention,287,https://clinicaltrials.gov/show/NCT04316299,None
607,NCT04319211,ClinicalTrials.gov,2020-03-20,2020-03-25,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",Other,Social Isolation,Social Isolation,200,https://clinicaltrials.gov/show/NCT04319211,None
608,NCT04319900,ClinicalTrials.gov,2020-03-20,2020-03-05,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Drug,Chloroquine + Favipiravir vs. Favipiravir,Chloroquine; favipiravir,150,https://clinicaltrials.gov/show/NCT04319900,ChiCTR2000030987
609,NCT04322344,ClinicalTrials.gov,2020-03-23,2020-03-23,False,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04322344,None
610,NCT04322786,ClinicalTrials.gov,2020-03-23,1998-01-01,True,"University College, London",Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",Drug,ACE inhibitors,ACE inhibitors,1302508,https://clinicaltrials.gov/show/NCT04322786,None
611,NCT04323332,ClinicalTrials.gov,2020-03-08,2020-03-01,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,50,https://clinicaltrials.gov/show/NCT04323332,None
612,NCT04323514,ClinicalTrials.gov,2020-03-18,2020-03-13,True,University of Palermo,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,Drug,Vitamin C,Vitamin C,500,https://clinicaltrials.gov/show/NCT04323514,None
613,NCT04323631,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Rambam Health Care Campus,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Drug,Hydroxychloroquine,Hydroxychloroquine,1116,https://clinicaltrials.gov/show/NCT04323631,None
614,NCT04324866,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Universita di Verona,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04324866,None
615,NCT04324996,ClinicalTrials.gov,2020-03-25,2020-03-21,True,Chongqing Public Health Medical Center,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,ATMP,Cells (NK),Cells (NK),90,https://clinicaltrials.gov/show/NCT04324996,None
616,NCT04325412,ClinicalTrials.gov,2020-03-25,2020-03-23,True,UMC Utrecht,Recruiting,Not Applicable,Observational,Netherlands,Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04325412,None
617,NCT04325919,ClinicalTrials.gov,2020-03-24,2020-02-24,True,Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,Clinical Presentation,No Intervention,No Intervention,170,https://clinicaltrials.gov/show/NCT04325919,None
618,NCT04326309,ClinicalTrials.gov,2020-03-26,2020-03-25,True,HealthMode Inc.,Recruiting,Not Applicable,Observational,United States,Audio Data Collection for Identification and Classification of Coughing,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04326309,None
619,NCT04331860,ClinicalTrials.gov,2020-03-30,2020-03-30,False,RAD-AID International,Recruiting,Not Applicable,Observational,United States,COVID-19 Public Image Registry,Clinical Presentation,No Intervention,No Intervention,500000,https://clinicaltrials.gov/show/NCT04331860,None
620,ISRCTN14966673,ISRCTN,2020-03-18,2020-03-20,False,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://isrctn.com/ISRCTN14966673,None
621,ChiCTR2000031639,ChiCTR,2020-04-05,2020-03-27,True,Peking University Sixth Hospital,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,192,http://www.chictr.org.cn/showproj.aspx?proj=51119,None
622,ChiCTR2000031630,ChiCTR,2020-04-05,2020-02-17,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Celecoxib,Celecoxib,60,http://www.chictr.org.cn/showproj.aspx?proj=50474,None
623,ChiCTR2000031627,ChiCTR,2020-04-05,2020-04-20,False,Second People's Hospital of Fuyang City,Not Recruiting,Not Applicable,Basic Science,China,Study for the Mechanism of the Relationship between Infection of novel coronavirus pneumonia (COVID-19) and Host Innate Immune,Clinical Presentation,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=51865,None
624,ChiCTR2000031589,ChiCTR,2020-04-05,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Investigation for the sleep quality in non-health care workers during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,462,http://www.chictr.org.cn/showproj.aspx?proj=51969,None
625,ChiCTR2000031587,ChiCTR,2020-04-04,2020-01-27,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"A paired clinical study for novel coronavirus pneumonia (COVID-19) patients with ordinary, severe, critical, and deceased patients in Tongji Hospital",Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51952,None
626,ChiCTR2000031540,ChiCTR,2020-04-03,2020-02-05,True,Affiliated Hospital of Zunyi Medical University,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.chictr.org.cn/showproj.aspx?proj=51684,None
627,ChiCTR2000031538,ChiCTR,2020-04-03,2020-04-03,False,"Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Health services research,China,Assessment of mental health status of first-line dental emergency medical personnel during novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,No Intervention,123,http://www.chictr.org.cn/showproj.aspx?proj=51938,None
628,ChiCTR2000031533,ChiCTR,2020-04-03,2020-04-10,False,Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Health services research,China,Survey of psychological status and related factors of emergency medical staff in the country during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,No Intervention,7000,http://www.chictr.org.cn/showproj.aspx?proj=51835,None
629,ChiCTR2000031504,ChiCTR,2020-04-03,2019-12-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multi-center telephone follow-up study of disease management and infection in rheumatic patients during novel coronavirus pneumonia (COVID-19) pandemic in Hubei province,Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51781,None
630,ChiCTR2000031503,ChiCTR,2020-04-03,2020-04-01,True,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),Other (device),Cardiopulmonary monitoring,Cardiopulmonary monitoring,100,http://www.chictr.org.cn/showproj.aspx?proj=51911,None
631,ChiCTR2000031501,ChiCTR,2020-04-02,2020-03-17,True,Eastern Theater General Hospital,Not Recruiting,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",ATMP,Plasma,Plasma,20,http://www.chictr.org.cn/showproj.aspx?proj=50254,None
632,ChiCTR2000031500,ChiCTR,2020-04-02,2020-03-05,True,Peking University First Hospital,Not Recruiting,Not Applicable,Health services research,China,Impact of measuring distance and cold outdoor environment on the screening of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,58,http://www.chictr.org.cn/showproj.aspx?proj=51897,None
633,ChiCTR2000031499,ChiCTR,2020-04-02,2020-02-10,True,Shanghai Oriental Hospital,Not Recruiting,Not Applicable,Observational,China,Sleep quality of patients with novel coronavirus pneumonia (COVID-19) treated in mobile cabin hospital: a retrospective study,Other,Sleep aids,Sleep aids,55,http://www.chictr.org.cn/showproj.aspx?proj=51915,None
634,ChiCTR2000031494,ChiCTR,2020-04-02,2020-02-01,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),36,http://www.chictr.org.cn/showproj.aspx?proj=51904,None
635,ChiCTR2000031465,ChiCTR,2020-04-02,2020-03-25,True,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus (2019-nCOV) IgG detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=51538,None
636,ChiCTR2000031454,ChiCTR,2020-04-01,2020-01-25,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),Drug,Rabeprazole + chloroquine vs. lopinavir + rabeprazole,Rabeprazole; chloroquine; lopinavir; rabeprazole,56,http://www.chictr.org.cn/showproj.aspx?proj=51693,None
637,ChiCTR2000031453,ChiCTR,2020-04-01,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",Drug,Nintedanib,Nintedanib,80,http://www.chictr.org.cn/showproj.aspx?proj=51859,None
638,ChiCTR2000031439,ChiCTR,2020-04-01,2020-03-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,A medical records based study for novel coronavirus pneumonia (COVID-19) patients undergoing endotracheal intubation,Other (physical),Mechanical ventilation,Mechanical ventilation,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51837,None
639,ChiCTR2000031438,ChiCTR,2020-04-01,2020-04-01,False,Affiliated Hospital of Southwest Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of changes in high risk factors of cervical spondylosis during novel coronavirus pneumonia (COVID-19) pandemic,Clinical Presentation,No Intervention,No Intervention,820,http://www.chictr.org.cn/showproj.aspx?proj=51815,None
640,ChiCTR2000031432,ChiCTR,2020-03-31,2020-05-01,False,Nanjing University,Not Recruiting,Phase 1,Basic Science,China,A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adults,ATMP,RNA Plasmid,RNA Plasmid,15,http://www.chictr.org.cn/showproj.aspx?proj=51646,None
641,ChiCTR2000031430,ChiCTR,2020-03-31,2020-03-20,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,ATMP,Cells (mesenchymal),Cells (mesenchymal),200,http://www.chictr.org.cn/showproj.aspx?proj=49254,None
642,ChiCTR2000031429,ChiCTR,2020-03-31,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"The Effects of novel coronavirus pneumonia (COVID-19) Risk Factors on Dynamic Changes of  Immunological, biochemical, and Metabolic Parameters: a Retrospective Observational Study",Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51816,None
643,ChiCTR2000031428,ChiCTR,2020-03-31,2020-02-05,True,Wuhan Asia Heart Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical application value of multiple tests for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://www.chictr.org.cn/showproj.aspx?proj=51813,None
644,ChiCTR2000031427,ChiCTR,2020-03-31,2020-03-25,True,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus infection (COVID-19) IgM detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=51809,None
645,ChiCTR2000031376,ChiCTR,2020-03-29,2020-03-28,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for safety and effectiveness analysis of data from novel coronavirus pneumonia (COVID-19) patients with conventional therapy,Drug,Unspecified Drug,Unspecified Drug,600,http://www.chictr.org.cn/showproj.aspx?proj=51724,None
646,ChiCTR2000031199,ChiCTR,2020-03-23,2020-02-04,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,A Medical Records Based Retrospective Study for Clinical Characteristics of severe Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=51478,None
647,EUCTR2020-001271-33-FR,EU Clinical Trials Register,2020-03-24,2020-03-31,False,CHU Angers,Authorised,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19 à risque d’aggravation secondaire : étude prospective multicentrique randomisée en double aveugle,Drug,Hydroxychloroquine,Hydroxychloroquine,1300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33,None
648,EUCTR2020-001281-11-FR,EU Clinical Trials Register,2020-03-26,2020-03-30,False,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration/viral effect relationship of hydroxychloroquine in COVID-19 patients in the intensive care unit..,Drug,Hydroxychloroquine,Hydroxychloroquine,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001281-11,None
649,EUCTR2020-001236-10-NL,EU Clinical Trials Register,2020-03-31,2020-03-31,False,UMC Amsterdam,Authorised,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,Drug,Imatinib,Imatinib,304,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,None
650,EUCTR2020-001010-38-NO,EU Clinical Trials Register,2020-03-16,2020-03-23,False,Akershus University Hospital,Authorised,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,Drug,Hydroxychloroquine,Hydroxychloroquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38,None
651,ACTRN12620000421932,ANZCTR,2020-03-30,2020-03-05,True,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Indonesia, Japan, Vietnam, Thailand, United States, Singapore, Hong Kong, Italy, Australia, China, South Korea, United Kingdom",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease (COVID-19),Drug,Oxygen,Oxygen,400,https://anzctr.org.au/ACTRN12620000421932.aspx,None
652,NCT03331445,ClinicalTrials.gov,2017-10-25,2017-10-24,True,University of British Columbia,Not Recruiting,Phase 2,Interventional,Canada,Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections,Pre 2020,Pre 2020,Pre 2020,20,https://clinicaltrials.gov/show/NCT03331445,None
653,NCT04275414,ClinicalTrials.gov,2020-02-14,2020-02-15,False,Qilu Hospital of Shandong University,Recruiting,Phase 2/Phase 3,Interventional,"China, Italy",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Drug,Bevacizumab,Bevacizumab,20,https://clinicaltrials.gov/show/NCT04275414,None
654,NCT04298060,ClinicalTrials.gov,2020-02-28,2020-04-01,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Drug,DAS181,DAS181,280,https://clinicaltrials.gov/show/NCT04298060,None
655,NCT04320238,ClinicalTrials.gov,2020-03-21,2020-01-21,True,Shanghai Jiaotong University,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,Drug,Interferon Alpha vs. Interferon Alpha + Thymosin Alpha,Interferon alpha; Thymosin alpha,2944,https://clinicaltrials.gov/show/NCT04320238,None
656,NCT04321811,ClinicalTrials.gov,2020-03-23,2020-03-21,True,xCures,Recruiting,Not Applicable,Observational,United States,"Behavior, Environment And Treatments for Covid-19",Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04321811,None
657,NCT04323878,ClinicalTrials.gov,2020-03-25,2020-04-06,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Observational,No Country Given,Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.,Other (physical),Mechanical ventilation,Mechanical ventilation,3000,https://clinicaltrials.gov/show/NCT04323878,None
658,NCT04324047,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Drug,Unspecified Drug,Unspecified Drug,1000,https://clinicaltrials.gov/show/NCT04324047,NCT04345991; EUCTR2020-001246-18
659,NCT04324528,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04324528,DRKS00021300
660,NCT04325867,ClinicalTrials.gov,2020-03-21,2020-03-31,False,Professor Adrian Covic,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04325867,None
661,NCT04326036,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Healeon Medical Inc,Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,ATMP,Stromal Vascular Fraction,Stromal Vascular Fraction,10,https://clinicaltrials.gov/show/NCT04326036,None
662,NCT04326075,ClinicalTrials.gov,2020-03-26,2020-04-06,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,No Country Given,Early CPAP in COVID Patients With Respiratory Failure.,Other (physical),Mechanical ventilation,Mechanical ventilation,900,https://clinicaltrials.gov/show/NCT04326075,None
663,NCT04326452,ClinicalTrials.gov,2020-03-25,2020-03-27,False,TMC HealthCare,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,Other (device),Bidirectional Oxygenation Valve,Bidirectional Oxygenation Valve,15,https://clinicaltrials.gov/show/NCT04326452,None
664,NCT04327180,ClinicalTrials.gov,2020-03-25,2020-03-30,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04327180,None
665,NCT04327349,ClinicalTrials.gov,2020-03-24,2020-03-28,True,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04327349,IRCT20181104041551N1
666,NCT04327674,ClinicalTrials.gov,2020-03-27,2020-03-14,True,Aarhus University,Recruiting,Not Applicable,Observational,Denmark,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,375,https://clinicaltrials.gov/show/NCT04327674,None
667,NCT04328272,ClinicalTrials.gov,2020-03-25,2020-03-28,False,Dr. Umar Farooq,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,75,https://clinicaltrials.gov/show/NCT04328272,None
668,NCT04328454,ClinicalTrials.gov,2020-03-27,2020-01-30,True,Shanghai 10th People's Hospital,Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04328454,None
669,NCT04329507,ClinicalTrials.gov,2020-03-26,2020-03-25,True,NHS Lothian,Not Recruiting,Not Applicable,Observational,No Country Given,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04329507,None
670,NCT04329559,ClinicalTrials.gov,2020-03-29,2020-03-30,False,Hepatopancreatobiliary Surgery Institute of Gansu Province,Recruiting,Not Applicable,Observational,China,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04329559,None
671,NCT04330144,ClinicalTrials.gov,2020-03-30,2020-04-01,True,Gangnam Severance Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2486,https://clinicaltrials.gov/show/NCT04330144,KCT0004907
672,NCT04330261,ClinicalTrials.gov,2020-03-30,2020-03-18,True,University of Calgary,Recruiting,Not Applicable,Observational,Canada,Clinical Characteristics and Outcomes of Pediatric COVID-19,Clinical Presentation,No Intervention,No Intervention,12500,https://clinicaltrials.gov/show/NCT04330261,None
673,NCT04330521,ClinicalTrials.gov,2020-03-30,2020-04-01,False,Stanford University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04330521,None
674,NCT04330586,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Korea University Guro Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,A Trial of Ciclesonide in Adults With Mild COVID-19,Drug,Ciclesonide + hydroxychloroquine vs. hydroxychloroquine,Ciclesonide; hydroxychloroquine ,141,https://clinicaltrials.gov/show/NCT04330586,None
675,NCT04331574,ClinicalTrials.gov,2020-03-30,2020-03-10,True,Società Italiana dell'Ipertensione Arteriosa-Lega Italiana,Recruiting,Not Applicable,Observational,Italy,Renin-Angiotensin System Inhibitors and COVID-19,Drug,ACE Inhibitors or ARBs,ACE Inhibitors; ARBs,2000,https://clinicaltrials.gov/show/NCT04331574,None
676,NCT04331613,ClinicalTrials.gov,2020-02-06,2020-01-27,True,Chinese Academy of Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,ATMP,Cells (IMRC),Cells (IMRC),9,https://clinicaltrials.gov/show/NCT04331613,None
677,NCT04332016,ClinicalTrials.gov,2020-03-30,2020-04-02,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,COVID-19 Biological Samples Collection,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04332016,None
678,NCT04332666,ClinicalTrials.gov,2020-03-27,2020-03-31,False,Erasme University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Drug,Angiotensin (1-7),Angiotensin (1-7),60,https://clinicaltrials.gov/show/NCT04332666,None
679,NCT04333251,ClinicalTrials.gov,2020-03-27,2020-04-01,False,Baylor Research Institute,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,ATMP,Plasma,Plasma,115,https://clinicaltrials.gov/show/NCT04333251,None
680,NCT04333472,ClinicalTrials.gov,2020-04-01,2020-04-06,False,Can-Fite BioPharma,Not Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,Drug,Piclidenoson,Piclidenoson,40,https://clinicaltrials.gov/show/NCT04333472,None
681,NCT04333693,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Spanish Society for Angiology and Vascular Surgery,Not Recruiting,Not Applicable,Observational,Spain,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04333693,None
682,NCT04333862,ClinicalTrials.gov,2020-04-01,2020-03-19,True,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Health System,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04333862,None
683,NCT04335019,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04335019,None
684,NCT04335201,ClinicalTrials.gov,2020-03-31,2020-04-06,True,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,No Country Given,Defibrotide in COVID-19 Pneumonia,Drug,Defibrotide,Defibrotide,50,https://clinicaltrials.gov/show/NCT04335201,EUCTR2020-001513-20
685,ACTRN12620000443998,ANZCTR,2020-04-06,2020-05-01,False,Flinders Medical Centre,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,58,https://anzctr.org.au/ACTRN12620000443998.aspx,None
686,ACTRN12620000444987,ANZCTR,2020-04-06,2020-04-07,False,South Metropolitan Health Service,Not Recruiting,Not Applicable,Observational,Australia,COVID-19 Research Response (ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections COVID-19 Research Response Trial),Clinical Presentation,No Intervention,No Intervention,100000,https://anzctr.org.au/ACTRN12620000444987.aspx,None
687,ACTRN12620000448943,ANZCTR,2020-04-06,2020-06-01,False,Deakin University,Not Recruiting,Not Applicable,Interventional,Australia,Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,Other (psych),Psychological,Psychological,154,https://anzctr.org.au/ACTRN12620000448943.aspx,None
688,ACTRN12620000447954,ANZCTR,2020-04-06,2020-03-31,True,Royal Brisbane & Women's Hospital,Recruiting,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,150,https://anzctr.org.au/ACTRN12620000447954.aspx,None
689,ACTRN12620000438954,ANZCTR,2020-04-06,2020-04-20,False,Griffith University,Not Recruiting,Not Applicable,Observational,Australia,Utilizing lung ultrasound in COVID-19 patients in ICU – comparison of management strategies on survival and time on ventilation.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://anzctr.org.au/ACTRN12620000438954.aspx,None
690,ACTRN12620000449932,ANZCTR,2020-04-06,2020-04-10,False,University of Melbourne,Not Recruiting,Not Applicable,Observational,Australia,Maternal and neonatal outcomes from women infected with SARS-COV2 (COVID-19) during pregnancy,Clinical Presentation,No Intervention,No Intervention,200,https://anzctr.org.au/ACTRN12620000449932.aspx,None
691,ACTRN12620000454976,ANZCTR,2020-04-08,2020-04-09,False,Austin Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,Drug,Zinc,Zinc,160,https://anzctr.org.au/ACTRN12620000454976.aspx,None
692,ChiCTR2000031860,ChiCTR,2020-04-12,2020-04-27,False,Beijing Sports University,Not Recruiting,Not Applicable,Observational,China,Study for the exercise rehabilitation therapy for the dysfunction of cured discharged novel coronavirus pneumonia (COVID-19) patients,Other (exercise),Exercise,Exercise,150,http://www.chictr.org.cn/showproj.aspx?proj=52198,None
693,ChiCTR2000031836,ChiCTR,2020-04-11,2020-01-23,True,The First Affiliated Hospital of Yangtze University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based study for the Clinical Characteristics Of Hospitalized Novel Coronavirus Pneumonia (COVID-19) Patients With Acute Respiratory Distress Syndrome,Clinical Presentation,No Intervention,No Intervention,45,http://www.chictr.org.cn/showproj.aspx?proj=52213,None
694,ChiCTR2000031834,ChiCTR,2020-04-11,2020-04-20,False,Jiangsu Province Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),Telehealth,Telehealth,Telehealth,120,http://www.chictr.org.cn/showproj.aspx?proj=52216,None
695,ChiCTR2000031794,ChiCTR,2020-04-10,2020-04-08,True,Huanggang Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for analysis clinical characteristics and risk factors of death in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,130,http://www.chictr.org.cn/showproj.aspx?proj=52193,None
696,ChiCTR2000031783,ChiCTR,2020-04-10,2020-03-24,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Bolivia,Investigation for Prevention Awareness against COVID-19,Other,No Intervention,No Intervention,883,http://www.chictr.org.cn/showproj.aspx?proj=51832,None
697,ChiCTR2000031782,ChiCTR,2020-04-10,2020-04-13,False,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,A questionnaire investigation of hydroxychloroquine for its potential protective effect against novel coronavirus infection (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,550,http://www.chictr.org.cn/showproj.aspx?proj=51934,None
698,ChiCTR2000031781,ChiCTR,2020-04-10,2020-04-09,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",ATMP,Vaccine,Vaccine,500,http://www.chictr.org.cn/showproj.aspx?proj=52006,None
699,ChiCTR2000031779,ChiCTR,2020-04-10,2020-01-01,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of novel coronavirus pneumonia (COVID-19) upon male reproductive system,Clinical Presentation,No Intervention,No Intervention,50,http://www.chictr.org.cn/showproj.aspx?proj=52051,None
700,ChiCTR2000031772,ChiCTR,2020-04-09,2020-01-10,True,Fujian Provincial Maternity and Child Health Hospital,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),Other,Health Education,Health Education,105,http://www.chictr.org.cn/showproj.aspx?proj=52165,None
701,ChiCTR2000031770,ChiCTR,2020-04-09,2020-01-22,True,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Experiences in nursing care for patients with suspected novel coronavirus pneumonia (COVID-19) in Shanghai,Clinical Presentation,No Intervention,No Intervention,119,http://www.chictr.org.cn/showproj.aspx?proj=52148,None
702,ChiCTR2000031752,ChiCTR,2020-04-09,2020-01-01,True,The First Affiliated Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Observational,China,A medical records based observational study for myocardial injury and cardiac function in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,75,http://www.chictr.org.cn/showproj.aspx?proj=52135,None
703,ChiCTR2000031751,ChiCTR,2020-04-08,2020-04-01,True,Wuhan Fourth Hospital,Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-2019) patients' prognosis and their influence on heart and lung function,Prognosis,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=52130,None
704,ChiCTR2000031735,ChiCTR,2020-04-08,2020-03-01,True,Huzhou Central Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (NK),Cells (NK),20,http://www.chictr.org.cn/showproj.aspx?proj=50613,None
705,ChiCTR2000031734,ChiCTR,2020-04-08,2020-03-19,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danorevir sodium tablets combined with ritonavir in the treatment of novel Coronavirus Pneumonia (COVID-19): a randomized, open-label, controlled trial",Drug,Danorevir + ritonavir,Danorevir; ritonavir,40,http://www.chictr.org.cn/showproj.aspx?proj=52103,None
706,ChiCTR2000031705,ChiCTR,2020-04-07,2020-03-10,True,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for early biological warning signals in patients with acute renal injury caused by novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51793,None
707,ChiCTR2000031700,ChiCTR,2020-04-07,2020-04-21,False,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Development and clinical application of novel coronavirus pneumonia (COVID-19) antigen reagent,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,http://www.chictr.org.cn/showproj.aspx?proj=52052,None
708,ChiCTR2000031699,ChiCTR,2020-04-07,2020-02-01,True,Wenzhou Central Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Study for immune antibody and multi-group function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,33,http://www.chictr.org.cn/showproj.aspx?proj=51924,None
709,ChiCTR2000031675,ChiCTR,2020-04-06,2020-04-06,False,Women's Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based retrospective analysis of maternal and infant outcomes in Cesarean delivery in Hangzhou non pneumonia Hospital during pandemic of Novel coronovirus pneumonia(COVID-19),Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=52037,None
710,ChiCTR2000031672,ChiCTR,2020-04-06,2020-04-01,True,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.chictr.org.cn/showproj.aspx?proj=51940,None
711,ChiCTR2000030750,ChiCTR,2020-03-13,2020-03-01,True,Shenzhen Third People's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,ATMP,Vaccine,Vaccine,120,http://www.chictr.org.cn/showproj.aspx?proj=50928,None
712,ChiCTR2000030494,ChiCTR,2020-03-05,2020-03-01,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Early risk stratification of the novel coronavirus infected diseases (COVID-19): a multicenter retrospective study  (ERS-COVID-19 study),Prognosis,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=50077,None
713,ChiCTR2000030331,ChiCTR,2020-02-28,2020-02-01,True,The First Affiliated Hospital Division of Life Sciences and Medicine University of Science and Technology of China,Recruiting,Not Applicable,Epidemiological research,China,Construction of a Bio information platform for novel coronavirus pneumonia (COVID-19) patients follow-up in Anhui,Clinical Presentation,No Intervention,No Intervention,498,http://www.chictr.org.cn/showproj.aspx?proj=50271,None
714,ChiCTR2000030328,ChiCTR,2020-02-28,2020-03-02,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,Cancelled by the investigator                            Clinical application of inhaled acetylcysteine solution in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Acetylcysteine,Acetylcysteine,60,http://www.chictr.org.cn/showproj.aspx?proj=50241,None
715,EUCTR2020-001301-23-FR,EU Clinical Trials Register,2020-03-26,2020-04-10,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,Drug,Naproxen,Naproxen,584,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23,None
716,EUCTR2020-001335-28-NL,EU Clinical Trials Register,2020-03-27,2020-03-29,False,InflaRx GmbH,Authorised,Phase 2/Phase 3,Interventional,Netherlands,An open label phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,Drug,IFX-1,IFX-1,130,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28,None
717,EUCTR2020-001381-11-FR,EU Clinical Trials Register,2020-03-29,2020-04-08,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,554,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11,None
718,EUCTR2020-001442-19-ES,EU Clinical Trials Register,2020-04-03,2020-04-02,True,Institut de Recerca Hospital de la Santa Creu i Sant Pau,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",Drug,Tocilizumab + hydroxychloroquine + azithromycin,Tocilizumab; hydroxychloroquine; azithromycin,276,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19,None
719,EUCTR2020-001385-11-ES,EU Clinical Trials Register,2020-04-03,2020-03-28,True,Plan Nacional sobre el Sida (PNS),Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,Drug (Chemoprophylaxis),Emtricitabine/tenofovir + hydroxychloroquine,Emtricitabine; tenofovir; hydroxychloroquine,4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11,None
720,EUCTR2020-001409-21-ES,EU Clinical Trials Register,2020-04-03,2020-04-01,True,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,Drug,Defibrotide,Defibrotide,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21,None
721,EUCTR2020-001333-13-FR,EU Clinical Trials Register,2020-04-02,2020-04-09,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,Drug,Dexamethasone + hydroxychloroquine vs. hydroxychloroquine,Dexamethasone; hydroxychloroquine,122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13,None
722,EUCTR2020-001492-33-FR,EU Clinical Trials Register,2020-04-01,2020-04-10,False,L'Hôpital Fondation Adolphe de Rothschild,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,Drug,Dornase alfa,Dornase alfa,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33,None
723,EUCTR2020-001194-69-ES,EU Clinical Trials Register,2020-04-07,2020-03-30,True,Felix Gutierrez Rodero,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),Drug (Chemoprophylaxis),Mefloquine,Mefloquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69,None
724,EUCTR2020-001565-37-ES,EU Clinical Trials Register,2020-04-07,2020-04-03,True,ISGlobal,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,Drug,Hydroxychloroquine,Hydroxychloroquine,440,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,None
725,EUCTR2020-001421-31-ES,EU Clinical Trials Register,2020-04-07,2020-04-06,True,Sociedad Espaola de Farmacia Hospitalaria,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1530,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31,None
726,EUCTR2020-001606-33-ES,EU Clinical Trials Register,2020-04-07,2020-04-07,False,Instituto Investigacin Sanitario Biocruces Bizkaia,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,132,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33,None
727,EUCTR2020-001307-16-ES,EU Clinical Trials Register,2020-04-08,2020-04-01,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,Drug,Corticosteroids,Methylprednisolone,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16,None
728,NCT03680274,ClinicalTrials.gov,2018-09-19,2018-11-08,False,University of Sherbrooke,Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C,Pre 2020,Pre 2020,Pre 2020,800,https://clinicaltrials.gov/show/NCT03680274,None
729,NCT04245631,ClinicalTrials.gov,2020-01-26,2020-01-01,True,Beijing Ditan Hospital,Recruiting,Not Applicable,Observational,China,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04245631,None
730,NCT04252274,ClinicalTrials.gov,2020-01-29,2020-01-30,False,Shanghai Public Health Clinical Center,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Drug,Darunavir + Cobicistat,Darunavir; Cobicistat,30,https://clinicaltrials.gov/show/NCT04252274,None
731,NCT04261517,ClinicalTrials.gov,2020-02-06,2020-02-06,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04261517,None
732,NCT04274322,ClinicalTrials.gov,2020-02-16,2020-02-19,False,Peking University Third Hospital,Not Recruiting,Not Applicable,Observational,China,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Other (nutrition),Nutrition,Nutrition,117,https://clinicaltrials.gov/show/NCT04274322,None
733,NCT04290780,ClinicalTrials.gov,2020-02-27,2020-03-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04290780,None
734,NCT04291729,ClinicalTrials.gov,2020-02-27,2020-02-17,True,The Ninth Hospital of Nanchang,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir (w/ or w/o Interferon),Danoprevir; Ritonavir; Interferon,11,https://clinicaltrials.gov/show/NCT04291729,None
735,NCT04302766,ClinicalTrials.gov,2020-03-02,2020-04-01,False,U.S. Army Medical Research and Development Command,Not Recruiting,Phase 1,Expanded Access,No Country Given,Expanded Access Remdesivir (RDV; GS-5734™),Drug,Remdesivir,Remdesivir,Not Available,https://clinicaltrials.gov/show/NCT04302766,None
736,NCT04306055,ClinicalTrials.gov,2020-03-08,2020-03-13,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,Other,No Intervention,No Intervention,19491,https://clinicaltrials.gov/show/NCT04306055,None
737,NCT04310228,ClinicalTrials.gov,2020-03-09,2020-03-08,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Drug,Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,Favipiravir; tocilizumab,150,https://clinicaltrials.gov/show/NCT04310228,ChiCTR2000030894
738,NCT04315480,ClinicalTrials.gov,2020-03-14,2020-03-12,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Drug,Tocilizumab,Tocilizumab,38,https://clinicaltrials.gov/show/NCT04315480,None
739,NCT04317092,ClinicalTrials.gov,2020-03-19,2020-03-19,True,National Cancer Institute,Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Drug,Tocilizumab,Tocilizumab,400,https://clinicaltrials.gov/show/NCT04317092,EUCTR2020-001110-38
740,NCT04319315,ClinicalTrials.gov,2020-03-16,2020-03-11,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04319315,None
741,NCT04321265,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Heinrich-Heine University,Recruiting,Not Applicable,Observational,"Norway, France, Denmark, Germany",Outcomes and Prognostic Factors in COVID-19,Prognosis,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04321265,None
742,NCT04321369,ClinicalTrials.gov,2020-03-23,2020-03-09,True,Dr. Deneen Vojta,Not Recruiting,Not Applicable,Observational,United States,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,533,https://clinicaltrials.gov/show/NCT04321369,None
743,NCT04322773,ClinicalTrials.gov,2020-03-24,2020-04-05,True,Marius Henriksen,Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Drug,Tocilizumab vs. sarilumab,Tocilizumab; sarilumab,200,https://clinicaltrials.gov/show/NCT04322773,EUCTR2020-001275-32
744,NCT04324021,ClinicalTrials.gov,2020-03-25,2020-04-02,False,Swedish Orphan Biovitrum,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Drug,Emapalumab + Anakinra,Emapalumab; anakinra,54,https://clinicaltrials.gov/show/NCT04324021,None
745,NCT04325672,ClinicalTrials.gov,2020-03-26,2020-04-01,False,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,ATMP,Plasma,Plasma,0,https://clinicaltrials.gov/show/NCT04325672,None
746,NCT04326725,ClinicalTrials.gov,2020-03-26,2020-03-20,True,Istinye University,Recruiting,Not Applicable,Observational,Turkey,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc + Vitamin C,Hydroxychloroquine; Zinc; Vitamin C,80,https://clinicaltrials.gov/show/NCT04326725,None
747,NCT04328012,ClinicalTrials.gov,2020-03-27,2020-04-06,False,Bassett Healthcare,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. ARB (Losartan),Lopinavir/ritonavir; Hydroxychloroquine; ARB (Losartan),4000,https://clinicaltrials.gov/show/NCT04328012,None
748,NCT04329546,ClinicalTrials.gov,2020-03-29,2020-03-27,True,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,Switzerland,Understanding COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04329546,None
749,NCT04330300,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"National University of Ireland, Galway",Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,Drug,ACE inhibitors or ARBs vs. Calcium Channel Blockers or Thiazide/Thiazide-like diuretics ,ACE inhibitors; ARBs; Calcium Channel Blockers; Thiazide/Thiazide-like diuretics ,2414,https://clinicaltrials.gov/show/NCT04330300,None
750,NCT04330495,ClinicalTrials.gov,2020-03-31,2020-04-06,False,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04330495,None
751,NCT04331106,ClinicalTrials.gov,2020-03-27,2020-03-27,False,Charité University,Recruiting,Not Applicable,Observational,Germany,Survey of the Anxiety Associated With the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04331106,None
752,NCT04331470,ClinicalTrials.gov,2020-03-30,2020-04-04,True,Fasa University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Drug,Levamisole + budesonide/formoterol + lopinavir/ritonavir + hydroxychloroquine,Levamisole; budesonide; formoterol; Lopinavir/ritonavir; hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04331470,IRCT20200324046852N1
753,NCT04331509,ClinicalTrials.gov,2020-03-31,2020-03-23,True,King's College London,Recruiting,Not Applicable,Observational,"United States, United Kingdom",COVID-19 Symptom Tracker,Clinical Presentation,No Intervention,No Intervention,10000000,https://clinicaltrials.gov/show/NCT04331509,None
754,NCT04331665,ClinicalTrials.gov,2020-04-01,2020-04-20,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Drug,Ruxolitinib,Ruxolitinib,64,https://clinicaltrials.gov/show/NCT04331665,None
755,NCT04331834,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,440,https://clinicaltrials.gov/show/NCT04331834,None
756,NCT04332094,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Fundació Institut de Recerca Hospital de la Santa Creu i Sant Pau,Recruiting,Phase 2,Interventional,Spain,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",Drug,Hydroxychloroquine + Azithromycin + Tocilizumab,Hydroxychloroquine; azithromycin; tocilizumab,276,https://clinicaltrials.gov/show/NCT04332094,None
757,NCT04332913,ClinicalTrials.gov,2020-03-26,2020-04-01,False,University of L'Aquila,Recruiting,Not Applicable,Observational,Italy,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,Drug,Tocilizumab,Tocilizumab,30,https://clinicaltrials.gov/show/NCT04332913,None
758,NCT04333407,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Imperial College London,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Drug,Aspirin + clopidogrel + rivaroxaban + atorvastatin + omeprazole,Aspirin; clopidogrel; rivaroxaban; atorvastatin; omeprazole,3170,https://clinicaltrials.gov/show/NCT04333407,None
759,NCT04333849,ClinicalTrials.gov,2020-04-01,2020-03-27,True,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Other,Other,Other,100,https://clinicaltrials.gov/show/NCT04333849,None
760,NCT04333953,ClinicalTrials.gov,2020-03-31,2020-04-01,False,University of Missouri-Columbia,Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With HIV,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04333953,None
761,NCT04334005,ClinicalTrials.gov,2020-03-29,2020-04-10,False,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,Drug,Vitamin D,Vitamin D,200,https://clinicaltrials.gov/show/NCT04334005,None
762,NCT04334382,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Intermountain Health Care, Inc.",Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Drug,Hydroxychloroquine vs. azithromycin,Hydroxychloroquine; azithromycin,1550,https://clinicaltrials.gov/show/NCT04334382,None
763,NCT04335188,ClinicalTrials.gov,2020-03-31,2020-04-06,False,IHF GmbH - Institut for Herzinfarktforschung,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Rhineland-Palatinate (Germany),Clinical Presentation,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04335188,None
764,NCT04335630,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Memorial Hermann Health System,Recruiting,Not Applicable,Observational,United States,Cardiovascular Manifestations of COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04335630,None
765,NCT04336254,ClinicalTrials.gov,2020-03-28,2020-04-06,False,Renmin Hospital of Wuhan University,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04336254,None
766,NCT04336462,ClinicalTrials.gov,2020-03-25,2020-02-15,True,Shanghai Asclepius Meditec Inc.,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,Drug,Hydrogen + Oxygen vs Oxygen,Hydrogen; oxygen,100,https://clinicaltrials.gov/show/NCT04336462,None
767,NCT04336657,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04336657,None
768,NCT04336787,ClinicalTrials.gov,2020-04-03,2020-04-12,False,Istanbul Kültür University,Not Recruiting,Not Applicable,Observational,Turkey,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04336787,None
769,NCT04336904,ClinicalTrials.gov,2020-04-03,2020-03-25,True,Giuliano Rizzardini,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04336904,None
770,NCT04337151,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Royal National Orthopaedic Hospital NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04337151,None
771,NCT04337190,ClinicalTrials.gov,2020-04-03,2020-04-03,False,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),Drug,ARBs,ARBs,100,https://clinicaltrials.gov/show/NCT04337190,None
772,NCT04337216,ClinicalTrials.gov,2020-04-01,2020-05-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,10,https://clinicaltrials.gov/show/NCT04337216,None
773,NCT04337489,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Imperial College London,Not Recruiting,Not Applicable,Observational,No Country Given,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),Other (device),Wearable,Wearable,200,https://clinicaltrials.gov/show/NCT04337489,None
774,NCT04337502,ClinicalTrials.gov,2020-04-06,2019-12-23,True,Maastricht University,Not Recruiting,Not Applicable,Observational,China,Clinical and Radiomic Model of COVID-19,Other (software),Other,Other,300,https://clinicaltrials.gov/show/NCT04337502,None
775,NCT04337541,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Other (device),Masks,Masks,6000,https://clinicaltrials.gov/show/NCT04337541,None
776,NCT04337762,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Beat COVID LLC,Recruiting,Not Applicable,Observational,United States,Beat COVID-19 - Observational Trial,Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04337762,None
777,NCT04337983,ClinicalTrials.gov,2020-03-30,2020-04-15,False,Bicetre Hospital,Not Recruiting,Not Applicable,Observational,France,Hemodynamic Characteristics of Patients With SARS-CoV-2,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04337983,None
778,NCT04338100,ClinicalTrials.gov,2020-03-31,2020-04-06,False,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,No Country Given,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Prognosis,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04338100,None
779,NCT04338360,ClinicalTrials.gov,2020-04-03,2019-01-10,True,Mayo Clinic,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04338360,None
780,NCT04338698,ClinicalTrials.gov,2020-04-04,2020-04-07,False,Shehnoor Azhar,Not Recruiting,Phase 3,Interventional,No Country Given,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Drug,"Monotherapy and all Combinations of: Hydroxychloroquine, oseltamivir, and azithromycin",Hydroxychloroquine; osletamivir; azithromycin,500,https://clinicaltrials.gov/show/NCT04338698,None
781,NCT04338802,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Huilan Zhang,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Drug,Nintedanib,Nintedanib,96,https://clinicaltrials.gov/show/NCT04338802,None
782,NCT04338906,ClinicalTrials.gov,2020-04-03,2020-06-01,False,Heinrich-Heine University,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,Drug,Camostat Mesilate + hydroxychloroquine vs. hydroxychloroquine,Camostat Mesilate; hydroxychloroquine,334,https://clinicaltrials.gov/show/NCT04338906,None
783,NCT04339322,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04339322,None
784,NCT04339387,ClinicalTrials.gov,2020-04-06,2020-03-01,True,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,COVID-19 Risk Stratification,Prognosis,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04339387,None
785,NCT04339608,ClinicalTrials.gov,2020-04-07,2020-04-02,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Max COVID19- Study,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04339608,None
786,NCT04339660,ClinicalTrials.gov,2020-04-02,2020-02-01,True,Puren Hospital Affiliated to Wuhan University of Science and Technology,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04339660,None
787,NCT04341012,ClinicalTrials.gov,2020-04-07,2019-09-10,True,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,120,https://clinicaltrials.gov/show/NCT04341012,None
788,NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,False,Hospital Universitari de Bellvitge,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Drug,Tacrolimus + Corticosteroids,Tacrolimus; Methylprednisolone,84,https://clinicaltrials.gov/show/NCT04341038,EUCTR2020-001445-39
789,NCT04341103,ClinicalTrials.gov,2020-03-16,2020-04-01,False,CareDx,Not Recruiting,Not Applicable,Observational,No Country Given,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04341103,None
790,NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,True,Institut Gustave Roussy,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,1000,https://clinicaltrials.gov/show/NCT04341207,EUCTR2020-001250-21
791,NCT04341480,ClinicalTrials.gov,2020-04-07,2020-04-10,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,Clinical Presentation,No Intervention,No Intervention,207,https://clinicaltrials.gov/show/NCT04341480,None
792,NCT04341506,ClinicalTrials.gov,2020-04-07,2020-04-15,False,Northwestern Medicine,Not Recruiting,Not Applicable,Observational,No Country Given,Non-contact ECG Sensor System for COVID19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04341506,None
793,NCT04341519,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",Other (psych),No Intervention,No Intervention,1464,https://clinicaltrials.gov/show/NCT04341519,None
794,NCT04341792,ClinicalTrials.gov,2020-04-07,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04341792,None
795,NCT04342104,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Hospital General Universitario Morales Meseguer,Recruiting,Not Applicable,Observational,Spain,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04342104,None
796,NCT04342208,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,Other,Other,Other,500,https://clinicaltrials.gov/show/NCT04342208,None
797,NCT04342221,ClinicalTrials.gov,2020-04-08,2020-03-29,True,"University Hospital, Tübingen",Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,220,https://clinicaltrials.gov/show/NCT04342221,EUCTR2020-001224-33
798,NCT04343404,ClinicalTrials.gov,2020-04-08,2020-04-01,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,PLACE OF VENOVENOUS ECMO IN THE MANAGEMENT OF SEVERE REFRACTORY ARDS ASSOCIATED WITH SARS-COV-2,Drug,Oxygen,Oxygen,100,https://clinicaltrials.gov/show/NCT04343404,None
799,NCT04343677,ClinicalTrials.gov,2020-04-09,2020-04-01,True,United States Department of Defense,Not Recruiting,Phase 2,Interventional,United States,Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1450,https://clinicaltrials.gov/show/NCT04343677,None
800,NCT04344080,ClinicalTrials.gov,2020-04-09,2020-04-01,False,"University Hospital, Hamburg-Eppendorf",Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Other (device),Cytokine Adsorber,Cytokine Adsorber,24,https://clinicaltrials.gov/show/NCT04344080,DRKS00021199
801,NCT04344197,ClinicalTrials.gov,2020-04-09,2020-04-02,True,University of Rome Tor Vergata,Recruiting,Not Applicable,Observational,Italy,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",Clinical Presentation,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04344197,None
802,ACTRN12620000468921,ANZCTR,2020-04-14,2020-04-20,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,Other (psych),Psychological,Psychological,140,https://anzctr.org.au/ACTRN12620000468921.aspx,None
803,ACTRN12620000477921,ANZCTR,2020-04-16,2020-04-20,False,Dr. Michael Soares,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,Other (physical),Mechanical ventilation,Mechanical ventilation,1,https://anzctr.org.au/ACTRN12620000477921.aspx,None
804,ACTRN12620000472976,ANZCTR,2020-04-15,2020-04-27,False,Dr. Simon Joosten,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group Easybreathe® snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,Other (device),Masks,Masks,100,https://anzctr.org.au/ACTRN12620000472976.aspx,None
805,ACTRN12620000479909,ANZCTR,2020-04-16,2020-05-01,False,The George Institute for Global Health,Not Recruiting,Not Applicable,Observational,"Spain, United States, Italy, China, Australia, Germany",Mental health and wellbeing on general population during the COVID-19 outbreak,Other (psych),No Intervention,No Intervention,3000,https://anzctr.org.au/ACTRN12620000479909.aspx,None
806,ACTRN12620000470998,ANZCTR,2020-04-14,2020-04-20,False,Firebrick Pharma Pty Ltd,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of Nasodine® Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,Drug,Povidone Iodine,Povidone Iodine,20,https://anzctr.org.au/ACTRN12620000470998.aspx,None
807,ACTRN12620000473965,ANZCTR,2020-04-15,2020-06-01,False,University of Queensland,Not Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,Drug (Chemoprophylaxis),OM85,OM85,1000,https://anzctr.org.au/ACTRN12620000473965.aspx,None
808,ACTRN12620000474954,ANZCTR,2020-04-15,2020-04-27,False,Sir Charles Gairdner Hospital,Not Recruiting,Not Applicable,Observational,Australia,Airway Pressure Release Ventilation for mechanically ventilated patients with COVID-19 in Western Australian Intensive Care Units: an observational study,Other (physical),Mechanical ventilation,Mechanical ventilation,100,https://anzctr.org.au/ACTRN12620000474954.aspx,None
809,ACTRN12620000478910,ANZCTR,2020-04-16,2020-06-01,False,Monash Health,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,ATMP,Cells (stem cells),Cells (stem cells),24,https://anzctr.org.au/ACTRN12620000478910.aspx,None
810,ACTRN12620000480987,ANZCTR,2020-04-16,2020-06-01,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),Supplement,Probiotics,Probiotics,507,https://anzctr.org.au/ACTRN12620000480987.aspx,None
811,ChiCTR2000032098,ChiCTR,2020-04-19,2020-01-20,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=52477,None
812,ChiCTR2000032095,ChiCTR,2020-04-19,2020-03-18,True,The Third Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,"Study for Healthy Behavior, Psychological Analysis and Psychological Reconstruction Strategies of Students Population Keeping in Home Under the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",Other (psych),No Intervention,No Intervention,130,http://www.chictr.org.cn/showproj.aspx?proj=52565,None
813,ChiCTR2000032040,ChiCTR,2020-04-18,2020-04-01,True,Affiliated Hospital of Guangdong Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the curative effect of combined traditional Chinese and western medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,30,http://www.chictr.org.cn/showproj.aspx?proj=52529,None
814,ChiCTR2000032013,ChiCTR,2020-04-17,2020-02-02,True,The Fourth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,8,http://www.chictr.org.cn/showproj.aspx?proj=52483,None
815,ChiCTR2000032011,ChiCTR,2020-04-17,2020-04-17,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,Oxygen,45,http://www.chictr.org.cn/showproj.aspx?proj=52142,None
816,ChiCTR2000032010,ChiCTR,2020-04-17,2020-05-01,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus pneumonia (COVID-19) Intelligent Assistant Analysis System:A Multi-center Clinical Research,Clinical Presentation,No Intervention,No Intervention,3000,http://www.chictr.org.cn/showproj.aspx?proj=52479,None
817,ChiCTR2000032009,ChiCTR,2020-04-17,2020-02-08,True,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19) patients with chronic liver disease,Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=52490,None
818,ChiCTR2000031982,ChiCTR,2020-04-16,2020-04-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,Clinical observation for the effect of Ke-Gan-Li-Yan oral liquid on the relief of laryngeal symptoms of novel coronavirus pneumonia (COVID-19) convalescence and suspected patients and other susceptible people,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=52341,None
819,ChiCTR2000031955,ChiCTR,2020-04-16,2020-04-01,True,Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3808,http://www.chictr.org.cn/showproj.aspx?proj=52364,None
820,ChiCTR2000031954,ChiCTR,2020-04-16,2020-04-15,True,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Recruiting,Not Applicable,Observational,China,Medical Records Based Study for Maternal and Perinatal Outcomes of Women with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=52365,None
821,ChiCTR2000031944,ChiCTR,2020-04-15,2020-04-16,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,2000,http://www.chictr.org.cn/showproj.aspx?proj=52414,None
822,ChiCTR2000031930,ChiCTR,2020-04-15,2020-01-31,True,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics and therapeutic effect of 9 cases of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,9,http://www.chictr.org.cn/showproj.aspx?proj=51602,None
823,ChiCTR2000031928,ChiCTR,2020-04-14,2020-06-01,False,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,"Delineate the prevalence, risk factors, temporal distribution and epidemiological characteristics of hidden novel coronavirus (2019-nCoV) infection in the community",Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,http://www.chictr.org.cn/showproj.aspx?proj=52353,None
824,ChiCTR2000031888,ChiCTR,2020-04-13,2020-02-11,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=52106,None
825,ChiCTR2000031712,ChiCTR,2020-04-07,2020-04-01,True,The Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,No Country Given,Study for investigation of contamination by novel coronavirus pneumonia (COVID-19) in the clinical environment,Other,Other,Other,60,http://www.chictr.org.cn/showproj.aspx?proj=51650,None
826,ChiCTR2000030300,ChiCTR,2020-02-28,2020-02-20,True,Nanjing Second Hospital,Recruiting,Phase 1,Interventional,China,Cancelled by the investigator             Umbilical cord mesenchymal stem cells (hucMSCs) in the treatment of high risk novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,http://www.chictr.org.cn/showproj.aspx?proj=50022,None
827,ChiCTR2000029976,ChiCTR,2020-02-18,2020-02-18,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49631,None
828,ChiCTR2000029434,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=48889,None
829,ChiCTR2000029433,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=48898,None
830,EUCTR2020-001156-18-ES,EU Clinical Trials Register,2020-04-03,2020-03-27,True,Fundación para la Investigación Biomédica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,Drug,"Dolquine, Azithromycin, Lopinavir/ritonavir",Dolquine; Azithromycin; Lopinavir/ritonavir,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18,None
831,EUCTR2019-002688-89-ES,EU Clinical Trials Register,2019-07-26,2019-12-10,False,Histocell S.L.,Authorised,Phase 1/Phase 2,Interventional,Spain,"Clinical study to assess the safety and preliminary efficacy of HCR040, a drug based on mesenchymal stem cells, in patients with acute respiratory distress syndrome. (included patients COVID-19)",Pre 2020,Pre 2020,Pre 2020,26,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002688-89,None
832,EUCTR2020-001160-28-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Medica Scientia Innovation Research S.L. (MEDSIR),Authorised,Phase 2,Interventional,Spain,Tocilizumab plus Pembrolizumab in COVID-19,Drug,Tocilizumab + Pembrolizumab,Tocilizumab; Pembrolizumab,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001160-28,None
833,EUCTR2020-001262-11-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,False,Instituto de Investigación Sanitaria Fundación Jimenez Diaz,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,Drug,Cyclosporine A vs. lopinavir/ritonavir + interferon beta + darunavir + spironolactone + tocilizumab + chloroquine,Cyclosporine; lopinavir/ritonavir; interferon beta; darunavir; spironolactone; tocilizumab; chloroquine,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11,NCT04392531
834,EUCTR2020-001290-74-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Consorci Parc de Salut Mar (PSMAR),Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,Drug,Sarilumab vs. Hydroxychloroquine + Azithromycin,Sarilumab; Hydroxychloroquine; Azithromycin,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74,None
835,EUCTR2020-001406-27-FR,EU Clinical Trials Register,2020-04-03,2020-04-07,False,"University Hospital, Montpellier",Authorised,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,Drug,Hydroxychloroquine vs. Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27,None
836,EUCTR2020-001321-31-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Hospital Universitario de Fuenlabrada,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,Drug,Hydroxychloroquine + baricitinib or imatinib or lopinavir/ritonavir,Hydroxychloroquine; baricitinib; imatinib; lopinavir/ritonavir,165,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31,None
837,EUCTR2020-001437-12-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",Drug,"Cyclosporine, Tocilizumab",Cyclosporine; Tocilizumab,290,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12,None
838,EUCTR2020-001530-35-ES,EU Clinical Trials Register,2020-04-13,2020-04-09,True,Fundación para la investigación Biomédica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,Drug,Melatonin,Melatonin,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35,None
839,EUCTR2020-001587-29-ES,EU Clinical Trials Register,2020-04-13,2020-04-08,True,Barcelona Institute for Global Health,Authorised,Phase 4,Interventional,Spain,Preventing SARS-CoV-2 virus infection and severity of COVID-19 diseases during pregnancy with hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,714,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001587-29,None
840,EUCTR2020-001689-12-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Montreal Heart Institute,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),Drug,Colchicine,Colchicine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,None
841,EUCTR2020-001765-37-ES,EU Clinical Trials Register,2020-04-13,2020-04-11,True,Institut Català d'Oncologia,Authorised,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,Drug,Hydroxychloroquine,Hydroxychloroquine,103,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37,None
842,EUCTR2020-001379-34-ES,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Instituto de Investigación Sanitaria INCLIVA,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,Drug,Sevoflurane vs. Propofol,Sevoflurane; Propofol,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34,None
843,EUCTR2020-001511-25-ES,EU Clinical Trials Register,2020-04-15,2020-04-14,True,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,Drug,Colchicine,Colchicine,102,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25,None
844,EUCTR2020-001266-11-ES,EU Clinical Trials Register,2020-04-16,2020-04-16,False,Fundación Instituto de Investigación Sanitaria Fundación Jimenez Diaz,Authorised,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11,None
845,EUCTR2020-001254-22-BE,EU Clinical Trials Register,2020-03-24,2020-03-24,False,"University Hospital, Ghent",Authorised,Phase 4,Interventional,Belgium,Sargramostim in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Sargramostin,Sargramostin,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001254-22,None
846,IRCT20200310046736N1,IRCT,2020-04-01,2020-04-01,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,ATMP,Plasma,Plasma,45,http://en.irct.ir/trial/46424,None
847,IRCT20151113025025N3,IRCT,2020-03-29,2020-04-05,False,Tehran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with corona virus disease-2019 (COVID-19) referring to Sina Hospital in 2020,Drug,RAAS inhibitors,RAAS inhibitors,60,http://en.irct.ir/trial/46531,None
848,IRCT20100228003449N30,IRCT,2020-03-22,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,Drug,Hydroxychloroquine +  Oseltamivir + Lopinavir/ritonavir or Atazanavir/ritonavir ,Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir; Lopinavir/atazanavir,50,http://en.irct.ir/trial/46536,None
849,IRCT20100228003449N28,IRCT,2020-03-19,2020-03-15,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,30,http://en.irct.ir/trial/46538,None
850,IRCT20100228003449N27,IRCT,2020-03-16,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon ß in treatment  of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,30,http://en.irct.ir/trial/46545,None
851,IRCT20200316046792N1,IRCT,2020-03-17,2020-03-16,True,Iran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://en.irct.ir/trial/46554,None
852,IRCT20151227025726N12,IRCT,2020-03-23,2020-03-03,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),Drug,Interferon beta + hydroxychloroquine + osletamivir + lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,20,http://en.irct.ir/trial/46561,None
853,IRCT20170117032004N3,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,Drug,Vitamin A,Vitamin A,30,http://en.irct.ir/trial/46564,None
854,IRCT20100228003449N29,IRCT,2020-03-19,2020-03-18,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,Drug,Sofosbuvir + Ledipasvir vs. Hydroxychloroquine + Oseltamivir + Lopinavir/ritonavir,Sofosbuvir; Ledipasvir; Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir,50,http://en.irct.ir/trial/46567,None
855,IRCT20200317046797N1,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,Drug,Camostat Mesilate,Camostat Mesilate,40,http://en.irct.ir/trial/46573,None
856,IRCT20160625028622N1,IRCT,2020-03-22,2020-03-19,True,Qazvin University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,Drug,Noscapine,Noscapine,125,http://en.irct.ir/trial/46576,None
857,IRCT20120826010664N6,IRCT,2020-04-05,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,310,http://en.irct.ir/trial/46603,None
858,IRCT20131113015393N6,IRCT,2020-03-30,2020-02-28,True,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,Other (psych),Psychological,Psychological,62,http://en.irct.ir/trial/46609,None
859,IRCT20140528017891N8,IRCT,2020-03-28,2020-03-24,True,MOM Research and Innovation Center,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,http://en.irct.ir/trial/46623,None
860,IRCT20200321046828N1,IRCT,2020-03-26,2020-03-22,True,RNA Biotechnology,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,Drug,Unspecified,Unspecified,30,http://en.irct.ir/trial/46624,None
861,IRCT20190727044343N1,IRCT,2020-04-05,2020-03-16,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,Drug,Acetaminophen + Febuxostat vs.  Acetaminophen + Hydroxychloroquine,Febuxostat; Acetaminophen; Hydroxychloroquine,60,http://en.irct.ir/trial/46629,None
862,IRCT20140617018126N2,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46637,None
863,IRCT20150914024017N1,IRCT,2020-04-03,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,Drug,Interferon beta,Interferon beta,40,http://en.irct.ir/trial/46665,None
864,IRCT20140911019125N6,IRCT,2020-04-04,2020-04-04,False,Kerman University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,http://en.irct.ir/trial/46668,None
865,IRCT20160316027081N1,IRCT,2020-03-31,2020-03-23,True,Artesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,374,http://en.irct.ir/trial/46678,None
866,IRCT20151227025726N13,IRCT,2020-03-26,2020-03-11,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,Drug,Tocilizumab + hydroxychloroquine + oseltamivir + lopinavir/ritonavir,Tocilizumab; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,40,http://en.irct.ir/trial/46681,None
867,IRCT20160310026998N11,IRCT,2020-03-27,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,Drug,Metformin,Metformin,200,http://en.irct.ir/trial/46690,None
868,IRCT20160310026998N10,IRCT,2020-03-26,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,Drug,Metformin,Metformin,200,http://en.irct.ir/trial/46693,None
869,IRCT20180610040049N3,IRCT,2020-03-29,2020-04-08,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46697,None
870,IRCT20200324046847N1,IRCT,2020-03-31,2020-03-28,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,Drug,Septimeb,Septimeb,30,http://en.irct.ir/trial/46720,None
871,IRCT20140907019073N4,IRCT,2020-03-29,2020-04-03,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,Other,Homeopathy,Homeopathy,60,http://en.irct.ir/trial/46736,None
872,IRCT20200324046850N5,IRCT,2020-04-04,2020-04-19,False,Abadan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Study of the effect of vitamin C in patients with Covid-19,Drug,Vitamin C w or w/o Hydroxychloroquine or Chloroquine + Lopinavir/Ritonavir,Vitamin C; Hydroxychloroquine; Chloroquine; Lopinavir/Ritonavir,40,http://en.irct.ir/trial/46751,None
873,IRCT20200325046860N1,IRCT,2020-03-30,2020-03-15,True,Darmanara Co.,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,ATMP,Plasma,Plasma,200,http://en.irct.ir/trial/46759,None
874,IRCT20101219005416N2,IRCT,2020-04-03,2020-03-24,True,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/46775,None
875,IRCT20200317046797N2,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,Drug,Fingolimod,Fingolimod,40,http://en.irct.ir/trial/46786,None
876,IRCT20200325046860N2,IRCT,2020-04-01,2020-03-28,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,http://en.irct.ir/trial/46789,None
877,IRCT20170611034452N11,IRCT,2020-03-31,2020-03-30,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/46803,None
878,IRCT20190917044805N2,IRCT,2020-03-31,2020-04-03,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,Drug,Vitamin C,Vitamin C,60,http://en.irct.ir/trial/46804,None
879,IRCT20120225009124N4,IRCT,2020-04-02,2020-04-18,False,Gorgan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",Drug (+ ATMP),"Intreventional: Dexamethason + Immunoglobulin vs. Dexamethason + Immunoglobulin + interferon beta

All Arms: Hydroxychloroquine + antiviral ",Dexamethason; Immunoglobulin; interferon beta; Hydroxychloroquine,105,http://en.irct.ir/trial/46810,None
880,IRCT20180802040678N4,IRCT,2020-04-01,2020-03-31,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,Drug,Losartan vs. amlodipine,Losartan; amlodipine,100,http://en.irct.ir/trial/46824,None
881,IRCT20150704023055N2,IRCT,2020-04-03,2020-03-24,True,Babol University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,Other (device),Hemoperfusion,Hemoperfusion,10,http://en.irct.ir/trial/46837,None
882,IRCT20200319046819N1,IRCT,2020-04-04,2020-04-02,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,Drug,Vitamin A + Vitamin D + Vitamin C + Vitamin B,Vitamin A; Vitamin D; Vitamin C; Vitamin B,60,http://en.irct.ir/trial/46838,None
883,JPRN-JapicCTI-205238,JPRN,2020-03-27,2020-03-31,False,"FUJIFILM Toyama Chemical Co., Ltd.",Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,Drug,Favipiravir,Favipiravir,96,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,None
884,JPRN-jRCTs031190226,JPRN,2020-02-27,2020-03-14,False,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,Drug,Favipiravir,Favipiravir,50,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,None
885,JPRN-UMIN000039986,JPRN,2020-03-31,2020-03-28,True,Yokohama City University,Not Recruiting,Not Applicable,Other,Japan,Risk factors of death from coronavirus disease 2019,Prognosis,No Intervention,No Intervention,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045582,None
886,JPRN-UMIN000040185,JPRN,2020-04-17,2020-04-17,False,Keio University School of Medicine,Recruiting,Not Applicable,Observational,Japan,Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease,Clinical Presentation,No Intervention,No Intervention,600,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045820,None
887,JPRN-UMIN000040188,JPRN,2020-04-17,2020-04-17,False,Yokohama City University,Not Recruiting,Not Applicable,Other,"Japan, North America",Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial,Not relevant,Not relevant,Not relevant,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045825,None
888,NCT03042143,ClinicalTrials.gov,2017-02-01,2019-01-07,True,Belfast Health and Social Care Trust,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19),Pre 2020,Pre 2020,Pre 2020,75,https://clinicaltrials.gov/show/NCT03042143,EUCTR2017-000584-33
889,NCT03891420,ClinicalTrials.gov,2019-03-15,2020-04-09,False,BioCryst Pharmaceuticals,Recruiting,Phase 1,Interventional,Brazil,"A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19",Pre 2020,Pre 2020,Pre 2020,66,https://clinicaltrials.gov/show/NCT03891420,None
890,NCT04092478,ClinicalTrials.gov,2019-09-13,2019-10-23,False,Konya Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,'' The Abdominal Crunch Position for COVID-19 Patients '',Not relevant,Not relevant,Not relevant,100,https://clinicaltrials.gov/show/NCT04092478,None
891,NCT04252118,ClinicalTrials.gov,2020-01-27,2020-01-27,False,Beijing 302 Hospital,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04252118,None
892,NCT04252664,ClinicalTrials.gov,2020-01-31,2020-02-12,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,Drug,Remdesivir,Remdesivir,308,https://clinicaltrials.gov/show/NCT04252664,None
893,NCT04257656,ClinicalTrials.gov,2020-01-31,2020-02-06,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,Drug,Remdesivir,Remdesivir,237,https://clinicaltrials.gov/show/NCT04257656,None
894,NCT04273646,ClinicalTrials.gov,2020-02-14,2020-04-20,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),48,https://clinicaltrials.gov/show/NCT04273646,None
895,NCT04276688,ClinicalTrials.gov,2020-02-11,2020-02-10,True,University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Drug,Lopinavir/ritonavir + Ribavirin + Interferon beta,Lopinavir/ritonavir; Ribavirin; Interferon beta,127,https://clinicaltrials.gov/show/NCT04276688,None
896,NCT04280224,ClinicalTrials.gov,2020-02-13,2020-02-15,False,Xinxiang Medical University,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,ATMP,Cells (NK),Cells (NK),30,https://clinicaltrials.gov/show/NCT04280224,None
897,NCT04299152,ClinicalTrials.gov,2020-02-28,2020-05-10,False,Tianhe Stem Cell Biotechnologies Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,ATMP,Cells (stem cells),Cells (stem cells),20,https://clinicaltrials.gov/show/NCT04299152,None
898,NCT04304690,ClinicalTrials.gov,2020-03-09,2020-03-16,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04304690,None
899,NCT04315896,ClinicalTrials.gov,2020-03-18,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Drug,Hydroxychloroquine,Hydroxychloroquine,500,https://clinicaltrials.gov/show/NCT04315896,None
900,NCT04318015,ClinicalTrials.gov,2020-03-19,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04318015,None
901,NCT04320277,ClinicalTrials.gov,2020-03-20,2020-05-16,False,Hospital of Prato,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Drug,Baricitinib,Baricitinib,200,https://clinicaltrials.gov/show/NCT04320277,None
902,NCT04320953,ClinicalTrials.gov,2020-03-21,2020-03-16,True,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,Other (device),Non-contact Endoscopy,Non-contact Endoscopy,5,https://clinicaltrials.gov/show/NCT04320953,None
903,NCT04321174,ClinicalTrials.gov,2020-03-18,2020-04-17,False,Darrell Tan,Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,1220,https://clinicaltrials.gov/show/NCT04321174,None
904,NCT04322487,ClinicalTrials.gov,2020-03-23,2020-04-08,False,Catholic University of the Sacred Heart,Recruiting,Not Applicable,Observational,Italy,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04322487,None
905,NCT04323345,ClinicalTrials.gov,2020-03-23,2020-04-15,False,Misr University for Science and Technology,Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04323345,None
906,NCT04323787,ClinicalTrials.gov,2020-03-24,2020-03-30,False,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,50000,https://clinicaltrials.gov/show/NCT04323787,None
907,NCT04324073,ClinicalTrials.gov,2020-03-25,2020-03-27,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Drug,Sarilumab,Sarilumab,239,https://clinicaltrials.gov/show/NCT04324073,None
908,NCT04324190,ClinicalTrials.gov,2020-03-26,2020-04-08,False,Gunther Meinlschmidt,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,Other (psych),Psychological,Psychological,600,https://clinicaltrials.gov/show/NCT04324190,None
909,NCT04324736,ClinicalTrials.gov,2020-03-25,2020-03-10,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,"""COVID-19 and Diabetes Outcomes""",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04324736,None
910,NCT04325048,ClinicalTrials.gov,2020-03-25,2020-04-01,False,Cordio Medical,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,Other (software),eHealth,eHealth,5000,https://clinicaltrials.gov/show/NCT04325048,None
911,NCT04325061,ClinicalTrials.gov,2020-03-25,2020-04-03,True,Dr. Negrin University Hospital,Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,Drug,Corticosteroids,Dexamethasone,200,https://clinicaltrials.gov/show/NCT04325061,EUCTR2020-001278-31
912,NCT04325633,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Drug,Naproxen,Naproxen,584,https://clinicaltrials.gov/show/NCT04325633,None
913,NCT04326426,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Vanda Pharmaceuticals,Recruiting,Phase 3,Interventional,United States,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,Drug,Tradipitant,Tradipitant,300,https://clinicaltrials.gov/show/NCT04326426,None
914,NCT04327804,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Dr. Deneen Vojta,Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,120,https://clinicaltrials.gov/show/NCT04327804,None
915,NCT04329650,ClinicalTrials.gov,2020-03-31,2020-04-15,True,Judit Pich Martínez,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Drug,Siltuximab vs. Corticosteroids,Siltuximab; Methylprednisolone,200,https://clinicaltrials.gov/show/NCT04329650,EUCTR2020-001413-20
916,NCT04331054,ClinicalTrials.gov,2020-03-29,2020-04-13,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,Drug,Corticosteroids + formoterol,Budesonide; formoterol,436,https://clinicaltrials.gov/show/NCT04331054,EUCTR2020-001306-35
917,NCT04331171,ClinicalTrials.gov,2020-03-30,2020-03-17,True,Weprom,Recruiting,Not Applicable,Observational,France,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Other (device),Other,Other,3000000,https://clinicaltrials.gov/show/NCT04331171,None
918,NCT04333420,ClinicalTrials.gov,2020-04-01,2020-03-31,True,InflaRx GmbH,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,"Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",Drug,IFX-1,IFX-1,130,https://clinicaltrials.gov/show/NCT04333420,EUCTR2020-001335-28
919,NCT04333628,ClinicalTrials.gov,2020-04-01,2020-04-01,False,"HaEmek Medical Center, Israel",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Drug,Chloroquine,Chloroquine,210,https://clinicaltrials.gov/show/NCT04333628,None
920,NCT04334044,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Grupo Cooperativo Hemopatías Malignas,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Drug,Ruxolitinib,Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04334044,None
921,NCT04334434,ClinicalTrials.gov,2020-04-02,2020-04-20,False,Kubra Koce,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04334434,None
922,NCT04335773,ClinicalTrials.gov,2020-04-03,2020-04-03,False,"University Hospital, Akershus",Recruiting,Not Applicable,Observational,Norway,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",Clinical Presentation,No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04335773,None
923,NCT04336215,ClinicalTrials.gov,2020-04-02,2020-04-07,False,Rutgers University,Recruiting,Not Applicable,Observational,United States,Rutgers COVID-19 Cohort Study,Clinical Presentation,No Intervention,No Intervention,750,https://clinicaltrials.gov/show/NCT04336215,None
924,NCT04336384,ClinicalTrials.gov,2020-03-30,2020-03-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Impact of Covid-19 in Congenital Heart Disease,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04336384,None
925,NCT04338568,ClinicalTrials.gov,2020-04-04,2020-04-13,False,Hasselt University,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04338568,None
926,NCT04338672,ClinicalTrials.gov,2020-04-04,2020-04-05,False,Sheba Medical Center,Recruiting,Not Applicable,Observational,Israel,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,Health System,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04338672,None
927,NCT04339634,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,United States,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,Clinical Presentation,No Intervention,No Intervention,12123,https://clinicaltrials.gov/show/NCT04339634,None
928,NCT04340466,ClinicalTrials.gov,2020-04-07,2020-04-03,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,Clinical Presentation,No Intervention,No Intervention,220,https://clinicaltrials.gov/show/NCT04340466,None
929,NCT04341168,ClinicalTrials.gov,2020-04-03,2020-04-01,True,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04341168,None
930,NCT04341584,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Drug,Anakinra,Anakinra,240,https://clinicaltrials.gov/show/NCT04341584,None
931,NCT04342156,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Tan Tock Seng Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1200,https://clinicaltrials.gov/show/NCT04342156,None
932,NCT04342169,ClinicalTrials.gov,2020-04-07,2020-04-14,False,University of Utah,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04342169,None
933,NCT04342195,ClinicalTrials.gov,2020-04-08,2020-03-25,True,Columbia University,Recruiting,Not Applicable,Observational,United States,Acquiring Convalescent Specimens for COVID-19 Antibodies,Clinical Presentation,No Intervention,No Intervention,12,https://clinicaltrials.gov/show/NCT04342195,None
934,NCT04342650,ClinicalTrials.gov,2020-04-04,2020-04-08,False,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,Drug,Chloroquine,Chloroquine,210,https://clinicaltrials.gov/show/NCT04342650,None
935,NCT04343001,ClinicalTrials.gov,2020-04-08,2020-04-01,True,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Nigeria, Pakistan",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Drug,"Monotherapy and all Combinations of: ARB (Losartan), simvastatin, and aspirin",ARB (Losartan); simvastatin; aspirin,10000,https://clinicaltrials.gov/show/NCT04343001,None
936,NCT04343144,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Drug,Nivolumab,Nivolumab,92,https://clinicaltrials.gov/show/NCT04343144,None
937,NCT04343183,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Ochsner Health System,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Drug,Oxygen,Oxygen,48,https://clinicaltrials.gov/show/NCT04343183,None
938,NCT04343339,ClinicalTrials.gov,2020-04-08,2020-04-08,False,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04343339,None
939,NCT04343664,ClinicalTrials.gov,2020-04-09,2020-04-12,False,Tjhin Wiguna,Not Recruiting,Not Applicable,Observational,Indonesia,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Other (psych),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04343664,None
940,NCT04343690,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04343690,None
941,NCT04343755,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,ATMP,Plasma,Plasma,55,https://clinicaltrials.gov/show/NCT04343755,None
942,NCT04343794,ClinicalTrials.gov,2020-02-20,2020-04-01,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Other (device),Biosensors,Biosensors,200,https://clinicaltrials.gov/show/NCT04343794,None
943,NCT04343963,ClinicalTrials.gov,2020-04-09,2020-04-04,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,Drug,Pyridostigmine,Pyridostigmine,436,https://clinicaltrials.gov/show/NCT04343963,None
944,NCT04344106,ClinicalTrials.gov,2020-04-08,2020-04-01,True,ELHARRAR Xavier,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Procedure,Positioning,Positioning,25,https://clinicaltrials.gov/show/NCT04344106,None
945,NCT04344171,ClinicalTrials.gov,2020-04-10,2020-03-30,True,ClarData,Recruiting,Not Applicable,Observational,"Romania, Germany",CovidDB: The Covid-19 Inpatient Database,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04344171,None
946,NCT04344210,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Telehealth,Telehealth,Telehealth,149,https://clinicaltrials.gov/show/NCT04344210,None
947,NCT04344236,ClinicalTrials.gov,2020-04-08,2020-04-09,False,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Drug,Povidone Iodine,Povidone Iodine,48,https://clinicaltrials.gov/show/NCT04344236,None
948,NCT04344444,ClinicalTrials.gov,2020-04-10,2020-04-10,False,LCMC Health,Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,600,https://clinicaltrials.gov/show/NCT04344444,None
949,NCT04344535,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Stony Brook University,Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04344535,None
950,NCT04344548,ClinicalTrials.gov,2020-04-10,2020-04-13,False,National University of Colombia,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,ATMP,Cells (NK),Cells (NK),10,https://clinicaltrials.gov/show/NCT04344548,None
951,NCT04344730,ClinicalTrials.gov,2020-04-09,2020-04-10,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Drug,"Dexamethasone, Oxygen",Dexamethasone; Oxygen,550,https://clinicaltrials.gov/show/NCT04344730,EUCTR2020-001457-43
952,NCT04344756,ClinicalTrials.gov,2020-04-09,2020-04-20,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Tinzaparin or Heparin,Tinzaparin; Heparin,808,https://clinicaltrials.gov/show/NCT04344756,None
953,NCT04344782,ClinicalTrials.gov,2020-04-09,2020-04-15,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Bevacizumab,Bevacizumab,130,https://clinicaltrials.gov/show/NCT04344782,None
954,NCT04344834,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Covid-19 on Egyptian Health Care Workers and General Population Mental Health,Other (psych),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04344834,None
955,NCT04344938,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,Other,No Intervention,No Intervention,874,https://clinicaltrials.gov/show/NCT04344938,None
956,NCT04344964,ClinicalTrials.gov,2020-04-10,2020-04-15,False,Austin Health,Not Recruiting,Not Applicable,Observational,No Country Given,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,Telehealth,Telehealth,Telehealth,150,https://clinicaltrials.gov/show/NCT04344964,None
957,NCT04345315,ClinicalTrials.gov,2020-04-10,2020-03-27,True,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Not Applicable,Observational,Italy,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04345315,None
958,NCT04345406,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Tanta University,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Drug,ACE inhibitors,ACE inhibitors,60,https://clinicaltrials.gov/show/NCT04345406,None
959,NCT04345445,ClinicalTrials.gov,2020-04-08,2020-04-15,False,University of Malaya,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,310,https://clinicaltrials.gov/show/NCT04345445,None
960,NCT04345510,ClinicalTrials.gov,2020-04-12,2020-04-20,False,German Cancer Research Center (DKFZ),Not Recruiting,Not Applicable,Observational,No Country Given,Testing for COVID-19 Infection in Asymptomatic Persons,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04345510,None
961,NCT04345523,ClinicalTrials.gov,2020-04-02,2020-04-03,False,Cristina Avendaño-Solá,Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,ATMP,Plasma,Plasma,278,https://clinicaltrials.gov/show/NCT04345523,None
962,NCT04345536,ClinicalTrials.gov,2020-04-05,2020-03-15,True,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04345536,None
963,NCT04345549,ClinicalTrials.gov,2020-04-10,2020-02-26,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,18,https://clinicaltrials.gov/show/NCT04345549,None
964,NCT04345640,ClinicalTrials.gov,2020-04-10,2020-04-14,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Not Applicable,Observational,India,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04345640,None
965,NCT04345887,ClinicalTrials.gov,2020-04-10,2020-04-21,False,Istanbul University-Cerrahpasa,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,Drug,Spironolactone,Spironolactone,60,https://clinicaltrials.gov/show/NCT04345887,None
966,NCT04346017,ClinicalTrials.gov,2020-04-13,2020-03-20,True,Francis Corazza,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04346017,None
967,NCT04346043,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,Genomics,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04346043,None
968,NCT04346056,ClinicalTrials.gov,2020-04-13,2020-04-14,False,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04346056,None
969,NCT04346160,ClinicalTrials.gov,2020-04-10,2020-04-14,False,D'Annunzio University of Chieti–Pescara,Not Recruiting,Not Applicable,Observational,Italy,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,25,https://clinicaltrials.gov/show/NCT04346160,None
970,NCT04346186,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"Copenhagen University Hospital, Herlev Hospital",Not Recruiting,Not Applicable,Observational,Denmark,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30000,https://clinicaltrials.gov/show/NCT04346186,None
971,NCT04346264,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Ludwig Boltzmann Institute for Lung Health,Recruiting,Not Applicable,Observational,Austria,CoVid-19 - Infection and Antibody Formation in the Viennese Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5500,https://clinicaltrials.gov/show/NCT04346264,None
972,NCT04346329,ClinicalTrials.gov,2020-04-10,2020-04-20,False,National University of Colombia,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,86,https://clinicaltrials.gov/show/NCT04346329,None
973,NCT04346342,ClinicalTrials.gov,2020-04-09,2020-03-06,True,UMC Amsterdam,Recruiting,Not Applicable,Observational,Netherlands,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Other (physical),Mechanical ventilation,Mechanical ventilation,1000,https://clinicaltrials.gov/show/NCT04346342,None
974,NCT04346368,ClinicalTrials.gov,2020-03-23,2020-04-01,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04346368,None
975,NCT04346810,ClinicalTrials.gov,2020-04-08,2020-04-15,False,Hôpital Raymond-Poincaré,Not Recruiting,Not Applicable,Observational,No Country Given,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04346810,None
976,NCT04346927,ClinicalTrials.gov,2020-04-13,2020-04-10,True,Yasemin Çırak,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation for Patients Diagnosed With Coronavirus,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04346927,None
977,NCT04346953,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Other (exercise),Exercise,Exercise,128,https://clinicaltrials.gov/show/NCT04346953,None
978,NCT04347070,ClinicalTrials.gov,2020-04-10,2017-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Implementation of Physiotherapy on COVID-19 Patients in ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,150,https://clinicaltrials.gov/show/NCT04347070,None
979,NCT04347369,ClinicalTrials.gov,2020-03-18,2020-01-17,True,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04347369,None
980,NCT04347460,ClinicalTrials.gov,2020-04-08,2020-03-27,True,Technische Universität München,Recruiting,Not Applicable,Observational,Germany,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04347460,None
981,NCT04347850,ClinicalTrials.gov,2020-04-09,2020-02-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04347850,None
982,NCT04347876,ClinicalTrials.gov,2020-04-14,2020-04-11,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04347876,None
983,NCT04347889,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Stony Brook University,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,1212,https://clinicaltrials.gov/show/NCT04347889,None
984,NCT04347941,ClinicalTrials.gov,2020-04-08,2020-04-11,False,University College Hospital Galway,Not Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Procedure,Positioning,Positioning,200,https://clinicaltrials.gov/show/NCT04347941,None
985,NCT04347980,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Centre Chirurgical Marie Lannelongue,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Drug,Dexamethasone + Hydroxychloroquine vs. Hydroxychloroquine,Dexamethasone; Hydroxychloroquine,122,https://clinicaltrials.gov/show/NCT04347980,None
986,NCT04348227,ClinicalTrials.gov,2020-04-10,2019-01-01,True,Hôpital Universitaire Fattouma Bourguiba,Not Recruiting,Not Applicable,Observational,Tunisia,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04348227,None
987,NCT04348383,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,Drug,Defibrotide,Defibrotide,120,https://clinicaltrials.gov/show/NCT04348383,None
988,NCT04348396,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Istituto Nazionale di Ricovero e Cura per Anziani,Not Recruiting,Not Applicable,Observational,Italy,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04348396,None
989,NCT04348422,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluating the Immune Response for COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04348422,None
990,NCT04348448,ClinicalTrials.gov,2020-04-13,2020-04-01,True,AUSL Romagna Rimini,Not Recruiting,Not Applicable,Observational,No Country Given,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",Drug,Canakinumab,Canakinumab,100,https://clinicaltrials.gov/show/NCT04348448,None
991,NCT04348461,ClinicalTrials.gov,2020-04-10,2020-04-06,True,Instituto de Investigación Sanitaria Fundación Jimenez Diaz,Not Recruiting,Phase 2,Interventional,No Country Given,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04348461,None
992,NCT04348695,ClinicalTrials.gov,2020-04-13,2020-04-12,False,La Fundación de Investigación HM,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Drug,Ruxolitinib + Simvastatin,Ruxolitinib; Simvastatin,94,https://clinicaltrials.gov/show/NCT04348695,EUCTR2020-001405-23
993,NCT04348864,ClinicalTrials.gov,2020-04-13,2020-04-16,False,Neuroganics LLC,Recruiting,Not Applicable,Interventional,United States,COVID-19 Antibody Self-testing Using Virtual Point-of-care,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04348864,None
994,NCT04348877,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Interventional,Egypt,Plasma Rich Antibodies From Recovered Patients From COVID19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04348877,None
995,NCT04349371,ClinicalTrials.gov,2020-04-12,2020-04-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,Drug (Chemoprophylaxis),Chloroquine,Chloroquine,350,https://clinicaltrials.gov/show/NCT04349371,None
996,NCT04349410,ClinicalTrials.gov,2020-04-11,2020-04-11,False,The Camelot Foundation,Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Drug (+ ATMP),Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Doxycycline vs. Hydroxychloroquine + Clindamycin vs. Hydroxychloroquine  + Clindamycin + Primaquine vs. Remdesivir vs. Tocilizumab vs. Corticosteroids vs. Interferon alpha vs. Losartan vs. Plasma,Hydroxychloroquine;  Azithromycin;  Doxycycline; Clindamycin; Primaquine; Remdesivir; Tocilizumab; Corticosteroids; Interferon alpha; Losartan; Plasma,500,https://clinicaltrials.gov/show/NCT04349410,None
997,NCT04349618,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Other (physical),Mechanical ventilation,Mechanical ventilation,200,https://clinicaltrials.gov/show/NCT04349618,None
998,NCT04349982,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,ICU Trial in Critical Ill COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04349982,None
999,NCT04350086,ClinicalTrials.gov,2020-04-13,2020-04-20,False,"University Hospital, Limoges",Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,Drug,Dexmedetomidine,Dexmedetomidine,10,https://clinicaltrials.gov/show/NCT04350086,None
1000,NCT04350099,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,Emotional Burden of Healthcare Professionals and Covid Infection 19,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04350099,None
1001,NCT04350281,ClinicalTrials.gov,2020-04-13,2020-04-09,True,University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Drug,Interferon beta + Hydroxychloroquine vs. Hydroxychloroquine,Interferon beta; Hydroxychloroquine,80,https://clinicaltrials.gov/show/NCT04350281,None
1002,NCT04350671,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Interferon Beta 1a in Hospitalized COVID-19 Patients,Drug,Interferon beta + Lopinavir/Ritonavir + Hydroxychlroquine vs. Lopinavir/Ritonavir + Hydroxychloroquine,Interferon beta; Lopinavir/Ritonavir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04350671,None
1003,NCT04350684,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Umifenovir in Hospitalized COVID-19 Patients,Drug,Umifenovir + Interferon beta + Lopinavir/Ritonavir + Hydroxychloroquine vs. Interferon beta + Lopinavir/Ritonavir + Hydroxycholroquine,Umifenovir; Interferon beta; Lopinavir/Ritonavir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04350684,None
1004,NCT04350931,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/show/NCT04350931,None
1005,NCT04351295,ClinicalTrials.gov,2020-04-15,2020-04-17,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,Drug,Favipiravir,Favipiravir,40,https://clinicaltrials.gov/show/NCT04351295,None
1006,NCT04351490,ClinicalTrials.gov,2020-04-14,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,Drug,Zinv + Vitamin D,Zinc; Vitamin D,3140,https://clinicaltrials.gov/show/NCT04351490,None
1007,NCT04351529,ClinicalTrials.gov,2020-04-16,2020-04-01,True,AGMT,Recruiting,Not Applicable,Observational,Austria,Austrian COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04351529,None
1008,NCT04351542,ClinicalTrials.gov,2020-04-14,2020-03-06,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,32,https://clinicaltrials.gov/show/NCT04351542,None
1009,NCT04351620,ClinicalTrials.gov,2020-04-14,2020-04-01,True,University of Chicago,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,20,https://clinicaltrials.gov/show/NCT04351620,None
1010,NCT04351646,ClinicalTrials.gov,2020-04-07,2020-04-15,False,"St. George's, University of London",Not Recruiting,Not Applicable,Observational,United Kingdom,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04351646,None
1011,NCT04351659,ClinicalTrials.gov,2020-04-16,2020-04-01,True,KK Women's and Children's Hospital,Recruiting,Not Applicable,Observational,Singapore,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,ATMP,Plasma,Plasma,8,https://clinicaltrials.gov/show/NCT04351659,None
1012,NCT04351711,ClinicalTrials.gov,2020-04-10,2020-04-01,True,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04351711,None
1013,NCT04351763,ClinicalTrials.gov,2020-04-14,2020-04-27,False,Nicolaus Copernicus University,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Drug,Amiodarone or Verapamil,Amiodarone; Verapamil,804,https://clinicaltrials.gov/show/NCT04351763,None
1014,NCT04351789,ClinicalTrials.gov,2020-04-11,2020-04-01,True,"Copenhagen University Hospital, Hvidovre",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Other (psych),Psychological,Psychological,66,https://clinicaltrials.gov/show/NCT04351789,None
1015,NCT04351802,ClinicalTrials.gov,2020-04-16,2020-04-20,False,University Hospital Plymouth NHS Trust,Not Recruiting,Not Applicable,Observational,No Country Given,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,180,https://clinicaltrials.gov/show/NCT04351802,None
1016,NCT04352400,ClinicalTrials.gov,2020-04-03,2020-04-01,True,University Hospital Padova,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),Drug,Nafamostat,Nafamostat,256,https://clinicaltrials.gov/show/NCT04352400,None
1017,NCT04352517,ClinicalTrials.gov,2020-04-10,2020-03-16,True,University of Extremadura,Recruiting,Not Applicable,Observational,"Chile, Brazil, Uruguay",Influence Physical Activity Psychological Responses COVID-19 Pandemic,Other (exercise),Exercise,Exercise,3500,https://clinicaltrials.gov/show/NCT04352517,None
1018,NCT04352582,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Vaccination Attitudes,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04352582,None
1019,NCT04352803,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Regeneris Medical,Not Recruiting,Phase 1,Interventional,No Country Given,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04352803,None
1020,NCT04352959,ClinicalTrials.gov,2020-04-15,2020-04-27,False,Claude Bernard University,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,Drug,Bêta-cyclodextrin + citrox,Bêta-cyclodextrin; citrox,178,https://clinicaltrials.gov/show/NCT04352959,None
1021,NCT04353154,ClinicalTrials.gov,2020-04-15,2020-04-15,False,Ottawa Heart Institute Research Corporation,Not Recruiting,Not Applicable,Observational,No Country Given,The RAPID COVID TRIAGE Algorithm,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://clinicaltrials.gov/show/NCT04353154,None
1022,NCT04354155,ClinicalTrials.gov,2020-04-13,2020-05-15,False,Neil Goldenberg,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Drug,Heparin,Heparin,38,https://clinicaltrials.gov/show/NCT04354155,None
1023,NCT04354272,ClinicalTrials.gov,2020-04-10,2020-04-13,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of Dental Emergency Treatments During COVID19 Crisis,Clinical Presentation (Epidemiology),No Intervention,No Intervention,840,https://clinicaltrials.gov/show/NCT04354272,None
1024,NCT04354558,ClinicalTrials.gov,2020-04-06,2020-04-01,True,CHU de Amiens,Not Recruiting,Not Applicable,Observational,France,French Single Centre Experience of Critically Ill Patients With Covid 19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04354558,None
1025,NCT04354584,ClinicalTrials.gov,2020-04-13,2020-04-06,True,"Copenhagen University Hospital, Hvidovre",Recruiting,Not Applicable,Observational,Denmark,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04354584,None
1026,NCT04354753,ClinicalTrials.gov,2020-04-17,2020-03-28,True,Aarogyam UK,Not Recruiting,Not Applicable,Observational,United Kingdom,AiM COVID for Covid 19 Tracking and Prediction,Clinical Presentation (Epidemiology),No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04354753,None
1027,NCT04354857,ClinicalTrials.gov,2020-04-17,2020-03-27,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,454,https://clinicaltrials.gov/show/NCT04354857,None
1028,NCT04355026,ClinicalTrials.gov,2020-04-15,2020-04-10,True,Celje General Hospital,Recruiting,Phase 4,Interventional,Slovenia,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,Drug,Bromhexine + Hydroxychloroquine vs. Hydroxychloroquine,Bromhexine; Hydroxychloroquine,90,https://clinicaltrials.gov/show/NCT04355026,None
1029,NCT04355247,ClinicalTrials.gov,2020-04-17,2020-04-14,True,Auxilio Mutuo Cancer Center,Recruiting,Phase 2,Interventional,Puerto Rico,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Drug (Chemoprophylaxis),Corticosteroids,Methylprednisolone,20,https://clinicaltrials.gov/show/NCT04355247,None
1030,NCT04355494,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Alexion Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,France,SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19,Drug,Eculizumab,Eculizumab,Not Available,https://clinicaltrials.gov/show/NCT04355494,None
1031,NCT04355676,ClinicalTrials.gov,2020-04-17,2020-04-30,False,Karyopharm Therapeutics Inc,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,Drug,Selinexor,Selinexor,80,https://clinicaltrials.gov/show/NCT04355676,None
1032,NCT04355741,ClinicalTrials.gov,2020-04-15,2020-04-01,True,University Nova de Lisboa,Not Recruiting,Not Applicable,Observational,Portugal,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04355741,None
1033,NCT04356417,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,Drug,Synthetic anti-malarials,Synthetic anti-malarials,6000000,https://clinicaltrials.gov/show/NCT04356417,None
1034,NCT04356443,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Massachusetts General Hospital,Recruiting,Not Applicable,Observational,United States,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,Other (device),Respiratory Monitor,Respiratory Monitor,500,https://clinicaltrials.gov/show/NCT04356443,None
1035,NCT04356508,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Dr. Gerry Gin Wai Kwok,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Drug,Nivolumab,Nivolumab,15,https://clinicaltrials.gov/show/NCT04356508,None
1036,NCT04357275,ClinicalTrials.gov,2020-04-15,2020-03-13,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04357275,None
1037,NCT04357769,ClinicalTrials.gov,2020-04-16,2020-04-10,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,COVID-19 Pandemic Burden in Severe Mental Disease Patients,Other (psych),No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04357769,None
1038,NCT04357847,ClinicalTrials.gov,2020-04-09,2020-04-09,False,"University Hospital, Rouen",Recruiting,Not Applicable,Observational,France,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04357847,None
1039,ACTRN12620000417987,ANZCTR,2020-03-30,2020-03-30,False,Australian Defence Force Malaria and Infectious Disease Institute,Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,Drug,Chloroquine,Chloroquine,680,https://anzctr.org.au/ACTRN12620000417987.aspx,None
1040,ACTRN12620000486921,ANZCTR,2020-04-17,2020-04-20,False,Royal North Shore Hospital,Not Recruiting,Not Applicable,Observational,Australia,"AUSTRALIAN CARDIOVASCULAR COVID-19 REGISTRY (AUS-COVID) 
",Clinical Presentation,No Intervention,No Intervention,865,https://anzctr.org.au/ACTRN12620000486921.aspx,None
1041,ACTRN12620000457943,ANZCTR,2020-04-08,2020-04-14,False,Medical Research Institute of New Zealand,Not Recruiting,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,70,https://anzctr.org.au/ACTRN12620000457943.aspx,None
1042,ACTRN12620000492954,ANZCTR,2020-04-20,2020-05-01,False,University of New South Wales,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,Other (exercise),Exercise,Exercise,20,https://anzctr.org.au/ACTRN12620000492954.aspx,None
1043,ACTRN12620000482965,ANZCTR,2020-04-17,2020-03-17,True,Juan Pedro Fuentes García,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",Other (exercise),Exercise,Exercise,34,https://anzctr.org.au/ACTRN12620000482965.aspx,None
1044,ACTRN12620000498998,ANZCTR,2020-04-20,2020-04-22,False,Tenon Hospital,Not Recruiting,Not Applicable,Observational,France,Retrospective Study on surgical outcomes among surgical patients during the COVID-19 (SARS-CoV-2) Pandemic,Clinical Presentation,No Intervention,No Intervention,700,https://anzctr.org.au/ACTRN12620000498998.aspx,None
1045,ACTRN12620000493943,ANZCTR,2020-04-20,2020-04-07,True,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Front-line health care workers serial blood COVID-19 antibody results in relation to symptom presentation,Clinical Presentation,No Intervention,No Intervention,50,https://anzctr.org.au/ACTRN12620000493943.aspx,None
1046,ChiCTR2000032412,ChiCTR,2020-04-27,2020-05-15,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for the effectiveness and safety of Xi-Yan-Ping injection combined with conventional protocol in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,426,http://www.chictr.org.cn/showproj.aspx?proj=52988,None
1047,ChiCTR2000032400,ChiCTR,2020-04-27,2020-01-01,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Interventional,China,"the efficacy and safety of high dose intravenous vitamin C in the treatment of novel coronavirus pneumonia (COVID-19): a prospective, randomize, controlled trial",Drug,Vitamin C,Vitamin C,120,http://www.chictr.org.cn/showproj.aspx?proj=52958,None
1048,ChiCTR2000032399,ChiCTR,2020-04-27,2020-04-20,True,Xiaogan Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiaoyao capsule in the improvement of sleep mood disorder of convalescence patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52942,None
1049,ChiCTR2000032368,ChiCTR,2020-04-26,2020-04-15,True,China-Japan Friendship Hospital,Not Recruiting,Not Applicable,Health services research,China,Investigation on the mental health status and intervention of the medical staff of the national rescue medical team in hubei province during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,116,http://www.chictr.org.cn/showproj.aspx?proj=52933,None
1050,ChiCTR2000032367,ChiCTR,2020-04-26,2020-02-19,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=52972,None
1051,ChiCTR2000032346,ChiCTR,2020-04-26,2020-04-21,True,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=52692,None
1052,ChiCTR2000032314,ChiCTR,2020-04-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension,Drug,Aliskiren vs. Nifedipine,Aliskiren; Nifedipine,242,http://www.chictr.org.cn/showproj.aspx?proj=52867,None
1053,ChiCTR2000032313,ChiCTR,2020-04-25,2020-05-01,False,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Interventional,China,Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52916,None
1054,ChiCTR2000032242,ChiCTR,2020-04-24,2020-04-24,False,Mudanjiang Kang'an Hospital,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of oral kolimycin in the treatment of patients with new coronavirus pneumonia (CoVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,350,http://www.chictr.org.cn/showproj.aspx?proj=52824,None
1055,ChiCTR2000032239,ChiCTR,2020-04-23,2020-01-29,True,The First People's Hospital of Jiangxia District,Recruiting,Not Applicable,Observational,China,A medical records based study for epidemiological characteristics of 88 patients with new coronavirus pneumonia (COVID-19) and its impact on severe disease,Clinical Presentation (Epidemiology),No Intervention,No Intervention,88,http://www.chictr.org.cn/showproj.aspx?proj=52507,None
1056,ChiCTR2000032237,ChiCTR,2020-04-23,2020-04-01,True,Ezhou Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,No Country Given,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52699,None
1057,ChiCTR2000032233,ChiCTR,2020-04-23,2020-04-23,False,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Not Recruiting,Not Applicable,Observational,China,Clinical study for the potential impact of novel coronavirus pneumonia (COVID-19) on endocrine system,Clinical Presentation,No Intervention,No Intervention,28,http://www.chictr.org.cn/showproj.aspx?proj=52796,None
1058,ChiCTR2000032214,ChiCTR,2020-04-23,2020-05-01,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Screening of proprietary Chinese medicines in convalescent rehabilitation of novel coronavirus pneumonia (COVID-19) convalescent patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52781,None
1059,ChiCTR2000032213,ChiCTR,2020-04-23,2020-04-23,False,The First Affiliated Hospital of Chongqing Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the impact of wearing medical masks on oxygen saturation in adult surgical patients after general anaesthesia during novel coronavirus pneumonia (COVID-19) pandemic,Other (device),Masks,Masks,151,http://www.chictr.org.cn/showproj.aspx?proj=52788,None
1060,ChiCTR2000032205,ChiCTR,2020-04-23,2020-04-15,True,Wuhan Hospital Of Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52662,None
1061,ChiCTR2000032165,ChiCTR,2020-04-21,2020-04-25,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, parallel-controlled trial for Qi-Mai-Fei-Luo-Ping Mixture in the improvement of lung function of novel coronavirus pneumonia (COVID-19) in the convalescent period",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52679,None
1062,ChiCTR2000032162,ChiCTR,2020-04-21,2020-04-22,False,"Bayi Children's Hospital, Seventh Medical Centre, PLA General Hospital",Not Recruiting,Not Applicable,Observational,China,A medical records based study for ECMO in the rescue therapy of extremely critical novel coronavirus pneumonia (COVID-19) patients,Drug,Oxygen,Oxygen,80,http://www.chictr.org.cn/showproj.aspx?proj=52694,None
1063,ChiCTR2000032161,ChiCTR,2020-04-21,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A retrospective study for evolution and clinical outcomes study of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=52561,None
1064,ISRCTN18348009,ISRCTN,2020-04-15,2020-04-16,False,University of Valladolid,Not Recruiting,Not Applicable,Observational,Spain,Occupational health and safety among health care personnel in a COVID-19 pandemic,Clinical Presentation,No Intervention,No Intervention,80,http://isrctn.com/ISRCTN18348009,None
1065,ISRCTN51255782,ISRCTN,2020-04-14,2020-04-14,False,Labormedizinisches Zentrum Dr. Risch,Recruiting,Not Applicable,Observational,Liechtenstein,Can the Ava fertility tracker device detect early signs of COVID-19?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2170,http://isrctn.com/ISRCTN51255782,None
1066,ISRCTN80453162,ISRCTN,2020-04-14,2020-04-09,True,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Not Applicable,Observational,"Bosnia and Herzegovina, Lithuania, Monaco, Antigua and Barbuda, Iraq, Croatia, Comoros, Kazakhstan, Turkmenistan, Virgin Islands, U.S., Yemen, San Marino, Mauritius, Gibraltar, France, Puerto Rico, Portugal, Tanzania, Saint Pierre and Miquelon, South Sudan, Sri Lanka, Taiwan, Georgia, Cook Islands, China, Nepal, Montenegro, Syria, Saint Martin (French part), El Salvador, Libya, Democratic Republic of Congo, Bonaire Saint Eustatius and Saba, Brazil, Malawi, Argentina, Bhutan, Lesotho, Andorra, Dominican Republic, Greece, British Indian Ocean Territory, Hong Kong, Togo, Honduras, South Georgia and the South Sandwich Is, Switzerland, Macedonia, Guernsey, Liechtenstein, Maldives, Rwanda, Sint Maarten (Dutch part), Tonga, United States Minor Outlying Islands, Anguilla, Northern Mariana Islands, Algeria, Barbados, Nicaragua, Armenia, Belgium, Norway, Guyana, Grenada, India, Mayotte, Heard Island and Mcdonald Islands, Pakistan, Mauritania, Slovakia, Montserrat, New Zealand, Spain, Ghana, Malta, Ireland, Madagascar, Guadeloupe, Cyprus, Suriname, Saint Vincent and the Grenadines, Swaziland, Indonesia, Colombia, Belize, Qatar, Solomon Islands, Gabon, Somalia, Egypt, Pitcairn, Palau, Angola, Christmas Island, Russian Federation, Myanmar, Belarus, Svalbard and Jan Mayen, Ukraine, Haiti, Bulgaria, Cuba, Western Sahara, Tajikistan, Mozambique, New Caledonia, Australia, Niger, Saudi Arabia, Romania, Chad, Cocos (Keeling) Islands, Benin, Trinidad and Tobago, French Polynesia, Zambia, Aruba, Philippines, Botswana, Cayman Islands, Kosovo, Estonia, Saint Kitts and Nevis, Bermuda, Bahamas, Luxembourg, Uzbekistan, Djibouti, Equatorial Guinea, Sao Tome and Principe, Curacao, Zimbabwe, Albania, Bolivia, Eritrea, Guinea, Mexico, Cameroon, Nauru, Timor-Leste, French Southern Territories, Isle of Man, Japan, Costa Rica, Vanuatu, Senegal, Slovenia, Namibia, Bahrain, Tunisia, Denmark, Niue, Serbia, Malaysia, Venezuela, Martinique, Kuwait, Democratic Republic of Congo, Mali, Tuvalu, Turkey, Guam, Netherlands Antilles, Korea, North, French Guiana, Czech Republic, Finland, Saint Helena, Saint Lucia, Papua New Guinea, Bouvet Island, Kiribati, Austria, Wallis and Futuna, Sweden, Hungary, Bangladesh, Vietnam, Burkina Faso, Tokelau, Micronesia, Federated States of, Poland, Moldova, Jordan, Iceland, Macao, Sudan, Korea, South, Azerbaijan, Seychelles, Lebanon, Gambia, Thailand, Netherlands, Brunei, Guinea-Bissau, Kenya, Faroe Islands, Norfolk Island, Germany, Peru, Palestinian Territory, United Kingdom, Iran, Virgin Islands, British, Cambodia, Samoa, Sierra Leone, Afghanistan, Turks and Caicos Islands, Central African Republic, Nigeria, Panama, Saint Barthelemy, Canada, Chile, Antarctica, American Samoa, Dominica, Burundi, Uganda, Israel, Falkland Islands, Fiji, Guatemala, Mongolia, Greenland, Marshall Islands, Holy See (Vatican City State), United Arab Emirates, Cape Verde, Kyrgyzstan, Singapore, Ethiopia, Oman, South Africa, United States, Paraguay, Italy, Cote d'Ivoire, Jamaica, Ecuador, Uruguay, Jersey, Reunion, Laos, Liberia, Latvia, Morocco","The impact of the COVID-19 pandemic on the provision, practice, and outcomes of vascular surgery (COVER study)",Clinical Presentation,No Intervention,No Intervention,200,http://isrctn.com/ISRCTN80453162,None
1067,ISRCTN16912075,ISRCTN,2020-04-06,2020-04-06,False,University of Warwick,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19 – CPAP, high-flow nasal oxygen, and standard care",Drug,Oxygen,Oxygen,4002,http://isrctn.com/ISRCTN16912075,None
1068,ISRCTN13694948,ISRCTN,2020-04-01,2020-04-02,False,"University Hospital, Bern",Recruiting,Not Applicable,Observational,"Lebanon, Lithuania, New Zealand, Spain, Netherlands, Malta, Croatia, Ireland, Cyprus, Germany, France, Portugal, French Southern Territories, Isle of Man, United Kingdom, Slovenia, Denmark, Brazil, Turkey, Bulgaria, Israel, Greece, Czech Republic, Finland, Australia, Switzerland, Austria, Sweden, Liechtenstein, United States, South Africa, Italy, Belgium, Norway, Slovakia, Luxembourg",Distress and resilience of healthcare professionals during the COVID-19 (coronavirus) pandemic,Other (psych),No Intervention,No Intervention,400,http://isrctn.com/ISRCTN13694948,None
1069,ISRCTN51287266,ISRCTN,2019-12-06,2019-12-13,False,St. George's University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Aspergillosis in patients with severe influenza or coronavirus,Pre 2020,Pre 2020,Pre 2020,70,http://isrctn.com/ISRCTN51287266,None
1070,EUCTR2020-001391-15-IE,EU Clinical Trials Register,2020-03-31,2020-04-24,False,Royal College of Surgeons Ireland,Authorised,Phase 2,Interventional,Ireland,A randomized double-blind placebo-controlled trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.,ATMP,Alpha-1-proteinase inhibitor,Alpha-1-proteinase inhibitor,36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001391-15,None
1071,EUCTR2020-001329-30-AT,EU Clinical Trials Register,2020-04-03,2020-04-09,False,Massachusetts General Hospital,Authorised,Phase 4,Interventional,"China, Austria, United States",Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung Failure,Drug,Nitric oxide,Nitric oxide,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001329-30,None
1072,EUCTR2020-001527-14-NL,EU Clinical Trials Register,2020-04-06,2020-04-21,False,Erasmus MC,Authorised,Phase 4,Interventional,Netherlands,COVID-19: addition of azithromycin to chloroquine treatment,Drug,Chloroquine + Azithromycin,Chloroquine; Azithromycin,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001527-14,None
1073,EUCTR2017-001100-30-DE,EU Clinical Trials Register,2018-07-19,2018-10-24,False,Fachingen Heil- und Mineralbrunnen GmbH,Authorised,Phase 3,Interventional,Germany,"Investigation of efficacy and tolerability of the healing water Staatl. Fachingen STILL in patients for symptomatic treatment of heartburn in comparison to placebo
Adaption due to COVID-19",Not relevant,Not relevant,Not relevant,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001100-30,None
1074,EUCTR2020-001255-40-ES,EU Clinical Trials Register,2020-04-20,2020-04-16,True,Clínica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE storm caused by infection with COVID-19.,Drug,Sarilumab,Sarilumab,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001255-40,None
1075,EUCTR2020-001659-42-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19,Drug (Chemoprophylaxis),Antithrombin,Antithrombin,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001659-42,None
1076,EUCTR2020-001622-64-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Dr. Ana Pueyo Bastida,Authorised,Phase 4,Interventional,Spain,OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE,Drug,Corticosteroids,Prednisone,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64,None
1077,EUCTR2020-001440-26-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI),Authorised,Phase 3,Interventional,Spain,Study for the prevention of COVID-19 infection in healthcare personnel,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,184,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001440-26,None
1078,EUCTR2020-001327-13-AT,EU Clinical Trials Register,2020-03-30,2020-04-14,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,"A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC",Drug,Azithromycin,Azithromycin,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001327-13,None
1079,EUCTR2020-001459-42-DK,EU Clinical Trials Register,2020-04-14,2020-04-22,False,Zealand University Hospital,Authorised,Phase 2,Interventional,Denmark,"Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.
",Drug,Ruxolitinib,Ruxolitinib,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001459-42,None
1080,EUCTR2020-001417-21-BE,EU Clinical Trials Register,2020-04-01,2020-04-12,False,Institute of Tropical Medicine,Authorised,Phase 2,Interventional,Belgium,An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21,None
1081,EUCTR2020-001500-41-BE,EU Clinical Trials Register,2020-04-04,2020-04-03,True,"University Hospital, Ghent",Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,Drug,Anakinra or tocilizumab or siltuximab,Anakinra; tocilizumab; siltuximab,342,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41,None
1082,NCT04256395,ClinicalTrials.gov,2020-02-01,2020-02-01,False,Beijing Tsinghua Chang Gung Hospital,Recruiting,Not Applicable,Observational,China,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300000,https://clinicaltrials.gov/show/NCT04256395,None
1083,NCT04313946,ClinicalTrials.gov,2020-03-17,2020-03-18,False,Professor Adrian Covic,Recruiting,Not Applicable,Observational,"Romania, Italy, United Kingdom",Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04313946,None
1084,NCT04318444,ClinicalTrials.gov,2020-03-20,2020-03-29,False,Columbia University,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1600,https://clinicaltrials.gov/show/NCT04318444,None
1085,NCT04319016,ClinicalTrials.gov,2020-03-20,2020-01-01,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04319016,None
1086,NCT04319445,ClinicalTrials.gov,2020-03-20,2020-03-22,False,Wake Forest University,Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04319445,None
1087,NCT04320017,ClinicalTrials.gov,2020-03-20,2020-03-20,False,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04320017,None
1088,NCT04320056,ClinicalTrials.gov,2020-03-19,2020-04-20,False,Laval University,Recruiting,Not Applicable,Interventional,Canada,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Drug,Oxygen,Oxygen,216,https://clinicaltrials.gov/show/NCT04320056,None
1089,NCT04320862,ClinicalTrials.gov,2020-03-23,2020-04-03,False,Duke University,Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Response Network,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200000,https://clinicaltrials.gov/show/NCT04320862,None
1090,NCT04323839,ClinicalTrials.gov,2020-03-24,2020-03-20,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04323839,None
1091,NCT04326920,ClinicalTrials.gov,2020-03-24,2020-03-24,False,"University Hospital, Ghent",Recruiting,Phase 4,Interventional,"Belgium, Italy",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Drug,Sargramostim,Sargramostim,80,https://clinicaltrials.gov/show/NCT04326920,None
1092,NCT04327479,ClinicalTrials.gov,2020-03-26,2020-03-26,False,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,728,https://clinicaltrials.gov/show/NCT04327479,None
1093,NCT04329572,ClinicalTrials.gov,2020-03-29,2020-04-23,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,400,https://clinicaltrials.gov/show/NCT04329572,None
1094,NCT04330599,ClinicalTrials.gov,2020-03-31,2020-05-05,False,Queen Mary University of London,Not Recruiting,Not Applicable,Observational,No Country Given,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,Clinical Presentation,No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04330599,None
1095,NCT04330638,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"University Hospital, Ghent",Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Drug,Anakinta + Siltuximab vs. Tocilizumab + Anakinra vs. Tocilizumab vs. Siltuximab vs. Anakinra,Anakinra; Siltuximab; Tocilizumab,342,https://clinicaltrials.gov/show/NCT04330638,None
1096,NCT04331808,ClinicalTrials.gov,2020-03-31,2020-03-30,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Drug,Tocilizumab,Tocilizumab,228,https://clinicaltrials.gov/show/NCT04331808,None
1097,NCT04332380,ClinicalTrials.gov,2020-03-30,2020-05-01,False,Del Rosario University,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04332380,None
1098,NCT04332835,ClinicalTrials.gov,2020-03-31,2020-05-01,False,Del Rosario University,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study",ATMP (+ Drug),Plasma + Hydroxychloroquine vs. Hydroxychloroquine,Plasma; Hydroxychloroquine,80,https://clinicaltrials.gov/show/NCT04332835,None
1099,NCT04333589,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Drug,Favipiravir,Favipiravir,210,https://clinicaltrials.gov/show/NCT04333589,None
1100,NCT04334265,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,750,https://clinicaltrials.gov/show/NCT04334265,None
1101,NCT04334291,ClinicalTrials.gov,2020-04-01,2020-03-23,True,Iván J. Núñez Gil,Recruiting,Not Applicable,Observational,Spain,"International COVID19 Clinical Evaluation Registry,",Clinical Presentation,No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04334291,None
1102,NCT04334980,ClinicalTrials.gov,2020-03-31,2020-04-30,False,Symvivo Corporation,Not Recruiting,Phase 1,Interventional,Canada,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",ATMP,Vaccine,Vaccine,84,https://clinicaltrials.gov/show/NCT04334980,None
1103,NCT04335032,ClinicalTrials.gov,2020-04-01,2020-04-13,False,S.L.A. Pharma AG,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),Drug,Eicosapentaenoic acid,Eicosapentaenoic acid,240,https://clinicaltrials.gov/show/NCT04335032,None
1104,NCT04335123,ClinicalTrials.gov,2020-03-31,2020-03-25,True,University of Kansas Medical Center,Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,Drug,ARB (Losartan),ARB (Losartan),50,https://clinicaltrials.gov/show/NCT04335123,None
1105,NCT04337008,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Renin Angiotensin System - CoronaVirus,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04337008,None
1106,NCT04338009,ClinicalTrials.gov,2020-04-01,2020-03-31,True,University of Pennsylvania,Recruiting,Not Applicable,Interventional,United States,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,152,https://clinicaltrials.gov/show/NCT04338009,None
1107,NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Drug,Anakinra or Tocilizumab,Anakinra; Tocilizumab,40,https://clinicaltrials.gov/show/NCT04339712,EUCTR2020-001039-29
1108,NCT04341493,ClinicalTrials.gov,2020-04-07,2020-04-06,True,Hugo Mendieta Zeron,Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Drug,Hydroxychloroquine vs. Nitazoxanide,Hydroxychloroquine; nitazoxanide,86,https://clinicaltrials.gov/show/NCT04341493,None
1109,NCT04344184,ClinicalTrials.gov,2020-04-09,2020-06-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI),Drug,Vitamin C,Vitamin C,200,https://clinicaltrials.gov/show/NCT04344184,None
1110,NCT04344327,ClinicalTrials.gov,2020-04-09,2020-04-10,False,French Cardiology Society,Not Recruiting,Not Applicable,Observational,France,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,Clinical Presentation,No Intervention,No Intervention,2878,https://clinicaltrials.gov/show/NCT04344327,None
1111,NCT04344431,ClinicalTrials.gov,2020-04-09,2020-04-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Drug,Oxygen,Oxygen,100,https://clinicaltrials.gov/show/NCT04344431,None
1112,NCT04345601,ClinicalTrials.gov,2020-04-10,2020-05-01,False,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04345601,None
1113,NCT04345679,ClinicalTrials.gov,2020-04-11,2020-04-14,False,Orthosera Kft.,Not Recruiting,Phase 1,Interventional,No Country Given,Anti COVID-19 Convalescent Plasma Therapy,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04345679,None
1114,NCT04346212,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Hospital de Mataró,Recruiting,Not Applicable,Observational,Spain,Oropharyngeal Dysphagia in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04346212,None
1115,NCT04346797,ClinicalTrials.gov,2020-04-06,2020-04-16,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,France,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Drug,Eculizumab,Eculizumab,120,https://clinicaltrials.gov/show/NCT04346797,None
1116,NCT04347694,ClinicalTrials.gov,2020-04-12,2020-04-11,True,Medical University of Vienna,Recruiting,Not Applicable,Observational,Austria,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04347694,None
1117,NCT04347993,ClinicalTrials.gov,2020-04-13,2020-03-27,True,Hackensack Meridian Health,Recruiting,Not Applicable,Observational,United States,"A Prospective ""Universal"" Observational Database for COVID-19",Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04347993,None
1118,NCT04348474,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine + Azithromycin ,Hydroxychloroquine; Azithromycin ,200,https://clinicaltrials.gov/show/NCT04348474,None
1119,NCT04348929,ClinicalTrials.gov,2020-04-10,2020-04-16,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04348929,None
1120,NCT04349202,ClinicalTrials.gov,2020-04-13,2020-04-10,True,William Beaumont Hospitals,Recruiting,Not Applicable,Observational,United States,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Clinical Presentation,No Intervention,No Intervention,50000,https://clinicaltrials.gov/show/NCT04349202,None
1121,NCT04350580,ClinicalTrials.gov,2020-04-08,2020-04-11,True,Centre Hospitalier St. Anne,Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds,ATMP,Immunoglobulin,Immunoglobulin,138,https://clinicaltrials.gov/show/NCT04350580,EUCTR2020-001570-30
1122,NCT04351724,ClinicalTrials.gov,2020-04-10,2020-04-16,True,Medical University of Vienna,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Drug,"Chloroquine or Hydroxychloroquine vs. lopinavir/ritonavir

Substudies: Rovaroxaban, Clazakizumab, Candesartan",Chloroquine; Hydroxychloroquine; Lopinavir/Ritonavir; Rovaroxaban; Clazakizumab; Candesartan,500,https://clinicaltrials.gov/show/NCT04351724,EUCTR2020-001302-30
1123,NCT04351854,ClinicalTrials.gov,2020-04-16,2020-04-20,False,University of Cologne,Not Recruiting,Not Applicable,Observational,Germany,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04351854,None
1124,NCT04352608,ClinicalTrials.gov,2020-04-14,2020-04-16,False,"Sinovac Research and Development Co., Ltd.",Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),ATMP,Vaccine,Vaccine,744,https://clinicaltrials.gov/show/NCT04352608,None
1125,NCT04352764,ClinicalTrials.gov,2020-04-16,2020-03-27,True,Texas Cardiac Arrhythmia Research Foundation,Recruiting,Not Applicable,Observational,United States,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,https://clinicaltrials.gov/show/NCT04352764,None
1126,NCT04352946,ClinicalTrials.gov,2020-04-16,2020-04-24,False,GeoSentinel Foundation,Not Recruiting,Phase 3,Interventional,United States,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,374,https://clinicaltrials.gov/show/NCT04352946,None
1127,NCT04353037,ClinicalTrials.gov,2020-04-09,2020-04-07,True,UnitedHealth Group,Recruiting,Phase 2,Interventional,United States,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,Drug,Hydroxychloroquine,Hydroxychloroquine,850,https://clinicaltrials.gov/show/NCT04353037,None
1128,NCT04353518,ClinicalTrials.gov,2020-04-16,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug,Mycobacterium,Mycobacterium,4000,https://clinicaltrials.gov/show/NCT04353518,None
1129,NCT04353609,ClinicalTrials.gov,2020-04-15,2020-04-18,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",Clinical Presentation,No Intervention,No Intervention,13770,https://clinicaltrials.gov/show/NCT04353609,None
1130,NCT04354870,ClinicalTrials.gov,2020-04-16,2020-04-03,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,COVID-19 PrEP HCW HCQ Study,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04354870,None
1131,NCT04355052,ClinicalTrials.gov,2020-04-16,2020-04-11,True,Sheba Medical Center,Recruiting,Phase 3,Interventional,Israel,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",Drug,Camostat Mesilate + Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Camostat Mesilate; Hydroxychloroquine; Azithromycin,250,https://clinicaltrials.gov/show/NCT04355052,None
1132,NCT04355234,ClinicalTrials.gov,2020-04-17,2020-04-24,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2200,https://clinicaltrials.gov/show/NCT04355234,None
1133,NCT04355338,ClinicalTrials.gov,2020-04-17,2020-05-15,False,Butantan Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),Clinical Presentation (Epidemiology),No Intervention,No Intervention,4100,https://clinicaltrials.gov/show/NCT04355338,None
1134,NCT04355429,ClinicalTrials.gov,2020-04-17,2020-05-05,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Drug,Captopril,Captopril,230,https://clinicaltrials.gov/show/NCT04355429,None
1135,NCT04355481,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04355481,None
1136,NCT04355507,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Computed Tomography for COVID-19 Diagnosis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,https://clinicaltrials.gov/show/NCT04355507,None
1137,NCT04355715,ClinicalTrials.gov,2020-04-17,2019-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04355715,None
1138,NCT04355754,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Medical University of Gdańsk,Recruiting,Not Applicable,Interventional,Poland,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,40,https://clinicaltrials.gov/show/NCT04355754,None
1139,NCT04355793,ClinicalTrials.gov,2020-04-18,2020-04-15,True,Incyte Corporation,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,Drug,Ruxolitinib,Ruxolitinib,Not Available,https://clinicaltrials.gov/show/NCT04355793,None
1140,NCT04355884,ClinicalTrials.gov,2020-04-19,2020-04-20,False,University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04355884,None
1141,NCT04355962,ClinicalTrials.gov,2020-03-26,2020-04-23,False,University of Zurich,Recruiting,Phase 3,Interventional,Switzerland,Sevoflurane in COVID-19 ARDS (SevCov),Drug,Sevoflurane,Sevoflurane,64,https://clinicaltrials.gov/show/NCT04355962,None
1142,NCT04356365,ClinicalTrials.gov,2020-04-21,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Other (psych),No Intervention,No Intervention,10084,https://clinicaltrials.gov/show/NCT04356365,None
1143,NCT04356560,ClinicalTrials.gov,2020-04-13,2020-03-23,True,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Observational,Denmark,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04356560,None
1144,NCT04356586,ClinicalTrials.gov,2020-04-17,2020-04-30,False,Sciensano,Recruiting,Not Applicable,Observational,Belgium,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04356586,None
1145,NCT04356677,ClinicalTrials.gov,2020-04-20,2020-04-01,True,"Bausch Health Americas, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug,Ribavirin,Ribavirin,50,https://clinicaltrials.gov/show/NCT04356677,None
1146,NCT04357106,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Centro de Hematologia y Medicina Interna,Recruiting,Phase 2,Interventional,Mexico,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04357106,None
1147,NCT04357327,ClinicalTrials.gov,2020-04-15,2020-04-16,False,Université Libre de Bruxelles,Recruiting,Not Applicable,Interventional,Italy,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04357327,None
1148,NCT04357366,ClinicalTrials.gov,2020-04-20,2020-04-15,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Drug,Anakinra + trimethoprim/sulfamethoxazole,Anakinra; trimethoprim; sulfamethoxazole,100,https://clinicaltrials.gov/show/NCT04357366,EUCTR2020-001466-11
1149,NCT04357418,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Centre Hospitalier de Ville-Evrard,Not Recruiting,Not Applicable,Observational,France,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,Other (psych),No Intervention,No Intervention,1320,https://clinicaltrials.gov/show/NCT04357418,None
1150,NCT04357496,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Centogene,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Epidemic Response Study,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04357496,None
1151,NCT04357574,ClinicalTrials.gov,2020-04-20,2020-04-14,True,Duke University,Recruiting,Not Applicable,Observational,United States,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,Telehealth,Telehealth,Telehealth,1000,https://clinicaltrials.gov/show/NCT04357574,None
1152,NCT04357613,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Versailles Hospital,Not Recruiting,Phase 2,Interventional,France,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Drug,Imatinib,Imatinib,99,https://clinicaltrials.gov/show/NCT04357613,None
1153,NCT04357782,ClinicalTrials.gov,2020-04-17,2020-04-16,True,Veteran Affairs Medical Center,Recruiting,Phase 1/Phase 2,Interventional,United States,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Drug,Vitamin C,Vitamin C,20,https://clinicaltrials.gov/show/NCT04357782,None
1154,NCT04357808,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Maria del Rosario Garcia de Vicuña Pinedo,Recruiting,Phase 2,Interventional,Spain,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Drug,Sarilumab,Sarilumab,30,https://clinicaltrials.gov/show/NCT04357808,EUCTR2020-001634-36
1155,NCT04357834,ClinicalTrials.gov,2020-04-17,2020-05-01,False,"University Hospital, Bern",Not Recruiting,Not Applicable,Observational,Switzerland,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,Other (device),Smartwatch,Smartwatch,100,https://clinicaltrials.gov/show/NCT04357834,None
1156,NCT04357860,ClinicalTrials.gov,2020-04-20,2020-04-27,True,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Sarilumab in Adults With COVID-19,Drug,Sarilumab,Sarilumab,120,https://clinicaltrials.gov/show/NCT04357860,EUCTR2020-001531-27
1157,NCT04357886,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04357886,None
1158,NCT04358042,ClinicalTrials.gov,2020-04-08,2020-04-25,False,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,PSYCHIATRIC Disorders and Covid-19,Other (psych),No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04358042,None
1159,NCT04358211,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Dr. Nakhle Saba,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04358211,None
1160,NCT04358406,ClinicalTrials.gov,2020-04-16,2020-06-01,False,BioAegis Therapeutics Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Rhu-pGSN for Severe Covid-19 Pneumonia,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04358406,None
1161,NCT04358510,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Dascena,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Mortality Prediction Model,Prognosis,No Intervention,No Intervention,114,https://clinicaltrials.gov/show/NCT04358510,None
1162,NCT04358536,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Dascena,Not Recruiting,Not Applicable,Observational,United States,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04358536,None
1163,NCT04358614,ClinicalTrials.gov,2020-04-19,2020-03-16,True,Fabrizio Cantini,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Baricitinib Therapy in COVID-19,Drug,Baricitinib,Baricitinib,12,https://clinicaltrials.gov/show/NCT04358614,None
1164,NCT04358627,ClinicalTrials.gov,2020-04-15,2020-04-15,False,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Observational,No Country Given,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,Drug,Dexmedetomidine,Dexmedetomidine,80,https://clinicaltrials.gov/show/NCT04358627,None
1165,NCT04358640,ClinicalTrials.gov,2020-04-21,2020-04-09,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Other (psych),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04358640,None
1166,NCT04358809,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug,Mycobacterium,Mycobacterium,480,https://clinicaltrials.gov/show/NCT04358809,None
1167,NCT04359095,ClinicalTrials.gov,2020-04-15,2020-05-11,False,National University of Colombia,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Lopinavir/Ritonavir vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin; Lopinavir/Ritonavir,1600,https://clinicaltrials.gov/show/NCT04359095,None
1168,NCT04359251,ClinicalTrials.gov,2020-04-13,2020-03-05,True,"Southeast University, China",Not Recruiting,Not Applicable,Interventional,China,Different PEEP Settings of COVID-19 Induced ARDS,Other (physical),Mechanical ventilation,Mechanical ventilation,20,https://clinicaltrials.gov/show/NCT04359251,None
1169,NCT04359290,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Philipps University Marburg Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Drug,Ruxolitinib,Ruxolitinib,15,https://clinicaltrials.gov/show/NCT04359290,None
1170,NCT04359316,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Azithromycin in Hospitalized COVID-19 Patients,Drug,Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04359316,None
1171,NCT04359329,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Sharon Nachman,Recruiting,Phase 2,Interventional,United States,Estrogen Patch for COVID-19 Symptoms,Drug,Estradiol,Estradiol,110,https://clinicaltrials.gov/show/NCT04359329,None
1172,NCT04359459,ClinicalTrials.gov,2020-04-20,2020-06-01,False,University Medical Center Groningen,Not Recruiting,Not Applicable,Observational,No Country Given,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04359459,None
1173,NCT04359615,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Favipiravir in Hospitalized COVID-19 Patients,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04359615,None
1174,NCT04359836,ClinicalTrials.gov,2020-04-20,2020-04-16,True,ProgenaBiome,Recruiting,Not Applicable,Observational,United States,A Study to Explore the Role of Gut Flora in COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04359836,None
1175,NCT04359849,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Portsmouth Hospitals NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Sequencing and Tracking of Phylogeny in COVID-19 Study,Genomics,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04359849,None
1176,NCT04359875,ClinicalTrials.gov,2020-04-18,2020-04-01,True,CHU de Tours,Not Recruiting,Not Applicable,Interventional,France,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,Telehealth,Telehealth,Telehealth,22000,https://clinicaltrials.gov/show/NCT04359875,None
1177,NCT04359914,ClinicalTrials.gov,2020-04-19,2020-04-15,True,University of Rostock,Recruiting,Not Applicable,Observational,Germany,Neurocognitive Impairment in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04359914,None
1178,NCT04359953,ClinicalTrials.gov,2020-04-17,2020-04-24,True,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Drug,Hydroxychloroquine + Telmisartan + Azithromycin,Hydroxychloroquine; Telmisartan; Azithromycin,1600,https://clinicaltrials.gov/show/NCT04359953,EUCTR2020-001303-16
1179,NCT04359992,ClinicalTrials.gov,2020-04-16,2020-04-17,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Study of Hemostasis in Case of Severe COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04359992,None
1180,NCT04360096,ClinicalTrials.gov,2020-04-21,2020-06-01,False,"NeuroRx, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Inhaled Aviptadil for the Treatment of Non-Acute Lung Injury in COVID-19,Drug,Aviptadil,Aviptadil,144,https://clinicaltrials.gov/show/NCT04360096,None
1181,NCT04360356,ClinicalTrials.gov,2020-04-19,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,Drug,Ivermectin + Nitazoxanide,Ivermectin; Nitazoxanide,100,https://clinicaltrials.gov/show/NCT04360356,None
1182,NCT04360486,ClinicalTrials.gov,2020-04-20,2020-06-01,False,U.S. Army Medical Research and Development Command,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04360486,None
1183,NCT04360538,ClinicalTrials.gov,2020-04-16,2020-04-08,True,University of Chicago,Recruiting,Not Applicable,Observational,United States,Long Term Outcomes of Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04360538,None
1184,NCT04360551,ClinicalTrials.gov,2020-04-21,2020-07-01,False,University of Hawaii,Not Recruiting,Phase 2,Interventional,United States,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,Drug,Telmisartan,Telmisartan,40,https://clinicaltrials.gov/show/NCT04360551,None
1185,NCT04360733,ClinicalTrials.gov,2020-04-22,2020-04-20,True,University of Bonn,Recruiting,Not Applicable,Observational,Germany,Precision Immunology to Determine the Immune Response in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04360733,None
1186,NCT04360759,ClinicalTrials.gov,2020-04-22,2020-05-01,False,University of Cape Town,Not Recruiting,Phase 3,Interventional,South Africa,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Drug,Chloroquine or hydroxychloroquine,Chloroquine; hydroxychloroquine,560,https://clinicaltrials.gov/show/NCT04360759,None
1187,NCT04360811,ClinicalTrials.gov,2020-04-22,2020-04-17,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3600,https://clinicaltrials.gov/show/NCT04360811,None
1188,NCT04360850,ClinicalTrials.gov,2020-04-21,2020-04-24,False,University of Washington,Recruiting,Not Applicable,Observational,United States,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,10000,https://clinicaltrials.gov/show/NCT04360850,None
1189,NCT04360863,ClinicalTrials.gov,2020-04-22,2020-04-24,False,University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,Other,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04360863,None
1190,NCT04360876,ClinicalTrials.gov,2020-04-22,2020-05-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2,Interventional,No Country Given,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,Drug,Corticosteroids,Dexamethasone,90,https://clinicaltrials.gov/show/NCT04360876,None
1191,NCT04360954,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Washington University in St. Louis,Recruiting,Not Applicable,Observational,United States,Evaluation of Antibody Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04360954,None
1192,NCT04360980,ClinicalTrials.gov,2020-04-22,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,Drug,Colchicine,Colchicine,80,https://clinicaltrials.gov/show/NCT04360980,None
1193,NCT04361019,ClinicalTrials.gov,2020-04-22,2020-04-16,True,Basque Country University,Recruiting,Not Applicable,Observational,Spain,Physical Activity in University Students Around COVID-19 Confinement,Other (exercise),No Intervention,No Intervention,25000,https://clinicaltrials.gov/show/NCT04361019,None
1194,NCT04361318,ClinicalTrials.gov,2020-04-18,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,Drug,Hydroxychloroquine + Nitazoxanide,Hydroxychloroquine; Nitazoxanide,100,https://clinicaltrials.gov/show/NCT04361318,None
1195,NCT04361422,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Tanta University,Not Recruiting,Phase 3,Interventional,No Country Given,Isotretinoin in Treatment of COVID-19,Drug,Isotretinoin,Isotretinoin,300,https://clinicaltrials.gov/show/NCT04361422,None
1196,NCT04361435,ClinicalTrials.gov,2020-04-12,2020-05-01,False,St. Justine's Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Lung Recruitment Device for COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,50,https://clinicaltrials.gov/show/NCT04361435,None
1197,NCT04361448,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Jessa Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04361448,None
1198,NCT04361461,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Apsen Farmaceutica S.A.,Not Recruiting,Phase 3,Interventional,Brazil,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),Drug,Hydroxychloroquine + Azythromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithormycin,500,https://clinicaltrials.gov/show/NCT04361461,None
1199,NCT04361500,ClinicalTrials.gov,2020-04-22,2020-04-15,True,Hannover Medical School,Recruiting,Not Applicable,Observational,Germany,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,Other (device),Blood filter,Blood filter,100,https://clinicaltrials.gov/show/NCT04361500,None
1200,NCT04361526,ClinicalTrials.gov,2020-04-21,2020-04-17,True,Manuel Castella,Recruiting,Not Applicable,Interventional,Spain,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Other (device),Cytokine Adsorber,Cytokine Adsorber,40,https://clinicaltrials.gov/show/NCT04361526,None
1201,NCT04361591,ClinicalTrials.gov,2020-04-22,2020-03-01,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,COVID-19 in Liver Transplant Recipients,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04361591,None
1202,NCT04361604,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,Clinical Presentation,No Intervention,No Intervention,270,https://clinicaltrials.gov/show/NCT04361604,None
1203,NCT04361786,ClinicalTrials.gov,2020-04-17,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04361786,None
1204,NCT04361903,ClinicalTrials.gov,2020-04-14,2020-04-25,False,Azienda Unita Sanitaria Locale Toscana Nord Ovest,Not Recruiting,Not Applicable,Observational,No Country Given,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,Drug,Ruxolitinib,Ruxolitinib,13,https://clinicaltrials.gov/show/NCT04361903,None
1205,NCT04361916,ClinicalTrials.gov,2020-04-14,2020-04-21,False,Mario Negri Institute for Pharmacological Research,Recruiting,Not Applicable,Interventional,Italy,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Other,Other,Other,425,https://clinicaltrials.gov/show/NCT04361916,None
1206,NCT04361981,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Sociedad Española de Angiología y Cirugía Vascular (SEACV),Not Recruiting,Not Applicable,Observational,Spain,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04361981,None
1207,NCT04362111,ClinicalTrials.gov,2020-04-21,2020-05-01,False,University of Alabama at Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Early Identification and Treatment of Cytokine Storm Syndrome in Covid-19,Drug,Anakinra,Anakinra,20,https://clinicaltrials.gov/show/NCT04362111,None
1208,NCT04362124,ClinicalTrials.gov,2020-04-21,2020-04-01,True,University of Antioquia,Not Recruiting,Phase 3,Interventional,Colombia,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04362124,None
1209,NCT04362358,ClinicalTrials.gov,2020-04-21,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Interventional,No Country Given,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04362358,None
1210,NCT04362943,ClinicalTrials.gov,2020-04-22,2020-04-20,True,Complejo Hospitalario Universitario de Albacete,Recruiting,Not Applicable,Observational,Spain,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,Drug,Baricitinib or Anakinra,Baricitinib; Anakinra,576,https://clinicaltrials.gov/show/NCT04362943,None
1211,NCT04362956,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Fundación Infant,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04362956,None
1212,NCT04363099,ClinicalTrials.gov,2020-04-23,2020-03-01,True,Maison de Santé Pluridisciplinaire de Creil,Recruiting,Not Applicable,Observational,France,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04363099,None
1213,NCT04363268,ClinicalTrials.gov,2020-04-23,2020-04-20,True,Medable Inc.,Recruiting,Not Applicable,Observational,United States,ACCESS A Master Digital Surveillance Protocol for COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000000,https://clinicaltrials.gov/show/NCT04363268,None
1214,NCT04363372,ClinicalTrials.gov,2020-04-24,2020-05-01,False,4D Pharma,Not Recruiting,Phase 2,Interventional,No Country Given,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,Drug,MRx-4DP0004,MRx-4DP0004,90,https://clinicaltrials.gov/show/NCT04363372,None
1215,NCT04363489,ClinicalTrials.gov,2020-04-23,2020-04-27,False,King's College London,Not Recruiting,Not Applicable,Observational,No Country Given,The CEDiD Study (COVID-19 Early Diagnosis in Doctors),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04363489,None
1216,NCT04363528,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Versailles Hospital,Not Recruiting,Not Applicable,Interventional,France,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04363528,None
1217,NCT04363541,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Instituto Nacional de Perinatología,Not Recruiting,Not Applicable,Interventional,No Country Given,Local Thermotherapy for Patients With Moderate Symptoms of COVID-19,Other (device),Heating pad,Heating pad,298,https://clinicaltrials.gov/show/NCT04363541,None
1218,NCT04363671,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Hôpital Cochin,Not Recruiting,Not Applicable,Observational,France,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),Other (psych),No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04363671,None
1219,NCT04363749,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,Other,Other,Other,30,https://clinicaltrials.gov/show/NCT04363749,None
1220,NCT04363788,ClinicalTrials.gov,2020-04-23,2020-02-28,True,Lazarski University,Not Recruiting,Not Applicable,Observational,Poland,Needle Stick Injuries in Emergency Medical Service Practice,Procedure,Double Gloves,Double Gloves,300,https://clinicaltrials.gov/show/NCT04363788,None
1221,NCT04363840,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Louisiana State University Health Sciences Center in New Orleans,Not Recruiting,Phase 2,Interventional,No Country Given,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Drug,Aspirin + Vitamin D vs. Aspirin,Aspirin; Vitamin D,1080,https://clinicaltrials.gov/show/NCT04363840,None
1222,NCT04363866,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Oregon Health and Science University,Not Recruiting,Phase 4,Interventional,United States,A Pilot Study to Assess Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04363866,None
1223,NCT04364022,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Calmy Alexandra,Recruiting,Phase 3,Interventional,Switzerland,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Lopinavir/Ritonavir,Hydroxychloroquine; Lopinavir/Ritonavir,420,https://clinicaltrials.gov/show/NCT04364022,None
1224,NCT04364711,ClinicalTrials.gov,2020-04-20,2020-05-01,False,UMC Utrecht,Not Recruiting,Not Applicable,Observational,No Country Given,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04364711,None
1225,NCT04364984,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Medical Practice Prof D. Ivanov,Recruiting,Not Applicable,Observational,Ukraine,"ARB, ACEi, DRi in COVID-19",Drug,ACE inhibitors,ACE inhibitors,10,https://clinicaltrials.gov/show/NCT04364984,None
1226,NCT04365127,ClinicalTrials.gov,2020-04-24,2020-04-27,False,Sara Ghandehari,Recruiting,Phase 1,Interventional,United States,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Drug,Progesterone,Progesterone,40,https://clinicaltrials.gov/show/NCT04365127,None
1227,NCT04365439,ClinicalTrials.gov,2020-04-18,2020-04-27,False,Enos Bernasconi,Not Recruiting,Not Applicable,Interventional,No Country Given,Convalescent Plasma for COVID-19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04365439,None
1228,NCT04365634,ClinicalTrials.gov,2020-04-25,2020-02-02,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,Clinical Presentation,No Intervention,No Intervention,306,https://clinicaltrials.gov/show/NCT04365634,None
1229,NCT04365699,ClinicalTrials.gov,2020-04-25,2020-04-08,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Cardiovascular Effects of COVID-19,Drug,AT-001,AT-001,500,https://clinicaltrials.gov/show/NCT04365699,None
1230,NCT04365738,ClinicalTrials.gov,2020-04-26,2020-03-11,True,Istanbul Bilgi University,Not Recruiting,Not Applicable,Interventional,Turkey,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,270,https://clinicaltrials.gov/show/NCT04365738,None
1231,NCT04365881,ClinicalTrials.gov,2020-04-26,2020-03-31,True,Modum Bad,Not Recruiting,Not Applicable,Observational,Norway,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Other (psych),No Intervention,No Intervention,10084,https://clinicaltrials.gov/show/NCT04365881,None
1232,NCT04365959,ClinicalTrials.gov,2020-04-21,2020-03-20,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,The Prone Position in Covid-19 Affected Patients,Procedure,Positioning,Positioning,56,https://clinicaltrials.gov/show/NCT04365959,None
1233,NCT04366050,ClinicalTrials.gov,2020-04-24,2020-04-01,True,"University of California, San Diego",Not Recruiting,Phase 2,Interventional,No Country Given,Ramipril for the Treatment of COVID-19,Drug,Ramipril,Ramipril,560,https://clinicaltrials.gov/show/NCT04366050,None
1234,NCT04366830,ClinicalTrials.gov,2020-04-24,2020-04-01,True,Mesoblast International,Not Recruiting,Not Applicable,Expanded Access,United States,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",ATMP,Cells (mesenchymal),Cells (mesenchymal),Not Available,https://clinicaltrials.gov/show/NCT04366830,None
1235,NCT04372069,ClinicalTrials.gov,2020-04-29,2020-04-09,True,London Ambulance Service NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,London Ambulance Service Experience of COVID-19,Health System,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04372069,None
1236,ACTRN12620000512921,ANZCTR,2020-04-27,2020-04-29,False,Gold Coast University Hospital,Not Recruiting,Not Applicable,Observational,Australia,SARS-CoV2 in children presenting to hospital: A repeating point prevalence study during the COVID-19 pandemic in South East Queensland,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,https://anzctr.org.au/ACTRN12620000512921.aspx,None
1237,ACTRN12620000516987,ANZCTR,2020-04-27,2020-06-02,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing a wellbeing app to support wellbeing during the Covid-19 pandemic,Other (psych),Psychological,Psychological,90,https://anzctr.org.au/ACTRN12620000516987.aspx,None
1238,ACTRN12620000517976,ANZCTR,2020-04-27,2020-05-21,False,"St. Vincents Hospital, Melbourne",Not Recruiting,Phase 3,Interventional,Australia,COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study),Drug,Heparin,Heparin,172,https://anzctr.org.au/ACTRN12620000517976.aspx,None
1239,ACTRN12620000527965,ANZCTR,2020-04-29,2020-05-01,False,Hunter New England Local Health District,Not Recruiting,Not Applicable,Observational,Australia,Neonatal CoVID-19 Study to evaluate the population health impacts of COVID-19 in mothers and their newborn infants cared for in tertiary and non-tertiary hospitals in Australia.,Clinical Presentation,No Intervention,No Intervention,1000,https://anzctr.org.au/ACTRN12620000527965.aspx,None
1240,ISRCTN13311119,ISRCTN,2020-04-24,2020-04-30,False,Eminentlabs GmbH,Recruiting,Phase 2,Interventional,India,START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,116,http://isrctn.com/ISRCTN13311119,None
1241,ISRCTN17898730,ISRCTN,2020-04-23,2020-04-07,True,Psychosocial Innovation Network,Recruiting,Not Applicable,Interventional,Serbia,Expressive writing for the reduction of psychological difficulties during the COVID-19 pandemic,Other (psych),Psychological,Psychological,150,http://isrctn.com/ISRCTN17898730,None
1242,ISRCTN83971151,ISRCTN,2020-03-25,2020-03-26,True,World Health Organization,Recruiting,Phase 3,Interventional,"Lebanon, Spain, Thailand, Ireland, Kenya, Peru, Germany, Indonesia, Iran, Qatar, Canada, Malaysia, Brazil, Argentina, Israel, Honduras, Switzerland, Saudi Arabia, South Africa, Italy, Philippines, Norway, India",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,Drug,Remdesivir vs. chloroquine/hydroxychloroquine vs. lopinavir/ritonavir vs. interferon beta,Remdesivir; chlorquine; hydroxychloroquine; lopinavir/ritonavir; interferon beta,10000,http://isrctn.com/ISRCTN83971151,EUCTR2020-001366-11; NCT04330690; PER-010-20; IRCT20200405046953N1; NCT04321616; EUCTR2020-000982-18; CTRI/2020/04/024773; LBCTR2020043495; EUCTR2020-002060-31; EUCTR2020-001549-38
1243,ChiCTR2000032632,ChiCTR,2020-05-04,2020-03-20,True,The First Affiliated Hospital of Xinjiang Medical University,Recruiting,Not Applicable,Interventional,China,The influence of COVID-19 pandemic on cardiovascular patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=53190,None
1244,ChiCTR2000032574,ChiCTR,2020-05-03,2020-01-01,True,Ganzhou People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Diagnostic value of chest CT in outpatient for novel coronavirus pneumonia (COVID-19) compared to RT-PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,248,http://www.chictr.org.cn/showproj.aspx?proj=53122,None
1245,ChiCTR2000032573,ChiCTR,2020-05-03,2020-05-02,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, controlled trial for Bu-Fei-Huo-Xue Capsule in the treatment of novel coronavirus pneumonia (COVID-19) convalescence patient with ''Fei-Pi-Qi-Xu zhen''",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=53225,None
1246,ChiCTR2000032527,ChiCTR,2020-05-01,2020-05-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Developing and validating of clinical prediction model for novel coronavirus pneumonia (COVID-19) patients progressing to critical type, acute respiratory distress syndrome and death: a medical records based study",Prognosis,No Intervention,No Intervention,8500,http://www.chictr.org.cn/showproj.aspx?proj=53196,None
1247,ChiCTR2000032514,ChiCTR,2020-05-01,2020-05-05,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Basic Science,China,Direct evidence of rectal cancer patient infected with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,13,http://www.chictr.org.cn/showproj.aspx?proj=53181,None
1248,ChiCTR2000032487,ChiCTR,2020-04-29,2020-03-26,True,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2000,http://www.chictr.org.cn/showproj.aspx?proj=52394,None
1249,ChiCTR2000032480,ChiCTR,2020-04-29,2020-04-29,False,China Academy of Chinese Medical Sciences,Not Recruiting,Not Applicable,Observational,China,Study on data management and diagnosis-treatment mode of TCM intervention for novel coronavirus pneumonia (COVID-19)  convalescence,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=52698,None
1250,ChiCTR2000032478,ChiCTR,2020-04-29,2020-02-03,True,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Recruiting,Not Applicable,Observational,China,TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,3000,http://www.chictr.org.cn/showproj.aspx?proj=52777,None
1251,ChiCTR2000032476,ChiCTR,2020-04-29,2020-03-23,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,Analysis of clinical features of novel coronavirus  pneumonia (COVID-19): a medical records based study,Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=53094,None
1252,ChiCTR2000032461,ChiCTR,2020-04-29,2020-05-06,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for effect of applying individualized Chinese herbal medicine in treatment of patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.chictr.org.cn/showproj.aspx?proj=52482,None
1253,ChiCTR2000032460,ChiCTR,2020-04-29,2020-01-20,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Not Recruiting,Not Applicable,Diagnostic test,China,Early warning model and new biomarker of severe novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,76,http://www.chictr.org.cn/showproj.aspx?proj=52875,None
1254,ChiCTR2000032459,ChiCTR,2020-04-29,2020-04-29,False,Henan Provincial Center for Disease Control and Prevention,Recruiting,Phase 1/Phase 2,Interventional,China,A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells),ATMP,Vaccine,Vaccine,288,http://www.chictr.org.cn/showproj.aspx?proj=53003,None
1255,ChiCTR2000032458,ChiCTR,2020-04-29,2020-02-29,True,Department of Science and Technology of Guizhou Province,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study: Leukopenia is more common in asymptomatic patients less than 18 years old with novel coronavirus pneumonia (COVID-19) in convalescence,Clinical Presentation,No Intervention,No Intervention,25,http://www.chictr.org.cn/showproj.aspx?proj=52779,None
1256,ChiCTR2000032457,ChiCTR,2020-04-29,2020-05-01,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Application of pulmonary rehabilitation exercise in the treatment of novel coronavirus pneumonia (COVID-19) patients during convalescence period.,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,http://www.chictr.org.cn/showproj.aspx?proj=52925,None
1257,ChiCTR2000032456,ChiCTR,2020-04-29,2020-03-01,True,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=53048,None
1258,ChiCTR2000032455,ChiCTR,2020-04-29,2020-04-28,True,Ningxia Ning'an Hospital,Recruiting,Not Applicable,Interventional,China,A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia,Other (psych),No Intervention,No Intervention,140,http://www.chictr.org.cn/showproj.aspx?proj=53050,None
1259,ChiCTR2000032135,ChiCTR,2020-04-20,2020-04-22,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of ulinastatin in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Ulinastatin,Ulinastatin,50,http://www.chictr.org.cn/showproj.aspx?proj=52506,None
1260,ChiCTR2000031896,ChiCTR,2020-04-14,2020-02-05,True,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the influence of novel coronavirus pneumonia (COVID-19) on mental health of Chinese public hospital stuffs,Other (psych),No Intervention,No Intervention,923,http://www.chictr.org.cn/showproj.aspx?proj=52332,None
1261,ChiCTR2000031327,ChiCTR,2020-03-27,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and death risk factors in severe novel coronavirus pneumonia (COVID-19) patients: a single-center respective analysis based on medical records,Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=51669,None
1262,ChiCTR2000031174,ChiCTR,2020-03-23,2020-03-23,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,China,Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,http://www.chictr.org.cn/showproj.aspx?proj=51437,None
1263,EUCTR2020-001723-13-FR,EU Clinical Trials Register,2020-04-08,2020-04-17,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study,Drug,"Azithromycin, Hydroxychloroquine, Lopinavir/Ritonavir",Azithromycin; Hydroxychloroquine; Lopinavir/Ritonavir,640,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001723-13,None
1264,EUCTR2020-001198-55-DK,EU Clinical Trials Register,2020-03-21,2020-04-03,False,Chronic Obstructive Pulmonary Disease Trial Network,Authorised,Phase 2,Interventional,Denmark,Early Treatment to Patients with Coronavirus (COVID),Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,226,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001198-55,None
1265,EUCTR2020-001686-36-FR,EU Clinical Trials Register,2020-04-14,2020-04-23,False,Assistance Publique – Hôpitaux de Marseille,Authorised,Phase 2,Interventional,France,"A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumonia",Drug,Avdoralimab,Avdoralimab,116,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001686-36,None
1266,EUCTR2020-001823-15-FR,EU Clinical Trials Register,2020-04-15,2020-04-28,False,CHU de Saint Etienne,Authorised,Phase 4,Interventional,France,Evaluation of the concentration-effect relationship of enoxaparin for thromboembolic prevention in COVID-19 resuscitation patients. COV-ENOX study,Drug,Enoxaparine,Enoxaparine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001823-15,None
1267,EUCTR2020-001722-66-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Fundació Clínic per a la Recerca Biomèdica,Authorised,Phase 2,Interventional,Spain,Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation,ATMP,Plasma,Plasma,116,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66,None
1268,EUCTR2020-001505-22-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Banc de Sang i Teixits,Authorised,Phase 1/Phase 2,Interventional,Spain,Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001505-22,None
1269,EUCTR2020-001717-20-ES,EU Clinical Trials Register,2020-04-27,2020-04-20,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19,Drug,Calcifediol,Calcifediol,1008,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001717-20,None
1270,EUCTR2020-001541-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19,Drug,Bevacizumab,Bevacizumab,22,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001541-39,None
1271,EUCTR2020-001618-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Oryzon Genomics S. A.,Authorised,Phase 2,Interventional,Spain,Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19.,Drug,Vafidemstat,Vafidemstat,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001618-39,None
1272,EUCTR2020-001408-41-DE,EU Clinical Trials Register,2020-04-07,2020-04-21,True,"University Hospital, Freiburg",Authorised,Phase 2,Interventional,Germany,Evaluation of efficacy and safety of an tocilizumab treatment in patients with severe COVID-19 pneumonia,Drug,Tocilizumab,Tocilizumab,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001408-41,DRKS00021238
1273,EUCTR2020-001345-38-GR,EU Clinical Trials Register,2020-03-31,2020-04-02,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS,Drug,Chloroquine,Chloroquine,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001345-38,None
1274,NCT04273763,ClinicalTrials.gov,2020-02-14,2020-02-16,False,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Drug,Bromhexine + Umifenovir + Interferon alpha vs. Umifenovir + interferon alpha,Bromhexine; Umifenovir; interferon alpha,18,https://clinicaltrials.gov/show/NCT04273763,None
1275,NCT04318301,ClinicalTrials.gov,2020-03-20,2020-03-21,False,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Hypertension in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,No Intervention,275,https://clinicaltrials.gov/show/NCT04318301,None
1276,NCT04321096,ClinicalTrials.gov,2020-03-23,2020-04-04,True,Aarhus University,Recruiting,Phase 1/Phase 2,Interventional,Denmark,The Impact of Camostat Mesilate on COVID-19 Infection,Drug,Camostat Mesilate,Camostat Mesilate,580,https://clinicaltrials.gov/show/NCT04321096,EUCTR2020-001200-42
1277,NCT04328441,ClinicalTrials.gov,2020-03-27,2020-03-25,True,UMC Utrecht,Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,ATMP,Vaccine,Vaccine,1500,https://clinicaltrials.gov/show/NCT04328441,None
1278,NCT04328480,ClinicalTrials.gov,2020-03-30,2020-04-17,False,Estudios Clínicos Latino América,Recruiting,Phase 3,Interventional,Argentina,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Drug,Colchicine,Colchicine,2500,https://clinicaltrials.gov/show/NCT04328480,None
1279,NCT04329923,ClinicalTrials.gov,2020-03-30,2020-04-09,False,"Ravi Amaravadi, MD",Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),Drug,Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04329923,None
1280,NCT04334928,ClinicalTrials.gov,2020-04-02,2020-04-15,False,Plan Nacional sobre el Sida (PNS),Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Drug,Emtricitabine/tenofovir disoproxil + hydroxychloroquine vs. hydroxychloroquine vs. Emtricitabine/tenofovir disoproxil,Emtricitabine/tenofovir disoproxil; hydroxychloroquine,4000,https://clinicaltrials.gov/show/NCT04334928,None
1281,NCT04335071,ClinicalTrials.gov,2020-04-02,2020-04-26,False,"University Hospital, Bern",Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),Drug,Tocilizumab,Tocilizumab,100,https://clinicaltrials.gov/show/NCT04335071,None
1282,NCT04338958,ClinicalTrials.gov,2020-04-07,2020-04-22,True,University of Jena,Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Drug,Ruxolitinib,Ruxolitinib,200,https://clinicaltrials.gov/show/NCT04338958,EUCTR2020-001481-11
1283,NCT04344249,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,850,https://clinicaltrials.gov/show/NCT04344249,None
1284,NCT04344457,ClinicalTrials.gov,2020-04-08,2020-04-16,False,"Perseverance Research Center, LLC",Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Drug,Hydroxychloroquine + Indomethacin + Azithromycin,Hydroxychloroquine; Indomethacin; Azithromycin,80,https://clinicaltrials.gov/show/NCT04344457,None
1285,NCT04345848,ClinicalTrials.gov,2020-04-07,2020-04-28,False,"University Hospital, Geneva",Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Drug,Heparin,Heparin,200,https://clinicaltrials.gov/show/NCT04345848,None
1286,NCT04347226,ClinicalTrials.gov,2020-04-02,2020-04-16,False,Matthew Dallos,Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Drug,Anti-Interleukin-8,Anti-Interleukin-8,138,https://clinicaltrials.gov/show/NCT04347226,None
1287,NCT04348435,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04348435,None
1288,NCT04349631,ClinicalTrials.gov,2020-04-06,2020-05-07,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),56,https://clinicaltrials.gov/show/NCT04349631,None
1289,NCT04351191,ClinicalTrials.gov,2020-04-14,2020-04-15,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,Hydroxychloroquine; Chloroquine ,400,https://clinicaltrials.gov/show/NCT04351191,None
1290,NCT04352465,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Azidus Brasil,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,Drug,Methotrexate,Methotrexate,42,https://clinicaltrials.gov/show/NCT04352465,None
1291,NCT04353271,ClinicalTrials.gov,2020-03-25,2020-04-17,False,University of South Alabama,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Trial of Hydroxychloroquine In Covid-19 Kinetics,Drug,Hydroxychloroquine,Hydroxychloroquine,58,https://clinicaltrials.gov/show/NCT04353271,None
1292,NCT04355611,ClinicalTrials.gov,2020-04-17,2020-04-20,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04355611,None
1293,NCT04356833,ClinicalTrials.gov,2020-04-14,2020-04-22,True,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Rt-PA for ARDS Due to COVID-19,Drug,Recombinant Tissue-Plasminogen Activator,Recombinant Tissue-Plasminogen Activator,24,https://clinicaltrials.gov/show/NCT04356833,EUCTR2020-001640-26
1294,NCT04356950,ClinicalTrials.gov,2020-04-16,2020-04-01,True,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,Clinical Presentation,No Intervention,No Intervention,175,https://clinicaltrials.gov/show/NCT04356950,None
1295,NCT04358939,ClinicalTrials.gov,2020-04-16,2020-04-27,False,CHU de Tours,Recruiting,Not Applicable,Interventional,France,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Procedure,Positioning,Positioning,248,https://clinicaltrials.gov/show/NCT04358939,None
1296,NCT04359225,ClinicalTrials.gov,2020-04-16,2020-06-30,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Comparison of 3D and 2D Telemedicine During Covid 19,Telehealth,Telehealth,Telehealth,80,https://clinicaltrials.gov/show/NCT04359225,None
1297,NCT04359654,ClinicalTrials.gov,2020-04-21,2020-05-01,False,"University College, London",Not Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Dornase Alfa for Treatment of COVID-19,Drug,Dornase alfa,Dornase alfa,50,https://clinicaltrials.gov/show/NCT04359654,None
1298,NCT04359706,ClinicalTrials.gov,2020-04-21,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04359706,None
1299,NCT04359797,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Vanderbilt University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Patient Positioning Pragmatic Trial,Procedure,Positioning,Positioning,300,https://clinicaltrials.gov/show/NCT04359797,None
1300,NCT04359810,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Max R. O'Donnell,Recruiting,Phase 2,Interventional,United States,Plasma Therapy of COVID-19 in Critically Ill Patients,ATMP,Plasma,Plasma,105,https://clinicaltrials.gov/show/NCT04359810,None
1301,NCT04361123,ClinicalTrials.gov,2020-04-22,2020-04-01,True,Dr. Michael Runyon,Recruiting,Not Applicable,Observational,United States,Atrium COVID-19 Syndromic and Serologic Surveillance,Clinical Presentation (Epidemiology),No Intervention,No Intervention,450000,https://clinicaltrials.gov/show/NCT04361123,None
1302,NCT04361643,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Hospital Universitario Getafe,Not Recruiting,Phase 4,Interventional,Spain,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,Drug,Lenalidomide,Lenalidomide,120,https://clinicaltrials.gov/show/NCT04361643,None
1303,NCT04361877,ClinicalTrials.gov,2020-04-20,2020-03-30,True,Klinikum der Universität München,Recruiting,Not Applicable,Observational,Germany,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),Clinical Presentation,No Intervention,No Intervention,1900,https://clinicaltrials.gov/show/NCT04361877,None
1304,NCT04361942,ClinicalTrials.gov,2020-04-17,2020-04-01,False,Red de Terapia Celular,Recruiting,Phase 2,Interventional,Spain,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04361942,EUCTR2020-001682-36
1305,NCT04362176,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Vanderbilt University,Recruiting,Phase 3,Interventional,United States,Passive Immunity Trial of Nashville II for COVID-19,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04362176,None
1306,NCT04362267,ClinicalTrials.gov,2020-04-23,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,Clinical Presentation (Epidemiology),No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04362267,None
1307,NCT04362345,ClinicalTrials.gov,2020-04-20,2020-04-09,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04362345,None
1308,NCT04363034,ClinicalTrials.gov,2020-04-23,2020-03-30,True,University of Arkansas,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04363034,None
1309,NCT04363047,ClinicalTrials.gov,2020-04-20,2020-05-01,False,University of Manchester,Not Recruiting,Not Applicable,Observational,United Kingdom,"Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19",Clinical Presentation,No Intervention,No Intervention,125,https://clinicaltrials.gov/show/NCT04363047,None
1310,NCT04363060,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,Drug,Azithromycin + Amoxicillin/Clavulanate vs. Amoxicillin/Clavulanate,Azithromycin; Amoxicillin/Clavulanate,104,https://clinicaltrials.gov/show/NCT04363060,None
1311,NCT04363450,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Louisiana State University Health Sciences Center in New Orleans,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1700,https://clinicaltrials.gov/show/NCT04363450,None
1312,NCT04364828,ClinicalTrials.gov,2020-04-22,2020-04-01,True,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,No Country Given,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04364828,None
1313,NCT04365231,ClinicalTrials.gov,2020-04-23,2020-04-01,True,"Hospital St. Joseph, Marseille",Not Recruiting,Phase 3,Interventional,France,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,50,https://clinicaltrials.gov/show/NCT04365231,None
1314,NCT04365309,ClinicalTrials.gov,2020-04-24,2020-02-10,True,Xijing Hospital,Recruiting,Phase 2/Phase 3,Interventional,China,Protective Effect of Aspirin on COVID-19 Patients,Drug,Aspirin,Aspirin,128,https://clinicaltrials.gov/show/NCT04365309,None
1315,NCT04365530,ClinicalTrials.gov,2020-04-26,2020-04-01,True,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Observational,France,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04365530,None
1316,NCT04365608,ClinicalTrials.gov,2020-04-24,2020-03-20,True,Lazarski University,Recruiting,Not Applicable,Interventional,Poland,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,Other (physical),Mechanical ventilation,Mechanical ventilation,90,https://clinicaltrials.gov/show/NCT04365608,None
1317,NCT04365816,ClinicalTrials.gov,2020-04-24,2020-05-01,False,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Observational,No Country Given,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04365816,None
1318,NCT04366024,ClinicalTrials.gov,2020-04-21,2020-01-17,True,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Novel Nomogram to Predict Severity of COVID-19,Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04366024,None
1319,NCT04366063,ClinicalTrials.gov,2020-04-20,2020-04-05,False,Royan Institute,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,https://clinicaltrials.gov/show/NCT04366063,IRCT20200217046526N2
1320,NCT04366089,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Dr. Roberto Poscia,Recruiting,Phase 2,Interventional,Italy,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Drug,Oxygen + Ozone,Oxygen; Ozone,152,https://clinicaltrials.gov/show/NCT04366089,None
1321,NCT04366154,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Centre Francois Baclesse,Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,Other (psych),No Intervention,No Intervention,385,https://clinicaltrials.gov/show/NCT04366154,None
1322,NCT04366167,ClinicalTrials.gov,2020-04-24,2020-04-18,True,Barts & The London NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04366167,None
1323,NCT04366180,ClinicalTrials.gov,2020-04-27,2020-04-24,True,Biosearch S.A.,Recruiting,Not Applicable,Interventional,Spain,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,Supplement,Probiotics,Probiotics,314,https://clinicaltrials.gov/show/NCT04366180,None
1324,NCT04366206,ClinicalTrials.gov,2020-04-19,2020-03-14,True,Centre Hospitalier Intercommunal Robert Ballanger,Recruiting,Not Applicable,Observational,France,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,Clinical Presentation,No Intervention,No Intervention,143,https://clinicaltrials.gov/show/NCT04366206,None
1325,NCT04366297,ClinicalTrials.gov,2020-04-23,2020-01-12,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Other (device),Intraosseous/Intravenous access device,Intraosseous/Intravenous access device,41,https://clinicaltrials.gov/show/NCT04366297,None
1326,NCT04366739,ClinicalTrials.gov,2020-04-24,2020-04-29,False,Centre Hospitalier St. Anne,Not Recruiting,Phase 3,Interventional,France,Repurposing of Chlorpromazine in Covid-19 Treatment,Drug,Chlorpromazine,Chlorpromazine,40,https://clinicaltrials.gov/show/NCT04366739,None
1327,NCT04366752,ClinicalTrials.gov,2020-04-27,2020-04-22,True,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04366752,None
1328,NCT04366817,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04366817,None
1329,NCT04366856,ClinicalTrials.gov,2020-04-26,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Procedure,Positioning,Positioning,500,https://clinicaltrials.gov/show/NCT04366856,None
1330,NCT04366882,ClinicalTrials.gov,2020-04-22,2020-04-14,True,Jessa Hospital,Recruiting,Not Applicable,Interventional,Belgium,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04366882,None
1331,NCT04366908,ClinicalTrials.gov,2020-04-25,2020-04-28,False,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,No Country Given,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Drug,Calcifediol,Calcifediol,1008,https://clinicaltrials.gov/show/NCT04366908,None
1332,NCT04366921,ClinicalTrials.gov,2020-04-17,2020-04-10,True,Academic Hospital Maastricht,Recruiting,Not Applicable,Observational,"Lithuania, Spain, Netherlands, Germany, France, Portugal, United Kingdom, Denmark, Russian Federation, Israel, Greece, Switzerland, Czech Republic, Austria, Sweden, Hungary, Poland, Italy, Belgium",European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,Drug,Oxygen,Oxygen,150,https://clinicaltrials.gov/show/NCT04366921,None
1333,NCT04366947,ClinicalTrials.gov,2020-04-23,2020-04-14,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access in Suspected/Confirmed COVID-19 Patient,Other (device),Intraosseous/Intravenous access device,Intraosseous/Intravenous access device,60,https://clinicaltrials.gov/show/NCT04366947,None
1334,NCT04367064,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04367064,None
1335,NCT04367129,ClinicalTrials.gov,2020-04-16,2020-04-14,True,"University Hospital, Ferrara",Recruiting,Not Applicable,Observational,Italy,Electrocardiogram Analysis in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04367129,None
1336,NCT04367142,ClinicalTrials.gov,2020-04-27,2020-05-01,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Rapid Detection of COVID-19 by Portable and Connected Biosensor,Other (device),Biosensors,Biosensors,200,https://clinicaltrials.gov/show/NCT04367142,None
1337,NCT04367350,ClinicalTrials.gov,2020-04-28,2020-03-20,True,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04367350,None
1338,NCT04367363,ClinicalTrials.gov,2020-04-17,2020-03-08,True,Jean Liu,Recruiting,Not Applicable,Observational,Singapore,Social Media and COVID-19,Other,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04367363,None
1339,NCT04367402,ClinicalTrials.gov,2020-04-17,2020-03-30,True,Azienda Ospedaliera San Paolo,Recruiting,Not Applicable,Observational,Italy,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04367402,None
1340,NCT04367636,ClinicalTrials.gov,2020-04-20,2020-04-20,False,University of Ghent,Not Recruiting,Not Applicable,Interventional,Belgium,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04367636,None
1341,NCT04367714,ClinicalTrials.gov,2020-04-27,2020-03-15,True,Region Midtjylland,Recruiting,Not Applicable,Observational,Denmark,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04367714,None
1342,NCT04367792,ClinicalTrials.gov,2020-04-27,2020-04-01,True,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Observational,Italy,Cardiac Injury in COVID-19: a Pathology Study,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04367792,None
1343,NCT04367805,ClinicalTrials.gov,2020-04-27,2020-04-27,False,CHU de Amiens,Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients With Hepatocellular Carcinoma,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04367805,None
1344,NCT04367857,ClinicalTrials.gov,2020-04-28,2020-04-18,True,Columbia University,Recruiting,Not Applicable,Observational,United States,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04367857,None
1345,NCT04367896,ClinicalTrials.gov,2020-04-27,2020-03-24,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,Clinical Presentation,No Intervention,No Intervention,1819,https://clinicaltrials.gov/show/NCT04367896,None
1346,NCT04368013,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Johan Normark,Not Recruiting,Not Applicable,Interventional,Sweden,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",Prognosis,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04368013,None
1347,NCT04368065,ClinicalTrials.gov,2020-04-28,2020-04-02,True,Iqvia Pty Ltd,Recruiting,Not Applicable,Observational,United States,Registry to Study Factors That May Impact COVID-19 Occurrence and Severity,Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04368065,None
1348,NCT04368143,ClinicalTrials.gov,2020-04-27,2020-04-01,True,Institute of Tropical Medicine,Recruiting,Not Applicable,Observational,Belgium,COVID-19 Immune Repertoire Sequencing,Genomics,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04368143,None
1349,NCT04368156,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Carlos Tornero,Recruiting,Not Applicable,Interventional,Spain,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,90,https://clinicaltrials.gov/show/NCT04368156,None
1350,NCT04368208,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Poitiers University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,Other (psych),No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04368208,None
1351,NCT04368234,ClinicalTrials.gov,2020-04-27,2020-05-05,False,Duke University,Recruiting,Not Applicable,Observational,United States,Duke COVID-19 Shared Data and Specimen Repository,Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04368234,None
1352,NCT04368260,ClinicalTrials.gov,2020-04-24,2020-04-24,False,University of Virginia,Recruiting,Not Applicable,Interventional,United States,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,https://clinicaltrials.gov/show/NCT04368260,None
1353,NCT04368299,ClinicalTrials.gov,2020-04-25,2020-05-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,No Country Given,Telemedicine for Follow-up of Systemic Lupus Erythematosus,Telehealth,Telehealth,Telehealth,150,https://clinicaltrials.gov/show/NCT04368299,None
1354,NCT04368312,ClinicalTrials.gov,2020-04-09,2020-05-06,False,"University Hospital, Essen",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impairment Due to Covid-19,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04368312,None
1355,NCT04368338,ClinicalTrials.gov,2020-04-28,2020-04-28,False,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Lung Ultrasound to Diagnose COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04368338,None
1356,NCT04368351,ClinicalTrials.gov,2020-04-27,2020-03-01,True,University of Roma La Sapienza,Not Recruiting,Not Applicable,Observational,Italy,Bacteriotherapy in the Treatment of COVID-19,Drug,Bacteriotherapy + Azithromycin + Hydroxychloroquine vs. Azithromycin + Hydrixychloroquine,Bacteriotherapy; Azithromycin; Hydroxychloroquine,70,https://clinicaltrials.gov/show/NCT04368351,None
1357,NCT04368377,ClinicalTrials.gov,2020-04-23,2020-04-06,True,University of Milan,Not Recruiting,Phase 2,Interventional,Italy,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Drug,Tirofiban + Clopidogrel + Aspirin + Fondaparinux,Tirofiban; Clopidogrel; Aspirin; Fondaparinux,5,https://clinicaltrials.gov/show/NCT04368377,None
1358,NCT04368390,ClinicalTrials.gov,2020-04-28,2020-04-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Neuroradiolological Analysis of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04368390,None
1359,NCT04368676,ClinicalTrials.gov,2020-04-26,2020-05-10,False,Lawson Health Research Institute,Not Recruiting,Phase 1,Interventional,Canada,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness,Traditional Medicine (other),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04368676,None
1360,NCT04368884,ClinicalTrials.gov,2020-04-29,2020-04-22,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04368884,None
1361,NCT04368975,ClinicalTrials.gov,2020-04-27,2020-03-12,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,ARDS Caused by COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04368975,None
1362,NCT04369274,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Massachusetts General Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04369274,None
1363,NCT04369300,ClinicalTrials.gov,2020-04-28,2020-04-24,True,Max Healthcare Insititute Limited,Not Recruiting,Not Applicable,Observational,No Country Given,Anxiety And Depression During COVID-19 IN INDIA,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04369300,None
1364,NCT04369365,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Dr. Matthias Preusser,Recruiting,Phase 2,Interventional,Austria,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Drug (Chemoprophylaxis),Azithromycin,Azithromycin,200,https://clinicaltrials.gov/show/NCT04369365,None
1365,NCT04369378,ClinicalTrials.gov,2020-04-24,2020-05-02,False,Lake Erie College of Osteopathic Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04369378,None
1366,NCT04369469,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Alexion Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,Drug,Ravulizumab,Ravulizumab,270,https://clinicaltrials.gov/show/NCT04369469,None
1367,NCT04369690,ClinicalTrials.gov,2020-04-20,2020-04-03,True,University of Ottawa,Recruiting,Not Applicable,Observational,Canada,"The Psychological, Social, and Economic Impacts of COVID-19",Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04369690,None
1368,NCT04369794,ClinicalTrials.gov,2020-04-27,2020-06-01,False,"University of Campinas, Brazil",Not Recruiting,Phase 4,Interventional,Brazil,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04369794,None
1369,NCT04369807,ClinicalTrials.gov,2020-04-22,2020-04-21,True,Perspectum Diagnostics Ltd,Recruiting,Not Applicable,Observational,United Kingdom,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,507,https://clinicaltrials.gov/show/NCT04369807,None
1370,NCT04369989,ClinicalTrials.gov,2020-04-28,2020-04-14,True,OSF Healthcare System,Recruiting,Not Applicable,Observational,United States,Observational Study of COVID-19 Treatment Efficacy,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04369989,None
1371,NCT04370197,ClinicalTrials.gov,2020-04-29,2020-03-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Covid-19 Epidemic on Acute Stroke Management,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04370197,None
1372,NCT04370249,ClinicalTrials.gov,2020-04-28,2020-04-09,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04370249,None
1373,NCT04370275,ClinicalTrials.gov,2020-04-29,2020-04-23,True,Latisana Hospital,Recruiting,Not Applicable,Observational,Italy,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,235,https://clinicaltrials.gov/show/NCT04370275,None
1374,NCT04370938,ClinicalTrials.gov,2020-04-29,2020-04-29,False,University of Pittsburgh,Recruiting,Not Applicable,Interventional,United States,Provider Burnout During COVID-19,Other (psych),Psychological,Psychological,250,https://clinicaltrials.gov/show/NCT04370938,None
1375,NCT04371289,ClinicalTrials.gov,2020-04-28,2020-04-01,True,Istituto Auxologico Italiano,Not Recruiting,Not Applicable,Observational,Italy,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,Clinical Presentation,No Intervention,No Intervention,5500,https://clinicaltrials.gov/show/NCT04371289,None
1376,NCT04371315,ClinicalTrials.gov,2020-04-24,2020-04-27,False,St. Jude Children's Research Hospital,Recruiting,Not Applicable,Observational,United States,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04371315,None
1377,NCT04371523,ClinicalTrials.gov,2020-04-28,2020-05-01,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Phase 3,Interventional,Canada,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1100,https://clinicaltrials.gov/show/NCT04371523,None
1378,NCT04371692,ClinicalTrials.gov,2020-04-28,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04371692,None
1379,NCT04372043,ClinicalTrials.gov,2020-04-29,2020-04-30,False,Saint-Joseph University,Not Recruiting,Not Applicable,Observational,Lebanon,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,Other (psych),No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04372043,None
1380,NCT04372199,ClinicalTrials.gov,2020-04-29,2020-04-29,False,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Not Applicable,Observational,Italy,SEVERITY SCORE FOR COVID-19 PNEUMONIA,Clinical Presentation,No Intervention,No Intervention,248,https://clinicaltrials.gov/show/NCT04372199,None
1381,NCT04372368,ClinicalTrials.gov,2020-04-29,2019-06-19,True,"University of Colorado, Denver",Not Recruiting,Not Applicable,Expanded Access,United States,Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04372368,None
1382,ACTRN12620000487910,ANZCTR,2020-04-20,2020-04-07,True,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Coronavirus (COVID-19) nasal/oral swab results compared to blood antibody results in COVID-19 clinic patients.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://anzctr.org.au/ACTRN12620000487910.aspx,None
1383,ACTRN12620000524998,ANZCTR,2020-04-28,2020-04-28,False,South Eastern Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community  (ReCOVER),Other (software),eHealth,eHealth,2000,https://anzctr.org.au/ACTRN12620000524998.aspx,None
1384,ChiCTR2000032770,ChiCTR,2020-05-10,2020-01-29,True,Department of Science and Technology of Guizhou Province,Not Recruiting,Not Applicable,Observational,China,Asymptomatic novel coronavirus pneumonia (COVID-19) patients Have Longer Treatment Cycle Than Mild and Moderate Patients: a medical records based study,Clinical Presentation,No Intervention,No Intervention,52,http://www.chictr.org.cn/showproj.aspx?proj=53228,None
1385,ChiCTR2000032769,ChiCTR,2020-05-09,2020-05-12,False,Beijing Ditan Hospital,Recruiting,Not Applicable,Interventional,China,"A randomized,double blinded, parallel  controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,342,http://www.chictr.org.cn/showproj.aspx?proj=53368,None
1386,ChiCTR2000032768,ChiCTR,2020-05-09,2020-01-01,True,"The Third Xiangya Hospital, Central South University",Not Recruiting,Not Applicable,Observational,China,Correlation between novel coronavirus pneumonia (COVID-19) and mental health of breast cancer patients: a cross-sectional study in Hunan Province,Other (psych),No Intervention,No Intervention,309,http://www.chictr.org.cn/showproj.aspx?proj=53460,None
1387,ChiCTR2000032767,ChiCTR,2020-05-09,2020-05-09,False,"Institute of Basic Research for Clinical Medicine, China Academy of Chinese Medical Sciences",Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Efficacy and Safety of ''clear lung detoxification soup'' in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,782,http://www.chictr.org.cn/showproj.aspx?proj=53476,None
1388,ChiCTR2000032743,ChiCTR,2020-05-09,2020-03-16,True,The First Affiliated Hospital of Dalian Medical University,Not Recruiting,Not Applicable,Observational,China,The effectiveness of diaphragmatic breathing relaxation training for improving sleep quality among nursing staff during the novel coronavirus pneumonia (COVID-19) pandemic: a before and after study,Other,Other,Other,151,http://www.chictr.org.cn/showproj.aspx?proj=53431,None
1389,ChiCTR2000032737,ChiCTR,2020-05-08,2020-05-08,False,The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical trial for the washed microbiota transplantation in the treatment of novel coronavirus pneumonia (COVID-19) patients suspected with gut microbiota dysbiosis,Other,Washed microbiota transplantation,Washed microbiota transplantation,60,http://www.chictr.org.cn/showproj.aspx?proj=53458,None
1390,ChiCTR2000032717,ChiCTR,2020-05-08,2020-02-12,True,Xi'an International Medical Center Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of high-dose vitamin C combined with traditional Chinese medicine in the treatment of moderate and severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine + Vitamin C,Traditional Medicine; Vitamin C,40,http://www.chictr.org.cn/showproj.aspx?proj=53322,None
1391,ChiCTR2000032716,ChiCTR,2020-05-08,2020-02-05,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,High dose intravenous vitamin C might be used as an important rescue therapy for aggravation of severe and critical novel coronavirus pneumonia (COVID-19) patients,Drug,Vitamin C,Vitamin C,12,http://www.chictr.org.cn/showproj.aspx?proj=53389,None
1392,ChiCTR2000032686,ChiCTR,2020-05-06,2020-05-04,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the application of novel coronavirus pneumonia (COVID-19) intestinal tract toxicity in diagnosis and its prognostic effect,Prognosis,No Intervention,No Intervention,390,http://www.chictr.org.cn/showproj.aspx?proj=53153,None
1393,ChiCTR2000032666,ChiCTR,2020-05-05,2020-04-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Follow-up study of pregnancy outcomes  of novel coronavirus pneumonia (COVID-19) complicated in the first and second trimester,Clinical Presentation,No Intervention,No Intervention,6,http://www.chictr.org.cn/showproj.aspx?proj=53285,None
1394,ChiCTR2000032635,ChiCTR,2020-05-04,2020-05-06,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for Screening of Chinese Patent Drugs in the Rehabilitation Treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52671,None
1395,ISRCTN68026880,ISRCTN,2020-04-30,2020-01-01,True,Imperial College London,Recruiting,Not Applicable,Observational,"Bosnia and Herzegovina, Lebanon, Spain, Thailand, Netherlands, Malta, Ireland, Germany, Mexico, Peru, Portugal, United Kingdom, Indonesia, Japan, Colombia, Qatar, Tunisia, Nigeria, Russian Federation, Canada, Chile, Brazil, Argentina, Uganda, Israel, Greece, Guatemala, Czech Republic, United Arab Emirates, Australia, Austria, Romania, Hungary, United States, South Africa, Italy, Belgium, Ecuador, India, Estonia, Egypt, Latvia","A global registry of women affected by COVID-19 in pregnancy and their babies, to guide treatment and prevention",Clinical Presentation,No Intervention,No Intervention,1000,http://isrctn.com/ISRCTN68026880,None
1396,EUCTR2020-001700-42-FR,EU Clinical Trials Register,2020-04-11,2020-05-06,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 2,Interventional,France,Efficacy of captopril  in Covid-19 patients suffering of pneumonia,Drug,Captopril,Captopril,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001700-42,None
1397,EUCTR2020-001635-27-FR,EU Clinical Trials Register,2020-04-06,2020-05-04,False,AB Science,Authorised,Phase 2,Interventional,France,Evaluation of a combination of Masitinib and Isoquercetin in the Treatment of Hospitalized COVID-19 Patients.,Drug,Masitinib + Isoquercetin vs. Hydroxychloroquine,Masitinib; Isoquercetin; Hydroxychloroquine,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001635-27,None
1398,EUCTR2020-001766-11-FR,EU Clinical Trials Register,2020-04-15,2020-04-29,False,Assistance Publique – Hôpitaux de Marseille,Authorised,Phase 2,Interventional,France,Losartan and spironolactone treatment for COVID-19 patients with acute respiratory failure in intensive care unit,Drug,Losartan + Spironolactone,Losartan; Spironolactone,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001766-11,None
1399,EUCTR2020-001370-30-GB,EU Clinical Trials Register,2020-04-15,2020-04-28,False,Novartis Pharmaceuticals,Authorised,Phase 3,Interventional,"Spain, United States, Italy, Germany, France, United Kingdom",Study of efficacy and safety of canakinumab treatment for CRS in participants with COVID-19-induced pneumonia.,Drug,Canakinumab,Canakinumab,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30,None
1400,EUCTR2020-001709-21-FR,EU Clinical Trials Register,2020-04-16,2020-04-29,False,CHU de Nancy,Authorised,Phase 4,Interventional,France,Low-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different doses,Drug,Heparin,Heparin,550,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001709-21,None
1401,EUCTR2020-001768-27-FR,EU Clinical Trials Register,2020-04-16,2020-04-27,False,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19",ATMP,Immunoglobulin,Immunoglobulin,39,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001768-27,None
1402,EUCTR2020-001598-66-FR,EU Clinical Trials Register,2020-04-16,2020-05-04,False,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,Curosurf® in Adult Acute Respiratory Distress Syndrome – 1,Drug,Poractant alfa,Poractant alfa,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001598-66,None
1403,EUCTR2020-001786-36-GB,EU Clinical Trials Register,2020-04-15,2020-05-06,False,Revimmune,Authorised,Phase 2,Interventional,"Spain, United States, Italy, Belgium, France, United Kingdom",Study of investigational medicinal product of CYT107 in patients with COVID-19 infection who have low number of lymphocytes in their blood (ILIAD 7 trial),Drug,CYT107,CYT107,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001786-36,None
1404,EUCTR2020-001632-10-DE,EU Clinical Trials Register,2020-04-20,2020-05-04,False,"University Hospital, Heidelberg",Authorised,Phase 2,Interventional,Germany,A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease,ATMP,Plasma,Plasma,174,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001632-10,None
1405,EUCTR2020-001783-28-HU,EU Clinical Trials Register,2020-04-29,2020-05-06,False,National Korányi Institute of Pulmonology,Authorised,Phase 3,Interventional,Hungary,BCG vaccination against COVID-19 infection in Hungary,ATMP,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001783-28,None
1406,EUCTR2020-000705-86-ES,EU Clinical Trials Register,2020-05-05,2020-04-26,True,Vall d'Hebron University Hospital,Authorised,Phase 4,Interventional,Spain,Control of inflammatory parameters with fish oil in parenteral nutrition,Supplement,Fish oil,Fish oil,117,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000705-86,None
1407,EUCTR2020-001891-14-ES,EU Clinical Trials Register,2020-05-05,2020-05-04,True,Fundación Neumosur,Authorised,Phase 2,Interventional,Spain,"Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)",Drug,Heparin,Heparin,140,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001891-14,None
1408,EUCTR2020-001825-29-ES,EU Clinical Trials Register,2020-05-05,2020-04-28,True,Navarrabiomed - Fundación Miguel Servet,Authorised,Phase 2/Phase 3,Interventional,Spain,CLINICAL TRIAL OF THE USE OF ANAKINRA (ANTI IL-1) IN CYTOKINE STORM SYNDROME (CSS) SECONDARY TO COVID-19,Drug,Anakinra vs. Hydoxychloroquine + Azithromycin + Lopinavir/ritonavir,Anakinra; Hydoxychloroquine; Azithromycin; Lopinavir/ritonavir,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001825-29,None
1409,EUCTR2020-002032-69-ES,EU Clinical Trials Register,2020-05-05,2020-05-04,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 2,Interventional,Spain,Clinical trial on the efficacy of tocilizumab in modifying the inflammatory parameters of patients with COVID-19,Drug,Tocilizumab,Tocilizumab,78,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002032-69,None
1410,EUCTR2020-001697-30-ES,EU Clinical Trials Register,2020-05-07,2020-04-23,True,Navarrabiomed - Fundación Miguel Servet,Authorised,Phase 3,Interventional,Spain,PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001697-30,None
1411,EUCTR2020-001603-16-ES,EU Clinical Trials Register,2020-05-08,2020-05-06,True,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 3,Interventional,Spain,Ensayo clínico aleatorizado para investigar la eficacia de la administración anticipada de la colchicina en pacientes mayores de 70 años y de alto riesgo en tener complicaciones pulmonares como neumonía asociada al coronavirus.,Drug,Colchicine,Colchicine,1024,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001603-16,None
1412,EUCTR2020-001375-32-NL,EU Clinical Trials Register,2020-04-03,2020-04-03,True,University Medical Center Groningen,Authorised,Phase 2,Interventional,Netherlands,Early intervention with Tocilizumab in patients with COVID-19 and hypoxia,Drug,Tocilizumab,Tocilizumab,354,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001375-32,NL8504
1413,EUCTR2020-001994-66-ES,EU Clinical Trials Register,2020-05-08,2020-05-06,True,Fundació Assistencial Mútua Terrassa,Authorised,Phase 3,Interventional,Spain,Study of the efficacy of ivermectin in the treatment and prevention of COVID-19,Drug,Ivermectin,Ivermectin,266,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001994-66,None
1414,EUCTR2020-001934-37-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION,Drug,Corticosteroids,Methylprednisolone,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001934-37,None
1415,EUCTR2020-002123-11-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Tatiana Cobo-Ibáñez,Authorised,Phase 4,Interventional,Spain,CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE HYDROXYCHLOROQUINE VS. CYCLOSPORINE - HYDROXYCHLOROQUINE TO COMPARE THEIR EFFICACY IN THE TREATMENT OF COVID-19 PNEUMONIA.,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Cyclosporine,Hydroxychloroquine; Cyclosporine,280,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002123-11,None
1416,EUCTR2020-001474-29-ES,EU Clinical Trials Register,2020-05-08,2020-05-07,True,Clínica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission,Drug,Ivermectin,Ivermectin,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001474-29,None
1417,EUCTR2020-001953-36-ES,EU Clinical Trials Register,2020-05-08,2020-05-08,False,"Grifols, S.A.",Authorised,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Patients with Coronavirus Disease (COVID-19),Drug,Alpha-1-proteinase inhibitor,Alpha-1-proteinase inhibitor,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001953-36,None
1418,NCT04324489,ClinicalTrials.gov,2020-03-25,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,Drug,DAS181,DAS181,4,https://clinicaltrials.gov/show/NCT04324489,None
1419,NCT04333550,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,Drug,Deferoxamine,Deferoxamine,50,https://clinicaltrials.gov/show/NCT04333550,None
1420,NCT04337047,ClinicalTrials.gov,2020-04-03,2020-03-31,True,Wefight,Not Recruiting,Not Applicable,Observational,France,Distress in Crisis Situations During COVID-19,Other (psych),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04337047,None
1421,NCT04337359,ClinicalTrials.gov,2020-04-03,2020-04-05,False,Novartis Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,Drug,Ruxolitinib,Ruxolitinib,Not Available,https://clinicaltrials.gov/show/NCT04337359,None
1422,NCT04342702,ClinicalTrials.gov,2020-04-04,2020-03-16,True,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,A Study on the Prospective Cohort Library of COVID-19 in Southeran,Clinical Presentation,No Intervention,No Intervention,504,https://clinicaltrials.gov/show/NCT04342702,None
1423,NCT04343768,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Drug,Hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1a vs. hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1b vs. hydroxychloroquine + Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir; interferon beta,60,https://clinicaltrials.gov/show/NCT04343768,None
1424,NCT04345614,ClinicalTrials.gov,2020-04-07,2020-04-08,False,"CalciMedica, Inc.",Recruiting,Phase 2,Interventional,United States,A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia,Drug,CM4620-Injectable Emulsion,CM4620-Injectable Emulsion,120,https://clinicaltrials.gov/show/NCT04345614,None
1425,NCT04346667,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,Hydroxychloroquine; chloroquine ,400,https://clinicaltrials.gov/show/NCT04346667,None
1426,NCT04350320,ClinicalTrials.gov,2020-04-14,2020-04-30,False,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Recruiting,Phase 3,Interventional,Spain,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Drug,Colchicine,Colchicine,102,https://clinicaltrials.gov/show/NCT04350320,None
1427,NCT04354597,ClinicalTrials.gov,2020-04-09,2020-05-01,False,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,200,https://clinicaltrials.gov/show/NCT04354597,None
1428,NCT04354701,ClinicalTrials.gov,2020-04-16,2020-03-17,True,Vanderbilt-Ingram Cancer Center,Recruiting,Not Applicable,Observational,United States,COVID-19 and Cancer Consortium Registry,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04354701,None
1429,NCT04354766,ClinicalTrials.gov,2020-04-17,2020-04-29,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04354766,None
1430,NCT04358926,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Assaf-Harofeh Medical Center,Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04358926,None
1431,NCT04359212,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Quovadis Associazione,Not Recruiting,Not Applicable,Observational,No Country Given,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,Drug,Heparin or Fondaparinux,Heparin; Fondaparinux,90,https://clinicaltrials.gov/show/NCT04359212,None
1432,NCT04359602,ClinicalTrials.gov,2020-04-21,2020-04-08,True,"University of California, Los Angeles",Recruiting,Not Applicable,Observational,United States,COVID-19 Recovered Volunteer Research Participant Pool Registry,Other,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04359602,None
1433,NCT04360122,ClinicalTrials.gov,2020-04-15,2020-05-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,Drug (Chemoprophylaxis),Levamisole + Isoprinosine vs. Levamisole vs. Isoprinosine,Levamisole; Isoprinosine,100,https://clinicaltrials.gov/show/NCT04360122,None
1434,NCT04361032,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",Drug,Tocilizumab,Tocilizumab,260,https://clinicaltrials.gov/show/NCT04361032,None
1435,NCT04364815,ClinicalTrials.gov,2020-04-22,2020-05-01,False,University of the Philippines,Not Recruiting,Phase 3,Interventional,No Country Given,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,960,https://clinicaltrials.gov/show/NCT04364815,None
1436,NCT04366765,ClinicalTrials.gov,2020-04-06,2020-03-19,True,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,COVID-19 Survival - The COVIVA Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04366765,None
1437,NCT04369456,ClinicalTrials.gov,2020-04-27,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04369456,None
1438,NCT04369820,ClinicalTrials.gov,2020-04-29,2020-03-31,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,C5a Receptor Expression - COVID-19 (C5-COV),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04369820,None
1439,NCT04369859,ClinicalTrials.gov,2020-04-29,2020-04-23,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Observational,France,Obstetric and Perinatal Outcomes of Women With COVID-19,Clinical Presentation,No Intervention,No Intervention,1300,https://clinicaltrials.gov/show/NCT04369859,None
1440,NCT04370171,ClinicalTrials.gov,2020-04-27,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04370171,None
1441,NCT04370288,ClinicalTrials.gov,2020-04-29,2020-04-19,True,Mashhad University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Drug,Methylene blue + Vitamin C + N-acetyl cysteine,Methylene blue; Vitamin C; N-acetyl cysteine,20,https://clinicaltrials.gov/show/NCT04370288,None
1442,NCT04371302,ClinicalTrials.gov,2020-04-29,2020-05-01,False,University of Malaya,Not Recruiting,Not Applicable,Observational,No Country Given,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,145,https://clinicaltrials.gov/show/NCT04371302,None
1443,NCT04371367,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Phase 2,Interventional,France,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",Drug,Avdoralimab,Avdoralimab,108,https://clinicaltrials.gov/show/NCT04371367,None
1444,NCT04371406,ClinicalTrials.gov,2020-04-29,2020-05-02,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,2770,https://clinicaltrials.gov/show/NCT04371406,None
1445,NCT04371510,ClinicalTrials.gov,2020-04-28,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04371510,None
1446,NCT04371562,ClinicalTrials.gov,2020-04-30,2020-03-01,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,Predicting Death and ICU Admission in COVID-19 Patients in ED,Prognosis,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04371562,None
1447,NCT04371601,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Fuzhou General Hospital,Not Recruiting,Phase 1,Interventional,China,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,ATMP (+ Drug),Cells (mesenchymal) + Oseltamivir + Oxygen + Hormones vs. Oseltamivir + Oxygen + Hormones,Cells (mesenchymal); Oseltamivir; Oxygen; Hormones,60,https://clinicaltrials.gov/show/NCT04371601,None
1448,NCT04371679,ClinicalTrials.gov,2020-04-30,2020-04-01,True,Hasselt University,Recruiting,Not Applicable,Observational,Belgium,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04371679,None
1449,NCT04371835,ClinicalTrials.gov,2020-04-28,2020-05-15,False,Kirby Institute,Not Recruiting,Not Applicable,Observational,No Country Given,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04371835,None
1450,NCT04371848,ClinicalTrials.gov,2020-04-22,2020-04-16,True,Laval University,Not Recruiting,Not Applicable,Observational,Canada,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study,Other (nutrition),No Intervention,No Intervention,2465,https://clinicaltrials.gov/show/NCT04371848,None
1451,NCT04371965,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Poitiers University Hospital,Not Recruiting,Phase 2,Interventional,France,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",Drug,Povidone Iodine,Povidone Iodine,24,https://clinicaltrials.gov/show/NCT04371965,None
1452,NCT04371978,ClinicalTrials.gov,2020-04-30,2020-05-15,False,Rabin Medical Center,Not Recruiting,Phase 3,Interventional,Israel,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,Drug,Linagliptin,Linagliptin,100,https://clinicaltrials.gov/show/NCT04371978,None
1453,NCT04372030,ClinicalTrials.gov,2020-04-22,2020-05-01,False,UCLouvain,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Care Use During the Covid19 Crisis,Health System,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04372030,None
1454,NCT04372082,ClinicalTrials.gov,2020-04-30,2020-05-01,False,"University Hospital, Lille",Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,Drug,Hydroxychloroquine vs. Diltiazem/Niclosamide,Hydroxychloroquine; Diltiazem/Niclosamide,480,https://clinicaltrials.gov/show/NCT04372082,None
1455,NCT04372472,ClinicalTrials.gov,2020-04-29,2020-04-07,True,"Cytovale, Inc.",Not Recruiting,Not Applicable,Observational,United States,SQuISH-COVID: A Pilot Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04372472,None
1456,NCT04372576,ClinicalTrials.gov,2020-04-29,2020-04-16,True,Semmelweis University,Recruiting,Not Applicable,Observational,Hungary,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04372576,None
1457,NCT04372602,ClinicalTrials.gov,2020-04-30,2020-06-30,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Duvelisib to Combat COVID-19,Drug,Duvelisib,Duvelisib,25,https://clinicaltrials.gov/show/NCT04372602,None
1458,NCT04372680,ClinicalTrials.gov,2020-04-30,2020-04-22,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,Other (physical),Mechanical ventilation,Mechanical ventilation,200,https://clinicaltrials.gov/show/NCT04372680,None
1459,NCT04372693,ClinicalTrials.gov,2020-04-27,2020-02-01,True,Kasr El Aini Hospital,Recruiting,Not Applicable,Interventional,Egypt,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,Other,Other,Other,180,https://clinicaltrials.gov/show/NCT04372693,None
1460,NCT04373005,ClinicalTrials.gov,2020-04-30,2020-05-04,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Screening of Cancer Patients to Assess Impact of COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04373005,None
1461,NCT04373109,ClinicalTrials.gov,2020-04-16,2020-04-16,False,Jeremia Held,Recruiting,Not Applicable,Observational,Switzerland,Stroke Rehabilitation Outcome During COVID-19 Lockdown,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04373109,None
1462,NCT04373148,ClinicalTrials.gov,2020-04-30,2020-04-08,True,Stanford University,Recruiting,Not Applicable,Observational,United States,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04373148,None
1463,NCT04373213,ClinicalTrials.gov,2020-04-30,2020-05-05,False,Erzincan University,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04373213,None
1464,NCT04373291,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Bandim Health Project,Not Recruiting,Phase 3,Interventional,No Country Given,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,ATMP,Vaccine,Vaccine,1500,https://clinicaltrials.gov/show/NCT04373291,EUCTR2020-001888-90
1465,NCT04373382,ClinicalTrials.gov,2020-04-30,2020-06-01,False,"Mount Sinai Hospital, Canada",Not Recruiting,Not Applicable,Interventional,Canada,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Other (psych),Psychological,Psychological,1000,https://clinicaltrials.gov/show/NCT04373382,None
1466,NCT04373486,ClinicalTrials.gov,2020-04-30,2020-03-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,Clinical Presentation (Epidemiology),No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04373486,None
1467,NCT04373824,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Interventional,India,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,Drug,Ivermectin,Ivermectin,50,https://clinicaltrials.gov/show/NCT04373824,None
1468,NCT04374058,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Dialisis Madariaga,Not Recruiting,Not Applicable,Observational,Argentina,Less Frequency Hemodialysis and COVID-19,Other,Other,Other,50,https://clinicaltrials.gov/show/NCT04374058,None
1469,NCT04374071,ClinicalTrials.gov,2020-04-30,2020-03-12,True,Henry Ford Health System,Not Recruiting,Not Applicable,Observational,United States,Early Short Course Corticosteroids in COVID-19,Drug,Corticosteroids,Methylprednisolone,250,https://clinicaltrials.gov/show/NCT04374071,None
1470,NCT04374123,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Instituto Ecuatoriano de Enfermedades Digestivas,Recruiting,Not Applicable,Observational,Ecuador,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,Clinical Presentation (Epidemiology),No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04374123,None
1471,NCT04374149,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Prisma Health-Upstate,Not Recruiting,Phase 2,Interventional,No Country Given,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,ATMP (+ Drug),Plasma vs. Plasma + Ruxolitinib,Plasma; Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04374149,None
1472,NCT04374422,ClinicalTrials.gov,2020-04-29,2020-04-10,True,Acibadem University,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 Pandemic and Female Sexual Behavior,Other,No Intervention,No Intervention,58,https://clinicaltrials.gov/show/NCT04374422,None
1473,NCT04374474,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Lawson Health Research Institute,Not Recruiting,Phase 4,Interventional,Canada,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,75,https://clinicaltrials.gov/show/NCT04374474,None
1474,NCT04374487,ClinicalTrials.gov,2020-04-29,2020-05-09,False,Max Healthcare Insititute Limited,Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04374487,None
1475,NCT04374539,ClinicalTrials.gov,2020-05-02,2020-04-29,True,Fundació Clínic per a la Recerca Biomèdica,Recruiting,Phase 2,Interventional,Spain,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,ATMP,Plasma,Plasma,116,https://clinicaltrials.gov/show/NCT04374539,None
1476,NCT04374552,ClinicalTrials.gov,2020-05-02,2020-05-05,False,Rutgers University,Not Recruiting,Phase 2,Interventional,United States,Asymptomatic COVID-19 Trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,140,https://clinicaltrials.gov/show/NCT04374552,None
1477,NCT04374695,ClinicalTrials.gov,2020-05-03,2020-05-01,True,Versailles Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,700,https://clinicaltrials.gov/show/NCT04374695,None
1478,NCT04374903,ClinicalTrials.gov,2020-05-03,2020-05-01,True,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Sirolimus,Azithromycin; Hydroxychloroquine; Sirolimus,58,https://clinicaltrials.gov/show/NCT04374903,None
1479,NCT04375176,ClinicalTrials.gov,2020-05-03,2020-04-27,True,Université Libre de Bruxelles,Recruiting,Not Applicable,Observational,Italy,Monocytes and NK Cells Activity in Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04375176,None
1480,NCT04375202,ClinicalTrials.gov,2020-04-29,2020-04-18,False,University of Perugia,Recruiting,Phase 2,Interventional,Italy,Colchicine in COVID-19: a Pilot Study,Drug,Colchicine,Colchicine,308,https://clinicaltrials.gov/show/NCT04375202,EUCTR2020-001475-33
1481,NCT04251871,ClinicalTrials.gov,2020-01-28,2020-01-22,True,Beijing 302 Hospital,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,150,https://clinicaltrials.gov/show/NCT04251871,None
1482,NCT04280705,ClinicalTrials.gov,2020-02-20,2020-02-21,True,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,"Japan, Spain, South Korea, Greece, United States, Denmark, Germany, Singapore, Mexico, United Kingdom",Adaptive COVID-19 Treatment Trial (ACTT),Drug,Remdesivir,Remdesivir,800,https://clinicaltrials.gov/show/NCT04280705,EUCTR2020-001052-18; JPRN-jRCT2031190264
1483,NCT04322513,ClinicalTrials.gov,2020-03-23,2020-03-24,False,University of Catanzaro,Recruiting,Not Applicable,Observational,Italy,Biomarkers for Identification of COVID-19 Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,110,https://clinicaltrials.gov/show/NCT04322513,None
1484,NCT04326790,ClinicalTrials.gov,2020-03-26,2020-04-03,True,National and Kapodistrian University of Athens,Recruiting,Phase 2,Interventional,Gibraltar,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,Drug,Colchicine,Colchicine,180,https://clinicaltrials.gov/show/NCT04326790,EUCTR2020-001455-40
1485,NCT04333225,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Baylor Research Institute,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,228,https://clinicaltrials.gov/show/NCT04333225,None
1486,NCT04333355,ClinicalTrials.gov,2020-03-31,2020-05-25,False,Hospital San Jose Tec de Monterrey,Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04333355,None
1487,NCT04333732,ClinicalTrials.gov,2020-03-31,2020-05-01,True,Washington University in St. Louis,Not Recruiting,Phase 3,Interventional,"South Africa, Zambia, Ireland, United States, Australia, Canada, United Kingdom",CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION,Drug (Chemoprophylaxis),Chloroquine/hydroxychloroquine,Chloroquine; hydroxychloroquine,55000,https://clinicaltrials.gov/show/NCT04333732,ISRCTN99916292
1488,NCT04336332,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Rutgers University,Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,160,https://clinicaltrials.gov/show/NCT04336332,None
1489,NCT04336774,ClinicalTrials.gov,2020-04-03,2020-05-01,False,Duke University,Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,Other (software),Other,Other,500,https://clinicaltrials.gov/show/NCT04336774,None
1490,NCT04340232,ClinicalTrials.gov,2020-04-03,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,Drug,Baricitinib,Baricitinib,80,https://clinicaltrials.gov/show/NCT04340232,None
1491,NCT04341441,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Henry Ford Health System,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,https://clinicaltrials.gov/show/NCT04341441,None
1492,NCT04341870,ClinicalTrials.gov,2020-04-06,2020-04-11,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",Drug,Sarilumab + Azithromycin + Hydroxychloroquine vs. Sarilumab,Sarilumab; azithromycin; hydroxychloroquine,27,https://clinicaltrials.gov/show/NCT04341870,None
1493,NCT04342806,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Duke University,Recruiting,Not Applicable,Observational,United States,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04342806,None
1494,NCT04343898,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04343898,None
1495,NCT04343989,ClinicalTrials.gov,2020-04-09,2020-03-31,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,90,https://clinicaltrials.gov/show/NCT04343989,None
1496,NCT04344041,ClinicalTrials.gov,2020-04-09,2020-04-15,True,"University Hospital, Angers",Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Drug,Vitamin D,Vitamin D,260,https://clinicaltrials.gov/show/NCT04344041,EUCTR2020-001602-34
1497,NCT04346082,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04346082,None
1498,NCT04348071,ClinicalTrials.gov,2020-04-13,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,Drug,Ruxolitinib,Ruxolitinib,80,https://clinicaltrials.gov/show/NCT04348071,None
1499,NCT04349098,ClinicalTrials.gov,2020-04-14,2020-04-17,True,Karyopharm Therapeutics Inc,Recruiting,Phase 2,Interventional,"Austria, Spain, Israel, United States, France, United Kingdom",Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Drug,Selinexor,Selinexor,230,https://clinicaltrials.gov/show/NCT04349098,EUCTR2020-001411-25
1500,NCT04351906,ClinicalTrials.gov,2020-04-09,2020-05-03,False,University of Giessen,Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Other (device),ECCO2R,ECCO2R,20,https://clinicaltrials.gov/show/NCT04351906,None
1501,NCT04353141,ClinicalTrials.gov,2020-04-16,2020-04-28,False,KU Leuven,Recruiting,Not Applicable,Observational,"Belgium, Italy, United Kingdom",International Lung UltraSound Analysis (ILUSA) Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1850,https://clinicaltrials.gov/show/NCT04353141,None
1502,NCT04353583,ClinicalTrials.gov,2020-04-06,2020-04-21,False,University of Giessen,Recruiting,Not Applicable,Observational,Germany,Renal Outcome in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04353583,None
1503,NCT04354610,ClinicalTrials.gov,2020-04-14,2020-04-27,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,57,https://clinicaltrials.gov/show/NCT04354610,None
1504,NCT04355637,ClinicalTrials.gov,2020-04-15,2020-04-21,True,Sara Varea,Recruiting,Phase 4,Interventional,Spain,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Drug,Corticosteroids,Budesonide,300,https://clinicaltrials.gov/show/NCT04355637,EUCTR2020-001616-18
1505,NCT04356885,ClinicalTrials.gov,2020-04-19,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,COVID-19 and Psychotic Symptoms in France,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04356885,None
1506,NCT04357314,ClinicalTrials.gov,2020-04-19,2020-05-31,False,French Cardiology Society,Not Recruiting,Not Applicable,Observational,No Country Given,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04357314,None
1507,NCT04357990,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Kerecis Ltd.,Recruiting,Not Applicable,Interventional,Iceland,Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19,Drug,Omega 3,Omega 3,81,https://clinicaltrials.gov/show/NCT04357990,None
1508,NCT04359121,ClinicalTrials.gov,2020-04-21,2020-04-15,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,COVID-19 and the Developement of Phobic Fears of Disease,Other (psych),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04359121,None
1509,NCT04359927,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04359927,None
1510,NCT04362969,ClinicalTrials.gov,2020-04-23,2020-05-01,False,"Hospital San Carlos, Madrid",Not Recruiting,Not Applicable,Observational,Ecuador,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04362969,None
1511,NCT04363008,ClinicalTrials.gov,2020-04-21,2020-03-30,True,University of British Columbia,Recruiting,Not Applicable,Observational,Canada,COVID 19 Biomarkers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,https://clinicaltrials.gov/show/NCT04363008,None
1512,NCT04363216,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Thomas Jefferson University,Not Recruiting,Phase 2,Interventional,No Country Given,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Drug,Vitamin C,Vitamin C,66,https://clinicaltrials.gov/show/NCT04363216,None
1513,NCT04363437,ClinicalTrials.gov,2020-04-23,2020-04-26,False,Maimonides Medical Center,Recruiting,Phase 2,Interventional,United States,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,Drug,Colchicine,Colchicine,70,https://clinicaltrials.gov/show/NCT04363437,None
1514,NCT04363593,ClinicalTrials.gov,2020-04-24,2020-05-04,False,Centre Hospitalier de Cornouaille,Recruiting,Not Applicable,Interventional,France,Serology COVID-19 From the Cornwall Hospital Union,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3200,https://clinicaltrials.gov/show/NCT04363593,None
1515,NCT04365972,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Tel Aviv University,Not Recruiting,Not Applicable,Interventional,Israel,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04365972,None
1516,NCT04366934,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Institut Pasteur,Recruiting,Not Applicable,Observational,France,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Clinical Presentation,No Intervention,No Intervention,24,https://clinicaltrials.gov/show/NCT04366934,None
1517,NCT04367207,ClinicalTrials.gov,2020-04-27,2020-05-01,False,University of Cape Town,Not Recruiting,Not Applicable,Observational,No Country Given,African Covid-19 Critical Care Outcomes Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04367207,None
1518,NCT04368637,ClinicalTrials.gov,2020-04-26,2020-05-03,False,Jordan Collaborating Cardiology Group,Recruiting,Not Applicable,Observational,Jordan,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04368637,None
1519,NCT04370015,ClinicalTrials.gov,2020-04-27,2020-05-15,False,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Interventional,No Country Given,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,374,https://clinicaltrials.gov/show/NCT04370015,None
1520,NCT04370678,ClinicalTrials.gov,2020-04-24,2020-04-17,True,Region Zealand,Not Recruiting,Not Applicable,Observational,Denmark,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,Other,No Intervention,No Intervention,79,https://clinicaltrials.gov/show/NCT04370678,None
1521,NCT04371250,ClinicalTrials.gov,2020-04-22,2020-04-30,False,Erasme University Hospital,Not Recruiting,Not Applicable,Observational,Belgium,Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.,Other (psych),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04371250,None
1522,NCT04371640,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Walter K. Kraft,Recruiting,Phase 1,Interventional,United States,Sirolimus in COVID-19 Phase 1,Drug,Sirolimus,Sirolimus,40,https://clinicaltrials.gov/show/NCT04371640,None
1523,NCT04372004,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04372004,None
1524,NCT04373161,ClinicalTrials.gov,2020-04-30,2020-03-20,True,Swedish Hospital,Not Recruiting,Not Applicable,Interventional,United States,Home Pulse Oximeter Use in Patients With COVID-19,Other (device),Biosensors,Biosensors,209,https://clinicaltrials.gov/show/NCT04373161,None
1525,NCT04373889,ClinicalTrials.gov,2020-04-13,2020-04-22,False,Sciensano,Recruiting,Not Applicable,Observational,Belgium,COVID-19 Among Healthcare Workers in Belgian Hospitals,Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04373889,None
1526,NCT04374019,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Susanne Arnold,Recruiting,Phase 2,Interventional,United States,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Ivermectin vs. Hydroxychloroquine vs. Camostat Mesilate,Azithromycin; Hydroxychloroquine; Ivermectin; Camostat Mesilate,240,https://clinicaltrials.gov/show/NCT04374019,None
1527,NCT04374032,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Bosnalijek D.D,Recruiting,Phase 2/Phase 3,Interventional,Bosnia and Herzegovina,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,Drug,Metenkefalin + Tridecactide,Metenkefalin; Tridecactide,120,https://clinicaltrials.gov/show/NCT04374032,None
1528,NCT04374045,ClinicalTrials.gov,2020-04-30,2020-04-30,False,CHU de Saint Etienne,Recruiting,Not Applicable,Observational,France,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04374045,None
1529,NCT04374097,ClinicalTrials.gov,2020-05-02,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,1778,https://clinicaltrials.gov/show/NCT04374097,None
1530,NCT04374110,ClinicalTrials.gov,2020-04-22,2020-05-05,False,"Institute of Cardiology, Warsaw",Recruiting,Not Applicable,Observational,Poland,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04374110,None
1531,NCT04374279,ClinicalTrials.gov,2020-05-04,2020-06-01,False,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Not Recruiting,Phase 2,Interventional,United States,Trial to Promote Recovery From COVID-19 With Ivermectin or Endocrine Therapy,Drug,Bicalutamide vs. Ivermectin,Bicalutamide; Ivermectin,60,https://clinicaltrials.gov/show/NCT04374279,None
1532,NCT04374370,ClinicalTrials.gov,2020-05-01,2020-03-10,True,AdventHealth,Not Recruiting,Not Applicable,Expanded Access,United States,SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP),ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04374370,None
1533,NCT04374617,ClinicalTrials.gov,2020-05-02,2020-04-01,True,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Not Applicable,Observational,Spain,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04374617,None
1534,NCT04374838,ClinicalTrials.gov,2020-05-01,2020-05-15,False,South Egypt Cancer Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of COVID-19 Pandemic on Pediatric Cancer Care,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04374838,None
1535,NCT04374942,ClinicalTrials.gov,2020-04-30,2020-04-30,True,Megan Landes,Recruiting,Phase 3,Interventional,Canada,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,988,https://clinicaltrials.gov/show/NCT04374942,ISRCTN14326006
1536,NCT04375137,ClinicalTrials.gov,2020-05-03,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Observational,Iran,Correlation Between Oxidative Stress Status and COVID-19 Severity,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04375137,None
1537,NCT04375644,ClinicalTrials.gov,2020-05-04,2020-05-11,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT),Other (psych),No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04375644,None
1538,NCT04375748,ClinicalTrials.gov,2020-04-21,2020-04-15,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04375748,None
1539,NCT04375774,ClinicalTrials.gov,2020-04-17,2020-05-01,False,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),Other (device),Masks,Masks,10,https://clinicaltrials.gov/show/NCT04375774,None
1540,NCT04376398,ClinicalTrials.gov,2020-05-04,2020-04-06,True,"University Clinic, UCLouvain",Recruiting,Not Applicable,Observational,Belgium,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,Health System,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04376398,None
1541,NCT04376515,ClinicalTrials.gov,2020-03-31,2020-03-20,True,"University of California, Irvine",Not Recruiting,Not Applicable,Interventional,United States,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),Other (psych),Psychological,Psychological,300,https://clinicaltrials.gov/show/NCT04376515,None
1542,NCT04376593,ClinicalTrials.gov,2020-05-03,2020-05-01,True,"University of California, Davis",Recruiting,Phase 1,Interventional,United States,PET/CT Imaging in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04376593,None
1543,NCT04376710,ClinicalTrials.gov,2020-05-04,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Observational,United States,Surgical Telemedicine in the COVID-19 Pandemic Era,Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04376710,None
1544,NCT04376788,ClinicalTrials.gov,2020-05-01,2020-05-05,False,Ain Shams University,Not Recruiting,Phase 2,Interventional,Egypt,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,ATMP,Plasma + Methylene Blue,Plasma; Methylene Blue,15,https://clinicaltrials.gov/show/NCT04376788,None
1545,NCT04376853,ClinicalTrials.gov,2020-04-20,2020-04-15,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,Other (device),Biosensors,Biosensors,50,https://clinicaltrials.gov/show/NCT04376853,None
1546,NCT04376905,ClinicalTrials.gov,2020-04-16,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04376905,None
1547,NCT04376944,ClinicalTrials.gov,2020-05-04,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,Other,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04376944,None
1548,NCT04376996,ClinicalTrials.gov,2020-05-04,2020-04-20,True,University of Ljubljana,Recruiting,Not Applicable,Observational,Slovenia,Slovenian National COVID-19 Prevalence Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04376996,None
1549,NCT04377035,ClinicalTrials.gov,2020-05-01,2020-03-31,True,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Observational,Denmark,The Role of Ultrasound in COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04377035,None
1550,NCT04377074,ClinicalTrials.gov,2020-05-04,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Other (psych),No Intervention,No Intervention,2880,https://clinicaltrials.gov/show/NCT04377074,None
1551,NCT04377308,ClinicalTrials.gov,2020-04-18,2020-05-01,False,University of Toledo,Recruiting,Phase 4,Interventional,United States,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,Drug,Fluoxetine,Fluoxetine,2000,https://clinicaltrials.gov/show/NCT04377308,None
1552,NCT04377412,ClinicalTrials.gov,2020-05-02,2020-05-01,True,"Zelazna Medical Centre, LLC",Recruiting,Not Applicable,Observational,"Lebanon, Spain, Poland, Israel, Albania, United States, Hong Kong, Italy, Taiwan, Norway, Australia, Germany, Czech Republic, France, Sweden",Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,8500,https://clinicaltrials.gov/show/NCT04377412,None
1553,NCT04377425,ClinicalTrials.gov,2020-04-29,2020-05-07,False,Aarhus University Hospital,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04377425,None
1554,NCT04377464,ClinicalTrials.gov,2020-05-04,2020-05-05,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 - Quality of Life After Infection,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04377464,None
1555,NCT04377477,ClinicalTrials.gov,2020-05-04,2020-05-10,False,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),Other,Radiation,Radiation,30,https://clinicaltrials.gov/show/NCT04377477,None
1556,NCT04377503,ClinicalTrials.gov,2020-05-02,2020-05-01,True,Hospital Sao Domingos,Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,40,https://clinicaltrials.gov/show/NCT04377503,None
1557,NCT04377581,ClinicalTrials.gov,2020-04-30,2020-04-09,True,Milton S. Hershey Medical Center,Recruiting,Not Applicable,Observational,United States,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",Other,No Intervention,No Intervention,25000,https://clinicaltrials.gov/show/NCT04377581,None
1558,NCT04377646,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Military Hospital of Tunis,Not Recruiting,Phase 3,Interventional,Tunisia,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,Hydroxychloroquine + Zinc,660,https://clinicaltrials.gov/show/NCT04377646,None
1559,NCT04377750,ClinicalTrials.gov,2020-04-23,2020-04-08,True,Hadassah Medical Organization,Recruiting,Phase 4,Interventional,Israel,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,Drug,Tocilizumab,Tocilizumab,500,https://clinicaltrials.gov/show/NCT04377750,None
1560,NCT04377763,ClinicalTrials.gov,2020-05-05,2020-05-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Developement and Evaluation of Serological Assays for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04377763,None
1561,NCT04377802,ClinicalTrials.gov,2020-05-04,2020-05-17,False,King Fahad Specialist Hospital,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,Health System,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04377802,None
1562,NCT04377815,ClinicalTrials.gov,2020-04-24,2020-04-23,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,Prognosis,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04377815,None
1563,NCT04377997,ClinicalTrials.gov,2020-05-01,2020-05-15,False,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04377997,None
1564,NCT04378244,ClinicalTrials.gov,2020-05-04,2020-06-12,False,Aveni Foundation,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,Other,Gene Therapy,Gene Therapy,18,https://clinicaltrials.gov/show/NCT04378244,None
1565,NCT04378257,ClinicalTrials.gov,2020-05-02,2020-06-01,False,Sultan Qaboos University,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,Other (psych),Psychological,Psychological,70,https://clinicaltrials.gov/show/NCT04378257,None
1566,NCT04378452,ClinicalTrials.gov,2020-04-15,2020-03-31,True,Fundació Institut Germans Trias i Pujol,Recruiting,Not Applicable,Observational,Spain,Assessment of the Psycho-social Impact of COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,65000,https://clinicaltrials.gov/show/NCT04378452,None
1567,NCT04378595,ClinicalTrials.gov,2020-05-05,2020-04-10,True,"University of Texas, Austin",Recruiting,Not Applicable,Observational,United States,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04378595,None
1568,NCT04378829,ClinicalTrials.gov,2020-05-03,2020-05-04,False,Konya Training and Research Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,"Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19",Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04378829,None
1569,NCT04378881,ClinicalTrials.gov,2020-05-05,2020-05-05,False,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,No Country Given,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04378881,None
1570,NCT04379037,ClinicalTrials.gov,2020-05-05,2020-07-01,False,Nemechek Technologies,Not Recruiting,Not Applicable,Interventional,No Country Given,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,50,https://clinicaltrials.gov/show/NCT04379037,None
1571,NCT04379089,ClinicalTrials.gov,2020-04-30,2020-04-29,True,University of Pittsburgh,Recruiting,Not Applicable,Observational,United States,Neurologic Manifestations of COVID 19 in Children,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04379089,None
1572,NCT04379154,ClinicalTrials.gov,2020-04-28,2020-04-14,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-CoV-2 (COVID-19),Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04379154,None
1573,NCT04379232,ClinicalTrials.gov,2020-05-04,2020-03-19,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center,Clinical Presentation,No Intervention,No Intervention,112,https://clinicaltrials.gov/show/NCT04379232,None
1574,NCT04379245,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients Infected With HIV and/or on PrEP,Clinical Presentation,No Intervention,No Intervention,4200,https://clinicaltrials.gov/show/NCT04379245,None
1575,NCT04379297,ClinicalTrials.gov,2020-05-06,2020-04-10,True,Luxembourg Institute of Health,Not Recruiting,Not Applicable,Observational,Luxembourg,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04379297,None
1576,NCT04379336,ClinicalTrials.gov,2020-05-04,2020-05-04,False,TASK Applied Science,Recruiting,Phase 3,Interventional,South Africa,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,ATMP,Vaccine,Vaccine,500,https://clinicaltrials.gov/show/NCT04379336,None
1577,NCT04379440,ClinicalTrials.gov,2020-05-03,2020-04-25,True,Raffaele Antonelli Incalzi,Recruiting,Not Applicable,Observational,Italy,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04379440,None
1578,NCT04379466,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04379466,None
1579,NCT04379479,ClinicalTrials.gov,2020-05-01,2020-05-01,False,"National Polytechnic Institute, Mexico",Not Recruiting,Phase 2,Interventional,Mexico,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Drug,Dialyzable Leukocyte,Dialyzable Leukocyte,562,https://clinicaltrials.gov/show/NCT04379479,None
1580,NCT04379518,ClinicalTrials.gov,2020-05-06,2020-05-30,False,Roswell Park Cancer Institute,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,Drug,Interferon alfa + Rintatolimod,Interferon alfa; Rintatolimod,80,https://clinicaltrials.gov/show/NCT04379518,None
1581,NCT04379661,ClinicalTrials.gov,2020-05-05,2020-04-03,True,Columbia University,Recruiting,Not Applicable,Interventional,United States,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,Other,Other,Other,52,https://clinicaltrials.gov/show/NCT04379661,None
1582,NCT04380519,ClinicalTrials.gov,2020-05-06,2020-04-23,True,"R-Pharm International, LLC",Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),Drug,RPH -104 vs. Olokizumab,RPH -104; Olokizumab,372,https://clinicaltrials.gov/show/NCT04380519,None
1583,NCT04380870,ClinicalTrials.gov,2020-05-05,2020-04-11,True,Center for Integrated Care,Recruiting,Not Applicable,Observational,United States,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,500,https://clinicaltrials.gov/show/NCT04380870,None
1584,NCT04380948,ClinicalTrials.gov,2020-05-06,2020-07-31,False,Washington University in St. Louis,Not Recruiting,Phase 1,Interventional,United States,"A Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",Drug,NT-17,NT-17,30,https://clinicaltrials.gov/show/NCT04380948,None
1585,ISRCTN87832712,ISRCTN,2020-05-05,2020-05-10,False,University of Ferrara,Recruiting,Not Applicable,Observational,Italy,Investigating the microorganisms found in the mouths of SARS-Cov-2 positive patients,Clinical Presentation,No Intervention,No Intervention,20,http://isrctn.com/ISRCTN87832712,None
1586,ISRCTN20867558,ISRCTN,2020-05-04,2020-05-01,True,University of Southampton,Recruiting,Not Applicable,Observational,United Kingdom,Survive and Thrive: exploring the wellbeing of doctors in a post-COVID-19 era,Other (psych),No Intervention,No Intervention,350,http://isrctn.com/ISRCTN20867558,None
1587,ISRCTN97041334,ISRCTN,2020-05-04,2020-03-23,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 social study: the effects of quarantine on mental health,Other (psych),No Intervention,No Intervention,1000000,http://isrctn.com/ISRCTN97041334,None
1588,ISRCTN10666798,ISRCTN,2020-04-23,2020-03-18,True,North Bristol NHS Trust,Recruiting,Not Applicable,Observational,"Ireland, United Kingdom",The COVID-19 Emergency Response Assessment Study: a survey of the psychological health of frontline doctors in the UK and Ireland during the coronavirus pandemic,Other (psych),No Intervention,No Intervention,6000,http://isrctn.com/ISRCTN10666798,None
1589,ChiCTR2000033003,ChiCTR,2020-05-17,2020-06-01,False,Beijing TIL Therapeutics,Not Recruiting,Not Applicable,Prevention,China,Novel coronavirus pneumonia (COVID-19) s-vax loaded autologous dendritic cell trial,ATMP,Cells (dendritic),Cells (dendritic),25,http://www.chictr.org.cn/showproj.aspx?proj=53790,None
1590,ChiCTR2000032919,ChiCTR,2020-05-15,2020-05-08,True,Wuhan Third Hospital,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=53274,None
1591,ChiCTR2000032915,ChiCTR,2020-05-15,2020-05-07,True,Hongqi Hospital Affiliated to Mudangjiang Medical University,Recruiting,Phase 4,Interventional,China,A randomized controlled trial for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the mild and common type novel coronavirus pneumonia (COVID-19) patients whose nCoV Nucleic acid did not turn negative after treated by hydroxychloroquine and Abidor,Drug,Artemisinin/piperaquine,Artemisinin/piperaquine,240,http://www.chictr.org.cn/showproj.aspx?proj=53658,None
1592,ChiCTR2000032895,ChiCTR,2020-05-15,2020-01-18,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,"Epidemiological, clinical and prognosticated features of novel coronavirus pneumonia (COVID-19) in Zhuhai",Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51841,None
1593,ChiCTR2000032884,ChiCTR,2020-05-14,2020-03-16,True,The First Affiliated Hospital of Dalian Medical University,Not Recruiting,Not Applicable,Observational,China,The duration and influencing factors of medical staff wearing disposable protective equipment in the isolation area during novel coronavirus pneumonia (COVID-19): an epidemiological study,Other (device),Protective equiptment,Protective equiptment,176,http://www.chictr.org.cn/showproj.aspx?proj=53473,None
1594,ChiCTR2000032842,ChiCTR,2020-05-13,2020-05-25,False,Southeast University,Not Recruiting,Not Applicable,Diagnostic test,No Country Given,Rapid Detection 2019-nCOV via Surface Plasamon Resonance,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=53621,None
1595,ChiCTR2000030262,ChiCTR,2020-02-26,2020-02-11,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical study of novel coronavirus (SARS-Cov-2) infection treated with aerosol inhalation (IFN-? plus anti-inflammatory factor TFF2),Drug,Interferon kappa + trefoil factor 2 (a gene-derived protein),Interferon Kappa; Gene-derived protein (trefoil factor 2),140,http://www.chictr.org.cn/showproj.aspx?proj=50136,None
1596,ChiCTR2000029638,ChiCTR,2020-02-08,2020-02-10,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",Drug,Interferon,Interferon,100,http://www.chictr.org.cn/showproj.aspx?proj=49224,None
1597,ChiCTR2000029605,ChiCTR,2020-02-06,2020-02-06,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49051,None
1598,ACTRN12620000555954,ANZCTR,2020-05-11,2020-06-01,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,"Randomised controlled trial of an app-based intervention, Anchored, to support the mental health of Australians recently unemployed due to COVID-19.",Other (psych),Psychological,Psychological,492,https://anzctr.org.au/ACTRN12620000555954.aspx,None
1599,ACTRN12620000554965,ANZCTR,2020-05-11,2020-05-14,False,St. Vincent's Health Network,Not Recruiting,Not Applicable,Observational,Australia,"ADAPT - COVID-19 Study - A prospective, observational cohort study at St Vincent’s Hospital Sydney",Clinical Presentation,No Intervention,No Intervention,300,https://anzctr.org.au/ACTRN12620000554965.aspx,None
1600,ACTRN12620000557932,ANZCTR,2020-05-11,2020-05-18,False,Dr Karin Ried,Not Recruiting,Not Applicable,Interventional,"United States, Australia, Germany","International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial",Drug,Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B + Vitamin C vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B,Hydroxychloroquine; Azithromycin; Zinc; Vitamin D; Vitamin B; Vitamin C,200,https://anzctr.org.au/ACTRN12620000557932.aspx,None
1601,ACTRN12620000566932,ANZCTR,2020-05-14,2020-08-03,False,University of Sydney,Not Recruiting,Phase 3,Interventional,Australia,Randomised clinical trial of interventions for the treatment of COVID-19 in the community setting for high risk older people.,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,https://anzctr.org.au/ACTRN12620000566932.aspx,None
1602,IRCT20200314046764N1,IRCT,2020-04-20,2020-04-26,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,Drug,"Interventional: Pirfenidine


Both Arms: Lopinavir/ritonavir + chloroquine + osiltamivir",Pirfenidine; Lopinavir/ritonavir; chloroquine; osiltamivir,40,http://en.irct.ir/trial/46533,None
1603,IRCT20150303021315N17,IRCT,2020-04-12,2020-03-15,True,Aryogen Pharmed,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in severe COVID-19,Drug,Tocilizumab,Tocilizumab,85,http://en.irct.ir/trial/46550,None
1604,IRCT20200312046749N1,IRCT,2020-03-28,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,Drug,TNF-alpha inhibitor,TNF-alpha inhibitor,80,http://en.irct.ir/trial/46551,None
1605,IRCT20190727044343N2,IRCT,2020-04-19,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,Drug,Atorvastatin,Atorvastatin,100,http://en.irct.ir/trial/46639,None
1606,IRCT20171122037571N2,IRCT,2020-04-12,2020-03-20,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,Drug,Remdesivir + hydroxychloroquine or chloroquine + lopinavir/ritonavir or atazanavir,Remdesivir; hydroxychloroquine; chloroquine; lopinavir/ritonavir; atazanavir,120,http://en.irct.ir/trial/46660,None
1607,IRCT20200324046850N2,IRCT,2020-03-29,2020-03-18,True,Abadan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,Drug,Daclatasvir/sofosbuvir vs. Ribavirin,Daclatasvir/sofosbuvir; Ribavirin,62,http://en.irct.ir/trial/46713,None
1608,IRCT20200323046841N1,IRCT,2020-03-28,2020-03-28,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46715,None
1609,IRCT20200322046833N1,IRCT,2020-04-03,2020-03-28,True,Center for Progress and Development of Iran,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,Drug,"Umifenovir

All Arms: Hydroxychloroquine + Atazanavir/Ritonavir",Umifenovir; Hydroxychloroquine; Atazanavir/Ritonavir,100,http://en.irct.ir/trial/46731,None
1610,IRCT20160131026298N2,IRCT,2020-04-20,2020-03-10,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,64,http://en.irct.ir/trial/46733,None
1611,IRCT20190804044429N1,IRCT,2020-04-11,2020-03-25,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,Drug,"Interventional: Interferon beta

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",Interferon beta; Hydroxychloroquine; lopinavir/ritonavir,70,http://en.irct.ir/trial/46741,None
1612,IRCT20160313027033N2,IRCT,2020-04-16,2020-04-02,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,Drug,Medium-chain triglycerides,Medium-chain triglycerides,120,http://en.irct.ir/trial/46762,None
1613,IRCT20200204046369N1,IRCT,2020-04-08,2020-04-14,False,Shiraz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,Drug,Corticosteroids,Methylprednisolone,48,http://en.irct.ir/trial/46776,None
1614,IRCT20180712040449N2,IRCT,2020-04-01,2020-03-23,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/46782,None
1615,IRCT20130812014333N145,IRCT,2020-03-30,2020-04-08,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with “Sofosbuvir standard of care therapeutic regimenVelpatasvir” to “standard of caretherapeutic regimen” in patients with COVID-19,Drug,Sofosbuvir/Velpatasvir with and without Hydroxychloroquine + lopinavir/ritonavir,Sofosbuvir/Velpatasvir; Hydroxychloroquine; lopinavir/ritonavir,80,http://en.irct.ir/trial/46790,None
1616,IRCT20200325046859N1,IRCT,2020-04-02,2020-04-04,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,ATMP,Plasma,Plasma,50,http://en.irct.ir/trial/46811,None
1617,IRCT20161204031229N3,IRCT,2020-04-08,2020-03-30,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,Drug,Teicoplanin with and without Hydroxychloroquine + lopinavir/ritonavir or atazanavir,Teicoplanin; Hydroxychloroquine; lopinavir/ritonavir; atazanavir,40,http://en.irct.ir/trial/46814,None
1618,IRCT20151228025732N51,IRCT,2020-04-08,2020-03-18,True,Semnan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris, Lepidium sativum supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46828,None
1619,IRCT20130917014693N10,IRCT,2020-04-08,2020-04-07,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,100,http://en.irct.ir/trial/46849,None
1620,IRCT20180610040049N4,IRCT,2020-04-03,2020-04-07,False,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46850,None
1621,IRCT20130812014333N147,IRCT,2020-04-22,2020-04-08,True,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Comparative assessment of the efficacy and safety of addon treatment with “Sofosbuvir-Daclatasvir”, “Lithium”,and “Trifluoprazine” to “standard of care in three groups of patients with COVID-19",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Sofosbuvir/Daclatasvir vs. Hydroxychloroquine + Lithium vs. Hydroxycholoquine + Trifluoprazine,Hydroxychloroquine; Sofosbuvir/Daclatasvir; Lithium; Trifluoprazine,80,http://en.irct.ir/trial/46853,None
1622,IRCT20081019001369N2,IRCT,2020-04-07,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46868,None
1623,IRCT20200402046923N1,IRCT,2020-04-09,2020-04-05,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://en.irct.ir/trial/46879,None
1624,IRCT20200328046886N1,IRCT,2020-04-12,2020-03-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,Drug,Daclatasvir/sofosbuvir,Daclatasvir/sofosbuvir,48,http://en.irct.ir/trial/46885,None
1625,IRCT20131215015805N2,IRCT,2020-05-04,2020-05-04,False,Shiraz University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Assessment of effect of levamisole on pneumonia caused by COVID-19,Drug,Levamisole,Levamisole,50,http://en.irct.ir/trial/46887,None
1626,IRCT20200404046933N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46893,None
1627,IRCT20200404046937N1,IRCT,2020-04-09,2020-04-09,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46903,None
1628,IRCT20080901001157N16,IRCT,2020-04-08,2020-03-30,True,HomaPharmed  Company,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46907,None
1629,IRCT20200404046934N1,IRCT,2020-04-13,2020-03-10,True,Qom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,130,http://en.irct.ir/trial/46913,None
1630,IRCT20200403046926N1,IRCT,2020-04-11,2020-04-08,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,Drug,Daclatasvir/sofosbuvir + hydroxychloroquine vs. hydroxychloroquine,Daclatasvir/sofosbuvir; hydroxychloroquine,60,http://en.irct.ir/trial/46926,None
1631,IRCT20151228025732N53,IRCT,2020-04-10,2020-04-20,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,ATMP,Plasma,Plasma,12,http://en.irct.ir/trial/46931,None
1632,IRCT20130306012728N8,IRCT,2020-04-12,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,http://en.irct.ir/trial/46932,None
1633,IRCT20180429039463N2,IRCT,2020-04-10,2020-03-20,True,Torbate-Heidaria University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",Other (psych),Psychological,Psychological,30,http://en.irct.ir/trial/46933,None
1634,IRCT20200404046935N1,IRCT,2020-04-20,2020-04-18,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46940,None
1635,IRCT20151227025726N14,IRCT,2020-04-10,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,Drug,Favipiravir vs. Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,84,http://en.irct.ir/trial/46942,None
1636,IRCT20200405046958N1,IRCT,2020-04-14,2020-04-13,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,Drug,Hydroxychloroquine,Hydroxychloroquine,60,http://en.irct.ir/trial/46946,None
1637,IRCT20200406046965N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46958,None
1638,IRCT20200405046960N1,IRCT,2020-04-08,2020-04-09,False,Ardabil University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,http://en.irct.ir/trial/46961,None
1639,IRCT20200318046812N2,IRCT,2020-04-08,2020-04-10,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,Drug,Corticosteroids + naproxen + azithromycin + hydroxychloroquine vs. naproxen + azithromycin + hydroxychloroquine vs. hydroxychloroquine + Lopinavit/ritonavir,Prednisolone; naproxen; azithromycin; hydroxychloroquine; Lopinavit/ritonavir,906,http://en.irct.ir/trial/46968,None
1640,IRCT20200317046797N4,IRCT,2020-04-14,2020-04-18,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,Drug,Bromhexine,Bromhexine,60,http://en.irct.ir/trial/46969,None
1641,IRCT20200404046948N1,IRCT,2020-04-15,2020-04-13,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,ATMP,Plasma,Plasma,60,http://en.irct.ir/trial/46973,None
1642,IRCT20180520039738N2,IRCT,2020-04-10,2020-04-07,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,Drug,Vitamin A,Vitamin A,140,http://en.irct.ir/trial/46974,None
1643,IRCT20081019001369N4,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,Drug,Minocycline,Minocycline,40,http://en.irct.ir/trial/46977,None
1644,IRCT20081019001369N3,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46978,None
1645,IRCT20200408046992N1,IRCT,2020-04-14,2020-04-16,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,Drug,Trifluoprazine + Hydroxychloroquine vs. Hydroxychloroquine,Trifluoprazine; hydroxychloroquine,70,http://en.irct.ir/trial/47006,None
1646,IRCT20200408046987N1,IRCT,2020-04-27,2020-05-04,False,Chistasazan Notash Fartak Company Limited.,Recruiting,Phase 3,Interventional,Iran,Dose-Finding Study of Ivermectin in the Treatment of COVID-19,Drug,Ivermectin,Ivermectin,100,http://en.irct.ir/trial/47012,None
1647,IRCT20180129038542N1,IRCT,2020-04-13,2020-04-06,True,University of Baqiyatallah,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,30,http://en.irct.ir/trial/47013,None
1648,IRCT20200317046797N3,IRCT,2020-04-11,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,ATMP,"Interventional: Immunoglobulin

Both Arms: hydroxychloroquine + ribavirin + lopinavir/ritonavir",Immunoglobulin; hydroxychloroquine; ribavirin; lopinavir/ritonavir,100,http://en.irct.ir/trial/47014,None
1649,IRCT20200317046797N5,IRCT,2020-04-19,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,Other (device),Hemoperfusion,Hemoperfusion,10,http://en.irct.ir/trial/47015,None
1650,IRCT20200404046937N2,IRCT,2020-04-13,2020-04-13,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47016,None
1651,IRCT20180923041093N5,IRCT,2020-04-10,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,Procedure,Foot bath,Foot bath,60,http://en.irct.ir/trial/47018,None
1652,IRCT20160131026298N3,IRCT,2020-04-30,2020-05-04,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the effect of Iranian medicine product, Algro, on patients with coronavirus 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47019,None
1653,IRCT20200406046968N1,IRCT,2020-04-14,2020-04-21,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,Drug,Tocilizumab,Tocilizumab,10,http://en.irct.ir/trial/47021,None
1654,IRCT20150808023559N20,IRCT,2020-04-11,2020-04-29,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,Drug,Favipravir + hydroxychloroquine vs. lopinavir/ritonavir + hydroxychloroquine,Favipravir; hydroxychloroquine; lopinavir/ritonavir,100,http://en.irct.ir/trial/47022,None
1655,IRCT20130616013690N7,IRCT,2020-05-01,2020-05-02,False,Shiraz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of interactive psycho-educational interventions on patients infected with COVID-19,Other (psych),Psychological,Psychological,50,http://en.irct.ir/trial/47034,None
1656,IRCT20200410047009N1,IRCT,2020-04-26,2020-04-13,True,Iran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,The effect of Naproxen in recovery and reducing mortality in patients with COVID-19,Drug,"Naproxen w/ and w/o Hydroxychloroquine, Oseltamivir, Lopinavir/ritonavir, chloroquine, ribavirin",Naproxen; Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir; chloroquine; ribavirin,101,http://en.irct.ir/trial/47052,None
1657,IRCT20200409047007N1,IRCT,2020-04-12,2020-04-13,False,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,ATMP,Plasma,Plasma,32,http://en.irct.ir/trial/47058,None
1658,IRCT20200408046990N1,IRCT,2020-04-18,2020-05-19,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47061,None
1659,IRCT20200411047025N1,IRCT,2020-04-14,2020-04-18,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,Drug,Vitamin C + Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Atazanavir/ritonavir,Vitamin C; Hydroxychloroquine; Atazanavir/ritonavir,110,http://en.irct.ir/trial/47078,None
1660,IRCT20080901001165N46,IRCT,2020-04-15,2020-03-30,True,Center for Progress and Development of Iran,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,Drug,Umifenovir,Umifenovir,200,http://en.irct.ir/trial/47087,None
1661,IRCT20200406046963N1,IRCT,2020-04-22,2020-03-30,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndrome,Drug,Hydroxychloroquine + Corticosteroids vs. Hydroxychloroquine,Methylprednisolone; Hydroxychloroquine,40,http://en.irct.ir/trial/47088,None
1662,IRCT20190122042450N4,IRCT,2020-04-16,2020-04-20,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,http://en.irct.ir/trial/47090,None
1663,IRCT20200411047030N1,IRCT,2020-04-17,2020-04-14,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,Drug,Melatonin + Hydroxychloroquine + Azithormycin vs. Hydroxychloroquine + Azithormycin,Melatonin; Hydroxychloroquine; azithormycin,82,http://en.irct.ir/trial/47099,None
1664,IRCT20200406046968N2,IRCT,2020-04-22,2020-05-04,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patients,ATMP,Plasma,Plasma,30,http://en.irct.ir/trial/47115,None
1665,IRCT20200413047053N1,IRCT,2020-04-15,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47139,None
1666,IRCT20081019001369N5,IRCT,2020-04-26,2020-05-02,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of lithium carbonate  on COVID-19,Drug,Lithium,Lithium,40,http://en.irct.ir/trial/47141,None
1667,IRCT20200408046988N1,IRCT,2020-04-29,2020-04-14,True,Gonabad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings,Drug,Melatonin + Hydroxychloroquine vs. Hydroxychloroquine,Melatonin; Hydroxychloroquine,60,http://en.irct.ir/trial/47142,None
1668,IRCT20200413047062N1,IRCT,2020-05-04,2020-04-13,True,Islamic Azad University,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atorvastatin in treatment of COVID-19 infection,Drug,Atorvastatin,Atorvastatin,76,http://en.irct.ir/trial/47146,None
1669,IRCT20191125045492N2,IRCT,2020-04-18,2020-04-23,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,Drug,Ozone,Ozone,80,http://en.irct.ir/trial/47149,None
1670,IRCT20200406046968N3,IRCT,2020-05-08,2020-04-29,True,Zist Daru Danesh Company,Recruiting,Phase 2,Interventional,Iran,effect of Interfron-beta1(zifron) on clinical improvement and prognosis of COVID-19 in Tabriz Imam-Reza hospital,Drug,Interferon beta + Hydroxycholoquine + Lopinavir/ritonavir vs. Hydroxycholoquine + Lopinavir/ritonavir,Interferon beta; Hydroxycholoquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/47152,None
1671,IRCT20200413047063N1,IRCT,2020-05-04,2020-03-20,True,National Institute for Medical Research Development,Recruiting,Phase 1/Phase 2,Interventional,Iran,Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical Trial,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://en.irct.ir/trial/47156,None
1672,IRCT20200413047052N1,IRCT,2020-05-07,2020-05-04,True,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"The effectiveness of educational-treatment package based on psychological flexibility in burnout, quality of working life, work-family conflict and mental health",Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/47160,None
1673,IRCT20200414047072N1,IRCT,2020-04-28,2020-04-14,True,Hilton Pharma Pvt. Ltd.,Recruiting,Not Applicable,Interventional,Pakistan,Use of Convalescent Plasma in the treatment of COVID-19,ATMP,Plasma,Plasma,357,http://en.irct.ir/trial/47163,None
1674,IRCT20200414047070N1,IRCT,2020-04-21,2020-05-04,False,Fasa University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of ppd on recovery of covid disease 19,Drug,Tuberculin w/ and w/o Chloroquine + Lopinavir/ritonavir,Tuberculin; Chloroquine; Lopinavir/ritonavir,50,http://en.irct.ir/trial/47169,None
1675,IRCT20170210032478N3,IRCT,2020-04-29,2020-04-18,True,National Research Institute of Tuberculosis and Lung Diseases,Recruiting,Phase 3,Interventional,Iran,Effect of  Formoterol in treatment of covid19,Drug,Formoterol,Formoterol,50,http://en.irct.ir/trial/47173,None
1676,IRCT20200415047082N1,IRCT,2020-04-21,2020-05-04,False,Jahrom University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of coronavirus disease",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://en.irct.ir/trial/47193,None
1677,IRCT20200413047056N1,IRCT,2020-04-17,2020-04-18,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,15,http://en.irct.ir/trial/47212,None
1678,IRCT20200418047116N1,IRCT,2020-05-04,2020-03-10,True,Gonabad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of Intravenous immunoglobulin on COVID-19 infection,ATMP,Immunoglobulin,Immunoglobulin,20,http://en.irct.ir/trial/47219,None
1679,IRCT20200415047089N1,IRCT,2020-04-19,2020-04-18,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47234,None
1680,IRCT20200415047092N1,IRCT,2020-04-20,2020-04-24,False,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,Drug,Azithromycin +  Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine vs. Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine,Azithromycin; oseltamivir; lopinavir/ritonavir; atazanavir; hydroxychloroquine,110,http://en.irct.ir/trial/47244,None
1681,IRCT20200416047104N1,IRCT,2020-04-23,2020-04-20,True,Shahre-kord University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of pomegranate tea on symptom relief of COVID-19 patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,66,http://en.irct.ir/trial/47251,None
1682,IRCT20200417047113N1,IRCT,2020-04-24,2020-04-27,False,Middle East Gene Therapy Corporation,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of NK cell therapy in COVID-19,ATMP,Cells (NK),Cells (NK),70,http://en.irct.ir/trial/47264,None
1683,IRCT20200416047099N1,IRCT,2020-04-21,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Plasma therapy in patient with COVID-19,ATMP,Plasma,Plasma,10,http://en.irct.ir/trial/47266,None
1684,IRCT20200418047122N1,IRCT,2020-05-03,2020-04-25,True,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the therapeutic effect of a combination drug including Apocynin, Niacin, and Tannin on COVID-19",Drug,Apocynin + Niacin + Tannin,Apocynin; Niacin; Tannin,80,http://en.irct.ir/trial/47268,None
1685,IRCT20200418047121N2,IRCT,2020-05-05,2020-05-09,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Stem cell therapy in COVID-19,ATMP,Cells (stem cells),Cells (stem cells),6,http://en.irct.ir/trial/47275,None
1686,IRCT20140407017169N2,IRCT,2020-04-28,2020-04-30,False,Social Development and Health Promotion Research Center,Recruiting,Not Applicable,Interventional,Iran,Effect of natural from Tahini oil product on corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47295,None
1687,IRCT20200329046892N1,IRCT,2020-05-02,2020-05-04,False,Rasht University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Trifluoperazine Effectiveness in Treatment of Coronavirus,Drug,Trifluoperazine,Trifluoperazine,70,http://en.irct.ir/trial/47300,None
1688,IRCT20080901001165N48,IRCT,2020-04-22,2020-03-30,True,Niak Pharmaceutical Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47318,None
1689,IRCT20151222025660N2,IRCT,2020-05-04,2020-04-13,True,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of Hydroxychloroquine on Novel Corona virus,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,140,http://en.irct.ir/trial/47319,None
1690,IRCT20200420047147N1,IRCT,2020-04-23,2020-05-04,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Evaluation the effects of Sitagliptin administration in patients with COVID-19,Drug,Sitagliptin + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Sitagliptin; Hydroxychloroquine; Lopinavir/ritonavir,84,http://en.irct.ir/trial/47334,None
1691,IRCT20200421047155N1,IRCT,2020-04-25,2020-04-29,False,Ardabil University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of tenofovir in covid-19,Drug,Tenofovir vs. Hydroxychloroquine,Tenofovir vs. Hydroxychloroquine,86,http://en.irct.ir/trial/47387,None
1692,IRCT20080901001165N49,IRCT,2020-04-25,2020-03-30,True,Andisheh Salamat Sabalan Medicinal Plants Company,Recruiting,Not Applicable,Interventional,Iran,"Evaluation efficacy of a herbal combination (contains Glycyrrhiza glabra, Mentha pulegium and Urtica) in controlling symptoms in patients with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47401,None
1693,IRCT20200422047168N1,IRCT,2020-04-29,2020-04-18,True,Ahvaz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial study on the therapeutic effect of Tenofovir besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19),Drug,Tenofovir + Chloroquine + Lopinavir/ritonavir vs. Chloroquine + Lopinavir/ritonavir,Tenofovir; Chloroquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/47437,None
1694,IRCT20200408046990N2,IRCT,2020-04-25,2020-04-29,False,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the colchicine tablet efficacy as an adjuvant therapy for patients with mild to moderate COVID-19,Drug,Colchicine,Colchicine,40,http://en.irct.ir/trial/47468,None
1695,IRCT20180114038350N3,IRCT,2020-05-01,2020-05-04,False,Sanandaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Deferiprone on the improvement of symptoms of Coronavirus 2019 (COVID 19),Drug,Deferiprone,Deferiprone,80,http://en.irct.ir/trial/47475,None
1696,IRCT20200426047206N1,IRCT,2020-04-28,2020-05-09,False,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of NBS powder in treatment of patients with  COVID-19,Supplement (+ Drug),NBS Powder vs. Hydroxychloroquine + Lopinavir/ritonavir,NBS Powder; Hydroxychloroquine; Lopinavir/ritonavir,46,http://en.irct.ir/trial/47495,None
1697,IRCT20120215009014N353,IRCT,2020-04-27,2020-05-14,False,Hamedan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/47501,None
1698,IRCT20140305016852N4,IRCT,2020-05-04,2020-04-20,True,Sabzevar University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test,Drug,Vitamin D vs. Vitamin C,Vitamin D; Vitamin C,30,http://en.irct.ir/trial/47508,None
1699,IRCT20180425039414N2,IRCT,2020-05-13,2020-04-20,True,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of zinc on the treatment and clinical course of patients with SARS-cov2 (COVID-19),Drug,Hydroxychloroqine + Zinc vs. Hydroxychloroquine,Hydroxychloroqine; Zinc,80,http://en.irct.ir/trial/47516,None
1700,IRCT20200427047215N1,IRCT,2020-05-05,2020-05-08,False,Isfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Indomethacin for Covid19 infection,Drug,Indomethacin,Indomethacin,60,http://en.irct.ir/trial/47520,None
1701,IRCT20121216011763N46,IRCT,2020-05-04,2020-05-04,False,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of curcumin-piperine in patients with coronavirus(COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47529,None
1702,IRCT20200426047212N1,IRCT,2020-05-02,2020-05-04,False,Shooshtar University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of of Inhalation of Thyme Oil in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://en.irct.ir/trial/47572,None
1703,IRCT20080901001165N50,IRCT,2020-05-01,2020-05-01,False,Sina Darou Laboratories Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19,Drug,Azithromycin,Azithromycin,80,http://en.irct.ir/trial/47576,None
1704,IRCT20080901001165N51,IRCT,2020-05-01,2020-05-01,False,Sina Darou Laboratories Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,80,http://en.irct.ir/trial/47577,None
1705,IRCT20200418047121N1,IRCT,2020-05-01,2020-05-09,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Study the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19",Drug,Vitamin C + Metformin + Azithromycin + Doxycycline,Vitamin C; Metformin; Azithromycin; Doxycycline,40,http://en.irct.ir/trial/47578,None
1706,IRCT20150808023559N21,IRCT,2020-05-09,2020-05-12,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,The Effect of Convalescent Plasma Therapy on  Patients with 19-COVID,ATMP,Plasma,Plasma,60,http://en.irct.ir/trial/47594,None
1707,IRCT20200501047258N1,IRCT,2020-05-04,2020-05-04,False,Oroumia University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of  convalescent plasma in COVID-19,ATMP,Plasma,Plasma,120,http://en.irct.ir/trial/47629,None
1708,IRCT20131129015584N2,IRCT,2020-05-08,2020-04-04,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of herbal syrup on patients with corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,152,http://en.irct.ir/trial/47639,None
1709,IRCT20080901001165N52,IRCT,2020-05-05,2020-04-20,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19,Drug,Corticosteroids,Methylprednisolone; Prednisone,50,http://en.irct.ir/trial/47641,None
1710,IRCT20160706028815N5,IRCT,2020-05-05,2020-05-20,False,Sabzevar University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group,Drug,Selenium,Selenium,40,http://en.irct.ir/trial/47682,None
1711,IRCT20171213037866N2,IRCT,2020-05-07,2020-05-09,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of jujube product on Covid-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/47684,None
1712,IRCT20200326046868N1,IRCT,2020-05-09,2020-05-21,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,effect of propolis  in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,88,http://en.irct.ir/trial/47934,None
1713,IRCT20200508047346N1,IRCT,2020-05-13,2020-05-21,False,Kowsar Biotechnology Co.,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of rabbit antibody against coronavirus in patients,ATMP,Antibodies,Antibodies,124,http://en.irct.ir/trial/47953,None
1714,IRCT20120215009014N354,IRCT,2020-05-12,2020-06-04,False,Hamedan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19",Drug,Corticosteroids,Hydrocortisone; Methylprednisolone; Dexamethasone,81,http://en.irct.ir/trial/48043,None
1715,KCT0005005,CRIS,2020-05-11,2020-05-11,False,Daegu Catholic University Medical Center,Not Recruiting,Not Applicable,Observational,South Korea,Psychiatric Consultation for COVID-19 Patients,Other (psych),Psychological,Psychological,54,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16339,None
1716,KCT0005003,CRIS,2020-05-11,2020-05-25,False,Gyeongsang National University Hospital,Not Recruiting,Phase 2,Interventional,South Korea,Clinical efficacy of Nafamostat for COVID-19 pneumonia,Drug,Nafamostat w/ or w/o Lopinavir / ritonavir + Hydroxychloroquine + Oxygen,Nafamostat; Lopinavir/ritonavir; Hydroxychloroquine; Oxygen,84,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635,None
1717,JPRN-UMIN000039873,JPRN,2020-03-19,2020-03-19,False,National Center for Global Health and Medicine,Recruiting,Not Applicable,Observational,Japan,COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,9999,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453,None
1718,JPRN-UMIN000040162,JPRN,2020-04-15,2020-04-14,True,University of Tokyo,Recruiting,Not Applicable,Observational,"Japan, Asia(except Japan), North America, South America, Australia, Europe, Africa",Multicenter observational study to examine the efficacy of protection during endoscopy examination for Covid-19 infection,Other,No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045790,None
1719,JPRN-UMIN000040193,JPRN,2020-04-18,2020-04-30,False,Osaka University Graduate School of Medicine,Not Recruiting,Not Applicable,Observational,Japan,"Evaluating the social function of people with dementia under the COVID-19 epidemic 
by the Japanese version of the social functioning in dementia scale",Other,No Intervention,No Intervention,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045831,None
1720,JPRN-UMIN000040211,JPRN,2020-04-21,2020-05-01,False,Kanagawa Cardiovascular and Respiratory Center,Recruiting,Not Applicable,Observational,Japan,"A Multicenter, Retrospective Study to Evaluate the Efficacy of Systemic Gluco-corticoid Against COVID-19",Drug,Corticosteroids,Corticosteroids,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045861,None
1721,JPRN-UMIN000040235,JPRN,2020-04-25,2020-04-23,True,Yuri Kumiai General Hospital,Recruiting,Not Applicable,Interventional,Japan,Examination of test accuracy of COVID-19 rapid antibody kit,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901,None
1722,JPRN-UMIN000040250,JPRN,2020-04-30,2020-05-08,False,Nihon University School of Medicine,Not Recruiting,Not Applicable,Observational,Japan,Changes of D-dimer in preventive period for COVID-19 for patients with chronic heart failure,Clinical Presentation,No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045918,None
1723,JPRN-UMIN000040278,JPRN,2020-05-08,2020-06-01,False,Nagasaki University,Not Recruiting,Not Applicable,Observational,Japan,Had COVID-19 Spread in Nagasaki Prefecture before the first confirmed case?,Clinical Presentation (Epidemiology),No Intervention,No Intervention,182,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045953,None
1724,JPRN-UMIN000040286,JPRN,2020-05-11,2020-05-12,False,University of Tokyo,Not Recruiting,Not Applicable,Interventional,Japan,Study on risk perception and behavioral change related to COVID-19,Other (psych),No Intervention,No Intervention,1980,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966,None
1725,JPRN-UMIN000040289,JPRN,2020-05-01,2020-05-01,False,Tokyo Women's Medical University,Not Recruiting,Not Applicable,Observational,Japan,Simulation study of tracheal intubation through an aerosol-box assuming COVID-19,Other (physical),Endotracheal Intubation,Endotracheal Intubation,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045947,None
1726,JPRN-UMIN000040295,JPRN,2020-05-02,2020-02-01,True,Japanese Red Cross Medical Center,Recruiting,Not Applicable,Observational,Japan,Prospective observational study on diagnosis and treatment of COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045974,None
1727,JPRN-UMIN000040335,JPRN,2020-05-08,2020-05-08,False,Takasaki University of Health and Welfare,Not Recruiting,Not Applicable,Observational,Japan,Impacts of COVID-19 prevention life in community-dwelling older adults and support measures,Other,No Intervention,No Intervention,346,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045960,None
1728,JPRN-UMIN000040401,JPRN,2020-05-15,2020-05-15,False,Tokyo Medical and Dental University,Recruiting,Not Applicable,Interventional,Japan,A feasibility study of remote rehabilitation using a wearable biological monitoring device in the patients with COVID-19,Other (device),Wearable,Wearable,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104,None
1729,CTRI/2020/03/024402,CTRI,2020-03-31,2020-04-08,False,Dr. Remesh Bhasi,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",Drug,Hydroxychloroquine,Hydroxychloroquine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,None
1730,CTRI/2020/04/024442,CTRI,2020-04-01,2020-04-08,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,Screening for symptoms of COVID-19,Clinical Presentation,No Intervention,No Intervention,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42687,None
1731,CTRI/2020/04/024413,CTRI,2020-04-01,2020-04-09,False,K M Amran Hossain,No Status Given,Not Applicable,Observational,Bangladesh,"Knowledge, attitude and fear of COVID-19 in Bangladesh",Other (psych),No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42718,None
1732,CTRI/2020/04/024473,CTRI,2020-04-03,2020-04-15,False,Discovery the Critical Care Research Network,Not Recruiting,Not Applicable,Observational,"United States, India, Italy, United Kingdom",Viral Infection and Respiratory illness Universal Study,Clinical Presentation,No Intervention,No Intervention,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42684,None
1733,CTRI/2020/04/024479,CTRI,2020-04-07,2020-04-13,False,Command Hospital Airforce,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Chloroquine in addition to standard therapy in COVID-19 patients,Drug,Chloroquine,Chloroquine,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,None
1734,CTRI/2020/04/024636,CTRI,2020-04-15,2020-05-01,False,DACH Jaipur,Not Recruiting,Not Applicable,Observational,India,Assessment of Objective clinical scoring system to rule out COVID-19 with high sensitivity,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42961,None
1735,CTRI/2020/04/024659,CTRI,2020-04-15,2020-04-27,False,SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,None
1736,CTRI/2020/04/024697,CTRI,2020-04-17,2020-04-17,False,Caring Mahajan Imaging,Not Recruiting,Not Applicable,Observational,India,COVID-19 Data-bank Project,Clinical Presentation,No Intervention,No Intervention,100000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42835,None
1737,CTRI/2020/04/024731,CTRI,2020-04-20,2020-04-24,False,Parul University,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate Preventive Effect of Ayurveda and Homeopathy Treatment in COVID 19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912,None
1738,CTRI/2020/04/024729,CTRI,2020-04-20,2020-04-21,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,"Topical Chloroquine Nasal Drops in Early Stage Covid 19-
Impact on Viral load and cure rates
",Drug,Chloroquine,Chloroquine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933,None
1739,CTRI/2020/04/024772,CTRI,2020-04-21,2020-04-28,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,Comparison of suspected or negative cases with confirmed cases of COVID-19 at Max Hospital,Clinical Presentation,No Intervention,No Intervention,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43079,None
1740,CTRI/2020/04/024747,CTRI,2020-04-21,2020-05-01,False,GSL Medical College,Not Recruiting,Not Applicable,Interventional,India,EFFECTIVENESS TO MANAGE COVID 19 PANDEMIC BY  TEACHING  VENTILATORY MANAGEMENT TO NON-ANAESTHESIOLOGY RESIDENTS,Other,Other,Other,26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115,None
1741,CTRI/2020/04/024775,CTRI,2020-04-21,2020-04-22,False,Indian Council Of Medical Research,Not Recruiting,Phase 2,Interventional,India,Study to assess the efficacy and safety of convalescent plasma in moderate COVID-19 disease.,ATMP,Plasma,Plasma,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149,None
1742,CTRI/2020/04/024749,CTRI,2020-04-21,2020-04-21,False,Serum Institute of India Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate the Efficacy of Recombinant BCG VPM1002 in Reducing Infection Incidence and Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Subjects,ATMP,Vaccine,Vaccine,5946,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972,None
1743,CTRI/2020/04/024806,CTRI,2020-04-22,2020-04-26,False,All India Institute of Medical Sciences,Recruiting,Phase 2,Interventional,India,Imatinib in COVID-19 infection,Drug,Imatinib,Imatinib,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,None
1744,CTRI/2020/04/024804,CTRI,2020-04-22,2020-04-30,False,International Stemcell Services Ltd,Not Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of safety and efficacy of convalescent plasma in COVID-19 patients,ATMP,Plasma,Plasma,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849,None
1745,CTRI/2020/04/024776,CTRI,2020-04-22,2020-04-23,False,Dr. Mahesh Mahich,Recruiting,Not Applicable,Interventional,India,"Novel Artificial Intelligence Algorithm to screen COVID-19 Patients from X-Ray , CT-Scan of Thorax and Voice Sampling through Android App and storage through Cloud",Other (software),eHealth,eHealth,1650,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160,None
1746,CTRI/2020/04/024784,CTRI,2020-04-22,2020-04-24,False,Dr. Sameer Malhotra,Not Recruiting,Not Applicable,Observational,India,ANXIETY AND DEPRESSION DURING COVID-19 IN INDIA,Other (psych),No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42939,None
1747,CTRI/2020/04/024805,CTRI,2020-04-22,2020-04-24,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Impact of Covid-19 pandemic on practice pattern of Indian urologists,Health System,No Intervention,No Intervention,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42979,None
1748,CTRI/2020/04/024833,CTRI,2020-04-24,2020-05-01,False,Dr. Narayanan Parameswaran,Not Recruiting,Not Applicable,Interventional,India,BCG-Denmark versus no-BCG for COVID 19 prevention,ATMP,Vaccine,Vaccine,1826,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,None
1749,CTRI/2020/04/024846,CTRI,2020-04-24,2020-04-30,False,Cadila Pharnmaceuticals,Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,Mycobacterium,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43004,None
1750,CTRI/2020/04/024857,CTRI,2020-04-25,2020-05-04,False,Welling Healthcare Private Limited,Not Recruiting,Phase 1/Phase 2,Interventional,India,Proving the efficacy of  Homeopathic treatment in prevention and cure of COVID-19.,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212,None
1751,CTRI/2020/04/024859,CTRI,2020-04-25,2020-04-25,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,To Study the Clinical characteristics and treatment Outcome of COVID-19 Patients admitted in hospitals of Max Healthcare (SCOPe Study),Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43232,None
1752,CTRI/2020/04/024858,CTRI,2020-04-25,2020-04-25,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Interventional,India,"â??To study the effectiveness of Ivermectin with standard of care treatment
versus standard of care treatment for COVID 19 cases. A Pilot Study",Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236,None
1753,CTRI/2020/04/024882,CTRI,2020-04-27,2020-04-28,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation in addition to standard of care in COVID-19 positive patients in a tertiary hospital.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899,None
1754,CTRI/2020/04/024904,CTRI,2020-04-28,2020-05-11,False,Director General Armed Forces Medical Services,Not Recruiting,Phase 3,Interventional,India,Treatment of COVID19 : A randomised controlled trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130,None
1755,CTRI/2020/04/024883,CTRI,2020-04-28,2020-04-29,False,Pankajakasthuri Herbal Research Foundation,Recruiting,Phase 4,Interventional,India,Clinical research on safety and efficacy of ZingiVir-H as an add on therapy in COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,112,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168,None
1756,CTRI/2020/04/024914,CTRI,2020-04-29,2020-05-08,False,Dr. Sulagna Bhattacharjee,Not Recruiting,Not Applicable,Observational,India,Characteristics of seriously ill COVID-19 patients admitted to a tertiary care centre,Clinical Presentation,No Intervention,No Intervention,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43323,None
1757,CTRI/2020/04/024915,CTRI,2020-04-29,2020-05-09,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",ATMP,Plasma,Plasma,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332,None
1758,CTRI/2020/04/024948,CTRI,2020-04-30,2020-05-15,False,Lady Hardinge Medical College,Not Recruiting,Phase 2,Interventional,India,"A clinical Trial to Study the Effects of Hydroxychloroquine, Ciclesonide and Ivermectin in treatment of moderate COVID-19 illness",Drug,Hydroxychloroquine vs. Ciclesonide vs. Ivermectin,Hydroxychloroquine; Ciclesonide; Ivermectin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364,None
1759,CTRI/2020/04/024949,CTRI,2020-04-30,2020-05-15,False,Lady Hardinge Medical College,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effect of Oral Niclosamide in mild and very mild COVID-19 cases,Drug,Niclosamide,Niclosamide,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400,None
1760,CTRI/2020/04/024947,CTRI,2020-04-30,2020-05-08,False,Dr. Priti Katre,Not Recruiting,Phase 3,Interventional,India,Clinical trial on effects of homeopathic medicine made from cadamba on COVID-19,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259,None
1761,CTRI/2020/05/024967,CTRI,2020-05-01,2020-05-11,False,MiLab LifeSciences,Not Recruiting,Phase 4,Interventional,India,Clinical trial on Immunity and antiviral for quarantine patients of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338,None
1762,CTRI/2020/05/024959,CTRI,2020-05-01,2020-05-01,False,Biocon Limited,Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,Drug,Itolizumab,Itolizumab,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,None
1763,CTRI/2020/05/024969,CTRI,2020-05-01,2020-05-10,False,Naiminath Homoeopathic Medical College Hospital and Research Centre,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as adjuvant in management of Covid-19 infection,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393,None
1764,CTRI/2020/05/024962,CTRI,2020-05-01,2020-05-05,False,Win medicare,Not Recruiting,Not Applicable,Interventional,India,The use of topical Povidone Iodine (PVP-I) oropharyngeal and intranasal application during the current coronavirus pandemic as a potential measure to reduce viral transmission,Drug,Povidone Iodine,Povidone Iodine,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237,None
1765,CTRI/2020/05/024981,CTRI,2020-05-02,2020-05-15,False,Dabur India Ltd,Not Recruiting,Not Applicable,Interventional,India,Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374,None
1766,CTRI/2020/05/024982,CTRI,2020-05-02,2020-05-15,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Effects of using hydroxychloroquine and azithromycin in the treatment of confirmed COVID-19 positive patients,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43432,None
1767,CTRI/2020/05/024983,CTRI,2020-05-02,2020-05-05,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,"Usage of topical lignocaine to decrease the gag reflex
while sampling for Covid-19: Does it affect the yield of

specimen?",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204,None
1768,CTRI/2020/05/024984,CTRI,2020-05-03,2020-05-12,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,How has the spread of COVID 19 disease affected the teaching and training of postgraduate students who are studying anaesthesiology,Other,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43425,None
1769,CTRI/2020/05/025010,CTRI,2020-05-04,2020-05-04,False,Indian Council Of Medical Research,Not Recruiting,Not Applicable,Observational,India,Hydroxychloroquine prophylaxis in Covid 19 infection,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43269,None
1770,CTRI/2020/05/024989,CTRI,2020-05-04,2020-05-11,False,Asian HealthCare Foundation,Not Recruiting,Not Applicable,Observational,India,Mechanism of Covid 19 infection in Humans,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43377,None
1771,CTRI/2020/05/024986,CTRI,2020-05-04,2020-05-13,False,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,HOMOEOPATHY IN PREVENTION OF COVID-19,Other,Homeopathy,Homeopathy,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455,None
1772,CTRI/2020/05/025013,CTRI,2020-05-05,2020-05-06,False,Haffkine Institute for Training Research and Testing,Not Recruiting,Phase 2,Interventional,India,Evaluation of BCG as potential therapy for COVID-19,ATMP,Vaccine,Vaccine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858,None
1773,CTRI/2020/05/025022,CTRI,2020-05-05,2020-05-06,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,Hydroxychloroquine in patients with mild COVID-19 illness with risk factors for severe disease,Drug,Hydroxychloroquine,Hydroxychloroquine,166,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183,None
1774,CTRI/2020/05/025067,CTRI,2020-05-06,2020-06-15,False,George Institute for Global Health India,Not Recruiting,Not Applicable,Interventional,India,A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,10990,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019,None
1775,CTRI/2020/05/025041,CTRI,2020-05-06,2020-05-06,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,Radiographic findings and their temporal changes in COVID-19 positive patient: A Prospective study,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43277,None
1776,CTRI/2020/05/025049,CTRI,2020-05-06,2020-05-08,False,Sai Nidan Homeopathy Clinic,Not Recruiting,Phase 2/Phase 3,Interventional,India,A CLINICAL TRIAL TO STUDY THE EFFICACY OF HOMOEOPATHIC MEDICINE IN PREVENTION AND CURE OF CORONA VIRUS DISEASE 19,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313,None
1777,CTRI/2020/05/025069,CTRI,2020-05-07,2020-05-16,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic Interventions in prevention of COVID-19 infection-A survey study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1324,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522,None
1778,CTRI/2020/05/025070,CTRI,2020-05-07,2020-05-09,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,An Observational study to identify the issues and challenges in cancer patients on active treatment during the COVID-19 Pandemic and the resulting Lockdown,Clinical Presentation,No Intervention,No Intervention,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43343,None
1779,CTRI/2020/05/025068,CTRI,2020-05-07,2020-05-27,False,Christian Medical College Vellore,Not Recruiting,Phase 3,Interventional,India,Can a medicine help in curing viral infection,Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449,None
1780,CTRI/2020/05/025071,CTRI,2020-05-08,2020-05-16,False,All India Institute of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Clinical trial evaluating two ventilator settings in Corona virus related severe lung diseases ( known as ARDS),Other (physical),Mechanical ventilation,Mechanical ventilation,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447,None
1781,CTRI/2020/05/025088,CTRI,2020-05-09,2020-05-20,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,India,Study of GUDUCHI TABLET on healthy individuals to prevent covid 19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555,None
1782,CTRI/2020/05/025089,CTRI,2020-05-09,2020-05-18,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Recruiting,Not Applicable,Observational,India,Effect of Hydroxychloroquine on QTc Interval,Drug,Hydroxychloroquine,Hydroxychloroquine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43506,None
1783,CTRI/2020/05/025093,CTRI,2020-05-11,2020-05-18,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of effect of Yashtimadhu tablet for the prevention of COVID -19 on healthy individuals.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539,None
1784,CTRI/2020/05/025092,CTRI,2020-05-11,2020-05-28,False,Science and Engineering Research Board (SERB),Not Recruiting,Not Applicable,Observational,India,Outcomes of viral infection in hematology patients,Clinical Presentation,No Intervention,No Intervention,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43608,None
1785,CTRI/2020/05/025091,CTRI,2020-05-11,2020-05-20,False,Siddha Central Research Institute,Not Recruiting,Not Applicable,Observational,India,Knowledge status of public about COVID 19 disease prevention and control  in Tamil Nadu,Other,No Intervention,No Intervention,125,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43622,None
1786,CTRI/2020/05/025114,CTRI,2020-05-12,2020-05-20,False,Glenmark Pharmaceuticals Ltd,Not Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir Compared to Standard Supportive Care in Patients With Mild to Moderate COVID-19.,Drug,Favipiravir,Favipiravir,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504,None
1787,CTRI/2020/05/025156,CTRI,2020-05-13,2020-05-18,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590,None
1788,CTRI/2020/05/025162,CTRI,2020-05-13,2020-05-26,False,Jawaharlal Institute of Postgraduate Medical Education and Research,Not Recruiting,Not Applicable,Interventional,India,Effect of pranayama and meditation on psychological well-being of healthcare workers during COVID-19 pandemic.,Other (psych),Psychological,Psychological,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650,None
1789,CTRI/2020/05/025161,CTRI,2020-05-13,2020-05-16,False,Ms Shukla Ashar Impex Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,To study the Effectiveness of herbal formulation - Aayudh Advance as a supplementary treatment for the Corona Virus 2019 (Covid-19) infected patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442,None
1790,CTRI/2020/05/025166,CTRI,2020-05-14,2020-05-19,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of ASHWAGANDHA TABLET on healthy individuals to prevent covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553,None
1791,CTRI/2020/05/025178,CTRI,2020-05-14,2020-05-18,False,All India Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Evaluation of the Immuno-Stimulatory Potential (Shareera Bala) of an Ayurveda Management Protocol in Cohort of Quarantined Delhi Police under Covid-19 Care Centers- An Exploratory Clinical Study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557,None
1792,CTRI/2020/05/025167,CTRI,2020-05-14,2020-05-17,False,Intas Pharmaceuticals Ltd,Not Recruiting,Phase 2,Interventional,India,Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19,Drug,Thymoquinone,Thymoquinone,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378,None
1793,CTRI/2020/05/025171,CTRI,2020-05-14,2020-05-16,False,All India Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Ayurveda protocol & COVID-19 exposed individuals: Clinical trial of an Ayurveda Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487,None
1794,NCT04273321,ClinicalTrials.gov,2020-02-15,2020-02-14,True,"Beijing Chaoyang Hospital, Capital Medical University",Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,Drug,Corticosteroids,Methylprednisolone,86,https://clinicaltrials.gov/show/NCT04273321,None
1795,NCT04278963,ClinicalTrials.gov,2020-02-19,2020-02-27,False,China Academy of Chinese Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04278963,None
1796,NCT04310865,ClinicalTrials.gov,2020-03-15,2020-11-01,False,Zhong Wang,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,116,https://clinicaltrials.gov/show/NCT04310865,None
1797,NCT04322396,ClinicalTrials.gov,2020-03-23,2020-04-06,False,Chronic Obstructive Pulmonary Disease Trial Network,Recruiting,Phase 2,Interventional,Denmark,Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; azithromycin,226,https://clinicaltrials.gov/show/NCT04322396,None
1798,NCT04334512,ClinicalTrials.gov,2020-04-02,2020-05-01,False,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,Drug,Hydroxychloroquine + azithromycin + vitamin C + vitamin D + zinc,Hydroxychloroquine; azithromycin; vitamin C; vitamin D; zinc,600,https://clinicaltrials.gov/show/NCT04334512,None
1799,NCT04335084,ClinicalTrials.gov,2020-04-02,2020-05-01,False,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Drug,Hydroxychloroquine + vitamin C + vitamin D + zinc,Hydroxychloroquine; vitamin C; vitamin D; zinc,600,https://clinicaltrials.gov/show/NCT04335084,None
1800,NCT04340219,ClinicalTrials.gov,2020-03-31,2020-03-30,True,"University Hospital, Ghent",Not Recruiting,Not Applicable,Observational,Belgium,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",Other (psych),No Intervention,No Intervention,394,https://clinicaltrials.gov/show/NCT04340219,None
1801,NCT04340544,ClinicalTrials.gov,2020-04-03,2020-04-22,True,"University Hospital, Tübingen",Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,2700,https://clinicaltrials.gov/show/NCT04340544,EUCTR2020-001512-26
1802,NCT04344015,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Thomas Jefferson University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,ATMP,Plasma,Plasma,2000,https://clinicaltrials.gov/show/NCT04344015,None
1803,NCT04346147,ClinicalTrials.gov,2020-04-07,2020-04-13,False,Hospital Universitario de Fuenlabrada,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Drug,"Lopinavir/ritonavir vs. Imatinib vs. Baricitinib

All in comibination with Hydroxychloroquine ",Hydroxychloroquine; Lopinavir/ritonavir; Imatinib; Baricitinib,165,https://clinicaltrials.gov/show/NCT04346147,None
1804,NCT04346199,ClinicalTrials.gov,2020-04-09,2020-05-11,True,AstraZeneca,Not Recruiting,Phase 2,Interventional,"France, Spain, Italy",Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug,Acalabrutinib,Acalabrutinib,140,https://clinicaltrials.gov/show/NCT04346199,PER-018-20; EUCTR2020-001644-25
1805,NCT04347915,ClinicalTrials.gov,2020-04-14,2020-05-06,False,Bukwang Pharmaceutical,Recruiting,Phase 2,Interventional,South Korea,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Drug,Clevudine vs. Hydroxychloroquine,Clevudine; Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04347915,None
1806,NCT04353323,ClinicalTrials.gov,2020-04-15,2020-05-25,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,COVID 19-Caregivers IGg Seroconversion,Clinical Presentation (Epidemiology),No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04353323,None
1807,NCT04354389,ClinicalTrials.gov,2020-04-15,2020-05-25,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,Italy,DAS181 for STOP COVID-19,Drug,DAS181,DAS181,82,https://clinicaltrials.gov/show/NCT04354389,None
1808,NCT04355871,ClinicalTrials.gov,2020-04-19,2020-03-18,True,Fundación SEIMC-GESIDA,Not Recruiting,Not Applicable,Observational,Spain,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Clinical Presentation,No Intervention,No Intervention,4035,https://clinicaltrials.gov/show/NCT04355871,None
1809,NCT04356690,ClinicalTrials.gov,2020-04-17,2020-05-08,False,Boston Medical Center,Recruiting,Phase 2,Interventional,United States,Etoposide in Patients With COVID-19 Infection,Drug,Etoposide,Etoposide,64,https://clinicaltrials.gov/show/NCT04356690,None
1810,NCT04365985,ClinicalTrials.gov,2020-04-26,2020-04-29,False,William Beaumont Hospitals,Recruiting,Phase 2,Interventional,United States,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Drug,"Ketamine, Naltrexone",Ketamine; Naltrexone,500,https://clinicaltrials.gov/show/NCT04365985,None
1811,NCT04366271,ClinicalTrials.gov,2020-04-23,2020-05-07,True,Hospital Infantil Universitario Niño Jesús,Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),106,https://clinicaltrials.gov/show/NCT04366271,EUCTR2020-001450-22
1812,NCT04370821,ClinicalTrials.gov,2020-04-27,2020-05-09,False,Villanova University,Recruiting,Not Applicable,Observational,United States,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",Other (psych),No Intervention,No Intervention,20000,https://clinicaltrials.gov/show/NCT04370821,None
1813,NCT04372056,ClinicalTrials.gov,2020-04-29,2020-05-06,False,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,The COVID-ICU Healthcare Professional Study,Other,No Intervention,No Intervention,2200,https://clinicaltrials.gov/show/NCT04372056,None
1814,NCT04373135,ClinicalTrials.gov,2020-04-30,2020-05-08,False,"University of California, Los Angeles",Recruiting,Not Applicable,Interventional,United States,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04373135,None
1815,NCT04375046,ClinicalTrials.gov,2020-05-01,2020-08-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme,ACE enzyme,24,https://clinicaltrials.gov/show/NCT04375046,None
1816,NCT04375709,ClinicalTrials.gov,2020-05-04,2020-03-15,True,Kantonsspital Winterthur (KSW),Recruiting,Not Applicable,Observational,Switzerland,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Other (exercise),Exercise,Exercise,60,https://clinicaltrials.gov/show/NCT04375709,None
1817,NCT04376476,ClinicalTrials.gov,2020-04-28,2020-05-05,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Host-pathogen Interactions During SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04376476,None
1818,NCT04377490,ClinicalTrials.gov,2020-05-05,2020-05-04,True,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04377490,None
1819,NCT04377607,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Nevsehir Public Hospital,Recruiting,Not Applicable,Observational,Turkey,Haemoglobin Concentration on COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04377607,None
1820,NCT04378686,ClinicalTrials.gov,2020-05-05,2020-04-23,True,UZ Leuven,Recruiting,Not Applicable,Observational,Belgium,Serological Testing for COVID-19 (SARS-CoV-2) in ESKD,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04378686,None
1821,NCT04379271,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Immunic AG,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)",Drug,Vidofludimus calcium,Vidofludimus calcium,230,https://clinicaltrials.gov/show/NCT04379271,EUCTR2020-001264-28
1822,NCT04379453,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Hospital Israelita Albert Einstein,Recruiting,Not Applicable,Interventional,Brazil,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,Procedure,Percutaneous Cardiovascular Intervention,Percutaneous Cardiovascular Intervention,10,https://clinicaltrials.gov/show/NCT04379453,None
1823,NCT04379492,ClinicalTrials.gov,2020-05-05,2020-05-05,False,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,120,https://clinicaltrials.gov/show/NCT04379492,None
1824,NCT04379544,ClinicalTrials.gov,2020-05-04,2020-04-23,True,University of Pennsylvania,Recruiting,Not Applicable,Observational,United States,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,Prognosis,No Intervention,No Intervention,105,https://clinicaltrials.gov/show/NCT04379544,None
1825,NCT04380376,ClinicalTrials.gov,2020-05-06,2020-04-30,True,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute",Recruiting,Phase 2,Interventional,Russian Federation,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,Drug,Melphalan,Melphalan,60,https://clinicaltrials.gov/show/NCT04380376,None
1826,NCT04380688,ClinicalTrials.gov,2020-05-07,2020-05-12,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,United States,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug,Acalabrutinib,Acalabrutinib,60,https://clinicaltrials.gov/show/NCT04380688,None
1827,NCT04380714,ClinicalTrials.gov,2020-05-07,2020-05-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,Clinical Presentation,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04380714,None
1828,NCT04380727,ClinicalTrials.gov,2020-04-28,2020-03-20,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Almitrine and COVID-19 Related Hypoxemia,Clinical Presentation,No Intervention,No Intervention,17,https://clinicaltrials.gov/show/NCT04380727,None
1829,NCT04380766,ClinicalTrials.gov,2020-04-21,2019-01-01,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Not Applicable,Observational,Italy,Covid-19 Pandemic and Pancreatic Surgery in Italy,Clinical Presentation,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04380766,None
1830,NCT04380779,ClinicalTrials.gov,2020-05-07,2020-04-13,True,Manuel Monreal,Recruiting,Not Applicable,Observational,Spain,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04380779,None
1831,NCT04380792,ClinicalTrials.gov,2020-05-07,2020-04-13,True,Manuel Monreal,Recruiting,Not Applicable,Observational,Spain,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04380792,None
1832,NCT04380909,ClinicalTrials.gov,2020-05-07,2020-05-06,True,University of Bern,Recruiting,Not Applicable,Interventional,Switzerland,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04380909,None
1833,NCT04380935,ClinicalTrials.gov,2020-05-04,2020-05-11,False,Indonesia University,Not Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04380935,None
1834,NCT04380987,ClinicalTrials.gov,2020-04-30,2020-05-04,False,Luxembourg Institute of Health,Recruiting,Not Applicable,Observational,Luxembourg,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04380987,None
1835,NCT04381000,ClinicalTrials.gov,2020-05-07,2020-04-01,True,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Recruiting,Not Applicable,Interventional,Greece,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,170,https://clinicaltrials.gov/show/NCT04381000,None
1836,NCT04381052,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Columbia University,Not Recruiting,Phase 2,Interventional,United States,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04381052,None
1837,NCT04381273,ClinicalTrials.gov,2020-05-06,2020-05-08,False,Heidelberg University,Recruiting,Not Applicable,Observational,Germany,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04381273,None
1838,NCT04381286,ClinicalTrials.gov,2020-04-23,2019-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Transpulmonary Driving Pressure in ARDS COVID19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04381286,None
1839,NCT04381312,ClinicalTrials.gov,2020-04-10,2020-04-09,True,"University Hospital, Grenoble",Recruiting,Not Applicable,Observational,France,Direct and Indirect Impact of COVID-19 In Older Populations,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04381312,None
1840,NCT04381338,ClinicalTrials.gov,2020-05-04,2020-05-10,False,University of Padova,Not Recruiting,Not Applicable,Interventional,Italy,Rehabilitation for People With COVID-19 in ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,92,https://clinicaltrials.gov/show/NCT04381338,None
1841,NCT04381364,ClinicalTrials.gov,2020-05-07,2020-05-15,True,Dr. Ola Blennow,Not Recruiting,Phase 2,Interventional,Sweden,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Drug,Ciclesonide,Ciclesonide,446,https://clinicaltrials.gov/show/NCT04381364,EUCTR2020-001928-34
1842,NCT04381377,ClinicalTrials.gov,2020-05-07,2020-04-29,True,NPO Petrovax,Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19,Drug,Azoximer bromide,Azoximer bromide,394,https://clinicaltrials.gov/show/NCT04381377,None
1843,NCT04381819,ClinicalTrials.gov,2020-05-04,2020-03-02,True,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04381819,None
1844,NCT04381858,ClinicalTrials.gov,2020-05-06,2020-05-06,False,Centenario Hospital Miguel Hidalgo,Recruiting,Phase 3,Interventional,Mexico,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,500,https://clinicaltrials.gov/show/NCT04381858,None
1845,NCT04381871,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Al-Neelain University,Not Recruiting,Phase 2/Phase 3,Interventional,Sudan,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,Drug,Gum Arabic,Gum Arabic,110,https://clinicaltrials.gov/show/NCT04381871,None
1846,NCT04382092,ClinicalTrials.gov,2020-05-06,2020-03-23,True,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Interventional,Belgium,Co-infection Management in COVID-19 Critically Ill,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,32,https://clinicaltrials.gov/show/NCT04382092,None
1847,NCT04382131,ClinicalTrials.gov,2020-05-08,2020-05-01,True,University of Edinburgh,Not Recruiting,Not Applicable,Interventional,United Kingdom,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19,Procedure,Nasal irrigation,Nasal irrigation,405,https://clinicaltrials.gov/show/NCT04382131,None
1848,NCT04382196,ClinicalTrials.gov,2020-05-08,2020-04-17,True,"University Hospital, Ghent",Not Recruiting,Not Applicable,Observational,Belgium,Impact of COVID-19 on Mental Health of Health Care Workers,Other (psych),No Intervention,No Intervention,497,https://clinicaltrials.gov/show/NCT04382196,None
1849,NCT04382235,ClinicalTrials.gov,2020-05-05,2020-03-26,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,Non-invasive Ventilatory Support of Patients Affected by COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,900,https://clinicaltrials.gov/show/NCT04382235,None
1850,NCT04382469,ClinicalTrials.gov,2020-05-05,2020-02-01,True,Alexandria University,Not Recruiting,Not Applicable,Observational,Egypt,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,Clinical Presentation,No Intervention,No Intervention,48,https://clinicaltrials.gov/show/NCT04382469,None
1851,NCT04382534,ClinicalTrials.gov,2020-04-26,2020-03-10,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04382534,None
1852,NCT04382560,ClinicalTrials.gov,2020-05-05,2020-05-02,True,University of Parma,Recruiting,Not Applicable,Interventional,Italy,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04382560,None
1853,NCT04382625,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Kootenai Health,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,120,https://clinicaltrials.gov/show/NCT04382625,None
1854,NCT04382729,ClinicalTrials.gov,2020-05-08,2020-04-17,True,University of Turin,Recruiting,Not Applicable,Interventional,Italy,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04382729,None
1855,NCT04382755,ClinicalTrials.gov,2020-05-07,2020-05-01,True,"University Hospital, Ghent",Not Recruiting,Phase 2,Interventional,Belgium,Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,Drug,Zilucoplan,Zilucoplan,81,https://clinicaltrials.gov/show/NCT04382755,None
1856,NCT04382781,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Spanish Network for Research in Infectious Diseases,Recruiting,Not Applicable,Observational,Spain,Immunosupressive Treatment in COVID-19 Patients,Drug,Immunosupressives,Immunosupressives,500,https://clinicaltrials.gov/show/NCT04382781,None
1857,NCT04382846,ClinicalTrials.gov,2020-05-07,2020-05-08,False,Tanta University,Not Recruiting,Phase 3,Interventional,No Country Given,Novel Regimens in COVID-19 Treatment,Drug,Nitazoxanide + Azithromycin vs. Ivermectin + Chloroquine vs. Ivermectin + Nitazoxanide vs. Nitazoxanide + Ivermectin + Azithromycin,Nitazoxanide + Ivermectin + Azithromycin + Chloroquine,80,https://clinicaltrials.gov/show/NCT04382846,None
1858,NCT04382924,ClinicalTrials.gov,2020-05-08,2020-07-01,False,Algernon Pharmaceuticals,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Confirmed COVID-19 Infected Hospitalized Patients,Drug,Ifenprodil,Ifenprodil,462,https://clinicaltrials.gov/show/NCT04382924,None
1859,NCT04383002,ClinicalTrials.gov,2020-05-01,2020-05-01,False,"University Health Network, Toronto",Not Recruiting,Phase 1,Interventional,No Country Given,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04383002,None
1860,NCT04383574,ClinicalTrials.gov,2020-05-09,2020-05-20,False,"Sinovac Research and Development Co., Ltd.",Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),ATMP,Vaccine,Vaccine,422,https://clinicaltrials.gov/show/NCT04383574,None
1861,NCT04383587,ClinicalTrials.gov,2020-05-07,2020-05-06,True,Mayo Clinic,Recruiting,Not Applicable,Interventional,United States,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04383587,None
1862,NCT04383626,ClinicalTrials.gov,2020-05-10,2020-03-02,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,Fear Among Dentists During COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,216,https://clinicaltrials.gov/show/NCT04383626,None
1863,NCT04383652,ClinicalTrials.gov,2020-05-07,2020-05-06,True,Kirby Institute,Recruiting,Not Applicable,Observational,Australia,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04383652,None
1864,NCT04383886,ClinicalTrials.gov,2020-05-08,2020-04-18,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04383886,None
1865,NCT04384029,ClinicalTrials.gov,2020-04-20,2020-03-24,True,Francois Mach,Not Recruiting,Not Applicable,Observational,Switzerland,The Geneva Covid-19 CVD Study,Clinical Presentation,No Intervention,No Intervention,7000,https://clinicaltrials.gov/show/NCT04384029,None
1866,NCT04384250,ClinicalTrials.gov,2020-05-10,2020-05-10,False,Mansoura University,Recruiting,Not Applicable,Observational,Egypt,Genetic Basis of COVID-19 Infection,Genomics,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04384250,None
1867,NCT04384380,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Taoyuan General Hospital,Recruiting,Phase 4,Interventional,Taiwan,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,45,https://clinicaltrials.gov/show/NCT04384380,None
1868,NCT04384419,ClinicalTrials.gov,2020-05-05,2020-05-29,False,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,"Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)",Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04384419,None
1869,NCT04384471,ClinicalTrials.gov,2020-05-01,2020-04-29,True,McGill University,Recruiting,Not Applicable,Observational,Canada,Covid-19 Pandemic: Patients' Experience in T1D,Other,No Intervention,No Intervention,384,https://clinicaltrials.gov/show/NCT04384471,None
1870,NCT04384549,ClinicalTrials.gov,2020-05-06,2020-05-11,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,France,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,ATMP,Vaccine,Vaccine,1120,https://clinicaltrials.gov/show/NCT04384549,EUCTR2020-001678-31
1871,NCT04384588,ClinicalTrials.gov,2020-04-29,2020-04-07,True,Fundacion Arturo Lopez Perez,Recruiting,Phase 2/Phase 3,Interventional,Chile,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04384588,None
1872,NCT04385212,ClinicalTrials.gov,2020-04-29,2020-03-13,True,"University Hospital, Geneva",Not Recruiting,Not Applicable,Observational,Switzerland,Outcomes in Hospitalized Older Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04385212,None
1873,NCT04385576,ClinicalTrials.gov,2020-04-28,2020-05-15,False,University of Malaya,Recruiting,Not Applicable,Interventional,Malaysia,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04385576,None
1874,NCT04278404,ClinicalTrials.gov,2020-02-18,2020-03-05,False,Duke University,Recruiting,Not Applicable,Observational,"United States, Canada","Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",Drug,Other,Other,5000,https://clinicaltrials.gov/show/NCT04278404,None
1875,NCT04307459,ClinicalTrials.gov,2020-03-10,2020-03-19,False,University of Milan,Recruiting,Not Applicable,Observational,Italy,Acute Respiratory Failure and COVID-19 in Real Life,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04307459,None
1876,NCT04311398,ClinicalTrials.gov,2020-03-14,2020-05-13,False,Huashan Hospital,Not Recruiting,Not Applicable,Observational,China,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04311398,None
1877,NCT04323644,ClinicalTrials.gov,2020-03-25,2020-01-01,True,University of Birmingham,Recruiting,Not Applicable,Observational,Spain,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Other (surgery),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04323644,None
1878,NCT04324684,ClinicalTrials.gov,2020-03-25,2020-03-31,False,Catholic University of the Sacred Heart,Not Recruiting,Not Applicable,Observational,Italy,Prognostic Factors Keeping Track for COVID-19 Pneumonia,Prognosis,No Intervention,No Intervention,198,https://clinicaltrials.gov/show/NCT04324684,None
1879,NCT04328961,ClinicalTrials.gov,2020-03-23,2020-03-31,False,University of Washington,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,2000,https://clinicaltrials.gov/show/NCT04328961,None
1880,NCT04331886,ClinicalTrials.gov,2020-03-31,2020-04-13,False,"Target PharmaSolutions, Inc.",Recruiting,Not Applicable,Observational,United States,An Observational Study of Patients With Coronavirus Disease 2019,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04331886,None
1881,NCT04334148,ClinicalTrials.gov,2020-04-02,2020-04-22,False,Adrian Hernandez,Recruiting,Phase 3,Interventional,United States,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,15000,https://clinicaltrials.gov/show/NCT04334148,None
1882,NCT04335097,ClinicalTrials.gov,2020-04-01,2020-04-22,False,Lars Wik,Recruiting,Not Applicable,Interventional,Norway,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Other (device),Biosensors,Biosensors,214,https://clinicaltrials.gov/show/NCT04335097,None
1883,NCT04335162,ClinicalTrials.gov,2020-04-03,2020-02-28,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Cardiovascular Complications and COVID-19 (CovCardioVasc),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04335162,None
1884,NCT04339998,ClinicalTrials.gov,2020-04-06,2020-04-15,False,University of Minnesota,Recruiting,Not Applicable,Observational,United States,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04339998,None
1885,NCT04340050,ClinicalTrials.gov,2020-04-07,2020-04-10,False,University of Chicago,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04340050,None
1886,NCT04340349,ClinicalTrials.gov,2020-04-02,2020-05-11,False,Instituto Nacional de Rehabilitacion,Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,Drug (Chemoprophylaxis),Hydroxychloroquine + bromhexine vs. bromhexine,Hydroxychloroquine; bromhexine,140,https://clinicaltrials.gov/show/NCT04340349,None
1887,NCT04341415,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Procedure,Auricular neuromodulation,Auricular neuromodulation,60,https://clinicaltrials.gov/show/NCT04341415,None
1888,NCT04342728,ClinicalTrials.gov,2020-04-08,2020-04-08,False,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Drug,Zinc + Vitamin C vs Zinc vs. Vitamin C,Zinc; vitamin C,520,https://clinicaltrials.gov/show/NCT04342728,None
1889,NCT04344002,ClinicalTrials.gov,2020-04-09,2020-04-21,False,Spanish Lung Cancer Group,Recruiting,Not Applicable,Observational,Spain,LunG canceR pAtients coVId19 Disease (GRAVID),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04344002,None
1890,NCT04344119,ClinicalTrials.gov,2020-04-09,2020-04-09,False,CHU de Nice,Recruiting,Not Applicable,Observational,France,Assessment of Chilbains Occuring During Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04344119,None
1891,NCT04345159,ClinicalTrials.gov,2020-04-10,2020-04-17,False,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Observational,France,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,Clinical Presentation,No Intervention,No Intervention,572,https://clinicaltrials.gov/show/NCT04345159,None
1892,NCT04347538,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Vanderbilt University,Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Procedure,Saline Nasal Irrigation,Saline Nasal Irrigation,90,https://clinicaltrials.gov/show/NCT04347538,None
1893,NCT04350476,ClinicalTrials.gov,2020-04-14,2020-07-01,False,Vivek Reddy,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04350476,None
1894,NCT04352348,ClinicalTrials.gov,2020-03-31,2020-03-31,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Prognosis,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04352348,None
1895,NCT04352751,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Hilton Pharma,Recruiting,Not Applicable,Interventional,Pakistan,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,ATMP,Plasma,Plasma,2000,https://clinicaltrials.gov/show/NCT04352751,None
1896,NCT04352933,ClinicalTrials.gov,2020-04-07,2020-05-11,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 3,Interventional,United Kingdom,PROLIFIC ChemoprophylaxisTrial (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,https://clinicaltrials.gov/show/NCT04352933,EUCTR2020-001331-26
1897,NCT04353206,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Noah Merin,Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04353206,None
1898,NCT04354259,ClinicalTrials.gov,2020-04-16,2020-05-13,False,"University Health Network, Toronto",Recruiting,Phase 2,Interventional,Canada,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,Drug,Interferon lambda,Interferon lambda,140,https://clinicaltrials.gov/show/NCT04354259,None
1899,NCT04354831,ClinicalTrials.gov,2020-04-14,2020-05-11,False,Medical College of Wisconsin,Recruiting,Phase 2,Interventional,United States,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,ATMP,Plasma,Plasma,131,https://clinicaltrials.gov/show/NCT04354831,None
1900,NCT04355624,ClinicalTrials.gov,2020-04-17,2020-04-15,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Kidney Involvement in COVID-19 Disease (COVKID),Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04355624,None
1901,NCT04357431,ClinicalTrials.gov,2020-04-21,2020-04-22,False,Assiut University,Recruiting,Not Applicable,Observational,Egypt,COVID-19 Among Egyptian Health Care Providers,Other,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04357431,None
1902,NCT04357457,ClinicalTrials.gov,2020-04-20,2020-05-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,France,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,Drug,Almitrine,Almitrine,212,https://clinicaltrials.gov/show/NCT04357457,EUCTR2020-001909-22
1903,NCT04358029,ClinicalTrials.gov,2020-04-20,2020-04-09,True,Vivek Reddy,Recruiting,Not Applicable,Observational,United States,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04358029,None
1904,NCT04361565,ClinicalTrials.gov,2020-04-22,2020-03-20,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04361565,None
1905,NCT04362085,ClinicalTrials.gov,2020-04-20,2020-05-11,False,"St. Michael's Hospital, Toronto",Recruiting,Phase 3,Interventional,Canada,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Drug,Heparin,Heparin,462,https://clinicaltrials.gov/show/NCT04362085,None
1906,NCT04362930,ClinicalTrials.gov,2020-04-24,2020-04-27,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04362930,None
1907,NCT04363333,ClinicalTrials.gov,2020-04-19,2020-04-27,False,Koç University,Recruiting,Not Applicable,Observational,Turkey,Obstructive Sleep Apnea & Covid-19 Outcomes,Clinical Presentation,No Intervention,No Intervention,275,https://clinicaltrials.gov/show/NCT04363333,None
1908,NCT04364009,ClinicalTrials.gov,2020-04-17,2020-04-27,True,CHU de Tours,Recruiting,Phase 3,Interventional,France,Anakinra for COVID-19 Respiratory Symptoms,Drug,Anakinra,Anakinra,240,https://clinicaltrials.gov/show/NCT04364009,EUCTR2020-001734-36
1909,NCT04364698,ClinicalTrials.gov,2020-04-24,2020-05-07,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Observational Cohort of COVID-19 Patients at Raymond-Poincare,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04364698,None
1910,NCT04364802,ClinicalTrials.gov,2020-04-25,2020-04-29,False,Alexandra Kejner,Recruiting,Phase 2,Interventional,United States,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Drug,Povidone Iodine,Povidone Iodine,250,https://clinicaltrials.gov/show/NCT04364802,None
1911,NCT04365166,ClinicalTrials.gov,2020-04-19,2020-04-21,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04365166,None
1912,NCT04365257,ClinicalTrials.gov,2020-04-24,2020-05-13,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Drug,Prazosin,Prazosin,220,https://clinicaltrials.gov/show/NCT04365257,None
1913,NCT04365335,ClinicalTrials.gov,2020-04-24,2020-04-25,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04365335,None
1914,NCT04365517,ClinicalTrials.gov,2020-04-14,2020-05-29,False,University of Milan,Not Recruiting,Phase 3,Interventional,Italy,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Drug,Sitagliptin,Sitagliptin,170,https://clinicaltrials.gov/show/NCT04365517,None
1915,NCT04365725,ClinicalTrials.gov,2020-04-25,2020-05-05,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",Drug,Remdesivir,Remdesivir,200,https://clinicaltrials.gov/show/NCT04365725,None
1916,NCT04367077,ClinicalTrials.gov,2020-04-27,2020-04-28,False,"Athersys, Inc",Recruiting,Phase 2/Phase 3,Interventional,United States,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),ATMP,Cells (stem cells),Cells (stem cells),400,https://clinicaltrials.gov/show/NCT04367077,None
1917,NCT04368221,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Rennes University Hospital,Not Recruiting,Not Applicable,Observational,France,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04368221,None
1918,NCT04378712,ClinicalTrials.gov,2020-04-29,2020-01-21,True,Guangzhou Institute of Respiratory Disease,Not Recruiting,Not Applicable,Interventional,China,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),Drug,Hydrogen + Oxygen,Hydrogen; Oxygen,90,https://clinicaltrials.gov/show/NCT04378712,None
1919,NCT04378777,ClinicalTrials.gov,2020-05-01,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Immunophenotyping Assessment in a COVID-19 Cohort,Genomics,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04378777,None
1920,NCT04378920,ClinicalTrials.gov,2020-05-05,2020-04-14,True,Institut de Cancérologie Strasbourg Europe (ICANS),Recruiting,Phase 1/Phase 2,Interventional,France,A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715),Drug,Trans Crocetin,Trans Crocetin,180,https://clinicaltrials.gov/show/NCT04378920,None
1921,NCT04379076,ClinicalTrials.gov,2020-05-05,2020-05-14,False,Revimmune,Recruiting,Phase 2,Interventional,United Kingdom,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,Drug,CYT107,CYT107,48,https://clinicaltrials.gov/show/NCT04379076,None
1922,NCT04379258,ClinicalTrials.gov,2020-04-22,2020-05-11,False,Hospital Universitario Getafe,Not Recruiting,Not Applicable,Observational,No Country Given,Analysis of Mortality of Critically Ill Patients With COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,650,https://clinicaltrials.gov/show/NCT04379258,None
1923,NCT04380896,ClinicalTrials.gov,2020-05-04,2020-04-27,True,Great Ormond Street Hospital for Children NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04380896,None
1924,NCT04381988,ClinicalTrials.gov,2020-05-08,2020-05-07,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,Drug,Hydroxychloroquine,Hydroxychloroquine,132,https://clinicaltrials.gov/show/NCT04381988,None
1925,NCT04382391,ClinicalTrials.gov,2020-04-14,2020-05-08,False,Allegheny Singer Research Institute,Recruiting,Not Applicable,Interventional,United States,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,20,https://clinicaltrials.gov/show/NCT04382391,None
1926,NCT04383470,ClinicalTrials.gov,2020-04-27,2020-04-26,True,University of Padova,Recruiting,Not Applicable,Observational,Greece,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04383470,None
1927,NCT04384042,ClinicalTrials.gov,2020-05-10,2020-05-01,True,Hospital Sultanah Bahiyah,Not Recruiting,Not Applicable,Observational,Malaysia,Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04384042,None
1928,NCT04384614,ClinicalTrials.gov,2020-05-09,2020-05-15,False,Direction des Soins de Santé de Base,Not Recruiting,Not Applicable,Observational,Tunisia,Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04384614,None
1929,NCT04384731,ClinicalTrials.gov,2020-05-07,2020-05-27,False,Dr. Christophe Lenclud,Not Recruiting,Phase 2,Interventional,No Country Given,Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Drug,Poractant alfa,Poractant alfa,20,https://clinicaltrials.gov/show/NCT04384731,None
1930,NCT04384887,ClinicalTrials.gov,2020-05-11,2020-04-25,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04384887,None
1931,NCT04384900,ClinicalTrials.gov,2020-05-11,2020-05-11,False,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Interventional,Denmark,Accelerated Prone Position Ventilation of Patients With COVID-19,Procedure,Positioning,Positioning,150,https://clinicaltrials.gov/show/NCT04384900,None
1932,NCT04384926,ClinicalTrials.gov,2020-05-11,2020-03-30,True,University of Birmingham,Recruiting,Not Applicable,Observational,Spain,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04384926,None
1933,NCT04385017,ClinicalTrials.gov,2020-05-10,2020-05-11,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Role of Inflammasomes in COVID-19 Disease,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04385017,None
1934,NCT04385043,ClinicalTrials.gov,2020-05-04,2020-05-01,True,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,ATMP,Plasma,Plasma,400,https://clinicaltrials.gov/show/NCT04385043,None
1935,NCT04385069,ClinicalTrials.gov,2020-04-20,2020-04-16,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04385069,None
1936,NCT04385095,ClinicalTrials.gov,2020-04-24,2020-03-16,False,Synairgen Research Limited,Recruiting,Phase 2,Interventional,United Kingdom,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,Drug,Interferon beta,Interferon beta,400,https://clinicaltrials.gov/show/NCT04385095,EUCTR2020-001023-14; ISRCTN14241621
1937,NCT04385108,ClinicalTrials.gov,2020-05-05,2020-05-12,False,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Interventional,France,Predictive Immune Biomarkers for COVID-19 Pathogenesis,Clinical Presentation,No Intervention,No Intervention,170,https://clinicaltrials.gov/show/NCT04385108,None
1938,NCT04385121,ClinicalTrials.gov,2020-04-16,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,France,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,Other (psych),No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04385121,None
1939,NCT04385199,ClinicalTrials.gov,2020-05-09,2020-05-04,True,Henry Ford Health System,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Patients With COVID-19,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04385199,None
1940,NCT04385264,ClinicalTrials.gov,2020-04-21,2020-05-12,False,University of Lausanne,Not Recruiting,Phase 2/Phase 3,Interventional,Switzerland,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04385264,None
1941,NCT04385771,ClinicalTrials.gov,2020-04-19,2020-06-01,False,Dr. Alexander Supady,Not Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Other (device),Cytokine Adsorber,Cytokine Adsorber,80,https://clinicaltrials.gov/show/NCT04385771,None
1942,NCT04385797,ClinicalTrials.gov,2020-05-07,2020-05-04,True,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS),Not Recruiting,Not Applicable,Observational,Spain,Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia,Other (psych),No Intervention,No Intervention,414,https://clinicaltrials.gov/show/NCT04385797,None
1943,NCT04385823,ClinicalTrials.gov,2020-05-11,2020-03-01,True,Assistance Publique – Hôpitaux de Paris (Louis Mourier),Not Recruiting,Not Applicable,Observational,France,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,Drug,Oxygen,Oxygen,62,https://clinicaltrials.gov/show/NCT04385823,None
1944,NCT04385914,ClinicalTrials.gov,2020-05-11,2020-05-01,True,Atlantic Health System,Not Recruiting,Not Applicable,Observational,No Country Given,Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04385914,None
1945,NCT04386044,ClinicalTrials.gov,2020-05-10,2020-06-01,False,Tameside General Hospital,Not Recruiting,Not Applicable,Observational,United Kingdom,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,Drug,Vitamin D,Vitamin D,1000,https://clinicaltrials.gov/show/NCT04386044,None
1946,NCT04386070,ClinicalTrials.gov,2020-04-30,2020-05-15,True,University of Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug,Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,6400,https://clinicaltrials.gov/show/NCT04386070,EUCTR2020-001448-24
1947,NCT04386083,ClinicalTrials.gov,2020-05-04,2020-05-01,True,University of the Philippines,Not Recruiting,Not Applicable,Observational,No Country Given,Neurologic Manifestations of COVID-19,Clinical Presentation,No Intervention,No Intervention,1342,https://clinicaltrials.gov/show/NCT04386083,None
1948,NCT04386109,ClinicalTrials.gov,2020-04-15,2020-04-01,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,Neonatal Complications of Coronavirus Disease (COVID-19),Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04386109,None
1949,NCT04386239,ClinicalTrials.gov,2020-05-07,2020-05-01,True,ASST Fatebenefratelli Sacco,Not Recruiting,Phase 1,Interventional,No Country Given,Study on the Use of Sarilumab in Patients With COVID-19 Infection,Drug,Sarilumab,Sarilumab,40,https://clinicaltrials.gov/show/NCT04386239,None
1950,NCT04386395,ClinicalTrials.gov,2020-05-06,2020-03-30,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Immune Changes in Severe COVID-19 Pulmonary Infections,Clinical Presentation,No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04386395,None
1951,NCT04386460,ClinicalTrials.gov,2020-05-12,2020-05-11,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Covid-19 and Prevention of Malnutrition After Confinement by Dentists,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04386460,None
1952,NCT04386512,ClinicalTrials.gov,2020-05-12,2020-05-15,False,Versailles Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1),Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04386512,None
1953,NCT04386551,ClinicalTrials.gov,2020-05-11,2020-05-11,False,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Detection of COVID-19 in Saliva Collection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,225,https://clinicaltrials.gov/show/NCT04386551,None
1954,NCT04386564,ClinicalTrials.gov,2020-05-11,2020-05-15,False,I.M. Sechenov First Moscow State Medical University,Not Recruiting,Not Applicable,Observational,Russian Federation,Kidney Injury Severity and COVID-19,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04386564,None
1955,NCT04386759,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04386759,None
1956,NCT04387279,ClinicalTrials.gov,2020-05-12,2020-04-24,True,Keimyung University Dongsan Medical Center,Recruiting,Not Applicable,Observational,South Korea,The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease,Other,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04387279,None
1957,NCT04387292,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Interventional,France,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04387292,None
1958,NCT04387643,ClinicalTrials.gov,2020-05-13,2020-03-01,True,Aarogyam UK,Not Recruiting,Not Applicable,Observational,India,Protecting Health Care Workers During the COVID-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,52,https://clinicaltrials.gov/show/NCT04387643,None
1959,NCT04387786,ClinicalTrials.gov,2020-05-11,2020-03-31,True,Feinstein Institute for Medical Research,Not Recruiting,Not Applicable,Observational,United States,Dornase Alfa Administered to Patients With COVID-19 (DACOVID),Drug,Dornase alfa,Dornase alfa,5,https://clinicaltrials.gov/show/NCT04387786,None
1960,NCT04387929,ClinicalTrials.gov,2020-05-13,2020-05-04,True,Istituto Clinico Humanitas,Recruiting,Not Applicable,Observational,Italy,Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04387929,None
1961,NCT04387955,ClinicalTrials.gov,2020-04-29,2020-05-01,False,Poitiers University Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04387955,None
1962,NCT04387968,ClinicalTrials.gov,2020-05-12,2020-06-18,False,Raphael Serreau,Not Recruiting,Not Applicable,Observational,France,Epidemiological Study of the Covid-19 Presto Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,700,https://clinicaltrials.gov/show/NCT04387968,None
1963,NCT04388410,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,ATMP,Plasma,Plasma,250,https://clinicaltrials.gov/show/NCT04388410,None
1964,NCT04388579,ClinicalTrials.gov,2020-05-12,2020-03-20,True,University of Lisbon,Not Recruiting,Not Applicable,Observational,Portugal,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04388579,None
1965,NCT04388605,ClinicalTrials.gov,2020-05-07,2020-04-21,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,Clinical Presentation,No Intervention,No Intervention,11000,https://clinicaltrials.gov/show/NCT04388605,None
1966,NCT04388644,ClinicalTrials.gov,2020-05-12,2020-02-20,True,Taipei City Hospital,Recruiting,Not Applicable,Observational,Taiwan,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04388644,None
1967,NCT04388657,ClinicalTrials.gov,2020-05-13,2020-05-01,True,Ramsay Générale de Santé,Recruiting,Not Applicable,Observational,France,"COVID-19, bLOod Coagulation and Thrombosis",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04388657,None
1968,NCT04388670,ClinicalTrials.gov,2020-05-12,2020-02-22,True,Policlinico Hospital,Recruiting,Not Applicable,Observational,Italy,Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04388670,None
1969,NCT04389294,ClinicalTrials.gov,2020-05-08,2020-05-05,True,"Hospital for Special Surgery, New York",Recruiting,Not Applicable,Interventional,United States,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04389294,None
1970,NCT04389320,ClinicalTrials.gov,2020-05-11,2020-03-15,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Antimalarial and Covid 19 in Rheumatoid Arthritis,Drug,Hydroxychloroquine,Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04389320,None
1971,NCT04389359,ClinicalTrials.gov,2020-05-12,2020-05-01,True,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04389359,None
1972,NCT04389671,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Windtree Therapeutics,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,The Safety and Preliminary Efficacy of Lucinactant in Adults With COVID-19,Drug,Lucinactant,Lucinactant,30,https://clinicaltrials.gov/show/NCT04389671,None
1973,NCT04390139,ClinicalTrials.gov,2020-05-07,2020-05-13,False,Banc de Sang i Teixits,Recruiting,Phase 1/Phase 2,Interventional,Spain,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04390139,None
1974,NCT04390165,ClinicalTrials.gov,2020-05-10,2020-05-01,True,Hospital Sultanah Bahiyah,Not Recruiting,Not Applicable,Observational,Malaysia,Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study,Clinical Presentation,No Intervention,No Intervention,760,https://clinicaltrials.gov/show/NCT04390165,None
1975,NCT04390178,ClinicalTrials.gov,2020-04-10,2020-04-10,False,Joakim Dillner,Not Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04390178,None
1976,NCT04390191,ClinicalTrials.gov,2020-05-12,2020-05-07,True,Icahn School of Medicine at Mount Sinai,Recruiting,Not Applicable,Interventional,United States,Early CPAP in COVID-19 Confirmed or Suspected Patients,Other (device),CPAP,CPAP,200,https://clinicaltrials.gov/show/NCT04390191,None
1977,NCT04394039,ClinicalTrials.gov,2020-05-13,2020-06-01,False,"National University, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Post-Pandemic Perception of Public Space in Singapore,Other,No Intervention,No Intervention,34,https://clinicaltrials.gov/show/NCT04394039,None
1978,ACTRN12620000445976,ANZCTR,2020-04-06,2020-04-10,False,University of Melbourne,Recruiting,Phase 3,Interventional,"New Zealand, Australia","To compare the effectiveness of two drugs (hydroxychloroquine and lopinavir/ritonavir alone or combined in treating hospitalized patients with confirmed COVID-19 compared to standard of care

",Drug,Lopinavir/ritonavir + hydroxychloroquine vs. lopinavir/ritonavir vs. hydroxychloroquine,Lopinavir/ritonavir; hydroxychloroquine,2500,https://anzctr.org.au/ACTRN12620000445976.aspx,None
1979,ACTRN12620000580976,ANZCTR,2020-05-19,2020-05-26,False,QIMR Berghofer Medical Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Tocilizumab for tReatment Of COVID-19 in intensive cARe patients (“TROCAR”),Drug,Tocilizumab,Tocilizumab,150,https://anzctr.org.au/ACTRN12620000580976.aspx,None
1980,ACTRN12620000588998,ANZCTR,2020-05-21,2020-05-29,False,Grand Medical Pty Ltd,Not Recruiting,Phase 2,Interventional,Australia,The safety and efficacy of STC3141 in patient with COVID-19 Acute Respiratory Distress Syndrome,Drug,STC3141,STC3141,160,https://anzctr.org.au/ACTRN12620000588998.aspx,None
1981,ACTRN12620000571976,ANZCTR,2020-05-15,2020-05-20,False,UNSW Sydney,Not Recruiting,Phase 1,Interventional,Australia,"Evaluation of Shift, a smartphone application for Junior Medical Officers in New South Wales during the COVID-19 epidemic.",Other (psych),Psychological,Psychological,75,https://anzctr.org.au/ACTRN12620000571976.aspx,None
1982,ACTRN12620000575932,ANZCTR,2020-05-18,2020-05-03,True,Royal North Shore Hospital,Recruiting,Not Applicable,Observational,Australia,Prevalence of the loss of smell in patients with COVID-19: The SMELLY Study,Clinical Presentation,No Intervention,No Intervention,100,https://anzctr.org.au/ACTRN12620000575932.aspx,None
1983,ACTRN12620000579998,ANZCTR,2020-05-19,2020-05-20,False,Mackay Hospital and Health Service,Not Recruiting,Not Applicable,Interventional,Australia,"In a simulation environment, is there a difference in time taken for consultant anaesthetists to perform spinal anaesthesia as compared to general anaesthesia on women, with suspected or confirmed COVID-19, who require emergency caesarean delivery?",Other,No Intervention,No Intervention,10,https://anzctr.org.au/ACTRN12620000579998.aspx,None
1984,ACTRN12620000590965,ANZCTR,2020-05-21,2020-06-01,False,The Royal Melbourne Hospital,Not Recruiting,Not Applicable,Observational,Australia,Psychological impact of COVID-19 pandemic on perioperative staff at the Royal Melbourne Hospital – a longitudinal study,Other (psych),Psychological,Psychological,90,https://anzctr.org.au/ACTRN12620000590965.aspx,None
1985,ISRCTN40580903,ISRCTN,2020-05-15,2020-05-16,True,University of Birmingham,Recruiting,Phase 2,Interventional,United Kingdom,Which treatment could lessen the severity of a coronavirus infection when compared with usual care in an NHS setting?,Drug,Gemtuzumab Ozogamicin,Gemtuzumab Ozogamicin,588,http://isrctn.com/ISRCTN40580903,EUCTR2020-001684-89
1986,ISRCTN85216856,ISRCTN,2020-05-11,2020-05-10,True,Universidad Tecnológica Equinoccial,Recruiting,Phase 2/Phase 3,Interventional,Ecuador,Using blood plasma to develop passive immunity to coronavirus in Ecuador,ATMP,Plasma,Plasma,200,http://isrctn.com/ISRCTN85216856,None
1987,ISRCTN44152751,ISRCTN,2020-05-04,2020-05-11,False,Norwegian Institute of Public Health,Not Recruiting,Not Applicable,Interventional,Norway,School opening in Norway during the COVID-19 pandemic,Other,Other,Other,116750,http://isrctn.com/ISRCTN44152751,None
1988,ChiCTR2000033200,ChiCTR,2020-05-23,2020-01-01,True,The Fifth Medical Center of Chinese General Hospital,Recruiting,Not Applicable,Observational,China,The real-world study for the change of early breast cancer diagnosis and treatment mode under the pandemic of Coronavirus Disease 2019 (COVID-19),Other,No Intervention,No Intervention,10000,http://www.chictr.org.cn/showproj.aspx?proj=54056,None
1989,ChiCTR2000033198,ChiCTR,2020-05-23,2020-05-25,False,"Beijing Friendship Hospital, Capital Medical University",Recruiting,Not Applicable,Observational,China,Status of management of surgery in Beijing during COVID-19,Health System,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=54015,None
1990,ChiCTR2000033197,ChiCTR,2020-05-23,2020-05-13,True,Beijing Cancer Hospital Medical,Not Recruiting,Not Applicable,Observational,China,Investigation of Mental Status for in-patients with gastrointestinal malignancy  during the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,65,http://www.chictr.org.cn/showproj.aspx?proj=53451,None
1991,ChiCTR2000033190,ChiCTR,2020-05-23,2020-03-01,True,The First Hospital of Changsha,Not Recruiting,Not Applicable,Observational,China,The research Of novel coronavirus pneumonia (COVID-19) patients' immune status and severity of disease,ATMP,Immunoglobulin,Immunoglobulin,60,http://www.chictr.org.cn/showproj.aspx?proj=54062,None
1992,ChiCTR2000033186,ChiCTR,2020-05-23,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Observational,China,A follow-up study about clinically diagnosed cases of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,116,http://www.chictr.org.cn/showproj.aspx?proj=53927,None
1993,ChiCTR2000033133,ChiCTR,2020-05-21,2020-02-12,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=53925,None
1994,ChiCTR2000033108,ChiCTR,2020-05-21,2020-05-20,True,Southern Medical University,Recruiting,Not Applicable,Observational,China,"Associations between suboptimal health status  and TraditChinese Medicine constitution of medical staff fighting the disease, recovered COVID-19 patients and the general public under the outbreak of novel coronavirus pneumonia: an epidemiological study",Clinical Presentation,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=54000,None
1995,ChiCTR2000033107,ChiCTR,2020-05-21,2020-05-01,True,"Daping Hospital, Army Medical University",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) patients with pre-existing HBV infection,Clinical Presentation,No Intervention,No Intervention,72,http://www.chictr.org.cn/showproj.aspx?proj=54010,None
1996,ChiCTR2000033105,ChiCTR,2020-05-21,2020-02-20,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Follow up study of convalescent patients of novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,400,http://www.chictr.org.cn/showproj.aspx?proj=52816,None
1997,ChiCTR2000033104,ChiCTR,2020-05-21,2020-03-07,True,The Third People's Hospital of Hubei Province,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study for rapid detection of novel coronavirus pneumonia (COVID-19) nucleic acid,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,670,http://www.chictr.org.cn/showproj.aspx?proj=53845,None
1998,ChiCTR2000033057,ChiCTR,2020-05-19,2020-02-25,True,The First Hospital of China Medical University,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for determination of the clinical effect of Internet-assisted pulmonary rehabilitation on patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,160,http://www.chictr.org.cn/showproj.aspx?proj=53529,None
1999,ChiCTR2000033056,ChiCTR,2020-05-19,2020-01-29,True,Guizhou Provincial Jiangjunshan Hospital,Not Recruiting,Not Applicable,Interventional,China,Convalescent Plasma in the treatment of 6 COVID-19 Patients,ATMP,Plasma,Plasma,6,http://www.chictr.org.cn/showproj.aspx?proj=53859,None
2000,ChiCTR2000033055,ChiCTR,2020-05-19,2020-05-20,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) and Symptomatic Venous Thromboembolism: a Multicenter Retrospective Study,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=53860,None
2001,ChiCTR2000033054,ChiCTR,2020-05-19,2020-05-19,False,Wuhan Mental Health Center,Recruiting,Not Applicable,Observational,No Country Given,The investigation of psychosocial stress status in juveniles during the pandemic of the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,800,http://www.chictr.org.cn/showproj.aspx?proj=53894,None
2002,ChiCTR2000033053,ChiCTR,2020-05-19,2020-02-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Efficacy of Early Prone Positioning in Non-Mechanical Ventilation novel coronavirus pneumonia (COVID-19) Patients with Severe Hypoxia- a single-center prospective cohort study,Procedure,Positioning,Positioning,60,http://www.chictr.org.cn/showproj.aspx?proj=53886,None
2003,ChiCTR2000033052,ChiCTR,2020-05-19,2020-03-16,True,Oscar Cano-Valderrama,Not Recruiting,Not Applicable,Observational,Spain,Acute Care Surgery during novel coronavirus pneumonia (COVID-19) pandemic in Spain,Other,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=53892,None
2004,ChiCTR2000033050,ChiCTR,2020-05-18,2020-05-04,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Observational,China,Effect of high dose intravenous vitamin C on moderate novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,Drug,Vitamin C,Vitamin C,110,http://www.chictr.org.cn/showproj.aspx?proj=53590,None
2005,ChiCTR2000033049,ChiCTR,2020-05-18,2020-05-19,False,Hongqi Hospital Affiliated to Mudangjiang Medical University,Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the untreated mild or common type novel coronavirus pneumonia (COVID-19) patients,Drug,Artemisinin/pipequine,Artemisinin/pipequine,160,http://www.chictr.org.cn/showproj.aspx?proj=53840,None
2006,EUCTR2020-001805-21-GB,EU Clinical Trials Register,2020-05-07,2020-05-15,False,University Hospitals Coventry and Warwickshire NHS Trust,Authorised,Phase 2,Interventional,United Kingdom,IMU-838 and Oseltamivir in treatment of Novel Coronavirus (COVID-19),Drug,IMU-838 + Oseltamivir,IMU-838; Oseltamivir,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001805-21,None
2007,EUCTR2020-001614-38-BE,EU Clinical Trials Register,2020-04-06,2020-04-22,False,UZ Leuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Azithromycin,Azithromycin,282,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001614-38,None
2008,EUCTR2020-001770-30-BE,EU Clinical Trials Register,2020-04-15,2020-04-21,False,CHU Ambroise Paré,Authorised,Phase 2,Interventional,Belgium,Experimental use of tocilizumab in COVID-19 related pneumonia.,Drug,Tocilizumab,Tocilizumab,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001770-30,None
2009,EUCTR2020-001995-13-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Fundación SEIMC-GESIDA,Authorised,Phase 2,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of tocilizumab for treating patients with COVID-19 pneumonia: the BREATH-19 Study,Drug,Tocilizumab,Tocilizumab,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001995-13,None
2010,EUCTR2020-002274-28-ES,EU Clinical Trials Register,2020-05-21,2020-05-19,True,Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA),Authorised,Phase 4,Interventional,Spain,Evaluation of the likely beneficial effects of vitamin D on infection with coronavirus.,Drug,Vitamin D,Vitamin D,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002274-28,None
2011,EUCTR2020-001704-42-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,Controlled and randomised trial to assess the safety and efficacy of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in hospital healthcare personnel (Sanitarios sin COVID-19).,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001704-42,None
2012,NCT04275388,ClinicalTrials.gov,2020-02-17,2020-05-15,False,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Observational,No Country Given,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,426,https://clinicaltrials.gov/show/NCT04275388,None
2013,NCT04313127,ClinicalTrials.gov,2020-03-15,2020-03-16,False,CanSino Biologics Inc.,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,ATMP,Adenovirus vector,Adenovirus vector,108,https://clinicaltrials.gov/show/NCT04313127,None
2014,NCT04321993,ClinicalTrials.gov,2020-03-24,2020-04-17,False,Lisa Barrett,Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. baricitinib vs. sarilumab,lopinavir/ritonavir; hydroxychloroquine; sarilumab,1000,https://clinicaltrials.gov/show/NCT04321993,None
2015,NCT04322565,ClinicalTrials.gov,2020-03-24,2020-04-20,False,AOU di Parma,Recruiting,Phase 2,Interventional,Italy,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Drug,Colchicine,Colchicine,310,https://clinicaltrials.gov/show/NCT04322565,None
2016,NCT04325893,ClinicalTrials.gov,2020-03-25,2020-04-01,False,"University Hospital, Angers",Recruiting,Phase 3,Interventional,"Monaco, France",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,1300,https://clinicaltrials.gov/show/NCT04325893,None
2017,NCT04326387,ClinicalTrials.gov,2020-03-26,2020-04-06,False,University of Cambridge,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of Novel Diagnostic Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04326387,None
2018,NCT04328129,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Institut Pasteur,Recruiting,Not Applicable,Interventional,French Guiana,Household Transmission Investigation Study for COVID-19 in French Guiana,Clinical Presentation (Epidemiology),No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04328129,None
2019,NCT04334252,ClinicalTrials.gov,2020-04-02,2020-04-17,False,Jessa Hospital,Recruiting,Not Applicable,Observational,Belgium,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,https://clinicaltrials.gov/show/NCT04334252,None
2020,NCT04338932,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Jessa Hospital,Not Recruiting,Not Applicable,Observational,Belgium,COVID-19 and Deep Venous Thrombosis,Clinical Presentation,No Intervention,No Intervention,12,https://clinicaltrials.gov/show/NCT04338932,None
2021,NCT04340921,ClinicalTrials.gov,2020-04-03,2020-05-14,False,Barts & The London NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Clinical Presentation,No Intervention,No Intervention,140,https://clinicaltrials.gov/show/NCT04340921,None
2022,NCT04341389,ClinicalTrials.gov,2020-04-07,2020-04-12,False,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),ATMP,Vaccine,Vaccine,508,https://clinicaltrials.gov/show/NCT04341389,None
2023,NCT04341935,ClinicalTrials.gov,2020-04-06,2020-06-30,False,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,Drug,Linagliptin,Linagliptin,20,https://clinicaltrials.gov/show/NCT04341935,None
2024,NCT04342182,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Erasmus Medical Center,Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),ATMP,Plasma,Plasma,426,https://clinicaltrials.gov/show/NCT04342182,None
2025,NCT04352699,ClinicalTrials.gov,2020-04-14,2020-03-15,True,CHU de Nice,Not Recruiting,Not Applicable,Observational,France,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04352699,None
2026,NCT04352842,ClinicalTrials.gov,2020-04-16,2020-01-21,True,RenJi Hospital,Not Recruiting,Not Applicable,Observational,China,Echocardiographic Manifestation in Patient With COVID-19 (EARLY-MYO COVID-19),Clinical Presentation,No Intervention,No Intervention,51,https://clinicaltrials.gov/show/NCT04352842,None
2027,NCT04358783,ClinicalTrials.gov,2020-04-21,2020-04-27,False,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04358783,None
2028,NCT04359537,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Shaheed Zulfiqar Ali Bhutto Medical University,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04359537,None
2029,NCT04361253,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Brigham and Women's Hospital,Recruiting,Phase 3,Interventional,United States,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,ATMP,Plasma,Plasma,220,https://clinicaltrials.gov/show/NCT04361253,None
2030,NCT04363346,ClinicalTrials.gov,2020-04-23,2020-05-14,False,University of Minnesota,Recruiting,Phase 1,Interventional,United States,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Drug,FT516,FT516,12,https://clinicaltrials.gov/show/NCT04363346,None
2031,NCT04363502,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04363502,None
2032,NCT04366960,ClinicalTrials.gov,2020-04-24,2020-05-14,True,Niguarda Hospital,Recruiting,Phase 3,Interventional,Italy,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,Drug,Enoxaparin,Enoxaparin,2712,https://clinicaltrials.gov/show/NCT04366960,EUCTR2020-001708-41
2033,NCT04367831,ClinicalTrials.gov,2020-04-27,2020-05-02,False,Columbia University,Recruiting,Phase 4,Interventional,United States,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Drug,Enoxaparin,Enoxaparin,100,https://clinicaltrials.gov/show/NCT04367831,None
2034,NCT04370782,ClinicalTrials.gov,2020-04-26,2020-04-28,False,"St. Francis Hospital, New York",Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Drug,Hydroxychloroquine + Azithromycin + Zinc vs. Hydroxychloroquine + Doxycycline + Zinc,Hydroxychloroquine; Azithromycin; Zinc; Doxycycline,750,https://clinicaltrials.gov/show/NCT04370782,None
2035,NCT04370808,ClinicalTrials.gov,2020-04-26,2020-06-01,False,University of Lisbon,Not Recruiting,Not Applicable,Observational,Portugal,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04370808,None
2036,NCT04371952,ClinicalTrials.gov,2020-04-27,2020-06-01,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),Drug,Doxycycline,Doxycycline,330,https://clinicaltrials.gov/show/NCT04371952,None
2037,NCT04372979,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Direction Centrale du Service de Sant des Armes,Not Recruiting,Phase 3,Interventional,France,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04372979,None
2038,NCT04374513,ClinicalTrials.gov,2020-05-02,2020-05-02,False,Damanhour University,Recruiting,Not Applicable,Observational,Egypt,Community Pharmacists Behaviour During Covid-19,Health System,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04374513,None
2039,NCT04375124,ClinicalTrials.gov,2020-05-01,2020-04-25,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Treatment of Angiotensin Peptide (1-7) for COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04375124,None
2040,NCT04377685,ClinicalTrials.gov,2020-05-05,2020-03-01,True,CHU de Saint Etienne,Recruiting,Not Applicable,Observational,France,Prediction of Clinical Course in COVID19 Patients,Prognosis,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04377685,None
2041,NCT04377724,ClinicalTrials.gov,2020-05-05,2020-04-27,True,Jörg Goldhahn,Not Recruiting,Not Applicable,Observational,Switzerland,Spread and Course of COVID-19 Infections,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04377724,None
2042,NCT04377789,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,Drug (Chemoprophylaxis),Quercetin,Quercetin,50,https://clinicaltrials.gov/show/NCT04377789,None
2043,NCT04388436,ClinicalTrials.gov,2020-05-11,2020-05-11,False,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,Post Covid-19 Cardiopulmonary and Immunological Changes,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04388436,None
2044,NCT04388631,ClinicalTrials.gov,2020-05-12,2020-05-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04388631,None
2045,NCT04388683,ClinicalTrials.gov,2020-05-13,2020-05-12,True,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,Inhaled Nitric Oxide for Preventing Progression in COVID-19,Drug,Nitric Oxide,Nitric Oxide,42,https://clinicaltrials.gov/show/NCT04388683,None
2046,NCT04389333,ClinicalTrials.gov,2020-05-09,2020-03-26,True,Changhai Hospital,Recruiting,Not Applicable,Interventional,China,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04389333,None
2047,NCT04389372,ClinicalTrials.gov,2020-05-05,2020-03-15,True,Fondazione IRCCS Istituto Neurologico Carlo Besta,Recruiting,Not Applicable,Interventional,Italy,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",Other (psych),Psychological,Psychological,50,https://clinicaltrials.gov/show/NCT04389372,None
2048,NCT04389385,ClinicalTrials.gov,2020-05-12,2020-05-01,True,TC Erciyes University,Not Recruiting,Phase 1,Interventional,Turkey,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),ATMP,Exosomes,Exosomes,60,https://clinicaltrials.gov/show/NCT04389385,None
2049,NCT04389463,ClinicalTrials.gov,2020-05-14,2020-05-11,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04389463,None
2050,NCT04389645,ClinicalTrials.gov,2020-05-13,2020-04-07,True,MeMed Diagnostics Ltd.,Not Recruiting,Not Applicable,Observational,Israel,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,52,https://clinicaltrials.gov/show/NCT04389645,None
2051,NCT04389658,ClinicalTrials.gov,2020-05-14,2020-05-07,True,Igenomix,Recruiting,Not Applicable,Observational,Spain,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04389658,None
2052,NCT04389684,ClinicalTrials.gov,2020-05-14,2020-05-15,False,Poitiers University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors,Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04389684,None
2053,NCT04389801,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Hesham Al-Inany,Not Recruiting,Phase 4,Interventional,No Country Given,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,Drug,Deferoxamine,Deferoxamine,200,https://clinicaltrials.gov/show/NCT04389801,None
2054,NCT04389944,ClinicalTrials.gov,2020-05-12,2020-03-31,True,"University Hospital, Basel",Recruiting,Not Applicable,Interventional,Switzerland,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,ATMP,Plasma,Plasma,15,https://clinicaltrials.gov/show/NCT04389944,None
2055,NCT04390061,ClinicalTrials.gov,2020-05-13,2020-06-01,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,No Country Given,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,Drug,Tofacitinib + Hydroxycloroquine vs. Hydroxycloroquine,Tofacitinib; Hydroxycloroquine,116,https://clinicaltrials.gov/show/NCT04390061,EUCTR2020-002035-30
2056,NCT04390152,ClinicalTrials.gov,2020-05-12,2020-06-01,False,BioXcellerator,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04390152,None
2057,NCT04390217,ClinicalTrials.gov,2020-05-13,2020-06-30,False,"Leading BioSciences, Inc",Not Recruiting,Phase 2,Interventional,No Country Given,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,Drug,LB1148,LB1148,120,https://clinicaltrials.gov/show/NCT04390217,None
2058,NCT04390269,ClinicalTrials.gov,2020-05-12,2020-05-10,True,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,Immunogenetics Predictors With COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04390269,None
2059,NCT04390412,ClinicalTrials.gov,2020-05-13,2020-05-04,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Low Dose Radiotherapy in COVID-19 Pneumonia,Other,Radiation,Radiation,5,https://clinicaltrials.gov/show/NCT04390412,IRCT20200509047366N1
2060,NCT04390464,ClinicalTrials.gov,2020-05-08,2020-05-08,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 4,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),Drug,Ravulizumab vs. Baricitinib,Ravulizumab; Baricitinib,1167,https://clinicaltrials.gov/show/NCT04390464,EUCTR2020-001354-22; ISRCTN11188345
2061,NCT04390477,ClinicalTrials.gov,2020-05-07,2020-05-04,True,Bioithas SL,Recruiting,Not Applicable,Interventional,Spain,Study to Evaluate the Effect of a Probiotic in COVID-19,Supplement,Probiotics,Probiotics,40,https://clinicaltrials.gov/show/NCT04390477,None
2062,NCT04390503,ClinicalTrials.gov,2020-05-14,2020-05-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for COVID-19 Close Contacts,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04390503,None
2063,NCT04390555,ClinicalTrials.gov,2020-05-06,2020-04-30,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,The Global PCHF-COVICAV Registry,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04390555,None
2064,NCT04391400,ClinicalTrials.gov,2020-05-14,2020-06-01,False,"Invivoscribe, Inc.",Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04391400,None
2065,NCT04391686,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Centre Hospitalier Arras,Not Recruiting,Not Applicable,Observational,France,Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04391686,None
2066,NCT04391712,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Lowell General Hospital,Recruiting,Phase 2,Interventional,United States,Cold Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,Other (device),Cold Laser Therapy,Cold Laser Therapy,20,https://clinicaltrials.gov/show/NCT04391712,None
2067,NCT04391829,ClinicalTrials.gov,2020-05-13,2020-05-12,True,UZ Brussel,Not Recruiting,Not Applicable,Interventional,No Country Given,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04391829,None
2068,NCT04391881,ClinicalTrials.gov,2020-05-14,2020-05-30,False,Cairo University,Not Recruiting,Not Applicable,Observational,No Country Given,Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04391881,None
2069,NCT04391920,ClinicalTrials.gov,2020-05-12,2020-05-01,True,"CytoSorbents, Inc",Not Recruiting,Not Applicable,Observational,No Country Given,Registry of CytoSorb Therapy in COVID-19 ICU Patients,Other (device),Cytokine Adsorber,Cytokine Adsorber,1000,https://clinicaltrials.gov/show/NCT04391920,None
2070,NCT04391946,ClinicalTrials.gov,2020-05-13,2020-06-01,False,French Innovative Leukemia Organisation,Not Recruiting,Not Applicable,Observational,No Country Given,Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04391946,None
2071,NCT04392089,ClinicalTrials.gov,2020-05-14,2020-05-01,True,"Copenhagen University Hospital, Hvidovre",Recruiting,Not Applicable,Observational,Denmark,Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04392089,None
2072,NCT04392141,ClinicalTrials.gov,2020-05-15,2020-04-01,True,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,Drug,Colchicine + Phenolic Monoterpenes,Colchicine; Phenolic Monoterpenes,200,https://clinicaltrials.gov/show/NCT04392141,None
2073,NCT04392245,ClinicalTrials.gov,2020-05-15,2020-04-15,True,Società Italiana di Chirurgia Colo-Rettale,Not Recruiting,Not Applicable,Observational,Italy,Proctologic Practice and Covid-19,Health System,No Intervention,No Intervention,1050,https://clinicaltrials.gov/show/NCT04392245,None
2074,NCT04392323,ClinicalTrials.gov,2020-05-15,2020-05-13,True,Northwell Health,Recruiting,Not Applicable,Interventional,United States,Incidence of COVID-19 Test Conversion in Post-surgical Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04392323,None
2075,NCT04392388,ClinicalTrials.gov,2020-05-15,2020-05-01,True,INSERM,Recruiting,Not Applicable,Observational,France,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis",Other,No Intervention,No Intervention,110000,https://clinicaltrials.gov/show/NCT04392388,None
2076,NCT04392401,ClinicalTrials.gov,2020-05-13,2020-05-11,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04392401,None
2077,NCT04392427,ClinicalTrials.gov,2020-05-12,2020-05-01,True,Mansoura University,Not Recruiting,Phase 3,Interventional,Egypt,New Antiviral Drugs for Treatment of COVID-19,Drug,Nitazoxanide + Ribavirin + Ivermectin,Nitazoxanide; Ribavirin; Ivermectin,100,https://clinicaltrials.gov/show/NCT04392427,None
2078,NCT04392453,ClinicalTrials.gov,2020-05-15,2020-05-01,True,Fondazione Don Carlo Gnocchi Onlus,Not Recruiting,Not Applicable,Interventional,No Country Given,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04392453,None
2079,NCT04392713,ClinicalTrials.gov,2020-05-05,2020-04-15,True,"Combined Military Hospital, Pakistan",Recruiting,Not Applicable,Interventional,Pakistan,Efficacy of Ivermectin in COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04392713,None
2080,NCT04392778,ClinicalTrials.gov,2020-04-25,2020-04-01,True,SBu Dr. Sadi Konuk Egitim ve Arastirma Hastanesi,Recruiting,Phase 1/Phase 2,Interventional,Turkey,Clinical Use of Stem Cells for the Treatment of Covid-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04392778,None
2081,NCT04393961,ClinicalTrials.gov,2020-04-24,2020-04-05,True,ProofPilot,Recruiting,Not Applicable,Interventional,United States,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04393961,None
2082,NCT04394000,ClinicalTrials.gov,2020-05-16,2020-05-04,True,Jessa Hospital,Not Recruiting,Not Applicable,Observational,Belgium,Impact of an Intensified Thromboprofylaxis Protocol in COVID-19,Drug,Heparin,Heparin,72,https://clinicaltrials.gov/show/NCT04394000,None
2083,NCT04394026,ClinicalTrials.gov,2020-05-15,2020-04-16,True,Francesco De Cobelli,Recruiting,Not Applicable,Observational,Italy,Imaging Feature of SARS-CoV2 Infection,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04394026,None
2084,NCT04394169,ClinicalTrials.gov,2020-05-13,2020-05-25,False,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Interventional,No Country Given,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,Other,Other,Other,102,https://clinicaltrials.gov/show/NCT04394169,None
2085,NCT04394182,ClinicalTrials.gov,2020-05-15,2020-04-21,True,Fundación Genesiscare,Recruiting,Not Applicable,Interventional,Spain,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,Other,"Radiation (with Lopinavir/ritonavir, Hydroxychloroquine, Azithromycin, Piperacillin/tazobactam, Heparin, Corticosteroids, Tocilizumab)",Radiation; Lopinavir/ritonavir; Hydroxychloroquine; Azithromycin; Piperacillin/tazobactam; Heparin; Methylprednisolone; Tocilizumab,15,https://clinicaltrials.gov/show/NCT04394182,None
2086,NCT04394195,ClinicalTrials.gov,2020-05-16,2020-03-25,True,CHU de Reims,Recruiting,Not Applicable,Observational,France,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04394195,None
2087,NCT04394208,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Cairo University,Not Recruiting,Phase 3,Interventional,Egypt,Silymarin in COVID-19 Pneumonia,Drug,Silymarin,Silymarin,50,https://clinicaltrials.gov/show/NCT04394208,None
2088,NCT04395833,ClinicalTrials.gov,2020-05-15,2020-04-07,True,"University Hospital, Brest",Not Recruiting,Not Applicable,Observational,France,National Survey on the Lockdown of Children With Disabilities,Other,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04395833,None
2089,NCT04259892,ClinicalTrials.gov,2020-02-05,2020-02-04,True,INSERM,Recruiting,Not Applicable,Observational,"France, French Guiana",Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.,Clinical Presentation,No Intervention,No Intervention,345,https://clinicaltrials.gov/show/NCT04259892,None
2090,NCT04306393,ClinicalTrials.gov,2020-03-10,2020-03-21,True,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Drug,Nitric oxide,Nitric oxide,200,https://clinicaltrials.gov/show/NCT04306393,EUCTR2020-001490-68
2091,NCT04318314,ClinicalTrials.gov,2020-03-17,2020-03-18,False,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04318314,None
2092,NCT04336761,ClinicalTrials.gov,2020-04-03,2020-04-15,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,Clinical Presentation (Epidemiology),No Intervention,No Intervention,914,https://clinicaltrials.gov/show/NCT04336761,None
2093,NCT04337346,ClinicalTrials.gov,2020-04-05,2020-04-05,False,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Covid 19 Anxiety in Endometriosis Patients,Other (psych),No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04337346,None
2094,NCT04338828,ClinicalTrials.gov,2020-04-05,2020-04-18,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,Drug,Nitric oxide,Nitric oxide,260,https://clinicaltrials.gov/show/NCT04338828,None
2095,NCT04338945,ClinicalTrials.gov,2020-04-07,2020-03-15,True,Ospedale Policlinico San Martino,Not Recruiting,Not Applicable,Observational,Italy,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,Other,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04338945,None
2096,NCT04341675,ClinicalTrials.gov,2020-04-05,2020-04-24,False,University of Cincinnati,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Drug,Sirolimus,Sirolimus,30,https://clinicaltrials.gov/show/NCT04341675,None
2097,NCT04342637,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Al-Azhar University,Not Recruiting,Not Applicable,Observational,"Egypt, Iran, United States",COVID-19 Endoscopy Survey,Other,Other,Other,163,https://clinicaltrials.gov/show/NCT04342637,None
2098,NCT04342663,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Washington University in St. Louis,Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Drug,Fluvoxamine,Fluvoxamine,152,https://clinicaltrials.gov/show/NCT04342663,None
2099,NCT04347681,ClinicalTrials.gov,2020-04-08,2020-04-18,False,King Fahad Specialist Hospital,Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,ATMP,Plasma,Plasma,40,https://clinicaltrials.gov/show/NCT04347681,None
2100,NCT04347928,ClinicalTrials.gov,2020-04-08,2020-04-20,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,Clinical Presentation,No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04347928,None
2101,NCT04348240,ClinicalTrials.gov,2020-04-15,2020-04-16,False,National Institute of Dental and Craniofacial Research (NIDCR),Recruiting,Not Applicable,Observational,United States,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04348240,None
2102,NCT04350736,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Theravance Biopharma,Recruiting,Phase 1,Interventional,United Kingdom,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Drug,TD-0903,TD-0903,54,https://clinicaltrials.gov/show/NCT04350736,None
2103,NCT04351399,ClinicalTrials.gov,2020-04-14,2020-04-27,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,318,https://clinicaltrials.gov/show/NCT04351399,None
2104,NCT04351633,ClinicalTrials.gov,2020-04-15,2020-04-23,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,52,https://clinicaltrials.gov/show/NCT04351633,None
2105,NCT04353011,ClinicalTrials.gov,2020-04-15,2020-04-20,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,312,https://clinicaltrials.gov/show/NCT04353011,None
2106,NCT04354714,ClinicalTrials.gov,2020-04-16,2020-06-30,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Ruxolitinib to Combat COVID-19,Drug,Ruxolitinib,Ruxolitinib,0,https://clinicaltrials.gov/show/NCT04354714,None
2107,NCT04355143,ClinicalTrials.gov,2020-04-14,2020-05-01,False,"University of California, Los Angeles",Recruiting,Phase 2,Interventional,United States,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),Drug,Colchicine,Colchicine,150,https://clinicaltrials.gov/show/NCT04355143,None
2108,NCT04355533,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1920,https://clinicaltrials.gov/show/NCT04355533,None
2109,NCT04355897,ClinicalTrials.gov,2020-04-15,2020-04-28,False,The Christ Hospital,Recruiting,Phase 1,Interventional,United States,CoVID-19 Plasma in Treatment of COVID-19 Patients,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04355897,None
2110,NCT04358081,ClinicalTrials.gov,2020-04-08,2020-05-01,False,Novartis Pharmaceuticals,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,444,https://clinicaltrials.gov/show/NCT04358081,None
2111,NCT04360837,ClinicalTrials.gov,2020-04-22,2020-05-06,False,Szeged University,Recruiting,Not Applicable,Interventional,Hungary,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04360837,None
2112,NCT04361214,ClinicalTrials.gov,2020-04-22,2020-05-05,False,University of Chicago,Recruiting,Phase 1,Interventional,United States,Leflunomide in Mild COVID-19 Patients,Drug,Leflunomide,Leflunomide,20,https://clinicaltrials.gov/show/NCT04361214,None
2113,NCT04361344,ClinicalTrials.gov,2020-04-16,2020-05-19,False,Centre Hospitalier de Pau,Recruiting,Not Applicable,Interventional,France,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04361344,None
2114,NCT04362189,ClinicalTrials.gov,2020-04-21,2020-05-15,False,Hope Biosciences,Not Recruiting,Phase 2,Interventional,United States,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04362189,None
2115,NCT04365153,ClinicalTrials.gov,2020-04-24,2020-04-24,False,The Cleveland Clinic,Recruiting,Phase 2,Interventional,United States,Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function Due to COVID-19,Drug,Canakinumab,Canakinumab,45,https://clinicaltrials.gov/show/NCT04365153,None
2116,NCT04365348,ClinicalTrials.gov,2020-04-25,2020-04-27,False,University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,Other (psych),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04365348,None
2117,NCT04365361,ClinicalTrials.gov,2020-04-25,2020-04-26,False,University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,The Psychological Impact of the COVID-19 on Students.,Other (psych),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04365361,None
2118,NCT04365764,ClinicalTrials.gov,2020-04-25,2020-03-14,True,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,Drug,Unspecified Drug,Unspecified Drug,400,https://clinicaltrials.gov/show/NCT04365764,None
2119,NCT04368000,ClinicalTrials.gov,2020-04-24,2020-04-29,False,University of Utah,Recruiting,Not Applicable,Interventional,United States,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Procedure,Positioning,Positioning,60,https://clinicaltrials.gov/show/NCT04368000,None
2120,NCT04368845,ClinicalTrials.gov,2020-04-20,2020-05-11,False,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Recruiting,Not Applicable,Interventional,Greece,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04368845,None
2121,NCT04372628,ClinicalTrials.gov,2020-04-30,2020-05-31,False,Vanderbilt University,Not Recruiting,Phase 2,Interventional,United States,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,Drug,Hydroxychloroquein vs. Lopinavir/ritonavir,Hydroxychloroquein; Lopinavir/ritonavir,900,https://clinicaltrials.gov/show/NCT04372628,None
2122,NCT04373096,ClinicalTrials.gov,2020-04-30,2020-06-01,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,Other (device),Hood,Hood,42,https://clinicaltrials.gov/show/NCT04373096,None
2123,NCT04374656,ClinicalTrials.gov,2020-05-01,2020-05-18,False,Johns Hopkins University,Recruiting,Not Applicable,Observational,United States,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04374656,None
2124,NCT04375501,ClinicalTrials.gov,2020-05-04,2020-02-01,True,Barts & The London NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,442,https://clinicaltrials.gov/show/NCT04375501,None
2125,NCT04376580,ClinicalTrials.gov,2020-04-30,2020-04-30,False,Tiva Group,Recruiting,Not Applicable,Observational,Argentina,Use of the Nasal Cannula During COVID-19,Other (device),Nasal cannula,Nasal cannula,100,https://clinicaltrials.gov/show/NCT04376580,None
2126,NCT04380402,ClinicalTrials.gov,2020-05-01,2020-05-20,False,Mount Auburn Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Atorvastatin as Adjunctive Therapy in COVID-19,Drug,Atorvastatin,Atorvastatin,300,https://clinicaltrials.gov/show/NCT04380402,None
2127,NCT04383678,ClinicalTrials.gov,2020-05-07,2020-03-01,True,Helsinki University Central Hospital,Recruiting,Not Applicable,Observational,"Italy, Finland, Germany, France, Sweden, United Kingdom",Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04383678,None
2128,NCT04384406,ClinicalTrials.gov,2020-05-10,2020-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,COVID-19 Outbreak Consequences for Outpatients Followed in PRM,Health System,No Intervention,No Intervention,467,https://clinicaltrials.gov/show/NCT04384406,None
2129,NCT04384445,ClinicalTrials.gov,2020-05-09,2020-05-01,True,Organicell Regenerative Medicine,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Organicell Flow for Patients With COVID-19,ATMP,Exosomes,Exosomes,20,https://clinicaltrials.gov/show/NCT04384445,None
2130,NCT04385147,ClinicalTrials.gov,2020-05-11,2020-05-18,False,Al-Azhar University,Recruiting,Not Applicable,Observational,"United States, Germany, Peru, Singapore, Egypt",Advanced Endoscopy During COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04385147,None
2131,NCT04386265,ClinicalTrials.gov,2020-05-11,2020-05-11,False,"SerenaGroup, Inc.",Recruiting,Not Applicable,Observational,"Poland, United States",Compassionate Use of Hyperbaric Oxygen Therapy,Drug,Oxygen,Oxygen,100,https://clinicaltrials.gov/show/NCT04386265,None
2132,NCT04386447,ClinicalTrials.gov,2020-05-12,2020-06-03,False,AOU di Parma,Not Recruiting,Phase 2,Interventional,"France, Italy",Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,Drug,Oxytocin,Oxytocin,145,https://clinicaltrials.gov/show/NCT04386447,None
2133,NCT04387240,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Princess Nourah Bint Abdulrahman University,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,Drug,Artesunate,Artesunate,22,https://clinicaltrials.gov/show/NCT04387240,None
2134,NCT04388618,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Princess Nourah Bint Abdulrahman University,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04388618,None
2135,NCT04390022,ClinicalTrials.gov,2020-05-07,2020-05-14,False,Clínica Universidad de Navarra,Recruiting,Phase 2,Interventional,Spain,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,Drug,Ivermectin,Ivermectin,24,https://clinicaltrials.gov/show/NCT04390022,None
2136,NCT04390074,ClinicalTrials.gov,2020-05-14,2020-06-01,False,Uppsala University,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04390074,None
2137,NCT04391101,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Hospital San Vicente Fundación,Not Recruiting,Phase 3,Interventional,Colombia,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),ATMP,Plasma,Plasma,231,https://clinicaltrials.gov/show/NCT04391101,None
2138,NCT04391738,ClinicalTrials.gov,2020-05-14,2020-02-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Association Between BMI and COVID-19,Clinical Presentation,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04391738,None
2139,NCT04392128,ClinicalTrials.gov,2020-05-15,2020-05-12,True,Institut de Cancérologie Strasbourg Europe (ICANS),Not Recruiting,Phase 2,Interventional,France,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; Azithromycin,114,https://clinicaltrials.gov/show/NCT04392128,None
2140,NCT04392232,ClinicalTrials.gov,2020-05-15,2020-05-05,True,TriHealth Inc.,Recruiting,Phase 2,Interventional,United States,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04392232,None
2141,NCT04393038,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Abivax S.A.,Recruiting,Phase 2/Phase 3,Interventional,France,ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,Drug,ABX464,ABX464,1034,https://clinicaltrials.gov/show/NCT04393038,None
2142,NCT04393051,ClinicalTrials.gov,2020-05-16,2020-05-20,False,AOU Pisana,Not Recruiting,Phase 2,Interventional,Italy,Baricitinib Compared to Standard Therapy in Patients With COVID-19,Drug,Baricitinib,Baricitinib,126,https://clinicaltrials.gov/show/NCT04393051,None
2143,NCT04393155,ClinicalTrials.gov,2020-05-06,2020-04-16,True,University of Vermont,Recruiting,Not Applicable,Observational,United States,Longitudinal COVID-19 Cohort Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,225,https://clinicaltrials.gov/show/NCT04393155,None
2144,NCT04393402,ClinicalTrials.gov,2020-05-15,2020-03-20,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,14,https://clinicaltrials.gov/show/NCT04393402,None
2145,NCT04393428,ClinicalTrials.gov,2020-05-14,2020-03-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04393428,None
2146,NCT04393558,ClinicalTrials.gov,2020-05-16,2020-04-20,True,Shirley Ryan AbilityLab,Recruiting,Not Applicable,Observational,United States,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,Other (device),Biosensors,Biosensors,100,https://clinicaltrials.gov/show/NCT04393558,None
2147,NCT04393727,ClinicalTrials.gov,2020-05-16,2020-05-01,True,AOU Pisana,Recruiting,Phase 2,Interventional,Italy,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,126,https://clinicaltrials.gov/show/NCT04393727,None
2148,NCT04393792,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Hampshire Hospitals NHS Foundation Trust,Recruiting,Phase 1,Interventional,United Kingdom,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,Drug,Povidone Iodine,Povidone Iodine,40,https://clinicaltrials.gov/show/NCT04393792,EUCTR2020-001721-31
2149,NCT04393805,ClinicalTrials.gov,2020-05-16,2020-06-01,False,Quovadis Associazione,Not Recruiting,Not Applicable,Observational,No Country Given,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,Drug,Heparin,Heparin,877,https://clinicaltrials.gov/show/NCT04393805,None
2150,NCT04393818,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Fundació d'investigació Sanitària de les Illes Balears,Not Recruiting,Phase 3,Interventional,No Country Given,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,Other (psych),Psychological,Psychological,560,https://clinicaltrials.gov/show/NCT04393818,None
2151,NCT04393974,ClinicalTrials.gov,2020-05-18,2020-03-24,True,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Cancer Patients,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04393974,None
2152,NCT04394013,ClinicalTrials.gov,2020-05-18,2020-06-01,False,Monash University Malaysia,Not Recruiting,Not Applicable,Interventional,Malaysia,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,Other (psych),Psychological,Psychological,70,https://clinicaltrials.gov/show/NCT04394013,None
2153,NCT04394390,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Bursa City Hospital,Recruiting,Not Applicable,Observational,Turkey,Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients?,Drug,Vitamin D,Vitamin D,100,https://clinicaltrials.gov/show/NCT04394390,None
2154,NCT04394403,ClinicalTrials.gov,2020-05-13,2020-05-14,False,Hebrew University of Jerusalem,Recruiting,Not Applicable,Interventional,Israel,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04394403,None
2155,NCT04394429,ClinicalTrials.gov,2020-05-18,2020-04-24,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,184,https://clinicaltrials.gov/show/NCT04394429,None
2156,NCT04394442,ClinicalTrials.gov,2020-05-17,2020-03-21,True,Samah Lutfy,Recruiting,Phase 2,Interventional,Saudi Arabia,Hydroxychloroquine in COVID-19 Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04394442,None
2157,NCT04395144,ClinicalTrials.gov,2020-05-15,2020-05-15,False,Hôpital de Verdun,Recruiting,Not Applicable,Interventional,Canada,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,Procedure,Positioning,Positioning,346,https://clinicaltrials.gov/show/NCT04395144,None
2158,NCT04395456,ClinicalTrials.gov,2020-05-19,2020-07-01,False,Amyndas Pharmaceuticals S.A.,Not Recruiting,Phase 2,Interventional,No Country Given,A Phase 2 Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),Drug,AMY-101,AMY-101,144,https://clinicaltrials.gov/show/NCT04395456,None
2159,NCT04395664,ClinicalTrials.gov,2020-05-19,2020-04-16,True,"Copenhagen University Hospital, Herlev and Gentofte Hospital",Recruiting,Not Applicable,Observational,Denmark,Arrhythmias in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04395664,None
2160,NCT04395742,ClinicalTrials.gov,2020-05-14,2020-05-01,True,Poitiers University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study",Clinical Presentation,No Intervention,No Intervention,93,https://clinicaltrials.gov/show/NCT04395742,None
2161,NCT04395755,ClinicalTrials.gov,2020-05-19,2020-04-01,True,Ospedale Policlinico San Martino,Not Recruiting,Not Applicable,Observational,Italy,Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed,Other (psych),No Intervention,No Intervention,503,https://clinicaltrials.gov/show/NCT04395755,None
2162,NCT04395768,ClinicalTrials.gov,2020-05-18,2020-05-25,False,"National Institute of Integrative Medicine, Australia",Not Recruiting,Phase 2,Interventional,No Country Given,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,Drug,Vitamin C + Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B ,Vitamin C; Hydroxychloroquine; Azithromycin; Zinc; Vitamin D; Vitamin B,200,https://clinicaltrials.gov/show/NCT04395768,None
2163,NCT04395794,ClinicalTrials.gov,2020-05-19,2020-05-07,True,Meshalkin Research Institute of Pathology of Circulation,Recruiting,Not Applicable,Observational,Russian Federation,SARS-CoV-2 Disguise Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04395794,None
2164,NCT04395885,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Sexual Function During COVID 19 Pandemic,Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04395885,None
2165,NCT04395911,ClinicalTrials.gov,2020-05-17,2020-06-01,False,SeaStar Medical,Not Recruiting,Not Applicable,Interventional,No Country Given,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,Other (device),Selective Cytopheretic Device,Selective Cytopheretic Device,35,https://clinicaltrials.gov/show/NCT04395911,None
2166,NCT04395976,ClinicalTrials.gov,2020-05-19,2020-06-10,False,British Ayurvedic Medical Council,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04395976,None
2167,NCT04396106,ClinicalTrials.gov,2020-05-16,2020-05-01,True,"Atea Pharmaceuticals, Inc.",Not Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),Drug,AT-527,AT-527,180,https://clinicaltrials.gov/show/NCT04396106,None
2168,NCT04396197,ClinicalTrials.gov,2020-05-17,2020-03-01,True,University Hospital Birmingham NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care,Other (exercise),No Intervention,No Intervention,92,https://clinicaltrials.gov/show/NCT04396197,None
2169,NCT04396210,ClinicalTrials.gov,2020-05-18,2020-05-14,True,"University Hospital, Ghent",Recruiting,Not Applicable,Observational,Belgium,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,Other,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04396210,None
2170,NCT04396314,ClinicalTrials.gov,2020-05-15,2020-09-01,False,University of Lleida,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Basic Body Awareness Therapy in Survivors of Covid-19 and Health Workers Regarding Post-traumatic Stress Disorders,Other (psych),Psychological,Psychological,54,https://clinicaltrials.gov/show/NCT04396314,None
2171,NCT04396600,ClinicalTrials.gov,2020-04-23,2020-05-25,False,University of Minnesota,Recruiting,Not Applicable,Observational,United States,The Professional Peer Resilience Initiative,Other (psych),Psychological,Psychological,1200,https://clinicaltrials.gov/show/NCT04396600,None
2172,NCT04397172,ClinicalTrials.gov,2020-05-20,2020-04-09,True,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04397172,None
2173,NCT04397237,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Pitié-Salpêtrière Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3600,https://clinicaltrials.gov/show/NCT04397237,None
2174,NCT04397328,ClinicalTrials.gov,2020-05-13,2020-05-19,False,Lawson Health Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,336,https://clinicaltrials.gov/show/NCT04397328,None
2175,NCT04397380,ClinicalTrials.gov,2020-05-16,2020-05-20,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04397380,None
2176,NCT04397523,ClinicalTrials.gov,2020-05-20,2020-04-30,True,Institute for Transfusion Medicine of RNM,Recruiting,Not Applicable,Interventional,North Macedonia,Efficacy and Safety of COVID-19 Convalescent Plasma,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04397523,None
2177,NCT04397588,ClinicalTrials.gov,2020-05-19,2020-04-21,True,Rennes University Hospital,Recruiting,Not Applicable,Observational,France,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,Other,Oxygen,Oxygen,300,https://clinicaltrials.gov/show/NCT04397588,None
2178,NCT04397614,ClinicalTrials.gov,2020-05-20,2020-06-01,False,University of Oklahoma,Not Recruiting,Not Applicable,Observational,United States,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,Other (software),eHealth,eHealth,500,https://clinicaltrials.gov/show/NCT04397614,None
2179,NCT04397666,ClinicalTrials.gov,2020-05-20,2020-05-15,True,Versailles Hospital,Recruiting,Not Applicable,Interventional,France,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,68,https://clinicaltrials.gov/show/NCT04397666,None
2180,NCT04397705,ClinicalTrials.gov,2020-05-20,2020-06-01,False,The Christie NHS Foundation Trust,Not Recruiting,Phase 1,Interventional,United Kingdom,Remote Monitoring of Cancer Patients With Suspected Covid-19,Other (device),Biosensors,Biosensors,30,https://clinicaltrials.gov/show/NCT04397705,None
2181,NCT04397822,ClinicalTrials.gov,2020-05-19,2020-04-16,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,COVID-19: Study of INFLAmmasome and PLAtelets Functions,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04397822,None
2182,NCT04397835,ClinicalTrials.gov,2020-04-21,2020-04-17,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population,Other (psych),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04397835,None
2183,NCT04397848,ClinicalTrials.gov,2020-05-19,2020-05-14,True,"University Health Network, Toronto",Recruiting,Not Applicable,Observational,Canada,Mental Health Outcomes in Healthcare Workers During COVID-19,Other (psych),No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04397848,None
2184,NCT04398264,ClinicalTrials.gov,2020-05-20,2020-05-30,False,Inova Health System,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics of COVID-19 Infection Among PREGnant Women,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04398264,None
2185,NCT04398277,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Kent State University,Recruiting,Not Applicable,Interventional,United States,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,Other (psych),Psychological,Psychological,1000,https://clinicaltrials.gov/show/NCT04398277,None
2186,NCT04398290,ClinicalTrials.gov,2020-05-20,2020-07-01,False,Roger Alvarez,Not Recruiting,Phase 2,Interventional,United States,iNOPulse for COVID-19,Drug,Nitric Oxide,Nitric Oxide,30,https://clinicaltrials.gov/show/NCT04398290,None
2187,NCT04398303,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Aspire Health Science,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,ACT-20 in Patients With Severe COVID-19 Pneumonia,Drug,ACT-20,ACT-20,70,https://clinicaltrials.gov/show/NCT04398303,None
2188,NCT04399746,ClinicalTrials.gov,2020-05-19,2020-03-15,True,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Recruiting,Not Applicable,Interventional,Mexico,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,Drug,Ivermectin + Azithromycin + Cholecalciferol,Ivermectin; Azithromycin; Cholecalciferol,30,https://clinicaltrials.gov/show/NCT04399746,None
2189,NCT04400032,ClinicalTrials.gov,2020-04-27,2020-05-01,False,Ottawa Hospital Research Institute,Not Recruiting,Phase 1,Interventional,Canada,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04400032,None
2190,NCT04404634,ClinicalTrials.gov,2020-05-22,2020-05-01,True,Yale University,Not Recruiting,Phase 2,Interventional,No Country Given,Convalescent Plasma To Limit COVID-19 Associated Complications,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04404634,None
2191,ACTRN12620000602921,ANZCTR,2020-05-25,2020-05-29,False,The Australian and New Zealand Intensive Care Research Centre	,Not Recruiting,Not Applicable,Observational,Australia,Post-Intensive Care Nutrition Status in Patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://anzctr.org.au/ACTRN12620000602921.aspx,None
2192,ACTRN12620000617965,ANZCTR,2020-05-27,2020-04-30,True,"St. Vincent's Hospital, Sydney",Recruiting,Not Applicable,Observational,Australia,Multi-site audit of COVID-19 airway interventions,Other,No Intervention,No Intervention,100,https://anzctr.org.au/ACTRN12620000617965.aspx,None
2193,ACTRN12620000593932,ANZCTR,2020-05-22,2020-08-01,False,Professor Julie Quinlivan,Not Recruiting,Not Applicable,Observational,Australia,Has the threat of SARS COVID-19 increased influenza vaccination rates in pregnant women?,Other,No Intervention,No Intervention,100,https://anzctr.org.au/ACTRN12620000593932.aspx,None
2194,ACTRN12620000609954,ANZCTR,2020-05-25,2020-04-16,True,Alfred Health,Recruiting,Not Applicable,Observational,Australia,Covid-19 Biobank of clinical samples and data for use in research to help understand the immune characteristics of people who are diagnosed with COVID19.,Clinical Presentation,No Intervention,No Intervention,250,https://anzctr.org.au/ACTRN12620000609954.aspx,None
2195,ACTRN12620000612910,ANZCTR,2020-05-25,2020-06-01,False,Cynata Therapeutics Limited,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEND (MEseNchymal coviD-19) Trial: a pilot study to investigate early efficacy of mesenchymal stem cells in adults with COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://anzctr.org.au/ACTRN12620000612910.aspx,None
2196,ChiCTR2000033433,ChiCTR,2020-05-31,2020-06-18,False,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Not Recruiting,Not Applicable,Interventional,China,Study for the Effect of Internet-based Cognitive Behavior Intervention on Perinatal Depression and Anxiety during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=54482,None
2197,ChiCTR2000033372,ChiCTR,2020-05-29,2020-03-12,True,Shandong University Qilu Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of leflunomide for Refractory novel coronavirus pneumonia (COVID-19): A non-Randomized Controlled Study,Drug,Leflunomide,Leflunomide,30,http://www.chictr.org.cn/showproj.aspx?proj=54408,None
2198,ChiCTR2000033364,ChiCTR,2020-05-29,2020-05-21,True,Shaanxi Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Observational,China,A correlation study between food intake and risk factors of PTSD after the COVID-19 of shift medical staff,Other (psych),No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=54280,None
2199,ChiCTR2000033347,ChiCTR,2020-05-28,2020-01-29,True,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Epidemiological and Clinical Characteristics of 20 Re-positive novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=53976,None
2200,ChiCTR2000033346,ChiCTR,2020-05-28,2020-02-29,True,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Erythrocyte Sedimentation Rate in novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=54388,None
2201,ChiCTR2000033345,ChiCTR,2020-05-28,2020-05-29,False,The Affiliated Hospital to Changchun University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the effect of Traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-1) in the high risk area,Traditional Medicine (Drug),Tradtional Medicine,Tradtional Medicine,10000,http://www.chictr.org.cn/showproj.aspx?proj=54282,None
2202,ChiCTR2000033342,ChiCTR,2020-05-28,2020-06-15,False,Children's Hospital of Fudan University,Not Recruiting,Not Applicable,Observational,China,The comprehensive evaluation of therapeutic drugs for pediatric novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Tradtional Medicine,Tradtional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=54371,None
2203,ChiCTR2000033323,ChiCTR,2020-05-28,2020-05-11,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Iraq,Severe Reluctant COVID-19 Patients Responding to Convalescent  Plasma; A case series,Drug,Plasma,Plasma,24,http://www.chictr.org.cn/showproj.aspx?proj=54346,None
2204,ChiCTR2000033320,ChiCTR,2020-05-27,2020-01-21,True,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=54321,None
2205,ChiCTR2000033319,ChiCTR,2020-05-27,2020-06-01,False,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Not Applicable,Observational,China,"A follow up research of exercise, cardiopulmonary and quality of Life for patients of novel coronavirus pneumonia (COVID-19)",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,85,http://www.chictr.org.cn/showproj.aspx?proj=54327,None
2206,ChiCTR2000033318,ChiCTR,2020-05-27,2020-02-18,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,104,http://www.chictr.org.cn/showproj.aspx?proj=54326,None
2207,ChiCTR2000033317,ChiCTR,2020-05-27,2020-05-25,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,China,Psychiatric admissions during the COVID-19 pandemic,Clinical Presentation,No Intervention,No Intervention,10000,http://www.chictr.org.cn/showproj.aspx?proj=54295,None
2208,ChiCTR2000033286,ChiCTR,2020-05-26,2020-02-15,True,Xiangyang Central Hospital,Not Recruiting,Not Applicable,Interventional,China,"A Randomized, Double-blind, Placebo-controlled trial for determination of the Efficacy and Safety of Baicalein in Hospitalized Adult  Mild and Moderate Patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Tradtional Medicine,Tradtional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=54176,None
2209,ChiCTR2000033284,ChiCTR,2020-05-26,2020-06-01,False,Guangzhou Women and Children's Medical Center,Not Recruiting,Not Applicable,Interventional,China,Study for the improvement of the quality of life of severe patients of novel coronavirus pneumonia (COVID-19) by the integrated Chinese medicine and Western medicine therapy,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,150,http://www.chictr.org.cn/showproj.aspx?proj=49590,None
2210,ChiCTR2000033261,ChiCTR,2020-05-25,2020-02-15,True,Jiangsu People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Usefulness of abdominal massage and ST-36 (Zusanli) acupressure in improving appetite of novel coronavirus pneumonia (COVID-19) patients treated in makeshift hospital,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=54185,None
2211,ChiCTR2000031539,ChiCTR,2020-04-03,2020-03-15,True,Wuhan Women and Children's Health Care Center,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Correlation between Angiotensin II Type 1 Receptor Blockers (ARBs) and  the Progression and Outcome of Novel Coronavirus Pneumonia (COVID-19),Drug,ARBs,ARBs,180,http://www.chictr.org.cn/showproj.aspx?proj=51893,None
2212,ChiCTR2000029479,ChiCTR,2020-02-02,2020-01-30,True,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia  (COVID-19) in the Community Population,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,20000,http://www.chictr.org.cn/showproj.aspx?proj=48773,None
2213,ISRCTN15254871,ISRCTN,2020-05-23,2020-05-18,True,Heim Pl National Pediatric Institute LaTRA Foundation,Recruiting,Not Applicable,Interventional,Hungary,Online parent training for reducing parenting stress during the coronavirus pandemic,Other (psych),Psychological,Psychological,300,http://isrctn.com/ISRCTN15254871,None
2214,ISRCTN13447477,ISRCTN,2020-05-22,2020-06-01,False,Royal Surrey County Hospital NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,A pilot study of the ability of povidone-iodine (PVP-I) 0.5% aqueous solution oral/nasal spray and mouthwash to kill the SARS-CoV-2 virus in people with COVID-19,Drug,Povidone Iodine,Povidone Iodine,25,http://isrctn.com/ISRCTN13447477,None
2215,ISRCTN64783542,ISRCTN,2020-05-22,2020-03-01,True,Oxford University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Investigating blood clotting changes in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,http://isrctn.com/ISRCTN64783542,None
2216,ISRCTN30564012,ISRCTN,2020-05-20,2020-05-20,True,University of Dundee,Recruiting,Phase 3,Interventional,United Kingdom,STOP-COVID19: Superiority Trial Of Protease inhibition in COVID-19 (coronavirus infection),Drug,Brensocatib,Brensocatib,300,http://isrctn.com/ISRCTN30564012,EUCTR2020-001643-13
2217,ISRCTN50212645,ISRCTN,2020-05-20,2020-06-01,False,"University College, London",Recruiting,Not Applicable,Interventional,United Kingdom,How effective are infection prevention and control measures that are informed by genetic analysis of coronavirus (rapid and standard) at preventing COVID-19 in NHS hospitals?,Genomics,Infection control,Infection control,2000,http://isrctn.com/ISRCTN50212645,None
2218,ISRCTN44324934,ISRCTN,2020-05-18,2020-04-30,True,University of Bristol,Recruiting,Not Applicable,Observational,United Kingdom,"The symptoms, virology and immunity of COVID in healthcare workers",Clinical Presentation,No Intervention,No Intervention,135,http://isrctn.com/ISRCTN44324934,None
2219,ISRCTN88057279,ISRCTN,2020-05-14,2020-05-18,False,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Preventative treatment for patients at risk of COVID-19 infection (PROTECT),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,http://isrctn.com/ISRCTN88057279,None
2220,ISRCTN10077335,ISRCTN,2020-04-07,2020-03-19,True,Klinikum der Universität München,Not Recruiting,Not Applicable,Observational,Germany,Comparison of lung water in COVID-19 patients and other patients with acute respiratory failure,Clinical Presentation,No Intervention,No Intervention,25,http://isrctn.com/ISRCTN10077335,None
2221,EUCTR2020-001644-25-FR,EU Clinical Trials Register,2020-04-11,2020-05-06,False,Acerta Pharma B.V.,Authorised,Phase 2,Interventional,"France, Spain, United States, Italy",A Phase 2 Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19,Drug,Acalabrutinib,Acalabrutinib,428,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001644-25,None
2222,EUCTR2020-001573-78-FR,EU Clinical Trials Register,2020-04-14,2020-05-06,False,Revimmune,Authorised,Phase 2,Interventional,"France, United States",Recombinant InterLeukin-7 (CYT107) to Improve clinical outcomes in lymphopenic pAtients with COVID-19 infection,Drug,Interleukin-7,Interleukin-7,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001573-78,None
2223,EUCTR2020-001754-21-FR,EU Clinical Trials Register,2020-04-17,2020-05-19,False,Assistance Publique – Hôpitaux de Marseille,Authorised,Phase 3,Interventional,France,An open prospective randomized therapeutic trial using ANAKINRA or TOCILIZUMAB alone or in combination with RUXOLITINIB in severe stage 2b and 3 COVID-19 disease,Drug,"Anakinra, Tocilizumab, Ruxolitinib",Anakinra; Tocilizumab; Ruxolitinib,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001754-21,None
2224,EUCTR2020-001536-98-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Mútua Terrassa University Hospital,Not Recruiting,Phase 3,Interventional,Spain,"Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare
personnel with high risk of infection.",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98,None
2225,EUCTR2020-001673-75-FR,EU Clinical Trials Register,2020-04-17,2020-05-06,False,ABIVAX,Authorised,Phase 2/Phase 3,Interventional,France,"Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to COVID-19 associated respiratory distress.",Drug,ABX464,ABX464,1034,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75,None
2226,EUCTR2020-001497-30-FR,EU Clinical Trials Register,2020-04-28,2020-05-12,False,Alexion Pharmaceuticals,Authorised,Phase 3,Interventional,"Spain, United States, Italy, Germany, France, United Kingdom",ravulizumab for the treatment of patients with Coronavirus Disease 2019,Drug,Ravulizumab,Ravulizumab,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30,None
2227,EUCTR2020-001739-28-BE,EU Clinical Trials Register,2020-04-10,2020-05-20,False,UZ Leuven,Authorised,Phase 2,Interventional,Belgium,"A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19.

",Drug,"Aprotinin, Heparin, Anakinra, Nadroparin",Aprotinin; Heparin; Anakinra; Nadroparin,210,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001739-28,None
2228,EUCTR2020-001870-32-DK,EU Clinical Trials Register,2020-05-05,2020-05-15,False,Novartis Pharmaceuticals,Authorised,Phase 2,Interventional,"Denmark, Hungary","Study to assess efficacy and safety of DFV890 in patients with COVID-19 pneumonia and impaired respiratory function
",Drug,DFV890,DFV890,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001870-32,None
2229,EUCTR2020-001623-13-GR,EU Clinical Trials Register,2020-04-22,2020-05-20,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,Triiodothyronine for the treatment of critically ill patients with COVID-19 infection (Thy-Support Study),Drug,Triiodothyronine,Triiodothyronine,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001623-13,None
2230,EUCTR2020-002287-31-ES,EU Clinical Trials Register,2020-05-25,2020-05-22,True,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS),Authorised,Phase 3,Interventional,Spain,COVID 19 prevention in nursing homes,Drug,Hydroxychloroquine,Hydroxychloroquine,1930,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002287-31,None
2231,EUCTR2020-002037-15-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Cristina Avendaño-Solá,Authorised,Phase 2,Interventional,Spain,"Multicenter, randomized, open-label study to evaluate the efficacy and safety of SOC + Sarilumab versus Standard of Care for the Early Treatment of COVID-19-pneumonia in Hospitalized Patients",Drug,Sarilumab,Sarilumab,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002037-15,None
2232,EUCTR2020-001960-28-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Investigation Institute Bioaraba,Authorised,Phase 4,Interventional,Spain,Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19),Drug,Vitamin D,Vitamin D,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001960-28,None
2233,EUCTR2020-001841-38-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Sociedad Española de Cardiología,Authorised,Phase 3,Interventional,Spain,"Colchicine for the Treatment of Hyperinflammation associated with Pneumonia due to COVID-19
",Drug,Colchicine,Colchicine,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001841-38,None
2234,EUCTR2020-001420-34-DK,EU Clinical Trials Register,2020-04-01,2020-04-14,False,Aarhus University,Authorised,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,Drug,Senicapoc,Senicapoc,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34,None
2235,EUCTR2020-001732-10-DE,EU Clinical Trials Register,2020-04-27,2020-05-28,False,Philipps University Marburg,Authorised,Phase 2,Interventional,Germany,"Ruxolitinib for treatment of Covid-19 Patienten with acute respiratory
distress syndrome",Drug,Ruxolitinib,Ruxolitinib,15,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001732-10,None
2236,EUCTR2020-001605-23-ES,EU Clinical Trials Register,2020-05-31,2020-05-29,True,Basque Health Service,Authorised,Phase 4,Interventional,Spain,Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infection,Drug,Hydroxychloroquine + Azithromycin vs. Lopinavir/ritonavir + Hydroxychloroquine,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001605-23,None
2237,EUCTR2020-002312-43-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,True,Hospital Universitario Severo Ochoa,Authorised,Phase 3,Interventional,Spain,"Clinical trial,  randomized, open-label, to evaluate the efficacy of  high-dose vitamin D  in patients with COVID-19 pneumonia",Drug,Vitamin D,Vitamin D,82,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002312-43,None
2238,EUCTR2020-001671-32-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,True,"Staidson (Beijing) Biopharmaceuticals Co., Ltd; Beijing Defengrui Biological Technology Co., Ltd.",Authorised,Phase 2,Interventional,Spain,"A clinical trial to investigate the efficacy and safety of a new compound for the treatment of COVID-19, called BDB-001. Patients in the trial will be randomly allocated to either the new treatment or the conventional treatment and will be aware of which treatment they are receiving",Drug,BDB-001,BDB-001,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001671-32,None
2239,NCT03648372,ClinicalTrials.gov,2018-08-24,2018-10-01,False,"Millennium Pharmaceuticals, Inc.",Recruiting,Phase 1,Interventional,United States,"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019 (COVID-19)",Pre 2020,Pre 2020,Pre 2020,80,https://clinicaltrials.gov/show/NCT03648372,None
2240,NCT04061382,ClinicalTrials.gov,2019-07-30,2019-10-15,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,Sero-epidemiological Survey of England in 2019/2020,Pre 2020,Pre 2020,Pre 2020,3500,https://clinicaltrials.gov/show/NCT04061382,ISRCTN11952463
2241,NCT04305457,ClinicalTrials.gov,2020-03-09,2020-03-21,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Drug,Nitric oxide,Nitric oxide,240,https://clinicaltrials.gov/show/NCT04305457,None
2242,NCT04320511,ClinicalTrials.gov,2020-03-23,2020-06-01,False,William Beaumont Hospitals,Recruiting,Not Applicable,Observational,United States,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04320511,None
2243,NCT04321278,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Hospital Israelita Albert Einstein,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithromycin,440,https://clinicaltrials.gov/show/NCT04321278,None
2244,NCT04331600,ClinicalTrials.gov,2020-03-30,2020-04-16,True,Wroclaw Medical University,Recruiting,Phase 4,Interventional,Poland,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,Drug,Chloroquine,Chloroquine,400,https://clinicaltrials.gov/show/NCT04331600,EUCTR2020-001469-35
2245,NCT04332107,ClinicalTrials.gov,2020-03-30,2020-05-22,False,Thomas M. Lietman,Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Drug,Azithromycin,Azithromycin,2271,https://clinicaltrials.gov/show/NCT04332107,None
2246,NCT04336956,ClinicalTrials.gov,2020-03-30,2020-04-07,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Covid-19 Pediatric Observatory,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04336956,None
2247,NCT04338347,ClinicalTrials.gov,2020-03-31,2020-07-21,False,Capricor Inc.,Not Recruiting,Not Applicable,Expanded Access,United States,CAP-1002 in Severe COVID-19 Disease,ATMP,Cells (allogeneic cardiosphere-derived),Cells (allogeneic cardiosphere-derived),Not Available,https://clinicaltrials.gov/show/NCT04338347,None
2248,NCT04341766,ClinicalTrials.gov,2020-04-01,2020-03-31,True,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04341766,None
2249,NCT04343742,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Genesis Foundation,Recruiting,Not Applicable,Observational,Colombia,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Drug,Chlorine dioxide,Chlorine dioxide,20,https://clinicaltrials.gov/show/NCT04343742,None
2250,NCT04346693,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Burnasyan Federal Medical Biophysical Center,Not Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Drug,Dalargin + Hydroxychloroquine + azithromycin + / - tocilizumab vs. Hydroxychloroquine + azithromycin + / - tocilizumab,Dalargin; Hydroxychloroquine; azithromycin; tocilizumab,320,https://clinicaltrials.gov/show/NCT04346693,None
2251,NCT04348370,ClinicalTrials.gov,2020-03-30,2020-04-20,False,Texas A&M University,Recruiting,Phase 4,Interventional,United States,BCG Vaccine for Health Care Workers as Defense Against COVID 19,ATMP,Vaccine,Vaccine,1800,https://clinicaltrials.gov/show/NCT04348370,None
2252,NCT04350450,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Montefiore Medical Center,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04350450,None
2253,NCT04352634,ClinicalTrials.gov,2020-04-08,2020-04-26,False,University of Chile,Recruiting,Not Applicable,Observational,"Lebanon, Spain, Netherlands, Bolivia, Germany, Mexico, Puerto Rico, Costa Rica, Tunisia, Nigeria, Venezuela, Chile, Argentina, Turkey, Guatemala, Australia, Saudi Arabia, Czech Republic, United States, Italy",The Covid-19 HEalth caRe wOrkErS (HEROES) Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04352634,None
2254,NCT04362995,ClinicalTrials.gov,2020-04-22,2020-04-23,False,St. Jude Children's Research Hospital,Recruiting,Not Applicable,Observational,United States,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,Clinical Presentation,No Intervention,No Intervention,1517,https://clinicaltrials.gov/show/NCT04362995,None
2255,NCT04363814,ClinicalTrials.gov,2020-04-19,2020-06-10,False,Inmunotek S.L.,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Drug,Bactek-R,Bactek-R,100,https://clinicaltrials.gov/show/NCT04363814,None
2256,NCT04373811,ClinicalTrials.gov,2020-04-26,2020-04-16,True,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Observational,France,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,Prognosis,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04373811,None
2257,NCT04374591,ClinicalTrials.gov,2020-05-02,2020-04-01,True,Mansoura University,Not Recruiting,Phase 1,Interventional,Egypt,Home-based Treatment of Computed Tomography and Clinically Suspected Novel COVID-19 With Adjuvant Inhalable Sodium Bicarbonate: A Preliminary Case Series,Drug,Sodium Bicarbonate,Sodium Bicarbonate,40,https://clinicaltrials.gov/show/NCT04374591,None
2258,NCT04376658,ClinicalTrials.gov,2020-05-04,2020-06-15,False,Hospital Moinhos de Vento,Not Recruiting,Not Applicable,Observational,No Country Given,Quality of Life and Patient-centered Outcomes After Hospitalization for COVID-19,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04376658,None
2259,NCT04377737,ClinicalTrials.gov,2020-05-04,2020-05-15,False,Fondation Lenval,Not Recruiting,Not Applicable,Interventional,France,Incidence of Covid-19 in School Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04377737,None
2260,NCT04379375,ClinicalTrials.gov,2020-05-04,2020-06-01,False,Medical College of Wisconsin,Not Recruiting,Not Applicable,Interventional,No Country Given,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,Other,Other,Other,300,https://clinicaltrials.gov/show/NCT04379375,None
2261,NCT04380532,ClinicalTrials.gov,2020-04-29,2020-05-15,False,Immunitor LLC,Not Recruiting,Phase 1/Phase 2,Interventional,"Mongolia, Canada",Tableted COVID-19 Therapeutic Vaccine,ATMP,Vaccine,Vaccine,20,https://clinicaltrials.gov/show/NCT04380532,None
2262,NCT04381351,ClinicalTrials.gov,2020-05-07,2020-04-16,True,Heinrich-Heine University,Recruiting,Not Applicable,Observational,Germany,Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04381351,None
2263,NCT04381884,ClinicalTrials.gov,2020-05-05,2020-05-18,False,Laboratorio Elea,Recruiting,Phase 2,Interventional,Argentina,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,Drug,Ivermectin,Ivermectin,45,https://clinicaltrials.gov/show/NCT04381884,None
2264,NCT04389996,ClinicalTrials.gov,2020-05-12,2020-05-14,False,Odense University Hospital,Recruiting,Not Applicable,Observational,Denmark,COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04389996,None
2265,NCT04390594,ClinicalTrials.gov,2020-05-14,2020-06-01,False,Institut Pasteur,Not Recruiting,Phase 3,Interventional,Senegal,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,258,https://clinicaltrials.gov/show/NCT04390594,None
2266,NCT04392869,ClinicalTrials.gov,2020-05-09,2019-10-23,True,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting,Other (psych),Psychological,Psychological,75,https://clinicaltrials.gov/show/NCT04392869,None
2267,NCT04393415,ClinicalTrials.gov,2020-05-15,2020-05-25,False,Aljazeera Hospital,Not Recruiting,Not Applicable,Interventional,Egypt,Using PRP and Cord Blood in Treatment of Covid -19,ATMP,Cells (stem cells),Cells (stem cells),100,https://clinicaltrials.gov/show/NCT04393415,None
2268,NCT04395105,ClinicalTrials.gov,2020-05-16,2020-05-21,False,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,Recruiting,Phase 3,Interventional,Argentina,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",Drug,Corticosteroids,Dexamethasone,284,https://clinicaltrials.gov/show/NCT04395105,None
2269,NCT04395482,ClinicalTrials.gov,2020-05-18,2020-04-15,True,University of Milano Bicocca,Recruiting,Not Applicable,Observational,"San Marino, Italy",Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04395482,None
2270,NCT04395781,ClinicalTrials.gov,2020-05-18,2020-05-18,False,KK Women's and Children's Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Pediatric Acute and Critical Care COVID-19 Registry of Asia,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04395781,None
2271,NCT04395872,ClinicalTrials.gov,2020-05-08,2020-05-28,False,Daegu Catholic University Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,Psychiatric Consultation for COVID-19 Patients,Other (psych),Psychological,Psychological,54,https://clinicaltrials.gov/show/NCT04395872,None
2272,NCT04397497,ClinicalTrials.gov,2020-05-20,2020-05-22,False,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,Italy,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),Drug,Mavrilimumab,Mavrilimumab,50,https://clinicaltrials.gov/show/NCT04397497,None
2273,NCT04397575,ClinicalTrials.gov,2020-05-13,2020-04-03,True,Federation Francophone de Cancerologie Digestive,Recruiting,Not Applicable,Observational,France,The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04397575,None
2274,NCT04398004,ClinicalTrials.gov,2020-05-17,2020-05-06,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,Drug,Clarithromycin,Clarithromycin,90,https://clinicaltrials.gov/show/NCT04398004,EUCTR2020-001882-36
2275,NCT04398147,ClinicalTrials.gov,2020-05-18,2020-05-01,True,CanSino Biologics Inc.,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,ATMP,Vaccine,Vaccine,696,https://clinicaltrials.gov/show/NCT04398147,None
2276,NCT04399109,ClinicalTrials.gov,2020-05-21,2020-05-20,True,Dr. Sze-Yuan Ooi,Recruiting,Not Applicable,Interventional,Australia,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),Other (software),eHealth,eHealth,2000,https://clinicaltrials.gov/show/NCT04399109,None
2277,NCT04399252,ClinicalTrials.gov,2020-05-19,2020-05-25,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,Supplement,Lactobaciltus rhamnosus,Lactobaciltus rhamnosus,1000,https://clinicaltrials.gov/show/NCT04399252,None
2278,NCT04399356,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Tufts Medical Center,Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide for Mild to Moderate COVID-19,Drug,Niclosamide,Niclosamide,100,https://clinicaltrials.gov/show/NCT04399356,None
2279,NCT04399603,ClinicalTrials.gov,2020-05-19,2020-05-18,True,Imperial College London,Not Recruiting,Not Applicable,Observational,United Kingdom,Mechanisms of Multi-organ Failure in COVID-19,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04399603,None
2280,NCT04399681,ClinicalTrials.gov,2020-05-21,2020-05-10,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04399681,None
2281,NCT04399798,ClinicalTrials.gov,2020-05-13,2020-05-15,False,IRCCS Policlinico San Matteo,Not Recruiting,Phase 2,Interventional,No Country Given,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,Drug,Baricitinib,Baricitinib,13,https://clinicaltrials.gov/show/NCT04399798,None
2282,NCT04400006,ClinicalTrials.gov,2020-05-21,2020-05-06,True,Marmara University,Not Recruiting,Not Applicable,Observational,Turkey,Ozone Therapy in the Prevention of COVID-19 Infection,Drug,Ozone,Ozone,71,https://clinicaltrials.gov/show/NCT04400006,None
2283,NCT04400058,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Octapharma,Not Recruiting,Phase 3,Interventional,No Country Given,OCTAGAM 10% THERAPY IN COVID-19 PATIENTS WITH SEVERE DISEASE PROGRESSION,ATMP,Immunoglobulin,Immunoglobulin,54,https://clinicaltrials.gov/show/NCT04400058,None
2284,NCT04400305,ClinicalTrials.gov,2020-05-21,2020-05-20,True,University of Victoria,Recruiting,Not Applicable,Interventional,Canada,"""Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",Other (software),eHealth,eHealth,40,https://clinicaltrials.gov/show/NCT04400305,None
2285,NCT04400461,ClinicalTrials.gov,2020-05-20,2020-05-15,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Recruiting,Not Applicable,Observational,Spain,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04400461,None
2286,NCT04400799,ClinicalTrials.gov,2020-05-15,2020-06-01,False,University of Zurich,Not Recruiting,Phase 3,Interventional,No Country Given,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,Drug,Heparin,Heparin,1000,https://clinicaltrials.gov/show/NCT04400799,None
2287,NCT04400812,ClinicalTrials.gov,2020-05-20,2020-05-19,True,Zagazig University,Recruiting,Not Applicable,Observational,Egypt,Attitude and Perception Towards COVID-19 Pandemic,Other,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04400812,None
2288,NCT04400838,ClinicalTrials.gov,2020-05-12,2020-05-01,True,University of Oxford,Not Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a Vaccine Against COVID-19,ATMP,Vaccine,Vaccine,10260,https://clinicaltrials.gov/show/NCT04400838,EUCTR2020-001228-32
2289,NCT04400890,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Dr. Marvin McCreary,Not Recruiting,Phase 2,Interventional,No Country Given,Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol for COVID-19,Drug,Resveratrol,Resveratrol,200,https://clinicaltrials.gov/show/NCT04400890,None
2290,NCT04400929,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Singapore General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,Drug,Sargramostim,Sargramostim,30,https://clinicaltrials.gov/show/NCT04400929,None
2291,NCT04401072,ClinicalTrials.gov,2020-05-22,2020-04-24,True,Damanhour University,Recruiting,Not Applicable,Observational,Egypt,Attitude of Egyptian Population Toward COVID 19 in Ramadan,Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04401072,None
2292,NCT04401098,ClinicalTrials.gov,2020-05-22,2020-05-02,True,Damanhour University,Recruiting,Not Applicable,Observational,Egypt,Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak,Other,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04401098,None
2293,NCT04401111,ClinicalTrials.gov,2020-05-22,2020-06-16,False,CHU de Nice,Not Recruiting,Not Applicable,Observational,France,One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU),Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04401111,None
2294,NCT04401124,ClinicalTrials.gov,2020-05-22,2020-05-25,False,Beijing Friendship Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Status of Management of Surgery in Beijing During COVID-19,Health System,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04401124,None
2295,NCT04401150,ClinicalTrials.gov,2020-05-21,2020-06-01,False,University of Sherbrooke,Not Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C - COVID-19,Drug,Vitamin C,Vitamin C,800,https://clinicaltrials.gov/show/NCT04401150,None
2296,NCT04401202,ClinicalTrials.gov,2020-05-21,2020-05-21,False,King Abdulaziz University,Recruiting,Phase 2,Interventional,Saudi Arabia,Nigella Sativa in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04401202,None
2297,NCT04401228,ClinicalTrials.gov,2020-05-21,2020-03-01,True,Clinique Saint Pierre Ottignies,Not Recruiting,Not Applicable,Observational,Belgium,Predictive Models for Intensive Care Admission and Death of COVID-19,Prognosis,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04401228,None
2298,NCT04401241,ClinicalTrials.gov,2020-05-18,2020-02-01,True,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,Not Recruiting,Not Applicable,Observational,Monaco,How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department,Clinical Presentation,No Intervention,No Intervention,257,https://clinicaltrials.gov/show/NCT04401241,None
2299,NCT04401254,ClinicalTrials.gov,2020-05-07,2020-05-01,True,Australian and New Zealand Intensive Care Research Centre,Not Recruiting,Not Applicable,Observational,Australia,Recovery of Patients From COVID-19 After Critical Illness,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04401254,None
2300,NCT04401371,ClinicalTrials.gov,2020-05-21,2020-05-01,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,Distance Learning for Dental Student During COVID-19 Pandemic,Other,No Intervention,No Intervention,418,https://clinicaltrials.gov/show/NCT04401371,None
2301,NCT04401410,ClinicalTrials.gov,2020-05-21,2020-07-30,False,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Anti-SARS Cov-2 T Cell Infusions for COVID 19,ATMP,Cells (T),Cells (T),20,https://clinicaltrials.gov/show/NCT04401410,None
2302,NCT04401423,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Columbia University,Not Recruiting,Phase 2,Interventional,No Country Given,TXA COVID-19 Clinical Trial,Drug,TXA127,TXA127,100,https://clinicaltrials.gov/show/NCT04401423,None
2303,NCT04401527,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Hope Pharmaceuticals,Not Recruiting,Phase 2,Interventional,No Country Given,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,Drug,Sodium Nitrite,Sodium Nitrite,200,https://clinicaltrials.gov/show/NCT04401527,None
2304,NCT04401540,ClinicalTrials.gov,2020-05-22,2020-05-01,True,Recep Tayyip Erdogan University Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Characteristics of Neonatal Covid-19 in Turkey,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04401540,None
2305,NCT04401644,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Somerset NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04401644,None
2306,NCT04402203,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Bangladesh Medical Research Council (BMRC),Recruiting,Phase 2/Phase 3,Interventional,Bangladesh,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,Drug,Favipiravir,Favipiravir,50,https://clinicaltrials.gov/show/NCT04402203,None
2307,NCT04402229,ClinicalTrials.gov,2020-05-21,2020-05-12,True,Versailles Hospital,Recruiting,Not Applicable,Observational,France,Psychological Impact of the Covid-19 Pandemic on Student Nurses,Other (psych),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04402229,None
2308,NCT04402814,ClinicalTrials.gov,2020-05-22,2020-05-05,True,Dr. Fadi Haddad,Recruiting,Not Applicable,Observational,United States,IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With Nasopharyngeal PCR Testing.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://clinicaltrials.gov/show/NCT04402814,None
2309,NCT04402840,ClinicalTrials.gov,2020-05-22,2020-04-24,True,West Virginia University,Recruiting,Not Applicable,Interventional,United States,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),Procedure,Stellate Ganglion Block,Stellate Ganglion Block,5,https://clinicaltrials.gov/show/NCT04402840,None
2310,NCT04402983,ClinicalTrials.gov,2020-05-22,2020-05-20,True,Istanbul Medipol University Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,34,https://clinicaltrials.gov/show/NCT04402983,None
2311,NCT04403009,ClinicalTrials.gov,2020-04-21,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Observational,China,The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04403009,None
2312,NCT04403035,ClinicalTrials.gov,2020-05-21,2020-05-10,True,Ascension South East Michigan,Recruiting,Not Applicable,Observational,United States,Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04403035,None
2313,NCT04403269,ClinicalTrials.gov,2020-05-18,2020-05-05,True,Versailles Hospital,Recruiting,Phase 2,Interventional,France,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",ATMP,Immunoglobulin,Immunoglobulin,35,https://clinicaltrials.gov/show/NCT04403269,None
2314,NCT04403438,ClinicalTrials.gov,2020-05-23,2020-04-01,True,Istanbul University,Recruiting,Not Applicable,Observational,Turkey,Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic,Clinical Presentation,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04403438,None
2315,NCT04403477,ClinicalTrials.gov,2020-05-20,2020-05-20,False,Bangabandhu Sheikh Mujib Medical University,Recruiting,Phase 2,Interventional,Bangladesh,Convalescent Plasma Therapy in Severe COVID-19 Infection,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04403477,None
2316,NCT04403555,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin and Doxycycine in COVID-19 Treatment,Drug,Ivermectin + Doxycycine vs. Chloroquine,Ivermectin; Doxycycline; Chloroquine,40,https://clinicaltrials.gov/show/NCT04403555,None
2317,NCT04403581,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Ain Shams University,Not Recruiting,Not Applicable,Observational,No Country Given,"Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",Other (psych),No Intervention,No Intervention,384,https://clinicaltrials.gov/show/NCT04403581,None
2318,NCT04403906,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Somerset NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Somerset and South Essex Coronavirus Antigen Testing,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04403906,None
2319,NCT04404192,ClinicalTrials.gov,2020-05-21,2020-11-01,False,"VistaGen Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,United States,PH94B in the Treatment of Adjustment Disorder With Anxiety,Other (psych),PH94B,PH94B,30,https://clinicaltrials.gov/show/NCT04404192,None
2320,NCT04404218,ClinicalTrials.gov,2020-05-24,2020-05-01,True,"University Health Network, Toronto",Not Recruiting,Phase 2,Interventional,No Country Given,The Açaí Berry COVID-19 Anti-Inflammation Trial,Supplement,Acai Berry,Acai Berry,480,https://clinicaltrials.gov/show/NCT04404218,None
2321,NCT04307693,ClinicalTrials.gov,2020-03-10,2020-03-11,False,Asan Medical Center,Not Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Drug,Lopinavir/ritonavir vs. hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,65,https://clinicaltrials.gov/show/NCT04307693,None
2322,NCT04317040,ClinicalTrials.gov,2020-03-19,2020-04-08,False,"OncoImmune, Inc.",Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,ATMP,Gene-derived protein,Gene-derived protein,230,https://clinicaltrials.gov/show/NCT04317040,None
2323,NCT04321421,ClinicalTrials.gov,2020-03-23,2020-03-17,True,Foundation IRCCS San Matteo Hospital,Not Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,ATMP,Plasma,Plasma,49,https://clinicaltrials.gov/show/NCT04321421,None
2324,NCT04327206,ClinicalTrials.gov,2020-03-25,2020-03-30,False,Murdoch Childrens Research Institute,Recruiting,Phase 3,Interventional,Australia,BCG Vaccination to Protect Healthcare Workers Against COVID-19,ATMP,Vaccine,Vaccine,10078,https://clinicaltrials.gov/show/NCT04327206,None
2325,NCT04327570,ClinicalTrials.gov,2020-03-26,2020-03-27,False,UZ Leuven,Recruiting,Not Applicable,Observational,Belgium,In-depth Immunological Investigation of COVID-19.,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04327570,None
2326,NCT04328467,ClinicalTrials.gov,2020-03-27,2020-04-06,False,University of Minnesota,Not Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04328467,None
2327,NCT04328493,ClinicalTrials.gov,2020-03-27,2020-04-07,False,University of Oxford,Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,Drug,Chloroquine,Chloroquine,250,https://clinicaltrials.gov/show/NCT04328493,None
2328,NCT04334629,ClinicalTrials.gov,2020-04-02,2020-05-26,False,King's College London,Recruiting,Phase 4,Interventional,United Kingdom,LIBERATE Trial in COVID-19,Drug,Ibuprofen,Ibuprofen,230,https://clinicaltrials.gov/show/NCT04334629,None
2329,NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-20,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Other,Other,Other,194,https://clinicaltrials.gov/show/NCT04334850,EUCTR2020-001324-33
2330,NCT04341610,ClinicalTrials.gov,2020-04-07,2020-04-20,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),0,https://clinicaltrials.gov/show/NCT04341610,None
2331,NCT04341714,ClinicalTrials.gov,2020-04-08,2020-03-16,True,Pierre and Marie Curie University,Recruiting,Not Applicable,Observational,France,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,450,https://clinicaltrials.gov/show/NCT04341714,None
2332,NCT04345289,ClinicalTrials.gov,2020-04-10,2020-05-01,True,Thomas Benfield,Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Drug (+ ATMP),Plamsa vs. Sarilumab vs. Hydroxychloroquine vs. Baricitinib,Plamsa; Sarilumab; Hydroxychloroquine; Baricitinib,1500,https://clinicaltrials.gov/show/NCT04345289,EUCTR2020-001367-88
2333,NCT04351516,ClinicalTrials.gov,2020-04-15,2020-04-21,True,"University Hospital, Tübingen",Recruiting,Phase 2/Phase 3,Interventional,Germany,Test and Treat COVID 65plus+,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04351516,EUCTR2020-001482-37
2334,NCT04354428,ClinicalTrials.gov,2020-04-16,2020-04-16,False,University of Washington,Recruiting,Phase 2/Phase 3,Interventional,United States,Treatment for COVID-19 in High-Risk Adult Outpatients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Vitamin C + Folic Acid,Azithromycin; Hydroxychloroquine; Vitamin C; Folic Acid,630,https://clinicaltrials.gov/show/NCT04354428,None
2335,NCT04359264,ClinicalTrials.gov,2020-04-16,2020-04-20,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,Other,Other,Other,392,https://clinicaltrials.gov/show/NCT04359264,None
2336,NCT04359693,ClinicalTrials.gov,2020-04-21,2020-04-22,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,Clinical Presentation,No Intervention,No Intervention,1071,https://clinicaltrials.gov/show/NCT04359693,None
2337,NCT04362059,ClinicalTrials.gov,2020-04-20,2020-06-27,True,University Hospital Southampton NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Drug,Bovactant,Bovactant,24,https://clinicaltrials.gov/show/NCT04362059,EUCTR2020-001886-35
2339,NCT04362150,ClinicalTrials.gov,2020-04-23,2020-04-21,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,Long-term Impact of Infection With Novel Coronavirus (COVID-19),Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04362150,None
2340,NCT04364594,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Interventional,Italy,COVID-19 Search in Conjunctival Cells,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04364594,None
2341,NCT04366115,ClinicalTrials.gov,2020-04-26,2020-06-01,False,AVM Biotechnology LLC,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Evaluating AVM0703 for Treatment of COVID-19,Drug,AVM0703,AVM0703,126,https://clinicaltrials.gov/show/NCT04366115,None
2342,NCT04366141,ClinicalTrials.gov,2020-04-24,2020-05-01,False,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,Other (device),Barrier,Barrier,120,https://clinicaltrials.gov/show/NCT04366141,None
2343,NCT04367337,ClinicalTrials.gov,2020-04-28,2020-03-25,True,"University of Social Sciences and Humanities, Warsaw",Recruiting,Not Applicable,Observational,"Gambia, Singapore, Poland, Israel, Switzerland, Italy, Germany, China, Australia, Canada, Malaysia, France, Romania, Portugal",Health Behavior Change During COVID-19 Pandemic,Other,No Intervention,No Intervention,5600,https://clinicaltrials.gov/show/NCT04367337,None
2344,NCT04368988,ClinicalTrials.gov,2020-04-24,2020-05-25,False,Novavax,Recruiting,Phase 1,Interventional,Australia,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant,ATMP,Vaccine,Vaccine,131,https://clinicaltrials.gov/show/NCT04368988,None
2345,NCT04373200,ClinicalTrials.gov,2020-04-22,2020-05-25,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,Human Ab Response & immunoMONItoring of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04373200,None
2346,NCT04374526,ClinicalTrials.gov,2020-05-02,2020-05-27,False,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Phase 2/Phase 3,Interventional,Italy,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,ATMP,Plasma,Plasma,182,https://clinicaltrials.gov/show/NCT04374526,None
2347,NCT04376879,ClinicalTrials.gov,2020-05-04,2020-05-16,False,CHU de Nancy,Recruiting,Not Applicable,Observational,France,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Prognosis,No Intervention,No Intervention,384,https://clinicaltrials.gov/show/NCT04376879,None
2348,NCT04377659,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,Drug,Tocilizumab,Tocilizumab,40,https://clinicaltrials.gov/show/NCT04377659,None
2349,NCT04378582,ClinicalTrials.gov,2020-05-05,2020-05-07,False,University of São Paulo General Hospital,Recruiting,Not Applicable,Observational,Brazil,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04378582,None
2350,NCT04378803,ClinicalTrials.gov,2020-05-04,2020-05-13,False,University of Miami,Not Recruiting,Not Applicable,Interventional,United States,Mindfulness Training for Seniors,Other (psych),Psychological,Psychological,53,https://clinicaltrials.gov/show/NCT04378803,None
2351,NCT04378842,ClinicalTrials.gov,2020-05-05,2020-05-18,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,COVID-19 and ICU-acquired MDR Bacteria,Clinical Presentation,No Intervention,No Intervention,690,https://clinicaltrials.gov/show/NCT04378842,None
2352,NCT04379063,ClinicalTrials.gov,2020-05-05,2020-05-13,False,Jon Bailey,Recruiting,Not Applicable,Observational,Canada,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress,Other (psych),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04379063,None
2353,NCT04382417,ClinicalTrials.gov,2020-05-04,2020-03-26,True,Region Västmanland,Recruiting,Not Applicable,Observational,Sweden,Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04382417,None
2354,NCT04382547,ClinicalTrials.gov,2020-05-08,2020-05-11,False,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,Recruiting,Phase 1/Phase 2,Interventional,Belarus,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04382547,None
2355,NCT04384497,ClinicalTrials.gov,2020-05-07,2020-05-07,False,Joakim Dillner,Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04384497,None
2356,NCT04385004,ClinicalTrials.gov,2020-05-08,2020-04-27,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,"Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU",Clinical Presentation,No Intervention,No Intervention,320,https://clinicaltrials.gov/show/NCT04385004,None
2357,NCT04386291,ClinicalTrials.gov,2020-05-11,2020-05-25,False,"Research Foundation for Mental Hygiene, Inc.",Recruiting,Not Applicable,Interventional,United States,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,360,https://clinicaltrials.gov/show/NCT04386291,None
2358,NCT04386720,ClinicalTrials.gov,2020-05-11,2020-05-25,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.,Other,Other,Other,20,https://clinicaltrials.gov/show/NCT04386720,None
2359,NCT04387890,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Hospital Italiano de Buenos Aires,Not Recruiting,Not Applicable,Observational,No Country Given,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04387890,None
2360,NCT04388527,ClinicalTrials.gov,2020-05-04,2020-04-30,True,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04388527,None
2361,NCT04393324,ClinicalTrials.gov,2020-05-17,2020-04-24,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Observational,Spain,The Critical Care Response to the COVID-19 Pandemic in Madrid,Health System,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04393324,None
2362,NCT04394104,ClinicalTrials.gov,2020-05-15,2020-05-27,False,Rutgers University,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Wellness Survey,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04394104,None
2363,NCT04395391,ClinicalTrials.gov,2020-05-19,2020-05-18,True,Exact Sciences Corporation,Not Recruiting,Not Applicable,Observational,United States,Home Usability Study of the SARS-CoV-2 (COVID-19) Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04395391,None
2364,NCT04397692,ClinicalTrials.gov,2020-05-19,2020-05-18,True,Beyond Air Ltd,Not Recruiting,Not Applicable,Interventional,United States,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04397692,None
2365,NCT04400448,ClinicalTrials.gov,2020-05-14,2020-06-01,False,Fundación para el Fomento de la Investigación Sanitaria y Biomedica de la Comunitat Valenciana,Not Recruiting,Not Applicable,Observational,No Country Given,Acceptance of Telemedicine During the COVID-19 Pandemic,Telehealth,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04400448,None
2366,NCT04401046,ClinicalTrials.gov,2020-05-22,2020-05-30,False,Institut Paoli-Calmettes,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04401046,None
2367,NCT04402892,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04402892,None
2368,NCT04402905,ClinicalTrials.gov,2020-05-20,2020-06-15,False,Centre de Recherches et d'Études Surla Pathologie Tropicale,Not Recruiting,Not Applicable,Observational,France,"Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)",Clinical Presentation,No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04402905,None
2369,NCT04402918,ClinicalTrials.gov,2020-05-18,2020-05-17,True,CHU de Besançon,Recruiting,Not Applicable,Interventional,France,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04402918,None
2370,NCT04403061,ClinicalTrials.gov,2020-05-23,2020-05-22,True,Asociación para el Estudio de las Enfermedades Infecciosas,Recruiting,Not Applicable,Observational,Spain,Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome,Prognosis,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04403061,None
2371,NCT04403243,ClinicalTrials.gov,2020-05-20,2020-05-08,True,Lomonosov Moscow State University Medical Research and Educational Center,Recruiting,Phase 2,Interventional,Russian Federation,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,Drug,Colchicine vs. Ruxolitinib vs. Secukinumab,Colchicine; Ruxolitinib; Secukinumab,70,https://clinicaltrials.gov/show/NCT04403243,None
2372,NCT04403646,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Hospital de Clínicas José de San Martín,Not Recruiting,Not Applicable,Interventional,No Country Given,Tannin Specific Natural Extract for COVID-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,https://clinicaltrials.gov/show/NCT04403646,None
2373,NCT04403672,ClinicalTrials.gov,2020-05-24,2020-05-18,True,Bangladesh Medical Research Council (BMRC),Recruiting,Not Applicable,Observational,Bangladesh,Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,120,https://clinicaltrials.gov/show/NCT04403672,None
2374,NCT04403685,ClinicalTrials.gov,2020-05-24,2020-05-08,True,Beneficência Portuguesa de São Paulo,Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,Drug,Tocilizumab,Tocilizumab,150,https://clinicaltrials.gov/show/NCT04403685,None
2375,NCT04404062,ClinicalTrials.gov,2020-05-22,2020-03-16,True,Richmond Pharmacology Limited,Not Recruiting,Not Applicable,Observational,United Kingdom,Validation of COVID-19 Tests,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04404062,None
2376,NCT04404179,ClinicalTrials.gov,2020-05-24,2020-03-27,True,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Observational,Pakistan,Setting up a COVID-19 Care Facility at a Prison in Pakistan,Other,No Intervention,No Intervention,69,https://clinicaltrials.gov/show/NCT04404179,None
2377,NCT04404244,ClinicalTrials.gov,2020-05-25,2020-01-01,True,Fatma Soliman Elsayed Ebeid,Recruiting,Not Applicable,Observational,Egypt,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04404244,None
2378,NCT04404426,ClinicalTrials.gov,2020-05-22,2020-06-15,False,Rennes University Hospital,Not Recruiting,Not Applicable,Interventional,France,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,Drug,Citrulline,Citrulline,100,https://clinicaltrials.gov/show/NCT04404426,None
2379,NCT04405102,ClinicalTrials.gov,2020-05-26,2020-07-06,False,Francois Lellouche,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19 Ozanimod Intervention Study,Drug,Ozanimod,Ozanimod,48,https://clinicaltrials.gov/show/NCT04405102,None
2380,NCT04405271,ClinicalTrials.gov,2020-05-26,2020-06-15,False,Hospital Italiano de Buenos Aires,Not Recruiting,Phase 3,Interventional,Argentina,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Drug (Chemoprophylaxis),Emtricitabine + Tenofovir alafenamide,Emtricitabine; Tenofovir alafenamide,1378,https://clinicaltrials.gov/show/NCT04405271,None
2381,NCT04405310,ClinicalTrials.gov,2020-05-26,2020-05-20,True,Grupo Mexicano para el Estudio de la Medicina Intensiva,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04405310,None
2382,NCT04405362,ClinicalTrials.gov,2020-05-18,2020-05-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,Other (psych),No Intervention,No Intervention,753,https://clinicaltrials.gov/show/NCT04405362,None
2383,NCT04405492,ClinicalTrials.gov,2020-05-19,2020-05-25,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1210,https://clinicaltrials.gov/show/NCT04405492,None
2384,NCT04405843,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Centro de Estudios en Infectología Pediátrica,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19,Drug,Ivermectin,Ivermectin,400,https://clinicaltrials.gov/show/NCT04405843,None
2385,NCT04405869,ClinicalTrials.gov,2020-05-25,2020-04-29,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Thromboembolic Events in Severe COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04405869,None
2386,NCT04405999,ClinicalTrials.gov,2020-05-18,2020-05-14,True,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health",Recruiting,Phase 4,Interventional,Russian Federation,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,Drug (Chemoprophylaxis),Bromhexine hydrochloride,Bromhexine hydrochloride,140,https://clinicaltrials.gov/show/NCT04405999,None
2387,NCT04406038,ClinicalTrials.gov,2020-05-26,2020-05-27,False,European University at St. Petersburg,Recruiting,Not Applicable,Observational,Russian Federation,"Study of the Spread of COVID-19 in Saint Petersburg, Russia",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1550,https://clinicaltrials.gov/show/NCT04406038,None
2388,NCT04406064,ClinicalTrials.gov,2020-05-26,2020-06-01,False,"Children's Hospital Medical Center, Cincinnati",Not Recruiting,Phase 2,Interventional,United States,Viral Specific T-cells for Treatment of COVID-19,ATMP,Cells (T),Cells (T),100,https://clinicaltrials.gov/show/NCT04406064,None
2389,NCT04406090,ClinicalTrials.gov,2020-05-26,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Endovascular Thrombectomy in COVID-19 Infected Patients,Procedure,Mechanical Trombectomy,Mechanical Trombectomy,50,https://clinicaltrials.gov/show/NCT04406090,None
2390,NCT04406233,ClinicalTrials.gov,2020-05-23,2020-05-23,False,University of São Paulo,Recruiting,Not Applicable,Observational,Brazil,Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,176,https://clinicaltrials.gov/show/NCT04406233,None
2391,NCT04406246,ClinicalTrials.gov,2020-05-24,2020-05-21,True,Materno-Perinatal Hospital of the State of Mexico,Recruiting,Phase 4,Interventional,Mexico,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,Drug,Nitazoxanide,Nitazoxanide,150,https://clinicaltrials.gov/show/NCT04406246,None
2392,NCT04406324,ClinicalTrials.gov,2020-05-13,2020-06-05,False,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Observational,France,COVID-19: Respiratory and Sleep Follow-up,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04406324,None
2393,NCT04406389,ClinicalTrials.gov,2020-05-26,2020-06-01,False,Weill Medical College of Cornell University,Not Recruiting,Phase 4,Interventional,United States,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),Drug,"Heparin, Fondapariniux, Argatroban",Heparin; Fondapariniux; Argatroban,186,https://clinicaltrials.gov/show/NCT04406389,None
2394,NCT04406493,ClinicalTrials.gov,2020-05-23,2020-04-28,True,Hillel Yaffe Medical Center,Recruiting,Not Applicable,Interventional,Israel,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04406493,None
2395,NCT04406532,ClinicalTrials.gov,2020-05-22,2020-07-01,False,Albert Einstein College of Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Home-Based Covid-19 Rehabilitation Program,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04406532,None
2396,NCT04406571,ClinicalTrials.gov,2020-05-27,2020-04-01,True,CHU de Reims,Recruiting,Not Applicable,Observational,France,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer,Health System,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04406571,None
2397,NCT04406688,ClinicalTrials.gov,2020-05-18,2020-05-25,False,"University Hospital, Muenster",Not Recruiting,Not Applicable,Observational,Germany,Prediction of Acute Kidney Injury in Patients With COVID-19,Prognosis,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04406688,None
2398,NCT04406844,ClinicalTrials.gov,2020-05-25,2020-05-09,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04406844,None
2399,NCT04407221,ClinicalTrials.gov,2020-05-03,2020-06-01,False,Vastra Gotaland Region,Not Recruiting,Not Applicable,Observational,Sweden,COVID-19 Research in Organ Transplant Recipients,Other,No Intervention,No Intervention,1100,https://clinicaltrials.gov/show/NCT04407221,None
2400,NCT04407273,ClinicalTrials.gov,2020-05-27,2020-05-14,True,Institut d'Investigació Sanitària Pere Virgili,Recruiting,Not Applicable,Observational,Spain,STATIN THERAPY AND COVID-19 INFECTION,Drug,Statins,Statins,1200,https://clinicaltrials.gov/show/NCT04407273,None
2401,NCT04407286,ClinicalTrials.gov,2020-05-19,2020-05-19,False,Arizona State University,Recruiting,Phase 1,Interventional,United States,Vitamin D Testing and Treatment for COVID 19,Drug,Vitamin D,Vitamin D,100,https://clinicaltrials.gov/show/NCT04407286,None
2402,NCT04407299,ClinicalTrials.gov,2020-05-23,2020-04-20,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Impact on Rheumatic Patients,Other,No Intervention,No Intervention,360,https://clinicaltrials.gov/show/NCT04407299,None
2403,NCT04407429,ClinicalTrials.gov,2020-05-27,2020-05-27,False,Medical University of Vienna,Recruiting,Not Applicable,Observational,Austria,Vienna Versus SARS-CoV-2 Virus Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04407429,None
2404,NCT04407468,ClinicalTrials.gov,2020-05-27,2020-05-01,True,Hospital General San Juan del Rio,Recruiting,Not Applicable,Observational,Mexico,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,Procedure,Positioning,Positioning,368,https://clinicaltrials.gov/show/NCT04407468,None
2405,NCT04407507,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",Drug,Ivermectin,Ivermectin,66,https://clinicaltrials.gov/show/NCT04407507,None
2406,NCT04407533,ClinicalTrials.gov,2020-05-27,2020-05-25,True,McGill University,Recruiting,Not Applicable,Observational,Canada,Dietary Intake and Eating Habits During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,1920,https://clinicaltrials.gov/show/NCT04407533,None
2407,NCT04407598,ClinicalTrials.gov,2020-05-27,2020-05-01,True,University of Leicester,Not Recruiting,Not Applicable,Observational,United Kingdom,COPD in the Time of COVID-19,Clinical Presentation,No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04407598,None
2408,NCT04408014,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Butantan Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo,Clinical Presentation (Epidemiology),No Intervention,No Intervention,18901,https://clinicaltrials.gov/show/NCT04408014,None
2409,NCT04408027,ClinicalTrials.gov,2020-05-26,2020-06-01,False,The Hospital for Sick Children,Not Recruiting,Not Applicable,Interventional,Canada,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04408027,None
2410,NCT04408040,ClinicalTrials.gov,2020-05-15,2020-06-01,False,"Northside Hospital, Inc.",Not Recruiting,Phase 2,Interventional,United States,Use of Convalescent Plasma for COVID-19,ATMP,Plasma,Plasma,700,https://clinicaltrials.gov/show/NCT04408040,None
2411,NCT04408222,ClinicalTrials.gov,2020-05-25,2020-04-16,True,Columbia University,Not Recruiting,Not Applicable,Observational,United States,Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure,Procedure,Positioning,Positioning,29,https://clinicaltrials.gov/show/NCT04408222,None
2412,NCT04408235,ClinicalTrials.gov,2020-05-26,2020-06-01,True,AOU di Modena,Not Recruiting,Phase 3,Interventional,Italy,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,Drug,Heparin,Heparin,300,https://clinicaltrials.gov/show/NCT04408235,EUCTR2020-001972-13
2413,NCT04408365,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Guy's and St Thomas' NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,"Endothelial Function, Inflammation and Organ Dysfunction in COVID-19",Clinical Presentation,No Intervention,No Intervention,82,https://clinicaltrials.gov/show/NCT04408365,None
2414,NCT04408391,ClinicalTrials.gov,2020-05-26,2020-06-01,False,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04408391,None
2415,ACTRN12620000640909,ANZCTR,2020-06-01,2020-06-08,False,University of Melbourne,Not Recruiting,Not Applicable,Interventional,Australia,"A phase II, open label non-randomised clinical trial of the safety and efficacy of the CovidCare app to support self-monitoring for COVID-19 symptoms in self-isolation and to determine the impacts on mental health",Other (software),eHealth,eHealth,200,https://anzctr.org.au/ACTRN12620000640909.aspx,None
2416,ACTRN12620000635965,ANZCTR,2020-05-29,2020-06-05,False,South Western Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,"Open label, prospective study for the Biofourmis Everion armband telemonitoring solution for patients during COVID-19 home isolation within South Western Sydney",Other (software),eHealth,eHealth,50,https://anzctr.org.au/ACTRN12620000635965.aspx,None
2417,ACTRN12620000641998,ANZCTR,2020-06-01,2020-06-03,False,University of Adelaide,Not Recruiting,Not Applicable,Observational,"United States, Australia",Ventricular Arrhythmias in Implantable Cardioverter Defibrillator Patients During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,6000,https://anzctr.org.au/ACTRN12620000641998.aspx,None
2418,ACTRN12620000636954,ANZCTR,2020-05-29,2020-06-05,False,South Western Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,COACHING FOR COVID-19: A Pilot Study Investigating the Effectiveness of Coaching on Psychological Outcomes in Hospital-Based Senior Doctors,Other (psych),Psychological,Psychological,35,https://anzctr.org.au/ACTRN12620000636954.aspx,None
2419,ACTRN12620000634976,ANZCTR,2020-05-29,2020-06-08,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing an Online Coping Skills Intervention for People Living with Chronic Illness During the Covid-19 Pandemic,Other (psych),Psychological,Psychological,46,https://anzctr.org.au/ACTRN12620000634976.aspx,None
2420,ACTRN12620000620921,ANZCTR,2020-05-28,2020-06-15,False,Rinaldo Bellomo,Not Recruiting,Not Applicable,Observational,"Italy, Canada, Belgium, Australia, Germany, United Kingdom","Angiotensin II Infusion in COVID-19-Associated Vasodilatory Shock: A multinational, multicentre registry",Clinical Presentation,No Intervention,No Intervention,315,https://anzctr.org.au/ACTRN12620000620921.aspx,None
2421,ChiCTR2000033627,ChiCTR,2020-06-07,2020-06-10,False,Rayak Hospital,Not Recruiting,Not Applicable,Interventional,Iraq,In vivo use of ivermectin (IVR) for treatment for corona virus infected patients: a randomized controlled trial,Drug,Ivermectin,Ivermectin,60,http://www.chictr.org.cn/showproj.aspx?proj=54707,None
2422,ChiCTR2000033609,ChiCTR,2020-06-07,2020-05-07,True,Yichang Central People's Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for nano short peptide nutrition intervention on the prognosis of patients with novel coronavirus pneumonia (COVID-19),Supplement,Peptides,Peptides,206,http://www.chictr.org.cn/showproj.aspx?proj=54788,None
2423,ChiCTR2000033580,ChiCTR,2020-06-06,2020-01-25,True,Yunnan CDC,Not Recruiting,Not Applicable,Observational,China,"Analysis of Characteristics of recurrent positive RT-PCR findings of recovered patients from novel coronavirus pneumonia (COVID-19) in Wuhan, China: a medical records based study",Clinical Presentation,No Intervention,No Intervention,758,http://www.chictr.org.cn/showproj.aspx?proj=54787,None
2424,ChiCTR2000033517,ChiCTR,2020-06-03,2020-06-05,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,China,Effectiveness of day care service on improving the physical and psychological well-being of people with dementia and easing the caregiving burden in COVID-19 pandemic,Other (psych),Psychological,Psychological,150,http://www.chictr.org.cn/showproj.aspx?proj=54668,None
2425,ChiCTR2000033514,ChiCTR,2020-06-03,2020-02-17,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,"A Survey Among Collage Students for Changes and impact factors of Lifestyle, Psychology and Weight During Keep Stay at Home for four months in the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",Other,No Intervention,No Intervention,14000,http://www.chictr.org.cn/showproj.aspx?proj=54579,None
2426,ChiCTR2000033491,ChiCTR,2020-06-02,2020-02-11,True,Huo-Shen-Shan Hospital,Not Recruiting,Phase 4,Interventional,China,Oral Favipiravir for Patients with Delayed SARS-Cov-2 viral RNA Clearance,Drug,Favipiravir,Favipiravir,9,http://www.chictr.org.cn/showproj.aspx?proj=54278,None
2427,ISRCTN99248812,ISRCTN,2020-05-29,2020-05-30,False,University of Oxford,Recruiting,Not Applicable,Interventional,United Kingdom,Peer support training for adolescents during the COVID-19 outbreak,Other (psych),Psychological,Psychological,100,http://isrctn.com/ISRCTN99248812,None
2428,ISRCTN15571919,ISRCTN,2020-05-28,2020-05-05,True,University of York,Recruiting,Not Applicable,Observational,"India, Bangladesh, Pakistan","Investigating the impact of COVID-19 and its response, on people with severe mental illness in South Asia",Clinical Presentation,No Intervention,No Intervention,2000,http://isrctn.com/ISRCTN15571919,None
2429,ISRCTN12107048,ISRCTN,2020-05-28,2020-06-08,False,University of Cambridge,Recruiting,Not Applicable,Interventional,United Kingdom,Supporting weight management during COVID-19,Other (exercise),Exercise,Exercise,360,http://isrctn.com/ISRCTN12107048,None
2430,ISRCTN11384058,ISRCTN,2020-05-26,2020-04-01,True,Policlinico San Martino Genoa,Recruiting,Not Applicable,Interventional,Italy,"A collaborative pilot study to monitor and optimise access to urgent surgery during the period of reduced resources in Genoa, Italy caused by the COVID-19 pandemic, using a bespoke referral process and the SWALIS 2020 model to prioritise surgery by clinical urgency and waiting time",Health System,No Intervention,No Intervention,300,http://isrctn.com/ISRCTN11384058,None
2431,ISRCTN10437835,ISRCTN,2020-05-21,2020-02-01,True,Fundación Pública Urxencias Sanitarias de Galicia,Recruiting,Not Applicable,Observational,Spain,Survival of patients suffering an out-of-hospital cardiac arrest treated by emergency services in Spain during the COVID-19 pandemic and 1 year later,Health System,No Intervention,No Intervention,4000,http://isrctn.com/ISRCTN10437835,None
2432,ISRCTN43900695,ISRCTN,2020-04-08,2020-05-04,False,Northumbria University,Not Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,Other,Sleep aids,Sleep aids,75,http://isrctn.com/ISRCTN43900695,None
2433,ISRCTN77353041,ISRCTN,2020-04-07,2020-04-08,False,University of Zurich,Not Recruiting,Not Applicable,Observational,Switzerland,Cohort study for predicting severe disease courses in patients presenting for coronavirus testing to the University of Zurich COVID-19 Testing Center,Clinical Presentation,No Intervention,No Intervention,2000,http://isrctn.com/ISRCTN77353041,None
2434,EUCTR2020-001597-30-GB,EU Clinical Trials Register,2020-04-09,2020-05-29,False,4D Pharma,Authorised,Phase 2,Interventional,"Ireland, United States, Italy, United Kingdom",A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infections,Drug,Bifidobacterium,Bifidobacterium,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001597-30,None
2435,EUCTR2020-001546-19-BE,EU Clinical Trials Register,2020-04-09,2020-04-21,False,Argenx BV,Authorised,Phase 1/Phase 2,Interventional,Belgium,A First-in-Human Study in Adult Subjects Hospitalized with Covid-19 to Investigate a new product called ARGX-117,Drug,ARGX-117,ARGX-117,6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001546-19,None
2436,EUCTR2020-002111-22-PL,EU Clinical Trials Register,2020-04-29,2020-06-26,False,University of Rzeszów,Authorised,Phase 3,Interventional,Poland,Study evaluating the impact of BCG vaccination on the incidence and course of SARS-CoV-2 infection among health care workers in Poland during the COVID-19 pandemic,Drug,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002111-22,None
2437,EUCTR2020-001904-41-GB,EU Clinical Trials Register,2020-04-30,2020-05-20,False,NHS Greater Glasgow and Clyde,Authorised,Phase 2,Interventional,United Kingdom,A study comparing favipiravir versus standard of care management as an early treatment arm in COVID-19 Hospitalized patients,Drug,Favipiravir,Favipiravir,302,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001904-41,None
2438,EUCTR2020-002091-12-BG,EU Clinical Trials Register,2020-05-05,2020-05-15,False,Huvepharma EOOD,Authorised,Phase 2,Interventional,Bulgaria,Study of ivermectin against COVID-19,Drug,Ivermectin,Ivermectin,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002091-12,None
2439,EUCTR2020-001849-39-SE,EU Clinical Trials Register,2020-04-28,2020-05-18,False,Region Skåne,Authorised,Phase 2,Interventional,Sweden,Treatment of COVID-19 with the inhalation drug pulmozyme,Drug,Dornase alfa,Dornase alfa,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001849-39,None
2440,EUCTR2020-001951-42-PL,EU Clinical Trials Register,2020-04-29,2020-05-08,False,Nicolaus Copernicus University,Authorised,Phase 3,Interventional,"Poland, Spain, Italy, Canada",Amiodarone or Verapamil in COVID-19 hospitalized patients with symptoms: Randomized clinical trial,Drug,Amiodarone vs. Verapamil,Amiodarone; Verapamil,804,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001951-42,None
2441,EUCTR2015-002340-14-NL,EU Clinical Trials Register,2015-07-13,2015-09-16,False,UMC Utrecht,Authorised,Phase 4,Interventional,"New Zealand, Spain, Netherlands, Croatia, Ireland, Greece, Denmark, Czech Republic, Finland, Hungary, Belgium, Australia, Germany, France, Romania, Portugal, United Kingdom",Adaptive trial in severe pneumonia (REMAP-CAP),Pre 2020,Pre 2020,Pre 2020,4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002340-14,None
2442,EUCTR2020-001038-36-DE,EU Clinical Trials Register,2020-04-14,2020-04-20,False,Biontech SE,Authorised,Phase 1/Phase 2,Interventional,Germany,Study to investigate the safety and effects of vaccines in healthy adults.,ATMP,Vaccine,Vaccine,196,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001038-36,None
2443,EUCTR2020-002130-33-BE,EU Clinical Trials Register,2020-05-06,2020-05-26,False,"University Hospital, Ghent",Authorised,Phase 2,Interventional,Belgium,Zilucoplan® in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Zilucoplan,Zilucoplan,81,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002130-33,None
2444,NCT04283461,ClinicalTrials.gov,2020-02-21,2020-03-16,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),ATMP,Vaccine,Vaccine,155,https://clinicaltrials.gov/show/NCT04283461,None
2445,NCT04292730,ClinicalTrials.gov,2020-02-28,2020-03-15,True,Gilead Sciences,Not Recruiting,Phase 3,Interventional,"Japan, Spain, Netherlands, South Korea, Switzerland, United States, Hong Kong, Italy, Taiwan, China, Germany, Singapore, France, Iran, Sweden, United Kingdom",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Drug,Remdesivir,Remdesivir,1600,https://clinicaltrials.gov/show/NCT04292730,EUCTR2020-000842-32
2446,NCT04292899,ClinicalTrials.gov,2020-02-28,2020-03-06,True,Gilead Sciences,Not Recruiting,Phase 3,Interventional,"Japan, Spain, Netherlands, South Korea, Switzerland, United States, Hong Kong, Italy, Taiwan, China, Germany, Singapore, France, Sweden, United Kingdom",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,Remdesivir,6000,https://clinicaltrials.gov/show/NCT04292899,EUCTR2020-000841-15
2447,NCT04320615,ClinicalTrials.gov,2020-03-23,2020-04-03,True,Roche,Not Recruiting,Phase 3,Interventional,"Spain, Netherlands, United States, Denmark, Italy, Canada, Germany, France, United Kingdom",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,450,https://clinicaltrials.gov/show/NCT04320615,EUCTR2020-001154-22
2448,NCT04322123,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Hospital do Coração,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithromycin,630,https://clinicaltrials.gov/show/NCT04322123,None
2449,NCT04322188,ClinicalTrials.gov,2020-03-24,2020-03-19,True,A.O. Ospedale Papa Giovanni XXIII,Not Recruiting,Not Applicable,Observational,Italy,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,Drug,Siltuximab,Siltuximab,220,https://clinicaltrials.gov/show/NCT04322188,None
2450,NCT04323228,ClinicalTrials.gov,2020-03-23,2020-07-01,False,King Saud University,Not Recruiting,Phase 4,Interventional,No Country Given,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,Supplement,Oral nutrition supplement,Oral nutrition supplement,30,https://clinicaltrials.gov/show/NCT04323228,None
2451,NCT04329832,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"Intermountain Health Care, Inc.",Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; azithromycin,300,https://clinicaltrials.gov/show/NCT04329832,None
2452,NCT04334967,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Providence Health & Services,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Drug,Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,13,https://clinicaltrials.gov/show/NCT04334967,None
2453,NCT04335747,ClinicalTrials.gov,2020-04-03,2020-04-23,False,Salome Kristensen,Recruiting,Not Applicable,Observational,Denmark,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Clinical Presentation,No Intervention,No Intervention,333,https://clinicaltrials.gov/show/NCT04335747,None
2454,NCT04336345,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Not Recruiting,Not Applicable,Observational,Mexico,Outcomes of Patients With COVID-19 in the Intensive Care Unit,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04336345,None
2455,NCT04337788,ClinicalTrials.gov,2020-04-03,2020-05-01,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04337788,None
2456,NCT04344509,ClinicalTrials.gov,2020-04-10,2020-06-01,False,Poitiers University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04344509,None
2457,NCT04344600,ClinicalTrials.gov,2020-04-10,2020-05-29,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,Drug,Interferon lambda,Interferon lambda,164,https://clinicaltrials.gov/show/NCT04344600,None
2458,NCT04344951,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Drug,Chloroquine,Chloroquine,60,https://clinicaltrials.gov/show/NCT04344951,None
2459,NCT04347278,ClinicalTrials.gov,2020-04-03,2020-04-22,False,Instituto de Investigacin Marqus de Valdecilla,Recruiting,Not Applicable,Observational,Spain,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,Drug,Unspecified,Unspecified,1000,https://clinicaltrials.gov/show/NCT04347278,None
2460,NCT04348214,ClinicalTrials.gov,2020-04-13,2020-04-22,False,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04348214,None
2461,NCT04348513,ClinicalTrials.gov,2020-04-09,2020-05-29,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Drug,Triiodothyronine,Triiodothyronine,60,https://clinicaltrials.gov/show/NCT04348513,None
2462,NCT04351243,ClinicalTrials.gov,2020-04-15,2020-04-12,True,Kinevant Sciences GmbH,Recruiting,Phase 2,Interventional,United States,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE).,Drug,Grimsilumab,Grimsilumab,270,https://clinicaltrials.gov/show/NCT04351243,None
2463,NCT04355364,ClinicalTrials.gov,2020-04-15,2020-04-21,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Phase 3,Interventional,France,Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE),Drug,Dornase alfa,Dornase alfa,100,https://clinicaltrials.gov/show/NCT04355364,None
2464,NCT04355442,ClinicalTrials.gov,2020-04-16,2020-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Evolution of Facial Trauma During COVID Containment Measures,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04355442,None
2465,NCT04357340,ClinicalTrials.gov,2020-04-13,2020-04-02,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04357340,None
2466,NCT04359407,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Walid Habre,Recruiting,Not Applicable,Observational,Switzerland,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients,Procedure,Positioning,Positioning,16,https://clinicaltrials.gov/show/NCT04359407,None
2467,NCT04363736,ClinicalTrials.gov,2020-04-21,2020-05-05,False,Roche,Recruiting,Phase 2,Interventional,United States,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,100,https://clinicaltrials.gov/show/NCT04363736,None
2468,NCT04363827,ClinicalTrials.gov,2020-04-24,2020-05-14,False,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Phase 2,Interventional,Italy,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Drug (+ Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2300,https://clinicaltrials.gov/show/NCT04363827,None
2469,NCT04365322,ClinicalTrials.gov,2020-04-25,2020-04-20,True,CHU de Besançon,Recruiting,Not Applicable,Observational,France,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04365322,None
2470,NCT04370210,ClinicalTrials.gov,2020-04-29,2020-05-04,False,Centre Hospitalier René Dubos,Recruiting,Not Applicable,Observational,France,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,Other (psych),No Intervention,No Intervention,464,https://clinicaltrials.gov/show/NCT04370210,None
2471,NCT04370236,ClinicalTrials.gov,2020-04-29,2020-07-01,False,"Inmune Bio, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,XPro1595 for the Treatment of Pulmonary Complications From COVID-19,Drug,XPro1595,XPro1595,366,https://clinicaltrials.gov/show/NCT04370236,None
2472,NCT04370886,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19,Other,No Intervention,No Intervention,456517,https://clinicaltrials.gov/show/NCT04370886,None
2473,NCT04373044,ClinicalTrials.gov,2020-04-17,2020-05-01,False,University of Southern California,Recruiting,Phase 2,Interventional,United States,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",Drug,Baricitinib + one of Hydroxychloroquine or Lopinavir/ritonavir or Remdesivir,Baricitinib; Hydroxychloroquine; Lopinavir/ritonavir; Remdesivir,144,https://clinicaltrials.gov/show/NCT04373044,None
2474,NCT04374461,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of N-acetylcysteine in Patients With COVID-19 Infection,Drug,N-acetylcysteine,N-acetylcysteine,86,https://clinicaltrials.gov/show/NCT04374461,None
2475,NCT04377672,ClinicalTrials.gov,2020-05-04,2020-05-28,False,Johns Hopkins University,Recruiting,Phase 1,Interventional,United States,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04377672,None
2476,NCT04384965,ClinicalTrials.gov,2020-05-08,2020-05-12,False,Centre for Addiction and Mental Health,Recruiting,Not Applicable,Interventional,Canada,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,Other (psych),Electroconvulsive Therapy,Electroconvulsive Therapy,200,https://clinicaltrials.gov/show/NCT04384965,None
2477,NCT04385186,ClinicalTrials.gov,2020-05-06,2020-06-20,False,"National Blood Center Foundation, Hemolife",Not Recruiting,Phase 2,Interventional,Colombia,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04385186,None
2478,NCT04385849,ClinicalTrials.gov,2020-05-07,2020-06-01,False,"ImmunityBio, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,Drug,N-803,N-803,30,https://clinicaltrials.gov/show/NCT04385849,None
2479,NCT04389554,ClinicalTrials.gov,2020-05-14,2020-05-14,False,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,D-dimer Levels in Pregnant With COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04389554,None
2480,NCT04391179,ClinicalTrials.gov,2020-05-15,2020-05-31,False,Yogendra Kanthi,Recruiting,Phase 2,Interventional,United States,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,Drug,Dipyridamole,Dipyridamole,80,https://clinicaltrials.gov/show/NCT04391179,None
2481,NCT04393233,ClinicalTrials.gov,2020-04-22,2020-04-23,False,"University Hospital, Brest",Recruiting,Not Applicable,Observational,France,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04393233,None
2482,NCT04396067,ClinicalTrials.gov,2020-05-18,2020-06-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Combination With Inhibitor of Neutrophil Elastase (All-trans Retinoic Acid ) and Isotretinoin May Enhances Neutralizing Antibodies in COVID -19 Infected Patients Better Than COVID-19 Inactivated Vaccines,Drug,Retinoic acid,Retinoic acid,360,https://clinicaltrials.gov/show/NCT04396067,None
2483,NCT04397757,ClinicalTrials.gov,2020-05-19,2020-05-13,True,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04397757,None
2484,NCT04397796,ClinicalTrials.gov,2020-05-18,2020-06-01,False,"NantKwest, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,ATMP,Cells (mesenchymal),Cells (mesenchymal),45,https://clinicaltrials.gov/show/NCT04397796,None
2485,NCT04401085,ClinicalTrials.gov,2020-05-21,2020-04-23,True,Institute of Health Information and Statistics of the Czech Republic,Not Recruiting,Not Applicable,Observational,Czech Republic,COVID-19: Herd Immunity Study in the Czech Republic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,27000,https://clinicaltrials.gov/show/NCT04401085,None
2486,NCT04401475,ClinicalTrials.gov,2020-05-21,2020-08-01,False,Edesa Biotech Inc.,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With Moderate to Severe COVID-19 Pneumonia",Drug,EB05,EB05,865,https://clinicaltrials.gov/show/NCT04401475,None
2487,NCT04402827,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Asociación para el Estudio de las Enfermedades Infecciosas,Recruiting,Not Applicable,Observational,Spain,Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04402827,None
2488,NCT04402879,ClinicalTrials.gov,2020-05-22,2020-05-25,False,University of Calgary,Recruiting,Not Applicable,Interventional,Canada,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,Procedure,Positioning,Positioning,596,https://clinicaltrials.gov/show/NCT04402879,None
2489,NCT04403932,ClinicalTrials.gov,2020-05-24,2020-04-17,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Observational,Spain,Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04403932,None
2490,NCT04405544,ClinicalTrials.gov,2020-05-26,2020-05-22,True,Ministry of Health of Russia,Recruiting,Not Applicable,Interventional,Russian Federation,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04405544,None
2491,NCT04405973,ClinicalTrials.gov,2020-05-25,2020-05-19,True,Dr. Alexander Supady,Recruiting,Not Applicable,Observational,Germany,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO,Prognosis,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04405973,None
2492,NCT04405986,ClinicalTrials.gov,2020-05-08,2020-05-19,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Exploring Brain Damages After COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,38,https://clinicaltrials.gov/show/NCT04405986,None
2493,NCT04406181,ClinicalTrials.gov,2020-04-28,2020-05-18,False,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04406181,None
2494,NCT04406545,ClinicalTrials.gov,2020-05-23,2020-05-15,True,"National Institute of Cardiology, Laranjeiras, Brazil",Recruiting,Not Applicable,Observational,Brazil,Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04406545,None
2495,NCT04407143,ClinicalTrials.gov,2020-05-25,2020-04-15,True,Fundación GECP,Recruiting,Not Applicable,Observational,Spain,Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04407143,None
2496,NCT04407169,ClinicalTrials.gov,2020-04-14,2020-06-01,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04407169,None
2497,NCT04407182,ClinicalTrials.gov,2020-05-25,2020-05-04,True,Catalysis SL,Recruiting,Phase 2,Interventional,Ecuador,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,Supplement,Viusid + Asbrip,Viusid + Asbrip,60,https://clinicaltrials.gov/show/NCT04407182,None
2498,NCT04407195,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Northeastern University,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Mental Health,Other (psych),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04407195,None
2499,NCT04407208,ClinicalTrials.gov,2020-05-16,2020-05-01,True,Biofarma,Recruiting,Phase 1,Interventional,Indonesia,Convalescent Plasma Therapy in Patients With COVID-19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04407208,None
2500,NCT04407260,ClinicalTrials.gov,2020-05-27,2020-03-06,True,Northwell Health,Not Recruiting,Not Applicable,Observational,United States,"The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Intubation and Mortality Rates in Hypoxic Patients With COVID-19.",Other (device),Hood,Hood,136,https://clinicaltrials.gov/show/NCT04407260,None
2501,NCT04407390,ClinicalTrials.gov,2020-05-22,2020-06-01,False,University of Copenhagen,Recruiting,Phase 2,Interventional,Denmark,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,Supplement,Nicotinamide riboside,Nicotinamide riboside,100,https://clinicaltrials.gov/show/NCT04407390,None
2502,NCT04407494,ClinicalTrials.gov,2020-05-27,2020-03-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,809,https://clinicaltrials.gov/show/NCT04407494,None
2503,NCT04407559,ClinicalTrials.gov,2020-05-27,2020-05-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,COVID-SErology in Rheumatoid Arthritis (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,216,https://clinicaltrials.gov/show/NCT04407559,None
2504,NCT04407663,ClinicalTrials.gov,2020-05-27,2020-03-03,True,"University of Campania ""Luigi Vanvitelli""",Not Recruiting,Not Applicable,Observational,Italy,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near",Telehealth,Telehealth,Telehealth,138,https://clinicaltrials.gov/show/NCT04407663,None
2505,NCT04407923,ClinicalTrials.gov,2020-05-28,2020-05-25,True,"University Hospital, Brest",Recruiting,Not Applicable,Observational,France,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment,Other,Other,Other,150,https://clinicaltrials.gov/show/NCT04407923,None
2506,NCT04408131,ClinicalTrials.gov,2020-05-28,2020-05-28,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04408131,None
2507,NCT04408157,ClinicalTrials.gov,2020-05-26,2020-05-20,True,King's College London,Not Recruiting,Not Applicable,Interventional,No Country Given,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,548,https://clinicaltrials.gov/show/NCT04408157,None
2508,NCT04408170,ClinicalTrials.gov,2020-05-26,2020-06-01,True,Manchester University NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04408170,ISRCTN86124626
2509,NCT04408196,ClinicalTrials.gov,2020-05-21,2020-05-25,False,Fondazione Don Carlo Gnocchi Onlus,Not Recruiting,Not Applicable,Observational,No Country Given,QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04408196,None
2510,NCT04408209,ClinicalTrials.gov,2020-05-25,2020-04-23,True,National and Kapodistrian University of Athens,Recruiting,Not Applicable,Interventional,Greece,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04408209,None
2511,NCT04408287,ClinicalTrials.gov,2020-05-20,2020-06-01,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,Improving Activity Engagement Among Persons With SCI During COVID-19,Other (exercise),Exercise,Exercise,50,https://clinicaltrials.gov/show/NCT04408287,None
2512,NCT04408378,ClinicalTrials.gov,2020-05-27,2020-06-05,False,Gaziosmanpasa Taksim Research and Education Hospital,Recruiting,Not Applicable,Observational,Turkey,Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients,Clinical Presentation,No Intervention,No Intervention,156,https://clinicaltrials.gov/show/NCT04408378,None
2513,NCT04408456,ClinicalTrials.gov,2020-05-24,2020-03-01,True,Postgraduate Institute of Medical Education and Research,Recruiting,Phase 3,Interventional,India,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04408456,None
2514,NCT04409184,ClinicalTrials.gov,2020-05-28,2020-05-01,True,Medical College of Wisconsin,Not Recruiting,Not Applicable,Observational,No Country Given,Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04409184,None
2515,NCT04409197,ClinicalTrials.gov,2020-05-18,2020-05-08,True,"University Hospital, Grenoble",Recruiting,Not Applicable,Observational,France,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",Clinical Presentation,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04409197,None
2516,NCT04409327,ClinicalTrials.gov,2020-05-28,2020-05-01,True,Restorbio Inc.,Recruiting,Phase 3,Interventional,United States,Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,Drug,RTB101,RTB101,550,https://clinicaltrials.gov/show/NCT04409327,None
2517,NCT04409483,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Epicentre,Not Recruiting,Phase 3,Interventional,No Country Given,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,928,https://clinicaltrials.gov/show/NCT04409483,None
2518,NCT04409509,ClinicalTrials.gov,2020-05-28,2020-06-01,False,CSL Behring,Not Recruiting,Phase 2,Interventional,No Country Given,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),Drug,Garadacimab,Garadacimab,124,https://clinicaltrials.gov/show/NCT04409509,None
2519,NCT04409522,ClinicalTrials.gov,2020-05-28,2020-05-12,True,Mohammad Sadegh Bagheri Baghdasht,Recruiting,Not Applicable,Interventional,Iran,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,Drug,Melatonin,Melatonin,55,https://clinicaltrials.gov/show/NCT04409522,None
2520,NCT04409535,ClinicalTrials.gov,2020-05-11,2020-05-07,True,University of New Mexico,Not Recruiting,Not Applicable,Observational,United States,Effects of the COVID-19 Health Emergency on Biopsychosocial Health,Other (psych),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04409535,None
2521,NCT04409743,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Stanford University,Recruiting,Not Applicable,Interventional,United States,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04409743,None
2522,NCT04409821,ClinicalTrials.gov,2020-05-22,2020-06-01,False,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Interventional,No Country Given,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04409821,None
2523,NCT04409847,ClinicalTrials.gov,2020-05-22,2020-06-01,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX),Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04409847,None
2524,NCT04409873,ClinicalTrials.gov,2020-05-28,2020-07-01,False,"University of California, San Francisco",Not Recruiting,Phase 2,Interventional,United States,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),Drug,Mouthwash,Mouthwash,120,https://clinicaltrials.gov/show/NCT04409873,None
2525,NCT04409899,ClinicalTrials.gov,2020-05-26,2020-03-20,True,Fundacio Puigvert,Recruiting,Not Applicable,Observational,Spain,The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department,Other (exercise),Exercise,Exercise,300,https://clinicaltrials.gov/show/NCT04409899,None
2526,NCT04409951,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Damanhour University,Not Recruiting,Not Applicable,Observational,Egypt,Pharmacy Education During Covid-19 Outbreak,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04409951,None
2527,NCT04410107,ClinicalTrials.gov,2020-05-25,2020-05-15,True,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Observational,Brazil,"Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19",Clinical Presentation,No Intervention,No Intervention,134,https://clinicaltrials.gov/show/NCT04410107,None
2528,NCT04410263,ClinicalTrials.gov,2020-05-18,2020-04-09,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,ATMP,Intestinal microbiome,Intestinal microbiome,300,https://clinicaltrials.gov/show/NCT04410263,None
2529,NCT04410328,ClinicalTrials.gov,2020-05-28,2020-06-21,False,Rutgers University,Not Recruiting,Phase 3,Interventional,No Country Given,Aggrenox To Treat Acute Covid-19,Drug,Dipyridamole,Dipyridamole,132,https://clinicaltrials.gov/show/NCT04410328,None
2530,NCT04410458,ClinicalTrials.gov,2020-05-29,2020-05-31,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial),Other,Other,Other,506517,https://clinicaltrials.gov/show/NCT04410458,None
2531,NCT04410471,ClinicalTrials.gov,2020-05-29,2020-05-29,False,Magdalena Salcedo,Recruiting,Not Applicable,Observational,Spain,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04410471,None
2532,NCT04410510,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Hospital Universitario San Ignacio,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,Drug,P2Et,P2Et,100,https://clinicaltrials.gov/show/NCT04410510,None
2533,NCT04410536,ClinicalTrials.gov,2020-05-25,2020-06-01,False,Fondazione IRCCS Istituto Neurologico Carlo Besta,Not Recruiting,Not Applicable,Interventional,Italy,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,Other,Other,Other,25,https://clinicaltrials.gov/show/NCT04410536,None
2534,NCT04410549,ClinicalTrials.gov,2020-05-21,2020-05-27,False,IRCCS Ospedale San Raffaele,Recruiting,Not Applicable,Interventional,Italy,Pulmonary Optical Coherence Tomography in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04410549,None
2535,NCT04410562,ClinicalTrials.gov,2020-05-26,2020-05-13,True,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy,Drug,Hydroxychloroquine,Hydroxychloroquine,714,https://clinicaltrials.gov/show/NCT04410562,None
2536,NCT04410692,ClinicalTrials.gov,2020-05-27,2020-05-15,True,"National University, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Can the Prediction Market Improve Predictions of COVID-19?,Other,Other,Other,560,https://clinicaltrials.gov/show/NCT04410692,None
2537,NCT04410718,ClinicalTrials.gov,2020-05-05,2020-04-20,True,Steno Diabetes Center Copenhagen,Recruiting,Not Applicable,Observational,Denmark,Glycaemia and Cardiac Function in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04410718,None
2538,NCT04410939,ClinicalTrials.gov,2020-05-22,2020-04-10,True,Istanbul Medipol University Hospital,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 PCR Test Results in Asymptomatic Pregnants,Clinical Presentation (Epidemiology),No Intervention,No Intervention,179,https://clinicaltrials.gov/show/NCT04410939,None
2539,NCT04411433,ClinicalTrials.gov,2020-05-23,2020-05-08,True,"Ministry of Health, Turkey",Recruiting,Phase 3,Interventional,Turkey,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,Drug,Favipiravir vs. Favipiravir + Hydroxychloroquine vs. Favipiravir + Azithromycin vs. Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Favipiravir; Azithromycin; Hydroxychloroquine,1000,https://clinicaltrials.gov/show/NCT04411433,None
2540,NCT04411511,ClinicalTrials.gov,2020-05-20,2020-05-06,True,Academic Hospital Maastricht,Recruiting,Not Applicable,Observational,Netherlands,"COVID-19, Obesity and Lifestyle in Children",Clinical Presentation,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04411511,None
2541,NCT04411563,ClinicalTrials.gov,2020-05-25,2020-05-21,True,Bakırköy Dr. Sadi Konuk Research And Training Hospital,Recruiting,Not Applicable,Observational,Turkey,Epigenetic Tools as Prognostic Predictors in Covid19,Prognosis,No Intervention,No Intervention,105,https://clinicaltrials.gov/show/NCT04411563,None
2542,NCT04411602,ClinicalTrials.gov,2020-05-22,2020-04-07,True,Ascension South East Michigan,Recruiting,Phase 1,Interventional,United States,Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD,ATMP,Plasma,Plasma,90,https://clinicaltrials.gov/show/NCT04411602,None
2543,NCT04411680,ClinicalTrials.gov,2020-05-29,2020-06-01,False,"Partner Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Study of Sargramostim in Patients With COVID-19,Drug,Sargramostim,Sargramostim,60,https://clinicaltrials.gov/show/NCT04411680,None
2544,NCT04412226,ClinicalTrials.gov,2020-05-31,2020-06-10,False,Derince Training and Research Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of Using Barrier Devices for Intubation in COVID-19 Patients,Other (device),Barrier,Barrier,13,https://clinicaltrials.gov/show/NCT04412226,None
2545,NCT04412239,ClinicalTrials.gov,2020-05-30,2020-04-20,True,Health Science Center of Xi'an Jiaotong University,Recruiting,Not Applicable,Interventional,Pakistan,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04412239,None
2546,NCT04412343,ClinicalTrials.gov,2020-05-29,2020-05-30,False,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,The Seniors COvid-19 Pandemic and Exercise Study,Other (exercise),Exercise,Exercise,600,https://clinicaltrials.gov/show/NCT04412343,None
2547,NCT04412369,ClinicalTrials.gov,2020-05-27,2020-06-01,False,University of Cambridge,Not Recruiting,Not Applicable,Observational,United Kingdom,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04412369,None
2548,NCT04412382,ClinicalTrials.gov,2020-05-26,2020-06-01,False,AOUI Verona,Not Recruiting,Not Applicable,Observational,No Country Given,Covid-19: Possible Role of Neutrophil Extracellular Traps,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04412382,None
2549,NCT04412395,ClinicalTrials.gov,2020-05-15,2020-06-01,False,"National Research Center, Egypt",Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,Supplement,Lactoferrin,Lactoferrin,516,https://clinicaltrials.gov/show/NCT04412395,None
2550,NCT04412460,ClinicalTrials.gov,2020-05-20,2020-03-20,True,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Echocardiography in Patients With Covid-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04412460,None
2551,NCT04412473,ClinicalTrials.gov,2020-05-27,2020-04-30,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04412473,None
2552,NCT04412486,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Dr. Gailen D. Marshall Jr.,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma (CCP) Transfusion,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04412486,None
2553,NCT04413058,ClinicalTrials.gov,2020-05-27,2020-04-10,True,Haydarpasa Numune Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Menstrual Cycle Characteristics of Healthcare Professionals,Other,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04413058,None
2554,NCT04413877,ClinicalTrials.gov,2020-05-25,2020-10-01,False,University of Liège,Not Recruiting,Not Applicable,Observational,No Country Given,Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),Other (software),eHealth,eHealth,600,https://clinicaltrials.gov/show/NCT04413877,None
2555,NCT04306497,ClinicalTrials.gov,2020-03-01,2020-01-22,True,"Jiangsu Famous Medical Technology Co., Ltd.",Not Recruiting,Not Applicable,Observational,China,TCM Differentiation and Treatment Protocol of COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,340,https://clinicaltrials.gov/show/NCT04306497,None
2556,NCT04311697,ClinicalTrials.gov,2020-03-14,2020-05-15,False,"NeuroRx, Inc.",Recruiting,Phase 2,Interventional,"Israel, United States",Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,Drug,Aviptadil,Aviptadil,144,https://clinicaltrials.gov/show/NCT04311697,None
2557,NCT04315948,ClinicalTrials.gov,2020-03-13,2020-03-22,True,INSERM,Recruiting,Phase 3,Interventional,"France, Luxembourg",Trial of Treatments for COVID-19 in Hospitalized Adults,Drug,Remdesivir vs. Lopinavir/ritonavir vs. Lopinavir/ritonavir + Interferon beta vs. Hydroxychloroquine,Remdesivir; Lopinavir/ritonavir; Interferon beta; Hydroxychloroquine,3100,https://clinicaltrials.gov/show/NCT04315948,EUCTR2020-000936-23
2558,NCT04326114,ClinicalTrials.gov,2020-03-26,2020-07-26,False,Complutense University of Madrid,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Other (training),Other,Other,240,https://clinicaltrials.gov/show/NCT04326114,None
2559,NCT04327401,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Hospital Sírio-Libanês,Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Drug,Dexamethasone,Dexamethasone,350,https://clinicaltrials.gov/show/NCT04327401,None
2560,NCT04327505,ClinicalTrials.gov,2020-03-25,2020-06-03,True,Karolinska Institutet,Recruiting,Phase 2/Phase 3,Interventional,"Sweden, Germany",Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04327505,EUCTR2020-001349-37; DRKS00021626
2561,NCT04327531,ClinicalTrials.gov,2020-03-27,2020-03-26,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04327531,None
2562,NCT04332081,ClinicalTrials.gov,2020-03-30,2020-04-06,False,NYU Langone Health,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,Drug,Oxygen,Oxygen,20,https://clinicaltrials.gov/show/NCT04332081,None
2563,NCT04333654,ClinicalTrials.gov,2020-04-01,2020-04-12,False,Sanofi,Not Recruiting,Phase 1,Interventional,"Belgium, France, United States, Netherlands",Hydroxychloroquine in Outpatient Adults With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,210,https://clinicaltrials.gov/show/NCT04333654,None
2564,NCT04336410,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Inovio Pharmaceuticals,Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Drug,INO-4800,INO-4800,120,https://clinicaltrials.gov/show/NCT04336410,None
2565,NCT04339816,ClinicalTrials.gov,2020-04-06,2020-05-13,True,Frantisek Duska,Recruiting,Phase 3,Interventional,Czech Republic,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,240,https://clinicaltrials.gov/show/NCT04339816,EUCTR2020-001456-18
2566,NCT04340479,ClinicalTrials.gov,2020-04-06,2020-06-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Observational,United States,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://clinicaltrials.gov/show/NCT04340479,None
2567,NCT04341142,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,130,https://clinicaltrials.gov/show/NCT04341142,None
2568,NCT04343092,ClinicalTrials.gov,2020-04-05,2020-04-18,False,University of Baghdad,Not Recruiting,Phase 1,Interventional,Iraq,Efficacy of Ivermectin as Add on Therapy in COVID19 Patients,Drug,Ivermectin + hydroxychloroquine vs. hydroxychloroquine,Ivermectin; hydroxychloroquine,100,https://clinicaltrials.gov/show/NCT04343092,None
2569,NCT04343248,ClinicalTrials.gov,2020-04-08,2020-05-12,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),Drug (Chemoprophylaxis),Nitazoxanide,Nitazoxanide,800,https://clinicaltrials.gov/show/NCT04343248,None
2570,NCT04345276,ClinicalTrials.gov,2020-04-10,2020-03-18,True,Huo-Shen-Shan Hospital,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir,Danoprevir; Ritonavir,10,https://clinicaltrials.gov/show/NCT04345276,None
2571,NCT04345692,ClinicalTrials.gov,2020-04-09,2020-03-26,True,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04345692,None
2572,NCT04347512,ClinicalTrials.gov,2020-04-11,2020-06-02,False,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,No Country Given,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04347512,None
2573,NCT04347798,ClinicalTrials.gov,2020-04-13,2020-09-01,False,University of Alberta,Recruiting,Not Applicable,Observational,Canada,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,Drug,Hydroxychloroquine or Chloroquine,Hydroxychloroquine; Chloroquine,500,https://clinicaltrials.gov/show/NCT04347798,None
2574,NCT04347824,ClinicalTrials.gov,2020-04-09,2020-04-27,False,"University Hospital, Göttingen",Recruiting,Not Applicable,Observational,Germany,Predict Adverse Events by Covid-19 Nephritis,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04347824,None
2575,NCT04348500,ClinicalTrials.gov,2020-04-13,2020-04-24,False,Cedars-Sinai Medical Center,Recruiting,Phase 2,Interventional,United States,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,Drug,Clazakizumab,Clazakizumab,60,https://clinicaltrials.gov/show/NCT04348500,None
2576,NCT04352985,ClinicalTrials.gov,2020-04-15,2020-05-29,False,Spectral Diagnostics (US) Inc.,Not Recruiting,Not Applicable,Expanded Access,United States,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,Other (device),Hemoperfusion,Hemoperfusion,Not Available,https://clinicaltrials.gov/show/NCT04352985,None
2577,NCT04355936,ClinicalTrials.gov,2020-04-17,2020-05-19,False,Laboratorio Elea,Recruiting,Phase 2,Interventional,Argentina,Telmisartan for Treatment of COVID-19 Patients,Drug,Telmisartan,Telmisartan,400,https://clinicaltrials.gov/show/NCT04355936,None
2578,NCT04356482,ClinicalTrials.gov,2020-04-17,2020-05-20,False,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Recruiting,Phase 1/Phase 2,Interventional,Mexico,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,ATMP,Plasma,Plasma,90,https://clinicaltrials.gov/show/NCT04356482,None
2579,NCT04358003,ClinicalTrials.gov,2020-04-20,2020-05-20,False,Marker Therapeutics AG,Recruiting,Not Applicable,Interventional,United States,Plasma Adsorption in Patients With Confirmed COVID-19,Other (device),Plasma Adsorption Cartridge,Plasma Adsorption Cartridge,2000,https://clinicaltrials.gov/show/NCT04358003,None
2580,NCT04359511,ClinicalTrials.gov,2020-04-20,2020-06-01,False,CHU de Tours,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Drug,Corticosteroids,Prednisone; Hydrocortisone,210,https://clinicaltrials.gov/show/NCT04359511,None
2581,NCT04359680,ClinicalTrials.gov,2020-04-20,2020-05-13,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers,Drug (Chemoprophylaxis),Nitazoxanide,Nitazoxanide,800,https://clinicaltrials.gov/show/NCT04359680,None
2582,NCT04359901,ClinicalTrials.gov,2020-04-20,2020-04-10,True,Westyn Branch-Elliman,Recruiting,Phase 2,Interventional,United States,Sarilumab for Patients With Moderate COVID-19 Disease,Drug,Sarilumab,Sarilumab,120,https://clinicaltrials.gov/show/NCT04359901,None
2583,NCT04361838,ClinicalTrials.gov,2020-04-16,2020-06-01,False,Kansas City Heart Rhythm Institute,Recruiting,Not Applicable,Interventional,United States,The COVID-19 ICU PRAYER Study,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04361838,None
2584,NCT04367870,ClinicalTrials.gov,2020-04-28,2020-05-23,False,UNICANCER,Recruiting,Not Applicable,Observational,France,COVID-19 Detection Test in Oncology,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04367870,None
2585,NCT04371926,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04371926,None
2586,NCT04372589,ClinicalTrials.gov,2020-04-24,2020-05-20,False,University of Manitoba,Recruiting,Phase 2/Phase 3,Interventional,"Brazil, Mexico, United States, Canada",Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),Drug,Heparin,Heparin,3000,https://clinicaltrials.gov/show/NCT04372589,None
2587,NCT04374084,ClinicalTrials.gov,2020-04-20,2020-05-10,False,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Recruiting,Not Applicable,Interventional,China,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04374084,None
2588,NCT04374786,ClinicalTrials.gov,2020-05-01,2020-05-15,False,University of Arizona,Recruiting,Not Applicable,Interventional,United States,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,Other (psych),Psychological,Psychological,328,https://clinicaltrials.gov/show/NCT04374786,None
2589,NCT04382040,ClinicalTrials.gov,2020-05-07,2020-05-08,False,MGC Pharmaceuticals,Recruiting,Phase 2,Interventional,Israel,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",Drug,Artemisinin + Curcumin + Frankincense + Vitamin C,Artemisinin; Curcumin; Frankincense; Vitamin C,50,https://clinicaltrials.gov/show/NCT04382040,None
2590,NCT04382066,ClinicalTrials.gov,2020-05-07,2020-05-12,False,PharmaMar,Recruiting,Phase 1,Interventional,Spain,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,Drug,Plitidepsin,Plitidepsin,27,https://clinicaltrials.gov/show/NCT04382066,None
2591,NCT04382950,ClinicalTrials.gov,2020-05-08,2020-07-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme + retonic acid,ACE enzyme + retonic acid,24,https://clinicaltrials.gov/show/NCT04382950,None
2592,NCT04384458,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Federal University of Ceara,Not Recruiting,Not Applicable,Interventional,Brazil,COVID-19 Prophylaxis With Hydroxychloroquine Associated With Zinc For High-Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,Hydroxychloroquine; Zinc,400,https://clinicaltrials.gov/show/NCT04384458,None
2593,NCT04385251,ClinicalTrials.gov,2020-05-08,2020-06-15,False,University of Minnesota,Not Recruiting,Not Applicable,Observational,"Argentina, United States, Denmark, United Kingdom",International SARS-CoV-2 (COVID-19) Infection Observational Study,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04385251,None
2594,NCT04385901,ClinicalTrials.gov,2020-05-06,2020-05-19,False,University of Missouri-Columbia,Recruiting,Not Applicable,Interventional,United States,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,72,https://clinicaltrials.gov/show/NCT04385901,None
2595,NCT04385940,ClinicalTrials.gov,2020-05-08,2020-06-01,False,University of Alberta,Not Recruiting,Phase 3,Interventional,No Country Given,Vitamin D and COVID-19 Management,Drug,Vitamin D,Vitamin D,64,https://clinicaltrials.gov/show/NCT04385940,None
2596,NCT04389567,ClinicalTrials.gov,2020-05-13,2020-05-12,True,Northwell Health,Not Recruiting,Not Applicable,Observational,United States,Famotidine Outpatient COVID-19 Treatment Study,Drug,Famotidine,Famotidine,10,https://clinicaltrials.gov/show/NCT04389567,None
2597,NCT04389580,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,Drug,Isotretinoin + Tamoxifen,Isotretinoin; Tamoxifen,160,https://clinicaltrials.gov/show/NCT04389580,None
2598,NCT04392414,ClinicalTrials.gov,2020-05-13,2020-05-01,True,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",Recruiting,Phase 2,Interventional,Russian Federation,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04392414,None
2599,NCT04393246,ClinicalTrials.gov,2020-05-16,2020-06-15,False,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,Drug,EDP1815 vs. Ambrisentan + Dapagliflozin,EDP1815; Ambrisentan; Dapagliflozin,1407,https://clinicaltrials.gov/show/NCT04393246,None
2600,NCT04394416,ClinicalTrials.gov,2020-05-08,2020-06-02,False,"University of Maryland, Baltimore",Recruiting,Phase 3,Interventional,United States,Trial of Imatinib for Hospitalized Adults With COVID-19,Drug,Imatinib,Imatinib,204,https://clinicaltrials.gov/show/NCT04394416,None
2601,NCT04395508,ClinicalTrials.gov,2020-05-15,2020-06-01,False,"Genentech, Inc.",Not Recruiting,Not Applicable,Expanded Access,United States,An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic,Not relevant,Not relevant,Not relevant,Not Available,https://clinicaltrials.gov/show/NCT04395508,None
2602,NCT04395924,ClinicalTrials.gov,2020-05-19,2020-05-05,True,Centre Hospitalier Régional d'Orleans,Recruiting,Not Applicable,Observational,France,Maternal-foetal Transmission of SARS-Cov-2,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04395924,None
2603,NCT04400279,ClinicalTrials.gov,2020-05-21,2020-06-01,False,University of British Columbia,Not Recruiting,Not Applicable,Interventional,No Country Given,The COVID-19 Pandemic and Exercise Study,Other (exercise),Exercise,Exercise,490,https://clinicaltrials.gov/show/NCT04400279,None
2604,NCT04403607,ClinicalTrials.gov,2020-05-20,2020-05-22,False,NHS Greater Glasgow and Clyde,Recruiting,Not Applicable,Observational,United Kingdom,Cardiac Imaging in SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04403607,None
2605,NCT04408066,ClinicalTrials.gov,2020-04-30,2020-04-30,False,LumiraDx UK Limited,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: A POC Test Under Research & Evaluation,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,https://clinicaltrials.gov/show/NCT04408066,None
2606,NCT04408183,ClinicalTrials.gov,2020-05-22,2020-06-01,False,"GeneOne Life Science, Inc.",Recruiting,Phase 2,Interventional,United States,GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,Drug (Chemoprophylaxis),GLS-1200,GLS-1200,225,https://clinicaltrials.gov/show/NCT04408183,None
2607,NCT04408326,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Guy's and St Thomas' NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome,Drug,Angiotensin II vs. Interleukin-1,Angiotensin II; Interleukin-1,50,https://clinicaltrials.gov/show/NCT04408326,None
2608,NCT04409496,ClinicalTrials.gov,2020-05-26,2020-06-01,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Chat-based Support for Preveting Smoking Relapse,Other,Other,Other,100,https://clinicaltrials.gov/show/NCT04409496,None
2609,NCT04409574,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals,Clinical Presentation,No Intervention,No Intervention,31,https://clinicaltrials.gov/show/NCT04409574,None
2610,NCT04409834,ClinicalTrials.gov,2020-05-28,2020-06-01,False,The TIMI Study Group,Not Recruiting,Phase 4,Interventional,No Country Given,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,Drug,Heparin,Heparin,750,https://clinicaltrials.gov/show/NCT04409834,None
2611,NCT04410484,ClinicalTrials.gov,2020-05-29,2020-05-22,True,Hull University Teaching Hospitals NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04410484,None
2612,NCT04411446,ClinicalTrials.gov,2020-05-26,2020-06-15,False,Vitamin D Study Group,Not Recruiting,Phase 4,Interventional,Argentina,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Drug,Vitamin D,Vitamin D,1265,https://clinicaltrials.gov/show/NCT04411446,None
2613,NCT04411459,ClinicalTrials.gov,2020-05-29,2020-02-01,True,Azienda Unita Sanitaria Locale di Bologna,Recruiting,Not Applicable,Observational,Italy,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04411459,None
2614,NCT04411576,ClinicalTrials.gov,2020-05-26,2020-04-23,True,Karolinska University Hospital,Recruiting,Not Applicable,Observational,Sweden,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare,Clinical Presentation (Epidemiology),No Intervention,No Intervention,40000,https://clinicaltrials.gov/show/NCT04411576,None
2615,NCT04411667,ClinicalTrials.gov,2020-05-29,2020-04-28,True,Dr. George Sakoulas,Recruiting,Phase 4,Interventional,United States,Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection,ATMP,Immunoglobulin,Immunoglobulin,40,https://clinicaltrials.gov/show/NCT04411667,None
2616,NCT04411784,ClinicalTrials.gov,2020-05-29,2020-05-20,True,Hull University Teaching Hospitals NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis",Other,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04411784,None
2617,NCT04412018,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Canadian Medical and Surgical Knowledge Translation Research Group,Recruiting,Phase 2,Interventional,Canada,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,Drug,Icosapent ethyl,Icosapent ethyl,100,https://clinicaltrials.gov/show/NCT04412018,None
2618,NCT04412031,ClinicalTrials.gov,2020-05-29,2019-11-11,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient,Clinical Presentation,No Intervention,No Intervention,802,https://clinicaltrials.gov/show/NCT04412031,None
2619,NCT04412538,ClinicalTrials.gov,2020-05-21,2020-05-15,True,Chinese Academy of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,ATMP,Vaccine,Vaccine,942,https://clinicaltrials.gov/show/NCT04412538,None
2620,NCT04412551,ClinicalTrials.gov,2020-06-01,2020-05-20,True,"Dalarna County Council, Sweden",Recruiting,Not Applicable,Observational,Sweden,Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04412551,None
2621,NCT04412746,ClinicalTrials.gov,2020-06-01,2020-04-01,True,University of Tlemcen,Recruiting,Not Applicable,Observational,Algeria,Covid-19 and Diabetes in West of Algeria,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04412746,None
2622,NCT04412772,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS,Drug,Tocilizumab,Tocilizumab,300,https://clinicaltrials.gov/show/NCT04412772,None
2623,NCT04412785,ClinicalTrials.gov,2020-06-01,2020-06-01,False,University of Pennsylvania,Not Recruiting,Phase 1,Interventional,United States,Cyclosporine in Patients With Moderate COVID-19,Drug,Cyclosporine,Cyclosporine,20,https://clinicaltrials.gov/show/NCT04412785,None
2624,NCT04413006,ClinicalTrials.gov,2020-05-21,2020-05-25,False,University of Manitoba,Recruiting,Not Applicable,Interventional,Canada,Self-compassion for Chronic Pain Virtual Group Treatment Program,Other (psych),Psychological,Psychological,28,https://clinicaltrials.gov/show/NCT04413006,None
2625,NCT04413045,ClinicalTrials.gov,2020-06-01,2020-05-20,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,"Novel COVID-19, A National Analysis",Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04413045,None
2626,NCT04413838,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Hospices Civils de Lyon,Not Recruiting,Phase 2,Interventional,France,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,Drug,Nivolumab,Nivolumab,120,https://clinicaltrials.gov/show/NCT04413838,None
2627,NCT04413864,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,Drug,Dexmedetomidine,Dexmedetomidine,50,https://clinicaltrials.gov/show/NCT04413864,None
2628,NCT04413955,ClinicalTrials.gov,2020-05-19,2020-05-31,False,"Children's Hospital Medical Center, Cincinnati",Not Recruiting,Not Applicable,Observational,No Country Given,Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA,Other (device),Blood filter,Blood filter,100,https://clinicaltrials.gov/show/NCT04413955,None
2629,NCT04413968,ClinicalTrials.gov,2020-06-02,2020-06-02,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04413968,None
2630,NCT04414059,ClinicalTrials.gov,2020-06-01,2020-06-15,False,Elsan,Not Recruiting,Not Applicable,Observational,France,Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients,Prognosis,No Intervention,No Intervention,155,https://clinicaltrials.gov/show/NCT04414059,None
2631,NCT04414098,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Marcelo Iastrebner,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib in the Treatment of Covid-19,Drug,Ruxolitinib,Ruxolitinib,100,https://clinicaltrials.gov/show/NCT04414098,None
2632,NCT04414124,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Kaleido Biosciences,Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,Drug,KB109,KB109,400,https://clinicaltrials.gov/show/NCT04414124,None
2633,NCT04414371,ClinicalTrials.gov,2020-05-31,2020-05-20,True,Rutgers University,Recruiting,Not Applicable,Interventional,United States,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04414371,None
2634,NCT04414410,ClinicalTrials.gov,2020-05-27,2020-05-12,True,CHU Ambroise Paré,Recruiting,Not Applicable,Observational,France,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04414410,None
2635,NCT04414631,ClinicalTrials.gov,2020-05-19,2020-06-01,False,"University Hospital, Basel",Not Recruiting,Phase 2,Interventional,Switzerland,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Drug,Conestat alfa,Conestat alfa,120,https://clinicaltrials.gov/show/NCT04414631,None
2636,NCT04414904,ClinicalTrials.gov,2020-05-29,2020-06-10,False,Imperial College London,Not Recruiting,Not Applicable,Observational,United Kingdom,Determining the Reproductive Health of Men Post-COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04414904,None
2637,NCT04415073,ClinicalTrials.gov,2020-05-29,2020-05-30,False,Syndax Pharmaceuticals,Recruiting,Phase 2,Interventional,United States,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,Drug,Axatilimab,Axatilimab,186,https://clinicaltrials.gov/show/NCT04415073,None
2638,NCT04415151,ClinicalTrials.gov,2020-06-02,2020-06-30,False,Yale University,Not Recruiting,Phase 2,Interventional,No Country Given,Tofacitinib for Treatment of Moderate COVID-19,Drug,Tofacitinib,Tofacitinib,60,https://clinicaltrials.gov/show/NCT04415151,None
2639,NCT04416009,ClinicalTrials.gov,2020-06-01,2020-07-05,False,Gaziosmanpasa Taksim Research and Education Hospital,Recruiting,Not Applicable,Observational,Turkey,Extracellular Water in Covid 19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,52,https://clinicaltrials.gov/show/NCT04416009,None
2640,NCT04416048,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Charité University,Not Recruiting,Phase 3,Interventional,Germany,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Drug,Rivaroxaban,Rivaroxaban,400,https://clinicaltrials.gov/show/NCT04416048,None
2641,NCT04416061,ClinicalTrials.gov,2020-06-01,2020-05-25,True,Hong Kong Sanatorium & Hospital,Not Recruiting,Not Applicable,Observational,Hong Kong,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04416061,None
2642,NCT04416100,ClinicalTrials.gov,2020-05-26,2020-04-29,True,Medical University Innsbruck,Recruiting,Not Applicable,Observational,Austria,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),Clinical Presentation,No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04416100,None
2643,NCT04416113,ClinicalTrials.gov,2020-05-24,2020-08-01,False,Cairo University,Not Recruiting,Not Applicable,Interventional,No Country Given,Photodynamic Therapy for the Treatment of COVID-19,Other,Photodynamic Therapy,Photodynamic Therapy,60,https://clinicaltrials.gov/show/NCT04416113,None
2644,NCT04416139,ClinicalTrials.gov,2020-05-30,2020-05-01,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2,Interventional,Mexico,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04416139,None
2645,NCT04416256,ClinicalTrials.gov,2020-05-29,2020-02-01,True,Paris Translational Research Center for Organ Transplantation,Recruiting,Not Applicable,Observational,France,COVID-19 Pandemic and Worldwide Organ Procurement,Health System,No Intervention,No Intervention,230000,https://clinicaltrials.gov/show/NCT04416256,None
2646,NCT04416308,ClinicalTrials.gov,2020-05-27,2020-05-29,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),Clinical Presentation (Epidemiology),No Intervention,No Intervention,13000,https://clinicaltrials.gov/show/NCT04416308,None
2647,NCT04416360,ClinicalTrials.gov,2020-05-19,2020-05-05,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,Other (psych),No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04416360,None
2648,NCT04416373,ClinicalTrials.gov,2020-05-29,2020-03-22,True,University Nova de Lisboa,Recruiting,Not Applicable,Observational,Portugal,COVID-19 and Pregnancy Outcomes,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04416373,None
2649,NCT04416438,ClinicalTrials.gov,2020-06-03,2020-06-15,False,French Innovative Leukemia Organisation,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04416438,None
2650,NCT04416919,ClinicalTrials.gov,2020-05-13,2020-06-15,False,University of Oklahoma,Not Recruiting,Not Applicable,Interventional,United States,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,Other (device),Masks,Masks,20,https://clinicaltrials.gov/show/NCT04416919,None
2651,NCT04417270,ClinicalTrials.gov,2020-06-01,2020-06-08,False,Northwell Health,Not Recruiting,Not Applicable,Interventional,No Country Given,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,Other (device),Biosensors,Biosensors,50,https://clinicaltrials.gov/show/NCT04417270,None
2652,NCT04417335,ClinicalTrials.gov,2020-05-25,2020-04-16,True,Radboud University,Not Recruiting,Phase 4,Interventional,Netherlands,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,ATMP,Vaccine,Vaccine,2014,https://clinicaltrials.gov/show/NCT04417335,EUCTR2020-001591-15
2653,NCT04418544,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Soniphi LLC,Recruiting,Not Applicable,Observational,United States,Vocal Feature Analysis Algorithm,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04418544,None
2654,NCT04418947,ClinicalTrials.gov,2020-05-29,2020-06-01,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,United States,Project Resurgence Communication Trial,Other,Other,Other,10000,https://clinicaltrials.gov/show/NCT04418947,None
2655,NCT04419025,ClinicalTrials.gov,2020-06-03,2020-06-15,False,Cambridge Health Alliance,Not Recruiting,Phase 4,Interventional,No Country Given,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,Drug,N-acetylcysteine,N-acetylcysteine,200,https://clinicaltrials.gov/show/NCT04419025,None
2656,ISRCTN14447421,ISRCTN,2020-06-05,2020-06-03,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 in care homes (VIVALDI),Clinical Presentation (Epidemiology),No Intervention,No Intervention,11000,http://isrctn.com/ISRCTN14447421,None
2657,ISRCTN59048638,ISRCTN,2020-06-04,2020-06-15,False,CLINEDEM,Recruiting,Not Applicable,Interventional,Mexico,Sulodexide in the treatment of COVID-19,Drug,Sulodexide,Sulodexide,600,http://isrctn.com/ISRCTN59048638,None
2658,ISRCTN55886926,ISRCTN,2020-06-01,2021-05-17,False,University of Cambridge,Recruiting,Not Applicable,Observational,United Kingdom,Investigation of COVID-19 symptoms and potential immunity in the general population,Clinical Presentation,No Intervention,No Intervention,90000,http://isrctn.com/ISRCTN55886926,None
2659,ISRCTN15324611,ISRCTN,2020-06-01,2020-04-06,True,SingHealth,Not Recruiting,Not Applicable,Observational,Singapore,"A study to assess the usefulness of combination of Vitamin D, magnesium and Vitamin B12 in older COVID-19 patients",Drug,Vitamin D + Vitamin B + Magnesium,Vitamin D; Vitamin B; Magnesium,40,http://isrctn.com/ISRCTN15324611,None
2660,ChiCTR2000033872,ChiCTR,2020-06-15,2020-02-01,True,Chongqing General Hospital,Not Recruiting,Not Applicable,Observational,China,Serum protein marker in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,350,http://www.chictr.org.cn/showproj.aspx?proj=54781,None
2661,ChiCTR2000033830,ChiCTR,2020-06-14,2020-06-12,True,Shengjing Hospital of China Medical University,Not Recruiting,Not Applicable,Observational,China,Development and Application of a Low-Cost Ear-Contactless Stethoscope Powered by Raspberry Pi and Python,Other (device),Stethoscope,Stethoscope,12,http://www.chictr.org.cn/showproj.aspx?proj=54971,None
2662,ChiCTR2000033798,ChiCTR,2020-06-12,2020-06-12,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The efficacy and safety of convalescent plasma therapy in novel coronavirus pneumonia (COVID-19): A medical records based retrospective cohort study,ATMP,Plasma,Plasma,150,http://www.chictr.org.cn/showproj.aspx?proj=55194,None
2663,ChiCTR2000033782,ChiCTR,2020-06-12,2020-06-18,False,"West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,1400,http://www.chictr.org.cn/showproj.aspx?proj=55039,None
2664,ChiCTR2000033781,ChiCTR,2020-06-12,2020-06-18,False,"West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,A medical records based study for predictors of novel coronavirus pneumonia (COVID-19) elderly patients,Clinical Presentation,No Intervention,No Intervention,114,http://www.chictr.org.cn/showproj.aspx?proj=55054,None
2665,ChiCTR2000033780,ChiCTR,2020-06-12,2020-06-11,True,Tianjin University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A medical records based study for analysis of Tongue Features of novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=55027,None
2666,ChiCTR2000033774,ChiCTR,2020-06-11,2020-03-02,True,Children's Hospital Affiliated to Zhejiang University School of Medicine,Not Recruiting,Phase 4,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets in Treating Pediatric novel coronavirus pneumonia (COVID-19),Drug,Bromhexine Hydrochloride,Bromhexine Hydrochloride,30,http://www.chictr.org.cn/showproj.aspx?proj=55097,None
2667,ChiCTR2000033745,ChiCTR,2020-06-11,2020-06-01,True,Maoming People's Hospital,Not Recruiting,Not Applicable,Observational,China,"Clinical study on the effect of Clarenicol oral liquid on the relief of pharyngeal symptoms of novel coronavirus pneumonia (COVID-19) in convalescence, suspected patients and other susceptible populations",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=55100,None
2668,ChiCTR2000033723,ChiCTR,2020-06-10,2020-06-09,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Observational,China,A study for long-term prognosis in hospitalized novel coronavirus pneumonia (COVID-19) patients,Prognosis,No Intervention,No Intervention,2500,http://www.chictr.org.cn/showproj.aspx?proj=54977,None
2669,ChiCTR2000033720,ChiCTR,2020-06-10,2020-05-01,True,Dongguan People's Hospital,Not Recruiting,Not Applicable,Observational,China,"Clinical observation of the relieving effect of Clarenicol oral liquid on the throat symptoms of novel coronavirus pneumonia (COVID-19) in convalescence, suspected patients and other susceptible people",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=55040,None
2670,ChiCTR2000033719,ChiCTR,2020-06-10,2020-03-15,True,Hospital Universitario Ramón y Cajal,Not Recruiting,Not Applicable,Observational,Spain,Hip Fracture in elderly people during COVID-19 State of Alarm in Spain: reports from a specialized Center,Clinical Presentation,No Intervention,No Intervention,206,http://www.chictr.org.cn/showproj.aspx?proj=55044,None
2671,ChiCTR2000033705,ChiCTR,2020-06-10,2020-02-27,True,Xijing Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the preliminary efficacy of Tocilizumab in the treatment of the patients with novel coronavirus pneumonia (COVID-19),Drug,Tocilizumab,Tocilizumab,61,http://www.chictr.org.cn/showproj.aspx?proj=54989,None
2672,EUCTR2020-001257-51-DK,EU Clinical Trials Register,2020-03-26,2020-04-15,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,568,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51,None
2673,EUCTR2020-001363-85-DK,EU Clinical Trials Register,2020-04-17,2020-04-23,False,Odense University Hospital,Not Recruiting,Phase 3,Interventional,Denmark,Medication for prevention of Corona-virus for Danish nursing home residents,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85,None
2674,EUCTR2020-001270-29-GB,EU Clinical Trials Register,2020-03-30,2020-04-02,False,Sanofi,Not Recruiting,Phase 2/Phase 3,Interventional,"Denmark, Czech Republic, Germany, France, Hungary, United Kingdom",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29,None
2675,EUCTR2020-001376-15-DE,EU Clinical Trials Register,2020-04-06,2020-05-13,False,Vakzine Projekt Management GmbH,Authorised,Phase 3,Interventional,Germany,A study to investigate whether vaccination with VPM1002 can reduce the sick days of healthcare professionals during the SARS-CoV-2 pandemic,ATMP,Vaccine,Vaccine,1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001376-15,None
2676,EUCTR2020-001411-25-GB,EU Clinical Trials Register,2020-04-06,2020-04-24,False,Karyopharm Therapeutics Inc,Authorised,Phase 2,Interventional,"Malaysia, Spain, Israel, United States, Italy, Germany, Belgium, India, Australia, Canada, France, Austria, United Kingdom",Low Dose Oral Selinexor in Patients with Severe COVID-19 Infection,Drug,Selinexor,Selinexor,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25,None
2677,EUCTR2020-001498-63-BE,EU Clinical Trials Register,2020-05-03,2020-05-18,False,Biophytis S.A.,Authorised,Phase 2,Interventional,"Belgium, France, United States, United Kingdom","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",Drug,BIO101,BIO101,310,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63,None
2678,EUCTR2020-001264-28-HU,EU Clinical Trials Register,2020-05-14,2020-05-28,False,Immunic AG,Authorised,Phase 2/Phase 3,Interventional,"Bulgaria, Greece, United States, Serbia, Germany, Romania, Hungary",A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment,Drug,Vidofludimus calcium,Vidofludimus calcium,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001264-28,None
2679,EUCTR2020-001937-11-GB,EU Clinical Trials Register,2020-06-08,2020-04-30,True,"University College, London",Authorised,Phase 2,Interventional,United Kingdom,"The COVASE study:
Investigation of an approved nebulised human Dnase enzyme (Pulmozyme) to reduce hyperinflammation in hospitalised people with COVID-19",Drug,Dornase alfa,Dornase alfa,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001937-11,None
2680,EUCTR2020-001244-26-AT,EU Clinical Trials Register,2020-03-31,2020-04-11,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial.,Drug,Solnatide,Solnatide,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001244-26,None
2681,DRKS00021439,German Clinical Trials Register,2020-04-20,2020-04-20,False,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,COVID-19 associated brainstem encephalitis - is SARS-CoV-2 a neurotropic agent?,Clinical Presentation,No Intervention,No Intervention,70,http://www.drks.de/DRKS00021439,None
2682,DRKS00021443,German Clinical Trials Register,2020-04-28,2020-04-23,True,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Feasibility and usability of video-based physical therapy for older people in the context of the COVID-19 pandemic,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,http://www.drks.de/DRKS00021443,None
2683,DRKS00021447,German Clinical Trials Register,2020-04-27,2020-05-01,False,Charité University,Not Recruiting,Phase 2,Interventional,Germany,CytoResc - CytoSorb Rescue for COVID-19 Cytokine Storm,Other (device),Cytokine Adsorber,Cytokine Adsorber,100,http://www.drks.de/DRKS00021447,None
2684,DRKS00021416,German Clinical Trials Register,2020-04-30,2020-04-29,True,Klinik fur Ophthalmologie,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 in tears in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,30,http://www.drks.de/DRKS00021416,None
2685,DRKS00021420,German Clinical Trials Register,2020-04-16,2020-04-01,True,Technische Universität München,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.drks.de/DRKS00021420,None
2686,DRKS00021424,German Clinical Trials Register,2020-06-12,2020-04-02,True,German Cancer Research Center (DKFZ),Not Recruiting,Not Applicable,Observational,Germany,Explorative Study of the Association of Oropharyngeal Microbiota Profiles with SARS-CoV-2 Infection and COVID-19 disease,Clinical Presentation,No Intervention,No Intervention,360,http://www.drks.de/DRKS00021424,None
2687,DRKS00021432,German Clinical Trials Register,2020-05-04,2020-04-20,True,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people,Other (psych),No Intervention,No Intervention,100,http://www.drks.de/DRKS00021432,None
2688,DRKS00021468,German Clinical Trials Register,2020-06-04,2020-06-05,False,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,Exploring immunological control mechanisms of SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,2000,http://www.drks.de/DRKS00021468,None
2689,DRKS00021399,German Clinical Trials Register,2020-04-20,2020-04-12,True,Dortmund Hospital,Recruiting,Not Applicable,Observational,Germany,Prospective gas chromatographic and spectrometric analysis of the exhalation of healthy test persons and of SARS-CoV2 infected patients as well as  of patients suffering from COVID-19 at the Klinikum Dortmund,Clinical Presentation,No Intervention,No Intervention,450,http://www.drks.de/DRKS00021399,None
2690,DRKS00021395,German Clinical Trials Register,2020-04-17,2020-04-20,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,The effects of the COVID-19 pandemic on mental health,Other (psych),No Intervention,No Intervention,60,http://www.drks.de/DRKS00021395,None
2691,DRKS00021516,German Clinical Trials Register,2020-04-22,2020-04-22,False,Kantonsspital Aarau,Recruiting,Not Applicable,Observational,Switzerland,Dysosmia and Dysgeusia in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021516,None
2692,DRKS00021521,German Clinical Trials Register,2020-04-22,2020-04-22,False,Zentrum fur Infektionskrankheiten,Recruiting,Not Applicable,Observational,Germany,Prevalence of COVID-19 in Children in Baden-Württemberg,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,http://www.drks.de/DRKS00021521,None
2693,DRKS00021523,German Clinical Trials Register,2020-04-27,2020-04-28,False,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,The influence of proton pump inhibitor therapy on the clinical course of COVID-19,Drug,Proton pump inhibitor,Proton pump inhibitor,200,http://www.drks.de/DRKS00021523,None
2694,DRKS00021522,German Clinical Trials Register,2020-04-22,2020-04-21,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,Local and systemic markers of inflammation and circadian rhythmicity in COVID-19 disease and their role in the prediction of clinical outcome,Clinical Presentation,No Intervention,No Intervention,50,http://www.drks.de/DRKS00021522,None
2695,DRKS00021527,German Clinical Trials Register,2020-04-24,2020-04-14,True,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: a group chat program in the psychiatric outpatient clinic of the Leipzig University Hospital,Other (psych),Psychological,Psychological,100,http://www.drks.de/DRKS00021527,None
2696,DRKS00021506,German Clinical Trials Register,2020-04-22,2020-03-18,True,"University Hospital Carl Gustav Carus, Dresden",Recruiting,Not Applicable,Observational,Germany,Registry of hospitalized pediatric Patients mit SARS-CoV-2 infection (COVID-19),Clinical Presentation,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021506,None
2697,DRKS00021514,German Clinical Trials Register,2020-04-24,2020-04-26,False,Forschung in der Operativen Medizin (IFOM),Not Recruiting,Not Applicable,Observational,Germany,Database for diagnosis and therapy of COVID-19 infected patients,Clinical Presentation,No Intervention,No Intervention,150,http://www.drks.de/DRKS00021514,None
2698,DRKS00021574,German Clinical Trials Register,2020-05-19,2020-04-08,True,Klinikum der Johann Wolfgang Goethe-Universitt Frankfurt am Main,Recruiting,Not Applicable,Observational,Germany,Investigation of the predictive value of coagulation parameters for the course of disease in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021574,None
2699,DRKS00021573,German Clinical Trials Register,2020-04-27,2020-04-30,False,"University Hospital, Heidelberg",Recruiting,Phase 1,Interventional,Germany,"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Covid-19",Drug,Proton pump inhibitor + Hydoxychloroquine + Midazolam + Yohimbine vs. Hydoxychloroquine + Midazolam + Yohimbine,Proton pump inhibitor; Hydoxychloroquine; Midazolam; Yohimbine,24,http://www.drks.de/DRKS00021573,None
2700,DRKS00021575,German Clinical Trials Register,2020-04-29,2020-05-03,False,"University Hospital, Halle (Saale)",Not Recruiting,Not Applicable,Observational,Germany,Covid-19 HOspitalized patients RegisTry,Clinical Presentation,No Intervention,No Intervention,750,http://www.drks.de/DRKS00021575,None
2701,DRKS00021578,German Clinical Trials Register,2020-04-28,2020-04-24,True,Universität Konstanz Lehrstuhl,Recruiting,Not Applicable,Observational,Germany,Validation of new detection methods for SARS CoV-2 in suspected COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,http://www.drks.de/DRKS00021578,None
2702,DRKS00021537,German Clinical Trials Register,2020-04-30,2020-04-17,True,Stuttgart Hospital,Recruiting,Not Applicable,Observational,Germany,Long term Analysis and Evaluation of morphologic and clinical Parameters in COVID-19 Patients: prospective development of a practical risk score,Clinical Presentation,No Intervention,No Intervention,150,http://www.drks.de/DRKS00021537,None
2703,DRKS00021585,German Clinical Trials Register,2020-04-29,2020-04-24,True,Vivantes Humboldt Klinikum,Recruiting,Not Applicable,Interventional,Germany,Lung Ultrasound in Covid-19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,220,http://www.drks.de/DRKS00021585,None
2704,DRKS00021588,German Clinical Trials Register,2020-05-04,2020-05-08,False,University of Erlangen-Nuremberg,Recruiting,Not Applicable,Interventional,Germany,Naturalistic evaluation of an Internet-based psychological training program for mental strain associated with the coronavirus / COVID-19 pandemic,Other (psych),Psychological,Psychological,1000,http://www.drks.de/DRKS00021588,None
2705,DRKS00021581,German Clinical Trials Register,2020-04-27,2020-04-27,False,Klinikum der Universität München,Recruiting,Not Applicable,Observational,Germany,Alterations in  inflammatory and coagulation variables in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021581,None
2706,DRKS00021582,German Clinical Trials Register,2020-05-12,2020-05-31,False,Heidelberg University,Not Recruiting,Not Applicable,Interventional,"Spain, United States, Germany, France, Mexico, United Kingdom","A short, animated video to improve COVID-19 hygiene uptake: an online randomized experiment with 20,000 participants",Other,Other,Other,20000,http://www.drks.de/DRKS00021582,None
2707,DRKS00021591,German Clinical Trials Register,2020-04-27,2020-05-03,False,Bundeswehrkrankenhaus Berlin,Not Recruiting,Not Applicable,Observational,Germany,Identification of predictive biomarkers for severe progression of COVID-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021591,None
2708,DRKS00021206,German Clinical Trials Register,2020-03-30,2020-03-26,True,Universitäts-Herzzentrum Freiburg Bad Krozingen,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Freiburg,Clinical Presentation,No Intervention,No Intervention,400,http://www.drks.de/DRKS00021206,None
2709,DRKS00021208,German Clinical Trials Register,2020-03-31,2020-04-03,False,Vorstand der Deutschen Gesellschaft for Perinatale Medizin (DGPM),Recruiting,Not Applicable,Observational,Germany,COVID-19 related obstetric and neonatal outcome study (CRONOS),Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021208,None
2710,DRKS00021214,German Clinical Trials Register,2020-04-01,2020-04-07,False,"University Hospital, Schleswig-Holstein",Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,Drug,Vitamin B3,Vitamin B3,1300,http://www.drks.de/DRKS00021214,None
2711,DRKS00021255,German Clinical Trials Register,2020-04-28,2020-05-01,False,Witten/Herdecke University,Not Recruiting,Not Applicable,Observational,Germany,Point-of-care coagulation testing in patients suffering from COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,http://www.drks.de/DRKS00021255,None
2712,DRKS00021254,German Clinical Trials Register,2020-04-03,2020-04-05,False,Universitätsklinikum Schleswig-Holstein,Recruiting,Not Applicable,Observational,Germany,"Investigation of the influence of the new coronavirus pandemic (COVID-19) on pain, mood and everyday life of patients with painful polyneuropathy",Other (psych),No Intervention,No Intervention,50,http://www.drks.de/DRKS00021254,None
2713,DRKS00021226,German Clinical Trials Register,2020-05-04,2020-05-07,False,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,"PROTEGO: PRospective Observational cohort Trial Evaluating correlation of clinical findings, symptoms and disease development of German in- or Outpatients infected with SARS-CoV-2 - a CHIR-Net Student-Initiated German Medical Audit trial COVID-19 study (CHIR-Net SIGMA study group)",Clinical Presentation,No Intervention,No Intervention,500,http://www.drks.de/DRKS00021226,None
2714,DRKS00021225,German Clinical Trials Register,2020-04-01,2020-04-02,False,Klinikum der Universität München,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry of the LMU Hospital Munich,Clinical Presentation,No Intervention,No Intervention,1500,http://www.drks.de/DRKS00021225,None
2715,DRKS00021220,German Clinical Trials Register,2020-04-01,2020-04-05,False,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,Evaluation of the performance of novel rapid diagnostics for COVID-19 at point-of-care,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,http://www.drks.de/DRKS00021220,None
2716,DRKS00021231,German Clinical Trials Register,2020-04-02,2020-04-03,False,Paracelsus Medical University ,Recruiting,Not Applicable,Observational,"Austria, Germany",Accompanying monitoring of primary care in GP practices during the COVID-19 pandemic,Health System,No Intervention,No Intervention,2000,http://www.drks.de/DRKS00021231,None
2717,DRKS00021166,German Clinical Trials Register,2020-03-27,2020-03-30,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Development of a test to measure the immune response in patients with Covid-19,Clinical Presentation,No Intervention,No Intervention,15,http://www.drks.de/DRKS00021166,None
2718,DRKS00021161,German Clinical Trials Register,2020-04-07,2020-02-15,True,Abteilung für Krankenhaushygiene,Recruiting,Not Applicable,Observational,Germany,Demographic and epidemiological characteristics of Covid-19 disease in Helios-Hospital and determinants of clinical course,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021161,None
2719,DRKS00021164,German Clinical Trials Register,2020-03-27,2020-03-16,True,Universität Duisburg-Essen,Recruiting,Not Applicable,Observational,Germany,Psychological distress of the COVID-19 pandemic: A comparison between cancer patients and healthy controls,Other (psych),No Intervention,No Intervention,220,http://www.drks.de/DRKS00021164,None
2720,DRKS00021145,German Clinical Trials Register,2020-04-08,2020-03-16,True,Deutsches Zentrum für Infektionsforschung (DZIF) e. V.,Recruiting,Not Applicable,Observational,"Austria, Spain, Ireland, Italy, Iceland, Belgium, Germany, Switzerland, France, Portugal, United Kingdom","Lean European Open Survey on 
SARS-CoV-2 (COVID-19)",Clinical Presentation,No Intervention,No Intervention,20000,http://www.drks.de/DRKS00021145,None
2721,DRKS00021152,German Clinical Trials Register,2020-04-07,2020-04-05,True,Medizinische Hochschule Hannover,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021152,None
2722,DRKS00021153,German Clinical Trials Register,2020-04-06,2020-04-07,False,Leuphana Universität Lüneburg,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on – tackling worries and finding strength for the crisis (COVID-19) in 10 steps,Other (psych),Psychological,Psychological,352,http://www.drks.de/DRKS00021153,None
2723,DRKS00021186,German Clinical Trials Register,2020-03-26,2020-03-26,False,KKH Bergstraße Abteilung,Recruiting,Not Applicable,Observational,Germany,"prospective observational study to evaluate transpulmonary pressure, end expiratory lung volume and intraabdominal pressure in mechanical ventilated patients with Covid-19",Clinical Presentation,No Intervention,No Intervention,45,http://www.drks.de/DRKS00021186,None
2724,DRKS00021301,German Clinical Trials Register,2020-04-16,2020-06-04,False,Universität Duisburg-Essen,Not Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,Other (psych),Psychological,Psychological,90,http://www.drks.de/DRKS00021301,None
2725,DRKS00021306,German Clinical Trials Register,2020-04-14,2020-03-31,True,"University Hospital, Bonn",Not Recruiting,Not Applicable,Observational,Germany,Covid-19 Case-Cluster-Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1400,http://www.drks.de/DRKS00021306,None
2726,DRKS00021289,German Clinical Trials Register,2020-04-14,2020-03-31,True,Performa Nord,Not Recruiting,Not Applicable,Observational,Germany,Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,http://www.drks.de/DRKS00021289,None
2727,DRKS00021295,German Clinical Trials Register,2020-05-04,2020-04-06,True,Nierenzentrum Heidelberg e.V.,Recruiting,Not Applicable,Observational,Germany,Clinical characteristics of renal patients with COVID-19 infection,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021295,None
2728,DRKS00021297,German Clinical Trials Register,2020-05-04,2020-04-06,True,Nierenzentrum Heidelberg e.V.,Recruiting,Not Applicable,Observational,Germany,Clinical and immunological predictors of SARS-CoV-2 infection and Covid-19 diseases in patients with renal diseases and healthy persons,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021297,None
2729,DRKS00021268,German Clinical Trials Register,2020-04-09,2020-04-20,False,"University Hospital, Erlangen",Not Recruiting,Not Applicable,Observational,Germany,VOICE: Online-Survey on distress and mental resources of medical health care workers during Covid-19-pandemic,Other (psych),No Intervention,No Intervention,2000,http://www.drks.de/DRKS00021268,None
2730,DRKS00021276,German Clinical Trials Register,2020-04-06,2020-04-12,False,"University Hospital, Rostock",Not Recruiting,Not Applicable,Observational,Germany,Dynamics of regional lung aeration non-invasive determined by electrical impedance tomography in patients with COVID 19,Clinical Presentation,No Intervention,No Intervention,24,http://www.drks.de/DRKS00021276,None
2731,DRKS00021270,German Clinical Trials Register,2020-04-15,2020-04-14,True,Krankenhaus Reinbek St. Adolf-Stift,Recruiting,Not Applicable,Observational,Germany,Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany,Clinical Presentation,No Intervention,No Intervention,900,http://www.drks.de/DRKS00021270,None
2732,DRKS00021273,German Clinical Trials Register,2020-04-20,2020-04-25,False,Goethe University Frankfurt,Recruiting,Not Applicable,Interventional,"Spain, Argentina, Singapore, Italy, Germany, France, Chile, Austria, Brazil",Effects of digital home exercise programs on physical and mental well-being during the COVID-19 pandemic: a multi-center trial,Other (exercise),Exercise,Exercise,544,http://www.drks.de/DRKS00021273,None
2733,DRKS00021134,German Clinical Trials Register,2020-03-19,2020-03-20,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Identification of host cell respiratory tract cell gene expression and epigenetic pattern after human SARS-CoV-2 infection (COVID-19),Genomics,No Intervention,No Intervention,60,http://www.drks.de/DRKS00021134,None
2734,DRKS00022057,German Clinical Trials Register,2020-06-05,2020-05-31,True,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Observational,Germany,Traumatological emergency consultations during the COVID-19 pandemic 2020,Health System,No Intervention,No Intervention,25000,http://www.drks.de/DRKS00022057,None
2735,DRKS00022054,German Clinical Trials Register,2020-06-02,2020-05-05,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,CovidCare 1 – Surveillance and care for confirmed and suspected patients with COVID-19 in general practice: an observational study,Clinical Presentation,No Intervention,No Intervention,400,http://www.drks.de/DRKS00022054,None
2736,DRKS00022067,German Clinical Trials Register,2020-06-12,2020-06-25,False,MSB Medical School Berlin,Not Recruiting,Not Applicable,Interventional,Germany,An intensive longitudinal study on habit formation of hand washing behavior during the COVID-19 pandemic,Procedure,Hand washing,Hand washing,134,http://www.drks.de/DRKS00022067,None
2737,DRKS00022071,German Clinical Trials Register,2020-05-29,2020-06-03,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Psychosocial functioning and stress factors of psychiatric patients during the COVID-19 pandemic: Telephone survey of patients in the psychiatric outpatient clinic of the Leipzig University Hospital,Other (psych),No Intervention,No Intervention,150,http://www.drks.de/DRKS00022071,None
2738,DRKS00022083,German Clinical Trials Register,2020-06-09,2020-05-20,True,Landesklinikum Neunkirchen,Recruiting,Not Applicable,Interventional,Austria,Evaluation of three commercially available rapid assays for detection of IgG and/or IGM antibodies to SARS-CoV-2 (COVID-19) for assessment of contact persons’ immune status and termination of quarantine and self-isolation – a prospective pilot study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,70,http://www.drks.de/DRKS00022083,None
2739,DRKS00022088,German Clinical Trials Register,2020-06-03,2020-06-02,True,"University Hospital, Erlangen",Recruiting,Not Applicable,Observational,Germany,"Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia, Germany",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2550,http://www.drks.de/DRKS00022088,None
2740,DRKS00021815,German Clinical Trials Register,2020-06-05,2020-06-30,False,Kassenärztliche Vereinigung Thüringen,Not Recruiting,Not Applicable,Observational,Germany,Investigation of the immune status against SARS-CoV-2 of medical professionals in Doctor's Practices in Thuringia (COVID-19 research project),Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,http://www.drks.de/DRKS00021815,None
2741,DRKS00021823,German Clinical Trials Register,2020-05-28,2020-05-29,False,"Klinik for Ansthesiologie, Intensivmedizin und Schmerztherapie",Not Recruiting,Not Applicable,Observational,Germany,"Survival and risk factors in Covid-19 and influenza, a retrospective analysis",Clinical Presentation,No Intervention,No Intervention,18000,http://www.drks.de/DRKS00021823,None
2742,DRKS00021810,German Clinical Trials Register,2020-05-27,2020-03-18,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,The role of immune-reactions in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021810,None
2743,DRKS00021605,German Clinical Trials Register,2020-04-28,2020-04-27,True,Klinikum Konstanz II. Medizin,Recruiting,Not Applicable,Observational,Germany,"COVID-19 in an academic teaching hospital in Konstanz/Germany - evaluation of the ""double rule out - single rule in"" concept (DURO-SIN)",Prognosis,No Intervention,No Intervention,200,http://www.drks.de/DRKS00021605,None
2744,DRKS00021611,German Clinical Trials Register,2020-05-12,2020-05-15,False,"Ortenauklinikum, Betriebsstelle Lahr",Recruiting,Not Applicable,Observational,Germany,Hypernatremia in critically ill patients with Covid-19,Clinical Presentation,No Intervention,No Intervention,33,http://www.drks.de/DRKS00021611,None
2745,DRKS00021612,German Clinical Trials Register,2020-04-30,2020-03-30,True,Technische Universität München,Recruiting,Not Applicable,Observational,Germany,CORRECT: COvid (Covid-19) Registry REChts der Isar intensive care Trial,Clinical Presentation,No Intervention,No Intervention,500,http://www.drks.de/DRKS00021612,None
2746,DRKS00021638,German Clinical Trials Register,2020-05-11,2020-04-17,True,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,Retrospective analysis of the relationship between invasive ventilation (considering COVID-19) and a Comprehensive Geriatric Assessment (CGA),Other (physical),Mechanical ventilation,Mechanical ventilation,1276,http://www.drks.de/DRKS00021638,None
2747,DRKS00021653,German Clinical Trials Register,2020-06-05,2020-04-21,True,Gesellschaft for Klinische Studien,Recruiting,Not Applicable,Observational,Germany,"Retrospective examination of the course of a Covid-19 infection
in patients with inflammatory bowel disease",Clinical Presentation,No Intervention,No Intervention,500,http://www.drks.de/DRKS00021653,None
2748,DRKS00021630,German Clinical Trials Register,2020-05-06,2020-05-08,False,"University Hospital, Schleswig-Holstein",Not Recruiting,Not Applicable,Observational,Germany,Detection of a delayed Treatment of urgent ophthalmologic Treatment during the SARS-CoV-2 pandemic (COVID-19),Health System,No Intervention,No Intervention,30,http://www.drks.de/DRKS00021630,None
2749,DRKS00021688,German Clinical Trials Register,2020-05-13,2020-03-01,True,Charité University,Recruiting,Not Applicable,Observational,Germany,Analysis of the Pathophysiology and Pathology of Corona Virus Disease 2019 (Pa-COVID-19),Clinical Presentation,No Intervention,No Intervention,1500,http://www.drks.de/DRKS00021688,None
2750,DRKS00021680,German Clinical Trials Register,2020-05-12,2020-05-06,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,Quality assurance of cochlear implant rehabilitation in times of the COVID-19 pandemic (Corona),Other,Other,Other,100,http://www.drks.de/DRKS00021680,None
2751,DRKS00021699,German Clinical Trials Register,2020-05-11,2020-05-12,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,lnfluence of the COVID-19-pandemic on the treatment of ENT patients,Clinical Presentation,No Intervention,No Intervention,20000,http://www.drks.de/DRKS00021699,None
2752,DRKS00021698,German Clinical Trials Register,2020-05-19,2020-04-07,True,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,Prospective COVID-19 Cohort Munich,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,http://www.drks.de/DRKS00021698,None
2753,DRKS00021658,German Clinical Trials Register,2020-05-05,2020-03-01,True,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Incidence and risk factors for acute kidney injury in COVID-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021658,None
2754,DRKS00021664,German Clinical Trials Register,2020-05-14,2020-05-20,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Influence of COVID-19 Infection on sensory organs in othorynolaryngology,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021664,None
2755,DRKS00021675,German Clinical Trials Register,2020-05-08,2020-05-07,True,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Sorting the wheat form the chaff – COVID-19 in the Emergency department,Clinical Presentation,No Intervention,No Intervention,340,http://www.drks.de/DRKS00021675,None
2756,DRKS00021677,German Clinical Trials Register,2020-05-11,2020-07-01,False,BG University Hospital Bergmannsheil Bochum,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 associated neuropathy and myopathy in Germany.,Clinical Presentation,No Intervention,No Intervention,200,http://www.drks.de/DRKS00021677,None
2757,DRKS00021676,German Clinical Trials Register,2020-05-08,2020-04-02,True,"University Hospital, Rostock",Recruiting,Not Applicable,Observational,Germany,Communication in times of the corona virus pandemic (COVID-19),Other (psych),No Intervention,No Intervention,200,http://www.drks.de/DRKS00021676,None
2758,DRKS00021671,German Clinical Trials Register,2020-05-06,2020-04-03,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,Neuroendocrine mechanisms Social isolation and psychobiological stress during the Covid-19 pandemic,Other (psych),No Intervention,No Intervention,200,http://www.drks.de/DRKS00021671,None
2759,DRKS00021727,German Clinical Trials Register,2020-05-12,2020-05-12,False,Universitäts-Herzzentrum Freiburg Bad Krozingen,Not Recruiting,Not Applicable,Observational,Germany,Incidence and long-term course of subclinical and clinical myocardial damage as well as pulmonary vascular and structural changes in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021727,None
2760,DRKS00021729,German Clinical Trials Register,2020-05-25,2020-05-12,True,Helios Universitätsklinikum Wuppertal,Not Recruiting,Not Applicable,Observational,Germany,A prospective trial on the prevalence and the variation over time of SARS-CoV-2 antibodies in hospital health care workers (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,http://www.drks.de/DRKS00021729,None
2761,DRKS00021732,German Clinical Trials Register,2020-06-10,2020-06-14,True,Klinikum St. Georg gGmbH,Not Recruiting,Not Applicable,Interventional,Germany,"Treatment of Sars-CoV2 infections (Covid-19) with valsartan vs placebo, a three-armed randomized, partly blinded trial",Drug,Valsartan,Valsartan,300,http://www.drks.de/DRKS00021732,EUCTR2020-001431-27
2762,DRKS00021706,German Clinical Trials Register,2020-05-15,2020-05-25,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: Online cognitive behavioral therapy for obsessive-compulsive disorder (OCD NET program),Other (psych),Psychological,Psychological,40,http://www.drks.de/DRKS00021706,None
2763,DRKS00021709,German Clinical Trials Register,2020-05-18,2020-05-25,False,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,Serial cross-sectional seroprevalence study of SARS-CoV-2 infection during and after the COVID-19 epidemic in Heidelberg and the Rhein-Neckar region,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,http://www.drks.de/DRKS00021709,None
2764,DRKS00021757,German Clinical Trials Register,2020-05-19,2020-05-22,False,Humboldt University of Berlin,Not Recruiting,Not Applicable,Observational,Germany,Impact of the COVID-19 Pandemic on Symptoms of Obessive Compulsive Disorder,Other (psych),No Intervention,No Intervention,70,http://www.drks.de/DRKS00021757,None
2765,DRKS00021763,German Clinical Trials Register,2020-05-29,2020-06-02,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Influence of the Corona regulation on the physical activity of hospital staff - COVID-19,Other (exercise),No Intervention,No Intervention,175,http://www.drks.de/DRKS00021763,None
2766,DRKS00021772,German Clinical Trials Register,2020-05-18,2020-03-25,True,"University Hospital, Würzburg",Recruiting,Not Applicable,Observational,Germany,Covid-19 related Obstetric Anaesthesia Longitudinal Assessment-Registry,Clinical Presentation,No Intervention,No Intervention,Not Available,http://www.drks.de/DRKS00021772,None
2767,DRKS00021775,German Clinical Trials Register,2020-06-10,2020-05-31,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,COVID-19 treatment outcomes at the University Medical Center Freiburg,Clinical Presentation,No Intervention,No Intervention,400,http://www.drks.de/DRKS00021775,None
2768,DRKS00021740,German Clinical Trials Register,2020-05-15,2020-04-05,True,"University Hospital, RWTH Aachen",Recruiting,Not Applicable,Observational,Germany,CoViD-19 imaging register study Aachen,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021740,None
2769,DRKS00021752,German Clinical Trials Register,2020-05-28,2020-05-29,False,MUC Research GmbH,Recruiting,Not Applicable,Observational,Germany,Study platform ArcHIV - Substudy on SARS-CoV-2 (COVID-19) IgG antibody prevalence in an HIV cohort,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,http://www.drks.de/DRKS00021752,None
2770,DRKS00021791,German Clinical Trials Register,2020-05-28,2020-04-08,True,University of Tübingen,Not Recruiting,Not Applicable,Observational,Germany,The Impact of quarantine and social distancing on mental health in the context of the Covid-19 pandemic,Other (psych),No Intervention,No Intervention,Not Available,http://www.drks.de/DRKS00021791,None
2771,SLCTR/2020/011,SLCTR,2020-05-04,2020-05-04,False,University of Kelaniya,Not Recruiting,Phase 4,Interventional,Sri Lanka,"Hydroxychloroquine for Post-Exposure Prophylaxis of COVID-19 among naval personnel: a placebo-controlled, randomized, clinical trial",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://slctr.lk/trials/slctr-2020-011,None
2772,IRCT20200128046294N2,IRCT,2020-03-14,2020-03-26,False,Digestive Disease Research Institute,Not Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Drug,Sofosbuvir + Daclatasvir,Sofosbuvir; Daclatasvir,70,http://en.irct.ir/trial/46463,None
2773,IRCT20200314046774N1,IRCT,2020-06-12,2020-05-04,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,treatment of COVID-19 whit vitamin A,Drug,Vitamin A,Vitamin A,94,http://en.irct.ir/trial/46519,None
2774,IRCT20200324046850N3,IRCT,2020-03-30,2020-04-20,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,Drug,"Investigational: Naproxen

All Arms: Hydroxychloroquine + Lopinavir/Ritonavir",Naproxen; Hydroxychloroquine; Lopinavir/Ritonavi,80,http://en.irct.ir/trial/46718,None
2775,IRCT20180923041093N3,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://en.irct.ir/trial/46721,None
2776,IRCT20180923041093N4,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://en.irct.ir/trial/46728,None
2777,IRCT20200324046850N1,IRCT,2020-03-29,2020-06-06,False,Abadan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,Drug,Vitamin D vs. N-acetylcysteine vs. Vitamin D + N-acetylcysteine,Vitamin D; N-acetylcysteine,100,http://en.irct.ir/trial/46732,None
2778,IRCT20200318046812N1,IRCT,2020-04-01,2020-04-01,False,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,Drug,Favipiravir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine,Favipiravir; hydroxychloroquine; Lopinavir/ritonavir,324,http://en.irct.ir/trial/46783,None
2779,IRCT20190810044500N5,IRCT,2020-05-18,2020-04-04,True,Yazd University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of colchicine in treatment of COVID-19,Drug,Colchicine,Colchicine,200,http://en.irct.ir/trial/46867,None
2780,IRCT20180725040596N2,IRCT,2020-04-18,2020-04-29,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,Drug,Umifenovir + Hydroxychloroquine vs. Lopinavir/ritonavir vs. Hydroxychloroquine,Umifenovir; Hydroxychloroquine; Lopinavir/ritonavir,100,http://en.irct.ir/trial/46897,None
2781,IRCT20200404046947N1,IRCT,2020-04-15,2020-03-28,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,Drug,Corticosteroids,Methylprednisolone,68,http://en.irct.ir/trial/46904,None
2782,IRCT20151228025732N52,IRCT,2020-04-09,2020-04-07,True,Semnan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19,Drug,Melatonin + Vitamin C + Zinc,Melatonin; Vitamin C; Zinc,30,http://en.irct.ir/trial/46963,None
2783,IRCT20081027001411N3,IRCT,2020-06-01,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of Prednisolone on treatment of COVID-19,Drug,Corticosteroids,Prednisolone,60,http://en.irct.ir/trial/46975,None
2784,IRCT20091201002804N12,IRCT,2020-06-01,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of surfactant on clinical outcome of patients with COVID-19,Drug,Surfactant,Surfactant,60,http://en.irct.ir/trial/46983,None
2785,IRCT20200217046526N1,IRCT,2020-04-13,2020-03-15,True,Iranian Academic Center for Education Culture and Research,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),6,http://en.irct.ir/trial/47030,None
2786,IRCT20200411047016N1,IRCT,2020-05-31,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Stopcivir syrup in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://en.irct.ir/trial/47044,None
2787,IRCT20190727044343N3,IRCT,2020-06-12,2020-06-09,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,ANIF1 effect on COVID-19,Drug,ANIF1,ANIF1,60,http://en.irct.ir/trial/47062,None
2788,IRCT20200223046586N2,IRCT,2020-05-30,2020-05-18,True,Shahroud University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,web- based communication between nurse and family member,Telehealth,Telehealth,Telehealth,74,http://en.irct.ir/trial/47091,None
2789,IRCT20081019001369N6,IRCT,2020-05-17,2020-06-21,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate  against COVID-19,Drug,Trans Sodium Crocetinate,Trans Sodium Crocetinate,30,http://en.irct.ir/trial/47188,None
2790,IRCT20091012002582N21,IRCT,2020-05-18,2019-05-05,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Effect of intrapulmonary injection of processed serum derived from covid-19 patients in reduction of pulmonary complications,ATMP,Plasma,Plasma,30,http://en.irct.ir/trial/47197,None
2791,IRCT20200325046859N2,IRCT,2020-04-26,2020-04-22,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of the 2-drug diet (hydroxychloroquine + umifenovir(Arbidol)) compared with Hydroxy chlorquine on the of mortality rate in patients with moderate symptoms of COVID-19 infections,Drug,Umifenovir + Hydroxycholoquine vs. Hydroxychloroquine,Umifenovir; Hydroxycholoquine,100,http://en.irct.ir/trial/47200,None
2792,IRCT20190418043307N1,IRCT,2020-05-17,2020-04-26,True,Ilam University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of selenium on covid-19 disease,Drug,Selenium,Selenium,100,http://en.irct.ir/trial/47209,None
2793,IRCT20200411047019N1,IRCT,2020-05-18,2020-06-04,False,Shiraz University of Mdical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of BCG Vaccine on Preventing COVID-19,ATMP,Vaccine,Vaccine,500,http://en.irct.ir/trial/47279,None
2794,IRCT20150303021315N19,IRCT,2020-05-27,2020-06-06,False,CinnaGen Company,Recruiting,Phase 2,Interventional,Iran,"Pembrolizumab (CinnaGen Co, Iran) in COVID-19",Drug,Pembrolizumab,Pembrolizumab,62,http://en.irct.ir/trial/47335,None
2795,IRCT20080901001165N59,IRCT,2020-05-27,2020-05-25,True,Niwasha Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Niwasha mouthwash in controlling the symptoms of patients with COVID-19,Drug,Mouthwash,Mouthwash,80,http://en.irct.ir/trial/47477,None
2796,IRCT20200209046427N1,IRCT,2020-06-07,2020-05-30,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of bee products on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47504,None
2797,IRCT20200428047228N1,IRCT,2020-05-16,2020-05-19,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,50,http://en.irct.ir/trial/47559,None
2798,IRCT20200501047259N1,IRCT,2020-05-17,2020-05-09,True,Oroumia University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,IVIG and COVID19,ATMP,Immunoglobulin,Immunoglobulin,40,http://en.irct.ir/trial/47609,None
2799,IRCT20200115046144N2,IRCT,2020-05-21,2020-05-31,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effects of nokhod-ab on fatigue,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/47645,None
2800,IRCT20131129015584N3,IRCT,2020-05-20,2020-05-04,True,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of hot cupping on corona symptoms,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/47665,None
2801,IRCT20150107020592N25,IRCT,2020-06-13,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Prone position effectiveness in Non invasive ventilation of covid-19 patients undergoing respiratory failure,Procedure,Positioning,Positioning,30,http://en.irct.ir/trial/47666,None
2802,IRCT20200502047268N1,IRCT,2020-05-16,2020-05-21,False,Semnan University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Evaluation of the effect of GCSF injection in treatment of COVID-19 patients with lymphopenia,Drug,Granulocyte colony-stimulating factor,Granulocyte colony-stimulating factor,10,http://en.irct.ir/trial/47692,None
2803,IRCT20200503047280N1,IRCT,2020-06-02,2020-05-09,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Laris-Teucrium Polium L.and Laris-Hyssop combined herbal medicine on the prevention of covid-19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://en.irct.ir/trial/47704,None
2804,IRCT20200418047126N1,IRCT,2020-05-14,2020-05-04,True,Ardabil University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of colchicine  in treatment of coronavirus,Drug,Colchicine,Colchicine,100,http://en.irct.ir/trial/47707,None
2805,IRCT20200405046951N1,IRCT,2020-06-11,2020-05-21,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Vitamin A and COVID-19,Drug,Vitamin A,Vitamin A,120,http://en.irct.ir/trial/47722,None
2806,IRCT20170211032494N3,IRCT,2020-05-25,2020-05-27,False,Tehran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Low dose whole lung irradiation for treatment of COVID-19 pneumonia,Other,Radiation,Radiation,10,http://en.irct.ir/trial/47735,None
2807,IRCT20081011001323N25,IRCT,2020-05-17,2020-05-21,False,Yasouj University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy  of  extract of  of Zingiber  cinnamomum  and  zataria multiflora    in covid-19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47935,None
2808,IRCT20200421047150N1,IRCT,2020-05-14,2020-05-12,True,DEY Company,Recruiting,Phase 2/Phase 3,Interventional,Iran,Stem cell treatment for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),90,http://en.irct.ir/trial/47964,None
2809,IRCT20180923041093N6,IRCT,2020-06-11,2020-05-13,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The efficacy of  barely-based traditional remedy on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47974,None
2810,IRCT20200509047360N1,IRCT,2020-05-16,2020-05-03,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The effect of cognitive-behavioral  intervention on improving COVID-19 fear symptoms, improving quality of life and improving mental health in patients with corona",Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/47979,None
2811,IRCT20140428017469N1,IRCT,2020-05-23,2020-06-13,False,Petroleum Industry Health Organization,Recruiting,Phase 3,Interventional,Iran,Polio Vaccine and COVID-19,ATMP,Vaccine,Vaccine,130000,http://en.irct.ir/trial/47989,None
2812,IRCT20200506047323N2,IRCT,2020-05-31,2020-05-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effects of Licorice in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47990,None
2813,IRCT20200509047373N1,IRCT,2020-05-23,2020-06-03,False,Health Medicine Chemistry Company,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Dinvl for Covid19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48001,None
2814,IRCT20151227025726N15,IRCT,2020-05-18,2020-04-08,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effects of Umifenovir (Arbidol) in COVID-19,Drug,Umifenovir,Umifenovir,100,http://en.irct.ir/trial/48018,None
2815,IRCT20150716023235N15,IRCT,2020-05-29,2020-05-21,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,sex hormones in coronavirus,Drug,Hormones,Hormones,80,http://en.irct.ir/trial/48019,None
2816,IRCT20200510047383N1,IRCT,2020-05-15,2020-05-21,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patients,Drug,Tocilizumab,Tocilizumab,100,http://en.irct.ir/trial/48024,None
2817,IRCT20120215009014N355,IRCT,2020-05-18,2020-06-04,False,Hamedan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of intravenous N-acetyl cysteine versus placebo in the treatment of patients with mild and moderate acute respiratory distress syndrome caused by COVID-19,Drug,N-acetylcysteine,N-acetylcysteine,92,http://en.irct.ir/trial/48039,None
2818,IRCT20200511047396N1,IRCT,2020-05-16,2020-05-21,False,CinnaGen Company,Recruiting,Phase 3,Interventional,Iran,Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in Mild to Moderate cases of Covid-19 at Baqiyatallal Hospital,Drug,Interferon beta,Interferon beta,100,http://en.irct.ir/trial/48048,None
2819,IRCT20170731035423N2,IRCT,2020-06-12,2020-05-21,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of the combination of BCc1 & Hep-S on hospitalized COVID-19 patients,Drug,BCc1 vs. Hep-S vs. BCc1 + Hep-S,BCc1; Hep-S,120,http://en.irct.ir/trial/48049,None
2820,IRCT20090609002017N35,IRCT,2020-05-17,2020-05-19,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Assessment of boron-containing compounds  and Oleoylethanolamid  supplementation in the treatment of COVID-19,Drug,Boron vs. Oleoylethanolamid vs. Boron + Oleoylethanolamid,Boron; Oleoylethanolamid,40,http://en.irct.ir/trial/48058,None
2821,IRCT20080901001165N55,IRCT,2020-05-23,2020-05-13,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19,Drug,N-acetylcysteine,N-acetylcysteine,72,http://en.irct.ir/trial/48061,None
2822,IRCT20080901001165N53,IRCT,2020-05-14,2020-05-14,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Interferon Beta1a nasal spray in controlling the symptoms of patients with COVID-19,Drug,Interferon beta,Interferon beta,100,http://en.irct.ir/trial/48066,None
2823,IRCT20200428047228N2,IRCT,2020-06-10,2020-05-19,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in  patients with covid-19,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,40,http://en.irct.ir/trial/48096,None
2824,IRCT20080901001165N60,IRCT,2020-05-28,2020-05-14,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Provita Capsule in controlling the symptoms of patients with COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,30,http://en.irct.ir/trial/48102,None
2825,IRCT20200506047323N1,IRCT,2020-05-23,2020-05-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effects of Ginger in treatment COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,84,http://en.irct.ir/trial/48114,None
2826,IRCT20080901001165N56,IRCT,2020-05-23,2020-05-16,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Evaluation efficacy of ""Curcumin and Resveratrol"" capsule  in controlling symptoms in patients with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48116,None
2827,IRCT20200405046960N2,IRCT,2020-05-19,2020-05-17,True,Ardabil University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48126,None
2828,IRCT20200516047462N1,IRCT,2020-05-17,2020-05-06,True,Kashan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/48141,None
2829,IRCT20151227025726N17,IRCT,2020-05-31,2020-04-24,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evolution of the efficacy and safety of Dexamethasone administration in COVID-19,Drug,Corticosteroids vs. Lopinavir/ritonavir,Dexamethasone; Lopinavir/ritonavir,48,http://en.irct.ir/trial/48153,None
2830,IRCT20200516047468N1,IRCT,2020-05-19,2020-04-08,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Investigation of the effect of intravenous vitamin C on definite patients with coronavirus pneumonia,Drug,Vitamin C,Vitamin C,50,http://en.irct.ir/trial/48176,None
2831,IRCT20150107020592N23,IRCT,2020-05-31,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Plasmapheresis and plasma exchanges;usefulness in covid-19 critically ill patients,ATMP,Plasma,Plasma,15,http://en.irct.ir/trial/48185,None
2832,IRCT20160809029275N1,IRCT,2020-05-30,2020-06-14,False,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,stem cell therapy in Covid-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://en.irct.ir/trial/48187,None
2833,IRCT20151226025699N3,IRCT,2020-05-20,2020-06-04,False,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of omega-3 supplementation in COVID-19,Drug,Omega 3,Omega 3,50,http://en.irct.ir/trial/48213,None
2834,IRCT20180608040007N2,IRCT,2020-06-13,2020-04-28,True,Yazd University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Auriculotherapy  in treatment of Covid 19,Other,Auriculotherapy,Auriculotherapy,70,http://en.irct.ir/trial/48218,None
2835,IRCT20200517047485N1,IRCT,2020-05-29,2020-06-20,False,Arak University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of combination therapies of COVID_19,Drug,Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Atazanavir/ritonavir; Hydroxychloroquine; Lopinavir/ritonavir,108,http://en.irct.ir/trial/48226,None
2836,IRCT20150107020592N22,IRCT,2020-05-25,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Cyclosporin for the Prevention and Treatment of COVID-19 Disease,Drug,Cyclosporine,Cyclosporine,60,http://en.irct.ir/trial/48262,None
2837,IRCT20200518047497N1,IRCT,2020-05-21,2020-05-25,False,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Laris - Hyssop combined herbal distilled on the improving clinical and paraclinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/48289,None
2838,IRCT20200519047510N1,IRCT,2020-05-28,2020-06-05,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the anti-inflammatory effects of curcumin in the treatment of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48292,None
2839,IRCT20151227025726N18,IRCT,2020-06-10,2020-06-22,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Pentaglobin effect in critically ill patients with COVID-19,Drug,Cyclosporine vs. Lopinavir/ritonavir,Cyclosporine; Lopinavir/ritonavir,30,http://en.irct.ir/trial/48312,None
2840,IRCT20161206031256N3,IRCT,2020-06-02,2020-05-23,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Using interferon to treat COVID-19,Drug,Interferon beta,Interferon beta,76,http://en.irct.ir/trial/48329,None
2841,IRCT20080901001165N58,IRCT,2020-05-27,2020-04-29,True,Bagheiat-allah University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating the efficacy and safety of Plasmapheresis in patients with Moderate to severe COVID-19,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/48394,None
2842,IRCT20160126026217N4,IRCT,2020-06-08,2020-06-21,False,Khoram-Abad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigation of the effects of prone position on  cardiac and respiratory status in patients with Coronavirus,Procedure,Positioning,Positioning,74,http://en.irct.ir/trial/48403,None
2843,IRCT20200422047168N2,IRCT,2020-05-30,2020-05-30,False,Ahvaz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Clinical trial study of the therapeutic effect of Ivermectin, besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19)",Drug,Ivermectin + Lopinavir/ritonavir + Chloriquine vs. Lopinavir/ritonavir + Chloriquine,Ivermectin; Lopinavir/ritonavir; Chloriquine,60,http://en.irct.ir/trial/48444,None
2844,IRCT20200525047562N1,IRCT,2020-06-14,2020-05-25,True,High Educational and Research Institute of Transfusion Medicine,Recruiting,Phase 3,Interventional,Iran,Treatment of Covid-19 patients with convalescent plasma,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/48493,None
2845,IRCT20200523047550N1,IRCT,2020-06-06,2020-04-20,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Umifenovir in treatment of covid-19,Drug,Umifenovir + Hydroxychloroquine vs Hydroxychloroquine,Umifenovir; Hydroxychloroquine,50,http://en.irct.ir/trial/48495,None
2846,IRCT20150107020592N24,IRCT,2020-06-08,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Oxycodone administration on pain control in patients with COVID-19,Drug,Oxycodone,Oxycodone,60,http://en.irct.ir/trial/48534,None
2847,IRCT20200518047497N2,IRCT,2020-06-06,2020-06-20,False,Zahravi Pharmaceutical Company,Not Recruiting,Phase 3,Interventional,Iran,Effect of Dinvl on improving of clinical and paraclinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/48644,None
2848,IRCT20120703010178N20,IRCT,2020-06-13,2020-06-21,False,Persisgen Par Pharmaceutical Company,Not Recruiting,Phase 3,Interventional,Iran,effect of anakinra in treatment of COVID-19,Drug,Anakinra,Anakinra,30,http://en.irct.ir/trial/48702,None
2849,IRCT20200412047042N1,IRCT,2020-06-11,2020-06-19,False,Jahrom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patients",Drug,Hydroxychloroquine + Raltagravir vs. Hydroxychloroquine + Raltagravir + Interferon beta vs. Hydroxychloroquine,Raltagravir; Interferon beta; Hydroxychloroquine,60,http://en.irct.ir/trial/48749,None
2850,KCT0005105,CRIS,2020-06-10,2020-04-08,True,Koera University Guro Hospital,Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults with Mild COVID-19,Drug,Ciclesonide,Ciclesonide,141,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795,None
2851,LBCTR2020043459,LBCTR,2020-04-16,2020-04-14,True,Hôtel-Dieu de France Hospital,Not Recruiting,Not Applicable,Observational,Lebanon,The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey,Other (psych),No Intervention,No Intervention,500,https://lbctr.moph.gov.lb/Trials/Details/3459,None
2852,JPRN-JapicCTI-205270,JPRN,2020-04-23,2020-05-25,False,"Chugai Pharmaceutical Co., Ltd.",Recruiting,Phase 3,Interventional,Japan,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia in Japan,Drug,Tocilizumab,Tocilizumab,10,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270,None
2853,JPRN-jRCT1032200025,JPRN,2020-05-01,2020-05-01,False,Watanabe Yoshiyuki,Recruiting,Not Applicable,Observational,Japan,new SARS-CoV-2 detection system (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://jrct.niph.go.jp/latest-detail/jRCT1032200025,None
2854,JPRN-jRCTs031190227,JPRN,2020-02-27,2020-04-01,False,Tokue Yutaka,Not Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,Drug,Lopinavir/ritonavir + hydroxychloroquine (w/ and w/o oseltamivir),Lopinavir/Ritonavir; Hydroxychloroquine; Oseltamivir,50,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,None
2855,JPRN-jRCTs031190269,JPRN,2020-03-27,2020-04-03,False,Sugiyama Haruhito,Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled trial to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",Drug,Ciclesonide,Ciclesonide,90,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,None
2856,JPRN-jRCTs031200026,JPRN,2020-05-01,2020-05-01,False,Kyoji Moriya,Recruiting,Phase 3,Interventional,Japan,Combination therapy of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia,Drug,Favipiravir + Nafamostat Mesilate,Favipiravir; Nafamostat Mesilate,160,https://jrct.niph.go.jp/latest-detail/jRCTs031200026,None
2857,JPRN-jRCTs032200044,JPRN,2020-06-03,2020-06-03,False,Wakabayashi Kenji,Recruiting,Phase 1/Phase 2,Interventional,Japan,Clinical safety and usefulness of the simple ventilator,Other (physical),Mechanical ventilation,Mechanical ventilation,10,https://jrct.niph.go.jp/latest-detail/jRCTs032200044,None
2858,JPRN-jRCTs041190120,JPRN,2020-03-02,2020-03-02,False,Doi Yohei,Not Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,Drug,Favipiravir,Favipiravir,86,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,None
2859,JPRN-jRCTs061200002,JPRN,2020-05-20,2020-05-20,False,Eiki Ichihara,Recruiting,Phase 2,Interventional,Japan,Teprenone for preventing aggravation of COVID-19,Drug,Teprenone,Teprenone,100,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,None
2860,JPRN-UMIN000039997,JPRN,2020-04-01,2020-04-01,False,Jichi Medical University,Recruiting,Not Applicable,Observational,Japan,"Prevention of COVID-19 infection in a medical institution 
and maintenance of medical system",Other,No Intervention,No Intervention,3700,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045600,None
2861,JPRN-UMIN000040219,JPRN,2020-04-22,2020-04-23,False,Yokohama City University,Not Recruiting,Not Applicable,Observational,Japan,A prospective cohort study to follow the health status of medical staff engage in COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045877,None
2862,JPRN-UMIN000040333,JPRN,2020-05-08,2020-05-20,False,Kanagawa Physicians Association,Recruiting,Not Applicable,Observational,Japan,Fact-finding survey on subclinical infection of SARS-CoV-2 in Kanagawa Prefecture,Clinical Presentation,No Intervention,No Intervention,1500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046025,None
2863,JPRN-UMIN000040341,JPRN,2020-05-09,2020-05-09,False,Takanawa Clinic,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Qing Fei Pai Du Tang for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023,None
2864,JPRN-UMIN000040353,JPRN,2020-05-11,2020-05-11,False,Oita San-ai Medical Center,Not Recruiting,Not Applicable,Observational,Japan,Examination in COVID-19 pandemic; Whether endoscopies really generate aerosol particles?,Other,Other,Other,90,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046029,None
2865,JPRN-UMIN000040405,JPRN,2020-05-18,2020-05-18,False,Japanese Society of Intensive Care Medicine,Not Recruiting,Not Applicable,Observational,"Japan, Asia(except Japan), North America, South America, Australia, Europe, Africa",International survey to investigate the implementation of ICU daily care for COVID-19,Health System,No Intervention,No Intervention,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046103,None
2866,JPRN-UMIN000040407,JPRN,2020-05-15,2020-05-15,False,Takanawa Clinic,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Jinhua Qinggan Granule for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108,None
2867,JPRN-UMIN000040451,JPRN,2020-05-20,2020-05-22,False,St. Marianna University School of Medicine,Not Recruiting,Not Applicable,Other,"Japan,North America,Europe",COVID 19 - What Families Think and Do? A Survey for Families Visiting the Pediatric Emergency Department,Other,No Intervention,No Intervention,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046169,None
2868,JPRN-UMIN000040453,JPRN,2020-05-25,2020-05-25,False,Daini Osaka Police Hospital,Not Recruiting,Not Applicable,Observational,Japan,Corona virus disease 2019 (COVID-19) antibody seroprevalence of the medical staff in the hospital with cluster of COVID-19.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046159,None
2869,JPRN-UMIN000040479,JPRN,2020-05-22,2020-05-22,False,Takanawa Clinic,Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of lactic acid bacteria for COVID-19,Drug,Lactic acid bacteria,Lactic acid bacteria,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202,None
2870,JPRN-UMIN000040516,JPRN,2020-05-26,2023-03-31,False,Chiba University,Recruiting,Not Applicable,Observational,Japan,Usefulness of PCR testing for COVID-19 before gastrointestinal endoscopy and hospitalization,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046253,None
2871,JPRN-UMIN000040520,JPRN,2020-05-26,2020-05-13,True,Oita San-ai Medical Center,Not Recruiting,Not Applicable,Observational,Japan,Examination in COVID-19 pandemic; Whether endoscopies really generate aerosol particles?,Procedure,Endoscopy,Endoscopy,90,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046256,None
2872,JPRN-UMIN000040563,JPRN,2020-05-28,2020-05-18,True,Juntendo University,Recruiting,Not Applicable,Observational,Japan,Prospective observational study on cytokine removal effect of continuous hemodiafiltration in COVID-19,Other (device),Cytokine Adsorber,Cytokine Adsorber,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046299,None
2873,JPRN-UMIN000040587,JPRN,2020-06-01,2020-06-01,False,Yokohama City University,Recruiting,Not Applicable,Observational,Japan,"The analysis of COVID-19 in saliva, gastric fluid and intestinal fluid on gastrointestinal endoscopy",Clinical Presentation,No Intervention,No Intervention,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046321,None
2874,JPRN-UMIN000040598,JPRN,2020-06-01,2020-06-01,False,Toho University Faculty of Medicine,Not Recruiting,Not Applicable,Observational,Japan,Clinical Outcomes of COVID-19 Infection in Hospitalized Patients with Cardiovascular Diseases and/or Risk Factors: CLAVIS-COVID,Clinical Presentation,No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046132,None
2875,JPRN-UMIN000040602,JPRN,2020-06-01,2020-06-15,False,Federal University of São Carlos,Not Recruiting,Phase 2,Interventional,South America,Homeopathy for Covid-19 in primary care,Other,Homeopathy,Homeopathy,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,None
2876,JPRN-UMIN000040614,JPRN,2020-06-01,2020-02-01,True,Japanese Red Cross Medical Center,Recruiting,Not Applicable,Observational,Japan,A retrospective study on the therapeutic effect of tocilizumab on COVID-19,Drug,Tocilizumab,Tocilizumab,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046354,None
2877,JPRN-UMIN000040616,JPRN,2020-06-01,2020-02-01,True,Japanese Red Cross Medical Center,Recruiting,Not Applicable,Observational,Japan,Retrospective study on clinical and pathological aspects of COVID-19,Clinical Presentation,No Intervention,No Intervention,5,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046355,None
2878,JPRN-UMIN000040617,JPRN,2020-06-01,2020-02-01,True,Japanese Red Cross Medical Center,Recruiting,Not Applicable,Observational,Japan,A retrospective study on serum markers in the diagnosis and differentiation of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046356,None
2879,JPRN-UMIN000040679,JPRN,2020-06-09,2020-06-08,True,Gunma Prefectural Cancer Center,Not Recruiting,Not Applicable,Observational,Japan,prospective cohort study of COVID-19 antibody for medical stuff in hospital,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046429,None
2880,JPRN-UMIN000040683,JPRN,2020-06-08,2020-06-08,False,Keio University,Not Recruiting,Not Applicable,Observational,Japan,"Longitudinal study on work style change, health and well-being due to pandemic of novel coronavirus infection (COVID-19)",Other (psych),No Intervention,No Intervention,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046432,None
2881,JPRN-UMIN000040694,JPRN,2020-06-09,2020-06-10,False,Kinki Health Administration Center,Not Recruiting,Not Applicable,Interventional,Japan,SUrveillance of SARS-CoV-2 Virus Antibody in Health CarE and CloSe-Contact WorkerS,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448,None
2882,PACTR202004801273802,PACTR,2020-04-02,2020-04-17,False,Lagos State Government,Not Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",Drug,Chloroquine vs. Hydroxychloroquine,Chloroquine; Hydroxychloroquine,600,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,None
2883,PACTR202004693933092,PACTR,2020-04-12,2020-04-15,False,Misr University for Science and Technology,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),ATMP,Vaccine,Vaccine,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,None
2884,PACTR202004761408382,PACTR,2020-04-13,2020-05-01,False,International Centre for Ethnomedicine and Drug Development and Neimeth International Pharmaceuticals Plc.,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot randomized trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,None
2885,PACTR202005599385499,PACTR,2020-04-16,2020-04-20,False,Cairo University,Not Recruiting,Phase 2,Interventional,Egypt,Folic acid: A new suggested prevention and treatment of COVID-19 infection.,Drug,Folic Acid,Folic Acid,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971,None
2886,PACTR202004893013257,PACTR,2020-04-21,2020-04-25,False,Dr. Birgit Whitman,Not Recruiting,Phase 3,Interventional,Ghana,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug,Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,6400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981,None
2887,PACTR202005681895696,PACTR,2020-04-26,2020-05-31,False,University of Oxford,Not Recruiting,Phase 1,Interventional,Kenya,A study to determine if a new COVID-19 vaccine safely generates protective immune responses in adults in Kenya,ATMP,Vaccine,Vaccine,400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988,None
2888,PACTR202005622389003,PACTR,2020-05-14,2020-06-01,False,Universite Cheikh Anta Diop ,Not Recruiting,Phase 3,Interventional,Senegal,"Hydroxychloroquine, Azithromycine and Zinc for the treatment of SARS-Cov2 infection in Senegal. COVID-19",Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,384,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053,None
2889,PACTR202006717277937,PACTR,2020-05-25,2020-10-01,False,Awolola Eniola Oladejo,Not Recruiting,Not Applicable,Interventional,Nigeria,Effect of Interferential Therapy on SARS-CoV-2. COVID-19,Other,Inferential Therapy,Inferential Therapy,48,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088,None
2890,PACTR202006899597082,PACTR,2020-05-29,2020-04-29,True,Malagasy Government,Not Recruiting,Phase 2,Interventional,Madagascar,Efficacy of a new COVID-19 treatment,Drug,Artesunate vs. Artesunate + Vitamin C,Artesunate; Vitamin C,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,None
2891,RBR-6m69fc,REBEC,2020-04-02,2020-04-01,True,University of Sevilla,Recruiting,Not Applicable,Interventional,Spain,"Therapeutic Pulmonary Telerehabilitation Protocol in patients affected by COVID-19, confined in their homes",Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,99,http://www.ensaiosclinicos.gov.br/rg/RBR-6m69fc/,None
2892,RBR-9pgwfc,REBEC,2020-04-09,2020-04-07,True,Hospital Universitário Bettina Ferro de Souza,Recruiting,Not Applicable,Observational,"Colombia, Spain, United States, Canada, Chile, France, Brazil, Portugal, United Kingdom",Psychological effects of social isolation in the coronavirus pandemic,Other (psych),No Intervention,No Intervention,2300,http://www.ensaiosclinicos.gov.br/rg/RBR-9pgwfc/,None
2893,RBR-8969zg,REBEC,2020-04-13,2020-04-14,False,University de São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Drug,N-acetylcysteine,N-acetylcysteine,200,http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/,None
2894,RBR-658khm,REBEC,2020-04-22,2020-04-01,True,Centro Medico Mazzei,Recruiting,Not Applicable,Interventional,Brazil,"Telemedicine in the Covid-19 pandemic in Brazil
in a medical clinic in the supplementary health sector in São Paulo, Brazil",Telehealth,Telehealth,Telehealth,90,http://www.ensaiosclinicos.gov.br/rg/RBR-658khm/,None
2895,RBR-6w5tbk,REBEC,2020-04-29,2020-04-30,False,Hospital Universitário de Brasília,Not Recruiting,Not Applicable,Interventional,Brazil,Effects of tests for covid-19 on the preservation of the healthcare workforce during pandemia in Brazil,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,http://www.ensaiosclinicos.gov.br/rg/RBR-6w5tbk/,None
2896,RBR-3k4wxb,REBEC,2020-05-05,2020-05-01,True,Hospital Santo António,Not Recruiting,Phase 2,Interventional,Brazil,"Evaluation of the use of Hydroxychlorochine in Chinese flu
",Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,45,http://www.ensaiosclinicos.gov.br/rg/RBR-3k4wxb/,None
2897,RBR-3rdhgm,REBEC,2020-05-14,2020-05-01,True,Faculdade de Medicina de Botucatu,Recruiting,Not Applicable,Interventional,Brazil,The role of early dialysis in the evolution of patients with COVID19,Other (device),Dialysis,Dialysis,118,http://www.ensaiosclinicos.gov.br/rg/RBR-3rdhgm/,None
2898,RBR-4vm3yy,REBEC,2020-05-15,2020-04-19,True,Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti,Recruiting,Not Applicable,Interventional,Brazil,Effect of convalescent plasma in patients with severe COVI-19,ATMP,Plasma,Plasma,20,http://www.ensaiosclinicos.gov.br/rg/RBR-4vm3yy/,None
2899,RBR-62y3h7,REBEC,2020-05-18,2020-05-01,True,Faculdade de Medicina de Botucatu,Recruiting,Not Applicable,Observational,Brazil,"Acute impairment of renal function in COVID-19: study on incidence, risk factors and mortality",Clinical Presentation,No Intervention,No Intervention,1000,http://www.ensaiosclinicos.gov.br/rg/RBR-62y3h7/,None
2900,RBR-9y32yy,REBEC,2020-05-24,2020-07-01,False,Sao Paulo State University (Universidade Estadual Paulista),Not Recruiting,Not Applicable,Interventional,Brazil,Acute and chronic cardiovascular and respiratory changes in COVID-19 hospitalized patients and the effect of physical rehabilitation supervised by telecommunication,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.ensaiosclinicos.gov.br/rg/RBR-9y32yy/,None
2901,RBR-9d8z6m,REBEC,2020-03-27,2020-03-30,False,Hospital do Coração,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine ,Hydroxychloroquine; Azithromycin,630,http://www.ensaiosclinicos.gov.br/rg/RBR-9d8z6m/,None
2902,RBR-2dxyx4,REBEC,2020-06-02,2020-06-04,False,Hospital Universitário Clementino Fraga Filho,Not Recruiting,Not Applicable,Interventional,Brazil,Mechanical ventilator for use in patients with respiratory failure due to Covid-19 (VExCO),Other (physical),Mechanical ventilation,Mechanical ventilation,5,http://www.ensaiosclinicos.gov.br/rg/RBR-2dxyx4/,None
2903,RBR-43hbks,REBEC,2020-06-03,2020-04-21,True,Universidade Federal de São Paulo,Recruiting,Not Applicable,Observational,Brazil,Evaluation with ultrasound on the bedside in serious patients with COVID-19,Other,No Intervention,No Intervention,50,http://www.ensaiosclinicos.gov.br/rg/RBR-43hbks/,None
2904,RBR-949z6v,REBEC,2020-05-06,2020-05-30,False,Faculdade de Medicina de Ribeirão Preto,Recruiting,Phase 2,Interventional,Brazil,Full versus prophylactic anticoagulation for the treatment of severe forms of Covid-19:,Drug,Heparin,Heparin,30,http://www.ensaiosclinicos.gov.br/rg/RBR-949z6v/,None
2905,RBR-876qb5,REBEC,2020-06-08,2020-05-27,True,University de São Paulo,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of severe cases of Covid-19 with Eculizumab,Drug,Eculizumab,Eculizumab,10,http://www.ensaiosclinicos.gov.br/rg/RBR-876qb5/,None
2906,RBR-4qjzh7,REBEC,2020-06-08,2020-04-17,True,Universidade Federal de São Paulo,Not Recruiting,Not Applicable,Observational,Brazil,Study of vascular complications in critically ill patients with coronavirus,Clinical Presentation,No Intervention,No Intervention,50,http://www.ensaiosclinicos.gov.br/rg/RBR-4qjzh7/,None
2907,RPCEC00000306,RPCEC,2020-04-13,2020-03-27,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,ATMP,Vaccine,Vaccine,80,https://rpcec.sld.cu/en/trials/RPCEC00000306-En,None
2908,RPCEC00000307,RPCEC,2020-04-14,2020-04-10,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 2,Interventional,Cuba,ESPERANZA study,Drug,Interferon alpha,Interferon alpha,120,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,None
2909,RPCEC00000308,RPCEC,2020-05-03,2020-05-04,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1,Interventional,Cuba,Pharmacodynamics of the Nasalferon in healthy volunteers.,Drug,Nasalferon,Nasalferon,30,https://rpcec.sld.cu/en/trials/RPCEC00000308-En,None
2910,RPCEC00000309,RPCEC,2020-05-05,2020-05-20,False,Colima State Health Service ,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Therapy for COVID-19-Phase I-II,Drug,Homeostec + Paracetamol,Homeostec; Paracetamol,50,https://rpcec.sld.cu/en/trials/RPCEC00000309-En,None
2911,RPCEC00000310,RPCEC,2020-05-05,2020-04-03,True,Centro Nacional de Biopreparados (BioCen),Recruiting,Not Applicable,Observational,Cuba,Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial,Drug,Biomodulin T,Biomodulin T,0,https://rpcec.sld.cu/en/trials/RPCEC00000310-En,None
2912,RPCEC00000311,RPCEC,2020-05-12,2020-03-28,True,Center of Molecular Immunology (CIM),Recruiting,Not Applicable,Interventional,Cuba,Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab,Drug,Itolizumab,Itolizumab,80,https://rpcec.sld.cu/en/trials/RPCEC00000311-En,None
2913,RPCEC00000312,RPCEC,2020-05-13,2020-04-29,True,Cuban Ministry of Public Health,Recruiting,Not Applicable,Observational,Cuba,PrevengHo-Vir Homeoprohylaxis COVID-2019,Other,Homeopathy,Homeopathy,180,https://rpcec.sld.cu/en/trials/RPCEC00000312-En,None
2914,RPCEC00000313,RPCEC,2020-05-14,2020-03-31,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Not Applicable,Interventional,Cuba,CIGB-258 at COVID-19,Drug,CIGB-258,CIGB-258,16,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,None
2915,RPCEC00000314,RPCEC,2020-05-22,2020-04-24,True,Finlay Vaccine Institute (IFV),Recruiting,Not Applicable,Interventional,Cuba,VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2,ATMP,Vaccine,Vaccine,115000,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,None
2916,RPCEC00000315,RPCEC,2020-05-22,2020-05-19,True,Finlay Vaccine Institute (IFV),Recruiting,Not Applicable,Interventional,Cuba,Evaluation of the synergistic effect of  sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study,Drug,Immunostimulants,Immunostimulants,60,https://rpcec.sld.cu/en/trials/RPCEC00000315-En,None
2917,RPCEC00000316,RPCEC,2020-05-28,2020-06-01,False,Centro Nacional de Biopreparados (BioCen),Not Recruiting,Not Applicable,Interventional,Cuba,Exploratory study of BMT IM to stimulate immune response in patients with CKD-5 on iterated hemodialysis,Drug,Biomodulin T,Biomodulin T,20,https://rpcec.sld.cu/en/trials/RPCEC00000316-En,None
2918,RPCEC00000317,RPCEC,2020-05-28,2020-06-01,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ATENEA-Co-300 study,Drug,CIGB-300,CIGB-300,20,https://rpcec.sld.cu/en/trials/RPCEC00000317-En,None
2919,RPCEC00000318,RPCEC,2020-05-29,2020-03-11,True,National Board of Science and Technology of the Ministry of Public Health (MINSAP),Recruiting,Not Applicable,Observational,Cuba,Heberon Alfa R in COVID-19,Drug,Interferon alpha,Interferon alpha,0,https://rpcec.sld.cu/en/trials/RPCEC00000318-En,None
2920,RPCEC00000319,RPCEC,2020-05-29,2020-04-13,True,Centro Nacional de Biopreparados (BioCen),Not Recruiting,Not Applicable,Observational,Cuba,Biomodulina T - IM - covid-19 - older adult - Confirmatory study,Drug,Biomodulin T,Biomodulin T,160,https://rpcec.sld.cu/en/trials/RPCEC00000319-En,None
2921,RPCEC00000320,RPCEC,2020-06-05,2020-06-08,False,National Center for Scientific Research (CNIC),Not Recruiting,Not Applicable,Interventional,Cuba,Rectal Ozone in the COVID-19 treatment,Drug,Ozone,Ozone,32,https://rpcec.sld.cu/en/trials/RPCEC00000320-En,None
2922,TCTR20200601002,TCTR,2020-05-28,2020-06-01,False,Self-sponsored,Recruiting,Not Applicable,Interventional,Malaysia,"A Randomized Controlled Trial on Effectiveness of Mental Health & Psychosocial Support Module (MHPSS) in Reduction of Depression, Anxiety and Stress among Healthcare Workers during COVID-19 Pandemic in Jerantut, Pahang",Other (psych),Psychological,Psychological,110,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6322,None
2923,TCTR20200527001,TCTR,2020-05-22,2020-03-13,True,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Observational,Thailand,Endotoxin and circulating bacteriome in severe COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,19,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6293,None
2924,TCTR20200514001,TCTR,2020-05-12,2020-06-01,False,Siriraj Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia â?? An open-label randomized controlled study â??,Drug,Favipiravir,Favipiravir,96,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6236,None
2925,TCTR20200426002,TCTR,2020-04-24,2020-03-30,True,Chulalongkorn University,Recruiting,Not Applicable,Observational,Thailand,Chula Covid-19 Rapid Test for Pandemic Control,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6132,None
2926,TCTR20200425001,TCTR,2020-04-25,2020-04-21,True,Pharmacoepidemiology and Statistics Research Center (PESRC),Recruiting,Not Applicable,Observational,Thailand,Mental Health Circumstances Among Healthcare Workers and General Public Under the Pandemic Situation of COVID-19,Other (psych),No Intervention,No Intervention,2500,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6136,None
2927,TCTR20200409006,TCTR,2020-04-03,2020-05-01,False,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID-19,Other (device),HA330,HA330,206,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016,None
2928,TCTR20200405001,TCTR,2020-04-05,2020-03-19,True,Chulalongkorn University,Recruiting,Not Applicable,Observational,Thailand,Use of Covid-19 Rapid Test for Hospital Care: GI Procedure,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6023,None
2929,TCTR20200404004,TCTR,2020-03-31,2020-04-27,False,Health Systems Research Institute (HSRI),Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID-19 patients,Drug,Chloroquine + Vitamin C,Chloroquine; Vitamin C,400,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995,None
2930,TCTR20200401002,TCTR,2020-03-31,2020-05-01,False,Wellcome Trust,Recruiting,Not Applicable,Observational,"Malaysia, Thailand, United Kingdom, Italy","Social, ethical and behavioural aspects of the novel coronavirus pandemic",Other,No Intervention,No Intervention,2640,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5997,None
2931,TCTR20200324001,TCTR,2020-03-21,2020-03-24,False,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,Covid-19 preparedness among Emergency Departments: a cross-sectional study in France.,Health System,No Intervention,No Intervention,650,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5976,None
2932,TCTR20200321001,TCTR,2020-03-20,2020-03-20,False,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,ED Response against Covid-19 pandemic,Other,No Intervention,No Intervention,5000,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5975,None
2933,NCT04315298,ClinicalTrials.gov,2020-03-15,2020-03-18,False,Regeneron Pharmaceuticals,Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,Drug,Sarilumab,Sarilumab,2500,https://clinicaltrials.gov/show/NCT04315298,None
2934,NCT04316377,ClinicalTrials.gov,2020-03-13,2020-03-25,False,"University Hospital, Akershus",Not Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,Drug,Hydroxychloroquine,Hydroxychloroquine,53,https://clinicaltrials.gov/show/NCT04316377,None
2935,NCT04321928,ClinicalTrials.gov,2020-03-20,2020-04-01,False,University of Pecs,Recruiting,Not Applicable,Interventional,Hungary,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Other,Health Education,Health Education,7576,https://clinicaltrials.gov/show/NCT04321928,None
2936,NCT04335279,ClinicalTrials.gov,2020-04-01,2020-04-09,False,Lady Davis Institute,Recruiting,Not Applicable,Interventional,Canada,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Other (psych),Psychological,Psychological,195,https://clinicaltrials.gov/show/NCT04335279,None
2937,NCT04335305,ClinicalTrials.gov,2020-03-31,2020-07-01,False,MedSIR,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,Drug,Tocilizumab + Pembrolizumab,Tocilizumab; pembrolizumab,24,https://clinicaltrials.gov/show/NCT04335305,None
2938,NCT04335851,ClinicalTrials.gov,2020-04-02,2020-04-06,False,Biruni University,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,Other (exercise),Exercise,Exercise,68,https://clinicaltrials.gov/show/NCT04335851,None
2939,NCT04339426,ClinicalTrials.gov,2020-04-07,2020-04-20,False,HonorHealth Research Institute,Recruiting,Phase 2,Interventional,United States,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Drug,Atovaquone + azithromycin,Atovaquone; azithromycin,25,https://clinicaltrials.gov/show/NCT04339426,None
2940,NCT04345653,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hackensack Meridian Health,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,44,https://clinicaltrials.gov/show/NCT04345653,None
2941,NCT04346420,ClinicalTrials.gov,2020-04-08,2020-04-09,False,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Other (device),Masks,Masks,12,https://clinicaltrials.gov/show/NCT04346420,None
2942,NCT04346589,ClinicalTrials.gov,2020-04-09,2020-04-15,False,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04346589,None
2943,NCT04347382,ClinicalTrials.gov,2020-04-11,2020-04-30,False,Sohaib Ashraf,Recruiting,Phase 3,Interventional,Pakistan,Honey & Nigella Sativa Trial Against COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,https://clinicaltrials.gov/show/NCT04347382,None
2944,NCT04348656,ClinicalTrials.gov,2020-04-13,2020-05-14,False,Hamilton Health Sciences Corporation,Recruiting,Phase 3,Interventional,"United States, Canada",CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),ATMP,Plasma,Plasma,1200,https://clinicaltrials.gov/show/NCT04348656,None
2945,NCT04348942,ClinicalTrials.gov,2020-04-13,2020-05-29,False,ObvioHealth,Recruiting,Not Applicable,Observational,United States,"A COVID-19 Symptom, Exposure and Immune Response Registry",Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04348942,None
2946,NCT04350073,ClinicalTrials.gov,2020-04-14,2020-04-20,False,Duke University,Recruiting,Not Applicable,Observational,United States,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04350073,None
2947,NCT04351139,ClinicalTrials.gov,2020-04-15,2020-05-06,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic in Gynecological Oncology,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04351139,None
2948,NCT04351581,ClinicalTrials.gov,2020-04-14,2020-05-18,True,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,215,https://clinicaltrials.gov/show/NCT04351581,EUCTR2020-001544-26
2949,NCT04355702,ClinicalTrials.gov,2020-04-17,2020-03-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Covid-19 in Lupus Patients,Clinical Presentation,No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04355702,None
2950,NCT04357041,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Illinois Institute of Technology,Not Recruiting,Not Applicable,Observational,United States,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being",Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04357041,None
2951,NCT04357444,ClinicalTrials.gov,2020-04-10,2020-06-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,Drug,ILT101,ILT101,30,https://clinicaltrials.gov/show/NCT04357444,EUCTR2020-001571-32
2952,NCT04359667,ClinicalTrials.gov,2020-04-16,2020-06-16,False,"University Hospital for Infectious Diseases, Croatia",Not Recruiting,Not Applicable,Observational,Croatia,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,Drug,Tocilizumab,Tocilizumab,30,https://clinicaltrials.gov/show/NCT04359667,None
2953,NCT04366323,ClinicalTrials.gov,2020-04-22,2020-04-27,True,Andalusian Network for Design and Translation of Advanced Therapies,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),26,https://clinicaltrials.gov/show/NCT04366323,EUCTR2020-001364-29
2954,NCT04367545,ClinicalTrials.gov,2020-04-27,2020-04-16,True,"University Hospital, Rouen",Recruiting,Not Applicable,Interventional,France,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04367545,None
2955,NCT04367662,ClinicalTrials.gov,2020-04-16,2020-04-09,True,"University Hospital, Rouen",Not Recruiting,Not Applicable,Interventional,France,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Clinical Presentation,No Intervention,No Intervention,99,https://clinicaltrials.gov/show/NCT04367662,None
2956,NCT04368728,ClinicalTrials.gov,2020-04-27,2020-04-29,False,Biontech SE,Recruiting,Phase 1,Interventional,United States,"Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults",ATMP,Vaccine,Vaccine,7600,https://clinicaltrials.gov/show/NCT04368728,None
2957,NCT04370223,ClinicalTrials.gov,2020-04-27,2020-05-25,False,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,Not Recruiting,Phase 3,Interventional,Spain,Ozone Auto-hemotherapy for COVID-19 Pneumonia,Drug,Ozone,Ozone,208,https://clinicaltrials.gov/show/NCT04370223,None
2958,NCT04371328,ClinicalTrials.gov,2020-04-29,2020-03-13,True,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Observational,France,Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1860,https://clinicaltrials.gov/show/NCT04371328,None
2959,NCT04371744,ClinicalTrials.gov,2020-04-30,2020-04-17,True,Assistance Publique – Hôpitaux de Marseille,Not Recruiting,Not Applicable,Observational,France,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,Other (software),Other,Other,100,https://clinicaltrials.gov/show/NCT04371744,None
2960,NCT04372017,ClinicalTrials.gov,2020-04-25,2020-05-14,False,Sanford Health,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1,https://clinicaltrials.gov/show/NCT04372017,None
2961,NCT04374565,ClinicalTrials.gov,2020-04-27,2020-05-05,False,University of Virginia,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,ATMP,Plasma,Plasma,29,https://clinicaltrials.gov/show/NCT04374565,None
2962,NCT04379310,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Nisantasi University,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),Drug,"ACE Inhibitors, Calcium Channel Blockers",ACE Inhibitors; Calcium Channel Blockers,54,https://clinicaltrials.gov/show/NCT04379310,None
2963,NCT04381923,ClinicalTrials.gov,2020-05-07,2020-06-01,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,No Country Given,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04381923,None
2964,NCT04381962,ClinicalTrials.gov,2020-05-07,2020-05-29,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),Drug,Azithromycin,Azithromycin,800,https://clinicaltrials.gov/show/NCT04381962,EUCTR2020-001740-26
2965,NCT04382495,ClinicalTrials.gov,2020-05-08,2020-06-01,False,El Zaitoun Specialized Hospital,Recruiting,Not Applicable,Observational,Egypt,The Impact of COVID-19 Pandemic on Cancer Care,Health System,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04382495,None
2966,NCT04387838,ClinicalTrials.gov,2020-05-13,2020-05-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff,Clinical Presentation (Epidemiology),No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04387838,None
2967,NCT04393636,ClinicalTrials.gov,2020-05-11,2020-06-05,False,Academic Hospital Maastricht,Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,eHealth,394,https://clinicaltrials.gov/show/NCT04393636,None
2968,NCT04395807,ClinicalTrials.gov,2020-05-18,2020-06-03,False,Lund University,Recruiting,Not Applicable,Interventional,Sweden,Helmet CPAP Versus HFNC in COVID-19,Other (device),CPAP vs. Nasal cannula,CPAP; Nasal cannula,120,https://clinicaltrials.gov/show/NCT04395807,None
2969,NCT04397510,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Frederick Health,Recruiting,Phase 4,Interventional,United States,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,Drug,Heparin,Heparin,50,https://clinicaltrials.gov/show/NCT04397510,None
2970,NCT04401293,ClinicalTrials.gov,2020-05-20,2020-04-26,True,Northwell Health,Recruiting,Phase 3,Interventional,United States,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,Drug,Heparin,Heparin,308,https://clinicaltrials.gov/show/NCT04401293,None
2971,NCT04401436,ClinicalTrials.gov,2020-05-22,2020-05-22,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO),Clinical Presentation,No Intervention,No Intervention,165,https://clinicaltrials.gov/show/NCT04401436,None
2972,NCT04402060,ClinicalTrials.gov,2020-05-22,2020-05-26,False,"Apellis Pharmaceuticals, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,Drug,APL-9,APL-9,66,https://clinicaltrials.gov/show/NCT04402060,None
2973,NCT04403100,ClinicalTrials.gov,2020-05-23,2020-06-03,False,Cardresearch,Recruiting,Phase 3,Interventional,Brazil,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",Drug,Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,1968,https://clinicaltrials.gov/show/NCT04403100,None
2974,NCT04403828,ClinicalTrials.gov,2020-05-24,2020-05-20,True,Fayoum University,Not Recruiting,Not Applicable,Observational,Egypt,Impact of COVID-19 on Personal Protection Among Dentist in Egypt,Other,No Intervention,No Intervention,323,https://clinicaltrials.gov/show/NCT04403828,None
2975,NCT04404270,ClinicalTrials.gov,2020-05-25,2020-05-26,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04404270,None
2976,NCT04408001,ClinicalTrials.gov,2020-05-28,2020-06-04,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04408001,None
2977,NCT04412265,ClinicalTrials.gov,2020-05-30,2020-03-01,True,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Frailty in Elderly Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04412265,None
2978,NCT04412356,ClinicalTrials.gov,2020-05-24,2020-06-04,False,Sahlgrenska University Hospital,Recruiting,Not Applicable,Interventional,Sweden,Timing of Tracheotomy in Covid-19 Patients,Other,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04412356,None
2979,NCT04413747,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Health Ricerca E Sviluppo S.r.l.,Not Recruiting,Not Applicable,Interventional,Italy,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04413747,None
2980,NCT04415086,ClinicalTrials.gov,2020-06-01,2020-06-01,False,University of São Paulo General Hospital,Recruiting,Phase 2,Interventional,Brazil,Treatment of Patients With COVID-19 With Convalescent Plasma,ATMP,Plasma,Plasma,120,https://clinicaltrials.gov/show/NCT04415086,None
2981,NCT04415879,ClinicalTrials.gov,2020-06-01,2020-06-01,False,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,Other (device),Masks,Masks,20,https://clinicaltrials.gov/show/NCT04415879,None
2982,NCT04416399,ClinicalTrials.gov,2020-06-03,2020-06-11,False,University of Oxford,Not Recruiting,Phase 2,Interventional,No Country Given,STerOids in COVID-19 Study,Drug,Corticosteroids,Budesonide,478,https://clinicaltrials.gov/show/NCT04416399,None
2983,NCT04417374,ClinicalTrials.gov,2020-06-03,2020-05-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19",Clinical Presentation,No Intervention,No Intervention,94,https://clinicaltrials.gov/show/NCT04417374,None
2984,NCT04418128,ClinicalTrials.gov,2020-06-03,2020-06-10,False,Gyeongsang National University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,Drug,Nafamostat Mesylate,Nafamostat Mesylate,84,https://clinicaltrials.gov/show/NCT04418128,None
2985,NCT04418193,ClinicalTrials.gov,2020-06-02,2020-04-06,True,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,Recruiting,Not Applicable,Observational,Monaco,Patient Preference Trial for COVID-19 (PPT-COVID),Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,100,https://clinicaltrials.gov/show/NCT04418193,None
2986,NCT04418206,ClinicalTrials.gov,2020-05-18,2020-06-01,False,CHU de Nice,Not Recruiting,Not Applicable,Interventional,France,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04418206,None
2987,NCT04418245,ClinicalTrials.gov,2020-06-04,2020-03-01,True,CHU de Nimes,Not Recruiting,Not Applicable,Observational,"Martinique, France",CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04418245,None
2988,NCT04418375,ClinicalTrials.gov,2020-06-02,2020-06-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),Clinical Presentation (Epidemiology),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04418375,None
2989,NCT04418505,ClinicalTrials.gov,2020-06-03,2020-07-01,False,Vielight Inc.,Not Recruiting,Not Applicable,Interventional,Canada,Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,Other,Photobiomodulation,Photobiomodulation,280,https://clinicaltrials.gov/show/NCT04418505,None
2990,NCT04418518,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Weill Medical College of Cornell University,Not Recruiting,Phase 3,Interventional,United States,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,ATMP,Plasma,Plasma,1200,https://clinicaltrials.gov/show/NCT04418518,None
2991,NCT04418531,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Piero Luigi Ruggenenti,Not Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in COVID 19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04418531,None
2992,NCT04418557,ClinicalTrials.gov,2020-06-03,2020-04-28,True,University Hospitals Cleveland Medical Center,Recruiting,Not Applicable,Observational,United States,COVID-19 and Obstetric Transmission,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04418557,None
2993,NCT04418609,ClinicalTrials.gov,2020-05-28,2020-05-01,True,Emanuela Keller,Recruiting,Not Applicable,Observational,Switzerland,Neuro-COVID-19: Neurological Complications of COVID-19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04418609,None
2994,NCT04419571,ClinicalTrials.gov,2020-06-04,2020-03-23,True,"Barking, Havering and Redbridge University Hospitals NHS Trust",Not Recruiting,Not Applicable,Observational,United Kingdom,Peri-Operative NLR in Emergency General Surgery During COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04419571,None
2995,NCT04419623,ClinicalTrials.gov,2020-06-03,2020-06-01,True,"Telios Pharma, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,Drug,TL-895,TL-895,146,https://clinicaltrials.gov/show/NCT04419623,None
2996,NCT04420182,ClinicalTrials.gov,2020-05-29,2020-06-08,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 Virtual Care at Home,Other (software),eHealth,eHealth,2000,https://clinicaltrials.gov/show/NCT04420182,None
2997,NCT04420260,ClinicalTrials.gov,2020-05-25,2020-07-01,False,Unidad de Investigación Genética Molecular,Not Recruiting,Not Applicable,Interventional,No Country Given,Primary Prevention of Infection by COVID-19 in Health Providers,Drug (Chemoprophylaxis),"Oropharygeal spray, Immunostimulant",Oropharygeal spray; Immunostimulant,300,https://clinicaltrials.gov/show/NCT04420260,None
2998,NCT04420273,ClinicalTrials.gov,2020-06-03,2020-06-15,False,Northwestern University,Not Recruiting,Not Applicable,Interventional,United States,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04420273,None
2999,NCT04420286,ClinicalTrials.gov,2020-06-05,2020-05-06,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France,Health System,No Intervention,No Intervention,9000,https://clinicaltrials.gov/show/NCT04420286,None
3000,NCT04420364,ClinicalTrials.gov,2020-06-04,2020-07-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,Other,Immunosupression,Immunosupression,50,https://clinicaltrials.gov/show/NCT04420364,None
3001,NCT04420390,ClinicalTrials.gov,2020-05-14,2020-05-01,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Interventional,Spain,Low Dose Radiotherapy for COVID-19 Pneumonitis,Other,Radiation,Radiation,41,https://clinicaltrials.gov/show/NCT04420390,None
3002,NCT04420416,ClinicalTrials.gov,2020-06-04,2020-04-01,True,Instituto Mexicano del Seguro Social,Recruiting,Not Applicable,Observational,Mexico,Mental Health and Academic Performance in COVID-19,Other (psych),No Intervention,No Intervention,720,https://clinicaltrials.gov/show/NCT04420416,None
3003,NCT04420468,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04420468,None
3004,NCT04420637,ClinicalTrials.gov,2020-06-04,2020-06-15,False,Medical University of Graz,Not Recruiting,Not Applicable,Observational,Austria,Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04420637,None
3005,NCT04420676,ClinicalTrials.gov,2020-06-04,2020-08-01,False,Medical University of Graz,Not Recruiting,Not Applicable,Interventional,Austria,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,Supplement,Probiotics,Probiotics,108,https://clinicaltrials.gov/show/NCT04420676,None
3006,NCT04420806,ClinicalTrials.gov,2020-06-05,2020-03-14,True,University of Erlangen-Nornberg Medical School,Not Recruiting,Not Applicable,Interventional,Germany,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,Other (exercise),Exercise,Exercise,21,https://clinicaltrials.gov/show/NCT04420806,None
3007,NCT04420988,ClinicalTrials.gov,2020-05-06,2020-06-30,False,Rutgers University,Not Recruiting,Not Applicable,Expanded Access,United States,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04420988,None
3008,NCT04421391,ClinicalTrials.gov,2020-06-04,2020-06-08,False,Therapeutic Solutions International,Recruiting,Not Applicable,Interventional,United States,QuadraMune(TM) for Prevention of COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,500,https://clinicaltrials.gov/show/NCT04421391,None
3009,NCT04421534,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,Drug,Lactoferrin,Lactoferrin,150,https://clinicaltrials.gov/show/NCT04421534,None
3010,NCT04421625,ClinicalTrials.gov,2020-05-18,2020-06-15,False,Institut de Cancérologie de l'Ouest,Not Recruiting,Not Applicable,Interventional,France,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04421625,None
3011,NCT04421664,ClinicalTrials.gov,2020-06-05,2020-03-25,True,McGill University,Recruiting,Phase 3,Interventional,"United States, Canada",Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04421664,None
3012,NCT04422379,ClinicalTrials.gov,2020-06-07,2020-06-07,False,Max Healthcare Insititute Limited,Not Recruiting,Not Applicable,Observational,India,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,Clinical Presentation,No Intervention,No Intervention,314,https://clinicaltrials.gov/show/NCT04422379,None
3013,NCT04422418,ClinicalTrials.gov,2020-06-03,2020-06-14,False,Khalifa University for Science and Technology,Recruiting,Not Applicable,Observational,United Arab Emirates,Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04422418,None
3014,NCT04422535,ClinicalTrials.gov,2020-06-03,2020-05-29,True,Matilde Zaballos,Recruiting,Not Applicable,Observational,Spain,Effects on the Qt Interval of COVID-19 Coronavirus Infection,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04422535,None
3015,NCT04422691,ClinicalTrials.gov,2020-06-05,2020-07-01,False,St. Olavs Hospital,Not Recruiting,Not Applicable,Observational,Norway,Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04422691,None
3016,NCT04422769,ClinicalTrials.gov,2020-06-04,2020-05-22,True,Washington University in St. Louis,Recruiting,Not Applicable,Observational,United States,Needs of Persons With Spinal Cord Injury (SCI),Other,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04422769,None
3017,NCT04423042,ClinicalTrials.gov,2020-06-05,2020-06-01,True,University of Calgary,Not Recruiting,Phase 3,Interventional,No Country Given,Tocilizumab in Coronavirus-19 Positive Patients,Drug,Tocilizumab,Tocilizumab,30,https://clinicaltrials.gov/show/NCT04423042,None
3018,NCT04423315,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Nisantasi University,Not Recruiting,Not Applicable,Observational,Turkey,Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04423315,None
3019,NCT04423692,ClinicalTrials.gov,2020-06-07,2020-04-01,True,Aljazeera Hospital,Recruiting,Not Applicable,Observational,Egypt,Knowledge About Covid-19 Infection,Other,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04423692,None
3020,NCT04424134,ClinicalTrials.gov,2020-05-27,2020-05-16,True,Lomonosov Moscow State University Medical Research and Educational Center,Recruiting,Phase 3,Interventional,Russian Federation,BromhexIne And Spironolactone For Coron?VirUs Infection Requiring HospiTalization,Drug,Bromhexine + Spironolactone,Bromhexine; Spironolactone,80,https://clinicaltrials.gov/show/NCT04424134,None
3021,NCT04425616,ClinicalTrials.gov,2020-06-03,2020-05-29,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,Other,Welfare,Welfare,1100,https://clinicaltrials.gov/show/NCT04425616,None
3022,NCT03376854,ClinicalTrials.gov,2017-12-07,2018-05-01,False,"University of Maryland, Baltimore",Recruiting,Phase 2,Interventional,United States,Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS,Pre 2020,Pre 2020,Pre 2020,20,https://clinicaltrials.gov/show/NCT03376854,None
3023,NCT04193878,ClinicalTrials.gov,2019-12-03,2020-06-01,False,Stanford University,Recruiting,Phase 3,Interventional,United States,ARrest RESpiraTory Failure From PNEUMONIA,Pre 2020,Pre 2020,Pre 2020,600,https://clinicaltrials.gov/show/NCT04193878,None
3024,NCT04303507,ClinicalTrials.gov,2020-03-06,2020-04-29,True,University of Oxford,Not Recruiting,Not Applicable,Interventional,"Thailand, United Kingdom",Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,Drug,Chloroquine or Hydroxychloroquine,Chloroquine; hydroxychloroquine,40000,https://clinicaltrials.gov/show/NCT04303507,EUCTR2020-001441-39
3025,NCT04315987,ClinicalTrials.gov,2020-03-18,2020-06-01,False,Azidus Brasil,Not Recruiting,Phase 2,Interventional,Brazil,NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),90,https://clinicaltrials.gov/show/NCT04315987,None
3026,NCT04322682,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Montreal Heart Institute,Recruiting,Phase 3,Interventional,"Spain, United States, Canada",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Drug,Colchicine,Colchicine,6000,https://clinicaltrials.gov/show/NCT04322682,None
3027,NCT04325906,ClinicalTrials.gov,2020-03-26,2020-04-02,False,Rush University Medical Center,Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Other (device),Nasal cannula,Nasal cannula,346,https://clinicaltrials.gov/show/NCT04325906,None
3028,NCT04331795,ClinicalTrials.gov,2020-04-01,2020-04-04,False,University of Chicago,Not Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Drug,Tocilizumab,Tocilizumab,32,https://clinicaltrials.gov/show/NCT04331795,None
3029,NCT04334460,ClinicalTrials.gov,2020-04-02,2020-05-04,False,Blade Therapeutics,Recruiting,Phase 2,Interventional,United States,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,Drug,BLD-2660,BLD-2660,120,https://clinicaltrials.gov/show/NCT04334460,None
3030,NCT04335786,ClinicalTrials.gov,2020-04-02,2020-04-17,True,Radboud University,Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Drug,Valsartan,Valsartan,651,https://clinicaltrials.gov/show/NCT04335786,EUCTR2020-001320-34
3031,NCT04337320,ClinicalTrials.gov,2020-04-05,2020-03-15,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study",Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04337320,None
3032,NCT04337996,ClinicalTrials.gov,2020-04-01,2020-06-01,False,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Dynamic Evaluation of COVID-19 Diagnostic Tests,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,165,https://clinicaltrials.gov/show/NCT04337996,None
3033,NCT04338074,ClinicalTrials.gov,2020-04-06,2020-06-01,False,University of Alabama at Birmingham,Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,Drug,Tranexamic acid,Tranexamic acid,100,https://clinicaltrials.gov/show/NCT04338074,None
3034,NCT04341116,ClinicalTrials.gov,2020-04-04,2020-04-11,False,I-Mab Biopharma Co. Ltd.,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Drug,TJ003234,TJ003234,144,https://clinicaltrials.gov/show/NCT04341116,None
3035,NCT04341922,ClinicalTrials.gov,2020-04-07,2020-05-09,False,Karolinska Institutet,Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Other (psych),Psychological,Psychological,670,https://clinicaltrials.gov/show/NCT04341922,None
3036,NCT04342884,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Wake Forest University,Recruiting,Not Applicable,Observational,United States,COVID-19 Community Research Partnership,Clinical Presentation,No Intervention,No Intervention,150000,https://clinicaltrials.gov/show/NCT04342884,None
3037,NCT04343651,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,Drug,Leronlimab,Leronlimab,75,https://clinicaltrials.gov/show/NCT04343651,None
3038,NCT04344145,ClinicalTrials.gov,2020-04-09,2020-04-16,False,Université Libre de Bruxelles,Not Recruiting,Not Applicable,Observational,Belgium,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,Other (psych),No Intervention,No Intervention,693,https://clinicaltrials.gov/show/NCT04344145,None
3039,NCT04344288,ClinicalTrials.gov,2020-04-10,2020-04-21,True,Hospices Civils de Lyon,Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,Drug,Corticosteroids,Prednisone,304,https://clinicaltrials.gov/show/NCT04344288,EUCTR2020-001553-48
3040,NCT04344925,ClinicalTrials.gov,2020-04-03,2020-04-18,False,Lawson Health Research Institute,Recruiting,Not Applicable,Observational,Canada,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,Other (device),Masks,Masks,50,https://clinicaltrials.gov/show/NCT04344925,None
3041,NCT04344977,ClinicalTrials.gov,2020-04-13,2020-06-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,"United States Minor Outlying Islands, United States",Collection of Anti-SARS-CoV-2 Immune Plasma,ATMP,Plasma,Plasma Collection,1500,https://clinicaltrials.gov/show/NCT04344977,None
3042,NCT04345861,ClinicalTrials.gov,2020-04-05,2020-04-11,False,"University Hospital, Montpellier",Not Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithormycin,7,https://clinicaltrials.gov/show/NCT04345861,None
3043,NCT04346121,ClinicalTrials.gov,2020-04-10,2020-04-15,False,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04346121,None
3044,NCT04346628,ClinicalTrials.gov,2020-04-10,2020-06-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,Drug,Favipiravir,Favipiravir,120,https://clinicaltrials.gov/show/NCT04346628,None
3045,NCT04347174,ClinicalTrials.gov,2020-03-31,2020-04-30,False,Cadila Pharnmaceuticals,Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,Mycobacterium,40,https://clinicaltrials.gov/show/NCT04347174,None
3046,NCT04347239,ClinicalTrials.gov,2020-04-13,2020-04-15,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),Drug,Leronlimab,Leronlimab,390,https://clinicaltrials.gov/show/NCT04347239,None
3047,NCT04348409,ClinicalTrials.gov,2020-04-03,2020-05-25,False,Azidus Brasil,Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,Drug,Nitazoxanide,Nitazoxanide,50,https://clinicaltrials.gov/show/NCT04348409,None
3048,NCT04348552,ClinicalTrials.gov,2020-04-13,2020-04-15,False,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04348552,None
3049,NCT04351152,ClinicalTrials.gov,2020-04-15,2020-04-30,False,"Humanigen, Inc.",Recruiting,Phase 3,Interventional,United States,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia,Drug,Lenzilumab,Lenzilumab,238,https://clinicaltrials.gov/show/NCT04351152,None
3050,NCT04351503,ClinicalTrials.gov,2020-04-15,2020-04-09,True,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04351503,None
3051,NCT04353596,ClinicalTrials.gov,2020-04-14,2020-04-15,True,Medical University Innsbruck,Recruiting,Phase 4,Interventional,"Austria, Germany",Stopping ACE-inhibitors in COVID-19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,208,https://clinicaltrials.gov/show/NCT04353596,EUCTR2020-001206-35
3052,NCT04355351,ClinicalTrials.gov,2020-04-17,2020-05-05,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04355351,None
3053,NCT04356495,ClinicalTrials.gov,2020-04-11,2020-07-01,True,"University Hospital, Bordeaux",Recruiting,Phase 3,Interventional,France,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Drug,Hydroxychloroquine vs. Imatinib vs. Favipiravir vs. Telmisartan vs. Vitamins,Hydroxychloroquine; Imatinib; Favipiravir; Telmisartan; Vitamins,1057,https://clinicaltrials.gov/show/NCT04356495,EUCTR2020-001435-27
3054,NCT04358588,ClinicalTrials.gov,2020-04-21,2020-04-17,True,Bellerophon,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,Drug,Nitric oxide,Nitric oxide,Not Available,https://clinicaltrials.gov/show/NCT04358588,None
3055,NCT04360278,ClinicalTrials.gov,2020-04-22,2020-04-21,True,National Institutes of Health Clinical Center (CC),Recruiting,Not Applicable,Observational,United States,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,ATMP,Plasma,Plasma,1500,https://clinicaltrials.gov/show/NCT04360278,None
3056,NCT04361474,ClinicalTrials.gov,2020-04-22,2020-05-18,True,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Phase 3,Interventional,France,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Drug,Corticosteroids,Budesonide,120,https://clinicaltrials.gov/show/NCT04361474,EUCTR2020-001667-85
3057,NCT04362813,ClinicalTrials.gov,2020-04-24,2020-04-30,True,Novartis Pharmaceuticals,Recruiting,Phase 3,Interventional,"Spain, United States, Italy, Russian Federation, Germany, France, United Kingdom",Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,Drug,Canakinumab,Canakinumab,450,https://clinicaltrials.gov/show/NCT04362813,EUCTR2020-001370-30
3058,NCT04363606,ClinicalTrials.gov,2020-04-24,2020-05-27,False,CHU de Saint Etienne,Recruiting,Not Applicable,Interventional,France,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Clinical Presentation,No Intervention,No Intervention,52,https://clinicaltrials.gov/show/NCT04363606,None
3059,NCT04365595,ClinicalTrials.gov,2020-04-24,2020-06-03,False,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04365595,None
3060,NCT04366232,ClinicalTrials.gov,2020-04-27,2020-06-01,True,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Not Recruiting,Phase 2,Interventional,France,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),Drug,Anakinra + Ruxolitinib vs. Anakinra,Anakinra; Ruxolitinib,54,https://clinicaltrials.gov/show/NCT04366232,EUCTR2020-001963-10
3061,NCT04366245,ClinicalTrials.gov,2020-04-22,2020-04-23,False,Andalusian Network for Design and Translation of Advanced Therapies,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,ATMP,Plasma,Plasma,72,https://clinicaltrials.gov/show/NCT04366245,None
3062,NCT04368871,ClinicalTrials.gov,2020-04-29,2020-04-28,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04368871,None
3063,NCT04369599,ClinicalTrials.gov,2020-04-28,2020-07-01,False,Emory University,Recruiting,Not Applicable,Interventional,United States,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19,Other (device),Thoracic Manipulation Vest,Thoracic Manipulation Vest,24,https://clinicaltrials.gov/show/NCT04369599,None
3064,NCT04373798,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Henning Bliddal,Recruiting,Not Applicable,Observational,Denmark,C-reactive Protein Levels Among Individuals With COVID-19,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04373798,None
3065,NCT04375098,ClinicalTrials.gov,2020-05-03,2020-05-04,False,Pontificia Universidad Católica de Chile,Recruiting,Phase 2,Interventional,Chile,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,ATMP,Plasma,Plasma,58,https://clinicaltrials.gov/show/NCT04375098,None
3066,NCT04375735,ClinicalTrials.gov,2020-04-22,2020-07-01,False,Lawson Health Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,London's Exogenous Surfactant Study for COVID19,Drug,Bovine Lipid Extract Surfactant,Bovine Lipid Extract Surfactant,20,https://clinicaltrials.gov/show/NCT04375735,None
3067,NCT04377711,ClinicalTrials.gov,2020-05-05,2020-06-08,False,Covis Pharma,Recruiting,Phase 3,Interventional,United States,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,Drug,Ciclesonide,Ciclesonide,400,https://clinicaltrials.gov/show/NCT04377711,None
3068,NCT04379531,ClinicalTrials.gov,2020-04-30,2020-04-25,True,Department of Health Care of Moscow,Not Recruiting,Not Applicable,Interventional,Russian Federation,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04379531,None
3069,NCT04380961,ClinicalTrials.gov,2020-05-07,2020-04-24,True,Janssen Pharmaceutical,Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,Drug,Sirukumab,Sirukumab,270,https://clinicaltrials.gov/show/NCT04380961,None
3070,NCT04381013,ClinicalTrials.gov,2020-05-07,2020-06-01,False,Stanford University,Not Recruiting,Not Applicable,Interventional,United States,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),Other (device),Other,Other,4,https://clinicaltrials.gov/show/NCT04381013,None
3071,NCT04382768,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Quimica Luar SRL,Recruiting,Not Applicable,Interventional,Argentina,Inhaled Ibuprofen to Treat COVID-19,Drug,Ibuprofen,Ibuprofen,40,https://clinicaltrials.gov/show/NCT04382768,None
3072,NCT04383899,ClinicalTrials.gov,2020-05-07,2020-09-30,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019,Drug,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04383899,None
3073,NCT04385160,ClinicalTrials.gov,2020-05-11,2020-05-13,False,Fondazione per la Ricerca Ospedale Maggiore,Recruiting,Not Applicable,Observational,"Spain, United States, Italy, Denmark, Germany, France, United Kingdom",Myeloproliferative Neoplasms (MPN) and COVID-19,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04385160,None
3074,NCT04386694,ClinicalTrials.gov,2020-05-08,2020-05-18,False,University of Nove de Julho,Recruiting,Not Applicable,Interventional,Brazil,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,Other,Photobiomodulation therapy + static magnetic field,Photobiomodulation therapy; static magnetic field,30,https://clinicaltrials.gov/show/NCT04386694,None
3075,NCT04386850,ClinicalTrials.gov,2020-05-11,2020-04-14,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Oral 25-hydroxyvitamin D3 and COVID-19,Drug,Vitamin D,Vitamin D,1500,https://clinicaltrials.gov/show/NCT04386850,IRCT20200401046909N1; IRCT20200401046909N2
3076,NCT04388813,ClinicalTrials.gov,2020-05-04,2020-05-28,False,Verily Life Sciences LLC,Recruiting,Not Applicable,Observational,United States,Predictors of Severe COVID-19 Outcomes,Prognosis,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04388813,None
3077,NCT04389450,ClinicalTrials.gov,2020-05-14,2020-06-04,False,Pluristem Ltd.,Recruiting,Phase 2,Interventional,"Israel, United States","Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",ATMP,Cells (mesenchymal),Cells (mesenchymal),140,https://clinicaltrials.gov/show/NCT04389450,None
3078,NCT04389489,ClinicalTrials.gov,2020-05-14,2020-05-14,False,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Postpartum Sexual Function in Pregnant Women With COVID-19,Other (psych),No Intervention,No Intervention,140,https://clinicaltrials.gov/show/NCT04389489,None
3079,NCT04389515,ClinicalTrials.gov,2020-05-14,2020-05-14,False,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,"Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19",Clinical Presentation,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04389515,None
3080,NCT04390516,ClinicalTrials.gov,2020-05-14,2020-03-24,True,Dascena,Not Recruiting,Not Applicable,Interventional,United States,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,Prognosis,No Intervention,No Intervention,197,https://clinicaltrials.gov/show/NCT04390516,None
3081,NCT04391127,ClinicalTrials.gov,2020-05-12,2020-05-04,True,Centenario Hospital Miguel Hidalgo,Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,Drug,Hydroxychloroquine vs. Ivermectin,Hydroxychloroquine; Ivermectin,200,https://clinicaltrials.gov/show/NCT04391127,None
3082,NCT04391166,ClinicalTrials.gov,2020-05-15,2020-05-20,False,Vanderbilt University,Recruiting,Not Applicable,Observational,United States,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic,Telehealth,Telehealth,Telehealth,150,https://clinicaltrials.gov/show/NCT04391166,None
3083,NCT04393142,ClinicalTrials.gov,2020-04-26,2020-05-05,False,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Not Applicable,Observational,Mexico,Serologic Testing of Household Contacts of Confirmed Cases of COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,92,https://clinicaltrials.gov/show/NCT04393142,None
3084,NCT04394078,ClinicalTrials.gov,2020-05-18,2020-05-06,True,Okan University,Not Recruiting,Not Applicable,Observational,Turkey,Impact of COVID-19 Pandemic on Depression and Quality of Life,Other (psych),No Intervention,No Intervention,543,https://clinicaltrials.gov/show/NCT04394078,None
3085,NCT04395170,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Lifefactors Zona Franca,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Convalescent Plasma Compared to Anti-COVID-19 Human Immunoglobulin and Standard Treatment (TE) in Hospitalized Patients,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,75,https://clinicaltrials.gov/show/NCT04395170,None
3086,NCT04399980,ClinicalTrials.gov,2020-05-21,2020-05-20,True,The Cleveland Clinic,Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,60,https://clinicaltrials.gov/show/NCT04399980,None
3087,NCT04400877,ClinicalTrials.gov,2020-05-22,2020-06-08,False,"University Hospital, Linköping",Recruiting,Not Applicable,Observational,Sweden,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04400877,None
3088,NCT04403880,ClinicalTrials.gov,2020-05-22,2020-05-13,True,HIV Vaccine Trials Network,Recruiting,Not Applicable,Observational,"Malawi, South Africa, Zimbabwe, Zambia, United States, Mozambique, Peru, Tanzania",Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,727,https://clinicaltrials.gov/show/NCT04403880,None
3089,NCT04405466,ClinicalTrials.gov,2020-05-19,2020-04-22,True,Miltenyi Biotec B.V. & Co. KG,Recruiting,Not Applicable,Observational,Germany,A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04405466,None
3090,NCT04407546,ClinicalTrials.gov,2020-05-27,2020-05-27,False,Jonsson Comprehensive Cancer Center,Recruiting,Not Applicable,Observational,United States,Role of Children in Transmission of COVID-19 to Immunocompromised Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04407546,None
3091,NCT04409249,ClinicalTrials.gov,2020-05-28,2020-03-15,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Prognosis in Pregnant With COVID-19,Prognosis,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04409249,None
3092,NCT04409886,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Maimonides Medical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04409886,None
3093,NCT04410016,ClinicalTrials.gov,2020-05-22,2020-05-25,False,University of Nottingham,Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,Other (psych),Psychological,Psychological,45,https://clinicaltrials.gov/show/NCT04410016,None
3094,NCT04410835,ClinicalTrials.gov,2020-05-14,2020-04-28,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04410835,None
3095,NCT04412252,ClinicalTrials.gov,2020-05-30,2020-06-04,False,Pfizer,Not Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,Drug,Tofacitinib,Tofacitinib,240,https://clinicaltrials.gov/show/NCT04412252,None
3096,NCT04412278,ClinicalTrials.gov,2020-05-30,2020-06-01,False,Okan University,Not Recruiting,Not Applicable,Observational,Turkey,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers,Other (exercise),No Intervention,No Intervention,392,https://clinicaltrials.gov/show/NCT04412278,None
3097,NCT04412655,ClinicalTrials.gov,2020-06-01,2020-05-05,True,"Universit degli Studi del Piemonte Orientale ""Amedeo Avogadro""",Not Recruiting,Not Applicable,Observational,Italy,Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry,Other,No Intervention,No Intervention,6609,https://clinicaltrials.gov/show/NCT04412655,None
3098,NCT04414293,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Hospital Provincial de Castellón,Not Recruiting,Not Applicable,Interventional,Spain,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,Other,Radiation,Radiation,41,https://clinicaltrials.gov/show/NCT04414293,None
3099,NCT04414618,ClinicalTrials.gov,2020-05-26,2020-06-11,False,RedHill Biopharma Limited,Recruiting,Phase 2,Interventional,United States,A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,Drug,Opaganib,Opaganib,40,https://clinicaltrials.gov/show/NCT04414618,None
3100,NCT04415359,ClinicalTrials.gov,2020-05-29,2020-05-20,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period,Clinical Presentation,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04415359,None
3101,NCT04416334,ClinicalTrials.gov,2020-06-03,2020-05-25,True,Instituto de Investigacin Marqus de Valdecilla,Recruiting,Phase 3,Interventional,Spain,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 70 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,Drug,Colchicine,Colchicine,1028,https://clinicaltrials.gov/show/NCT04416334,None
3102,NCT04420299,ClinicalTrials.gov,2020-06-05,2020-06-04,True,La Fundación de Investigación HM,Recruiting,Phase 2,Interventional,Spain,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,Drug,Bemiparin,Bemiparin,120,https://clinicaltrials.gov/show/NCT04420299,None
3103,NCT04422353,ClinicalTrials.gov,2020-06-07,2020-05-01,True,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,Other (exercise),Exercise,Exercise,60,https://clinicaltrials.gov/show/NCT04422353,None
3104,NCT04422509,ClinicalTrials.gov,2020-06-03,2020-06-25,False,Radboud University,Not Recruiting,Phase 1/Phase 2,Interventional,Netherlands,Lanadelumab for Treatment of COVID-19 Disease,Drug,Lanadelumab,Lanadelumab,80,https://clinicaltrials.gov/show/NCT04422509,None
3105,NCT04422522,ClinicalTrials.gov,2020-06-07,2020-03-15,True,Al-Azhar University,Not Recruiting,Not Applicable,Observational,Egypt,Fibromyalgia During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04422522,None
3106,NCT04422574,ClinicalTrials.gov,2020-06-08,2020-05-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,COVID 19 Serology in Pulmonologists,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,97,https://clinicaltrials.gov/show/NCT04422574,None
3107,NCT04422587,ClinicalTrials.gov,2020-06-05,2020-03-13,True,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Observational,France,Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,Clinical Presentation,No Intervention,No Intervention,1860,https://clinicaltrials.gov/show/NCT04422587,None
3108,NCT04422613,ClinicalTrials.gov,2020-06-05,2020-05-28,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04422613,None
3109,NCT04422626,ClinicalTrials.gov,2020-06-06,2020-07-01,False,University of Pecs,Not Recruiting,Not Applicable,Observational,No Country Given,Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure,Other (device),Cytokine Adsorber,Cytokine Adsorber,42,https://clinicaltrials.gov/show/NCT04422626,None
3110,NCT04422678,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Alexandria University,Not Recruiting,Phase 3,Interventional,No Country Given,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,Drug,Imatinib,Imatinib,30,https://clinicaltrials.gov/show/NCT04422678,None
3111,NCT04422873,ClinicalTrials.gov,2020-06-04,2020-06-03,True,University of Portsmouth,Not Recruiting,Not Applicable,Observational,United Kingdom,The Impact of COVID-19 on Dialysis Users,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04422873,None
3112,NCT04423003,ClinicalTrials.gov,2020-06-08,2020-03-01,True,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Observational,Germany,Endoscopic Interventions in Patients With COVID-19,Procedure,Endoscopy,Endoscopy,10,https://clinicaltrials.gov/show/NCT04423003,None
3113,NCT04423289,ClinicalTrials.gov,2020-06-06,2020-03-31,True,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Not Applicable,Interventional,Spain,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,Other (software),eHealth,eHealth,150,https://clinicaltrials.gov/show/NCT04423289,None
3114,NCT04423640,ClinicalTrials.gov,2020-05-27,2020-04-15,True,"Coordinación de Investigación en Salud, Mexico",Recruiting,Not Applicable,Observational,Mexico,Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04423640,None
3115,NCT04423770,ClinicalTrials.gov,2020-06-08,2020-06-08,False,American Dental Association,Recruiting,Not Applicable,Observational,United States,COVID-19 Related Health and Infection Control Practices Among Dentists,Other,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04423770,None
3116,NCT04423861,ClinicalTrials.gov,2020-06-08,2020-07-01,False,Azidus Brasil,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg TID for the Treatment of Hospitalized Patients With COVID-19,Drug,Nitazoxanide,Nitazoxanide,50,https://clinicaltrials.gov/show/NCT04423861,None
3117,NCT04423991,ClinicalTrials.gov,2020-06-08,2020-03-10,True,Dascena,Not Recruiting,Not Applicable,Interventional,United States,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,Other (software),Machine Learning,Machine Learning,290,https://clinicaltrials.gov/show/NCT04423991,None
3118,NCT04424004,ClinicalTrials.gov,2020-06-08,2020-06-15,False,Duke University,Not Recruiting,Not Applicable,Observational,No Country Given,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04424004,None
3119,NCT04424017,ClinicalTrials.gov,2020-06-08,2020-06-16,False,Egyptian Center for Research and Regenerative Medicine,Not Recruiting,Not Applicable,Observational,Egypt,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,726,https://clinicaltrials.gov/show/NCT04424017,None
3120,NCT04424082,ClinicalTrials.gov,2020-06-07,2020-06-07,False,Karolinska Institutet,Recruiting,Not Applicable,Interventional,Sweden,External Dead Space in Ventilated COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,40,https://clinicaltrials.gov/show/NCT04424082,None
3121,NCT04424771,ClinicalTrials.gov,2020-06-07,2020-03-01,True,Ospedale Policlinico San Martino,Recruiting,Not Applicable,Observational,Italy,Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia,Other (psych),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04424771,None
3122,NCT04424797,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Poudre Valley Health System,Recruiting,Not Applicable,Interventional,United States,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04424797,None
3123,NCT04424849,ClinicalTrials.gov,2020-06-08,2020-03-15,True,Tepecik Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients,Prognosis,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04424849,None
3124,NCT04424901,ClinicalTrials.gov,2020-05-29,2020-05-03,True,UConn Health,Recruiting,Phase 2,Interventional,United States,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,Drug,Dipyridamole,Dipyridamole,100,https://clinicaltrials.gov/show/NCT04424901,None
3125,NCT04424992,ClinicalTrials.gov,2020-06-04,2020-02-23,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,The Natural History of Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,1433,https://clinicaltrials.gov/show/NCT04424992,None
3126,NCT04425005,ClinicalTrials.gov,2020-06-08,2020-05-10,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,Other (exercise),Exercise,Exercise,70,https://clinicaltrials.gov/show/NCT04425005,None
3127,NCT04425044,ClinicalTrials.gov,2020-06-09,2020-04-12,True,Aarogyam UK,Not Recruiting,Not Applicable,Observational,India,AiM Covid Self Monitoring,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04425044,None
3128,NCT04425317,ClinicalTrials.gov,2020-05-27,2020-06-15,False,CRG UZ Brussel,Not Recruiting,Not Applicable,Interventional,No Country Given,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://clinicaltrials.gov/show/NCT04425317,None
3129,NCT04425382,ClinicalTrials.gov,2020-05-21,2020-03-01,True,Hamad Medical Corporation,Recruiting,Not Applicable,Observational,Qatar,Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar,Drug,Darunavir/Cobicistat vs. Lopinavir/Ritonavir,Darunavir/Cobicistat; Lopinavir/Ritonavir,200,https://clinicaltrials.gov/show/NCT04425382,None
3130,NCT04425460,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Zhejiang Hisun Pharmaceutical Co. Ltd.,Not Recruiting,Phase 3,Interventional,"China, Romania, Germany","A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",Drug,Favipiravir,Favipiravir,256,https://clinicaltrials.gov/show/NCT04425460,None
3131,NCT04425499,ClinicalTrials.gov,2020-06-08,2020-06-01,True,University of Montreal,Not Recruiting,Not Applicable,Interventional,No Country Given,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04425499,None
3132,NCT04425538,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,Drug,Infliximab,Infliximab,17,https://clinicaltrials.gov/show/NCT04425538,None
3133,NCT04425707,ClinicalTrials.gov,2020-06-08,2020-06-09,False,"Ministry of Health and Population, Egypt",Recruiting,Not Applicable,Interventional,Egypt,Ivermectin In Treatment of COVID 19 Patients,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04425707,None
3134,NCT04425733,ClinicalTrials.gov,2020-06-08,2020-07-07,False,Merck Sharp & Dohme Corp.,Not Recruiting,Phase 1,Interventional,No Country Given,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),Drug,MK-5475,MK-5475,64,https://clinicaltrials.gov/show/NCT04425733,None
3135,NCT04425772,ClinicalTrials.gov,2020-05-09,2020-06-12,False,"HeNan Sincere Biotech Co., Ltd",Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Azvudine,Azvudine,342,https://clinicaltrials.gov/show/NCT04425772,None
3136,NCT04425837,ClinicalTrials.gov,2020-05-29,2020-07-01,False,Fundación Santa Fe de Bogotá,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,ATMP,Plasma,Plasma,236,https://clinicaltrials.gov/show/NCT04425837,None
3137,NCT04425889,ClinicalTrials.gov,2020-06-06,2020-05-05,True,Hospital Universitario Dr. Jose E. Gonzalez,Not Recruiting,Not Applicable,Observational,Mexico,COVID-19 Antibodies Among Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,156,https://clinicaltrials.gov/show/NCT04425889,None
3138,NCT04425915,ClinicalTrials.gov,2020-06-07,2020-06-09,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 3,Interventional,India,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,ATMP,Plasma,Plasma,400,https://clinicaltrials.gov/show/NCT04425915,None
3139,NCT04426006,ClinicalTrials.gov,2020-06-09,2020-06-01,True,Institut Bergonié,Not Recruiting,Not Applicable,Interventional,France,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic - PRO-SERO-COV,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04426006,None
3140,NCT04426071,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Observational,Canada,The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,Other,No Intervention,No Intervention,142,https://clinicaltrials.gov/show/NCT04426071,None
3141,NCT04426084,ClinicalTrials.gov,2020-06-09,2020-03-01,True,Karolinska Institutet,Not Recruiting,Not Applicable,Observational,Sweden,Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study,Clinical Presentation,No Intervention,No Intervention,22784,https://clinicaltrials.gov/show/NCT04426084,None
3142,NCT04426201,ClinicalTrials.gov,2020-06-09,2020-06-22,False,Revimmune,Not Recruiting,Phase 2,Interventional,No Country Given,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-O ),Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04426201,None
3143,NCT04426253,ClinicalTrials.gov,2020-06-09,2020-06-05,True,Szeged University,Not Recruiting,Not Applicable,Observational,Hungary,"Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04426253,None
3144,NCT04426279,ClinicalTrials.gov,2020-06-09,2020-08-01,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04426279,None
3145,NCT04426292,ClinicalTrials.gov,2020-06-08,2020-05-12,True,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3500,https://clinicaltrials.gov/show/NCT04426292,None
3146,NCT04426305,ClinicalTrials.gov,2020-06-03,2020-05-21,True,University of Ghent,Recruiting,Not Applicable,Interventional,Belgium,Community Health Workers Against COVID19,Other (psych),Psychological,Psychological,140,https://clinicaltrials.gov/show/NCT04426305,None
3147,NCT04426318,ClinicalTrials.gov,2020-06-09,2020-06-10,False,"University of Wisconsin, Madison",Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 and the Healthy Minds Program for Educators,Other (psych),Psychological,Psychological,400,https://clinicaltrials.gov/show/NCT04426318,None
3148,NCT04426344,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Washington University in St. Louis,Not Recruiting,Not Applicable,Interventional,United States,Core Warming of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04426344,None
3149,NCT04427176,ClinicalTrials.gov,2020-06-10,2020-04-29,True,CHU de Saint Etienne,Recruiting,Not Applicable,Observational,France,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,Other (device),Masks,Masks,30,https://clinicaltrials.gov/show/NCT04427176,None
3150,NCT04427280,ClinicalTrials.gov,2020-05-21,2020-05-26,False,Royal Marsden NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://clinicaltrials.gov/show/NCT04427280,None
3151,NCT04427332,ClinicalTrials.gov,2020-06-10,2020-05-15,True,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Smell and Taste Disorders in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04427332,None
3152,NCT04427345,ClinicalTrials.gov,2020-06-04,2020-03-01,True,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Predictive Factors COVID-19 Patients,Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04427345,None
3153,NCT04427358,ClinicalTrials.gov,2020-06-10,2020-05-07,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04427358,None
3154,NCT04427631,ClinicalTrials.gov,2020-06-03,2020-06-22,False,Cambridgeshire Community Services NHS Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Exploring Interventions for Glue Ear During Covid-19,Other,Other,Other,20,https://clinicaltrials.gov/show/NCT04427631,None
3155,NCT04427735,ClinicalTrials.gov,2020-06-09,2019-01-24,True,Beijing Friendship Hospital,Recruiting,Not Applicable,Observational,China,Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI,Health System,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04427735,None
3156,NCT04428021,ClinicalTrials.gov,2020-06-07,2020-06-15,False,AOU Città della Salute e della Scienza di Torino,Not Recruiting,Phase 2,Interventional,No Country Given,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,ATMP,Plasma,Plasma,180,https://clinicaltrials.gov/show/NCT04428021,None
3157,NCT04428073,ClinicalTrials.gov,2020-06-08,2020-07-01,False,GeneCure Biotechnologies,Not Recruiting,Phase 1,Interventional,No Country Given,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,ATMP,Vaccine,Vaccine,32,https://clinicaltrials.gov/show/NCT04428073,None
3158,NCT04428099,ClinicalTrials.gov,2020-06-09,2020-01-13,True,University of the Balearic Islands,Recruiting,Not Applicable,Interventional,Spain,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,Telehealth,Telehealth,Telehealth,186,https://clinicaltrials.gov/show/NCT04428099,None
3159,NCT04428801,ClinicalTrials.gov,2020-04-08,2020-06-20,False,Celltex Therapeutics Corporation,Not Recruiting,Phase 2,Interventional,No Country Given,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),200,https://clinicaltrials.gov/show/NCT04428801,None
3160,NCT04429477,ClinicalTrials.gov,2020-06-09,2020-05-01,True,University of São Paulo,Recruiting,Not Applicable,Observational,Brazil,Cerebral Compliance Impairment in COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04429477,None
3161,NCT04429529,ClinicalTrials.gov,2020-06-09,2020-06-09,False,Tychan Pte Ltd.,Recruiting,Phase 1,Interventional,Singapore,"Safety of TY027, a Treatment for COVID-19, in Humans",Drug,TY027,TY027,25,https://clinicaltrials.gov/show/NCT04429529,None
3162,NCT04429763,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Trustem,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04429763,None
3163,NCT04429854,ClinicalTrials.gov,2020-06-09,2020-05-02,True,UZ Leuven,Recruiting,Phase 2,Interventional,Belgium,Donated Antibodies Working Against nCoV,ATMP,Plasma,Plasma,483,https://clinicaltrials.gov/show/NCT04429854,None
3164,ACTRN12620000501943,ANZCTR,2020-04-22,2020-05-20,False,Walter and Eliza Hall Institute of Medical Research,Recruiting,Phase 2/Phase 3,Interventional,Australia,COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2250,https://anzctr.org.au/ACTRN12620000501943.aspx,None
3165,ACTRN12620000500954,ANZCTR,2020-04-22,2020-05-01,False,Western Health,Not Recruiting,Not Applicable,Interventional,Australia,A reusable personalised ventilation hood: A phase 1 safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19.,Other (device),Hood,Hood,20,https://anzctr.org.au/ACTRN12620000500954.aspx,None
3166,ACTRN12620000674932,ANZCTR,2020-06-12,2020-07-14,False,University of Queensland,Not Recruiting,Phase 1,Interventional,Australia,"An interventional study to evaluate the safety and immune response of a vaccine against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) when given to healthy adult participants.",ATMP,Vaccine,Vaccine,120,https://anzctr.org.au/ACTRN12620000674932.aspx,None
3167,ACTRN12620000676910,ANZCTR,2020-06-15,2020-06-29,False,Monash Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Amnion cells for COVID-19 related respiratory failure,ATMP,Cells (amniotic epithelial),Cells (amniotic epithelial),40,https://anzctr.org.au/ACTRN12620000676910.aspx,None
3168,ISRCTN89951424,ISRCTN,2020-06-11,2020-06-15,False,University of Oxford,Recruiting,Phase 3,Interventional,Brazil,A phase III study to investigate a vaccine against COVID-19,ATMP,Vaccine,Vaccine,2000,http://isrctn.com/ISRCTN89951424,None
3169,ISRCTN93266696,ISRCTN,2020-06-11,2020-05-20,True,Queen Mary University of London,Recruiting,Not Applicable,Observational,United Kingdom,Studying the immune response and long-term morbidity of COVID-19 infection in pregnancy,Clinical Presentation,No Intervention,No Intervention,200,http://isrctn.com/ISRCTN93266696,None
3170,ISRCTN94091479,ISRCTN,2020-06-09,2020-06-15,False,"Tees, Esk and Wear Valleys NHS Foundation Trust",Recruiting,Not Applicable,Interventional,United Kingdom,Behavioural Activation in Social IsoLation (BASIL): Benefiting from activities to improve your mood while you are socially isolating,Other (psych),Psychological,Psychological,100,http://isrctn.com/ISRCTN94091479,None
3171,ISRCTN33578935,ISRCTN,2020-06-02,2020-06-01,True,Kimera Labs,Recruiting,Phase 2,Interventional,Germany,To study the treatment of COVID-19 with severe viral pneumonia by using purified stem cell exosomes,ATMP,Cells (mesenchymal),Cells (mesenchymal),64,http://isrctn.com/ISRCTN33578935,None
3172,ISRCTN40302986,ISRCTN,2020-05-26,2020-06-22,False,Lagos University Teaching Hospital,Recruiting,Phase 3,Interventional,Nigeria,Does ivermectin cure and/or prevent COVID-19?,Drug (+ Chemoprophylaxis),Ivermectin,Ivermectin,45,http://isrctn.com/ISRCTN40302986,None
3173,ISRCTN21363594,ISRCTN,2020-05-18,2020-05-01,True,King Saud Medical City,Recruiting,Not Applicable,Interventional,"Saudi Arabia, Oman, United Arab Emirates",Therapeutic plasma exchange (removal of the non-cell portion of blood) in critically ill adult patients with serious SARS CoV-2 disease (COVID-19),ATMP,Plasma,Plasma,80,http://isrctn.com/ISRCTN21363594,None
3174,ISRCTN28342533,ISRCTN,2020-05-04,2020-03-26,True,Sheffield Teaching Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of COVID-19 assessment in emergency departments and ambulance services,Clinical Presentation,No Intervention,No Intervention,20000,http://isrctn.com/ISRCTN28342533,None
3175,ISRCTN40092247,ISRCTN,2020-04-01,2020-03-20,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,UKOSS: Pandemic COVID-19 in pregnancy,Clinical Presentation,No Intervention,No Intervention,500,http://isrctn.com/ISRCTN40092247,None
3176,ISRCTN16483855,ISRCTN,2019-08-05,2019-07-01,True,"University College, London",Recruiting,Not Applicable,Interventional,United Kingdom,"Inhale work package 3 – rapid versus standard testing to diagnose lung infections in intensive care, including COVID-19 observational sub-study",Pre 2020,Pre 2020,Pre 2020,466,http://isrctn.com/ISRCTN16483855,None
3177,ChiCTR2000033980,ChiCTR,2020-06-19,2020-06-10,True,The Second Affiliated Hospital of Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,"A follow-up study of novel coronavirus pneumonia (COVID-19) patients in Wanzhou District, Chongqing",Clinical Presentation,No Intervention,No Intervention,67,http://www.chictr.org.cn/showproj.aspx?proj=55355,None
3178,ChiCTR2000033960,ChiCTR,2020-06-19,2020-02-10,True,Maternal and Child Health Hospital of Hubei Province,Recruiting,Not Applicable,Observational,China,A multicenter clinical study: transmission of COVID-19 and impact on health and developmental outcomes among newborns of mothers with confirmed/suspected COVID-19,Clinical Presentation,No Intervention,No Intervention,90,http://www.chictr.org.cn/showproj.aspx?proj=55376,None
3179,ChiCTR2000033936,ChiCTR,2020-06-17,2020-06-16,True,No Sponsor Name Given,Recruiting,Not Applicable,Prevention,China,Psychological Preparedness towards Novel Coronavirus Precautionary Measures – an online survey,Other (psych),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=55291,None
3180,ChiCTR2000033919,ChiCTR,2020-06-17,2020-06-16,True,Tianjin Medical University General Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for the influence of novel coronavirus pneumonia (COVID-19) on the symptoms of patients with achalasia,Clinical Presentation,No Intervention,No Intervention,286,http://www.chictr.org.cn/showproj.aspx?proj=55301,None
3181,ChiCTR2000033899,ChiCTR,2020-06-16,2020-06-04,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Health services research,Pakistan,Impact of COVID-19 on Laboratory Professionals-Early Evidences from a Survey at a Clinical Chemistry Laboratory in a Developing Country,Other,No Intervention,No Intervention,64,http://www.chictr.org.cn/showproj.aspx?proj=55295,None
3182,ChiCTR2000031707,ChiCTR,2020-04-07,2020-03-01,True,Shanghai Oriental Hospital,Recruiting,Not Applicable,Observational,China,Study for sleep quality of medical teams members moved to Hubei for the fighting of novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,No Intervention,47,http://www.chictr.org.cn/showproj.aspx?proj=52079,None
3183,EUCTR2020-001243-15-BE,EU Clinical Trials Register,2020-03-27,2020-03-26,True,UZ Leuven,Not Recruiting,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Itraconazole,Itraconazole,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15,None
3184,EUCTR2020-001411-25-DE,EU Clinical Trials Register,2020-04-01,2020-05-18,False,Karyopharm Therapeutics Inc,Authorised,Phase 2,Interventional,"Malaysia, Spain, Israel, United States, Italy, Germany, Belgium, India, Australia, Canada, France, Austria, United Kingdom",A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe COVID-19 Infection,Drug,Selinexor,Selinexor,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25,None
3185,EUCTR2020-001636-95-GB,EU Clinical Trials Register,2020-05-04,2020-05-20,False,University of Manchester,Authorised,Phase 2,Interventional,United Kingdom,Does subcutaneously(SC) administered of anakinra achieve good penetration in blood and result in reduce inflammation in patients with SARS-CoV-19?,Drug,Anakinra,Anakinra,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001636-95,None
3186,EUCTR2020-002293-28-SE,EU Clinical Trials Register,2020-05-13,2020-05-29,False,Karolinska University Hospital,Authorised,Phase 2,Interventional,Sweden,"Treatment with Omega-3 polyunsaturated fatty acids in COVID-19 patients.

A single-blind, randomized, placebo-controlled feasibility study.",Drug,Omega 3,Omega 3,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002293-28,None
3187,EUCTR2020-001889-10-GB,EU Clinical Trials Register,2020-05-15,2020-06-02,False,University of Oxford,Authorised,Phase 2,Interventional,United Kingdom,Treating COVID-19 infections with inhaled corticosteroids,Drug,Budesonide,Budesonide,478,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001889-10,None
3188,EUCTR2020-002120-37-GB,EU Clinical Trials Register,2020-06-08,2020-06-16,False,Thirty Respiratory Limited,Authorised,Phase 2/Phase 3,Interventional,"Spain, Netherlands, United States, Italy, Germany, France, United Kingdom","An open-label, adaptive randomized, controlled multicenter study to evaluate the efficacy and safety of RESP301+SOC vs SOC in hospitalized participants with COVID-19 requiring supplemental oxygen",Drug,Sodium Nitrite,Sodium Nitrite,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002120-37,None
3189,EUCTR2020-002233-15-DE,EU Clinical Trials Register,2020-05-13,2020-06-17,False,Charité Research Organisation GmbH,Authorised,Phase 2,Interventional,Germany,"A study to investigate the safety and efficacy of two approved drugs, niclosamide and camostat, administered alone and in combination and compared to placebo in COVID-19 patients",Drug,Niclosamide vs. Camostat Mesilate vs. Niclosamide + Camostat Mesilate,Niclosamide; Camostat Mesilate,72,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002233-15,None
3190,EUCTR2020-001784-88-FI,EU Clinical Trials Register,2020-04-17,2020-04-29,False,University of Helsinki,Authorised,Phase 3,Interventional,Finland,"A clinical study to evaluate the efficacy of different anti-viral drugs in
SARS-CoV-2 infected patients (COVID-19)",Drug,"Oxiklorin, Hydroxychloroquine, Remdesivir","Oxiklorin, Hydroxychloroquine, Remdesivir",582,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001784-88,None
3191,EUCTR2020-001497-30-GB,EU Clinical Trials Register,2020-04-27,2020-05-07,False,Alexion Pharmaceuticals,Authorised,Phase 3,Interventional,"Spain, United States, Italy, Germany, France, United Kingdom",ravulizumab for the treatment of patients with Coronavirus Disease 2019,Drug,Ravulizumab,Ravulizumab,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30,None
3192,EUCTR2020-001736-95-GB,EU Clinical Trials Register,2020-04-23,2020-04-28,False,University Hospital Southampton NHS Foundation Trust,Authorised,Phase 2,Interventional,United Kingdom,A Phase 2 Study for the Treatment of COVID 19 in Hospitalised Patients,Drug (+ ATMP),"Bemcentinib, Immunoglobulin, Acalabrutinib, Zilucoplan, Heparin",Bemcentinib; Immunoglobulin; Acalabrutinib; Zilucoplan; Heparin,825,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001736-95,None
3193,NCT04244591,ClinicalTrials.gov,2020-01-23,2020-01-26,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Drug,Corticosteroids,Methylprednisolone,80,https://clinicaltrials.gov/show/NCT04244591,None
3194,NCT04285190,ClinicalTrials.gov,2020-02-19,2020-02-26,False,"Tasly Pharmaceuticals, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,0,https://clinicaltrials.gov/show/NCT04285190,None
3195,NCT04303299,ClinicalTrials.gov,2020-02-24,2020-07-15,False,Rajavithi Hospital,Not Recruiting,Phase 3,Interventional,Thailand,"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial",Drug,"Various Combinations of: Oseltamivir, Chloroquine, Lopipinavir/Ritonavir, Darunavir/ritonavir, Favipiravir",Oseltamivir; Hydroxychloroquine; Lopinavir; Ritonavir; Darunavir; Favipiravir,320,https://clinicaltrials.gov/show/NCT04303299,None
3196,NCT04311177,ClinicalTrials.gov,2020-03-13,2020-04-09,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Drug,ARB (Losartan),ARB (Losartan),580,https://clinicaltrials.gov/show/NCT04311177,None
3197,NCT04312009,ClinicalTrials.gov,2020-03-13,2020-04-13,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,Drug,ARB (Losartan),ARB (Losartan),200,https://clinicaltrials.gov/show/NCT04312009,None
3198,NCT04312243,ClinicalTrials.gov,2020-03-15,2020-04-07,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,NO Prevention of COVID-19 for Healthcare Providers,Drug,Nitric oxide,Nitric oxide,470,https://clinicaltrials.gov/show/NCT04312243,None
3199,NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-15,True,Centre Leon Berard,Not Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Drug,Chloroquine + Nivolumab + Tocilizumab,Chloroquine; Nivolumab; Tocilizumab,384,https://clinicaltrials.gov/show/NCT04333914,EUCTR2020-001373-70
3200,NCT04340414,ClinicalTrials.gov,2020-03-03,2020-02-20,True,Peking Union Medical College Hospital,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Drug,Oxygen,Oxygen,10,https://clinicaltrials.gov/show/NCT04340414,None
3201,NCT04343781,ClinicalTrials.gov,2020-04-09,2020-03-22,True,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,Clinical Presentation,No Intervention,No Intervention,353,https://clinicaltrials.gov/show/NCT04343781,None
3202,NCT04346446,ClinicalTrials.gov,2020-04-14,2020-04-20,False,"Institute of Liver and Biliary Sciences, India",Not Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,ATMP,Plasma,Plasma,29,https://clinicaltrials.gov/show/NCT04346446,None
3203,NCT04347408,ClinicalTrials.gov,2020-04-07,2020-05-06,False,"Queen's University, Belfast",Recruiting,Not Applicable,Observational,United Kingdom,Seroprevalence of SARS-Cov-2 Antibodies in Children,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04347408,None
3204,NCT04353128,ClinicalTrials.gov,2020-04-16,2020-04-20,False,Instituto de Investigación Hospital Universitario La Paz,Recruiting,Phase 2/Phase 3,Interventional,Spain,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Drug (Chemoprophylaxis),Melatonin,Melatonin,450,https://clinicaltrials.gov/show/NCT04353128,None
3205,NCT04354818,ClinicalTrials.gov,2020-04-16,2020-05-11,False,Kirby Institute,Recruiting,Not Applicable,Observational,Australia,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04354818,None
3206,NCT04362319,ClinicalTrials.gov,2020-04-23,2020-05-15,False,University of Malaya,Not Recruiting,Not Applicable,Observational,Malaysia,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,85,https://clinicaltrials.gov/show/NCT04362319,None
3207,NCT04369066,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Institut Curie,Recruiting,Not Applicable,Interventional,France,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie",Clinical Presentation,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04369066,None
3208,NCT04370262,ClinicalTrials.gov,2020-04-27,2020-04-07,True,Northwell Health,Recruiting,Phase 3,Interventional,United States,Multi-site Adaptive Trials for COVID-19,Drug,Hydroxychloroquine + Famotidine vs. Hydroxychloroquine,Hydroxychloroquine; Famotidine,942,https://clinicaltrials.gov/show/NCT04370262,None
3209,NCT04371029,ClinicalTrials.gov,2020-04-28,2020-04-28,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Other,Polysomnography,Polysomnography,25,https://clinicaltrials.gov/show/NCT04371029,None
3210,NCT04374643,ClinicalTrials.gov,2020-04-30,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Descriptive Study of the PSYchological Impact of CONFinement Measures in Subjects With Mood Disorders,Other (psych),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04374643,None
3211,NCT04376814,ClinicalTrials.gov,2020-05-03,2020-03-29,True,Baqiyatallah Medical Sciences University,Not Recruiting,Not Applicable,Interventional,Iran,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,Drug,Favipiravir + Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,Favipiravir; Hydroxychloroquine; Lopinavir/ritonavir,40,https://clinicaltrials.gov/show/NCT04376814,None
3212,NCT04382053,ClinicalTrials.gov,2020-05-08,2020-05-27,True,Novartis Pharmaceuticals,Recruiting,Phase 2,Interventional,"Hungary, Denmark, Germany",Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,Drug,DFV890,DFV890,120,https://clinicaltrials.gov/show/NCT04382053,EUCTR2020-001870-32
3213,NCT04383535,ClinicalTrials.gov,2020-05-06,2020-05-15,False,Hospital Italiano de Buenos Aires,Recruiting,Not Applicable,Interventional,Argentina,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,ATMP,Plasma,Plasma,333,https://clinicaltrials.gov/show/NCT04383535,None
3214,NCT04383730,ClinicalTrials.gov,2020-05-08,2020-06-30,False,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Observational,"France, Spain, Germany",Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),Drug,Sedation,Sedation,400,https://clinicaltrials.gov/show/NCT04383730,None
3215,NCT04386369,ClinicalTrials.gov,2020-04-14,2020-04-15,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS,Other (physical),Mechanical ventilation,Mechanical ventilation,17,https://clinicaltrials.gov/show/NCT04386369,None
3216,NCT04387214,ClinicalTrials.gov,2020-05-12,2020-04-13,True,South Valley University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Pandemic and Academic Performance of Veterinary Students,Other,No Intervention,No Intervention,857,https://clinicaltrials.gov/show/NCT04387214,None
3217,NCT04387409,ClinicalTrials.gov,2020-05-11,2020-05-25,False,Vakzine Projekt Management GmbH,Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,Drug,VPM1002,VPM1002,1200,https://clinicaltrials.gov/show/NCT04387409,None
3218,NCT04388709,ClinicalTrials.gov,2020-05-12,2020-09-01,False,Icahn School of Medicine at Mount Sinai,Not Recruiting,Phase 2,Interventional,United States,Interferon Lambda Therapy for COVID-19,Drug,Interferon lambda,Interferon lambda,66,https://clinicaltrials.gov/show/NCT04388709,None
3219,NCT04389476,ClinicalTrials.gov,2020-05-14,2020-06-15,False,Kaohsiung Kai-Suan Psychiatric Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes,Other (psych),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04389476,None
3220,NCT04391140,ClinicalTrials.gov,2020-05-10,2020-05-13,False,Vall d'Hebron Research Institute (VHIR),Recruiting,Not Applicable,Interventional,Spain,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,Procedure,Positioning,Positioning,248,https://clinicaltrials.gov/show/NCT04391140,None
3221,NCT04394455,ClinicalTrials.gov,2020-05-03,2020-06-15,False,Universidad Nacional Autónoma de Honduras,Not Recruiting,Not Applicable,Interventional,Honduras,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,Other (psych),Psychological,Psychological,236,https://clinicaltrials.gov/show/NCT04394455,None
3222,NCT04395716,ClinicalTrials.gov,2020-05-19,2020-06-01,False,ProgenaBiome,Not Recruiting,Phase 1,Interventional,United States,A Study of ResCure™ to Treat COVID-19 Infection,Drug,Unspecified Therapy,Unspecified Therapy,50,https://clinicaltrials.gov/show/NCT04395716,None
3223,NCT04397562,ClinicalTrials.gov,2020-05-19,2020-04-29,True,Biocad,Not Recruiting,Phase 3,Interventional,Russian Federation,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,Drug,Levilimab,Levilimab,204,https://clinicaltrials.gov/show/NCT04397562,None
3224,NCT04397900,ClinicalTrials.gov,2020-05-19,2020-04-09,True,"TScan Therapeutics, Inc.",Recruiting,Not Applicable,Observational,United States,Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04397900,None
3225,NCT04397939,ClinicalTrials.gov,2020-05-19,2020-05-08,True,Icahn School of Medicine at Mount Sinai,Recruiting,Not Applicable,Observational,United States,Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04397939,None
3226,NCT04399733,ClinicalTrials.gov,2020-05-21,2020-07-01,False,Future Genetics Limited,Not Recruiting,Not Applicable,Observational,United Kingdom,EMPOWER - BAME vs COVID,Genomics,No Intervention,No Intervention,12800,https://clinicaltrials.gov/show/NCT04399733,None
3227,NCT04402944,ClinicalTrials.gov,2020-05-12,2020-06-18,False,Boston Children's Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Pulmozyme to Improve COVID-19 ARDS Outcomes,Drug,Dornase alfa,Dornase alfa,60,https://clinicaltrials.gov/show/NCT04402944,None
3228,NCT04402957,ClinicalTrials.gov,2020-05-12,2020-07-01,False,Arch Biopartners Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),Drug,LSALT peptide,LSALT peptide,60,https://clinicaltrials.gov/show/NCT04402957,None
3229,NCT04408339,ClinicalTrials.gov,2020-05-19,2020-04-15,True,"University Hospital, Hamburg-Eppendorf",Recruiting,Not Applicable,Observational,Germany,COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04408339,None
3230,NCT04412057,ClinicalTrials.gov,2020-05-29,2020-06-09,False,Aevi Genomic Medicine,Recruiting,Phase 2,Interventional,United States,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,Drug,CERC-002,CERC-002,82,https://clinicaltrials.gov/show/NCT04412057,None
3231,NCT04412317,ClinicalTrials.gov,2020-05-30,2020-06-03,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Use of PCR-Sars-CoV-2 in Children,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04412317,None
3232,NCT04413071,ClinicalTrials.gov,2020-05-23,2020-05-25,False,AORTICA Group,Not Recruiting,Not Applicable,Observational,Spain,Cardiac COVID-19 Health Care Workers,Clinical Presentation,No Intervention,No Intervention,142,https://clinicaltrials.gov/show/NCT04413071,None
3233,NCT04413435,ClinicalTrials.gov,2020-05-25,2020-06-30,False,Nevsehir Public Hospital,Recruiting,Not Applicable,Observational,Turkey,Clinical Characteristics of Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,105,https://clinicaltrials.gov/show/NCT04413435,None
3234,NCT04418284,ClinicalTrials.gov,2020-06-03,2020-06-05,False,South Valley University,Recruiting,Not Applicable,Observational,Egypt,Online Learning of Veterinary Anatomy During COVID-19 Pandemic,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04418284,None
3235,NCT04421404,ClinicalTrials.gov,2020-06-03,2020-06-08,False,Dr. Priscilla Hsue,Recruiting,Phase 2,Interventional,United States,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04421404,None
3236,NCT04422340,ClinicalTrials.gov,2020-06-08,2020-04-01,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Senior-COVID-Rea Multicentric Survey,Clinical Presentation,No Intervention,No Intervention,185,https://clinicaltrials.gov/show/NCT04422340,None
3237,NCT04424355,ClinicalTrials.gov,2020-06-05,2020-05-19,True,Department of Health Care of Moscow,Recruiting,Not Applicable,Observational,Russian Federation,Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,115,https://clinicaltrials.gov/show/NCT04424355,None
3238,NCT04424836,ClinicalTrials.gov,2020-06-07,2020-05-15,True,Sisli Hamidiye Etfal Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,HFNC Treatment in COVID-19 Pneumonia,Other (device),Nasal cannula,Nasal cannula,40,https://clinicaltrials.gov/show/NCT04424836,None
3239,NCT04424940,ClinicalTrials.gov,2020-05-20,2020-09-01,False,University of Kinshasa,Not Recruiting,Not Applicable,Observational,Democratic Republic of Congo,COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach,Other,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04424940,None
3240,NCT04425213,ClinicalTrials.gov,2020-05-28,2020-05-12,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Obesity and Mortality of Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04425213,None
3241,NCT04425252,ClinicalTrials.gov,2020-06-09,2020-06-12,False,"Clear Creek Bio, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,Drug,Brequinar,Brequinar,24,https://clinicaltrials.gov/show/NCT04425252,None
3242,NCT04425759,ClinicalTrials.gov,2020-06-08,2020-06-08,False,Hospital de Mataró,Recruiting,Not Applicable,Observational,Spain,Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19),Clinical Presentation,No Intervention,No Intervention,2400,https://clinicaltrials.gov/show/NCT04425759,None
3243,NCT04427267,ClinicalTrials.gov,2020-06-10,2020-06-03,True,"Federal State Budgetary Scientific Institution, Izmerov Research Institute of Occupational Health",Not Recruiting,Not Applicable,Observational,Russian Federation,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients,Other,PPE,PPE,6,https://clinicaltrials.gov/show/NCT04427267,None
3244,NCT04427865,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,Drug (Chemoprophylaxis),Lactoferrin,Lactoferrin,200,https://clinicaltrials.gov/show/NCT04427865,None
3245,NCT04427878,ClinicalTrials.gov,2020-06-10,2020-07-01,False,CHU de Nice,Not Recruiting,Not Applicable,Interventional,France,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,Clinical Presentation,No Intervention,No Intervention,5,https://clinicaltrials.gov/show/NCT04427878,None
3246,NCT04428268,ClinicalTrials.gov,2020-04-26,2020-03-10,True,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Phase 2,Interventional,Mexico,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,Drug,Chloroquine vs. Chloroquine + Losartan,Chloroquine; Losartan,20,https://clinicaltrials.gov/show/NCT04428268,None
3247,NCT04429334,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Inotrem,Not Recruiting,Phase 2,Interventional,France,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",Drug,Nangibotide,Nangibotide,60,https://clinicaltrials.gov/show/NCT04429334,None
3248,NCT04429555,ClinicalTrials.gov,2020-06-09,2020-07-31,False,MediciNova,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",Drug,Ibudilast,Ibudilast,40,https://clinicaltrials.gov/show/NCT04429555,None
3249,NCT04429711,ClinicalTrials.gov,2020-05-24,2020-05-12,True,Sheba Medical Center,Recruiting,Not Applicable,Interventional,Israel,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04429711,None
3250,NCT04429724,ClinicalTrials.gov,2020-06-10,2020-06-01,True,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Professional Exposure Assessment to Covid-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04429724,None
3251,NCT04429815,ClinicalTrials.gov,2020-06-11,2020-07-01,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,Clinical Presentation,No Intervention,No Intervention,489,https://clinicaltrials.gov/show/NCT04429815,None
3252,NCT04429828,ClinicalTrials.gov,2020-06-11,2020-06-13,False,University of Nottingham,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Psychological Wellbeing for Healthcare Students,Other (psych),Psychological,Psychological,45,https://clinicaltrials.gov/show/NCT04429828,None
3253,NCT04429867,ClinicalTrials.gov,2020-06-10,2020-05-07,True,WellStar Health System,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,700,https://clinicaltrials.gov/show/NCT04429867,None
3254,NCT04430062,ClinicalTrials.gov,2020-06-11,2020-05-01,True,Azienda Socio Sanitaria Territoriale di Lodi,Not Recruiting,Not Applicable,Observational,Italy,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital,Other,No Intervention,No Intervention,14,https://clinicaltrials.gov/show/NCT04430062,None
3255,NCT04430608,ClinicalTrials.gov,2020-05-26,2020-05-25,True,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Interventional,Denmark,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,Other (device),Biosensors,Biosensors,72,https://clinicaltrials.gov/show/NCT04430608,None
3256,NCT04431180,ClinicalTrials.gov,2020-06-12,2020-06-13,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,Other,Other,Other,403535,https://clinicaltrials.gov/show/NCT04431180,None
3257,NCT04431284,ClinicalTrials.gov,2020-06-10,2020-06-01,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,Other,No Intervention,No Intervention,46,https://clinicaltrials.gov/show/NCT04431284,None
3258,NCT04431297,ClinicalTrials.gov,2020-06-12,2020-06-01,True,Icahn School of Medicine at Mount Sinai,Not Recruiting,Not Applicable,Interventional,United States,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04431297,None
3259,NCT04431310,ClinicalTrials.gov,2020-05-11,2020-03-27,True,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Observational,Denmark,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04431310,None
3260,NCT04431453,ClinicalTrials.gov,2020-06-08,2020-06-01,False,Gilead Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",Drug,Remdesivir,Remdesivir,52,https://clinicaltrials.gov/show/NCT04431453,EUCTR2020-001803-17
3261,NCT04431466,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Federal University of São Carlos,Not Recruiting,Phase 2,Interventional,Brazil,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,Drug,Ivermectin,Ivermectin,64,https://clinicaltrials.gov/show/NCT04431466,None
3262,NCT04431856,ClinicalTrials.gov,2020-06-12,2020-05-15,True,University of Miami,Recruiting,Not Applicable,Interventional,United States,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Other (psych),Psychological,Psychological,68,https://clinicaltrials.gov/show/NCT04431856,None
3263,NCT04431908,ClinicalTrials.gov,2020-06-12,2020-06-15,False,Yale University,Not Recruiting,Not Applicable,Observational,No Country Given,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04431908,None
3264,NCT04432272,ClinicalTrials.gov,2020-06-12,2020-06-01,True,William Beaumont Hospitals,Not Recruiting,Phase 2,Interventional,United States,ANTIBODY-LEVEL BASED ANALYSIS OF COVID CONVALESCENT SERUM (ABACCuS),ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04432272,None
3265,NCT04432324,ClinicalTrials.gov,2020-06-12,2020-06-01,True,"Grifols, S.A.",Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,100,https://clinicaltrials.gov/show/NCT04432324,EUCTR2020-001696-32
3266,NCT04432948,ClinicalTrials.gov,2020-06-14,2020-05-15,True,General and Maternity Hospital of Athens Elena Venizelou,Recruiting,Not Applicable,Observational,Greece,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04432948,None
3267,NCT04433000,ClinicalTrials.gov,2020-06-12,2020-03-15,True,University of Siena,Recruiting,Not Applicable,Observational,Italy,Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,34,https://clinicaltrials.gov/show/NCT04433000,None
3268,NCT04433039,ClinicalTrials.gov,2020-06-14,2020-05-22,True,Alexandria University,Not Recruiting,Not Applicable,Observational,Egypt,COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising,Clinical Presentation,No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04433039,None
3269,NCT04433286,ClinicalTrials.gov,2020-06-10,2020-06-15,False,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04433286,None
3270,NCT04434131,ClinicalTrials.gov,2020-06-09,2020-04-28,True,University of New Mexico,Recruiting,Phase 2,Interventional,United States,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04434131,None
3271,NCT04434157,ClinicalTrials.gov,2020-06-12,2020-03-28,True,Hospital Regional de Alta Especialidad de Ixtapaluca,Not Recruiting,Not Applicable,Observational,Mexico,Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,221,https://clinicaltrials.gov/show/NCT04434157,None
3272,NCT02765191,ClinicalTrials.gov,2016-05-02,2016-04-01,True,Uppsala University,Recruiting,Not Applicable,Interventional,Sweden,MR-Evaluation of Renal Function In Septic Patients,Pre 2020,Pre 2020,Pre 2020,20,https://clinicaltrials.gov/show/NCT02765191,None
3273,NCT03963622,ClinicalTrials.gov,2019-05-06,2020-07-01,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Careful Ventilation in COVID-19 -Induced Acute Respiratory Distress Syndrome,Pre 2020,Pre 2020,Pre 2020,370,https://clinicaltrials.gov/show/NCT03963622,None
3274,NCT04269525,ClinicalTrials.gov,2020-02-07,2020-02-06,True,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),16,https://clinicaltrials.gov/show/NCT04269525,None
3275,NCT04288102,ClinicalTrials.gov,2020-02-24,2020-03-05,False,Beijing 302 Hospital,Not Recruiting,Phase 2,Interventional,China,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04288102,None
3276,NCT04304053,ClinicalTrials.gov,2020-03-05,2020-03-18,True,Fundació Lluita contra la SIDA,Not Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Drug (Chemoprophylaxis),Darunavir + cobicistat + hydroxychloroquine,Darunavir; cobicistat; hydroxychloroquine,2250,https://clinicaltrials.gov/show/NCT04304053,EUCTR2020-001031-27
3277,NCT04308668,ClinicalTrials.gov,2020-03-11,2020-03-17,False,University of Minnesota,Not Recruiting,Phase 3,Interventional,"United States, Canada",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1309,https://clinicaltrials.gov/show/NCT04308668,None
3278,NCT04312997,ClinicalTrials.gov,2020-03-16,2020-06-16,False,"Pulmotect, Inc.",Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Drug,"PUL-042, unspecified immunomodulatory drug",PUL-042 (unspecified immunomodulatory drug),100,https://clinicaltrials.gov/show/NCT04312997,None
3279,NCT04313023,ClinicalTrials.gov,2020-03-16,2020-06-09,False,"Pulmotect, Inc.",Recruiting,Phase 2,Interventional,United States,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Drug,"PUL-042, unspecified immunomodulatory drug",PUL-042 (unspecified immunomodulatory drug),200,https://clinicaltrials.gov/show/NCT04313023,None
3280,NCT04314232,ClinicalTrials.gov,2020-03-17,2020-03-18,False,"University Hospital, Akershus",Recruiting,Not Applicable,Observational,Norway,Mechanisms for Covid-19 Disease Complications,Prognosis,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04314232,None
3281,NCT04318366,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Universita Vita-Salute San Raffaele,Recruiting,Not Applicable,Observational,Italy,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04318366,None
3282,NCT04320472,ClinicalTrials.gov,2020-03-22,2020-03-23,False,Ictal Group,Recruiting,Not Applicable,Observational,"Colombia, Spain, United States, France, Brazil",Acute Encephalopathy in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04320472,None
3283,NCT04320732,ClinicalTrials.gov,2020-03-23,2020-03-27,False,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Risk Factors for Community- and Workplace Transmission of COVID-19,Clinical Presentation,No Intervention,No Intervention,250000,https://clinicaltrials.gov/show/NCT04320732,None
3284,NCT04323592,ClinicalTrials.gov,2020-03-19,2020-03-23,False,University of Trieste,Not Recruiting,Not Applicable,Observational,Italy,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Drug,Corticosteroids,Methylprednisolone,173,https://clinicaltrials.gov/show/NCT04323592,None
3285,NCT04323761,ClinicalTrials.gov,2020-03-24,2020-03-27,True,Gilead Sciences,Not Recruiting,Not Applicable,Expanded Access,"Spain, Netherlands, Ireland, Cyprus, Germany, France, Portugal, United Kingdom, Slovenia, Denmark, Canada, Israel, Greece, Australia, Switzerland, Czech Republic, Austria, Romania, Hungary, Poland, United States, Italy, Iceland, Belgium, Estonia, Slovakia",Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),Drug,Remdesivir,Remdesivir,Not Available,https://clinicaltrials.gov/show/NCT04323761,EUCTR2020-001453-49
3286,NCT04323800,ClinicalTrials.gov,2020-03-24,2020-06-10,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Stem Coronavirus (CSSC-001),ATMP,Plasma,Plasma,487,https://clinicaltrials.gov/show/NCT04323800,None
3287,NCT04324463,ClinicalTrials.gov,2020-03-25,2020-04-21,False,Population Health Research Institute,Recruiting,Phase 3,Interventional,Canada,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Drug,Chloroquine + azithromycin,Chloroquine; azithromycin,4000,https://clinicaltrials.gov/show/NCT04324463,None
3288,NCT04325646,ClinicalTrials.gov,2020-03-26,2020-03-13,True,Institut Pasteur,Recruiting,Not Applicable,Observational,France,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04325646,None
3289,NCT04328285,ClinicalTrials.gov,2020-03-25,2020-04-14,True,CHU de Saint Etienne,Not Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1200,https://clinicaltrials.gov/show/NCT04328285,EUCTR2020-001188-96
3290,NCT04329533,ClinicalTrials.gov,2020-03-26,2020-04-13,False,University of Arizona,Recruiting,Not Applicable,Interventional,United States,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Other (psych),Psychological,Psychological,150,https://clinicaltrials.gov/show/NCT04329533,None
3291,NCT04329611,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Dr. Michael Hill,Not Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,1660,https://clinicaltrials.gov/show/NCT04329611,None
3292,NCT04331366,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Emory University,Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Other (device),Bidirectional Oxygenation Valve,Bidirectional Oxygenation Valve,5,https://clinicaltrials.gov/show/NCT04331366,None
3293,NCT04331899,ClinicalTrials.gov,2020-03-27,2020-04-24,False,Stanford University,Recruiting,Phase 2,Interventional,United States,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Drug,Interferon lambda,Interferon lambda,120,https://clinicaltrials.gov/show/NCT04331899,None
3294,NCT04332991,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Massachusetts General Hospital,Not Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,479,https://clinicaltrials.gov/show/NCT04332991,None
3295,NCT04335136,ClinicalTrials.gov,2020-04-01,2020-04-30,True,Apeiron Biologics,Recruiting,Phase 2,Interventional,"Austria, Denmark, Germany",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,ACE enzyme,200,https://clinicaltrials.gov/show/NCT04335136,EUCTR2020-001172-15
3296,NCT04337918,ClinicalTrials.gov,2020-04-06,2020-05-08,False,Sanotize Research and Development corp.,Recruiting,Phase 2,Interventional,Canada,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Drug,Nitric oxide,Nitric oxide,200,https://clinicaltrials.gov/show/NCT04337918,None
3297,NCT04339790,ClinicalTrials.gov,2020-04-08,2020-07-01,False,National Institute of Mental Health (NIMH),Recruiting,Not Applicable,Observational,United States,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,Other (psych),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04339790,None
3298,NCT04341285,ClinicalTrials.gov,2020-03-30,2020-08-01,False,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04341285,None
3299,NCT04341688,ClinicalTrials.gov,2020-04-06,2020-08-01,False,Aga Khan University,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Drug,Mouthwash,Mouthwash,50,https://clinicaltrials.gov/show/NCT04341688,None
3300,NCT04342689,ClinicalTrials.gov,2020-04-08,2020-06-03,False,Yale University,Recruiting,Phase 3,Interventional,United States,The Role of Resistant Starch in COVID-19 Infection,Supplement,Resistant Potato Starch,Resistant Potato Starch,1500,https://clinicaltrials.gov/show/NCT04342689,None
3301,NCT04342897,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Eli Lilly and Company,Recruiting,Phase 2,Interventional,United States,A Study of LY3127804 in Participants With COVID-19,Drug,LY3127804,LY3127804,200,https://clinicaltrials.gov/show/NCT04342897,None
3302,NCT04343261,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Saint Francis Care,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,ATMP,Plasma,Plasma,47,https://clinicaltrials.gov/show/NCT04343261,None
3303,NCT04343729,ClinicalTrials.gov,2020-04-09,2020-04-18,False,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Not Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,Drug,Corticosteroids,Methylprednisolone,425,https://clinicaltrials.gov/show/NCT04343729,None
3304,NCT04343976,ClinicalTrials.gov,2020-04-09,2020-06-22,False,Raymond Chung,Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,Drug,Interferon lambda,Interferon lambda,20,https://clinicaltrials.gov/show/NCT04343976,None
3305,NCT04344561,ClinicalTrials.gov,2020-04-10,2020-05-25,False,Johns Hopkins University,Recruiting,Not Applicable,Interventional,United States,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Procedure,Positioning,Positioning,70,https://clinicaltrials.gov/show/NCT04344561,None
3306,NCT04344587,ClinicalTrials.gov,2020-04-08,2020-04-23,False,Boston University,Recruiting,Not Applicable,Interventional,United States,Awake Prone Position for Early Hypoxemia in COVID-19,Procedure,Positioning,Positioning,560,https://clinicaltrials.gov/show/NCT04344587,None
3307,NCT04345419,ClinicalTrials.gov,2020-04-11,2020-06-16,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,A Real-life Experience on Treatment of Patients With COVID 19,Drug,Chloroquine vs. Favipiravir vs. Nitazoxanide vs. Ivermectin vs. Niclosamide,Chloroquine; Favipiravir; Nitazoxanide; Ivermectin; Niclosamide,120,https://clinicaltrials.gov/show/NCT04345419,None
3308,NCT04346277,ClinicalTrials.gov,2020-04-13,2020-05-18,False,Implicit Bioscience,Not Recruiting,Not Applicable,Expanded Access,Italy,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,IC14,Not Available,https://clinicaltrials.gov/show/NCT04346277,None
3309,NCT04346355,ClinicalTrials.gov,2020-04-12,2020-03-31,True,Azienda Unita Sanitaria Locale Reggio Emilia,Not Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Drug,Tocilizumab,Tocilizumab,126,https://clinicaltrials.gov/show/NCT04346355,EUCTR2020-001386-37
3310,NCT04346615,ClinicalTrials.gov,2020-04-09,2020-04-25,False,"Biohaven Pharmaceuticals, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,Drug,Vazegepant,Vazegepant,120,https://clinicaltrials.gov/show/NCT04346615,None
3311,NCT04347954,ClinicalTrials.gov,2020-04-13,2020-06-11,False,Stanford University,Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Drug,Povidone Iodine,Povidone Iodine,45,https://clinicaltrials.gov/show/NCT04347954,None
3312,NCT04349241,ClinicalTrials.gov,2020-04-13,2020-04-18,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Favipiravir in Management of COVID-19,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04349241,None
3313,NCT04350593,ClinicalTrials.gov,2020-04-14,2020-04-22,False,Saint Luke's Health System,Recruiting,Phase 3,Interventional,United States,Dapagliflozin in Respiratory Failure in Patients With COVID-19,Drug,Dapagliflozin,Dapagliflozin,900,https://clinicaltrials.gov/show/NCT04350593,None
3314,NCT04351347,ClinicalTrials.gov,2020-04-15,2020-06-16,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,Drug,Chloroquine + Nitazoxanide vs. Chloroquine + Ivermectin vs. Chloroquine ,Chloroquine; Nitazoxanide; Ivermectin,300,https://clinicaltrials.gov/show/NCT04351347,None
3315,NCT04352491,ClinicalTrials.gov,2020-04-14,2020-04-24,False,"Institute of Liver and Biliary Sciences, India",Not Recruiting,Not Applicable,Observational,India,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,Other (psych),No Intervention,No Intervention,347,https://clinicaltrials.gov/show/NCT04352491,None
3316,NCT04353180,ClinicalTrials.gov,2020-04-10,2020-06-01,False,Kafrelsheikh University,Not Recruiting,Phase 3,Interventional,Egypt,Assessment the Activity Value of 13- Cis-Retinoic Acid (Isotretinoin) in the Treatment of COVID-19 (Randomized),Drug,Isotretinoin,Isotretinoin,1000,https://clinicaltrials.gov/show/NCT04353180,None
3317,NCT04353284,ClinicalTrials.gov,2020-04-16,2020-06-19,False,Yale University,Recruiting,Phase 2,Interventional,United States,Camostat Mesylate in COVID-19 Outpatients,Drug,Camostat Mesilate,Camostat Mesilate,114,https://clinicaltrials.gov/show/NCT04353284,None
3318,NCT04353336,ClinicalTrials.gov,2020-04-15,2020-05-23,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacay of Chloroquine in COVID-19 Treatment,Drug,Chloroquine,Chloroquine,40,https://clinicaltrials.gov/show/NCT04353336,None
3319,NCT04353674,ClinicalTrials.gov,2020-04-07,2020-04-28,False,Lawson Health Research Institute,Recruiting,Phase 1,Interventional,Canada,Modulation of Hyperinflammation in COVID-19,Other (device),Dialysis,Dialysis,40,https://clinicaltrials.gov/show/NCT04353674,None
3320,NCT04354441,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Sir Mortimer B. Davis - Jewish General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04354441,None
3321,NCT04354519,ClinicalTrials.gov,2020-04-06,2020-03-14,True,Swansea University,Recruiting,Not Applicable,Observational,United Kingdom,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04354519,None
3322,NCT04354792,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Kasr El Aini Hospital,Not Recruiting,Not Applicable,Observational,Egypt,Asymptomatic COVID-19 Infection Among Healthcare Workers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04354792,None
3323,NCT04354805,ClinicalTrials.gov,2020-04-17,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Administration of Chlorpromazine as a Treatment for COVID-19,Drug,Chlorpromazine,Chlorpromazine,100,https://clinicaltrials.gov/show/NCT04354805,None
3324,NCT04355728,ClinicalTrials.gov,2020-04-13,2020-04-25,False,Camillo Ricordi,Recruiting,Phase 1/Phase 2,Interventional,United States,Use of UC-MSCs for COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04355728,None
3325,NCT04355767,ClinicalTrials.gov,2020-04-17,2020-07-01,False,Stanford University,Not Recruiting,Phase 3,Interventional,United States,Convalescent Plasma in Outpatients With COVID-19,ATMP,Plasma,Plasma,600,https://clinicaltrials.gov/show/NCT04355767,None
3326,NCT04356534,ClinicalTrials.gov,2020-04-15,2020-04-19,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Recruiting,Not Applicable,Interventional,Bahrain,Convalescent Plasma Trial in COVID -19 Patients,ATMP,Plasma,Plasma,40,https://clinicaltrials.gov/show/NCT04356534,None
3327,NCT04356937,ClinicalTrials.gov,2020-04-19,2020-04-20,False,Massachusetts General Hospital,Recruiting,Phase 3,Interventional,United States,Efficacy of Tocilizumab on Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,278,https://clinicaltrials.gov/show/NCT04356937,None
3328,NCT04357028,ClinicalTrials.gov,2020-04-19,2020-06-16,False,Kasr El Aini Hospital,Recruiting,Phase 3,Interventional,Egypt,Measles Vaccine in HCW,ATMP,Vaccine,Vaccine,200,https://clinicaltrials.gov/show/NCT04357028,None
3329,NCT04357535,ClinicalTrials.gov,2020-04-19,2020-04-12,True,Hakeam Abdulaziz Hakeam,Recruiting,Not Applicable,Observational,Saudi Arabia,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,226,https://clinicaltrials.gov/show/NCT04357535,None
3330,NCT04357639,ClinicalTrials.gov,2020-04-20,2020-05-28,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),Clinical Presentation,No Intervention,No Intervention,1040,https://clinicaltrials.gov/show/NCT04357639,None
3331,NCT04357730,ClinicalTrials.gov,2020-04-18,2020-05-14,False,Denver Health and Hospital Authority,Recruiting,Phase 2,Interventional,United States,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,Drug,Alteplase,Alteplase,60,https://clinicaltrials.gov/show/NCT04357730,None
3332,NCT04358068,ClinicalTrials.gov,2020-04-20,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,2000,https://clinicaltrials.gov/show/NCT04358068,None
3333,NCT04358380,ClinicalTrials.gov,2020-04-18,2020-04-15,True,Austral University,Recruiting,Not Applicable,Observational,Argentina,Liver Injury in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,34,https://clinicaltrials.gov/show/NCT04358380,None
3334,NCT04358549,ClinicalTrials.gov,2020-04-16,2020-04-17,False,"Fujifilm Pharmaceuticals U.S.A., Inc.",Recruiting,Phase 2,Interventional,United States,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,Drug,Favipiravir,Favipiravir,50,https://clinicaltrials.gov/show/NCT04358549,None
3335,NCT04358835,ClinicalTrials.gov,2020-04-16,2020-09-01,False,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Keto-diet for Intubated Critical Care COVID-19,Other (nutrition),Nutrition,Nutrition,15,https://clinicaltrials.gov/show/NCT04358835,None
3336,NCT04359277,ClinicalTrials.gov,2020-04-20,2020-04-21,False,NYU Langone Health,Recruiting,Phase 3,Interventional,United States,A Randomized Trial of Anticoagulation Strategies in COVID-19,Drug,"Enoxaparin, Heparin",Enoxaparin; Heparin,1000,https://clinicaltrials.gov/show/NCT04359277,None
3337,NCT04360824,ClinicalTrials.gov,2020-04-13,2020-05-06,False,University of Iowa,Recruiting,Phase 4,Interventional,United States,Covid-19 Associated Coagulopathy,Drug,Enoxaparin,Enoxaparin,170,https://clinicaltrials.gov/show/NCT04360824,None
3338,NCT04361396,ClinicalTrials.gov,2020-04-22,2020-07-01,False,Centre Hospitalier René Dubos,Recruiting,Not Applicable,Interventional,France,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04361396,None
3339,NCT04361552,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Emory University,Not Recruiting,Phase 3,Interventional,United States,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),Drug,Tocilizumab,Tocilizumab,0,https://clinicaltrials.gov/show/NCT04361552,None
3340,NCT04362137,ClinicalTrials.gov,2020-04-22,2020-03-31,False,Novartis Pharmaceuticals,Recruiting,Phase 3,Interventional,"Spain, United States, Italy, Russian Federation, Germany, United Kingdom","Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",Drug,Ruxolitinib,Ruxolitinib,402,https://clinicaltrials.gov/show/NCT04362137,EUCTR2020-001662-11
3341,NCT04362332,ClinicalTrials.gov,2020-04-20,2020-04-14,True,UMC Utrecht,Not Recruiting,Phase 4,Interventional,Netherlands,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",Drug,Chloroquine vs. hydroxychloroquine,Chloroquine; hydroxychloroquine,25,https://clinicaltrials.gov/show/NCT04362332,None
3342,NCT04362865,ClinicalTrials.gov,2020-04-24,2020-04-27,False,National Cancer Institute (NCI),Recruiting,Not Applicable,Observational,United States,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04362865,None
3343,NCT04363203,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Dr. Salomeh Keyhani,Not Recruiting,Phase 3,Interventional,United States,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; Azithromycin,300,https://clinicaltrials.gov/show/NCT04363203,None
3344,NCT04363385,ClinicalTrials.gov,2020-04-21,2020-05-15,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Interventional,France,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04363385,None
3345,NCT04363463,ClinicalTrials.gov,2020-04-22,2020-11-01,False,Centre Hospitalier Régional d'Orleans,Not Recruiting,Not Applicable,Interventional,France,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Procedure,Positioning,Positioning,400,https://clinicaltrials.gov/show/NCT04363463,None
3346,NCT04363853,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Instituto Nacional de Cancerología,Recruiting,Phase 2,Interventional,Mexico,Tocilizumab Treatment in Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,200,https://clinicaltrials.gov/show/NCT04363853,None
3347,NCT04364737,ClinicalTrials.gov,2020-04-22,2020-04-17,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04364737,None
3348,NCT04364763,ClinicalTrials.gov,2020-04-20,2020-06-25,False,"Renibus Therapuetics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),Drug,Stannous protoporphyrin,Stannous protoporphyrin,252,https://clinicaltrials.gov/show/NCT04364763,None
3349,NCT04364893,ClinicalTrials.gov,2020-04-07,2020-04-06,True,D'Or Institute for Research and Education,Recruiting,Not Applicable,Interventional,Brazil,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,700,https://clinicaltrials.gov/show/NCT04364893,None
3350,NCT04365101,ClinicalTrials.gov,2020-04-22,2020-05-13,False,Celularity Incorporated,Recruiting,Phase 1/Phase 2,Interventional,United States,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19),ATMP,Cells (NK),Cells (NK),86,https://clinicaltrials.gov/show/NCT04365101,None
3351,NCT04365582,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Phase 3,Interventional,France,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,Drug,Hydroxychloroquine vs. Azithromycin vs. Lopinavir/ritonavir,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,640,https://clinicaltrials.gov/show/NCT04365582,None
3352,NCT04366778,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Thrombosis and Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,325,https://clinicaltrials.gov/show/NCT04366778,None
3353,NCT04366791,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Emory University,Recruiting,Phase 1/Phase 2,Interventional,United States,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Other,Radiation,Radiation,10,https://clinicaltrials.gov/show/NCT04366791,None
3354,NCT04366986,ClinicalTrials.gov,2020-04-23,2020-06-23,False,Pregistry,Recruiting,Not Applicable,Observational,United States,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,Clinical Presentation,No Intervention,No Intervention,25000,https://clinicaltrials.gov/show/NCT04366986,None
3355,NCT04367740,ClinicalTrials.gov,2020-04-27,2020-04-28,False,"University of North Carolina, Chapel Hill",Recruiting,Not Applicable,Observational,United States,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,https://clinicaltrials.gov/show/NCT04367740,None
3356,NCT04368897,ClinicalTrials.gov,2020-04-27,2020-05-01,False,"Applied Biology, Inc.",Recruiting,Not Applicable,Observational,Spain,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04368897,None
3357,NCT04368923,ClinicalTrials.gov,2020-04-24,2020-03-15,True,Cairo University,Not Recruiting,Not Applicable,Interventional,Egypt,Management of Covid-19 Patients During Home Isolation,Drug,Oxygen,Oxygen,60,https://clinicaltrials.gov/show/NCT04368923,None
3358,NCT04369742,ClinicalTrials.gov,2020-04-25,2020-04-15,True,NYU Langone Health,Not Recruiting,Phase 2,Interventional,United States,Treating COVID-19 With Hydroxychloroquine (TEACH),Drug,Hydroxychloroquine,Hydroxychloroquine,626,https://clinicaltrials.gov/show/NCT04369742,None
3359,NCT04370834,ClinicalTrials.gov,2020-04-30,2020-05-28,False,National Cancer Institute (NCI),Recruiting,Phase 2,Interventional,United States,Tocilizumab for Patients With Cancer and COVID-19 Disease,Drug,Tocilizumab,Tocilizumab,217,https://clinicaltrials.gov/show/NCT04370834,None
3360,NCT04371354,ClinicalTrials.gov,2020-04-28,2020-04-27,True,Fundación Miguel Servet,Recruiting,Not Applicable,Observational,Spain,Outcomes of Covid-19 Protective Measures in Endoscopy,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04371354,None
3361,NCT04371393,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 3,Interventional,United States,MSCs in COVID-19 ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),300,https://clinicaltrials.gov/show/NCT04371393,None
3362,NCT04371419,ClinicalTrials.gov,2020-04-28,2020-05-13,False,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Health Messaging to Underserved Communities,Other,Health Education,Health Education,15475,https://clinicaltrials.gov/show/NCT04371419,None
3363,NCT04371432,ClinicalTrials.gov,2020-04-29,2020-07-01,False,National Human Genome Research Institute (NHGRI),Recruiting,Not Applicable,Observational,United States,Genetics of COVID-19 Susceptibility and Manifestations,Genomics,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04371432,None
3364,NCT04371471,ClinicalTrials.gov,2020-04-30,2020-03-01,True,Groupe Hospitalier La Rochelle,Not Recruiting,Not Applicable,Observational,France,Covid-19 Pandemic Triage Score,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04371471,None
3365,NCT04371822,ClinicalTrials.gov,2020-04-29,2020-08-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,Egypt,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,Drug,"SnPP Protoporphyrin, Porphyrin",SnPP Protoporphyrin; Porphyrin,56,https://clinicaltrials.gov/show/NCT04371822,None
3366,NCT04372186,ClinicalTrials.gov,2020-04-29,2020-05-14,False,"Genentech, Inc.",Recruiting,Phase 3,Interventional,"South Africa, United States, Kenya, Peru, Mexico",A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,379,https://clinicaltrials.gov/show/NCT04372186,None
3367,NCT04373460,ClinicalTrials.gov,2020-04-30,2020-06-03,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,ATMP,Plasma,Plasma,1344,https://clinicaltrials.gov/show/NCT04373460,None
3368,NCT04373707,ClinicalTrials.gov,2020-05-01,2020-05-13,False,CHU de Nancy,Recruiting,Phase 4,Interventional,France,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,Drug,Heparin,Heparin,602,https://clinicaltrials.gov/show/NCT04373707,None
3369,NCT04373733,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Chelsea and Westminster Hospital NHS Foundation Trust,Recruiting,Phase 3,Interventional,United Kingdom,Early Intervention in COVID-19: Favipiravir Verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe,Drug,Favipiravir vs. Hydroxychloroquine + Azithromycin + Zinc,Favipiravir; Hydroxychloroquine; Azithromycin; Zinc,450,https://clinicaltrials.gov/show/NCT04373733,EUCTR2020-001449-38
3370,NCT04373759,ClinicalTrials.gov,2020-04-30,2020-05-02,False,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Recruiting,Not Applicable,Observational,"Martinique, France",Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04373759,None
3371,NCT04375397,ClinicalTrials.gov,2020-05-04,2020-06-06,False,AbbVie,Recruiting,Phase 2,Interventional,United States,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,Drug,Ibrutinib,Ibrutinib,46,https://clinicaltrials.gov/show/NCT04375397,None
3372,NCT04375761,ClinicalTrials.gov,2020-04-30,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,COVID-19: Human Epidemiology and Response to SARS-CoV-2,Clinical Presentation (Epidemiology),No Intervention,No Intervention,8000,https://clinicaltrials.gov/show/NCT04375761,None
3373,NCT04376684,ClinicalTrials.gov,2020-05-04,2020-05-28,True,GlaxoSmithKline,Recruiting,Phase 2,Interventional,"Spain, United States, United Kingdom",Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,Drug,Otilimab,Otilimab,800,https://clinicaltrials.gov/show/NCT04376684,EUCTR2020-001759-42
3374,NCT04376775,ClinicalTrials.gov,2020-05-04,2020-05-11,False,"University Hospital, Bordeaux",Not Recruiting,Not Applicable,Observational,France,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,Clinical Presentation,No Intervention,No Intervention,3602,https://clinicaltrials.gov/show/NCT04376775,None
3375,NCT04377100,ClinicalTrials.gov,2020-05-05,2020-07-01,False,National Institute of Mental Health (NIMH),Not Recruiting,Not Applicable,Interventional,United States,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Other (psych),No Intervention,No Intervention,750,https://clinicaltrials.gov/show/NCT04377100,None
3376,NCT04377334,ClinicalTrials.gov,2020-04-16,2020-08-01,False,"University Hospital, Tübingen",Not Recruiting,Phase 2,Interventional,Germany,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04377334,None
3377,NCT04377568,ClinicalTrials.gov,2020-04-30,2020-07-15,False,The Hospital for Sick Children,Not Recruiting,Phase 2,Interventional,Canada,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04377568,None
3378,NCT04377620,ClinicalTrials.gov,2020-05-04,2020-05-24,False,Incyte Corporation,Recruiting,Phase 3,Interventional,United States,Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),Drug,Ruxolitinib,Ruxolitinib,500,https://clinicaltrials.gov/show/NCT04377620,None
3379,NCT04377776,ClinicalTrials.gov,2020-05-05,2020-05-04,True,IRCCS Ospedale San Raffaele,Not Recruiting,Not Applicable,Observational,Italy,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",Clinical Presentation,No Intervention,No Intervention,644,https://clinicaltrials.gov/show/NCT04377776,None
3380,NCT04380818,ClinicalTrials.gov,2020-05-04,2020-06-05,False,Grupo de Investigación Clínica en Oncología Radioterapia (GICOR),Recruiting,Not Applicable,Interventional,Spain,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Other (+ Drug),"Radiation with or without hydroxychloroquine, lopinavir/ritonavir, azithromycin, cortocosteroids, Heparin, oxygen",Radiation; hydroxychloroquine; lopinavir/ritonavir; azithromycin; methylprednisolone; dexamethasone; prednisone; Heparin; oxygen,106,https://clinicaltrials.gov/show/NCT04380818,None
3381,NCT04382586,ClinicalTrials.gov,2020-05-07,2020-06-01,False,BeiGene,Recruiting,Phase 2,Interventional,United States,Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,Drug,Zanubrutinib,Zanubrutinib,52,https://clinicaltrials.gov/show/NCT04382586,None
3382,NCT04382651,ClinicalTrials.gov,2020-05-08,2020-06-11,False,Novartis Pharmaceuticals,Recruiting,Phase 2,Interventional,United States,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,Drug,MAS825,MAS825,120,https://clinicaltrials.gov/show/NCT04382651,None
3383,NCT04382794,ClinicalTrials.gov,2020-05-08,2020-05-14,False,University of Milan,Not Recruiting,Not Applicable,Observational,Italy,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients,Drug,Sitagliptin,Sitagliptin,319,https://clinicaltrials.gov/show/NCT04382794,None
3384,NCT04383444,ClinicalTrials.gov,2020-05-09,2020-07-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Surveillance of Individuals Following SARS-CoV-2 Exposure,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1050,https://clinicaltrials.gov/show/NCT04383444,None
3385,NCT04383457,ClinicalTrials.gov,2020-05-04,2020-06-15,False,Vastra Gotaland Region,Recruiting,Not Applicable,Observational,Sweden,Covid-19 Triage Using Camera-based AI,Other (device),Other,Other,500,https://clinicaltrials.gov/show/NCT04383457,None
3386,NCT04383613,ClinicalTrials.gov,2020-05-05,2020-05-15,False,"St. Michael's Hospital, Toronto",Recruiting,Not Applicable,Interventional,Canada,Prone Positioning for Patients on General Medical Wards With COVID19,Procedure,Positioning,Positioning,350,https://clinicaltrials.gov/show/NCT04383613,None
3387,NCT04384055,ClinicalTrials.gov,2020-05-08,2020-03-21,True,Stanford University,Recruiting,Not Applicable,Observational,United States,Predicting Outcomes for Covid-19 Using Sonography,Prognosis,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04384055,None
3388,NCT04385238,ClinicalTrials.gov,2020-05-10,2020-05-15,False,Pregistry,Not Recruiting,Not Applicable,Observational,United States,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,7000,https://clinicaltrials.gov/show/NCT04385238,None
3389,NCT04386252,ClinicalTrials.gov,2020-05-11,2020-07-01,False,"Aivita Biomedical, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Phase Ib-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,ATMP,Vaccine,Vaccine,180,https://clinicaltrials.gov/show/NCT04386252,None
3390,NCT04386616,ClinicalTrials.gov,2020-05-11,2020-06-02,False,"Genentech, Inc.",Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,Drug,Astegolimab vs. UTTR1147A,Astegolimab; UTTR1147A,300,https://clinicaltrials.gov/show/NCT04386616,None
3391,NCT04387656,ClinicalTrials.gov,2020-05-13,2020-05-21,False,National Cancer Institute (NCI),Recruiting,Not Applicable,Observational,United States,"NCI COVID-19 in Cancer Patients, NCCAPS Study",Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04387656,None
3392,NCT04387760,ClinicalTrials.gov,2020-05-09,2020-07-14,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Not Recruiting,Phase 2/Phase 3,Interventional,Bahrain,Favipiravir vs Hydroxychloroquine in COVID -19,Drug,Hydroxychloroquine vs. Favipiravir,Hydroxychloroquine; Favipiravir,150,https://clinicaltrials.gov/show/NCT04387760,None
3393,NCT04387799,ClinicalTrials.gov,2020-05-13,2020-05-13,False,Catholic University of the Sacred Heart,Not Recruiting,Not Applicable,Observational,Italy,Determinants of COVID-19 Pneumonia (MC-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,520,https://clinicaltrials.gov/show/NCT04387799,None
3394,NCT04388826,ClinicalTrials.gov,2020-05-13,2020-06-18,False,Veru Inc.,Recruiting,Phase 2,Interventional,United States,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,Drug,Veru-111,Veru-111,40,https://clinicaltrials.gov/show/NCT04388826,None
3395,NCT04389411,ClinicalTrials.gov,2020-05-13,2020-07-01,False,McGill University,Not Recruiting,Phase 3,Interventional,No Country Given,The COvid-19 Symptom MOntelukast Trial,Drug,Montelukast,Montelukast,600,https://clinicaltrials.gov/show/NCT04389411,None
3396,NCT04389710,ClinicalTrials.gov,2020-04-27,2020-04-15,True,Thomas Jefferson University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04389710,None
3397,NCT04389840,ClinicalTrials.gov,2020-05-13,2020-06-03,False,Chimerix,Recruiting,Phase 2/Phase 3,Interventional,United States,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,Drug,Heparin,Heparin,524,https://clinicaltrials.gov/show/NCT04389840,None
3398,NCT04390126,ClinicalTrials.gov,2020-05-14,2020-04-20,True,CHU Dijon,Not Recruiting,Not Applicable,Observational,France,COVID-19 Related Lockdown Effects On Chronic Diseases,Other,Other,Other,1200,https://clinicaltrials.gov/show/NCT04390126,None
3399,NCT04391309,ClinicalTrials.gov,2020-05-14,2020-07-01,False,Implicit Bioscience,Not Recruiting,Phase 2,Interventional,United States,IC14 (Anti-CD14) Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,IC14,300,https://clinicaltrials.gov/show/NCT04391309,None
3400,NCT04391816,ClinicalTrials.gov,2020-05-15,2020-07-01,False,National Institute on Alcohol Abuse and Alcoholism (NIAAA),Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,Other,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04391816,None
3401,NCT04392219,ClinicalTrials.gov,2020-04-29,2020-04-10,True,Ridgeback Biotherapeutics,Recruiting,Phase 1,Interventional,"United States, United Kingdom","COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",Drug,EIDD-2801,EIDD-2801,130,https://clinicaltrials.gov/show/NCT04392219,None
3402,NCT04392973,ClinicalTrials.gov,2020-05-10,2020-05-21,False,King Abdullah International Medical Research Center,Recruiting,Not Applicable,Interventional,Saudi Arabia,FAvipiravir and HydroxyChloroquine Combination Therapy,Drug,Favipiravir + Hydroxychloroquine,Favipiravir; Hydroxychloroquine,520,https://clinicaltrials.gov/show/NCT04392973,None
3403,NCT04393311,ClinicalTrials.gov,2020-05-15,2020-07-01,False,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,Drug,Ulinastatin,Ulinastatin,150,https://clinicaltrials.gov/show/NCT04393311,None
3404,NCT04393948,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Brigham and Women's Hospital,Recruiting,Not Applicable,Interventional,United States,Lung Irradiation for COVID-19 Pneumonia,Other,Radiation,Radiation,48,https://clinicaltrials.gov/show/NCT04393948,None
3405,NCT04394117,ClinicalTrials.gov,2020-05-18,2020-06-19,False,The George Institute for Global Health,Recruiting,Phase 4,Interventional,Australia,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,Drug,ARBs,ARBs,605,https://clinicaltrials.gov/show/NCT04394117,None
3406,NCT04394377,ClinicalTrials.gov,2020-05-08,2020-06-21,False,Brazilian Clinical Research Institute,Recruiting,Phase 4,Interventional,Brazil,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,Drug,Rivaroxaban + Heparin,Rivaroxaban; Heparin,600,https://clinicaltrials.gov/show/NCT04394377,None
3407,NCT04394793,ClinicalTrials.gov,2020-05-17,2020-06-13,False,All India Institute of Medical Sciences,Recruiting,Not Applicable,Interventional,India,Low Dose Radiation Therapy for Covid-19 Pneumonia,Other,Radiation,Radiation,10,https://clinicaltrials.gov/show/NCT04394793,None
3408,NCT04394884,ClinicalTrials.gov,2020-05-19,2020-07-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND),Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04394884,None
3409,NCT04395300,ClinicalTrials.gov,2020-05-19,2020-03-30,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Sleep Quality in Healthcare Personnel During COVID-19,Other (psych),No Intervention,No Intervention,143,https://clinicaltrials.gov/show/NCT04395300,None
3410,NCT04395859,ClinicalTrials.gov,2020-05-18,2020-05-27,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Observational,France,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04395859,None
3411,NCT04396353,ClinicalTrials.gov,2020-05-18,2020-06-04,False,University of São Paulo General Hospital,Recruiting,Not Applicable,Observational,Brazil,EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19,Other (exercise),Exercise,Exercise,1061,https://clinicaltrials.gov/show/NCT04396353,None
3412,NCT04397718,ClinicalTrials.gov,2020-05-14,2020-07-01,False,VA Office of Research and Development,Not Recruiting,Phase 2,Interventional,United States,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,Drug,Degarelix,Degarelix,198,https://clinicaltrials.gov/show/NCT04397718,None
3413,NCT04399005,ClinicalTrials.gov,2020-05-19,2020-05-25,False,The First Affiliated Hospital of Zhejiang Chinese Medical University,Not Recruiting,Not Applicable,Interventional,China,The Efficacy Comparing Daily and After-each-case Room Disinfection.,Other,Other,Other,240,https://clinicaltrials.gov/show/NCT04399005,None
3414,NCT04399317,ClinicalTrials.gov,2020-05-18,2020-05-28,False,Hamad Medical Corporation,Recruiting,Not Applicable,Interventional,Qatar,Flow Controlled Ventilation in ARDS Associated With COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,20,https://clinicaltrials.gov/show/NCT04399317,None
3415,NCT04399889,ClinicalTrials.gov,2020-05-21,2020-06-18,False,"Joanne Kurtzberg, MD",Recruiting,Phase 1/Phase 2,Interventional,United States,hCT-MSCs for COVID19 ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04399889,None
3416,NCT04399967,ClinicalTrials.gov,2020-05-19,2020-06-13,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,China,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",Other,Other,Other,842,https://clinicaltrials.gov/show/NCT04399967,None
3417,NCT04401449,ClinicalTrials.gov,2020-05-22,2020-05-20,True,National Institutes of Health Clinical Center (CC),Recruiting,Not Applicable,Observational,United States,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,Clinical Presentation,No Intervention,No Intervention,92,https://clinicaltrials.gov/show/NCT04401449,None
3418,NCT04401579,ClinicalTrials.gov,2020-05-22,2020-05-08,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,"Japan, South Korea, United States, Mexico, Singapore",Adaptive COVID-19 Treatment Trial 2 (ACTT-II),Drug,Baricitinib + Remdesivir vs. Remdesivir,Baricitinib; Remdesivir,1032,https://clinicaltrials.gov/show/NCT04401579,JPRN-jRCT2031200035
3419,NCT04402866,ClinicalTrials.gov,2020-05-22,2020-06-24,True,Theravance Biopharma,Recruiting,Phase 2,Interventional,United Kingdom,TD-0903 for ALI Associated With COVID-19,Drug,TD-0903,TD-0903,159,https://clinicaltrials.gov/show/NCT04402866,EUCTR2020-001807-18
3420,NCT04403386,ClinicalTrials.gov,2020-05-23,2020-06-01,False,National Institute of Environmental Health Sciences (NIEHS),Recruiting,Not Applicable,Observational,United States,"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04403386,None
3421,NCT04404361,ClinicalTrials.gov,2020-05-22,2020-05-22,False,CTI BioPharma,Recruiting,Phase 3,Interventional,United States,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,Drug,Pacritinib,Pacritinib,358,https://clinicaltrials.gov/show/NCT04404361,None
3422,NCT04405076,ClinicalTrials.gov,2020-05-13,2020-05-29,False,"ModernaTX, Inc.",Recruiting,Phase 2,Interventional,United States,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",ATMP,Vaccine,Vaccine,600,https://clinicaltrials.gov/show/NCT04405076,None
3423,NCT04405570,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Ridgeback Biotherapeutics,Recruiting,Phase 2,Interventional,United States,"A Safety, Tolerability and Efficacy of EIDD-2801 to Eliminate Infectious Virus Detection in Persons With COVID-19",Drug,EIDD-2801,EIDD-2801,44,https://clinicaltrials.gov/show/NCT04405570,None
3424,NCT04405739,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Ridgeback Biotherapeutics,Recruiting,Phase 2,Interventional,United States,The Effect of EIDD-2801 on Viral Shedding of SARS-CoV-2 (COVID-19),Drug,EIDD-2801,EIDD-2801,60,https://clinicaltrials.gov/show/NCT04405739,None
3425,NCT04405908,ClinicalTrials.gov,2020-05-25,2020-06-19,False,Clover Biopharmaceuticals,Recruiting,Phase 1,Interventional,Australia,SCB-2019 as COVID-19 Vaccine,ATMP,Vaccine,Vaccine,150,https://clinicaltrials.gov/show/NCT04405908,None
3426,NCT04405921,ClinicalTrials.gov,2020-05-26,2020-07-01,False,Centre Hôpital Universitaire Farhat Hached,Not Recruiting,Phase 3,Interventional,Tunisia,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,200,https://clinicaltrials.gov/show/NCT04405921,None
3427,NCT04405934,ClinicalTrials.gov,2020-05-07,2020-07-01,False,"University College, London",Not Recruiting,Not Applicable,Interventional,No Country Given,COG-UK Project Hospital-Onset COVID-19 Infections Study,Genomics,Genomics,Genomics,2000,https://clinicaltrials.gov/show/NCT04405934,None
3428,NCT04407117,ClinicalTrials.gov,2020-05-27,2017-03-23,True,Dr. Claus Anders Bertelsen,Not Recruiting,Not Applicable,Observational,Denmark,Appendicitis During the National Lockdown During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,6000000,https://clinicaltrials.gov/show/NCT04407117,None
3429,NCT04407130,ClinicalTrials.gov,2020-05-17,2020-06-16,False,"International Centre for Diarrhoeal Disease Research, Bangladesh",Recruiting,Phase 2,Interventional,Bangladesh,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,Drug,Ivermectin + Doxycycline vs. Ivermectin,Ivermectin; Doxycycline,72,https://clinicaltrials.gov/show/NCT04407130,None
3430,NCT04407572,ClinicalTrials.gov,2020-05-27,2020-04-20,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women,Clinical Presentation,No Intervention,No Intervention,44,https://clinicaltrials.gov/show/NCT04407572,None
3431,NCT04407585,ClinicalTrials.gov,2020-05-27,2020-06-01,False,King's College London,Recruiting,Not Applicable,Observational,United Kingdom,Testing the Accuracy of a Digital Test to Diagnose Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000000,https://clinicaltrials.gov/show/NCT04407585,None
3432,NCT04407689,ClinicalTrials.gov,2020-05-27,2020-06-08,False,Revimmune,Recruiting,Phase 2,Interventional,France,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04407689,None
3433,NCT04408248,ClinicalTrials.gov,2020-05-27,2020-07-01,False,Guy's and St Thomas' NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,AKI Biomarkers in Coronavirus(COVID)-19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04408248,None
3434,NCT04409262,ClinicalTrials.gov,2020-05-28,2020-06-16,False,Roche,Recruiting,Phase 3,Interventional,"Brazil, United States",A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,Drug,Tocilizumab + Remdesivir vs. Remdesivir,Tocilizumab; Remdesivir,450,https://clinicaltrials.gov/show/NCT04409262,None
3435,NCT04409925,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Exactis Innovation,Not Recruiting,Phase 1,Interventional,No Country Given,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),Drug,rhDNase I,rhDNase I,25,https://clinicaltrials.gov/show/NCT04409925,None
3436,NCT04410159,ClinicalTrials.gov,2020-05-27,2020-06-22,False,Universiti Sains Islam Malaysia,Recruiting,Phase 2,Interventional,Malaysia,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,Drug,Povidone Iodine vs. Essential Oil,Povidone Iodine; Essential Oil,20,https://clinicaltrials.gov/show/NCT04410159,None
3437,NCT04410354,ClinicalTrials.gov,2020-04-28,2020-06-16,False,"ViralClear Pharmaceuticals, Inc.",Recruiting,Phase 2,Interventional,United States,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,Drug,Merimepodib + Remdesivir vs. Remdesivir,Merimepodib; Remdesivir,40,https://clinicaltrials.gov/show/NCT04410354,None
3438,NCT04411147,ClinicalTrials.gov,2020-05-30,2020-06-17,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Sequelae and Immunity,Clinical Presentation,No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04411147,None
3439,NCT04411628,ClinicalTrials.gov,2020-05-29,2020-05-28,True,Eli Lilly and Company,Recruiting,Phase 1,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,Drug,LY3819253,LY3819253,40,https://clinicaltrials.gov/show/NCT04411628,None
3440,NCT04412291,ClinicalTrials.gov,2020-06-01,2020-06-11,False,Karolinska University Hospital,Recruiting,Phase 2,Interventional,Sweden,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",Drug,Anakinra vs. Tocilizumab,Anakinra; Tocilizumab,120,https://clinicaltrials.gov/show/NCT04412291,None
3441,NCT04412304,ClinicalTrials.gov,2020-05-30,2020-03-06,True,Karolinska Institutet,Not Recruiting,Not Applicable,Observational,Sweden,Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients,Drug,Anticoagulants,Anticoagulants,166,https://clinicaltrials.gov/show/NCT04412304,None
3442,NCT04412330,ClinicalTrials.gov,2020-05-12,2020-05-01,True,University of Kentucky,Recruiting,Not Applicable,Interventional,United States,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,20,https://clinicaltrials.gov/show/NCT04412330,None
3443,NCT04412668,ClinicalTrials.gov,2020-06-01,2020-06-12,False,"aTyr Pharma, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,Drug,ATYR1923,ATYR1923,30,https://clinicaltrials.gov/show/NCT04412668,None
3444,NCT04414267,ClinicalTrials.gov,2020-06-01,2020-05-26,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 4,Interventional,Greece,Bacillus Calmette-guérin Vaccination to Prevent COVID-19,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/show/NCT04414267,EUCTR2020-002448-21
3445,NCT04415060,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Sunnybrook Health Sciences Centre,Not Recruiting,Phase 3,Interventional,Canada,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,Drug,Isoflurane + Sevoflurane,Isoflurane; Sevoflurane,752,https://clinicaltrials.gov/show/NCT04415060,None
3446,NCT04416347,ClinicalTrials.gov,2020-05-06,2020-06-15,False,St. George's University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,COVID19 Clinical Predictors and Outcome,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04416347,None
3447,NCT04416464,ClinicalTrials.gov,2020-06-03,2020-06-15,False,University of Porto,Not Recruiting,Not Applicable,Observational,Portugal,Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04416464,None
3448,NCT04417257,ClinicalTrials.gov,2020-05-28,2020-06-29,False,Laurent Pharmaceuticals Inc.,Not Recruiting,Phase 2,Interventional,Canada,Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,Drug,LAU-7b,LAU-7b,300,https://clinicaltrials.gov/show/NCT04417257,None
3449,NCT04417673,ClinicalTrials.gov,2020-06-04,2020-07-01,False,National Human Genome Research Institute (NHGRI),Not Recruiting,Not Applicable,Observational,United States,Living With Sickle Cell Disease in the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04417673,None
3450,NCT04419610,ClinicalTrials.gov,2020-04-16,2020-07-01,False,Imperial College London,Not Recruiting,Phase 1,Interventional,No Country Given,RAS and Coagulopathy in COVID19,Drug,TRV027,TRV027,60,https://clinicaltrials.gov/show/NCT04419610,None
3451,NCT04420247,ClinicalTrials.gov,2020-06-02,2020-04-16,True,Centro de Estudos e Pesquisa em Emergências Médicas e Terapia Intensiva (CEPETI),Recruiting,Phase 3,Interventional,Brazil,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,Drug,Chloroquine or Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,https://clinicaltrials.gov/show/NCT04420247,None
3452,NCT04420312,ClinicalTrials.gov,2020-06-05,2020-03-01,True,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms,Clinical Presentation,No Intervention,No Intervention,1024,https://clinicaltrials.gov/show/NCT04420312,None
3453,NCT04420338,ClinicalTrials.gov,2020-06-05,2020-06-05,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04420338,None
3454,NCT04420741,ClinicalTrials.gov,2020-06-04,2020-06-15,True,Par Johansson,Recruiting,Phase 2,Interventional,Denmark,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,Drug,Ilopros,Ilopros,80,https://clinicaltrials.gov/show/NCT04420741,EUCTR2020-001296-33
3455,NCT04421027,ClinicalTrials.gov,2020-06-05,2020-06-12,True,Eli Lilly and Company,Recruiting,Phase 3,Interventional,"Spain, Argentina, United States, Italy, Russian Federation, Germany, Mexico, Brazil, United Kingdom",A Study of Baricitinib (LY3009104) in Participants With COVID-19,Drug,Baricitinib,Baricitinib,400,https://clinicaltrials.gov/show/NCT04421027,EUCTR2020-001517-21
3456,NCT04421508,ClinicalTrials.gov,2020-06-05,2020-07-01,False,Bellerophon Pulse Technologies,Not Recruiting,Phase 3,Interventional,United States,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,Drug,Nitric Oxide,Nitric Oxide,500,https://clinicaltrials.gov/show/NCT04421508,None
3457,NCT04422470,ClinicalTrials.gov,2020-06-08,2020-06-22,False,"National Research Center for Hematology, Russia",Recruiting,Not Applicable,Observational,Russian Federation,Registry of Patients With Hematologic Disease and COVID-19 in Russia,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04422470,None
3458,NCT04422561,ClinicalTrials.gov,2020-06-06,2020-05-31,True,Zagazig University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Prophylactic Ivermectin in COVID-19 Contacts,Drug (Chemoprophylaxis),Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04422561,None
3459,NCT04423978,ClinicalTrials.gov,2020-06-08,2020-05-04,True,Azienda Unita Sanitaria Locale Reggio Emilia,Recruiting,Not Applicable,Observational,Italy,Implications of Covid-19 on the Lifestyle Changes,Other,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04423978,None
3460,NCT04424446,ClinicalTrials.gov,2020-06-09,2020-07-01,False,National Institutes of Health Clinical Center (CC),Recruiting,Not Applicable,Observational,United States,Saliva/Nares as Source of Detection for SARS-CoV-2 at NIH,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,https://clinicaltrials.gov/show/NCT04424446,None
3461,NCT04425031,ClinicalTrials.gov,2020-06-05,2020-08-01,False,Aalborg University Hospital,Not Recruiting,Phase 4,Interventional,Denmark,Handling Oxygenation Targets in COVID-19,Drug,Oxygen,Oxygen,780,https://clinicaltrials.gov/show/NCT04425031,None
3462,NCT04425629,ClinicalTrials.gov,2020-06-08,2020-06-16,False,Regeneron Pharmaceuticals,Recruiting,Phase 1/Phase 2,Interventional,United States,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19",Drug,REGN10933 + REGN10987,REGN10933; REGN10987,1054,https://clinicaltrials.gov/show/NCT04425629,None
3463,NCT04425720,ClinicalTrials.gov,2020-06-02,2020-07-05,False,Montefiore Medical Center,Not Recruiting,Not Applicable,Interventional,United States,Use of Remote Monitoring for COVID-19 Patient,Other (device),Biosensors,Biosensors,300,https://clinicaltrials.gov/show/NCT04425720,None
3464,NCT04425850,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Eurnekian Public Hospital,Not Recruiting,Not Applicable,Observational,Argentina,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19,Drug,Ivermectin + Carrageenan,Ivermectin; Carrageenan,70,https://clinicaltrials.gov/show/NCT04425850,None
3465,NCT04425863,ClinicalTrials.gov,2020-06-08,2020-05-01,True,Eurnekian Public Hospital,Not Recruiting,Not Applicable,Observational,Argentina,IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19,Drug,"Ivermectin, Aspirin, Dexamethasone, Enoxaparin",Ivermectin; Aspirin; Dexamethasone; Enoxaparin,100,https://clinicaltrials.gov/show/NCT04425863,None
3466,NCT04426266,ClinicalTrials.gov,2020-06-08,2020-05-01,True,Szeged University,Not Recruiting,Not Applicable,Observational,Hungary,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04426266,None
3467,NCT04426695,ClinicalTrials.gov,2020-06-08,2020-06-10,False,Regeneron Pharmaceuticals,Recruiting,Phase 1/Phase 2,Interventional,United States,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",Drug,REGN10933 vs. REGN10987,REGN10933; REGN10987,1860,https://clinicaltrials.gov/show/NCT04426695,None
3468,NCT04427098,ClinicalTrials.gov,2020-05-29,2020-05-22,False,AOU di Bologna Policlinico S.Orsola-Malpighi,Recruiting,Phase 2,Interventional,Italy,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04427098,EUCTR2020-001308-40
3469,NCT04427137,ClinicalTrials.gov,2020-06-10,2020-06-09,True,Centre for Addiction and Mental Health,Recruiting,Not Applicable,Interventional,Canada,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,Other (psych),Electroconvulsive Therapy,Electroconvulsive Therapy,50,https://clinicaltrials.gov/show/NCT04427137,None
3470,NCT04427501,ClinicalTrials.gov,2020-06-09,2020-06-13,False,Eli Lilly and Company,Recruiting,Phase 2,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Participants With Early Mild to Moderate COVID-19 Illness,Drug,LY3819253,LY3819253,400,https://clinicaltrials.gov/show/NCT04427501,None
3471,NCT04427566,ClinicalTrials.gov,2020-06-05,2020-06-11,False,Ohio State University Comprehensive Cancer Center,Recruiting,Phase 2,Interventional,United States,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,Other,Radiation,Radiation,24,https://clinicaltrials.gov/show/NCT04427566,None
3472,NCT04428008,ClinicalTrials.gov,2020-06-07,2020-06-01,True,Inova Health System,Not Recruiting,Phase 2,Interventional,No Country Given,Thymosin Alpha 1 to Prevent COVID-19 Infection in Elderly Renal Dialysis Patients,Drug,Thymalfasin,Thymalfasin,240,https://clinicaltrials.gov/show/NCT04428008,None
3473,NCT04429620,ClinicalTrials.gov,2020-06-10,2020-05-30,True,Szeged University,Recruiting,Not Applicable,Observational,Hungary,Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04429620,None
3474,NCT04430049,ClinicalTrials.gov,2020-06-10,2020-06-22,False,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Observational,France,"Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients",Other (psych),No Intervention,No Intervention,240,https://clinicaltrials.gov/show/NCT04430049,None
3475,NCT04430322,ClinicalTrials.gov,2020-06-11,2020-03-01,True,Centre Hospitalier Régional Metz-Thionville,Recruiting,Not Applicable,Observational,France,Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study,Prognosis,No Intervention,No Intervention,330,https://clinicaltrials.gov/show/NCT04430322,None
3476,NCT04430374,ClinicalTrials.gov,2020-06-11,2020-06-02,True,Hamad Medical Corporation,Recruiting,Not Applicable,Observational,Qatar,Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04430374,None
3477,NCT04431414,ClinicalTrials.gov,2020-06-09,2020-06-11,False,COVID-19 Prevention Network,Recruiting,Not Applicable,Observational,"Peru, Tanzania, Malawi, Argentina, South Africa, Zimbabwe, Zambia, United States, Kenya, Botswana, Mozambique, Mexico, Brazil",A Study of Immune Responses to the Virus That Causes COVID-19,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04431414,None
3478,NCT04431869,ClinicalTrials.gov,2020-06-11,2020-07-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Observational,United States,In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04431869,None
3479,NCT04432051,ClinicalTrials.gov,2020-06-11,2020-05-26,True,Gaziosmanpasa Taksim Research and Education Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Use of Lung Ultrasonography in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04432051,None
3480,NCT04432103,ClinicalTrials.gov,2020-06-12,2020-06-19,False,Centro Medico ABC,Not Recruiting,Phase 3,Interventional,No Country Given,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,ATMP,Plasma,Plasma,36,https://clinicaltrials.gov/show/NCT04432103,None
3481,NCT04432298,ClinicalTrials.gov,2020-06-12,2020-06-20,False,FibroGen,Recruiting,Phase 2,Interventional,United States,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease",Drug,Pamrevlumab,Pamrevlumab,130,https://clinicaltrials.gov/show/NCT04432298,None
3482,NCT04432766,ClinicalTrials.gov,2020-06-12,2020-07-20,False,Bio-Thera Solutions,Not Recruiting,Phase 1,Interventional,No Country Given,A Phase 1 Study to Assess BAT2020 in Hospitalized Patients Infected With SARS-CoV-2 (COVID-19),Drug,BAT2020,BAT2020,174,https://clinicaltrials.gov/show/NCT04432766,None
3483,NCT04432779,ClinicalTrials.gov,2020-06-15,2020-06-25,False,CHU St. Pierre,Not Recruiting,Not Applicable,Observational,Belgium,Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04432779,None
3484,NCT04432805,ClinicalTrials.gov,2020-06-15,2020-06-15,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,160,https://clinicaltrials.gov/show/NCT04432805,None
3485,NCT04432870,ClinicalTrials.gov,2020-06-12,2020-06-09,True,Massachusetts General Hospital,Recruiting,Not Applicable,Observational,United States,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study,Health System,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04432870,None
3486,NCT04432922,ClinicalTrials.gov,2020-06-15,2020-07-01,False,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Observational,France,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection",Other (psych),No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04432922,None
3487,NCT04432961,ClinicalTrials.gov,2020-06-15,2020-07-01,False,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19),Other (software),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04432961,None
3488,NCT04432987,ClinicalTrials.gov,2020-06-15,2020-05-25,True,Acibadem University,Recruiting,Phase 2,Interventional,Turkey,Dornase Alpha for the Treatment of COVID-19,Drug,Dornase alfa,Dornase alfa,60,https://clinicaltrials.gov/show/NCT04432987,None
3489,NCT04433013,ClinicalTrials.gov,2020-06-14,2020-07-01,False,Nanyang Technological University,Not Recruiting,Phase 3,Interventional,No Country Given,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04433013,None
3490,NCT04433026,ClinicalTrials.gov,2020-06-14,2020-07-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,"BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19",Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04433026,None
3491,NCT04433078,ClinicalTrials.gov,2020-06-10,2020-06-22,False,Temple University,Recruiting,Phase 2,Interventional,United States,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,Drug,Doxycycline,Doxycycline,20,https://clinicaltrials.gov/show/NCT04433078,None
3492,NCT04433260,ClinicalTrials.gov,2020-06-09,2020-06-01,True,Queen Mary University of London,Not Recruiting,Not Applicable,Observational,No Country Given,COVID19 and Physical and Emotional Wellbeing of HCP,Other (psych),No Intervention,No Intervention,1050,https://clinicaltrials.gov/show/NCT04433260,None
3493,NCT04433312,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,Health System,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04433312,None
3494,NCT04433325,ClinicalTrials.gov,2020-06-12,2020-06-01,True,Rennes University Hospital,Not Recruiting,Not Applicable,Observational,France,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04433325,None
3495,NCT04433364,ClinicalTrials.gov,2020-06-15,2020-06-02,True,Sahlgrenska University Hospital,Recruiting,Not Applicable,Observational,Sweden,COPE - COVID-19 in Pregnancy and Early Childhood,Clinical Presentation,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04433364,None
3496,NCT04433546,ClinicalTrials.gov,2020-05-28,2020-06-26,False,PhaseBio Pharmaceuticals Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,"PB1046, a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).",Drug,PB1046,PB1046,210,https://clinicaltrials.gov/show/NCT04433546,None
3497,NCT04433754,ClinicalTrials.gov,2020-06-12,2020-03-01,True,Usak University,Not Recruiting,Not Applicable,Observational,Turkey,The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04433754,None
3498,NCT04433871,ClinicalTrials.gov,2020-04-24,2020-04-27,False,"University Hospital, Caen",Recruiting,Not Applicable,Observational,France,COVID-19 in Pediatric Oncology and Hematology Centers in France,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04433871,None
3499,NCT04433910,ClinicalTrials.gov,2020-05-06,2020-06-01,True,Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,Recruiting,Phase 2,Interventional,Germany,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,ATMP,Plasma,Plasma,106,https://clinicaltrials.gov/show/NCT04433910,EUCTR2020-001310-38
3500,NCT04433949,ClinicalTrials.gov,2020-06-12,2020-06-12,False,Emory University,Recruiting,Phase 3,Interventional,United States,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,Other,Radiation,Radiation,52,https://clinicaltrials.gov/show/NCT04433949,None
3501,NCT04434118,ClinicalTrials.gov,2020-06-13,2020-03-20,True,Sadat City University,Recruiting,Not Applicable,Observational,Egypt,Hydroxychloroquine May Reduce Risk of COVID-19 Infection in Rheumatoid Arthritis Patients:,Drug,"Hydroxychloroqine, Methotrexate, Glucocorticoids, Leflunomide, Sulphasalazine",Hydroxychloroqine; Methotrexate; Glucocorticoids; Leflunomide; Sulphasalazine,600,https://clinicaltrials.gov/show/NCT04434118,None
3502,NCT04434248,ClinicalTrials.gov,2020-06-13,2020-04-23,True,Chromis LLC,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Drug,Favipiravir,Favipiravir,330,https://clinicaltrials.gov/show/NCT04434248,None
3503,NCT04434261,ClinicalTrials.gov,2020-06-15,2020-05-11,True,Instituto Brasileiro de Controle do Câncer,Recruiting,Not Applicable,Observational,Brazil,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1500,https://clinicaltrials.gov/show/NCT04434261,None
3504,NCT04434417,ClinicalTrials.gov,2020-06-09,2020-04-15,True,European Institute of Oncology,Recruiting,Not Applicable,Observational,Italy,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04434417,None
3505,NCT04435015,ClinicalTrials.gov,2020-06-16,2020-08-01,False,Yale University,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,Drug,Camostat Mesilate,Camostat Mesilate,200,https://clinicaltrials.gov/show/NCT04435015,None
3506,NCT04435028,ClinicalTrials.gov,2020-06-15,2019-01-14,True,Horus University,Not Recruiting,Not Applicable,Observational,Egypt,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,Drug,Ketotifen,Ketotifen,111,https://clinicaltrials.gov/show/NCT04435028,None
3507,NCT04435041,ClinicalTrials.gov,2020-06-16,2020-06-01,True,University of Oxford,Not Recruiting,Not Applicable,Observational,United Kingdom,Remote-by-Default Care in the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,1,https://clinicaltrials.gov/show/NCT04435041,None
3508,NCT04435080,ClinicalTrials.gov,2020-06-15,2020-03-15,True,Koç University,Not Recruiting,Not Applicable,Observational,Turkey,Physical Rehabilitation in ICU in ARDS Patients With COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,35,https://clinicaltrials.gov/show/NCT04435080,None
3509,NCT04435106,ClinicalTrials.gov,2020-05-26,2020-04-03,True,Shaare Zedek Medical Center,Not Recruiting,Not Applicable,Observational,Israel,Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19),Drug,Opaganib,Opaganib,23,https://clinicaltrials.gov/show/NCT04435106,None
3510,NCT04435119,ClinicalTrials.gov,2020-06-12,2020-03-15,True,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,Covid-19 and Vitamin D in Nursing-home,Drug,Vitamin D,Vitamin D,96,https://clinicaltrials.gov/show/NCT04435119,None
3511,NCT04435184,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Johns Hopkins University,Not Recruiting,Phase 2,Interventional,United States,Crizanlizumab for Treating COVID-19 Vasculopathy,Drug,Crizanlizumab,Crizanlizumab,40,https://clinicaltrials.gov/show/NCT04435184,None
3512,NCT04435223,ClinicalTrials.gov,2020-06-16,2020-04-07,True,CHU Dijon,Not Recruiting,Not Applicable,Observational,France,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen,Clinical Presentation,No Intervention,No Intervention,62,https://clinicaltrials.gov/show/NCT04435223,None
3513,NCT04435275,ClinicalTrials.gov,2020-06-09,2020-06-30,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Virtual Assistant for COVID-19 PPE,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04435275,None
3514,NCT04435314,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Azidus Brasil,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,Drug,Nitazoxanide,Nitazoxanide,200,https://clinicaltrials.gov/show/NCT04435314,None
3515,NCT04435327,ClinicalTrials.gov,2020-06-12,2020-08-17,False,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04435327,None
3516,NCT04435353,ClinicalTrials.gov,2020-06-14,2020-03-22,True,Astana Medical University,Recruiting,Not Applicable,Interventional,Kazakhstan,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,Other,Vibroacoustic Therapy,Vibroacoustic Therapy,200,https://clinicaltrials.gov/show/NCT04435353,None
3517,NCT04435379,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Vakzine Projekt Management GmbH,Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,Drug,VPM1002,VPM1002,2038,https://clinicaltrials.gov/show/NCT04435379,EUCTR2020-001675-33
3518,NCT04435457,ClinicalTrials.gov,2020-06-02,2020-06-01,True,University of Texas Southwestern Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,Cardiovascular Implications of COVID-19,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04435457,None
3519,NCT04435587,ClinicalTrials.gov,2020-06-15,2020-07-01,False,Mahidol University,Not Recruiting,Phase 4,Interventional,Thailand,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,Drug,Ivermectin vs. Hydroxychloroquine + Darunavir/ritonavir,Ivermectin; Hydroxychloroquine; Darunavir/ritonavir,80,https://clinicaltrials.gov/show/NCT04435587,None
3520,NCT04435717,ClinicalTrials.gov,2020-06-11,2020-05-04,True,Hospital Universitario Ramón y Cajal,Recruiting,Phase 2,Interventional,Spain,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),Drug,Tocilizumab,Tocilizumab,78,https://clinicaltrials.gov/show/NCT04435717,None
3521,NCT04435795,ClinicalTrials.gov,2020-06-16,2020-06-25,False,McGill University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Inhaled Ciclesonide for Outpatients With COVID19,Drug,Ciclesonide,Ciclesonide,454,https://clinicaltrials.gov/show/NCT04435795,None
3522,NCT04435808,ClinicalTrials.gov,2020-06-04,2020-04-14,True,University of New Mexico,Recruiting,Phase 1/Phase 2,Interventional,United States,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04435808,None
3523,NCT04436276,ClinicalTrials.gov,2020-06-15,2020-07-13,False,Janssen Pharmaceutical,Not Recruiting,Phase 1/Phase 2,Interventional,"Belgium, United States",A Study of Ad26COVS1 in Adults,ATMP,Vaccine,Vaccine,1045,https://clinicaltrials.gov/show/NCT04436276,None
3524,NCT04436458,ClinicalTrials.gov,2020-06-16,2020-08-01,False,"First Wave Bio, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide In Moderate COVID-19,Drug,Niclosamide,Niclosamide,100,https://clinicaltrials.gov/show/NCT04436458,None
3525,NCT04436471,ClinicalTrials.gov,2020-06-16,2020-06-17,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,38,https://clinicaltrials.gov/show/NCT04436471,None
3526,NCT04436484,ClinicalTrials.gov,2020-06-12,2020-04-29,True,University Hospital Plymouth NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Immune Biomarkers of Outcome From COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04436484,None
3527,NCT04437121,ClinicalTrials.gov,2020-06-15,2020-04-30,True,University of Thessaly,Not Recruiting,Not Applicable,Observational,Greece,Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece,Other,No Intervention,No Intervention,397,https://clinicaltrials.gov/show/NCT04437121,None
3528,NCT04437342,ClinicalTrials.gov,2020-06-15,2020-06-01,True,General and Maternity Hospital of Athens Elena Venizelou,Not Recruiting,Not Applicable,Observational,Greece,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,Other (psych),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04437342,None
3529,NCT04437693,ClinicalTrials.gov,2020-06-17,2020-07-01,False,Hamad Medical Corporation,Not Recruiting,Phase 3,Interventional,No Country Given,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,https://clinicaltrials.gov/show/NCT04437693,None
3530,NCT04437706,ClinicalTrials.gov,2020-06-17,2020-07-01,False,Duke University,Not Recruiting,Not Applicable,Observational,United States,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04437706,None
3531,NCT04437719,ClinicalTrials.gov,2020-06-17,2020-06-30,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Interventional,France,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04437719,None
3532,NCT04437823,ClinicalTrials.gov,2020-06-17,2020-06-01,True,Jinnah Hospital,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04437823,None
3533,NCT04437875,ClinicalTrials.gov,2020-06-16,2020-06-17,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,38,https://clinicaltrials.gov/show/NCT04437875,None
3534,NCT04437901,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Observational,"Spain, Netherlands, Italy, Belgium, United Kingdom",COVIDAR - Arrhythmias in COVID-19,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04437901,None
3535,NCT04437940,ClinicalTrials.gov,2020-06-17,2020-06-15,True,Acibadem University,Recruiting,Not Applicable,Observational,Turkey,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,35,https://clinicaltrials.gov/show/NCT04437940,None
3536,NCT04438057,ClinicalTrials.gov,2020-06-17,2020-07-06,False,Metro Infectious Disease Consultants,Not Recruiting,Phase 2,Interventional,United States,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,ATMP,Plasma,Plasma,150,https://clinicaltrials.gov/show/NCT04438057,None
3537,NCT04438070,ClinicalTrials.gov,2020-06-17,2020-04-10,True,St. Joseph's Healthcare Hamilton,Recruiting,Not Applicable,Interventional,Canada,COVID Screening Strategies in Homeless Shelters,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04438070,None
3538,NCT04438239,ClinicalTrials.gov,2020-06-10,2020-06-30,False,Azienda Unita Sanitaria Locale Reggio Emilia,Not Recruiting,Not Applicable,Observational,No Country Given,Rehabilitation Needs After COVID-19 Hospital Treatment,Other (physio),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04438239,None
3539,NCT04438629,ClinicalTrials.gov,2020-06-16,2020-03-26,True,AOUI Verona,Recruiting,Not Applicable,Observational,Italy,Evaluation of Immune Response in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04438629,None
3540,NCT04438694,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Cairo University,Recruiting,Phase 1/Phase 2,Interventional,Egypt,Use of Convalescent Plasma for Treatment of Patients With COVID-19 Infection,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04438694,None
3541,NCT04438837,ClinicalTrials.gov,2020-06-18,2020-06-01,True,Rambam Health Care Campus,Not Recruiting,Not Applicable,Interventional,Israel,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,582,https://clinicaltrials.gov/show/NCT04438837,None
3542,NCT04438850,ClinicalTrials.gov,2020-04-10,2020-06-01,False,IRCCS Don Calabria Ospedale Sacro Cuore,Not Recruiting,Phase 2,Interventional,"Spain, Italy",COVidIVERmectin: Ivermectin for Treatment of Covid-19,Drug,Ivermectin,Ivermectin,102,https://clinicaltrials.gov/show/NCT04438850,None
3543,NCT04438863,ClinicalTrials.gov,2020-06-17,2020-09-01,False,Sheba Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,90,https://clinicaltrials.gov/show/NCT04438863,None
3544,NCT04438941,ClinicalTrials.gov,2020-06-17,2020-03-25,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic,Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04438941,None
3545,NCT04438954,ClinicalTrials.gov,2020-06-17,2020-05-05,True,Ankara Yildirim Beyazit University,Not Recruiting,Not Applicable,Observational,Turkey,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels",Other (psych),No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04438954,None
3546,NCT04438967,ClinicalTrials.gov,2020-06-15,2020-06-16,False,Miro Health,Recruiting,Not Applicable,Observational,United States,Brain Health in the Time of COVID-19,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04438967,None
3547,NCT04438980,ClinicalTrials.gov,2020-06-18,2020-05-15,True,Fundación Miguel Servet,Recruiting,Phase 3,Interventional,Spain,Glucocorticoids in COVID-19 (CORTIVID),Drug,Corticosteroids,Methylprednisolone,72,https://clinicaltrials.gov/show/NCT04438980,EUCTR2020-001827-15
3548,NCT04438993,ClinicalTrials.gov,2020-06-18,2020-05-29,True,NHS Lanarkshire,Recruiting,Not Applicable,Observational,United Kingdom,The COVID-19 Disease and CARdiac Events Study,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04438993,None
3549,NCT04439006,ClinicalTrials.gov,2020-06-17,2020-06-15,True,Jennifer Woyach,Not Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,Drug,Ibrutinib,Ibrutinib,72,https://clinicaltrials.gov/show/NCT04439006,None
3550,NCT04439045,ClinicalTrials.gov,2020-06-03,2020-06-14,False,"University Health Network, Toronto",Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,Drug,VPM1002,VPM1002,3626,https://clinicaltrials.gov/show/NCT04439045,None
3551,NCT04439071,ClinicalTrials.gov,2020-06-17,2020-06-30,False,PTC Therapeutics,Not Recruiting,Phase 2/Phase 3,Interventional,"Spain, United States",A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19),Drug,PTC299,PTC299,380,https://clinicaltrials.gov/show/NCT04439071,None
3552,NCT04439084,ClinicalTrials.gov,2020-06-17,2020-03-06,True,Stanford University,Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With Chronic Liver Diseases,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04439084,None
3553,NCT04440007,ClinicalTrials.gov,2020-06-17,2020-08-01,False,"Sorrento Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With SOC Versus SOC in Subjects With COVID-19,Drug,Abivertinib,Abivertinib,80,https://clinicaltrials.gov/show/NCT04440007,None
3554,NCT04440098,ClinicalTrials.gov,2020-06-18,2020-04-22,True,University of Miami,Not Recruiting,Not Applicable,Observational,United States,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,Other (psych),No Intervention,No Intervention,1008,https://clinicaltrials.gov/show/NCT04440098,None
3555,NCT04441372,ClinicalTrials.gov,2020-06-17,2020-08-01,False,"Medecins Sans Frontieres, Spain",Not Recruiting,Not Applicable,Observational,Bangladesh,Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 (COVID-19) Respiratory Infection,Prognosis,No Intervention,No Intervention,850,https://clinicaltrials.gov/show/NCT04441372,None
3556,NCT04441385,ClinicalTrials.gov,2020-06-18,2020-06-26,False,Hospital Universitario Infanta Leonor,Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,Drug,Maraviroc,Maraviroc,200,https://clinicaltrials.gov/show/NCT04441385,None
3557,NCT04441398,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Azidus Brasil,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,Drug,Nitazoxanide,Nitazoxanide,300,https://clinicaltrials.gov/show/NCT04441398,None
3558,NCT04441424,ClinicalTrials.gov,2020-06-12,2020-04-03,True,Alkarkh Health Directorate-Baghdad,Not Recruiting,Not Applicable,Interventional,Iraq,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,ATMP (+ Drug),Plasma + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Plasma; Hydroxychloroquine; Azithromycin,49,https://clinicaltrials.gov/show/NCT04441424,None
3559,NCT04441489,ClinicalTrials.gov,2020-06-16,2020-03-27,True,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,Not Recruiting,Not Applicable,Observational,Monaco,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,Clinical Presentation,No Intervention,No Intervention,13,https://clinicaltrials.gov/show/NCT04441489,None
3560,NCT04441502,ClinicalTrials.gov,2020-06-12,2020-03-30,True,IRCCS Policlinico San Donato,Recruiting,Not Applicable,Observational,Italy,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,Clinical Presentation,No Intervention,No Intervention,240,https://clinicaltrials.gov/show/NCT04441502,None
3561,NCT04441632,ClinicalTrials.gov,2020-06-18,2020-06-15,True,Cedars-Sinai Medical Center,Recruiting,Not Applicable,Interventional,United States,Effect of Positive Attitudes on Behavior and Wellness,Other (psych),Psychological,Psychological,50,https://clinicaltrials.gov/show/NCT04441632,None
3562,NCT04441684,ClinicalTrials.gov,2020-05-20,2020-04-17,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Interventional,France,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04441684,None
3563,NCT04441814,ClinicalTrials.gov,2020-06-18,2019-07-23,True,Fondazione IRCCS Istituto Nazionale dei Tumori,Recruiting,Not Applicable,Observational,Italy,FOUND - Ancillary Study to Smile Protocol NCT03654105,Clinical Presentation,No Intervention,No Intervention,960,https://clinicaltrials.gov/show/NCT04441814,None
3564,NCT04441918,ClinicalTrials.gov,2020-06-06,2020-06-05,True,"Shanghai Junshi Bioscience Co., Ltd.",Recruiting,Phase 1,Interventional,China,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",Drug,JS016,JS016,40,https://clinicaltrials.gov/show/NCT04441918,None
3565,NCT04441996,ClinicalTrials.gov,2020-06-19,2020-07-01,False,Emory University,Not Recruiting,Phase 4,Interventional,United States,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04441996,None
3566,NCT04442048,ClinicalTrials.gov,2020-06-19,2020-07-01,False,Canadian Cancer Trials Group,Not Recruiting,Phase 3,Interventional,No Country Given,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,Drug,IMM-101,IMM-101,1500,https://clinicaltrials.gov/show/NCT04442048,None
3567,NCT04442152,ClinicalTrials.gov,2020-06-19,2020-06-01,True,Promundo,Recruiting,Not Applicable,Interventional,Rwanda,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04442152,None
3568,NCT04442165,ClinicalTrials.gov,2020-06-16,2020-07-15,False,Institute of Tropical Medicine,Not Recruiting,Not Applicable,Observational,No Country Given,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique,Clinical Presentation (Epidemiology),No Intervention,No Intervention,15393,https://clinicaltrials.gov/show/NCT04442165,None
3569,NCT04442178,ClinicalTrials.gov,2020-06-19,2020-06-30,False,Revimmune,Not Recruiting,Phase 2,Interventional,No Country Given,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04442178,None
3570,NCT04442191,ClinicalTrials.gov,2020-05-11,2020-05-05,True,"University of Illinois, Chicago",Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as a Possible Treatment for COVID-19,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04442191,None
3571,NCT04442204,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04442204,None
3572,NCT04442217,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,Other,Other,Other,4000,https://clinicaltrials.gov/show/NCT04442217,None
3573,NCT04442230,ClinicalTrials.gov,2020-06-17,2020-06-01,True,"Altimmune, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),ATMP,Vaccine,Vaccine,96,https://clinicaltrials.gov/show/NCT04442230,None
3574,NCT04442243,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,Other (psych),No Intervention,No Intervention,889,https://clinicaltrials.gov/show/NCT04442243,None
3575,NCT04442282,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,5041,https://clinicaltrials.gov/show/NCT04442282,None
3576,NCT04442308,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Parental Stress After the Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,1440,https://clinicaltrials.gov/show/NCT04442308,None
3577,NCT04442360,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04442360,None
3578,NCT04442386,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Other (psych),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04442386,None
3579,NCT04442958,ClinicalTrials.gov,2020-06-17,2020-05-15,True,Bagcilar Training and Research Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Convalescent Immune Plasma Therapy,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04442958,None
3580,NCT04443075,ClinicalTrials.gov,2020-06-03,2020-06-22,False,The First Affiliated Hospital Xi'an Jiaotong University,Recruiting,Not Applicable,Observational,China,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress,Clinical Presentation,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04443075,None
3581,NCT04443140,ClinicalTrials.gov,2020-06-21,2020-03-15,True,Zeynep Kamil Maternity and Pediatric Research and Training Hospital,Recruiting,Not Applicable,Observational,Turkey,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04443140,None
3582,NCT04443179,ClinicalTrials.gov,2020-06-19,2013-04-05,True,King's College London,Recruiting,Not Applicable,Observational,United Kingdom,Brain Imaging in Babies Study,Clinical Presentation,No Intervention,No Intervention,790,https://clinicaltrials.gov/show/NCT04443179,None
3583,NCT04443270,ClinicalTrials.gov,2020-06-17,2020-06-22,False,Centro Médico Nacional 20 de Noviembre,Not Recruiting,Phase 1,Interventional,Mexico,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Other (Chemoprophylaxis),Chloroquine,Chloroquine,200,https://clinicaltrials.gov/show/NCT04443270,None
3584,NCT04443361,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Insomnia After the COVID-19 Pandemic,Other,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04443361,None
3585,NCT04443673,ClinicalTrials.gov,2020-06-18,2020-06-22,False,Instituto Nacional de Enfermedades Respiratorias,Recruiting,Not Applicable,Interventional,Mexico,Glycine Supplement for Severe COVID-19,Supplement,Glycine,Glycine,82,https://clinicaltrials.gov/show/NCT04443673,None
3586,NCT04443699,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Predictors of Mental Well-being During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04443699,None
3587,NCT04443725,ClinicalTrials.gov,2020-06-20,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,Drug,Hydroxychloroquine + Sofosbuvir + Daclatasvir,Hydroxychloroquine; Sofosbuvir; Daclatasvir,100,https://clinicaltrials.gov/show/NCT04443725,None
3588,NCT04443764,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,287,https://clinicaltrials.gov/show/NCT04443764,None
3589,NCT04443803,ClinicalTrials.gov,2020-06-19,2020-07-01,False,Randy Loftus,Not Recruiting,Not Applicable,Observational,No Country Given,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program,Clinical Presentation (Epidemiology),No Intervention,No Intervention,9,https://clinicaltrials.gov/show/NCT04443803,None
3590,NCT04443868,ClinicalTrials.gov,2020-06-20,2020-09-01,False,Sanotize Research and Development corp.,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,Drug,Nitric Oxide,Nitric Oxide,300,https://clinicaltrials.gov/show/NCT04443868,None
3591,NCT04443881,ClinicalTrials.gov,2020-06-18,2020-05-08,True,Fundación Miguel Servet,Recruiting,Phase 2/Phase 3,Interventional,Spain,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),Drug,Anakinra,Anakinra,180,https://clinicaltrials.gov/show/NCT04443881,None
3592,NCT04444115,ClinicalTrials.gov,2020-06-20,2020-06-22,False,Modum Bad,Not Recruiting,Not Applicable,Observational,No Country Given,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,10084,https://clinicaltrials.gov/show/NCT04444115,None
3593,NCT04444271,ClinicalTrials.gov,2020-05-27,2020-05-01,True,"Armed Forces Bone Marrow Transplant Center, Pakistan",Recruiting,Phase 2,Interventional,Pakistan,Mesenchymal Stem Cell Infusion for COVID-19 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04444271,None
3594,NCT04444310,ClinicalTrials.gov,2020-06-19,2020-06-15,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Antibody Responses in Contacts of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04444310,None
3595,NCT04444336,ClinicalTrials.gov,2020-06-21,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04444336,None
3596,NCT04444401,ClinicalTrials.gov,2020-06-22,2020-06-15,True,European Institute of Oncology,Recruiting,Not Applicable,Observational,Italy,Registry on NEN Patients and COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04444401,None
3597,NCT04444531,ClinicalTrials.gov,2020-06-22,2020-03-20,True,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,Not Recruiting,Not Applicable,Observational,Spain,Clinical Improvement and COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,18,https://clinicaltrials.gov/show/NCT04444531,None
3598,NCT04444557,ClinicalTrials.gov,2020-06-21,2020-04-17,True,Sisli Hamidiye Etfal Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,Other (psych),No Intervention,No Intervention,97,https://clinicaltrials.gov/show/NCT04444557,None
3599,NCT04444596,ClinicalTrials.gov,2020-06-18,2020-06-17,True,Medical University Innsbruck,Recruiting,Not Applicable,Interventional,Austria,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04444596,None
3600,NCT04444609,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Imperial College London,Not Recruiting,Not Applicable,Observational,No Country Given,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04444609,None
3601,NCT04444661,ClinicalTrials.gov,2020-06-19,2020-06-10,True,University of Erlangen-Nornberg Medical School,Not Recruiting,Not Applicable,Observational,Germany,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise,Other,No Intervention,No Intervention,21,https://clinicaltrials.gov/show/NCT04444661,None
3602,NCT04444674,ClinicalTrials.gov,2020-06-15,2020-06-01,True,"University of Witwatersrand, South Africa",Not Recruiting,Phase 1/Phase 2,Interventional,South Africa,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,ATMP,Vaccine,Vaccine,2000,https://clinicaltrials.gov/show/NCT04444674,None
3603,NCT04444687,ClinicalTrials.gov,2020-06-15,2020-08-01,False,"University Hospital, Basel",Not Recruiting,Not Applicable,Observational,No Country Given,COVID 19: Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,Other,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04444687,None
3604,NCT04444700,ClinicalTrials.gov,2020-06-22,2020-06-25,False,University of São Paulo General Hospital,Recruiting,Phase 3,Interventional,Brazil,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic,Drug,Heparin,Heparin,462,https://clinicaltrials.gov/show/NCT04444700,None
3605,NCT04444713,ClinicalTrials.gov,2020-06-20,2020-06-22,False,Modum Bad,Not Recruiting,Not Applicable,Observational,No Country Given,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,Other (psych),No Intervention,No Intervention,10084,https://clinicaltrials.gov/show/NCT04444713,None
3606,NCT04445194,ClinicalTrials.gov,2020-06-16,2020-06-22,False,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,ATMP,Vaccine,Vaccine,50,https://clinicaltrials.gov/show/NCT04445194,None
3607,NCT04445207,ClinicalTrials.gov,2020-06-20,2020-06-22,False,Jonathan Gerber,Not Recruiting,Not Applicable,Expanded Access,United States,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04445207,None
3608,NCT04445220,ClinicalTrials.gov,2020-06-22,2020-08-01,False,"Sentien Biotechnologies, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04445220,None
3609,NCT04445233,ClinicalTrials.gov,2020-06-22,2020-04-29,True,"University of North Carolina, Chapel Hill",Recruiting,Not Applicable,Observational,United States,COVID-19 Household Transmission Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04445233,None
3610,NCT04445246,ClinicalTrials.gov,2020-06-09,2020-05-23,True,Hamad Medical Corporation,Recruiting,Phase 2,Interventional,Qatar,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,Drug,Iloprost,Iloprost,40,https://clinicaltrials.gov/show/NCT04445246,None
3611,NCT04445259,ClinicalTrials.gov,2020-05-27,2020-06-20,False,Guy's and St Thomas' NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04445259,None
3612,NCT04445272,ClinicalTrials.gov,2020-06-13,2020-05-22,True,Fundación SEIMC-GESIDA,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,500,https://clinicaltrials.gov/show/NCT04445272,None
3613,NCT04445285,ClinicalTrials.gov,2020-06-22,2020-04-28,True,Jon Simmons,Recruiting,Phase 2,Interventional,United States,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,Drug,Dornase alpha,Dornase alpha,44,https://clinicaltrials.gov/show/NCT04445285,None
3614,NCT04445311,ClinicalTrials.gov,2020-06-19,2020-05-31,True,Zagazig University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin in Treatment of COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04445311,None
3615,NCT04445324,ClinicalTrials.gov,2020-06-22,2020-07-01,False,Centre de Recherche de l'Institut Universitaire en Santé Mentale de Montréal,Not Recruiting,Not Applicable,Interventional,Canada,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,Other (psych),Psychological,Psychological,48,https://clinicaltrials.gov/show/NCT04445324,None
3616,NCT04445337,ClinicalTrials.gov,2020-06-09,2020-07-01,False,University of Nebraska,Not Recruiting,Not Applicable,Interventional,No Country Given,Stellate Ganglion Blockade in COVID-19 Positive Patients,Clinical Presentation,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04445337,None
3617,NCT04445376,ClinicalTrials.gov,2020-06-22,2020-06-25,False,Government College University Faisalabad,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,Other (exercise),Exercise,Exercise,150,https://clinicaltrials.gov/show/NCT04445376,None
3618,NCT04445389,ClinicalTrials.gov,2020-06-19,2020-06-17,True,"Genexine, Inc.",Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",ATMP,Vaccine,Vaccine,190,https://clinicaltrials.gov/show/NCT04445389,None
3619,NCT04445402,ClinicalTrials.gov,2020-06-22,2020-04-30,True,Columbia University,Recruiting,Not Applicable,Observational,United States,Pediatrics HOT COVID-19 Database in NY Tristate,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04445402,None
3620,NCT04445415,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04445415,None
3621,NCT04445428,ClinicalTrials.gov,2020-06-22,2020-07-01,False,Bandim Health Project,Not Recruiting,Phase 4,Interventional,Guinea-Bissau,OPV as Potential Protection Against COVID,ATMP,Vaccine,Vaccine,3400,https://clinicaltrials.gov/show/NCT04445428,None
3622,NCT04445441,ClinicalTrials.gov,2020-06-22,2020-05-01,True,Centre Muraz,Recruiting,Not Applicable,Observational,Burkina Faso,An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso,Other,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04445441,None
3623,NCT04445454,ClinicalTrials.gov,2020-06-19,2020-06-12,True,University of Liège,Recruiting,Phase 1/Phase 2,Interventional,Belgium,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04445454,None
3624,NCT04445467,ClinicalTrials.gov,2020-06-22,2020-07-01,False,Bayside Health,Not Recruiting,Phase 2,Interventional,No Country Given,An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection,Drug,Favipiravir,Favipiravir,190,https://clinicaltrials.gov/show/NCT04445467,None
3625,NCT04445493,ClinicalTrials.gov,2020-06-18,2020-07-01,False,"MindRhythm, Inc.",Not Recruiting,Not Applicable,Observational,No Country Given,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ),Other,Other,Other,250,https://clinicaltrials.gov/show/NCT04445493,None
3626,NCT04445506,ClinicalTrials.gov,2020-06-19,2020-04-01,True,The Miriam Hospital,Not Recruiting,Not Applicable,Observational,United States,Short Term Corticosteroids in SARS-CoV2 Patients,Drug,Corticosteroids,Dexamethasone,50,https://clinicaltrials.gov/show/NCT04445506,None
3627,NCT04445597,ClinicalTrials.gov,2020-06-22,2020-05-07,True,UZ Leuven,Recruiting,Not Applicable,Interventional,Belgium,Unraveling the Mechanisms of Olfactory Dysfunction in COVID-19,Clinical Presentation,No Intervention,No Intervention,8,https://clinicaltrials.gov/show/NCT04445597,None
3628,NCT04445610,ClinicalTrials.gov,2020-06-23,2020-07-01,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,ATMP,Vaccine,Vaccine,60,https://clinicaltrials.gov/show/NCT04445610,None
3629,NCT04445623,ClinicalTrials.gov,2020-06-04,2020-07-01,False,AOUI Verona,Not Recruiting,Phase 3,Interventional,Italy,Prasugrel in Severe COVID-19 Pneumonia,Drug,Prasugrel,Prasugrel,128,https://clinicaltrials.gov/show/NCT04445623,None
3630,NCT04445870,ClinicalTrials.gov,2020-06-23,2020-05-01,True,CHU de Reims,Recruiting,Not Applicable,Observational,France,Dramatic Changes in Oncology Care Pathway During COVID-19 Pandemic : The French ONCOCARE-COV Study,Health System,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04445870,None
3631,NCT04445935,ClinicalTrials.gov,2020-06-23,2020-06-28,False,Hamad Medical Corporation,Recruiting,Phase 4,Interventional,Qatar,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,Drug,Bivalirudin,Bivalirudin,100,https://clinicaltrials.gov/show/NCT04445935,None
3632,NCT04445961,ClinicalTrials.gov,2020-06-22,2020-05-01,True,I.M. Sechenov First Moscow State Medical University,Recruiting,Not Applicable,Observational,Russian Federation,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04445961,None
3633,NCT04446065,ClinicalTrials.gov,2020-06-23,2020-07-30,False,MELISA Institute Genomics & Proteomics Research SpA,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Protection of Health Workers Against COVID-19,Drug (Chemoprophylaxis),Epigallocatechin gallate,Epigallocatechin gallate,524,https://clinicaltrials.gov/show/NCT04446065,None
3634,NCT04446104,ClinicalTrials.gov,2020-05-11,2020-05-13,False,"National University Hospital, Singapore",Recruiting,Phase 3,Interventional,Singapore,A Preventive Treatment for Migrant Workers at High-risk of Covid-19,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Ivermectin vs. Zinc + Vitamin C vs. Povidone Iodine vs. Vitamin C,Hydroxychloroquine; Ivermectin; Zinc; Vitamin C; Povidone Iodine,5000,https://clinicaltrials.gov/show/NCT04446104,None
3635,NCT04446169,ClinicalTrials.gov,2020-06-20,2020-07-12,False,University of Florence,Recruiting,Not Applicable,Observational,Italy,COVID-19 (SARS-CoV-2) in Urine and Semen,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04446169,None
3636,NCT04446286,ClinicalTrials.gov,2020-06-23,2020-06-18,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With SARS-CoV-2,Drug,Oxygen,Oxygen,50,https://clinicaltrials.gov/show/NCT04446286,None
3637,NCT04446338,ClinicalTrials.gov,2020-06-22,2020-05-13,True,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04446338,None
3638,NCT04446377,ClinicalTrials.gov,2020-06-23,2020-06-29,False,"AI Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,United States,A Study of LAM-002A for the Prevention of Progression of COVID-19,Drug,Apilimod Dimesylate,Apilimod Dimesylate,142,https://clinicaltrials.gov/show/NCT04446377,None
3639,NCT04446429,ClinicalTrials.gov,2020-06-22,2020-06-26,False,"Applied Biology, Inc.",Not Recruiting,Not Applicable,Interventional,Brazil,Anti-Androgen Treatment for COVID-19,Drug,Ivermectin + Azythromycin + Dutasteride vs. Ivermectin + Azythromycin,Ivermectin; Azythromycin; Dutasteride,254,https://clinicaltrials.gov/show/NCT04446429,None
3640,NCT04447131,ClinicalTrials.gov,2020-06-17,2020-04-29,True,University of São Paulo,Recruiting,Not Applicable,Observational,Brazil,Effect of COVID-19 on Platelet Aggregation,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04447131,None
3641,NCT04447144,ClinicalTrials.gov,2020-06-23,2020-06-01,True,Cairo University,Recruiting,Not Applicable,Observational,Egypt,"Nutritional Habits, and COVID-19 Outcome",Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04447144,None
3642,NCT04447209,ClinicalTrials.gov,2020-06-17,2020-06-06,True,University of Malaya,Recruiting,Not Applicable,Observational,Malaysia,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,Other,Other,Other,300,https://clinicaltrials.gov/show/NCT04447209,None
3643,NCT04447222,ClinicalTrials.gov,2020-06-11,2020-05-12,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors,Other (psych),No Intervention,No Intervention,1242,https://clinicaltrials.gov/show/NCT04447222,None
3644,NCT04447235,ClinicalTrials.gov,2020-06-22,2020-07-01,False,Instituto do Câncer do Estado de São Paulo,Not Recruiting,Phase 2,Interventional,No Country Given,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,Drug,Ivermectin + Losartan,Ivermectin; Losartan,176,https://clinicaltrials.gov/show/NCT04447235,None
3645,NCT04447469,ClinicalTrials.gov,2020-06-23,2020-06-01,True,"Kiniksa Pharmaceuticals, Ltd.",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,573,https://clinicaltrials.gov/show/NCT04447469,None
3646,NCT04447495,ClinicalTrials.gov,2020-06-23,2020-07-01,False,Medical College of Wisconsin,Not Recruiting,Not Applicable,Observational,No Country Given,Self-sampling for the Study of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04447495,None
3647,NCT04447534,ClinicalTrials.gov,2020-06-23,2020-06-23,False,Tanta University,Recruiting,Phase 3,Interventional,Egypt,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,Drug,Chloroquine + Zinc vs. Chloroquine,Chloroquine; Zinc,200,https://clinicaltrials.gov/show/NCT04447534,None
3648,NCT04447638,ClinicalTrials.gov,2020-06-24,2020-03-20,True,Çanakkale Onsekiz Mart University,Not Recruiting,Not Applicable,Observational,Turkey,Percutaneous Tracheostomy With COVID-19,Procedure,Tracheostomy,Tracheostomy,12,https://clinicaltrials.gov/show/NCT04447638,None
3649,NCT04448054,ClinicalTrials.gov,2020-06-23,2020-05-20,True,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Observational,France,"Imaging Covid Involvement of Leptomeninges, Olfactory and Limbic Areas",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04448054,None
3650,NCT04448119,ClinicalTrials.gov,2020-06-24,2020-06-01,True,Appili Therapeutics Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Control of COVID-19 Outbreaks in Long Term Care,Drug,Favipiravir,Favipiravir,760,https://clinicaltrials.gov/show/NCT04448119,None
3651,NCT04448145,ClinicalTrials.gov,2020-06-24,2020-03-26,True,Columbia University,Recruiting,Not Applicable,Observational,United States,Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04448145,None
3652,NCT04448405,ClinicalTrials.gov,2020-06-19,2020-06-18,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Covid-19 Lockdown and Deviant Sexual Fantasies,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04448405,None
3653,NCT04448418,ClinicalTrials.gov,2020-06-01,2020-05-20,True,Unità Operativa Complessa Ostetricia e Ginecologia,Recruiting,Not Applicable,Observational,Italy,The Impact of COVID-19 Outbreak on Trans-population's Health in Italy,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04448418,None
3654,NCT04448704,ClinicalTrials.gov,2020-06-25,2020-06-22,True,Yale-NUS College,Recruiting,Not Applicable,Observational,Singapore,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04448704,None
3655,NCT04448717,ClinicalTrials.gov,2020-06-18,2020-06-16,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04448717,None
3656,NCT04448743,ClinicalTrials.gov,2020-06-22,2020-06-01,True,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Role of Microparticles in Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,175,https://clinicaltrials.gov/show/NCT04448743,None
3657,NCT04448756,ClinicalTrials.gov,2020-06-25,2020-06-27,False,Merck KGaA,Not Recruiting,Phase 2,Interventional,United States,M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia,Drug,M5049,M5049,150,https://clinicaltrials.gov/show/NCT04448756,None
3658,NCT04448769,ClinicalTrials.gov,2020-06-23,2020-06-01,True,CHU de Nancy,Not Recruiting,Not Applicable,Interventional,No Country Given,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04448769,None
3659,NCT04448782,ClinicalTrials.gov,2020-06-17,2020-03-09,True,Corporació Sanitària Parc Taulí ,Recruiting,Not Applicable,Observational,Spain,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04448782,None
3660,NCT04449042,ClinicalTrials.gov,2020-06-22,2020-04-01,True,Boston Children's Hospital,Recruiting,Not Applicable,Observational,United States,The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry,Clinical Presentation,No Intervention,No Intervention,15000,https://clinicaltrials.gov/show/NCT04449042,None
3661,NCT04449081,ClinicalTrials.gov,2020-06-25,2020-04-25,True,Melaka Manipal Medical College,Not Recruiting,Not Applicable,Observational,Malaysia,"Knowledge, Attitude and Practice of Dental Students About COVID-19",Other,No Intervention,No Intervention,215,https://clinicaltrials.gov/show/NCT04449081,None
3662,NCT04449094,ClinicalTrials.gov,2020-06-25,2020-02-28,True,CHU de Nice,Not Recruiting,Not Applicable,Observational,France,Emergence of the COVID 19 Epidemic in the City of Nice,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04449094,None
3663,NCT04449276,ClinicalTrials.gov,2020-06-18,2020-06-17,True,CureVac AG,Recruiting,Phase 1,Interventional,Germany,"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",ATMP,Vaccine,Vaccine,168,https://clinicaltrials.gov/show/NCT04449276,None
3664,NCT04449380,ClinicalTrials.gov,2020-06-23,2020-07-01,False,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,Italy,Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients,Drug,Interferon beta,Interferon beta,126,https://clinicaltrials.gov/show/NCT04449380,None
3665,ACTRN12620000688987,ANZCTR,2020-06-19,2020-06-02,True,The Royal Melbourne Hospital,Not Recruiting,Not Applicable,Interventional,Australia,"Comparing the user seal check and fit test between two types of N95 respirators - the Halyard N95 Particulate Filter Respirators and the ProShield® N-95 masks
",Other (device),Mask,Mask,80,https://anzctr.org.au/ACTRN12620000688987.aspx,None
3666,ACTRN12620000698976,ANZCTR,2020-06-23,2020-06-10,True,Royal Prince Alfred Hopsital,Recruiting,Not Applicable,Interventional,Australia,Maintaining the health of people with and without COVID-19 during isolation,Other,Other,Other,40,https://anzctr.org.au/ACTRN12620000698976.aspx,None
3667,ACTRN12620000692932,ANZCTR,2020-06-22,2020-06-24,False,University of Adelaide,Not Recruiting,Not Applicable,Observational,United States,Atrial Fibrillation in Patients with an Implantable Cardiac Device during the COVID-19 Pandemic,Other,No Intervention,No Intervention,10000,https://anzctr.org.au/ACTRN12620000692932.aspx,None
3668,ACTRN12620000707965,ANZCTR,2020-06-29,2020-06-30,False,Accelagen Pty Ltd,Not Recruiting,Phase 3,Interventional,Australia,"A Placebo-Controlled Study to Evaluate the effect of the recombinant Bacillus Calmette–Guérin (BCG) vaccine VPM1002 on the Incidence or Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Participants in Australia
",ATMP,Vaccine,Vaccine,3468,https://anzctr.org.au/ACTRN12620000707965.aspx,None
3669,ACTRN12620000702910,ANZCTR,2020-06-26,2020-06-29,False,Austin Health,Not Recruiting,Not Applicable,Observational,Australia,Fit testing of N95 filtering facepieces for anaesthetists and nurses treating COVID-19 patients,Other (device),Mask,Mask,60,https://anzctr.org.au/ACTRN12620000702910.aspx,None
3670,ISRCTN13990999,ISRCTN,2020-06-24,2020-04-03,True,IRCCS Don Calabria Ospedale Sacro Cuore,Not Recruiting,Not Applicable,Observational,Italy,A diagnostic study comparing different tests for the diagnosis of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,http://isrctn.com/ISRCTN13990999,None
3671,ISRCTN12394803,ISRCTN,2020-06-22,2020-04-27,True,Imperial College London,Recruiting,Not Applicable,Observational,"Austria, Gambia, Spain, Netherlands, Slovenia, Greece, Italy, Taiwan, Nepal, Germany, Switzerland, France, Latvia, United Kingdom","DIAMONDS-SEARCH study: Designing new tests that can diagnose the causes of fever, including COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,http://isrctn.com/ISRCTN12394803,None
3672,ISRCTN60400862,ISRCTN,2020-06-22,2020-05-15,True,Abbott,Recruiting,Not Applicable,Observational,United Kingdom,"Evaluation of a COVID-19 antibody test: What is the performance of the Panbio™ COVID-19 IgG/IgM rapid test device in fingerstick blood, venous whole blood, serum and plasma in adult participants?",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,206,http://isrctn.com/ISRCTN60400862,None
3673,ISRCTN13471603,ISRCTN,2020-06-17,2020-06-08,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Management of patients with heart failure with preserved ejection fraction: what do patients and providers need and want?,Other,Other,Other,50,http://isrctn.com/ISRCTN13471603,None
3674,ISRCTN54917435,ISRCTN,2020-06-15,2020-06-25,False,Uppsala County Council,Recruiting,Not Applicable,Interventional,Sweden,Could prone positioning increase lung function for patients with severe COVID-19 infection?,Procedure,Positioning,Positioning,240,http://isrctn.com/ISRCTN54917435,None
3675,ISRCTN15475176,ISRCTN,2020-06-10,2020-05-24,True,King Saud Medical City,Recruiting,Not Applicable,Observational,Saudi Arabia,A Saudi Arabia based study into the impact of coronavirus infection on the nervous system,Clinical Presentation,No Intervention,No Intervention,1000,http://isrctn.com/ISRCTN15475176,None
3676,ISRCTN17072692,ISRCTN,2020-06-04,2020-06-08,False,Imperial College London,Recruiting,Phase 1,Interventional,United Kingdom,Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women,ATMP,Vaccine,Vaccine,320,http://isrctn.com/ISRCTN17072692,None
3677,ISRCTN69546370,ISRCTN,2020-06-02,2020-06-08,False,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,Best available treatment study for inflammatory conditions associated with COVID-19,Clinical Presentation,No Intervention,No Intervention,1800,http://isrctn.com/ISRCTN69546370,None
3678,ISRCTN86534580,ISRCTN,2020-03-22,2020-03-25,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,PRINCIPLE: A trial evaluating treatments for suspected COVID-19 in people aged 50 years and above with pre-existing conditions and those aged 65 years and above,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,http://isrctn.com/ISRCTN86534580,EUCTR2020-001209-22
3679,ISRCTN37530113,ISRCTN,2020-01-31,2017-09-04,True,Central Norway Regional Health Authority,Recruiting,Not Applicable,Interventional,Norway,Enhanced cognitive behavioral therapy for children and adolescents with obsessive compulsive disorder: an open trial,Other (psych),Psychological,Psychological,70,http://isrctn.com/ISRCTN37530113,None
3680,ISRCTN18274006,ISRCTN,2019-07-29,2018-09-25,True,Academic and Clinical Central Office for Research and Development (ACCORD),Recruiting,Not Applicable,Observational,United Kingdom,Understanding cognitive decline after stroke and the impact of COVID-19,Pre 2020,Pre 2020,Pre 2020,2000,http://isrctn.com/ISRCTN18274006,None
3681,ISRCTN55201674,ISRCTN,2018-09-24,2018-08-06,True,Salford Royal NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,B-cells in stroke-associated infection,Pre 2020,Pre 2020,Pre 2020,130,http://isrctn.com/ISRCTN55201674,None
3682,ChiCTR2000034164,ChiCTR,2020-06-27,2020-07-08,False,Chinese Academy of Sciences,Not Recruiting,Not Applicable,Interventional,China,Trauma Healing Project Based on Chinese Mind-Body Wisdom in the novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,340,http://www.chictr.org.cn/showproj.aspx?proj=55154,None
3683,ChiCTR2000034112,ChiCTR,2020-06-24,2020-06-25,False,Shulan (Hangzhou) Hospital; Center for Disease Control and Prevention of Guangxi Zhuang Autonomous Region,Not Recruiting,Phase 1,Prevention,China,"A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18-59 years and 60 years and above",ATMP,Vaccine,Vaccine,168,http://www.chictr.org.cn/showproj.aspx?proj=55524,None
3684,ChiCTR2000034076,ChiCTR,2020-06-22,2020-05-23,True,Beijing TIL Therapeutics,Recruiting,Not Applicable,Interventional,China,Novel coronavirus pneumonia (COVID-19) loaded autologous dendritic cell trial,ATMP,Cells (dendritic),Cells (dendritic),25,http://www.chictr.org.cn/showproj.aspx?proj=55582,None
3685,ChiCTR2000029589,ChiCTR,2020-02-05,2020-02-06,False,Beijing Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A prospective, randomized,open, multi-center clinical trial evaluating  the efficiency and safety of Reduning injection  in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49104,None
3686,EUCTR2020-001767-86-IE,EU Clinical Trials Register,2020-04-15,2020-06-25,False,University College Dublin,Authorised,Phase 2,Interventional,Ireland,trial comparing different doses of single-dose tocilizumab in adults with severe COVID-19 infection,Drug,Tocilizumab,Tocilizumab,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001767-86,None
3687,EUCTR2020-001777-71-GB,EU Clinical Trials Register,2020-04-30,2020-05-06,False,Guy's and St Thomas' NHS Foundation Trust,Authorised,Phase 4,Interventional,United Kingdom,Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patients,Drug,Ruxolitinib,Ruxolitinib,59,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001777-71,None
3688,EUCTR2020-001745-40-IT,EU Clinical Trials Register,2020-06-24,2020-04-23,True,ASST Fatebenefratelli Sacco,Authorised,Phase 2,Interventional,Italy,PILOT STUDY ON THE USE OF SARILUMAB IN PATIENTS WITH COVID-19 INFECTION,Drug,Sarilumab,Sarilumab,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001745-40,None
3689,EUCTR2020-001501-24-IT,EU Clinical Trials Register,2020-06-24,2020-04-28,True,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Authorised,Phase 2,Interventional,Italy,PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19),Drug (+ Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001501-24,None
3690,EUCTR2020-001390-76-IT,EU Clinical Trials Register,2020-06-24,2020-04-27,True,IRCCS Istituto Nazionale per le Malattie Infettive “Lazzaro Spallanzani”,Authorised,Phase 3,Interventional,Italy,"A phase 3, randomized, open-labeled, multi-center study comparing clinical efficacy and safety of intravenous sarilumab plus standard of care compared to standard of care, in the treatment of patients with severe COVID-19 pneumonia .",Drug,Sarilumab,Sarilumab,171,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001390-76,None
3691,EUCTR2020-001528-32-IT,EU Clinical Trials Register,2020-06-24,2020-05-14,True,IRCCS Istituto Nazionale per le Malattie Infettive “Lazzaro Spallanzani”,Authorised,Phase 3,Interventional,Italy,Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antivirals,Drug,Lopinavir/ritonavir vs. Hydroxychloroquine vs. Darunavir vs. Favipiravir,Lopinavir/ritonavir; Hydroxychloroquine; Darunavir; Favipiravir,435,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001528-32,None
3692,EUCTR2020-001987-28-IT,EU Clinical Trials Register,2020-06-24,2020-05-06,True,IRCCS Ospedale San Raffaele,Authorised,Phase 3,Interventional,Italy,PRECOV: a randomized controlled clinical trial on the effects of hydroxychloroquine in the prevention of COVID-19 in healthcare workers at risk,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001987-28,None
3693,EUCTR2020-001172-15-DE,EU Clinical Trials Register,2020-03-23,2020-04-08,False,Apeiron Biologics,Authorised,Phase 2,Interventional,"United States, Denmark, Russian Federation, Germany, Austria, United Kingdom",Recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treat-ment for patients with COVID-19,Drug,ACE enzyme,ACE enzyme,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001172-15,None
3694,EUCTR2020-001921-30-IT,EU Clinical Trials Register,2020-06-26,2020-05-14,True,AOU di Modena,Authorised,Phase 3,Interventional,Italy,"Steroids and unfractionated heparin in critically-ill patients with pneumonia from COVID-19 infection. A multicenter, interventional, randomized, three arms study design.",Drug,"Corticosteroids, Heparin",Methylprednisolone; Heparin,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001921-30,None
3695,EUCTR2020-001795-15-IT,EU Clinical Trials Register,2020-06-26,2020-05-07,True,IRCCS Ospedale San Raffaele,Authorised,Phase 2,Interventional,Italy,Clinical study aimed to verify the efficacy and safety of mavrilimumab in COVID-19-associated pneumonia in patients who have signs of excessive inflammation,Drug,Mavrilimumab,Mavrilimumab,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001795-15,None
3696,EUCTR2020-001854-23-IT,EU Clinical Trials Register,2020-06-26,2020-04-27,True,Società Italiana di Malattie Infettive e Tropicali,Authorised,Phase 2/Phase 3,Interventional,Italy,A study with immunotherapy for Moderate COVID-19,Drug,Tocilizumab vs. Hydroxychloroquine vs. Siltuximab vs. Canakinumab vs. Sarilumab vs. Baricitinib vs. Methylprednisolone,Tocilizumab; Hydroxychloroquine; Siltuximab; Canakinumab; Sarilumab; Baricitinib; Methylprednisolone,1400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001854-23,None
3697,EUCTR2020-001558-23-IT,EU Clinical Trials Register,2020-06-26,2020-04-09,True,Azienda Sanitaria Unica Regionale (ASUR),Authorised,Phase 3,Interventional,Italy,Hydroxychloroquine sulfate early administration in symptomatic out of hospital COVID-19 positive patients. Hydro-Stop-COVID19 Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001558-23,None
3698,NL8536,Netherlands Trial Register,2020-04-15,2020-04-28,False,Zuyderland Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Neurological Manifestations of COVID-19 and Indications of an Association with Respiratory Failure,Clinical Presentation,No Intervention,No Intervention,285,https://trialregister.nl/trial/8536,None
3699,NL8512,Netherlands Trial Register,2020-04-02,2020-03-18,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,"The use of ACE2 receptor increasing medication at hospital admission and
mortality rates in COVID-19 patiënts 
",Drug,ACE inhibitors,ACE inhibitors,400,https://trialregister.nl/trial/8512,None
3700,NL8551,Netherlands Trial Register,2020-04-23,2020-04-23,False,Zuyderland Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Covid High-intensity Immunosuppression in Cytokine release syndrome,Drug,Corticosteroids + Tocilizumab,Methylprednisolone; Tocilizumab,160,https://trialregister.nl/trial/8551,None
3701,NL8501,Netherlands Trial Register,2020-04-01,2020-03-23,True,Interactive Studios,Recruiting,Not Applicable,Observational,Netherlands,"Using eHealth to support COVID-19 education, self-assessment and symptom tracking.",Other (software),eHealth,eHealth,2000,https://trialregister.nl/trial/8501,None
3702,NL8522,Netherlands Trial Register,2020-04-12,2020-04-08,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,The Digital Doc in the Emergency Department: The solution for patient care in the Covid-19 pandemic?,Telehealth,Telehealth,Telehealth,50,https://trialregister.nl/trial/8522,None
3703,NL8523,Netherlands Trial Register,2020-04-13,2020-04-26,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,Volatile Anaesthetics in COVID-19 – a pilot study,Drug,Isoflurane,Isoflurane,20,https://trialregister.nl/trial/8523,None
3704,NL8562,Netherlands Trial Register,2020-04-21,2020-04-01,True,None (investigator initiated study),Not Recruiting,Not Applicable,Observational,Netherlands,Bioelectric Impedance Analysis in COVID-19 positive patients. A prospective prevalence study,Clinical Presentation,No Intervention,No Intervention,50,https://trialregister.nl/trial/8562,None
3705,NL8563,Netherlands Trial Register,2020-04-22,2020-04-22,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Patient’s knowledge And behavior oN the COVID-19 disease and as DEterMInants of Contamination,Other,No Intervention,No Intervention,170,https://trialregister.nl/trial/8563,None
3706,NL8570,Netherlands Trial Register,2020-04-29,2020-05-10,False,Franciscus Gasthuis & Vlietland,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 infections in health care workers,Clinical Presentation,No Intervention,No Intervention,300,https://trialregister.nl/trial/8570,None
3707,NL8529,Netherlands Trial Register,2020-04-14,2020-05-01,False,MCC Omnes (Sittard),Not Recruiting,Not Applicable,Observational,Netherlands,General practice cooperative COVID-19 centre Urmond,Health System,No Intervention,No Intervention,2000,https://trialregister.nl/trial/8529,None
3708,NL8572,Netherlands Trial Register,2020-04-30,2020-04-19,True,University Medical Center Groningen,Recruiting,Not Applicable,Observational,Netherlands,Prevalence of asymptomatic deep vein thrombosis in admitted COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,100,https://trialregister.nl/trial/8572,None
3709,NL8576,Netherlands Trial Register,2020-04-20,2020-04-20,False,Franciscus Gasthuis & Vlietland,Not Recruiting,Not Applicable,Observational,Netherlands,Effect van COVID-19 op kwaliteit van leven bij astma,Other (psych),No Intervention,No Intervention,80,https://trialregister.nl/trial/8576,None
3710,NL8521,Netherlands Trial Register,2020-04-13,2020-05-08,False,UMC Amsterdam,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,Drug,Oxygen,Oxygen,13,https://trialregister.nl/trial/8521,None
3711,NL8580,Netherlands Trial Register,2020-04-28,2020-04-28,False,No Sponsor Name Given,Recruiting,Not Applicable,Unknown,Netherlands,Metabolic syndrome And Severity of Covid-19,Clinical Presentation,No Intervention,No Intervention,100,https://trialregister.nl/trial/8580,None
3712,NL8578,Netherlands Trial Register,2020-05-02,2020-07-13,False,Rode Kruis Ziekenhuis Beverwijk,Not Recruiting,Not Applicable,Interventional,Netherlands,Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19),Drug,Alkaline phosphatase,Alkaline phosphatase,124,https://trialregister.nl/trial/8578,None
3713,NL8577,Netherlands Trial Register,2020-05-06,2020-05-15,False,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,eHealth,394,https://trialregister.nl/trial/8577,None
3714,NL8587,Netherlands Trial Register,2020-05-06,2020-05-07,False,CIRO,Recruiting,Not Applicable,Observational,Netherlands,Quality of life in COVID-19 survivors,Other (psych),No Intervention,No Intervention,500,https://trialregister.nl/trial/8587,None
3715,NL8589,Netherlands Trial Register,2020-05-07,2020-04-23,True,Dr. L.G. Visser,Recruiting,Not Applicable,Observational,Netherlands,Biomarker-based Early Anti-inflammatory Therapy for severe COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://trialregister.nl/trial/8589,None
3716,NL8528,Netherlands Trial Register,2020-04-15,2020-04-22,False,UMC Utrecht,Not Recruiting,Not Applicable,Observational,Netherlands,Control of COVID-19 in hospitals,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://trialregister.nl/trial/8528,None
3717,NL8535,Netherlands Trial Register,2020-04-15,2020-03-30,True,CIRO,Recruiting,Not Applicable,Observational,Netherlands,Functional status and health status in COVID-19 patients pre and post rehabilitation,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,https://trialregister.nl/trial/8535,None
3718,NL8538,Netherlands Trial Register,2020-04-17,2020-04-17,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Netherlands,Sleep position related to hospital length of stay in admitted COVID-19 patients,Procedure,Positioning,Positioning,342,https://trialregister.nl/trial/8538,None
3719,NL8513,Netherlands Trial Register,2020-04-07,2020-04-13,False,Reade Research BV,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in rheumatic patients: a prospective cohort study,Clinical Presentation,No Intervention,No Intervention,8000,https://trialregister.nl/trial/8513,None
3720,NL8609,Netherlands Trial Register,2020-05-11,2020-05-25,False,Radboud University Medical Centre,Not Recruiting,Not Applicable,Interventional,Netherlands,Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS),ATMP,Vaccine,Vaccine,100,https://trialregister.nl/trial/8609,None
3721,NL8613,Netherlands Trial Register,2020-05-12,2020-03-23,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort; MaastrICCht.,Clinical Presentation,No Intervention,No Intervention,250,https://trialregister.nl/trial/8613,None
3722,NL8543,Netherlands Trial Register,2020-04-18,2020-04-14,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,COVID19 ultrasound triage,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://trialregister.nl/trial/8543,None
3723,NL8625,Netherlands Trial Register,2020-05-15,2020-05-15,False,UMC Utrecht,Recruiting,Not Applicable,Observational,Netherlands,Hocus POCUS: a tool for increasing the efficiency of diagnosing venous thromboembolic disease in critically ill COVID-19 patients?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://trialregister.nl/trial/8625,None
3724,NL8547,Netherlands Trial Register,2020-04-22,2020-04-16,True,Radboud University Medical Centre,Recruiting,Not Applicable,Interventional,Netherlands,"REDUCING HOSPITAL ADMISSION OF ELDERLY IN SARS-CoV-2 PANDEMIC VIA THE INDUCTION OF TRAINED IMMUNITY BY BACILLUS CALMETTE-GUÉRIN VACCINATION, A RANDOMIZED CONTROLLED TRIAL",ATMP,Vaccine,Vaccine,1600,https://trialregister.nl/trial/8547,EUCTR2020-001591-15
3725,NL8627,Netherlands Trial Register,2020-05-18,2020-03-01,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Netherlands,Association of BMI with COVID-19 incidence and severity,Clinical Presentation,No Intervention,No Intervention,200,https://trialregister.nl/trial/8627,None
3726,NL8633,Netherlands Trial Register,2020-05-13,2020-05-13,False,Leiden University Medical Center,Recruiting,Not Applicable,Interventional,Netherlands,"A randomized, double blinded clinical trial of convalescent plasma compared to standard plasma for treatment of hospitalized non-ICU patients with COVID-19 infections",ATMP,Plasma,Plasma,430,https://trialregister.nl/trial/8633,None
3727,NL8645,Netherlands Trial Register,2020-05-19,2020-03-23,True,UMC Amsterdam,Recruiting,Not Applicable,Observational,Netherlands,Sero-surveillance SARS-CoV-2,Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,https://trialregister.nl/trial/8645,None
3728,NL8668,Netherlands Trial Register,2020-05-28,2020-05-28,False,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Observational,Netherlands,Lifestyle of pregnant women during COVID-19 pandemic,Other,No Intervention,No Intervention,20,https://trialregister.nl/trial/8668,None
3729,NL8473,Netherlands Trial Register,2020-03-23,2020-03-23,False,National Institute for Public Health and the Environment (RIVM),Recruiting,Not Applicable,Observational,Netherlands,Immunity against SARS-CoV-2 in Dutch population,Clinical Presentation,No Intervention,No Intervention,7000,https://trialregister.nl/trial/8473,None
3730,NL8490,Netherlands Trial Register,2020-03-31,2020-04-12,False,UMC Utrecht,Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",Drug,Chloroquine vs. hydroxychloroquine,Chloroquine; hydroxychloroquine,950,https://trialregister.nl/trial/8490,None
3731,NL8526,Netherlands Trial Register,2020-04-14,2020-04-26,False,Zuyderland Medical Centre,Not Recruiting,Not Applicable,Observational,Netherlands,Neuroinvasion in COVID-19,Clinical Presentation,No Intervention,No Intervention,10,https://trialregister.nl/trial/8526,None
3732,NL8685,Netherlands Trial Register,2020-05-10,2020-05-18,False,KNVB,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in professional soccer players (COPROS study),Clinical Presentation (Epidemiology),No Intervention,No Intervention,140,https://trialregister.nl/trial/8685,None
3733,NL8694,Netherlands Trial Register,2020-06-10,2020-04-17,True,Leiden University Medical Center,Recruiting,Not Applicable,Observational,Netherlands,Prospective diagnosis of Covid-19 ïnfectionusing exhaled breath analysis by electronic nose,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://trialregister.nl/trial/8694,None
3734,NL8706,Netherlands Trial Register,2020-06-09,2020-03-01,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Extracorporeal membrane oxygenation in patients with coronavirus disease 2019,Drug,Oxygen,Oxygen,200,https://trialregister.nl/trial/8706,None
3735,NL8705,Netherlands Trial Register,2020-06-04,2020-06-04,False,CIRO,Recruiting,Not Applicable,Observational,Netherlands,Quality of life in patients with suspected COVID-19,Other (psych),No Intervention,No Intervention,10000,https://trialregister.nl/trial/8705,None
3736,NL8710,Netherlands Trial Register,2020-06-12,2020-07-01,False,Erasmus MC,Not Recruiting,Not Applicable,Observational,Netherlands,"COVID-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: a combined rehabilitation, pulmonary, and intensive care perspective",Clinical Presentation,No Intervention,No Intervention,335,https://trialregister.nl/trial/8710,None
3737,NL8714,Netherlands Trial Register,2020-06-12,2020-08-01,False,ZonMw,Not Recruiting,Not Applicable,Observational,Netherlands,"The impact of COVID-19 among illiterate people and people with a mild intellectual disabilities: preventative measures, (mental) health and support needs",Other (psych),No Intervention,No Intervention,1000,https://trialregister.nl/trial/8714,None
3738,NL8729,Netherlands Trial Register,2020-06-26,2020-08-01,False,UMC Utrecht,Not Recruiting,Not Applicable,Observational,Netherlands,Primary care Research on Outcomes of COVID-19,Clinical Presentation,No Intervention,No Intervention,274,https://trialregister.nl/trial/8729,None
3739,NL8460,Netherlands Trial Register,2020-03-16,2020-03-16,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Biomarkers for prognosis in critically ill COVID-19 patients : a prospective cohort study,Prognosis,No Intervention,No Intervention,100,https://trialregister.nl/trial/8460,None
3740,NL8483,Netherlands Trial Register,2020-03-26,2020-03-16,True,Fred Foundation; Noaber Foundation,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,Other,Other,Other,17000,https://trialregister.nl/trial/8483,None
3741,NL8485,Netherlands Trial Register,2020-03-27,2020-03-27,False,Maxima MC,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 during pregnancy: a prospective observational cohort,Clinical Presentation,No Intervention,No Intervention,20,https://trialregister.nl/trial/8485,None
3742,NL8491,Netherlands Trial Register,2020-03-31,2020-03-31,False,UMC Amsterdam,Recruiting,Not Applicable,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection (CounterCovid) study,Drug,Imatinib,Imatinib,386,https://trialregister.nl/trial/8491,None
3743,NL8497,Netherlands Trial Register,2020-03-31,2020-03-15,True,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound vs CT scan in COVID-19 disease,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://trialregister.nl/trial/8497,None
3744,NL8498,Netherlands Trial Register,2020-03-31,2020-03-15,True,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound (LUS) as a tool to determine the clinical course in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,20,https://trialregister.nl/trial/8498,None
3745,NCT04324606,ClinicalTrials.gov,2020-03-20,2020-04-23,True,University of Oxford,Not Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),ATMP,Vaccine,Vaccine,1090,https://clinicaltrials.gov/show/NCT04324606,EUCTR2020-001072-15; ISRCTN15281137
3746,NCT04381936,ClinicalTrials.gov,2020-05-07,2020-03-19,True,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Randomized Evaluation of COVID-19 Therapy,Drug,Lopinavir/ritonavir vs. corticosteroids vs. hydroxychloroquine vs. azithromycin vs. tocilizumab,Lopinavir/ritonavir; dexamethasone; hydrocortisone;  hydroxychloroquine; azithromycin; tocilizumab,12000,https://clinicaltrials.gov/ct2/show/NCT04381936,"EUCTR2020-001113-21, ISRCTN50189673"
3747,NCT04348305,ClinicalTrials.gov,2020-04-11,2020-04-17,True,Scandinavian Critical Care Trials Group,Not Recruiting,Phase 3,Interventional,Denmark,Hydrocortisone for COVID-19 and Severe Hypoxia,Drug,Corticosteroids,Hydrocortisone,1000,https://clinicaltrials.gov/ct2/show/NCT04348305,EUCTR2020-001395-15
3748,NCT04327388,ClinicalTrials.gov,2020-03-26,2020-03-28,True,Sanofi,Recruiting,Phase 3,Interventional,"Argentina, Brazil, Russian Federation, Chile, Germany, Spain, Italy, Japan, France, Israel, Canada",Sarilumab COVID-19,Drug,Sarilumab,Sarilumab,400,https://clinicaltrials.gov/ct2/show/NCT04327388,EUCTR2020-001162-12
3749,NCT04451083,ClinicalTrials.gov,2020-06-21,2020-07-01,False,Ono Pharmaceutical Co. Ltd,Recruiting,Phase 1,Interventional,Japan,Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects,Drug,Camostat Mesilate,Camostat Mesilate,Drug: FOY-305,14,JPRN-JapicCTI-205326
